data_1rgr_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1rgr _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.7 p90 . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 121.566 0.698 . . . . 0.0 109.782 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -100.47 136.81 39.77 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.432 -177.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -102.41 116.78 33.33 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.3 mp -130.91 111.96 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 -175.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.3 m -94.25 131.04 40.25 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 168.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.9 tt -134.86 141.87 46.47 Favored 'General case' 0 CA--C 1.556 1.206 0 CA-C-N 113.91 -1.495 . . . . 0.0 108.488 -173.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 . . . . . 0 N--CA 1.488 1.444 0 C-N-CA 123.293 0.637 . . . . 0.0 109.894 177.834 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 CA--C 1.558 1.281 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.464 ' HA3' ' H ' ' A' ' 104' ' ' ALA . . . 140.82 36.17 0.11 Allowed Glycine 0 CA--C 1.546 1.975 0 N-CA-C 116.848 1.499 . . . . 0.0 116.848 -166.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -137.25 175.82 9.26 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 174.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 45.7 m -149.05 119.15 7.19 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 119.919 -1.738 . . . . 0.0 107.775 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 pt -97.22 132.23 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.461 -172.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -79.5 -177.49 5.82 Favored 'General case' 0 CA--C 1.556 1.193 0 CA-C-O 123.478 1.608 . . . . 0.0 111.673 156.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.75 163.03 25.67 Favored Glycine 0 CA--C 1.54 1.599 0 CA-C-N 113.751 -1.568 . . . . 0.0 116.576 -149.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.2 -156.74 20.48 Favored Glycine 0 N--CA 1.471 1.02 0 CA-C-N 112.553 -1.824 . . . . 0.0 114.135 177.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.72 -43.05 76.19 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 115.799 1.778 . . . . 0.0 115.799 177.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -62.33 -38.34 89.1 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 117.536 2.421 . . . . 0.0 117.536 172.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -142.17 89.35 8.7 Favored Pre-proline 0 CA--C 1.553 1.068 1 N-CA-C 99.424 -4.287 . . . . 0.0 99.424 -168.265 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -100.31 130.73 0.16 Allowed 'Trans proline' 0 CA--C 1.548 1.193 0 CA-C-N 124.361 2.593 . . . . 0.0 110.655 -175.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 72.0 t60 . . . . . 0 CA--C 1.582 2.177 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 154.274 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo . . . . . 0 CA--C 1.548 1.225 0 CA-C-O 122.534 0.973 . . . . 0.0 110.969 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 75.7 m -145.3 128.75 16.95 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 -174.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.498 ' H ' ' HA ' ' A' ' 126' ' ' ARG . 24.6 mm -74.41 115.81 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 -177.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -104.26 155.95 18.31 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 113.044 -1.889 . . . . 0.0 107.446 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . 0.31 97.6 mt -96.28 120.0 45.07 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.688 0 N-CA-C 104.686 -2.339 . . . . 0.0 104.686 160.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 43.4 m -92.42 -25.0 18.68 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 120.57 -1.331 . . . . 0.0 113.486 168.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -138.66 150.74 46.55 Favored 'General case' 0 CA--C 1.56 1.331 0 CA-C-N 120.72 1.6 . . . . 0.0 110.473 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -99.32 126.23 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 104.762 -2.31 . . . . 0.0 104.762 170.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.25 28.7 mm -73.96 120.77 83.0 Favored Pre-proline 0 CA--C 1.571 1.755 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 176.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.64 132.12 22.85 Favored 'Trans proline' 0 C--N 1.368 1.586 0 C-N-CA 123.834 3.022 . . . . 0.0 113.045 -175.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 74.94 0.08 59.32 Favored Glycine 0 CA--C 1.551 2.323 0 N-CA-C 118.59 2.196 . . . . 0.0 118.59 -168.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -88.1 -162.38 38.04 Favored Glycine 0 CA--C 1.544 1.904 0 CA-C-N 119.161 1.481 . . . . 0.0 113.525 177.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.464 ' H ' ' HA3' ' A' ' 76' ' ' GLY . . . -57.24 -58.05 9.94 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -50.47 -45.68 56.36 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 117.843 2.534 . . . . 0.0 117.843 172.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.38 -40.53 73.92 Favored 'General case' 0 CA--C 1.56 1.341 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 177.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . 0.256 0.0 OUTLIER -72.14 -55.49 7.2 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 178.231 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.6 t70 . . . . . 0 CA--C 1.557 1.237 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -173.519 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 122.76 1.267 . . . . 0.0 114.39 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.7 m -85.67 104.87 15.79 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 112.568 -2.105 . . . . 0.0 107.455 -161.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . 0.336 11.0 tp -57.93 104.07 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.497 0 CA-C-O 122.339 1.066 . . . . 0.0 112.323 -170.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.428 ' HA ' ' CG ' ' A' ' 126' ' ' ARG 0.317 0.1 OUTLIER -82.9 -63.62 1.33 Allowed 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 112.602 -2.09 . . . . 0.0 110.413 -176.142 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -132.49 135.54 46.08 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 173.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 5.7 p -119.13 112.47 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 105.709 -1.959 . . . . 0.0 105.709 171.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.487 HD22 ' CB ' ' A' ' 140' ' ' ALA 0.27 23.2 m-80 77.7 -78.89 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 122.821 1.296 . . . . 0.0 109.966 -174.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -159.5 -12.94 0.06 Allowed 'General case' 0 CA--C 1.573 1.838 0 C-N-CA 127.399 2.28 . . . . 0.0 110.951 -176.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.4 t -68.25 134.83 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.394 0 C-N-CA 125.376 1.47 . . . . 0.0 110.124 175.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -87.17 97.04 10.54 Favored 'General case' 0 CA--C 1.553 1.068 0 CA-C-N 113.434 -1.712 . . . . 0.0 108.638 177.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . 0.325 2.9 m -97.11 -142.49 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.599 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.498 ' HA ' ' H ' ' A' ' 94' ' ' ILE 0.323 0.9 OUTLIER 71.82 -83.66 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 124.664 1.185 . . . . 0.0 111.2 -173.299 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.56 69.87 10.17 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 123.752 1.739 . . . . 0.0 109.406 177.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.1 m -143.72 166.49 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 -175.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 46.7 m -56.71 129.74 42.46 Favored 'General case' 0 CA--C 1.568 1.666 0 CA-C-N 112.96 -1.927 . . . . 0.0 109.639 150.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -48.49 -32.22 7.55 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 168.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.1 m -57.62 -45.03 85.89 Favored 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 168.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.36 -38.52 84.1 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 169.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -73.23 -44.29 59.79 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 116.914 2.19 . . . . 0.0 116.914 172.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.411 HG23 ' HB ' ' B' ' 6' ' ' VAL . 4.6 p -57.71 -44.93 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 168.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -60.0 -50.8 72.32 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-O 117.089 -1.434 . . . . 0.0 112.055 170.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.63 -31.91 69.94 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 117.939 2.57 . . . . 0.0 117.939 172.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 73.3 mt -59.26 -53.75 54.67 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 125.071 1.348 . . . . 0.0 113.619 164.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -68.6 -35.95 78.03 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 117.358 2.355 . . . . 0.0 117.358 172.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -64.09 -14.28 53.58 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 117.044 2.238 . . . . 0.0 117.044 169.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.487 ' CB ' HD22 ' A' ' 121' ' ' ASN . . . -54.99 -24.0 22.06 Favored 'General case' 0 CA--C 1.561 1.368 0 N-CA-C 118.756 2.873 . . . . 0.0 118.756 160.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 93.61 -125.99 8.45 Favored Glycine 0 N--CA 1.475 1.268 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 168.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.2 m -79.94 -3.36 47.86 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 168.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -149.93 106.8 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -166.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.4 m -81.74 117.55 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 124.192 0.997 . . . . 0.0 110.572 170.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 45.4 mtm180 -99.45 90.59 4.57 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 175.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 42.5 mt -94.25 128.52 40.76 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.322 -169.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -127.49 121.68 31.38 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 103.231 -2.877 . . . . 0.0 103.231 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 18.3 m -131.38 119.44 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 CA-C-N 119.815 1.189 . . . . 0.0 110.923 -163.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 122.378 1.085 . . . . 0.0 111.256 -176.967 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.558 1.273 0 CA-C-O 122.55 1.167 . . . . 0.0 111.406 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -138.31 128.18 25.34 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 170.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 20.7 ttpp -78.97 114.5 17.97 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.551 170.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 85.8 m -88.66 126.54 35.35 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 122.412 1.101 . . . . 0.0 109.059 175.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -80.66 133.8 35.77 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 113.886 -1.506 . . . . 0.0 108.502 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.411 ' HB ' HG23 ' A' ' 134' ' ' VAL . 7.6 p . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 -170.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 26.8 p90 . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -113.67 141.54 47.1 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.196 -172.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.9 117.7 34.7 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.3 mp -123.76 131.08 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 -174.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.0 m -101.15 127.13 47.85 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 162.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.0 tp -133.79 130.75 38.43 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 113.979 -1.464 . . . . 0.0 107.574 -176.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 . . . . . 0 N--CA 1.485 1.307 0 O-C-N 121.352 -0.842 . . . . 0.0 109.848 178.494 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.3 tt . . . . . 0 N--CA 1.48 1.075 0 CA-C-O 118.119 -0.943 . . . . 0.0 110.101 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.414 ' HA3' ' CA ' ' A' ' 103' ' ' GLY . . . 103.75 44.36 1.67 Allowed Glycine 0 CA--C 1.533 1.179 0 N-CA-C 117.392 1.717 . . . . 0.0 117.392 173.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -160.24 168.35 25.56 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.95 1.3 . . . . 0.0 108.487 176.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.0 m -131.81 119.7 21.62 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 120.622 -1.299 . . . . 0.0 111.068 -163.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.7 pt -95.51 129.22 45.93 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.279 -174.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.57 -173.92 4.35 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-O 123.299 1.523 . . . . 0.0 110.243 161.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.47 160.17 22.69 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 123.88 1.822 . . . . 0.0 116.046 -137.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -103.96 -162.0 24.77 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 111.26 -2.47 . . . . 0.0 115.449 -178.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 53.1 p -54.45 -40.16 68.12 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 116.395 1.998 . . . . 0.0 116.395 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -88.49 0.5 56.22 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 116.363 1.986 . . . . 0.0 116.363 175.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -163.27 87.84 1.27 Allowed Pre-proline 0 CA--C 1.557 1.242 0 N-CA-C 101.275 -3.602 . . . . 0.0 101.275 -176.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -97.5 143.19 0.67 Allowed 'Trans proline' 0 CA--C 1.549 1.265 0 CA-C-N 124.043 2.48 . . . . 0.0 111.073 -174.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 57.6 t60 . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 167.158 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo . . . . . 0 CA--C 1.545 1.039 0 CA-C-O 121.159 0.399 . . . . 0.0 112.371 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 67.9 m -154.93 109.52 2.99 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 17.6 mm -74.09 118.85 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 174.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.4 ' HB2' ' O ' ' A' ' 115' ' ' ASP . 2.2 p90 -143.65 134.05 24.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.148 -1.387 . . . . 0.0 108.255 -171.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 86.9 mt -83.31 121.75 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 177.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.8 m -96.9 -26.17 15.16 Favored 'General case' 0 CA--C 1.558 1.264 0 CA-C-N 112.659 -2.064 . . . . 0.0 113.501 173.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -132.45 158.37 42.2 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 123.903 1.811 . . . . 0.0 112.121 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -121.92 118.01 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 N-CA-C 102.622 -3.103 . . . . 0.0 102.622 177.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.262 1.6 mp -72.33 131.46 84.91 Favored Pre-proline 0 CA--C 1.567 1.621 0 CA-C-O 118.291 -0.861 . . . . 0.0 108.82 174.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -62.19 134.74 50.57 Favored 'Trans proline' 0 CA--C 1.555 1.547 0 C-N-CA 123.332 2.688 . . . . 0.0 113.531 172.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.18 12.69 84.38 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 117.349 1.7 . . . . 0.0 117.349 -161.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.414 ' CA ' ' HA3' ' A' ' 76' ' ' GLY . . . -93.87 166.52 27.55 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-O 122.203 0.891 . . . . 0.0 113.589 177.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.82 -39.79 76.28 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 116.6 2.074 . . . . 0.0 116.6 -175.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.85 -26.32 65.09 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 172.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.03 -52.39 17.19 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 162.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -58.59 -60.9 3.09 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 125.922 1.689 . . . . 0.0 114.312 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.8 t70 . . . . . 0 CA--C 1.552 1.027 0 C-N-CA 124.089 0.955 . . . . 0.0 110.885 175.789 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 95' ' ' PHE 0.315 11.9 t70 . . . . . 0 CA--C 1.535 0.385 0 CA-C-O 115.745 -2.074 . . . . 0.0 108.622 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 12.6 m -155.23 93.59 1.53 Allowed 'General case' 0 N--CA 1.48 1.037 0 O-C-N 125.47 1.731 . . . . 0.0 107.95 -173.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.4 tp -65.77 127.04 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-O 121.326 0.584 . . . . 0.0 109.967 175.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.517 ' HA ' ' HB3' ' A' ' 126' ' ' ARG 0.338 4.1 pp -96.31 -51.38 4.4 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 116.336 1.976 . . . . 0.0 116.336 171.631 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -135.93 138.56 42.49 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 103.637 -2.727 . . . . 0.0 103.637 -176.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 10.8 p -125.58 121.03 59.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 173.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.521 HD22 ' CB ' ' A' ' 140' ' ' ALA 0.31 38.6 m-80 80.88 -80.65 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 124.181 1.943 . . . . 0.0 109.474 -177.395 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -163.69 -17.37 0.03 OUTLIER 'General case' 0 CA--C 1.568 1.663 0 CA-C-N 110.322 -3.126 . . . . 0.0 109.893 -174.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.4 t -65.46 136.65 26.34 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.268 0 CA-C-O 123.568 1.651 . . . . 0.0 109.647 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -85.25 79.61 9.47 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 111.233 -2.712 . . . . 0.0 110.743 177.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . 0.264 1.2 m -87.03 -106.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 CA-C-O 116.672 -1.633 . . . . 0.0 107.883 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.609 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.254 25.0 ptt180 52.04 -88.87 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 116.604 2.075 . . . . 0.0 116.604 177.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.609 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 25.1 tt0 -86.53 72.77 10.21 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-O 123.259 1.504 . . . . 0.0 108.877 167.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.3 p -139.88 170.25 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 177.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 3.1 m -58.34 136.67 57.45 Favored 'General case' 0 CA--C 1.559 1.29 0 CA-C-N 114.062 -1.426 . . . . 0.0 111.739 159.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . 0.264 2.4 p-80 -46.79 -37.66 8.97 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 117.174 2.287 . . . . 0.0 117.174 171.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 53.6 p -56.33 -52.35 64.88 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 172.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.57 -36.48 78.61 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 173.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.12 -52.53 18.79 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 116.083 1.882 . . . . 0.0 116.083 172.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.9 p -53.43 -44.16 54.53 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.183 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 171.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -63.93 -48.77 75.26 Favored 'General case' 0 C--O 1.212 -0.878 0 CA-C-O 116.038 -1.934 . . . . 0.0 111.807 172.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.77 -28.67 70.14 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 117.384 2.365 . . . . 0.0 117.384 170.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -60.31 -53.98 51.13 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.008 1.323 . . . . 0.0 113.925 166.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -67.91 -39.15 83.63 Favored 'General case' 0 CA--C 1.569 1.691 0 N-CA-C 115.788 1.773 . . . . 0.0 115.788 171.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -74.05 0.31 14.1 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 116.866 2.173 . . . . 0.0 116.866 171.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.521 ' CB ' HD22 ' A' ' 121' ' ' ASN . . . -57.71 -6.75 0.56 Allowed 'General case' 0 CA--C 1.555 1.172 0 N-CA-C 119.317 3.08 . . . . 0.0 119.317 157.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.62 -137.98 16.38 Favored Glycine 0 C--N 1.345 1.072 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 174.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.9 m -79.34 -8.56 59.17 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 169.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -147.76 112.72 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 CA-C-O 123.674 1.702 . . . . 0.0 107.244 -165.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.424 ' HA ' ' HB2' ' A' ' 140' ' ' ALA . 4.3 t -101.55 114.1 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 112.411 -2.177 . . . . 0.0 106.814 -169.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 70.1 mtm180 -96.08 91.79 6.12 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -177.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 45.4 mt -90.88 136.91 32.76 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.033 -173.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -128.49 121.49 29.0 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 104.867 -2.272 . . . . 0.0 104.867 173.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -129.53 122.43 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 -173.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 56.4 ttm . . . . . 0 N--CA 1.477 0.916 0 O-C-N 124.442 1.088 . . . . 0.0 110.062 164.9 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.562 1.43 0 CA-C-O 122.948 1.356 . . . . 0.0 110.883 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -150.1 113.93 5.05 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 172.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -86.42 125.29 33.59 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.399 175.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 96.7 m -98.85 136.38 38.95 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-O 122.497 1.141 . . . . 0.0 110.008 176.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -84.95 129.19 34.84 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 113.508 -1.678 . . . . 0.0 108.198 173.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 p . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 177.499 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 33.3 p90 . . . . . 0 N--CA 1.48 1.057 0 CA-C-O 121.869 0.842 . . . . 0.0 109.975 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -109.99 131.87 54.67 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 114.389 -1.278 . . . . 0.0 108.223 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.89 126.19 37.86 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 114.362 -1.29 . . . . 0.0 109.294 176.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 40.9 mt -129.26 126.26 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 103.946 -2.613 . . . . 0.0 103.946 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.8 m -109.77 127.6 54.74 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 168.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.453 ' HB3' ' CG2' ' A' ' 144' ' ' VAL . 4.4 tp -127.44 162.11 27.14 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 113.347 -1.752 . . . . 0.0 107.396 175.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 . . . . . 0 N--CA 1.481 1.104 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.432 168.226 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.8 mp . . . . . 0 N--CA 1.48 1.054 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.424 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 129.97 50.4 0.12 Allowed Glycine 0 CA--C 1.54 1.61 0 C-N-CA 124.08 0.848 . . . . 0.0 114.526 -172.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.445 ' HA ' ' H ' ' A' ' 100' ' ' ILE . 36.8 p90 -151.88 158.36 43.11 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 165.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.1 m -96.05 154.0 17.47 Favored 'General case' 0 C--N 1.316 -0.888 0 O-C-N 119.569 -1.957 . . . . 0.0 110.533 171.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.423 HG21 HD13 ' A' ' 96' ' ' ILE . 2.5 pp -116.39 132.82 64.89 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-N 111.168 -2.742 . . . . 0.0 108.398 168.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.44 -171.3 3.29 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-O 123.613 1.673 . . . . 0.0 109.138 163.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.14 156.44 23.54 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 123.392 1.551 . . . . 0.0 115.251 -142.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.14 -158.58 23.19 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 111.955 -2.123 . . . . 0.0 113.643 -178.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 72.8 p -54.88 -41.55 70.99 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 117.736 2.495 . . . . 0.0 117.736 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -76.54 -13.59 60.07 Favored 'General case' 0 CA--C 1.568 1.663 0 N-CA-C 116.183 1.92 . . . . 0.0 116.183 172.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.31 82.0 6.51 Favored Pre-proline 0 CA--C 1.56 1.345 0 N-CA-C 102.557 -3.127 . . . . 0.0 102.557 -176.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -104.99 120.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.359 1.102 0 CA-C-N 124.976 2.813 . . . . 0.0 110.846 -169.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -179.447 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo . . . . . 0 CA--C 1.547 1.169 0 CA-C-O 122.507 0.961 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 66.8 m -155.7 127.65 7.51 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 103.83 -2.655 . . . . 0.0 103.83 -177.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 17.3 mm -76.28 122.3 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -110.02 151.06 27.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 113.057 -1.883 . . . . 0.0 107.936 178.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.423 HD13 HG21 ' A' ' 79' ' ' ILE . 20.6 mm -94.24 100.92 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.205 0 N-CA-C 102.979 -2.971 . . . . 0.0 102.979 165.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.2 t -80.82 -47.35 13.98 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 114.989 1.478 . . . . 0.0 114.989 -176.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . 0.277 10.4 ptmt -143.75 152.47 41.3 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 121.782 0.801 . . . . 0.0 111.727 -173.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.12 123.21 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 N-CA-C 103.886 -2.635 . . . . 0.0 103.886 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.445 ' H ' ' HA ' ' A' ' 77' ' ' PHE 0.267 1.7 mp -72.96 125.88 90.83 Favored Pre-proline 0 CA--C 1.566 1.576 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 173.137 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -60.95 129.52 29.18 Favored 'Trans proline' 0 C--N 1.364 1.367 0 C-N-CA 123.329 2.686 . . . . 0.0 114.296 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.87 5.45 69.81 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 118.481 2.153 . . . . 0.0 118.481 -169.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.424 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -79.08 -175.63 47.21 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 124.31 0.957 . . . . 0.0 114.486 173.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.88 -40.15 94.67 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 116.077 1.88 . . . . 0.0 116.077 -174.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.03 -36.84 80.58 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 173.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.32 -35.21 75.73 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 116.445 2.017 . . . . 0.0 116.445 167.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -70.64 -57.32 4.83 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 125.704 1.602 . . . . 0.0 112.395 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.0 t70 . . . . . 0 CA--C 1.557 1.225 0 C-N-CA 123.831 0.853 . . . . 0.0 112.443 -177.146 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 C--O 1.238 0.495 0 N-CA-C 103.717 -2.697 . . . . 0.0 103.717 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 45.0 m -89.98 90.52 8.19 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 113.085 -1.87 . . . . 0.0 108.169 -170.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.5 tp -61.77 121.83 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.009 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.401 ' HA ' ' HB3' ' A' ' 126' ' ' ARG . 1.5 pp -106.33 -50.67 3.1 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 113.16 -1.836 . . . . 0.0 115.91 175.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -123.33 132.75 54.1 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 177.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 5.8 p -122.22 116.39 48.99 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 N-CA-C 104.142 -2.54 . . . . 0.0 104.142 168.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.568 HD22 ' CB ' ' A' ' 140' ' ' ALA 0.282 18.5 m-80 79.83 -74.65 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 CA-C-O 123.348 1.547 . . . . 0.0 110.176 -174.203 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -167.54 -16.74 0.02 OUTLIER 'General case' 0 CA--C 1.578 2.027 0 CA-C-N 111.471 -2.604 . . . . 0.0 109.64 -175.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.0 t -67.66 134.78 29.65 Favored 'Isoleucine or valine' 0 C--N 1.361 1.099 0 CA-C-N 120.415 1.462 . . . . 0.0 110.351 176.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -86.27 99.45 11.58 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 113.419 -1.719 . . . . 0.0 109.046 176.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.3 m -95.93 -101.19 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 CA-C-O 116.401 -1.762 . . . . 0.0 107.381 175.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.49 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.316 18.8 ptt180 50.97 -90.89 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.254 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 177.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.49 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 4.9 tt0 -88.23 65.57 8.12 Favored 'General case' 0 CA--C 1.557 1.225 0 CA-C-O 122.991 1.377 . . . . 0.0 109.54 171.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.7 p -130.36 169.86 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 176.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 33.2 m -61.02 134.87 57.53 Favored 'General case' 0 CA--C 1.56 1.342 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.43 158.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -47.28 -33.41 5.57 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 117.922 2.564 . . . . 0.0 117.922 171.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.7 m -62.06 -38.88 90.46 Favored 'General case' 0 CA--C 1.562 1.439 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 173.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.62 -34.69 76.19 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 115.521 1.675 . . . . 0.0 115.521 166.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -72.44 -49.8 30.84 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 116.234 1.938 . . . . 0.0 116.234 174.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.442 HG23 ' HB ' ' B' ' 6' ' ' VAL . 4.0 p -49.88 -44.24 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.221 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 164.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -64.09 -49.21 73.14 Favored 'General case' 0 C--O 1.216 -0.658 0 CA-C-O 116.075 -1.917 . . . . 0.0 112.556 172.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.47 -32.75 73.68 Favored 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 117.184 2.29 . . . . 0.0 117.184 176.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -58.25 -46.47 85.9 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 162.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -72.36 -37.69 68.74 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 171.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -64.98 -19.95 66.24 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 116.272 1.953 . . . . 0.0 116.272 170.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.568 ' CB ' HD22 ' A' ' 121' ' ' ASN . . . -52.11 -10.66 0.13 Allowed 'General case' 0 CA--C 1.554 1.103 0 N-CA-C 119.246 3.054 . . . . 0.0 119.246 162.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 70.18 -154.51 52.66 Favored Glycine 0 C--N 1.348 1.243 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -175.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.5 m -59.83 -5.09 0.84 Allowed 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 118.506 2.78 . . . . 0.0 118.506 176.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.96 105.79 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 -170.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.453 ' CG2' ' HB3' ' A' ' 68' ' ' LEU . 15.8 m -85.88 123.1 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.07 174.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -108.13 90.22 3.23 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 56.7 mt -90.69 139.27 30.87 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.471 -171.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -135.64 117.88 15.58 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 104.52 -2.4 . . . . 0.0 104.52 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 35.3 m -129.64 118.53 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -164.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 53.2 ttm . . . . . 0 N--CA 1.489 1.518 0 CA-C-N 118.882 0.765 . . . . 0.0 109.746 173.498 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.557 1.212 0 CA-C-O 122.504 1.145 . . . . 0.0 111.285 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -136.24 128.05 29.2 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-O 123.507 1.622 . . . . 0.0 109.328 170.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 10.7 ttpp -97.42 111.27 23.6 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 113.754 -1.566 . . . . 0.0 107.796 172.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.412 HG22 HG22 ' A' ' 134' ' ' VAL . 88.5 m -93.76 144.66 25.21 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.418 -1.265 . . . . 0.0 109.108 173.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -87.19 145.02 26.57 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 113.864 -1.516 . . . . 0.0 108.672 178.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.442 ' HB ' HG23 ' A' ' 134' ' ' VAL . 7.6 p . . . . . 0 C--O 1.248 1.01 0 N-CA-C 104.5 -2.408 . . . . 0.0 104.5 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 27.0 p90 . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 121.609 0.719 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -101.46 133.15 46.54 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.812 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -97.84 128.52 44.51 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.72 170.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.402 HG13 ' HB2' ' A' ' 146' ' ' LEU . 23.5 pt -136.67 111.83 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 -174.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.0 m -91.96 120.24 32.44 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.7 tt -116.52 137.57 52.07 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 175.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 . . . . . 0 N--CA 1.483 1.222 0 O-C-N 120.956 -1.09 . . . . 0.0 111.564 177.17 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.456 ' CD1' HG12 ' A' ' 144' ' ' VAL . 0.1 OUTLIER . . . . . 0 CA--C 1.558 1.274 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 69.4 36.37 77.75 Favored Glycine 0 C--N 1.344 1.014 0 N-CA-C 118.761 2.264 . . . . 0.0 118.761 164.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -150.48 163.51 38.25 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 123.563 1.649 . . . . 0.0 108.489 174.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.5 m -127.25 127.82 45.01 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.582 -169.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.3 pp -101.18 124.03 54.6 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 113.504 -1.68 . . . . 0.0 108.643 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -85.68 -170.86 3.31 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 123.452 1.596 . . . . 0.0 110.051 158.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.1 159.34 24.34 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-O 123.859 1.811 . . . . 0.0 115.604 -136.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -104.24 -162.6 24.58 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 111.082 -2.559 . . . . 0.0 113.742 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 70.2 p -52.83 -41.75 64.5 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 116.67 2.1 . . . . 0.0 116.67 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -80.15 -17.32 52.8 Favored 'General case' 0 CA--C 1.565 1.55 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 175.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.29 96.07 4.27 Favored Pre-proline 0 CA--C 1.552 1.028 0 N-CA-C 101.822 -3.399 . . . . 0.0 101.822 -175.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -96.73 143.41 0.84 Allowed 'Trans proline' 0 CA--C 1.548 1.194 0 CA-C-N 123.688 2.353 . . . . 0.0 111.472 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 16.8 t60 . . . . . 0 CA--C 1.565 1.532 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 167.271 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo . . . . . 0 CA--C 1.549 1.256 0 N-CA-C 110.636 -0.563 . . . . 0.0 110.636 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.5 m 78.3 106.87 0.07 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 168.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 11.3 mm -75.55 117.56 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 -173.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -128.4 135.44 49.54 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -171.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 89.5 mt -72.5 118.83 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.388 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 175.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.431 ' CG2' ' HG3' ' B' ' 3' ' ' LYS . 14.3 t -87.75 -29.69 20.85 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 169.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -144.25 163.08 34.7 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-O 125.568 2.604 . . . . 0.0 110.343 -174.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.2 pt -115.4 129.17 72.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 111.051 -2.795 . . . . 0.0 103.539 173.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.294 1.5 mp -72.19 123.78 89.95 Favored Pre-proline 0 CA--C 1.57 1.715 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 170.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.93 132.08 42.95 Favored 'Trans proline' 0 C--N 1.367 1.545 0 C-N-CA 123.558 2.838 . . . . 0.0 114.203 172.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 71.52 9.95 69.88 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 118.084 1.994 . . . . 0.0 118.084 -166.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -91.01 -179.29 43.06 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-O 123.033 1.351 . . . . 0.0 112.397 177.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.65 -33.79 66.82 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 117.523 2.416 . . . . 0.0 117.523 -174.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.94 -32.88 72.38 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 117.961 2.578 . . . . 0.0 117.961 165.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.35 -39.41 93.84 Favored 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 167.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.48 -56.02 6.75 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.387 1.075 . . . . 0.0 113.624 175.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.7 t70 . . . . . 0 CA--C 1.562 1.415 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -178.17 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 . . . . . 0 C--O 1.239 0.547 1 N-CA-C 100.091 -4.04 . . . . 0.0 100.091 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.8 m -75.02 86.93 2.34 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 112.992 -1.913 . . . . 0.0 109.097 -176.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 30.1 pt -64.91 121.22 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 125.065 1.346 . . . . 0.0 111.024 -174.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.841 HD11 ' H ' ' A' ' 149' ' ' MET . 0.0 OUTLIER -101.55 -50.17 3.81 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 112.736 -2.029 . . . . 0.0 112.778 -179.457 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.434 ' H ' HD21 ' A' ' 118' ' ' LEU . 78.4 m-85 -111.4 140.91 45.6 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 169.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.1 p -127.93 120.05 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 104.465 -2.42 . . . . 0.0 104.465 165.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.571 HD22 ' CB ' ' A' ' 140' ' ' ALA 0.27 24.5 m-80 79.67 -74.45 0.05 Allowed 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 123.592 1.663 . . . . 0.0 110.453 -176.162 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -164.49 -10.88 0.03 OUTLIER 'General case' 0 CA--C 1.578 2.038 0 CA-C-N 111.355 -2.657 . . . . 0.0 110.203 177.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.1 t -71.46 134.42 29.98 Favored 'Isoleucine or valine' 0 C--N 1.36 1.03 0 C-N-CA 125.682 1.593 . . . . 0.0 109.745 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -84.67 100.79 11.69 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 113.698 -1.592 . . . . 0.0 109.299 172.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -96.97 -96.86 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 CA-C-O 116.08 -1.914 . . . . 0.0 106.894 171.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.479 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.302 18.9 ptt180 46.79 -89.37 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 -178.374 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.479 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 6.6 mt-10 -85.9 65.95 9.37 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-O 123.672 1.701 . . . . 0.0 109.087 177.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.1 p -138.75 168.38 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 22.9 m -60.33 132.79 55.0 Favored 'General case' 0 CA--C 1.561 1.388 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.884 158.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 10.2 p-80 -46.53 -32.69 3.54 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 118.166 2.654 . . . . 0.0 118.166 170.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.5 m -62.4 -40.37 96.28 Favored 'General case' 0 CA--C 1.561 1.381 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 173.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.74 -37.69 87.07 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 167.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -66.94 -52.18 46.11 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 172.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 4.9 p -53.65 -42.25 50.15 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.421 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 172.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -72.33 -39.82 67.88 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 116.267 -1.825 . . . . 0.0 112.93 174.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.59 -29.19 69.04 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 117.162 2.282 . . . . 0.0 117.162 165.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -62.78 -48.96 76.88 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.819 1.647 . . . . 0.0 114.93 165.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -68.21 -35.71 78.4 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 168.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -64.65 -23.19 67.18 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 116.379 1.992 . . . . 0.0 116.379 171.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.571 ' CB ' HD22 ' A' ' 121' ' ' ASN . . . -54.2 -11.06 0.43 Allowed 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 118.794 2.887 . . . . 0.0 118.794 162.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 89.1 -136.98 13.92 Favored Glycine 0 C--N 1.345 1.066 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 172.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 26.8 m -77.75 -2.96 38.83 Favored 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 170.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.85 106.74 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 -170.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.456 HG12 ' CD1' ' A' ' 75' ' ' LEU . 10.7 m -88.39 116.21 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.324 1.45 . . . . 0.0 109.292 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 56.1 mtm180 -104.01 89.34 3.26 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -176.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.402 ' HB2' HG13 ' A' ' 66' ' ' ILE . 23.9 mt -88.33 138.34 31.52 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.736 0.779 . . . . 0.0 109.0 -170.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -120.97 127.53 51.89 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 5.7 p -133.55 112.45 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 CA-C-O 121.65 0.738 . . . . 0.0 109.85 175.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' MET . . . . . 0.841 ' H ' HD11 ' A' ' 118' ' ' LEU . 27.3 ttt . . . . . 0 CA--C 1.544 0.739 0 C-N-CA 126.343 1.857 . . . . 0.0 110.793 161.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.56 1.356 0 CA-C-O 122.728 1.251 . . . . 0.0 110.899 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -142.0 127.04 18.39 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 123.082 1.42 . . . . 0.0 107.937 170.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.431 ' HG3' ' CG2' ' A' ' 97' ' ' THR . 1.6 tmmt? -89.91 122.13 32.66 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.024 169.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 62.8 m -92.35 135.87 33.67 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 122.715 1.245 . . . . 0.0 108.951 171.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -92.27 133.58 35.7 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 113.855 -1.52 . . . . 0.0 107.865 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . 0.254 11.7 p . . . . . 0 C--O 1.248 1.015 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 -169.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 40.9 p90 . . . . . 0 N--CA 1.478 0.955 0 CA-C-O 121.917 0.865 . . . . 0.0 110.686 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -107.43 135.92 48.09 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 114.55 -1.204 . . . . 0.0 108.077 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -95.43 127.59 41.59 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.841 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.409 HG21 HD12 ' A' ' 68' ' ' LEU . 4.2 mp -135.24 122.91 37.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 -177.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.7 m -105.22 122.79 46.66 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 173.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.409 HD12 HG21 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -120.7 132.57 55.15 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 114.305 -1.316 . . . . 0.0 108.581 -175.869 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 . . . . . 0 CA--C 1.547 0.842 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.812 -176.598 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.492 ' H ' HD23 ' A' ' 75' ' ' LEU 0.405 0.2 OUTLIER . . . . . 0 N--CA 1.499 2.008 0 N-CA-C 118.016 2.599 . . . . 0.0 118.016 . . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.29 20.44 17.86 Favored Glycine 0 C--O 1.218 -0.855 0 CA-C-O 115.437 -2.868 . . . . 0.0 117.18 168.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -158.46 117.27 3.07 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 121.745 2.773 . . . . 0.0 109.678 -169.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.6 m -87.79 127.0 35.32 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.211 -1.359 . . . . 0.0 110.823 172.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.4 pp -105.74 127.22 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 113.62 -1.627 . . . . 0.0 108.947 -176.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -79.55 -173.05 3.56 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 124.015 1.864 . . . . 0.0 111.321 159.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -101.59 160.57 18.1 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-N 112.937 -1.938 . . . . 0.0 114.95 -142.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.23 -162.22 21.75 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 110.939 -2.631 . . . . 0.0 111.711 -173.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.419 HG22 ' HB2' ' A' ' 92' ' ' PRO . 13.3 p -52.52 -43.1 64.91 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 117.661 2.467 . . . . 0.0 117.661 -173.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -97.99 12.43 34.27 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 174.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -155.17 69.74 5.56 Favored Pre-proline 0 CA--C 1.555 1.151 0 N-CA-C 101.96 -3.348 . . . . 0.0 101.96 174.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -88.79 126.73 1.8 Allowed 'Trans proline' 0 C--N 1.365 1.444 0 CA-C-N 126.659 3.414 . . . . 0.0 112.208 -163.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 84.5 t60 . . . . . 0 N--CA 1.5 2.048 0 N-CA-C 115.213 1.561 . . . . 0.0 115.213 157.921 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.419 ' HB2' HG22 ' A' ' 83' ' ' THR . 14.6 Cg_endo . . . . . 0 CA--C 1.557 1.664 0 CA-C-O 122.732 1.055 . . . . 0.0 112.932 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.5 t -161.33 159.22 28.16 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 -172.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 12.2 mm -99.61 120.17 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 N-CA-C 105.256 -2.128 . . . . 0.0 105.256 -175.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -111.41 149.68 30.89 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 113.442 -1.708 . . . . 0.0 107.205 -174.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 23.0 mt -94.78 111.27 25.22 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.319 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 165.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 96.8 m -85.81 -30.85 22.66 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 117.264 -1.351 . . . . 0.0 113.431 169.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . 0.282 8.9 ptmm? -141.41 164.08 31.19 Favored 'General case' 0 CA--C 1.557 1.246 0 CA-C-N 120.673 1.579 . . . . 0.0 112.177 173.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.7 tp -115.26 137.51 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 N-CA-C 104.57 -2.381 . . . . 0.0 104.57 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.273 1.6 mp -83.6 116.86 66.71 Favored Pre-proline 0 CA--C 1.57 1.743 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 168.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -63.0 146.01 94.57 Favored 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 123.736 2.957 . . . . 0.0 113.979 172.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.3 -13.65 26.2 Favored Glycine 0 CA--C 1.547 2.073 0 N-CA-C 117.586 1.794 . . . . 0.0 117.586 -169.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -83.19 -169.62 45.02 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 118.911 1.356 . . . . 0.0 113.162 173.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.89 -51.29 27.09 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -170.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.0 -32.86 72.44 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 116.915 2.191 . . . . 0.0 116.915 173.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.07 -51.3 48.2 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 170.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -65.06 -62.22 1.68 Allowed 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 125.313 1.445 . . . . 0.0 112.986 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 . . . . . 0 N--CA 1.486 1.348 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 -177.772 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.2 p30 . . . . . 0 CA--C 1.558 1.267 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.8 m -144.79 84.27 1.72 Allowed 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 175.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 28.1 pt -56.58 108.63 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 CA-C-O 123.558 1.646 . . . . 0.0 111.042 175.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.3 pp -101.19 -41.37 6.75 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 112.564 -2.107 . . . . 0.0 115.526 178.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -127.59 143.76 51.14 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.401 HG11 HD22 ' A' ' 146' ' ' LEU . 3.3 t -136.56 108.0 6.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 101.294 -3.595 . . . . 0.0 101.294 178.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.608 HD22 ' HB1' ' A' ' 140' ' ' ALA 0.283 25.0 m-80 82.51 -80.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 123.44 1.59 . . . . 0.0 109.504 178.593 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -152.82 -14.07 0.16 Allowed 'General case' 0 CA--C 1.568 1.635 0 CA-C-N 111.815 -2.448 . . . . 0.0 111.196 177.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.2 t -68.86 136.98 25.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 124.893 1.277 . . . . 0.0 109.733 174.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -96.08 101.08 12.7 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 112.574 -2.103 . . . . 0.0 109.018 176.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . 0.261 1.6 m -100.42 -103.84 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 CA-C-O 116.773 -1.584 . . . . 0.0 107.178 178.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.581 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.363 26.9 ptt85 44.21 -92.87 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 125.139 1.376 . . . . 0.0 114.572 -169.9 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.581 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 16.6 tt0 -72.84 74.84 1.15 Allowed 'General case' 0 CA--C 1.555 1.142 0 CA-C-O 124.297 1.998 . . . . 0.0 110.98 170.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.3 p -149.0 166.54 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 CA-C-N 111.993 -2.367 . . . . 0.0 105.232 -178.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.6 122.49 10.71 Favored 'General case' 0 CA--C 1.557 1.224 0 CA-C-N 111.841 -2.436 . . . . 0.0 110.462 154.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -49.48 -31.24 9.59 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 117.436 2.384 . . . . 0.0 117.436 175.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.1 m -58.86 -38.05 77.89 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 115.373 1.619 . . . . 0.0 115.373 171.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.61 -37.06 79.47 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 165.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.19 -54.6 34.96 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 171.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.444 HG22 HG23 ' B' ' 4' ' ' THR . 9.8 p -52.45 -43.43 41.57 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 166.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -58.14 -50.39 73.65 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-O 115.888 -2.006 . . . . 0.0 111.817 171.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.55 -35.43 77.75 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 117.146 2.276 . . . . 0.0 117.146 173.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 9.3 mp -55.82 -52.6 63.43 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 125.04 1.336 . . . . 0.0 114.007 164.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -71.35 -31.82 67.8 Favored 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 174.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -67.16 -30.23 70.15 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 115.332 1.605 . . . . 0.0 115.332 171.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.608 ' HB1' HD22 ' A' ' 121' ' ' ASN . . . -50.27 -33.06 18.52 Favored 'General case' 0 CA--C 1.56 1.332 0 N-CA-C 117.202 2.297 . . . . 0.0 117.202 159.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 91.21 -125.18 7.9 Favored Glycine 0 C--N 1.348 1.229 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 166.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 11.6 m -73.38 -10.36 59.66 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 118.043 2.609 . . . . 0.0 118.043 169.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.2 104.44 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 -170.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.2 m -86.88 118.4 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 113.383 -1.735 . . . . 0.0 109.557 175.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 62.5 mtm180 -97.57 91.79 5.6 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 172.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.401 HD22 HG11 ' A' ' 120' ' ' VAL . 86.2 mt -93.24 138.69 31.39 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.906 0.86 . . . . 0.0 108.985 -173.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -130.67 120.99 24.73 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 177.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 21.2 m -130.77 129.64 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -166.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 23.9 ptt? . . . . . 0 N--CA 1.48 1.044 0 CA-C-O 122.46 1.124 . . . . 0.0 111.587 168.991 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 8.1 p90 . . . . . 0 CA--C 1.55 0.98 0 CA-C-O 122.194 0.997 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -115.06 149.19 37.88 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 123.738 1.733 . . . . 0.0 109.188 173.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 12.0 ttpp -103.97 109.28 20.98 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 113.189 -1.823 . . . . 0.0 107.305 176.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.444 HG23 HG22 ' A' ' 134' ' ' VAL . 0.2 OUTLIER -76.59 131.31 38.84 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.625 175.979 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -85.58 121.92 28.95 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 C--O 1.248 0.977 0 N-CA-C 104.193 -2.521 . . . . 0.0 104.193 -170.314 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 34.0 p90 . . . . . 0 CA--C 1.551 1.008 0 CA-C-O 122.414 1.102 . . . . 0.0 112.575 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -101.53 129.16 47.56 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 113.354 -1.748 . . . . 0.0 108.254 166.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -116.29 129.27 56.19 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 114.224 -1.353 . . . . 0.0 109.163 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 6.2 pt -135.82 115.36 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 -174.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.3 m -86.43 118.18 25.7 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 171.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.2 tt -124.14 140.46 52.94 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 113.14 -1.845 . . . . 0.0 106.198 -171.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 . . . . . 0 N--CA 1.483 1.218 0 O-C-N 121.431 -0.793 . . . . 0.0 109.378 -176.455 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.9 mp . . . . . 0 CA--C 1.555 1.137 0 N-CA-C 106.349 -1.722 . . . . 0.0 106.349 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 127.57 50.39 0.15 Allowed Glycine 0 CA--C 1.543 1.815 0 C-N-CA 124.516 1.055 . . . . 0.0 114.916 -175.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -159.33 149.58 19.15 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 122.998 1.38 . . . . 0.0 109.97 174.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 70.7 m -99.91 116.35 31.75 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.408 -0.807 . . . . 0.0 111.62 -175.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.1 pt -88.46 122.86 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.311 176.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.65 -172.09 3.87 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-O 123.263 1.506 . . . . 0.0 110.644 164.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.43 161.05 22.99 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-O 123.389 1.55 . . . . 0.0 116.341 -136.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.49 -162.58 23.43 Favored Glycine 0 N--CA 1.464 0.564 0 CA-C-N 111.919 -2.14 . . . . 0.0 116.298 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 59.6 p -52.08 -40.53 61.35 Favored 'General case' 0 CA--C 1.567 1.628 0 CA-C-N 112.516 -1.842 . . . . 0.0 115.595 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -78.82 -30.54 45.39 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 172.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -134.52 91.37 21.95 Favored Pre-proline 0 N--CA 1.478 0.972 0 N-CA-C 102.402 -3.185 . . . . 0.0 102.402 -173.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -100.01 147.81 0.44 Allowed 'Trans proline' 0 CA--C 1.549 1.251 0 CA-C-N 124.557 2.663 . . . . 0.0 111.221 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.476 ' HB2' ' CD2' ' B' ' 1' ' ' TYR . 43.3 t60 . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 166.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.553 1.448 0 N-CA-C 110.482 -0.622 . . . . 0.0 110.482 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 39.9 m 79.73 119.31 0.05 Allowed 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 167.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.488 HG13 ' CB ' ' A' ' 133' ' ' ALA . 10.0 mm -96.1 125.67 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 104.905 -2.258 . . . . 0.0 104.905 -172.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.401 ' HB2' ' O ' ' A' ' 115' ' ' ASP . 32.3 p90 -140.67 128.52 21.82 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 112.317 -2.22 . . . . 0.0 106.58 -159.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 73.6 mt -87.64 114.93 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.2 t -97.77 -13.85 21.14 Favored 'General case' 0 CA--C 1.559 1.301 0 CA-C-N 113.224 -1.807 . . . . 0.0 114.805 169.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm -141.11 158.11 44.36 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-O 124.832 2.253 . . . . 0.0 109.93 -173.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.29 131.87 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 111.531 -2.577 . . . . 0.0 105.894 -176.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.275 1.6 mp -78.69 131.62 67.2 Favored Pre-proline 0 CA--C 1.57 1.716 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 167.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.17 130.56 34.8 Favored 'Trans proline' 0 C--N 1.367 1.517 0 C-N-CA 123.416 2.744 . . . . 0.0 115.132 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 70.48 13.33 70.94 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 118.167 2.027 . . . . 0.0 118.167 -168.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -90.0 -162.11 38.04 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 124.371 0.986 . . . . 0.0 114.675 -175.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.27 -53.85 21.66 Favored 'General case' 0 CA--C 1.557 1.229 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -170.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.05 -24.49 64.18 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 117.286 2.328 . . . . 0.0 117.286 168.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.96 -34.98 71.98 Favored 'General case' 0 CA--C 1.565 1.551 0 N-CA-C 115.964 1.838 . . . . 0.0 115.964 168.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -55.29 6.01 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 124.929 1.292 . . . . 0.0 112.26 174.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.9 t70 . . . . . 0 N--CA 1.487 1.405 0 C-N-CA 123.26 0.624 . . . . 0.0 112.612 -174.964 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 95' ' ' PHE 0.308 6.9 m-20 . . . . . 0 N--CA 1.466 0.327 0 CA-C-O 116.728 -1.606 . . . . 0.0 108.248 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 69.4 m -160.37 102.42 1.39 Allowed 'General case' 0 N--CA 1.473 0.677 0 O-C-N 126.337 2.273 . . . . 0.0 107.352 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -99.0 150.27 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.416 0 CA-C-O 122.617 1.199 . . . . 0.0 108.911 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.732 HD11 ' H ' ' A' ' 149' ' ' MET . 0.0 OUTLIER -120.61 -37.36 3.02 Favored 'General case' 0 N--CA 1.502 2.154 0 C-N-CA 126.504 1.922 . . . . 0.0 111.784 -171.056 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -126.67 150.66 48.85 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-O 122.755 1.264 . . . . 0.0 108.237 173.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.547 ' HB ' HH22 ' A' ' 126' ' ' ARG . 14.6 p -129.65 121.22 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 169.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.468 HD22 ' HB2' ' A' ' 140' ' ' ALA 0.358 12.8 m-80 79.14 -88.67 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 123.595 1.664 . . . . 0.0 107.845 178.626 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -144.21 -16.45 0.58 Allowed 'General case' 0 CA--C 1.568 1.636 0 CA-C-N 110.478 -3.055 . . . . 0.0 110.37 174.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.7 t -66.45 134.54 29.82 Favored 'Isoleucine or valine' 0 C--N 1.36 1.054 0 CA-C-O 123.92 1.819 . . . . 0.0 109.949 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -89.47 57.8 4.12 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 110.254 -3.157 . . . . 0.0 112.923 173.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.401 ' HB ' ' H ' ' A' ' 126' ' ' ARG . 1.8 m -70.86 -163.94 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.333 0 CA-C-O 123.632 1.682 . . . . 0.0 108.496 161.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.547 HH22 ' HB ' ' A' ' 120' ' ' VAL 0.525 4.3 mmt85 86.51 -49.27 0.05 Allowed 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 115.019 1.489 . . . . 0.0 115.019 176.164 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -76.21 51.86 0.71 Allowed 'General case' 0 CA--C 1.571 1.756 0 CA-C-N 114.186 -1.37 . . . . 0.0 113.276 155.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.405 HG23 ' H ' ' A' ' 126' ' ' ARG . 30.4 m -148.58 170.15 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 -170.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 44.6 p -61.73 141.12 58.07 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 113.293 -1.776 . . . . 0.0 111.814 155.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -44.39 -33.74 1.76 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 117.175 2.287 . . . . 0.0 117.175 171.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.1 m -62.78 -40.72 98.19 Favored 'General case' 0 CA--C 1.564 1.489 0 N-CA-C 115.702 1.742 . . . . 0.0 115.702 176.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.06 -37.94 81.87 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 169.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.488 ' CB ' HG13 ' A' ' 94' ' ' ILE . . . -67.8 -47.26 69.58 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 116.152 -1.88 . . . . 0.0 115.968 169.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.419 HG23 HG21 ' B' ' 4' ' ' THR . 13.0 p -53.39 -46.37 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-N 121.351 1.887 . . . . 0.0 113.221 166.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -53.18 -46.91 69.15 Favored 'General case' 0 CA--C 1.555 1.16 0 CA-C-O 117.527 -1.225 . . . . 0.0 113.02 168.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.63 -26.82 67.25 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 117.534 2.42 . . . . 0.0 117.534 170.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.429 ' CD2' HH21 ' A' ' 126' ' ' ARG . 3.5 mm? -68.76 -49.35 59.43 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 125.6 1.56 . . . . 0.0 113.845 171.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -66.22 -34.27 77.65 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 165.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -72.43 -21.65 61.22 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 116.932 2.197 . . . . 0.0 116.932 174.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.468 ' HB2' HD22 ' A' ' 121' ' ' ASN . . . -51.58 -20.8 2.13 Favored 'General case' 0 CA--C 1.563 1.451 0 N-CA-C 117.584 2.438 . . . . 0.0 117.584 155.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.78 -147.29 27.76 Favored Glycine 0 C--N 1.35 1.356 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 174.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 18.5 m -61.84 -6.5 2.76 Favored 'General case' 0 CA--C 1.571 1.783 0 N-CA-C 117.553 2.427 . . . . 0.0 117.553 173.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -146.58 101.68 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 -170.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.42 ' HA ' ' HB3' ' A' ' 140' ' ' ALA . 29.8 m -84.18 116.92 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.293 172.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.435 ' HB2' ' HA ' ' A' ' 121' ' ' ASN . 57.7 mtp85 -94.35 106.12 18.1 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 174.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 11.3 mt -107.02 124.05 49.08 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 -166.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -116.84 130.14 56.52 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 -174.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.02 127.77 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 176.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' MET . . . . . 0.732 ' H ' HD11 ' A' ' 118' ' ' LEU . 67.3 mtt . . . . . 0 N--CA 1.475 0.799 0 C-N-CA 126.048 1.739 . . . . 0.0 108.671 171.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 1' ' ' TYR . . . . . 0.476 ' CD2' ' HB2' ' A' ' 87' ' ' HIS . 0.0 OUTLIER . . . . . 0 CA--C 1.557 1.226 0 CA-C-O 122.728 1.251 . . . . 0.0 110.565 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -157.12 151.11 24.72 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 123.351 1.548 . . . . 0.0 109.951 168.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.74 137.16 37.03 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 -176.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.419 HG21 HG23 ' A' ' 134' ' ' VAL . 27.6 m -85.34 133.78 34.13 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 166.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.95 99.98 12.52 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 -177.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 C--O 1.25 1.091 0 N-CA-C 103.042 -2.947 . . . . 0.0 103.042 -165.315 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 17.8 p90 . . . . . 0 N--CA 1.475 0.792 0 CA-C-O 122.38 1.086 . . . . 0.0 108.101 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -114.03 136.2 53.18 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 113.697 -1.592 . . . . 0.0 107.71 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -99.63 121.42 41.19 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -172.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 18.2 mt -130.99 114.93 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 104.233 -2.506 . . . . 0.0 104.233 -172.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.0 m -96.6 124.91 40.74 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 169.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.453 ' HB3' ' CG2' ' A' ' 144' ' ' VAL . 5.2 tp -127.86 166.82 17.53 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 113.29 -1.777 . . . . 0.0 107.144 176.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 . . . . . 0 N--CA 1.48 1.074 0 O-C-N 121.352 -0.843 . . . . 0.0 109.392 164.456 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.481 1.1 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 113.5 43.34 0.83 Allowed Glycine 0 CA--C 1.533 1.179 0 N-CA-C 117.155 1.622 . . . . 0.0 117.155 167.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.404 ' HA ' ' H ' ' A' ' 100' ' ' ILE . 3.8 p90 -156.72 157.7 35.6 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.526 1.131 . . . . 0.0 109.11 172.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 51.1 m -96.66 137.76 35.25 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 120.621 -1.3 . . . . 0.0 110.155 171.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.2 pt -107.21 125.87 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.85 178.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.572 ' HB3' ' HG1' ' A' ' 97' ' ' THR . . . -83.25 -178.46 7.09 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 124.254 1.978 . . . . 0.0 110.001 167.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.51 159.08 25.79 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 112.923 -1.944 . . . . 0.0 115.228 -141.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -109.26 -170.97 20.63 Favored Glycine 0 C--O 1.224 -0.496 0 CA-C-N 110.472 -2.864 . . . . 0.0 113.034 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 29.6 p -43.5 -43.36 5.39 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 118.442 2.756 . . . . 0.0 118.442 -176.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -78.07 -28.64 48.88 Favored 'General case' 0 CA--C 1.561 1.403 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 175.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . 0.258 2.0 t30 -143.81 71.96 17.03 Favored Pre-proline 0 CA--C 1.562 1.404 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -175.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -103.44 145.83 0.17 Allowed 'Trans proline' 0 C--N 1.375 1.937 0 CA-C-N 124.629 2.689 . . . . 0.0 111.652 -171.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 . . . . . 0 N--CA 1.495 1.812 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 162.71 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo . . . . . 0 CA--C 1.555 1.556 0 CA-C-O 121.962 0.734 . . . . 0.0 112.1 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.2 t -161.23 128.35 4.08 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 -173.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.424 HG13 ' HB2' ' A' ' 133' ' ' ALA . 24.3 mm -76.31 121.1 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -133.01 131.66 40.96 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -175.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . 0.288 92.8 mt -65.56 127.82 27.31 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.908 0 CA-C-O 122.547 1.165 . . . . 0.0 109.374 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.572 ' HG1' ' HB3' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -81.34 -48.42 11.99 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.933 1.293 . . . . 0.0 113.63 174.871 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.436 ' HZ3' ' HB2' ' A' ' 98' ' ' LYS 0.286 0.0 OUTLIER -143.42 163.67 32.44 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-O 123.021 1.391 . . . . 0.0 110.573 -176.432 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -108.24 116.56 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 103.607 -2.738 . . . . 0.0 103.607 173.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.404 ' H ' ' HA ' ' A' ' 77' ' ' PHE . 1.4 mp -68.0 129.17 93.24 Favored Pre-proline 0 CA--C 1.57 1.746 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 176.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.19 131.12 35.05 Favored 'Trans proline' 0 CA--C 1.555 1.529 0 C-N-CA 123.468 2.779 . . . . 0.0 114.112 172.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.4 1.27 88.36 Favored Glycine 0 CA--C 1.551 2.292 0 N-CA-C 117.72 1.848 . . . . 0.0 117.72 -164.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -78.33 157.53 44.61 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.281 0.943 . . . . 0.0 114.117 172.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.86 -25.39 67.88 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 117.51 2.411 . . . . 0.0 117.51 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.87 -44.46 89.63 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 173.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.74 -38.67 73.54 Favored 'General case' 0 CA--C 1.563 1.473 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 172.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -67.79 -62.7 1.29 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 125.16 1.384 . . . . 0.0 112.724 173.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.9 t70 . . . . . 0 N--CA 1.485 1.318 0 C-N-CA 124.242 1.017 . . . . 0.0 112.709 -171.526 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 . . . . . 0 C--O 1.241 0.626 0 N-CA-C 100.569 -3.863 . . . . 0.0 100.569 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 41.8 m -78.85 93.02 4.93 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 112.932 -1.94 . . . . 0.0 108.846 -168.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.4 tp -58.25 116.77 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.65 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.409 ' HA ' ' HB3' ' A' ' 126' ' ' ARG 0.266 1.9 pp -100.17 -50.42 3.97 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 113.216 -1.811 . . . . 0.0 114.638 175.706 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -126.41 133.09 51.36 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 104.605 -2.368 . . . . 0.0 104.605 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.6 p -123.84 117.45 51.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 170.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.468 HD22 ' HB2' ' A' ' 140' ' ' ALA 0.306 22.4 m-80 80.38 -69.85 0.09 Allowed 'General case' 0 N--CA 1.501 2.121 0 CA-C-O 123.334 1.54 . . . . 0.0 110.681 -174.401 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -172.05 -25.06 0.01 OUTLIER 'General case' 0 CA--C 1.575 1.914 0 C-N-CA 128.537 2.735 . . . . 0.0 109.178 -172.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.2 t -66.48 133.92 30.6 Favored 'Isoleucine or valine' 0 C--N 1.363 1.167 0 C-N-CA 125.298 1.439 . . . . 0.0 110.775 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -83.8 98.94 9.99 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 113.292 -1.776 . . . . 0.0 110.227 174.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 126' ' ' ARG . 2.3 m -86.48 -98.34 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 CA-C-O 115.911 -1.995 . . . . 0.0 107.632 171.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.481 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.274 5.7 ptt180 45.88 -99.58 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 CA-C-N 120.589 1.54 . . . . 0.0 113.638 178.44 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.481 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 1.1 tm-20 -80.05 81.22 6.35 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-O 123.407 1.575 . . . . 0.0 109.006 170.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.58 167.44 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 CA-C-N 112.76 -2.018 . . . . 0.0 106.179 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 25.0 m -60.58 132.49 54.05 Favored 'General case' 0 CA--C 1.561 1.372 0 CA-C-N 114.129 -1.396 . . . . 0.0 110.104 156.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 -46.54 -33.45 4.09 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 117.987 2.588 . . . . 0.0 117.987 171.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 12.0 m -62.97 -38.24 90.31 Favored 'General case' 0 CA--C 1.558 1.268 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 175.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.04 -34.34 77.85 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 165.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.424 ' HB2' HG13 ' A' ' 94' ' ' ILE . . . -70.46 -51.95 25.59 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 116.382 1.993 . . . . 0.0 116.382 173.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.404 HG21 ' HB ' ' B' ' 6' ' ' VAL . 4.3 p -50.05 -43.64 20.96 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.374 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 165.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -64.74 -48.19 75.47 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 116.842 -1.551 . . . . 0.0 113.374 175.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.7 -31.95 71.41 Favored 'General case' 0 CA--C 1.563 1.471 0 N-CA-C 116.561 2.06 . . . . 0.0 116.561 176.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.8 mp -60.3 -52.1 66.7 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 125.32 1.448 . . . . 0.0 114.743 166.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -67.12 -33.95 76.55 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 167.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -65.16 -24.18 67.32 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 173.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.468 ' HB2' HD22 ' A' ' 121' ' ' ASN . . . -50.97 -25.75 5.09 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 118.024 2.601 . . . . 0.0 118.024 163.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 66.96 83.91 0.1 Allowed Glycine 0 C--N 1.351 1.387 0 CA-C-O 118.695 -1.059 . . . . 0.0 113.11 157.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.8 m 75.04 -30.09 0.2 Allowed 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 117.237 2.31 . . . . 0.0 117.237 -175.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.0 108.84 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 -172.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.453 ' CG2' ' HB3' ' A' ' 68' ' ' LEU . 16.9 m -89.55 123.0 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 114.317 -1.31 . . . . 0.0 109.754 176.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -96.27 93.07 6.67 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 172.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 64.6 mt -98.5 133.5 42.77 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -171.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -131.55 115.38 16.05 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 178.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 35.7 m -126.32 129.13 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 -166.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.483 1.183 0 CA-C-O 121.574 0.702 . . . . 0.0 111.237 169.929 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 1.6 p90 . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 122.493 1.14 . . . . 0.0 112.31 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -139.33 138.11 36.37 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 113.852 -1.522 . . . . 0.0 107.501 172.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.55 122.26 34.8 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.153 -1.385 . . . . 0.0 108.627 177.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 96.8 m -86.8 133.47 33.64 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 173.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -74.81 142.74 44.19 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.117 173.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.404 ' HB ' HG21 ' A' ' 134' ' ' VAL . 7.4 p . . . . . 0 C--O 1.254 1.29 0 CA-C-N 113.976 -1.465 . . . . 0.0 108.661 169.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 32.9 p90 . . . . . 0 N--CA 1.477 0.921 0 CA-C-O 122.332 1.063 . . . . 0.0 111.646 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -110.18 130.25 55.57 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.45 126.79 41.89 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.158 174.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.2 mp -134.24 119.76 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 -176.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.2 m -95.42 122.73 38.44 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 168.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.455 ' HB3' HG21 ' A' ' 144' ' ' VAL . 9.9 tt -125.96 134.94 51.36 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 113.88 -1.509 . . . . 0.0 107.541 -173.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 . . . . . 0 N--CA 1.478 0.967 0 CA-C-O 122.209 1.005 . . . . 0.0 109.457 179.113 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.7 mp . . . . . 0 N--CA 1.477 0.913 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.547 ' HA3' ' H ' ' A' ' 104' ' ' ALA . . . 138.47 39.12 0.11 Allowed Glycine 0 CA--C 1.535 1.284 0 N-CA-C 118.088 1.995 . . . . 0.0 118.088 -175.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -166.5 137.27 3.38 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 124.369 2.033 . . . . 0.0 109.119 -176.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.401 ' HB2' ' HB3' ' A' ' 98' ' ' LYS . 46.1 m -95.0 126.78 40.58 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 113.667 -1.606 . . . . 0.0 112.378 -173.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 96' ' ' ILE . 4.1 pt -93.37 130.51 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 113.945 -1.479 . . . . 0.0 110.856 177.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.15 -171.79 3.66 Favored 'General case' 0 CA--C 1.556 1.176 0 CA-C-O 123.057 1.408 . . . . 0.0 110.522 163.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.76 161.47 28.32 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-O 122.888 1.271 . . . . 0.0 115.802 -146.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -108.73 -162.5 20.39 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 112.47 -1.865 . . . . 0.0 113.502 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 70.3 p -50.07 -40.86 46.77 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 116.699 2.111 . . . . 0.0 116.699 178.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -95.54 7.18 46.99 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -162.79 90.53 1.27 Allowed Pre-proline 0 CA--C 1.561 1.398 0 N-CA-C 101.101 -3.666 . . . . 0.0 101.101 178.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -106.01 125.88 0.05 OUTLIER 'Trans proline' 0 CA--C 1.55 1.323 0 CA-C-N 124.577 2.67 . . . . 0.0 110.799 -177.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 . . . . . 0 N--CA 1.496 1.859 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 161.902 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo . . . . . 0 CA--C 1.554 1.523 0 N-CA-C 111.043 -0.407 . . . . 0.0 111.043 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 55.3 m 79.58 119.53 0.05 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.308 1.443 . . . . 0.0 108.161 166.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 26.6 mm -80.89 140.34 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' A' ' 115' ' ' ASP . 13.3 m-85 -123.23 150.86 42.9 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 114.328 -1.305 . . . . 0.0 111.097 175.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 79' ' ' ILE . 53.7 mt -103.21 107.44 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 N-CA-C 103.951 -2.611 . . . . 0.0 103.951 150.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.2 m -95.92 -17.18 21.25 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 174.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.401 ' HB3' ' HB2' ' A' ' 78' ' ' SER 0.273 40.7 tttp -139.26 157.61 45.6 Favored 'General case' 0 CA--C 1.563 1.449 0 CA-C-O 123.818 1.77 . . . . 0.0 110.549 -175.453 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.75 129.9 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 105.299 -2.112 . . . . 0.0 105.299 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.268 1.5 mp -78.51 132.74 64.68 Favored Pre-proline 0 CA--C 1.569 1.705 0 CA-C-O 118.35 -0.833 . . . . 0.0 108.921 169.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -62.9 133.26 40.73 Favored 'Trans proline' 0 C--N 1.367 1.525 0 C-N-CA 123.411 2.741 . . . . 0.0 114.682 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 71.63 4.9 59.19 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 118.383 2.113 . . . . 0.0 118.383 -169.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.409 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -82.79 -172.32 48.23 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.084 0.85 . . . . 0.0 114.119 -179.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.547 ' H ' ' HA3' ' A' ' 76' ' ' GLY . . . -63.27 -48.77 76.75 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -174.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.418 ' HA ' HD11 ' A' ' 68' ' ' LEU . . . -70.05 -30.19 67.39 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 118.026 2.602 . . . . 0.0 118.026 176.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.5 -40.55 93.17 Favored 'General case' 0 CA--C 1.567 1.602 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 163.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.46 -61.47 1.97 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.565 1.546 . . . . 0.0 112.728 177.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.7 t70 . . . . . 0 N--CA 1.482 1.162 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 -177.869 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.413 ' O ' ' HA ' ' A' ' 95' ' ' PHE 0.307 11.0 t70 . . . . . 0 C--O 1.213 -0.816 0 CA-C-O 117.226 -1.368 . . . . 0.0 107.608 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 75.7 m -96.8 69.59 2.45 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 120.38 1.446 . . . . 0.0 110.799 -170.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.5 tp -67.29 115.67 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-O 121.867 0.841 . . . . 0.0 108.785 174.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.1 pp -102.24 -40.57 6.72 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.435 1.642 . . . . 0.0 115.435 177.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -138.97 145.59 39.92 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 -175.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.2 t -132.94 113.42 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 102.753 -3.054 . . . . 0.0 102.753 -176.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.517 HD22 ' HB2' ' A' ' 140' ' ' ALA 0.341 22.0 m-80 84.02 -85.1 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 123.342 1.544 . . . . 0.0 108.726 -179.665 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -156.11 -4.35 0.12 Allowed 'General case' 0 CA--C 1.565 1.522 0 CA-C-N 111.564 -2.562 . . . . 0.0 110.575 173.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.3 t -67.82 139.75 20.31 Favored 'Isoleucine or valine' 0 C--N 1.357 0.93 0 C-N-CA 125.29 1.436 . . . . 0.0 109.282 -178.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -81.74 71.32 8.76 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-N 111.288 -2.687 . . . . 0.0 112.939 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . 0.287 0.6 OUTLIER -82.79 -105.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-O 116.79 -1.576 . . . . 0.0 107.899 178.862 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.641 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.311 27.3 ptt85 49.3 -87.53 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 116.822 2.156 . . . . 0.0 116.822 179.636 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.641 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 27.6 tt0 -81.81 72.53 8.86 Favored 'General case' 0 CA--C 1.555 1.137 0 CA-C-O 123.418 1.58 . . . . 0.0 110.095 167.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.9 p -145.85 167.86 8.01 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 CA-C-N 113.403 -1.726 . . . . 0.0 106.71 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 7.0 m -59.42 132.75 54.93 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 114.044 -1.435 . . . . 0.0 110.2 157.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -48.12 -31.91 6.2 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 117.607 2.447 . . . . 0.0 117.607 169.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 13.9 m -61.91 -38.53 88.71 Favored 'General case' 0 CA--C 1.564 1.486 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 173.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -69.28 -34.14 74.28 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 115.656 1.725 . . . . 0.0 115.656 164.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.18 -52.65 53.61 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 170.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.412 HG23 HG21 ' B' ' 4' ' ' THR . 12.7 p -50.41 -46.43 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 164.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -55.0 -50.42 69.06 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-O 116.68 -1.629 . . . . 0.0 112.606 172.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.88 -31.94 72.26 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 117.148 2.277 . . . . 0.0 117.148 170.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -59.55 -51.69 68.74 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 165.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -66.92 -42.4 85.47 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 171.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -69.59 -12.47 61.67 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 117.431 2.382 . . . . 0.0 117.431 173.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.517 ' HB2' HD22 ' A' ' 121' ' ' ASN . . . -53.49 -19.73 4.03 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 118.661 2.837 . . . . 0.0 118.661 157.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 83.26 -140.17 19.62 Favored Glycine 0 C--N 1.345 1.03 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 11.0 m -70.35 -5.84 31.05 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 116.605 2.076 . . . . 0.0 116.605 173.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -147.8 110.84 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -170.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.455 HG21 ' HB3' ' A' ' 68' ' ' LEU . 11.9 m -84.2 115.97 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 114.071 -1.422 . . . . 0.0 109.401 171.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.412 ' HB3' ' HA ' ' A' ' 121' ' ' ASN . 7.8 tpp180 -90.55 107.23 19.03 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 170.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 79.2 mt -108.27 135.64 49.25 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -172.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -125.54 118.2 25.24 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 177.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.43 121.84 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -177.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 49.6 ttm . . . . . 0 N--CA 1.481 1.107 0 CA-C-O 122.16 0.981 . . . . 0.0 112.671 168.546 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.559 1.303 0 CA-C-O 122.68 1.229 . . . . 0.0 111.399 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -136.11 122.14 20.15 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 172.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 13.9 ttpp -95.88 112.78 24.42 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 113.923 -1.49 . . . . 0.0 107.583 173.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.412 HG21 HG23 ' A' ' 134' ' ' VAL . 4.6 m -76.28 131.02 39.0 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 172.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.94 105.46 17.78 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 178.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 11.7 t . . . . . 0 C--O 1.245 0.821 0 N-CA-C 102.363 -3.199 . . . . 0.0 102.363 -165.82 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 26.3 p90 . . . . . 0 N--CA 1.481 1.091 0 CA-C-O 120.862 0.363 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -122.04 133.73 54.79 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 122.617 1.198 . . . . 0.0 108.965 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -104.98 117.11 33.18 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 -176.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.489 HG13 ' HB2' ' A' ' 146' ' ' LEU . 3.1 pt -137.1 115.22 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 -168.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.9 m -94.77 130.26 41.39 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 171.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 105' ' ' ALA . 0.5 OUTLIER -129.68 166.79 19.09 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 113.871 -1.513 . . . . 0.0 109.694 172.911 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 . . . . . 0 N--CA 1.478 0.958 0 CA-C-O 122.13 0.966 . . . . 0.0 110.686 175.178 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.5 mp . . . . . 0 N--CA 1.482 1.153 0 N-CA-C 110.547 -0.168 . . . . 0.0 110.547 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 136.59 25.91 0.43 Allowed Glycine 0 CA--C 1.542 1.77 0 CA-C-O 117.999 -1.445 . . . . 0.0 114.886 -175.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -129.27 165.84 20.61 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 123.912 1.815 . . . . 0.0 107.72 172.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 35.2 m -111.94 143.98 42.02 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 154.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.4 pp -107.56 128.91 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 113.045 -1.889 . . . . 0.0 108.481 170.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -84.15 -166.26 1.38 Allowed 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 123.915 1.817 . . . . 0.0 108.633 162.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.51 157.78 22.57 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 123.697 1.721 . . . . 0.0 113.835 -138.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -104.88 -163.85 24.08 Favored Glycine 0 CA--C 1.522 0.511 0 CA-C-N 111.349 -2.425 . . . . 0.0 113.0 178.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 61.0 p -51.16 -40.1 57.83 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 116.798 2.147 . . . . 0.0 116.798 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -88.03 -5.72 58.34 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 175.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -149.49 82.88 6.65 Favored Pre-proline 0 CA--C 1.558 1.259 0 N-CA-C 101.747 -3.427 . . . . 0.0 101.747 177.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -106.75 128.52 0.05 OUTLIER 'Trans proline' 0 C--N 1.361 1.193 0 CA-C-N 125.298 2.928 . . . . 0.0 110.943 -173.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.56 0.695 . . . . 0.0 112.355 169.092 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo . . . . . 0 CA--C 1.555 1.556 0 N-CA-C 110.044 -0.791 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.9 m 76.15 110.21 0.07 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.058 1.343 . . . . 0.0 108.776 165.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 15.8 mm -73.28 129.53 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -119.2 153.54 34.77 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 112.993 -1.912 . . . . 0.0 108.981 -175.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . 0.258 10.9 mm -98.42 106.58 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.685 0 N-CA-C 100.24 -3.985 . . . . 0.0 100.24 170.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.0 t -93.45 -49.86 5.71 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 -173.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.508 ' HZ2' ' HB2' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -133.94 136.18 44.05 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 169.51 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -79.49 138.4 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 177.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.343 1.5 mp -72.88 115.57 41.44 Favored Pre-proline 0 CA--C 1.568 1.663 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 171.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -68.61 140.95 48.72 Favored 'Trans proline' 0 C--N 1.369 1.634 0 C-N-CA 123.328 2.685 . . . . 0.0 113.067 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.3 7.79 73.36 Favored Glycine 0 CA--C 1.552 2.399 0 N-CA-C 118.177 2.031 . . . . 0.0 118.177 -174.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -99.09 -165.76 30.09 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-N 119.217 1.509 . . . . 0.0 112.719 177.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.03 -30.72 71.16 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 176.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.43 ' HA ' HD12 ' A' ' 68' ' ' LEU . . . -69.21 -40.85 77.77 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 116.873 2.175 . . . . 0.0 116.873 172.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.51 -41.63 96.29 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 170.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -72.96 -52.7 13.53 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 115.019 1.488 . . . . 0.0 115.019 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.0 t70 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 176.979 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 . . . . . 0 C--O 1.235 0.337 0 N-CA-C 103.288 -2.856 . . . . 0.0 103.288 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 21.5 m -84.64 82.52 8.38 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 114.414 -1.266 . . . . 0.0 109.508 -175.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.6 tp -64.21 123.09 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 CA-C-O 122.527 1.155 . . . . 0.0 111.441 -174.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -111.96 -53.28 2.72 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 112.334 -2.212 . . . . 0.0 112.053 174.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -122.63 133.66 54.52 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 -170.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.5 t -126.61 111.88 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 103.353 -2.832 . . . . 0.0 103.353 -178.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.535 HD22 ' CB ' ' A' ' 140' ' ' ALA 0.278 10.0 m-80 81.5 -78.4 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 123.371 1.558 . . . . 0.0 109.496 178.318 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -152.18 -22.47 0.18 Allowed 'General case' 0 CA--C 1.576 1.955 0 C-N-CA 128.219 2.607 . . . . 0.0 109.618 175.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.3 t -59.56 137.64 21.7 Favored 'Isoleucine or valine' 0 C--N 1.362 1.145 0 C-N-CA 125.469 1.508 . . . . 0.0 110.911 176.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -105.6 103.35 12.84 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 113.022 -1.899 . . . . 0.0 108.437 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . 0.262 0.5 OUTLIER -97.48 -90.24 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-O 117.012 -1.47 . . . . 0.0 108.166 176.806 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.516 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.32 23.1 ptt180 51.16 -88.37 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 117.351 2.352 . . . . 0.0 117.351 178.601 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.516 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 2.8 mp0 -85.58 67.13 9.98 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 123.505 1.621 . . . . 0.0 109.472 173.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.3 p -137.13 169.17 20.08 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-O 124.263 1.982 . . . . 0.0 105.924 -178.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 5.3 m -59.25 134.94 57.46 Favored 'General case' 0 CA--C 1.56 1.334 0 CA-C-N 112.701 -2.045 . . . . 0.0 110.643 157.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -45.78 -32.9 2.76 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 117.656 2.465 . . . . 0.0 117.656 169.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 9.4 m -63.41 -40.41 97.13 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -69.42 -36.74 76.98 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 168.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -67.23 -50.51 60.38 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 172.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.7 p -52.96 -45.11 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 114.544 1.312 . . . . 0.0 114.544 166.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -60.42 -47.0 88.0 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-O 115.553 -2.165 . . . . 0.0 112.515 173.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.18 -35.97 82.52 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 117.044 2.239 . . . . 0.0 117.044 172.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -50.79 -54.26 25.04 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.299 1.04 . . . . 0.0 113.627 162.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -69.39 -38.45 78.01 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 174.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -63.4 -21.59 66.38 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 172.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.535 ' CB ' HD22 ' A' ' 121' ' ' ASN . . . -53.33 -22.81 7.87 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 118.674 2.842 . . . . 0.0 118.674 168.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 65.7 89.17 0.05 OUTLIER Glycine 0 C--N 1.351 1.384 0 CA-C-N 118.771 0.714 . . . . 0.0 114.5 155.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . 0.268 20.4 m 72.17 -30.3 0.21 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 118.02 2.6 . . . . 0.0 118.02 -172.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -146.82 110.72 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 -172.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.428 ' CG2' ' HB3' ' A' ' 68' ' ' LEU . 33.5 m -83.57 120.75 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.429 171.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -101.66 91.26 4.34 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 174.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.489 ' HB2' HG13 ' A' ' 66' ' ' ILE . 61.2 mt -95.31 137.9 33.74 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 122.536 1.16 . . . . 0.0 108.361 -172.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -127.67 124.64 38.42 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 175.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 28.6 m -134.13 115.91 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -163.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 32.9 ttm . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 -175.603 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.56 1.338 0 CA-C-O 122.964 1.364 . . . . 0.0 111.673 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.88 157.92 39.98 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 123.225 1.488 . . . . 0.0 109.904 168.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.04 136.55 42.64 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 113.603 -1.635 . . . . 0.0 106.853 172.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 88.5 m -102.5 136.08 42.98 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 167.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -78.61 140.82 38.4 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-O 123.667 1.699 . . . . 0.0 108.812 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 C--O 1.243 0.731 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 -178.745 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 20.9 p90 . . . . . 0 CA--C 1.552 1.028 0 CA-C-O 121.491 0.663 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -110.84 126.75 54.98 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.76 124.99 34.68 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.189 174.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.417 HG13 ' HB2' ' A' ' 146' ' ' LEU . 3.1 pt -137.95 108.28 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 -175.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.8 m -91.39 118.26 30.38 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 172.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.446 ' HB3' ' CG2' ' A' ' 144' ' ' VAL . 3.9 tp -115.42 167.4 10.9 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 113.977 -1.465 . . . . 0.0 108.198 174.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 . . . . . 0 N--CA 1.482 1.125 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 170.125 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.412 HD21 ' CE2' ' A' ' 77' ' ' PHE . 1.3 tt . . . . . 0 CA--C 1.573 1.829 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 110.91 16.84 9.47 Favored Glycine 0 N--CA 1.478 1.489 0 N-CA-C 117.559 1.783 . . . . 0.0 117.559 169.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.412 ' CE2' HD21 ' A' ' 75' ' ' LEU . 27.7 p90 -143.0 173.0 11.94 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 124.306 2.003 . . . . 0.0 108.5 171.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.7 m -122.12 155.09 36.45 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 123.705 1.717 . . . . 0.0 106.481 176.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.1 pt -121.72 127.05 75.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 111.635 -2.53 . . . . 0.0 109.107 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.37 -168.26 1.29 Allowed 'General case' 0 CA--C 1.556 1.187 0 CA-C-O 123.339 1.542 . . . . 0.0 109.995 159.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.39 159.9 26.48 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 123.409 1.56 . . . . 0.0 115.16 -145.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.37 -160.84 23.31 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-N 111.906 -2.147 . . . . 0.0 113.542 178.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 30.3 p -52.83 -41.2 64.0 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 -178.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -83.04 -8.83 59.5 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 176.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.01 96.98 2.09 Favored Pre-proline 0 CA--C 1.556 1.197 0 N-CA-C 102.32 -3.215 . . . . 0.0 102.32 -173.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -99.15 134.84 0.26 Allowed 'Trans proline' 0 CA--C 1.551 1.338 0 CA-C-N 123.96 2.45 . . . . 0.0 111.543 174.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.449 ' HB2' ' CD2' ' B' ' 1' ' ' TYR . 9.1 t-80 . . . . . 0 N--CA 1.498 1.926 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 155.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo . . . . . 0 CA--C 1.547 1.141 0 CA-C-O 121.339 0.475 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.6 m 78.22 107.67 0.07 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.461 1.104 . . . . 0.0 108.534 166.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 13.0 mm -74.99 127.51 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 106.376 -1.712 . . . . 0.0 106.376 -177.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -115.18 149.42 37.69 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 113.432 -1.713 . . . . 0.0 108.458 -175.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 22.3 mm -97.35 104.23 15.64 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.278 0 N-CA-C 104.388 -2.449 . . . . 0.0 104.388 171.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.427 HG21 ' HG3' ' B' ' 3' ' ' LYS . 12.2 t -79.51 -46.64 17.01 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 -177.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.0 ptmt -150.31 146.03 26.51 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.772 0.796 . . . . 0.0 111.099 -170.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.54 135.1 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 178.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.7 mp -82.9 117.62 69.14 Favored Pre-proline 0 CA--C 1.565 1.52 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 172.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.69 135.16 51.01 Favored 'Trans proline' 0 C--N 1.367 1.537 0 C-N-CA 123.442 2.761 . . . . 0.0 113.09 169.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 87.33 -9.97 70.98 Favored Glycine 0 CA--C 1.548 2.156 0 N-CA-C 117.707 1.843 . . . . 0.0 117.707 -169.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -85.91 -179.58 50.01 Favored Glycine 0 CA--C 1.538 1.472 0 CA-C-N 119.44 1.62 . . . . 0.0 113.602 175.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.09 -33.7 72.2 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 117.1 2.259 . . . . 0.0 117.1 -177.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.62 -35.18 68.0 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 118.567 2.803 . . . . 0.0 118.567 169.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.85 -32.04 71.43 Favored 'General case' 0 CA--C 1.558 1.274 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 171.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.02 -53.59 8.14 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 119.706 1.139 . . . . 0.0 112.827 172.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.2 t70 . . . . . 0 N--CA 1.484 1.24 0 C-N-CA 123.773 0.829 . . . . 0.0 112.555 -170.927 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 . . . . . 0 CA--C 1.535 0.382 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 64.3 m -88.93 89.92 8.19 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -175.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.407 HG12 HD13 ' A' ' 137' ' ' LEU . 6.7 tp -63.21 128.01 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.073 178.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.416 ' HA ' ' HB3' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -114.93 -54.15 2.59 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 112.422 -2.172 . . . . 0.0 114.421 177.076 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -119.79 134.65 55.16 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 -174.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.1 p -123.94 118.34 53.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 169.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.607 HD22 ' CB ' ' A' ' 140' ' ' ALA 0.298 11.6 m-80 78.5 -81.25 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 122.953 1.359 . . . . 0.0 109.604 -177.213 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -152.91 -20.88 0.16 Allowed 'General case' 0 CA--C 1.568 1.659 0 C-N-CA 127.859 2.464 . . . . 0.0 110.177 -177.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.2 t -64.35 135.19 28.35 Favored 'Isoleucine or valine' 0 C--N 1.362 1.122 0 C-N-CA 125.318 1.447 . . . . 0.0 110.358 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -90.8 97.54 11.24 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 113.072 -1.877 . . . . 0.0 108.307 172.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . 0.282 0.2 OUTLIER -93.48 -93.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-O 116.447 -1.739 . . . . 0.0 107.159 170.263 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.594 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.292 11.3 ptt180 48.39 -88.69 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 117.851 2.538 . . . . 0.0 117.851 178.615 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.594 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 1.7 tt0 -84.1 66.86 9.47 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-O 123.674 1.702 . . . . 0.0 108.804 172.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -139.7 169.96 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 CA-C-N 112.606 -2.088 . . . . 0.0 106.513 178.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 7.7 m -60.5 136.5 58.07 Favored 'General case' 0 CA--C 1.561 1.375 0 CA-C-N 113.439 -1.709 . . . . 0.0 110.843 159.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -45.3 -35.23 3.34 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 118.263 2.69 . . . . 0.0 118.263 170.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 79.0 p -60.31 -42.24 95.15 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 116.786 2.143 . . . . 0.0 116.786 172.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -70.68 -37.78 73.66 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 169.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -59.79 -55.49 33.66 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 169.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.42 ' CG2' ' HB ' ' B' ' 6' ' ' VAL . 2.2 p -53.13 -46.84 55.77 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 170.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -60.55 -45.99 91.84 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 115.838 -2.03 . . . . 0.0 112.844 176.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.7 -34.57 78.61 Favored 'General case' 0 CA--C 1.558 1.278 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 171.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.407 HD13 HG12 ' A' ' 117' ' ' ILE . 9.6 mp -58.65 -46.55 86.9 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 165.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -70.33 -33.06 71.04 Favored 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 170.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -73.26 -14.96 61.42 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 116.455 2.02 . . . . 0.0 116.455 172.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.607 ' CB ' HD22 ' A' ' 121' ' ' ASN . . . -56.91 1.06 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.172 0 N-CA-C 119.227 3.047 . . . . 0.0 119.227 162.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 77.25 -146.51 31.92 Favored Glycine 0 C--N 1.344 1.019 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 176.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.8 m -72.0 -6.95 45.87 Favored 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 173.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -147.49 107.71 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 -165.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.446 ' CG2' ' HB3' ' A' ' 68' ' ' LEU . 23.1 m -92.48 123.91 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 114.073 -1.422 . . . . 0.0 108.612 -174.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -103.15 87.12 2.82 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.417 ' HB2' HG13 ' A' ' 66' ' ' ILE . 73.7 mt -91.33 133.9 35.05 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 -170.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -124.42 121.83 35.97 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 33.3 m -129.56 117.53 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -167.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 27.5 ttt . . . . . 0 N--CA 1.482 1.165 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -175.365 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 1' ' ' TYR . . . . . 0.449 ' CD2' ' HB2' ' A' ' 87' ' ' HIS . 0.3 OUTLIER . . . . . 0 CA--C 1.559 1.297 0 CA-C-O 122.887 1.327 . . . . 0.0 110.718 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 66.1 tttp -135.15 134.46 40.2 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-O 123.405 1.574 . . . . 0.0 108.205 165.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.427 ' HG3' HG21 ' A' ' 97' ' ' THR . 1.1 tmmt? -104.28 126.91 51.78 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 113.809 -1.541 . . . . 0.0 109.051 173.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 91.1 m -98.2 139.82 33.42 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 114.173 -1.376 . . . . 0.0 109.343 172.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -87.45 128.01 35.22 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 113.926 -1.488 . . . . 0.0 108.936 175.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.42 ' HB ' ' CG2' ' A' ' 134' ' ' VAL . 4.1 p . . . . . 0 C--O 1.248 1.025 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 175.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 8.8 p90 . . . . . 0 N--CA 1.481 1.078 0 CA-C-O 121.658 0.742 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -124.91 137.65 54.27 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 114.608 -1.178 . . . . 0.0 108.971 -177.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -103.27 132.3 49.64 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.66 175.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 21.0 pt -135.55 127.12 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -175.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.2 m -95.26 121.62 37.1 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 170.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 mp -119.75 126.9 52.18 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.373 -1.285 . . . . 0.0 107.632 -174.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.548 0.873 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.39 -172.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.484 1.265 0 CA-C-O 118.558 -0.734 . . . . 0.0 111.363 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.06 37.71 2.86 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 117.427 1.731 . . . . 0.0 117.427 162.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -152.33 143.76 23.37 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 -172.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.1 m -106.91 122.25 46.04 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.572 -1.194 . . . . 0.0 108.538 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.1 pt -108.13 129.56 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 CA-C-O 121.674 0.749 . . . . 0.0 109.952 -171.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.57 -171.4 3.52 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-O 123.597 1.665 . . . . 0.0 111.281 158.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.44 159.65 21.15 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-O 123.713 1.73 . . . . 0.0 115.057 -137.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -102.77 -162.14 25.9 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 111.441 -2.38 . . . . 0.0 111.874 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 44.3 p -55.15 -40.38 70.53 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 116.922 2.193 . . . . 0.0 116.922 -174.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -75.51 -21.97 57.54 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 116.353 1.983 . . . . 0.0 116.353 174.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.411 HD21 ' CE1' ' A' ' 130' ' ' HIS . 0.1 OUTLIER -145.28 95.94 4.98 Favored Pre-proline 0 CA--C 1.553 1.075 0 N-CA-C 101.498 -3.519 . . . . 0.0 101.498 -173.916 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -93.32 137.29 1.33 Allowed 'Trans proline' 0 CA--C 1.554 1.475 0 CA-C-N 124.079 2.493 . . . . 0.0 111.646 -177.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 . . . . . 0 N--CA 1.495 1.783 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 161.471 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo . . . . . 0 CA--C 1.545 1.056 0 CA-C-O 120.946 0.311 . . . . 0.0 112.113 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 66.8 m 73.17 138.6 0.05 Allowed 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 122.438 1.113 . . . . 0.0 109.323 176.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 15.0 mm -94.43 121.71 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 -169.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -124.57 138.17 54.34 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 -174.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 82.4 mt -82.35 122.98 37.83 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.627 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 169.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 89.3 m -93.57 -33.84 13.57 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 117.627 -1.177 . . . . 0.0 113.907 172.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . 0.354 8.1 ptmm? -140.27 167.75 21.4 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-O 123.534 1.635 . . . . 0.0 110.885 173.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -109.14 129.22 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 103.835 -2.654 . . . . 0.0 103.835 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.314 22.5 mt -83.74 121.76 76.26 Favored Pre-proline 0 CA--C 1.564 1.503 0 CA-C-O 117.915 -1.041 . . . . 0.0 108.789 175.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -55.96 141.18 86.48 Favored 'Trans proline' 0 C--N 1.371 1.746 0 C-N-CA 124.075 3.183 . . . . 0.0 115.581 178.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.95 15.04 79.83 Favored Glycine 0 CA--C 1.547 2.058 0 N-CA-C 117.27 1.668 . . . . 0.0 117.27 -164.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -89.23 176.83 43.9 Favored Glycine 0 C--N 1.34 0.772 0 C-N-CA 124.721 1.153 . . . . 0.0 115.578 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.37 -48.54 75.11 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 177.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.23 -34.0 74.16 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.69 -44.35 81.97 Favored 'General case' 0 CA--C 1.561 1.388 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 168.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.4 -65.4 0.82 Allowed 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 124.637 1.175 . . . . 0.0 111.791 176.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.2 t70 . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 115.478 1.659 . . . . 0.0 115.478 -174.142 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.3 p30 . . . . . 0 CA--C 1.542 0.651 0 N-CA-C 101.068 -3.678 . . . . 0.0 101.068 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.5 m -67.49 79.82 0.17 Allowed 'General case' 0 CA--C 1.554 1.108 0 CA-C-N 113.409 -1.723 . . . . 0.0 111.531 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.6 pt -70.14 100.61 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-O 123.406 1.574 . . . . 0.0 108.8 -176.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.8 pp -96.41 -38.7 9.93 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 112.909 -1.951 . . . . 0.0 114.94 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -125.46 140.55 52.68 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 123.273 1.511 . . . . 0.0 107.067 177.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.5 t -134.0 113.04 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 102.259 -3.238 . . . . 0.0 102.259 -179.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.585 HD22 ' HB1' ' A' ' 140' ' ' ALA 0.32 22.3 m-80 83.97 -78.05 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 123.934 1.826 . . . . 0.0 110.134 179.572 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -156.38 -23.9 0.1 Allowed 'General case' 0 CA--C 1.572 1.791 0 CA-C-N 110.472 -3.058 . . . . 0.0 109.276 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.3 t -61.73 138.78 21.71 Favored 'Isoleucine or valine' 0 C--N 1.361 1.066 0 C-N-CA 125.604 1.561 . . . . 0.0 111.087 -177.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -94.88 87.91 5.13 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 111.348 -2.66 . . . . 0.0 110.81 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . 0.287 0.5 OUTLIER -92.37 -98.52 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 CA-C-O 117.104 -1.427 . . . . 0.0 108.154 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.611 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.315 15.1 ptt180 48.37 -89.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 -179.514 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.611 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 21.9 tt0 -74.68 75.49 2.05 Favored 'General case' 0 CA--C 1.557 1.237 0 CA-C-O 123.738 1.732 . . . . 0.0 110.323 166.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -155.0 164.35 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 -175.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 34.0 m -60.06 132.11 52.92 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-N 113.586 -1.643 . . . . 0.0 109.671 156.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . 0.411 ' CE1' HD21 ' A' ' 85' ' ' ASN . 9.2 p-80 -46.82 -31.45 3.05 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 118.212 2.671 . . . . 0.0 118.212 171.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.6 m -60.09 -38.59 83.37 Favored 'General case' 0 CA--C 1.561 1.375 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 173.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -71.07 -35.93 72.08 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 166.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -59.88 -53.71 54.74 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 168.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 9.7 p -55.99 -41.92 69.73 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.444 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 166.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -57.57 -43.56 84.61 Favored 'General case' 0 CA--C 1.556 1.191 0 CA-C-O 117.626 -1.178 . . . . 0.0 113.458 171.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.14 -33.43 75.45 Favored 'General case' 0 CA--C 1.558 1.263 0 N-CA-C 116.397 1.999 . . . . 0.0 116.397 167.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.65 -50.96 71.85 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 165.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -65.98 -38.33 88.27 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 173.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -65.96 -28.46 68.92 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 116.353 1.983 . . . . 0.0 116.353 171.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.585 ' HB1' HD22 ' A' ' 121' ' ' ASN . . . -52.43 -33.21 43.01 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 117.443 2.386 . . . . 0.0 117.443 161.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 93.62 -120.15 6.19 Favored Glycine 0 C--N 1.345 1.051 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 166.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.3 m -86.71 0.29 54.91 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 117.426 2.38 . . . . 0.0 117.426 168.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.95 101.99 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 -170.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.415 ' HA ' ' HB2' ' A' ' 140' ' ' ALA . 15.5 m -88.02 118.64 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 114.04 -1.436 . . . . 0.0 109.654 176.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 40.8 mtt180 -98.58 87.65 3.87 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 178.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 53.3 mt -90.45 136.52 33.0 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -170.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -122.72 120.39 33.49 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 104.515 -2.402 . . . . 0.0 104.515 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -123.44 120.62 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 -176.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 28.3 ttt . . . . . 0 N--CA 1.476 0.835 0 O-C-N 124.519 1.137 . . . . 0.0 109.982 162.449 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 1.3 p90 . . . . . 0 CA--C 1.56 1.342 0 CA-C-O 122.569 1.176 . . . . 0.0 110.741 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -132.99 133.99 43.87 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-O 123.017 1.389 . . . . 0.0 108.473 170.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -95.69 124.96 39.95 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 113.782 -1.554 . . . . 0.0 108.736 169.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 4.7 m -83.69 140.41 32.16 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 123.309 1.528 . . . . 0.0 109.21 167.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -98.99 105.79 17.97 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 104.889 -2.263 . . . . 0.0 104.889 -177.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 12.3 t . . . . . 0 C--O 1.256 1.428 0 CA-C-O 123.03 1.395 . . . . 0.0 107.803 -165.983 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.44 ' HB3' ' HG2' ' A' ' 149' ' ' MET . 13.3 p90 . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 121.368 0.604 . . . . 0.0 110.353 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -107.77 132.99 52.8 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.562 172.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.22 121.4 43.59 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 113.824 -1.535 . . . . 0.0 108.593 -177.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 13.5 pt -135.32 118.7 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 -174.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.7 m -89.96 124.2 34.53 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 168.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.5 tp -116.05 125.0 51.84 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 114.22 -1.354 . . . . 0.0 109.293 -171.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 . . . . . 0 N--CA 1.471 0.594 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.423 -176.094 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.6 mp . . . . . 0 CA--C 1.56 1.341 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 145.71 67.41 0.01 OUTLIER Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 167.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -163.62 141.01 7.32 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 124.292 1.996 . . . . 0.0 108.772 176.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.8 m -92.85 128.22 38.63 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 112.208 -2.269 . . . . 0.0 110.846 -178.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.9 pp -103.63 125.74 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.866 178.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.86 -175.53 2.55 Favored 'General case' 0 CA--C 1.555 1.138 0 CA-C-O 123.624 1.678 . . . . 0.0 111.076 164.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.03 155.73 20.01 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-O 123.591 1.662 . . . . 0.0 115.469 -141.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.13 -160.29 21.51 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 111.37 -2.415 . . . . 0.0 113.891 177.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 38.9 p -58.67 -38.7 78.74 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 115.578 1.695 . . . . 0.0 115.578 -174.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -96.53 12.91 29.85 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 175.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -163.67 76.83 1.71 Allowed Pre-proline 0 N--CA 1.481 1.103 0 N-CA-C 100.868 -3.753 . . . . 0.0 100.868 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -100.12 127.58 0.14 Allowed 'Trans proline' 0 C--N 1.364 1.382 0 CA-C-N 125.198 2.892 . . . . 0.0 111.07 -166.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 41.7 t60 . . . . . 0 CA--C 1.566 1.593 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 162.412 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo . . . . . 0 CA--C 1.54 0.783 0 N-CA-C 113.634 0.59 . . . . 0.0 113.634 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.7 m -158.64 122.67 4.0 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 -173.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.405 HG13 ' CB ' ' A' ' 133' ' ' ALA . 21.0 mm -79.42 126.06 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 -173.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 22.8 m-30 -117.72 161.54 19.52 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.646 -1.615 . . . . 0.0 107.32 -176.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 89.2 mt -105.8 112.73 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 103.738 -2.69 . . . . 0.0 103.738 149.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.6 m -95.61 -18.64 20.4 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 169.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -136.99 153.62 50.63 Favored 'General case' 0 CA--C 1.556 1.2 0 CA-C-O 124.301 2.0 . . . . 0.0 109.954 178.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -113.43 125.63 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-N 112.98 -1.918 . . . . 0.0 105.947 175.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.279 1.4 mp -71.55 127.61 90.86 Favored Pre-proline 0 CA--C 1.567 1.6 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 171.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.57 130.75 41.69 Favored 'Trans proline' 0 C--N 1.365 1.399 0 C-N-CA 123.558 2.838 . . . . 0.0 115.141 176.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 72.98 9.87 76.68 Favored Glycine 0 CA--C 1.551 2.324 0 N-CA-C 118.306 2.082 . . . . 0.0 118.306 -169.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -84.98 -168.71 45.03 Favored Glycine 0 C--N 1.336 0.577 0 N-CA-C 115.625 1.01 . . . . 0.0 115.625 -176.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.81 -52.61 55.86 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.7 -37.46 82.31 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 115.887 -2.006 . . . . 0.0 114.491 173.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.72 -51.18 66.11 Favored 'General case' 0 CA--C 1.562 1.438 0 CA-C-N 121.366 1.894 . . . . 0.0 114.936 173.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.8 -60.93 3.06 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 125.182 1.393 . . . . 0.0 113.25 176.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.2 t70 . . . . . 0 CA--C 1.557 1.248 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -173.815 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . 0.267 17.2 t70 . . . . . 0 N--CA 1.468 0.448 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.8 m -139.33 92.02 2.55 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 -177.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.31 121.66 31.67 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.29 0 CA-C-O 122.445 1.116 . . . . 0.0 109.692 170.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.727 HD12 ' H ' ' A' ' 149' ' ' MET . 0.0 OUTLIER -106.05 -46.98 3.95 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.337 1.055 . . . . 0.0 113.144 179.504 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.455 ' H ' HD23 ' A' ' 118' ' ' LEU . 68.1 m-85 -120.39 141.26 50.27 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 175.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.7 p -128.66 122.17 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 170.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.613 HD22 ' HB2' ' A' ' 140' ' ' ALA 0.314 34.1 m-80 79.19 -76.17 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 123.622 1.677 . . . . 0.0 110.767 -177.379 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -163.47 -20.85 0.04 OUTLIER 'General case' 0 CA--C 1.572 1.794 0 CA-C-N 111.291 -2.686 . . . . 0.0 109.778 -175.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.4 t -64.48 136.21 26.86 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.168 0 C-N-CA 125.334 1.453 . . . . 0.0 110.249 -177.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -88.69 80.92 7.14 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 112.237 -2.256 . . . . 0.0 110.392 175.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -86.3 -89.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-O 117.074 -1.441 . . . . 0.0 107.892 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.671 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.305 11.6 ptt180 46.22 -92.96 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 124.993 1.317 . . . . 0.0 114.393 -177.661 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.671 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 16.3 mt-10 -84.2 66.79 9.49 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 123.866 1.793 . . . . 0.0 111.947 175.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.5 p -133.34 168.09 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 112.607 -2.088 . . . . 0.0 105.918 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 96.6 m -59.66 137.01 58.16 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-N 113.609 -1.632 . . . . 0.0 110.627 157.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -46.91 -37.62 9.19 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 171.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.9 m -56.23 -45.42 79.96 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 177.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.34 -39.06 88.96 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 171.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.405 ' CB ' HG13 ' A' ' 94' ' ' ILE . . . -68.04 -51.1 50.69 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 116.278 1.955 . . . . 0.0 116.278 171.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -59.94 -39.35 79.88 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 N-CA-C 115.888 1.81 . . . . 0.0 115.888 173.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.79 -42.77 97.67 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-O 117.223 -1.37 . . . . 0.0 113.051 167.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.71 -31.36 72.55 Favored 'General case' 0 CA--C 1.565 1.527 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 169.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.5 mp -61.49 -55.48 30.59 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 125.52 1.528 . . . . 0.0 112.322 166.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -64.01 -31.88 73.23 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 116.729 2.122 . . . . 0.0 116.729 170.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -66.44 -27.66 68.0 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 169.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.613 ' HB2' HD22 ' A' ' 121' ' ' ASN . . . -51.81 -42.67 62.68 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 115.826 1.787 . . . . 0.0 115.826 159.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 90.07 -129.03 9.52 Favored Glycine 0 C--N 1.349 1.275 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 165.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.0 t -72.26 -2.04 17.49 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 117.353 2.353 . . . . 0.0 117.353 168.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.97 107.56 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 -173.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.442 ' HA ' ' HB3' ' A' ' 140' ' ' ALA . 4.2 t -113.94 105.85 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 -169.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -89.65 92.11 8.94 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -178.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 22.1 mt -93.96 131.22 39.64 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 -175.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -120.15 128.39 53.38 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 104.686 -2.339 . . . . 0.0 104.686 -178.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -136.64 128.37 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' MET . . . . . 0.727 ' H ' HD12 ' A' ' 118' ' ' LEU . 63.9 mtm . . . . . 0 C--O 1.239 0.519 0 C-N-CA 127.016 2.126 . . . . 0.0 109.465 172.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.554 1.098 0 CA-C-O 123.33 1.538 . . . . 0.0 110.398 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 22.7 tptp -151.28 121.94 7.47 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 113.632 -1.622 . . . . 0.0 107.833 170.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 6.0 ptmm? -75.7 109.41 9.26 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 113.918 -1.492 . . . . 0.0 111.26 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 26.3 m -81.43 126.97 32.28 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 123.287 1.518 . . . . 0.0 108.884 -178.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.94 106.17 18.33 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 113.331 -1.759 . . . . 0.0 106.891 -174.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 42.8 t . . . . . 0 C--O 1.251 1.179 0 N-CA-C 105.218 -2.142 . . . . 0.0 105.218 -178.752 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 21.8 p90 . . . . . 0 N--CA 1.477 0.884 0 CA-C-O 121.857 0.837 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -98.42 126.39 43.93 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.47 125.37 35.15 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 113.368 -1.742 . . . . 0.0 108.199 173.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.449 ' HB ' ' HB2' ' A' ' 146' ' ' LEU . 19.0 mt -126.61 131.83 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 -176.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.3 m -106.6 120.69 42.63 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 171.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.4 tp -124.93 145.57 49.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 113.39 -1.732 . . . . 0.0 107.739 176.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.408 ' HG3' ' HB3' ' A' ' 104' ' ' ALA . 2.7 pt-20 . . . . . 0 CA--C 1.559 1.314 0 O-C-N 121.218 -0.926 . . . . 0.0 110.71 173.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.497 HD22 ' H ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.403 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 76.1 50.48 7.61 Favored Glycine 0 C--N 1.338 0.663 0 N-CA-C 116.229 1.251 . . . . 0.0 116.229 175.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -155.2 149.29 25.8 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 123.172 1.463 . . . . 0.0 108.036 173.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.6 m -97.31 136.07 38.32 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.164 177.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.2 pt -110.13 123.74 66.29 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-O 121.95 0.881 . . . . 0.0 109.576 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.7 177.42 8.14 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-O 124.292 1.996 . . . . 0.0 110.247 157.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -96.75 164.71 22.99 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-O 124.24 2.022 . . . . 0.0 115.582 -140.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -102.78 -166.88 26.19 Favored Glycine 0 CA--C 1.521 0.465 0 CA-C-N 110.543 -2.828 . . . . 0.0 112.364 -175.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 63.1 p -44.57 -42.51 7.38 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 118.014 2.598 . . . . 0.0 118.014 -177.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -88.19 -7.6 56.61 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 115.993 1.849 . . . . 0.0 115.993 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.405 HD22 ' H ' ' B' ' 2' ' ' LYS 0.267 4.4 t30 -151.99 58.59 2.71 Favored Pre-proline 0 CA--C 1.571 1.755 0 CA-C-O 116.667 -1.635 . . . . 0.0 107.632 -178.508 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -97.57 135.04 0.37 Allowed 'Trans proline' 0 C--N 1.373 1.83 0 CA-C-N 126.282 3.279 . . . . 0.0 111.538 -170.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.522 ' HB2' ' CG ' ' B' ' 1' ' ' TYR . 7.9 t-80 . . . . . 0 N--CA 1.502 2.169 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 163.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo . . . . . 0 CA--C 1.558 1.708 0 N-CA-C 110.403 -0.653 . . . . 0.0 110.403 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 53.1 m 75.71 134.72 0.05 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.991 1.316 . . . . 0.0 109.816 165.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 23.4 mm -96.14 124.44 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 105.812 -1.921 . . . . 0.0 105.812 -172.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -129.6 126.22 37.96 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -175.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . 0.349 60.2 mt -66.44 129.6 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.287 0 CA-C-O 122.895 1.331 . . . . 0.0 108.648 174.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.4 m -87.69 -41.4 13.38 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 124.846 1.258 . . . . 0.0 113.325 171.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -140.4 160.95 38.86 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 124.174 1.94 . . . . 0.0 110.465 -175.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -114.4 109.93 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 102.365 -3.198 . . . . 0.0 102.365 174.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.254 1.5 mp -66.71 121.28 76.74 Favored Pre-proline 0 CA--C 1.564 1.516 0 CA-C-O 117.774 -1.107 . . . . 0.0 109.395 -177.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -63.22 138.05 64.58 Favored 'Trans proline' 0 C--N 1.364 1.387 0 C-N-CA 123.373 2.715 . . . . 0.0 113.387 172.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.45 -6.83 56.49 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 117.977 1.951 . . . . 0.0 117.977 -168.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.403 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -90.01 176.81 42.64 Favored Glycine 0 CA--C 1.537 1.439 0 CA-C-O 122.435 1.019 . . . . 0.0 113.025 174.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.408 ' HB3' ' HG3' ' A' ' 69' ' ' GLU . . . -67.52 -36.82 81.77 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 117.332 2.345 . . . . 0.0 117.332 -175.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.06 -35.37 78.1 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 116.37 1.989 . . . . 0.0 116.37 168.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.8 -31.72 69.79 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 115.524 1.675 . . . . 0.0 115.524 166.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.34 -61.61 1.77 Allowed 'General case' 0 CA--C 1.566 1.584 0 C-N-CA 124.581 1.152 . . . . 0.0 111.739 171.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.8 t70 . . . . . 0 CA--C 1.556 1.209 0 C-N-CA 124.901 1.281 . . . . 0.0 112.369 -173.723 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 20.4 t70 . . . . . 0 C--O 1.24 0.581 0 N-CA-C 100.292 -3.966 . . . . 0.0 100.292 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.2 m -71.52 78.13 0.79 Allowed 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 113.026 -1.897 . . . . 0.0 109.982 -173.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 5.1 tp -73.86 109.97 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -174.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.402 ' HA ' ' HB3' ' A' ' 126' ' ' ARG . 0.2 OUTLIER -110.0 -47.61 3.3 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 113.171 -1.831 . . . . 0.0 114.157 -175.224 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -116.87 136.5 52.9 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 172.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 14.0 p -124.86 123.73 66.33 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 170.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.435 HD22 ' HB3' ' A' ' 140' ' ' ALA 0.302 28.9 m-80 77.85 -84.46 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 123.757 1.741 . . . . 0.0 108.921 179.971 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -151.57 -22.14 0.2 Allowed 'General case' 0 CA--C 1.574 1.882 0 CA-C-N 110.82 -2.9 . . . . 0.0 109.131 -176.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.3 t -68.41 136.71 25.91 Favored 'Isoleucine or valine' 0 C--N 1.363 1.155 0 C-N-CA 125.781 1.632 . . . . 0.0 110.224 -178.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -89.5 98.98 12.08 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 111.999 -2.364 . . . . 0.0 108.457 170.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . 0.26 0.4 OUTLIER -95.01 -98.36 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 173.233 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.589 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.287 16.1 ptt85 51.7 -92.39 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 116.855 2.169 . . . . 0.0 116.855 176.965 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.589 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 8.5 tt0 -77.65 64.54 2.97 Favored 'General case' 0 CA--C 1.56 1.34 0 CA-C-O 123.648 1.689 . . . . 0.0 110.967 167.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -139.02 167.6 20.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 2.7 m -58.84 134.46 56.91 Favored 'General case' 0 CA--C 1.557 1.222 0 CA-C-N 112.697 -2.047 . . . . 0.0 110.7 157.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -45.41 -32.72 2.23 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 117.499 2.407 . . . . 0.0 117.499 168.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.9 m -60.55 -43.12 97.58 Favored 'General case' 0 CA--C 1.556 1.203 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 175.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -69.67 -37.36 76.64 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 167.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -60.25 -59.27 5.68 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 170.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.435 HG22 HG22 ' B' ' 4' ' ' THR . 0.9 OUTLIER -50.81 -42.44 23.03 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 N-CA-C 116.43 2.011 . . . . 0.0 116.43 171.521 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.65 -48.18 75.75 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 116.317 -1.801 . . . . 0.0 112.607 174.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.51 -28.51 66.11 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 117.23 2.307 . . . . 0.0 117.23 174.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 5.0 mp -54.98 -53.5 54.86 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.159 1.383 . . . . 0.0 113.402 163.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -73.41 -38.58 65.52 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 172.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -65.93 0.11 2.01 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 116.549 2.055 . . . . 0.0 116.549 169.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.448 ' HB1' ' HA ' ' A' ' 144' ' ' VAL . . . -56.8 -9.96 0.93 Allowed 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 120.315 3.45 . . . . 0.0 120.315 162.088 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 102.69 -105.25 2.72 Favored Glycine 0 C--N 1.342 0.886 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 161.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.6 m -113.43 -7.83 13.43 Favored 'General case' 0 CA--C 1.576 1.943 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 163.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.19 111.98 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 -165.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.448 ' HA ' ' HB1' ' A' ' 140' ' ' ALA . 3.4 t -96.94 116.81 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 112.676 -2.056 . . . . 0.0 107.553 -174.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -99.83 91.07 4.66 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 177.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.449 ' HB2' ' HB ' ' A' ' 66' ' ' ILE . 22.9 mt -83.16 135.16 34.9 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -128.55 126.15 39.75 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.3 p -132.48 116.69 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 -173.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 25.2 ttt . . . . . 0 N--CA 1.474 0.726 0 CA-C-O 123.201 1.477 . . . . 0.0 108.516 168.336 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 1' ' ' TYR . . . . . 0.522 ' CG ' ' HB2' ' A' ' 87' ' ' HIS . 0.4 OUTLIER . . . . . 0 CA--C 1.557 1.224 0 CA-C-O 122.227 1.013 . . . . 0.0 111.548 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . 0.405 ' H ' HD22 ' A' ' 85' ' ' ASN . 4.3 mptp? -127.8 144.97 51.07 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 123.414 1.578 . . . . 0.0 107.707 165.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -101.26 126.69 48.03 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.03 176.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.435 HG22 HG22 ' A' ' 134' ' ' VAL . 98.4 m -97.38 130.94 44.47 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.031 172.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -76.66 138.98 40.38 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 113.964 -1.471 . . . . 0.0 109.564 170.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 6.0 p . . . . . 0 C--O 1.254 1.301 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.012 172.997 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 25.1 p90 . . . . . 0 N--CA 1.479 1.012 0 CA-C-O 121.995 0.902 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -109.5 145.53 36.11 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 113.99 -1.459 . . . . 0.0 108.848 176.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -107.52 121.57 44.9 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 112.658 -2.065 . . . . 0.0 106.095 -175.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.6 mp -130.64 128.26 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 -176.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.1 m -100.35 132.56 45.65 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 122.838 1.304 . . . . 0.0 107.547 163.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.404 HD11 ' HA ' ' A' ' 105' ' ' ALA . 9.6 tt -130.05 130.16 44.57 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 113.141 -1.845 . . . . 0.0 107.83 -169.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 . . . . . 0 N--CA 1.481 1.109 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 177.912 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.413 HD11 ' HB3' ' A' ' 137' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.56 1.355 0 CA-C-O 119.342 -0.361 . . . . 0.0 111.465 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 65.18 51.67 47.94 Favored Glycine 0 C--N 1.346 1.11 0 N-CA-C 117.279 1.671 . . . . 0.0 117.279 166.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -155.3 157.95 38.0 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 112.929 -1.635 . . . . 0.0 107.376 173.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.0 m -122.28 126.87 49.07 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 122.484 1.135 . . . . 0.0 109.341 -173.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 pt -91.33 127.77 43.5 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-N 113.444 -1.707 . . . . 0.0 109.309 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -83.87 -175.54 5.86 Favored 'General case' 0 CA--C 1.555 1.167 0 CA-C-O 123.641 1.686 . . . . 0.0 110.291 156.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.14 157.35 24.08 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 123.161 1.423 . . . . 0.0 116.58 -140.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -108.84 -169.36 20.84 Favored Glycine 0 N--CA 1.466 0.663 0 CA-C-N 111.914 -2.143 . . . . 0.0 114.289 178.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.406 HG22 ' HB2' ' A' ' 92' ' ' PRO . 18.2 p -43.69 -44.59 6.58 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 117.952 2.575 . . . . 0.0 117.952 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -85.55 -15.24 43.32 Favored 'General case' 0 CA--C 1.564 1.506 0 N-CA-C 115.915 1.82 . . . . 0.0 115.915 177.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.444 HD22 ' H ' ' B' ' 2' ' ' LYS . 4.4 t30 -150.64 73.92 8.8 Favored Pre-proline 0 CA--C 1.562 1.41 0 N-CA-C 103.893 -2.632 . . . . 0.0 103.893 -176.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -107.59 144.09 0.07 OUTLIER 'Trans proline' 0 C--N 1.374 1.915 0 CA-C-N 124.656 2.699 . . . . 0.0 112.446 -169.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 15.1 t60 . . . . . 0 N--CA 1.498 1.961 0 N-CA-C 114.695 1.369 . . . . 0.0 114.695 161.216 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.406 ' HB2' HG22 ' A' ' 83' ' ' THR . 19.1 Cg_endo . . . . . 0 CA--C 1.551 1.341 0 CA-C-O 121.593 0.58 . . . . 0.0 112.503 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 74.7 m -150.67 139.33 20.67 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 -179.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.415 HG13 ' HB3' ' A' ' 133' ' ' ALA . 31.5 mm -79.65 129.76 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 175.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.448 ' HA ' ' O ' ' A' ' 115' ' ' ASP 0.276 4.9 p90 -135.49 122.06 20.77 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 113.824 -1.534 . . . . 0.0 110.994 -177.067 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 71.0 mt -74.75 109.86 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 168.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 12.8 m -94.64 -14.62 24.73 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 114.978 -1.01 . . . . 0.0 113.714 172.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 29.5 tttp -139.53 150.12 44.72 Favored 'General case' 0 CA--C 1.557 1.243 0 CA-C-O 124.356 2.027 . . . . 0.0 110.343 -175.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -117.2 125.02 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 N-CA-C 103.924 -2.621 . . . . 0.0 103.924 174.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.5 mp -74.14 133.55 78.24 Favored Pre-proline 0 CA--C 1.566 1.572 0 CA-C-O 118.518 -0.754 . . . . 0.0 109.324 171.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.5 132.87 40.0 Favored 'Trans proline' 0 CA--C 1.554 1.512 0 C-N-CA 123.301 2.668 . . . . 0.0 113.687 171.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.19 11.93 85.08 Favored Glycine 0 CA--C 1.546 2.028 0 N-CA-C 117.383 1.713 . . . . 0.0 117.383 -164.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -84.09 170.75 47.67 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-O 123.086 1.381 . . . . 0.0 114.244 177.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.21 -43.98 89.79 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 112.286 -1.957 . . . . 0.0 115.387 178.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.404 ' HA ' HD11 ' A' ' 68' ' ' LEU . . . -67.17 -32.93 74.35 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 118.496 2.776 . . . . 0.0 118.496 173.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.37 -39.01 91.75 Favored 'General case' 0 CA--C 1.567 1.598 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 165.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -67.32 -60.93 2.18 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.378 1.471 . . . . 0.0 113.042 173.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 N--CA 1.487 1.413 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -172.795 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.448 ' O ' ' HA ' ' A' ' 95' ' ' PHE 0.278 8.3 t70 . . . . . 0 N--CA 1.474 0.749 0 CA-C-O 117.729 -1.129 . . . . 0.0 109.127 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 48.5 m -72.61 74.67 1.08 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.411 1.084 . . . . 0.0 113.246 -169.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.0 tp -67.68 103.95 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 171.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.428 ' HA ' ' HB3' ' A' ' 126' ' ' ARG 0.293 1.0 OUTLIER -91.18 -54.96 3.72 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 113.104 -1.862 . . . . 0.0 113.145 177.632 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.409 ' H ' HD13 ' A' ' 118' ' ' LEU . 20.2 m-85 -118.28 138.92 52.04 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 105.358 -2.089 . . . . 0.0 105.358 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.8 p -127.28 114.9 38.66 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 170.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.544 HD22 ' HB3' ' A' ' 140' ' ' ALA 0.352 14.5 m-80 80.05 -83.03 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 123.489 1.614 . . . . 0.0 109.7 -177.704 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -148.3 -25.68 0.34 Allowed 'General case' 0 CA--C 1.566 1.579 0 CA-C-N 111.126 -2.761 . . . . 0.0 109.411 -178.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.3 t -61.75 135.72 26.02 Favored 'Isoleucine or valine' 0 C--N 1.362 1.119 0 C-N-CA 125.385 1.474 . . . . 0.0 110.286 174.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -97.92 72.29 2.22 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 112.117 -2.311 . . . . 0.0 109.852 175.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -63.21 -86.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 116.243 -1.837 . . . . 0.0 110.401 176.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.744 ' HD2' ' H ' ' A' ' 127' ' ' GLU 0.325 0.1 OUTLIER 49.22 -98.58 0.05 Allowed 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 120.269 1.395 . . . . 0.0 113.353 171.827 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.744 ' H ' ' HD2' ' A' ' 126' ' ' ARG . 10.2 mt-10 -80.64 69.13 7.08 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 126.695 1.998 . . . . 0.0 110.414 174.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.8 p -139.11 169.3 17.61 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 CA-C-N 112.87 -1.968 . . . . 0.0 106.093 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 46.8 m -60.15 135.21 57.65 Favored 'General case' 0 CA--C 1.558 1.288 0 CA-C-N 113.16 -1.836 . . . . 0.0 110.624 157.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 3.6 p-80 -46.15 -35.31 4.94 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 170.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.2 m -62.69 -43.04 99.81 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 125.311 1.444 . . . . 0.0 114.761 176.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.16 -37.33 87.07 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 169.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.415 ' HB3' HG13 ' A' ' 94' ' ' ILE . . . -69.66 -50.93 39.37 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 116.466 2.024 . . . . 0.0 116.466 172.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.419 ' CG2' ' HB ' ' B' ' 6' ' ' VAL . 3.3 p -52.17 -42.67 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.475 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 170.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -72.82 -38.46 67.15 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 115.506 -2.188 . . . . 0.0 113.503 174.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.17 -34.05 77.16 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 116.937 2.199 . . . . 0.0 116.937 170.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.413 ' HB3' HD11 ' A' ' 75' ' ' LEU . 7.8 mp -55.59 -49.13 73.59 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.491 1.516 . . . . 0.0 114.939 162.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -68.05 -35.74 78.73 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 168.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.49 -20.76 66.12 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 173.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.544 ' HB3' HD22 ' A' ' 121' ' ' ASN . . . -52.86 -11.67 0.25 Allowed 'General case' 0 CA--C 1.561 1.377 0 N-CA-C 118.527 2.788 . . . . 0.0 118.527 161.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 79.97 -143.29 25.16 Favored Glycine 0 C--N 1.347 1.188 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 174.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 17.3 m -71.34 -4.52 26.56 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 116.691 2.108 . . . . 0.0 116.691 173.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.07 107.81 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 -170.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.5 t -93.66 114.84 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 113.797 -1.547 . . . . 0.0 108.24 -174.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 75.0 mtt-85 -96.39 94.82 7.65 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 -177.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 34.0 mt -99.58 138.82 36.14 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 122.069 0.938 . . . . 0.0 109.043 -170.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -128.78 115.82 18.54 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.24 129.15 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -173.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 CA--C 1.548 0.879 0 CA-C-O 123.307 1.527 . . . . 0.0 112.503 164.618 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 1.1 p90 . . . . . 0 N--CA 1.478 0.961 0 CA-C-O 122.977 1.37 . . . . 0.0 112.828 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . 0.444 ' H ' HD22 ' A' ' 85' ' ' ASN . 0.3 OUTLIER -136.6 144.86 44.34 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 112.738 -2.028 . . . . 0.0 110.888 166.919 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 10.0 ttpp -92.24 109.97 21.35 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 113.534 -1.667 . . . . 0.0 108.481 178.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.402 HG23 HG23 ' A' ' 134' ' ' VAL . 98.7 m -88.38 131.93 34.65 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 122.401 1.096 . . . . 0.0 108.784 175.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.11 155.48 32.36 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 113.848 -1.524 . . . . 0.0 109.971 175.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.419 ' HB ' ' CG2' ' A' ' 134' ' ' VAL . 7.7 p . . . . . 0 C--O 1.247 0.957 0 N-CA-C 104.392 -2.447 . . . . 0.0 104.392 -171.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 14.5 p90 . . . . . 0 CA--C 1.558 1.258 0 CA-C-O 121.272 0.558 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -126.66 135.49 51.24 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 122.099 0.952 . . . . 0.0 108.846 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.27 120.62 42.85 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.059 -174.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.6 mp -135.1 125.32 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 -172.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.9 m -98.8 122.53 42.16 Favored 'General case' 0 CA--C 1.557 1.213 0 CA-C-O 122.338 1.066 . . . . 0.0 108.302 173.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 mp -118.26 127.21 53.51 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.576 1.55 . . . . 0.0 108.594 -174.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 . . . . . 0 N--CA 1.476 0.875 0 CA-C-O 121.223 0.535 . . . . 0.0 110.154 -178.837 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 119.319 -0.372 . . . . 0.0 111.753 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.41 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 103.14 41.2 2.29 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 115.848 1.099 . . . . 0.0 115.848 164.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -158.32 127.2 5.56 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 123.425 1.583 . . . . 0.0 107.435 -175.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.3 m -87.56 137.45 32.32 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 121.246 -0.908 . . . . 0.0 111.126 174.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.5 pp -118.02 130.25 73.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 114.403 -1.271 . . . . 0.0 107.978 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -92.38 -169.68 2.29 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-O 123.288 1.518 . . . . 0.0 109.871 160.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.69 159.41 24.78 Favored Glycine 0 CA--C 1.537 1.459 0 CA-C-O 123.551 1.64 . . . . 0.0 115.783 -140.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.11 -162.26 21.87 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 111.606 -2.297 . . . . 0.0 112.316 -176.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 67.8 p -54.02 -41.11 67.65 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 117.373 2.361 . . . . 0.0 117.373 -177.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -75.51 -15.64 60.37 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 116.469 2.025 . . . . 0.0 116.469 173.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.42 HD21 ' CE1' ' A' ' 130' ' ' HIS . 0.1 OUTLIER -152.77 86.05 4.29 Favored Pre-proline 0 CA--C 1.56 1.343 0 N-CA-C 101.585 -3.487 . . . . 0.0 101.585 -177.511 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -99.41 125.02 0.15 Allowed 'Trans proline' 0 CA--C 1.547 1.126 0 CA-C-N 124.241 2.55 . . . . 0.0 110.533 -170.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 60.7 t60 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 174.279 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo . . . . . 0 CA--C 1.551 1.36 0 N-CA-C 110.805 -0.498 . . . . 0.0 110.805 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 43.6 m 70.7 144.04 0.06 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 122.667 1.222 . . . . 0.0 109.204 175.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 10.1 mm -91.78 126.05 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 -174.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -124.83 142.1 51.66 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 -178.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . 0.254 46.9 mt -85.32 119.52 34.08 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.541 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 175.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 91.8 m -85.92 -33.21 21.25 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 117.806 -1.093 . . . . 0.0 113.476 169.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . 0.285 0.0 OUTLIER -141.01 163.66 32.38 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-O 124.779 2.228 . . . . 0.0 111.324 179.218 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -104.18 119.87 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 166.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 24.0 mm -65.68 127.77 93.3 Favored Pre-proline 0 CA--C 1.566 1.58 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.164 178.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.74 129.06 32.62 Favored 'Trans proline' 0 C--N 1.365 1.406 0 C-N-CA 123.606 2.871 . . . . 0.0 115.286 -178.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.49 11.39 80.09 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 118.54 2.176 . . . . 0.0 118.54 -170.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.41 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -92.35 -175.92 41.9 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 124.546 1.069 . . . . 0.0 113.937 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.4 -51.96 63.62 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 117.146 2.276 . . . . 0.0 117.146 -171.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.04 -33.19 64.72 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 175.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -67.09 -44.74 79.23 Favored 'General case' 0 CA--C 1.563 1.457 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 169.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.33 -54.55 6.33 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 123.638 0.775 . . . . 0.0 112.306 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 . . . . . 0 N--CA 1.486 1.358 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -179.051 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 2.7 p30 . . . . . 0 CA--C 1.552 1.056 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 40.0 m -127.81 79.61 1.91 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 176.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.5 tp -56.45 116.55 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-O 121.997 0.904 . . . . 0.0 110.666 -178.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.414 ' HB2' ' HD3' ' A' ' 126' ' ' ARG . 3.0 pp -110.19 -47.85 3.25 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 116.785 2.143 . . . . 0.0 116.785 -174.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -126.64 138.07 53.38 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 177.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.1 t -128.44 109.8 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 100.543 -3.873 . . . . 0.0 100.543 175.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.603 HD22 ' HB2' ' A' ' 140' ' ' ALA 0.378 8.9 m-80 83.3 -88.48 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 122.921 1.343 . . . . 0.0 109.389 179.86 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -145.26 -13.82 0.52 Allowed 'General case' 0 CA--C 1.567 1.627 0 CA-C-N 111.401 -2.636 . . . . 0.0 110.59 175.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.3 t -67.58 133.03 32.18 Favored 'Isoleucine or valine' 0 C--N 1.359 0.994 0 C-N-CA 125.431 1.492 . . . . 0.0 109.997 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -84.19 98.09 9.75 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 112.476 -2.147 . . . . 0.0 109.599 172.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . 0.258 2.0 m -97.51 -103.26 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-O 116.281 -1.818 . . . . 0.0 106.97 173.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.563 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.289 13.2 ptt180 50.4 -93.33 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 120.217 1.371 . . . . 0.0 114.237 179.585 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.563 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 2.4 tt0 -79.25 68.68 5.3 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-O 123.425 1.583 . . . . 0.0 111.031 173.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.8 p -144.3 168.89 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.96 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 -173.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 27.4 m -61.76 130.86 47.81 Favored 'General case' 0 CA--C 1.559 1.3 0 CA-C-N 113.119 -1.855 . . . . 0.0 110.038 156.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . 0.42 ' CE1' HD21 ' A' ' 85' ' ' ASN . 2.1 p-80 -47.7 -29.44 3.05 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 118.587 2.81 . . . . 0.0 118.587 169.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.1 m -63.09 -37.91 89.07 Favored 'General case' 0 CA--C 1.565 1.543 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 171.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -70.25 -36.13 74.27 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 165.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.19 -55.61 30.26 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 114.695 1.368 . . . . 0.0 114.695 169.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.3 p -53.1 -40.55 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.162 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 169.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -58.17 -52.19 66.59 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 116.311 -1.804 . . . . 0.0 112.691 168.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.68 -35.62 74.83 Favored 'General case' 0 CA--C 1.561 1.391 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 173.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 9.6 mp -54.46 -53.92 47.86 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 125.296 1.438 . . . . 0.0 113.813 164.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -68.41 -33.54 74.4 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 116.507 2.04 . . . . 0.0 116.507 172.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -64.11 -32.19 73.66 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 115.17 1.544 . . . . 0.0 115.17 171.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.603 ' HB2' HD22 ' A' ' 121' ' ' ASN . . . -52.91 -36.57 59.69 Favored 'General case' 0 CA--C 1.557 1.214 0 N-CA-C 117.234 2.309 . . . . 0.0 117.234 163.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.12 -133.61 12.0 Favored Glycine 0 C--N 1.348 1.214 0 N-CA-C 111.644 -0.582 . . . . 0.0 111.644 167.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.3 t -66.4 -7.97 22.7 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 118.756 2.873 . . . . 0.0 118.756 170.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.32 107.84 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 -172.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.448 ' HA ' ' HB3' ' A' ' 140' ' ' ALA . 4.3 t -106.31 110.47 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 113.006 -1.907 . . . . 0.0 107.539 -173.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -101.77 91.46 4.41 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 78.0 mt -89.43 144.51 26.0 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 113.524 -1.671 . . . . 0.0 108.975 -175.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -133.15 115.97 15.7 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 103.446 -2.798 . . . . 0.0 103.446 173.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 19.6 m -119.57 155.39 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -170.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 60.7 ttp . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 122.494 1.14 . . . . 0.0 110.095 172.898 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 1.3 p90 . . . . . 0 CA--C 1.562 1.408 0 CA-C-O 122.313 1.054 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -133.72 125.21 28.1 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 123.141 1.448 . . . . 0.0 107.852 171.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 3.0 ttpt -96.76 133.56 41.18 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 113.872 -1.513 . . . . 0.0 108.131 175.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.3 150.14 27.02 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-O 123.121 1.439 . . . . 0.0 109.076 177.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -109.03 126.29 52.99 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 -176.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . 0.321 0.5 OUTLIER . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 173.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . 0.251 26.9 p90 . . . . . 0 CA--C 1.551 0.984 0 CA-C-O 121.652 0.739 . . . . 0.0 111.077 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -124.32 131.07 53.5 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -167.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -83.44 123.99 30.24 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 113.888 -1.505 . . . . 0.0 110.906 171.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.413 HG13 ' HB2' ' A' ' 146' ' ' LEU . 7.9 pt -140.33 118.12 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 -168.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.0 m -97.1 131.18 44.13 Favored 'General case' 0 CA--C 1.554 1.109 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 173.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.3 mp -125.35 131.53 52.98 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.176 179.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 . . . . . 0 N--CA 1.485 1.307 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -174.185 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.559 1.32 0 CA-C-O 118.635 -0.697 . . . . 0.0 112.497 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.406 ' CA ' ' HA3' ' A' ' 103' ' ' GLY . . . 106.19 15.79 16.8 Favored Glycine 0 N--CA 1.479 1.532 0 N-CA-C 121.118 3.207 . . . . 0.0 121.118 172.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -150.05 143.62 25.25 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 124.483 2.087 . . . . 0.0 108.857 -177.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.0 m -111.91 128.38 56.13 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 112.357 -2.202 . . . . 0.0 108.422 178.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.5 pp -109.2 126.72 66.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.495 -1.23 . . . . 0.0 109.609 -173.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -83.36 -171.89 3.84 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-O 123.401 1.572 . . . . 0.0 110.715 162.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -98.9 163.82 20.5 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-O 123.999 1.888 . . . . 0.0 115.829 -143.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -111.45 -164.06 17.84 Favored Glycine 0 N--CA 1.464 0.553 0 CA-C-N 110.854 -2.673 . . . . 0.0 111.086 -172.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.3 p -51.64 -40.41 59.92 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 117.714 2.487 . . . . 0.0 117.714 -173.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -80.26 -17.54 51.9 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 171.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . 0.303 6.3 t30 -138.2 54.76 7.66 Favored Pre-proline 0 CA--C 1.567 1.633 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -174.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -100.44 124.79 0.12 Allowed 'Trans proline' 0 C--N 1.365 1.442 0 CA-C-N 124.804 2.751 . . . . 0.0 111.312 -157.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 . . . . . 0 N--CA 1.487 1.412 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 174.633 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo . . . . . 0 CA--C 1.547 1.147 0 N-CA-C 114.161 0.793 . . . . 0.0 114.161 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 58.5 m -161.17 132.18 5.36 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 13.9 mm -82.29 124.88 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 -179.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -120.89 155.28 34.52 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 113.91 -1.495 . . . . 0.0 108.78 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 83.9 mt -92.62 117.39 35.88 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.629 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 158.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.402 ' CG2' ' HG3' ' B' ' 3' ' ' LYS . 10.1 t -86.04 -31.98 21.68 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 115.378 1.621 . . . . 0.0 115.378 169.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.464 ' HZ2' ' HB2' ' A' ' 98' ' ' LYS 0.342 0.0 OUTLIER -143.54 164.4 30.47 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 124.618 2.151 . . . . 0.0 110.707 177.456 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -104.55 132.48 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 174.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.259 43.9 mt -87.75 117.21 68.21 Favored Pre-proline 0 CA--C 1.561 1.397 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 172.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.13 146.61 80.4 Favored 'Trans proline' 0 C--N 1.369 1.654 0 C-N-CA 123.673 2.915 . . . . 0.0 115.722 176.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.76 -8.84 47.45 Favored Glycine 0 CA--C 1.544 1.872 0 N-CA-C 117.649 1.82 . . . . 0.0 117.649 -170.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.406 ' HA3' ' CA ' ' A' ' 76' ' ' GLY . . . -96.54 -168.88 34.11 Favored Glycine 0 CA--C 1.539 1.564 0 CA-C-N 119.171 1.486 . . . . 0.0 115.098 -177.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.28 -47.5 79.29 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -175.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.59 -37.92 88.11 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 178.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.25 -44.85 90.52 Favored 'General case' 0 CA--C 1.564 1.489 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 168.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -66.62 -63.13 1.13 Allowed 'General case' 0 CA--C 1.564 1.498 0 C-N-CA 125.323 1.449 . . . . 0.0 113.136 178.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 CA--C 1.561 1.382 0 C-N-CA 124.651 1.18 . . . . 0.0 113.69 -179.201 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 . . . . . 0 CA--C 1.542 0.64 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.9 m -73.49 90.63 1.74 Allowed 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 113.912 -1.494 . . . . 0.0 108.784 -172.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.1 tp -66.76 118.18 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 CA-C-O 122.295 1.045 . . . . 0.0 110.312 -171.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.424 ' HA ' ' HB3' ' A' ' 126' ' ' ARG 0.328 3.1 pp -99.41 -51.31 3.82 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 112.424 -2.171 . . . . 0.0 115.046 178.29 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -133.76 140.84 47.21 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 -176.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.7 t -128.87 110.06 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 102.774 -3.047 . . . . 0.0 102.774 -178.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.636 HD22 ' HB3' ' A' ' 140' ' ' ALA 0.295 8.2 m-80 82.26 -79.04 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 123.3 1.524 . . . . 0.0 108.935 178.08 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.41 ' H ' ' H ' ' A' ' 123' ' ' VAL . 5.6 tp10 -154.27 -9.03 0.14 Allowed 'General case' 0 CA--C 1.568 1.668 0 CA-C-N 111.712 -2.495 . . . . 0.0 111.782 171.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.41 ' H ' ' H ' ' A' ' 122' ' ' GLU . 2.4 t -68.17 137.03 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.189 0 CA-C-O 123.492 1.615 . . . . 0.0 109.871 -179.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -86.86 98.11 11.03 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 111.316 -2.675 . . . . 0.0 109.869 177.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . 0.28 2.7 m -108.77 -110.53 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 CA-C-O 116.356 -1.783 . . . . 0.0 107.464 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.471 ' HD3' ' H ' ' A' ' 127' ' ' GLU 0.362 0.0 OUTLIER 53.57 -82.68 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -179.533 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.471 ' H ' ' HD3' ' A' ' 126' ' ' ARG . 19.6 mt-10 -86.28 68.86 10.38 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-O 123.356 1.551 . . . . 0.0 109.308 171.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.6 p -143.06 167.08 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 CA-C-O 123.849 1.785 . . . . 0.0 107.061 -178.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 11.6 m -56.38 129.1 39.09 Favored 'General case' 0 CA--C 1.558 1.257 0 CA-C-N 113.289 -1.778 . . . . 0.0 110.217 157.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -47.94 -31.95 5.84 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 117.701 2.482 . . . . 0.0 117.701 173.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.8 m -59.32 -41.51 89.26 Favored 'General case' 0 CA--C 1.559 1.305 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 172.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -70.51 -36.41 73.76 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 167.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.58 -56.08 23.77 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 170.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.412 ' CG2' HG23 ' B' ' 6' ' ' VAL . 0.5 OUTLIER -55.4 -39.86 54.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 N-CA-C 115.891 1.812 . . . . 0.0 115.891 167.854 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.99 -54.84 33.43 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 115.383 -2.246 . . . . 0.0 111.272 168.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.76 -35.0 73.71 Favored 'General case' 0 CA--C 1.561 1.373 0 N-CA-C 117.565 2.431 . . . . 0.0 117.565 172.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.6 mp -57.74 -49.61 75.98 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 165.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -73.31 -34.94 65.99 Favored 'General case' 0 CA--C 1.564 1.511 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 175.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.19 -28.69 67.48 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 115.921 1.823 . . . . 0.0 115.921 171.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.636 ' HB3' HD22 ' A' ' 121' ' ' ASN . . . -51.62 -36.7 46.9 Favored 'General case' 0 CA--C 1.56 1.339 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 158.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 91.39 -131.68 10.9 Favored Glycine 0 C--N 1.349 1.286 0 CA-C-O 122.488 1.049 . . . . 0.0 110.518 167.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.5 m -76.63 -2.19 31.45 Favored 'General case' 0 CA--C 1.557 1.244 0 N-CA-C 117.148 2.277 . . . . 0.0 117.148 168.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.09 108.18 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 -171.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.46 ' HA ' ' HB1' ' A' ' 140' ' ' ALA . 6.7 t -116.04 116.33 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 113.834 -1.53 . . . . 0.0 107.348 -165.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.401 ' HB2' ' HA ' ' A' ' 121' ' ' ASN . 1.9 mpp_? -93.59 91.66 7.18 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 174.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.413 ' HB2' HG13 ' A' ' 66' ' ' ILE . 78.3 mt -91.45 141.38 28.81 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 176.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -132.86 113.82 13.33 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 103.562 -2.755 . . . . 0.0 103.562 176.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 32.2 m -127.68 139.51 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -165.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 26.1 ptm . . . . . 0 N--CA 1.479 0.993 0 CA-C-O 122.341 1.067 . . . . 0.0 110.427 170.681 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 2.8 p90 . . . . . 0 CA--C 1.557 1.234 0 CA-C-O 122.436 1.112 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -120.49 149.46 42.37 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-O 124.162 1.934 . . . . 0.0 108.267 167.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.402 ' HG3' ' CG2' ' A' ' 97' ' ' THR . 0.5 OUTLIER -103.5 130.04 50.79 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 113.434 -1.712 . . . . 0.0 109.001 168.616 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 1.3 m -86.94 147.2 25.86 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 122.456 1.122 . . . . 0.0 109.877 168.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -114.53 113.34 24.29 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -171.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.412 HG23 ' CG2' ' A' ' 134' ' ' VAL . 62.0 t . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 -169.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 37.7 p90 . . . . . 0 N--CA 1.477 0.912 0 CA-C-O 121.649 0.737 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -129.19 141.84 51.04 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 123.011 1.386 . . . . 0.0 109.37 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -97.73 121.9 40.18 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 112.905 -1.952 . . . . 0.0 108.559 173.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.428 HG13 ' HB2' ' A' ' 146' ' ' LEU . 8.8 pt -131.46 109.42 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 -172.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.7 m -93.49 124.29 37.39 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 122.337 1.065 . . . . 0.0 108.391 175.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.3 mp -110.33 131.05 55.4 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 113.471 -1.695 . . . . 0.0 107.49 177.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -170.71 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 119.495 -0.288 . . . . 0.0 111.139 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.428 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 102.07 55.19 0.88 Allowed Glycine 0 N--CA 1.464 0.52 0 C-N-CA 124.176 0.893 . . . . 0.0 113.703 166.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -158.92 138.87 12.0 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-O 123.315 1.531 . . . . 0.0 111.152 178.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.0 m -100.0 120.16 39.39 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 122.854 1.311 . . . . 0.0 110.622 176.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.7 pt -95.45 136.09 27.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-N 113.087 -1.87 . . . . 0.0 109.876 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.04 -178.39 6.53 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-O 123.782 1.754 . . . . 0.0 109.698 157.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -103.85 166.46 15.72 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-O 124.059 1.922 . . . . 0.0 116.319 -136.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -99.23 -162.07 29.45 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 111.242 -2.479 . . . . 0.0 112.499 -172.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 45.7 p -51.97 -43.09 63.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 116.517 2.043 . . . . 0.0 116.517 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -83.0 -13.73 55.37 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 116.277 1.954 . . . . 0.0 116.277 173.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.495 HD22 ' H ' ' B' ' 2' ' ' LYS 0.289 9.0 t30 -139.15 55.46 7.48 Favored Pre-proline 0 CA--C 1.565 1.529 0 CA-C-O 117.065 -1.445 . . . . 0.0 107.534 -172.905 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -83.63 132.3 5.7 Favored 'Trans proline' 0 C--N 1.365 1.412 0 CA-C-N 126.051 3.197 . . . . 0.0 112.648 -162.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 166.606 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo . . . . . 0 CA--C 1.547 1.163 0 CA-C-O 120.886 0.286 . . . . 0.0 112.141 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.8 m -155.81 130.0 8.78 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 -177.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 15.6 mm -83.32 110.06 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 -177.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -130.18 130.83 45.2 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 -167.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . 0.298 82.5 mt -81.73 120.11 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.736 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 176.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 12.3 t -89.72 -28.88 19.11 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 168.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.7 ptmm? -144.4 161.68 38.4 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-O 122.659 1.219 . . . . 0.0 109.777 172.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.02 139.27 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 177.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.279 1.5 mp -79.14 124.93 84.37 Favored Pre-proline 0 CA--C 1.57 1.743 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.331 -179.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -67.35 146.99 77.07 Favored 'Trans proline' 0 CA--C 1.56 1.79 0 C-N-CA 123.398 2.732 . . . . 0.0 113.107 166.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.451 ' H ' ' CB ' ' A' ' 106' ' ' ALA . . . 85.76 -14.06 53.7 Favored Glycine 0 CA--C 1.548 2.122 0 N-CA-C 117.245 1.658 . . . . 0.0 117.245 -164.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.428 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -96.23 -166.3 33.99 Favored Glycine 0 CA--C 1.539 1.541 0 CA-C-N 118.914 1.357 . . . . 0.0 115.82 177.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.61 -51.19 70.95 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -177.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.48 -38.39 80.7 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 124.573 1.17 . . . . 0.0 114.075 169.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.451 ' CB ' ' H ' ' A' ' 102' ' ' GLY . . . -46.19 -40.14 10.81 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 117.538 2.421 . . . . 0.0 117.538 166.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.403 HE21 ' HB2' ' A' ' 107' ' ' GLN . 0.0 OUTLIER -82.38 -53.17 6.22 Favored 'General case' 0 CA--C 1.568 1.642 0 C-N-CA 123.734 0.813 . . . . 0.0 112.665 173.946 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.9 t70 . . . . . 0 N--CA 1.487 1.393 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -172.354 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 . . . . . 0 CA--C 1.542 0.645 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 65.9 p -67.51 89.32 0.23 Allowed 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 113.408 -1.724 . . . . 0.0 111.147 169.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.414 HD12 HD12 ' A' ' 137' ' ' LEU . 27.6 pt -74.27 101.19 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 123.683 1.706 . . . . 0.0 108.854 -176.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.422 ' HA ' ' HB3' ' A' ' 126' ' ' ARG . 1.4 pp -79.95 -39.1 30.9 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 112.58 -2.1 . . . . 0.0 115.578 177.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -132.89 150.46 52.16 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 175.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.4 p -131.2 124.11 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 172.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.573 HD22 ' HB1' ' A' ' 140' ' ' ALA 0.272 31.0 m-80 78.77 -70.2 0.11 Allowed 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 123.26 1.505 . . . . 0.0 111.554 -178.039 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -177.93 -10.65 0.01 OUTLIER 'General case' 0 CA--C 1.583 2.213 0 C-N-CA 129.229 3.011 . . . . 0.0 109.391 -177.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.1 t -64.67 137.89 24.11 Favored 'Isoleucine or valine' 0 C--N 1.364 1.204 0 C-N-CA 125.801 1.641 . . . . 0.0 109.987 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -82.04 94.15 7.13 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 112.545 -2.116 . . . . 0.0 109.979 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . 0.339 0.8 OUTLIER -110.5 -112.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 CA-C-O 117.546 -1.216 . . . . 0.0 108.593 179.781 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.563 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.315 17.3 ptt180 55.15 -86.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 -174.982 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.563 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 32.9 mt-10 -82.06 69.47 8.78 Favored 'General case' 0 CA--C 1.555 1.156 0 CA-C-O 123.92 1.819 . . . . 0.0 109.986 172.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.7 m -137.0 166.34 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 112.627 -2.079 . . . . 0.0 105.677 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 25.8 p -55.83 135.69 51.76 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 113.12 -1.855 . . . . 0.0 111.301 149.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -50.04 -29.8 9.48 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 116.66 2.096 . . . . 0.0 116.66 167.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.1 m -57.09 -56.05 26.81 Favored 'General case' 0 CA--C 1.559 1.315 0 C-N-CA 124.432 1.093 . . . . 0.0 112.348 169.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -57.5 -38.7 75.04 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 173.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -62.15 -55.78 25.35 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 115.883 1.809 . . . . 0.0 115.883 166.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.7 p -57.74 -40.37 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 176.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -61.36 -44.38 97.26 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 116.657 -1.639 . . . . 0.0 112.999 168.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.59 -31.84 73.23 Favored 'General case' 0 CA--C 1.563 1.48 0 N-CA-C 117.628 2.455 . . . . 0.0 117.628 169.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.414 HD12 HD12 ' A' ' 117' ' ' ILE . 6.5 mp -60.07 -48.76 80.38 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 125.752 1.621 . . . . 0.0 113.29 166.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -69.67 -32.83 71.69 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 168.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -67.71 -22.83 65.24 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 116.278 1.955 . . . . 0.0 116.278 171.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.573 ' HB1' HD22 ' A' ' 121' ' ' ASN . . . -51.9 -27.73 13.86 Favored 'General case' 0 CA--C 1.555 1.155 0 N-CA-C 118.072 2.619 . . . . 0.0 118.072 157.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 97.08 -116.15 5.43 Favored Glycine 0 C--N 1.344 1.025 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 166.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.6 m -92.5 1.27 57.34 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 116.413 2.005 . . . . 0.0 116.413 166.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.37 102.1 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 -171.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 1.4 m -85.09 116.33 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-N 113.72 -1.582 . . . . 0.0 109.821 173.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 31.8 mtp180 -100.79 87.79 3.41 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 122.443 1.116 . . . . 0.0 108.103 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.428 ' HB2' HG13 ' A' ' 66' ' ' ILE . 32.6 mt -87.5 133.94 33.69 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -170.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -118.9 119.57 34.74 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.4 p -127.05 121.65 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -176.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 52.3 ttm . . . . . 0 N--CA 1.477 0.888 0 CA-C-O 122.816 1.293 . . . . 0.0 110.286 163.342 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 1.1 p90 . . . . . 0 CA--C 1.555 1.17 0 CA-C-O 122.02 0.914 . . . . 0.0 111.352 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . 0.495 ' H ' HD22 ' A' ' 85' ' ' ASN . 4.6 mptp? -138.81 145.54 40.23 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 113.401 -1.727 . . . . 0.0 108.4 172.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 7.4 ttpp -100.0 111.25 23.56 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 114.109 -1.405 . . . . 0.0 107.878 175.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 87.3 m -89.79 131.18 35.87 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 114.565 -1.198 . . . . 0.0 108.864 175.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.66 147.02 35.74 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 113.724 -1.58 . . . . 0.0 109.199 173.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.256 1.402 0 CA-C-N 113.652 -1.613 . . . . 0.0 109.836 172.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.418 ' HB3' ' HB2' ' A' ' 149' ' ' MET . 32.4 p90 . . . . . 0 CA--C 1.551 0.999 0 CA-C-O 121.929 0.871 . . . . 0.0 110.65 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -115.61 129.81 56.64 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.055 175.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -88.47 127.15 35.51 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 113.679 -1.6 . . . . 0.0 110.944 175.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 20.8 mm -130.73 126.7 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 -177.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.6 m -88.9 132.79 34.53 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-O 123.561 1.648 . . . . 0.0 108.175 167.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.6 tp -136.01 150.17 49.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 112.263 -2.244 . . . . 0.0 107.931 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 122.065 0.936 . . . . 0.0 110.419 173.426 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.6 mp . . . . . 0 N--CA 1.485 1.277 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.417 ' HA3' ' CA ' ' A' ' 103' ' ' GLY . . . 120.41 45.07 0.41 Allowed Glycine 0 CA--C 1.535 1.307 0 C-N-CA 124.476 1.036 . . . . 0.0 115.408 178.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -157.2 138.89 14.09 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 123.4 1.571 . . . . 0.0 109.472 -178.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.6 m -106.67 113.8 27.51 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.431 -1.259 . . . . 0.0 112.395 -166.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.1 pt -92.39 123.58 44.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.041 -175.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -83.34 -170.86 3.26 Favored 'General case' 0 CA--C 1.557 1.24 0 CA-C-O 123.5 1.619 . . . . 0.0 110.043 159.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.72 160.65 23.48 Favored Glycine 0 CA--C 1.539 1.54 0 CA-C-O 123.715 1.73 . . . . 0.0 117.126 -138.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -109.62 -161.47 19.14 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-N 111.289 -2.456 . . . . 0.0 114.251 178.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 43.1 p -54.26 -41.87 69.31 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 117.222 2.304 . . . . 0.0 117.222 178.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -81.44 -19.28 42.77 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 116.371 1.989 . . . . 0.0 116.371 172.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -141.27 84.04 13.09 Favored Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 102.587 -3.116 . . . . 0.0 102.587 -171.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -99.27 123.1 0.13 Allowed 'Trans proline' 0 CA--C 1.548 1.221 0 CA-C-N 124.385 2.602 . . . . 0.0 109.733 -175.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 39.1 t-80 . . . . . 0 N--CA 1.495 1.808 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 162.553 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo . . . . . 0 CA--C 1.542 0.913 0 CA-C-O 121.888 0.703 . . . . 0.0 112.791 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 63.0 m -160.5 124.79 3.65 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 -176.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.433 HG13 ' HB3' ' A' ' 133' ' ' ALA . 11.1 mm -69.86 131.94 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -170.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.417 ' HB2' ' O ' ' A' ' 115' ' ' ASP . 21.2 p90 -140.38 128.82 22.68 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.405 -1.271 . . . . 0.0 108.297 -168.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 70.2 mt -85.25 112.02 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 173.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 23.2 m -85.86 -28.56 24.34 Favored 'General case' 0 CA--C 1.556 1.199 0 CA-C-N 113.667 -1.606 . . . . 0.0 113.191 169.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -134.73 159.01 42.64 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 123.486 1.613 . . . . 0.0 111.203 -173.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -120.57 124.79 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 103.316 -2.846 . . . . 0.0 103.316 177.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.287 1.2 mp -66.51 130.72 94.14 Favored Pre-proline 0 CA--C 1.573 1.854 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.304 170.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.94 132.09 40.44 Favored 'Trans proline' 0 CA--C 1.554 1.493 0 C-N-CA 123.432 2.754 . . . . 0.0 114.156 173.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.46 14.17 82.77 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 117.249 1.66 . . . . 0.0 117.249 -163.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.417 ' CA ' ' HA3' ' A' ' 76' ' ' GLY . . . -89.92 171.07 37.03 Favored Glycine 0 C--N 1.337 0.638 0 CA-C-O 122.672 1.151 . . . . 0.0 114.388 -177.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.62 -38.0 70.84 Favored 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -172.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.28 -38.71 88.42 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 172.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.86 -42.71 76.71 Favored 'General case' 0 CA--C 1.562 1.421 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 170.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -72.54 -52.12 17.0 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.202 1.001 . . . . 0.0 113.685 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.1 t70 . . . . . 0 N--CA 1.48 1.054 0 C-N-CA 124.512 1.125 . . . . 0.0 112.351 -176.932 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.417 ' O ' ' HB2' ' A' ' 95' ' ' PHE 0.289 35.1 t70 . . . . . 0 C--O 1.222 -0.361 0 CA-C-O 117.069 -1.444 . . . . 0.0 111.258 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 45.4 m -155.78 77.57 0.97 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 -170.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.0 tp -66.65 124.39 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-O 121.667 0.746 . . . . 0.0 109.261 171.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.436 ' HA ' ' HB3' ' A' ' 126' ' ' ARG 0.259 0.8 OUTLIER -108.38 -43.97 4.21 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 174.699 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -129.85 133.68 47.07 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 104.786 -2.302 . . . . 0.0 104.786 177.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.7 p -123.76 123.49 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 174.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . 0.32 32.7 m-80 80.77 -72.2 0.06 Allowed 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 123.954 1.835 . . . . 0.0 110.37 -175.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.414 ' H ' ' H ' ' A' ' 123' ' ' VAL . 6.3 tp10 -177.11 -17.57 0.01 OUTLIER 'General case' 0 CA--C 1.576 1.959 0 C-N-CA 129.006 2.923 . . . . 0.0 109.247 -173.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.414 ' H ' ' H ' ' A' ' 122' ' ' GLU . 2.2 t -64.9 135.56 28.02 Favored 'Isoleucine or valine' 0 C--N 1.363 1.173 0 C-N-CA 125.69 1.596 . . . . 0.0 110.131 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -78.84 86.41 4.75 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 111.131 -2.759 . . . . 0.0 111.226 173.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -94.99 -105.12 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 176.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.619 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.285 14.0 ptt85 47.42 -98.68 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.674 1.189 . . . . 0.0 113.85 -176.549 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.619 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 1.5 tt0 -71.46 72.95 0.72 Allowed 'General case' 0 CA--C 1.555 1.146 0 CA-C-O 124.227 1.965 . . . . 0.0 111.885 168.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.7 p -147.34 167.41 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 CA-C-N 112.141 -2.299 . . . . 0.0 105.153 -174.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 34.9 p -57.2 130.85 48.01 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 112.579 -2.1 . . . . 0.0 112.051 156.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -48.16 -33.1 7.86 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 116.845 2.165 . . . . 0.0 116.845 168.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 13.2 m -63.61 -38.94 93.04 Favored 'General case' 0 CA--C 1.559 1.301 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 172.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.11 -32.93 73.58 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 167.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.433 ' HB3' HG13 ' A' ' 94' ' ' ILE . . . -73.18 -47.81 40.57 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 171.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.434 HG23 HG21 ' B' ' 4' ' ' THR . 11.3 p -52.07 -44.82 40.54 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.532 0 CA-C-N 120.47 1.486 . . . . 0.0 113.87 162.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -53.98 -52.02 62.05 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-O 115.989 -1.958 . . . . 0.0 112.23 170.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.24 -29.86 68.78 Favored 'General case' 0 CA--C 1.558 1.266 0 N-CA-C 118.108 2.633 . . . . 0.0 118.108 175.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 7.0 mp -55.49 -52.88 62.2 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.161 1.384 . . . . 0.0 112.821 162.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -69.33 -41.24 76.93 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 171.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -66.86 -4.65 9.83 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 116.524 2.046 . . . . 0.0 116.524 169.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -52.0 -36.08 48.68 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 117.018 2.229 . . . . 0.0 117.018 158.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 64.97 79.01 0.19 Allowed Glycine 0 C--N 1.348 1.233 0 O-C-N 123.849 0.718 . . . . 0.0 113.115 163.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . 0.267 15.7 m 73.81 -27.08 0.19 Allowed 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 117.561 2.43 . . . . 0.0 117.561 -172.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -145.88 107.98 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -171.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 1.6 t -91.14 115.16 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 125.846 1.658 . . . . 0.0 107.324 175.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 5.2 ttp180 -97.3 100.16 11.61 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 172.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 36.8 mt -90.75 142.41 27.79 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.532 -175.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -131.17 113.57 14.04 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 173.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.72 123.73 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -175.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' MET . . . . . 0.418 ' HB2' ' HB3' ' A' ' 63' ' ' TYR . 25.7 ttt . . . . . 0 N--CA 1.479 0.98 0 O-C-N 124.366 1.041 . . . . 0.0 111.208 165.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.561 1.367 0 CA-C-O 123.699 1.714 . . . . 0.0 110.835 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -161.6 123.0 2.81 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 172.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -82.17 122.94 28.52 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 114.201 -1.363 . . . . 0.0 109.054 175.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.434 HG21 HG23 ' A' ' 134' ' ' VAL . 2.9 m -81.91 127.3 32.88 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 122.177 0.989 . . . . 0.0 108.389 170.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.0 103.53 16.24 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 9.5 t . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -169.53 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 43.0 p90 . . . . . 0 N--CA 1.478 0.955 0 CA-C-O 121.816 0.817 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -102.26 138.46 39.17 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.14 176.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -107.07 125.41 51.01 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.455 HG12 ' HB2' ' A' ' 146' ' ' LEU . 0.1 OUTLIER -141.72 111.69 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 -174.501 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 86.3 m -84.67 129.81 34.79 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 122.224 1.012 . . . . 0.0 108.352 170.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 105' ' ' ALA . 0.9 OUTLIER -137.62 128.14 26.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 113.317 -1.765 . . . . 0.0 107.085 -176.189 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 . . . . . 0 N--CA 1.481 1.122 0 O-C-N 121.943 -0.473 . . . . 0.0 110.303 179.528 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.7 tt . . . . . 0 CA--C 1.569 1.681 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.28 41.69 2.35 Favored Glycine 0 N--CA 1.475 1.259 0 O-C-N 120.434 -1.416 . . . . 0.0 116.376 168.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -151.76 165.95 32.85 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 122.643 1.211 . . . . 0.0 110.883 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.32 121.75 20.52 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 168.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 96' ' ' ILE . 6.4 pt -90.97 133.69 31.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 113.331 -1.758 . . . . 0.0 111.006 -177.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.36 -174.81 4.77 Favored 'General case' 0 CA--C 1.558 1.274 0 CA-C-O 123.258 1.504 . . . . 0.0 110.055 158.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -96.18 159.45 21.98 Favored Glycine 0 CA--C 1.539 1.568 0 CA-C-O 123.2 1.444 . . . . 0.0 116.059 -144.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -108.35 -164.19 20.99 Favored Glycine 0 N--CA 1.47 0.933 0 CA-C-N 112.276 -1.962 . . . . 0.0 112.226 -176.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 43.5 p -50.49 -39.11 47.5 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 118.355 2.724 . . . . 0.0 118.355 -177.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -73.8 -23.87 59.74 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 171.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -139.37 74.89 34.15 Favored Pre-proline 0 CA--C 1.567 1.622 0 N-CA-C 104.209 -2.515 . . . . 0.0 104.209 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -107.98 115.59 0.03 OUTLIER 'Trans proline' 0 C--N 1.364 1.386 0 CA-C-N 125.26 2.914 . . . . 0.0 111.092 -164.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 179.846 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo . . . . . 0 CA--C 1.546 1.101 0 CA-C-O 122.779 1.075 . . . . 0.0 112.533 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 58.7 m -158.61 140.15 13.46 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 177.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 21.7 mm -81.46 130.07 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 -177.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.424 ' HA ' ' O ' ' A' ' 115' ' ' ASP . 40.4 m-85 -119.4 149.82 41.21 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 113.484 -1.689 . . . . 0.0 110.509 175.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 79' ' ' ILE . 72.6 mt -106.06 114.55 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 104.381 -2.451 . . . . 0.0 104.381 148.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.9 t -98.74 -6.38 29.58 Favored 'General case' 0 CA--C 1.564 1.496 0 N-CA-C 115.386 1.625 . . . . 0.0 115.386 168.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -141.82 147.51 37.35 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-O 123.774 1.75 . . . . 0.0 108.963 -177.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.33 123.55 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 N-CA-C 103.224 -2.88 . . . . 0.0 103.224 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.368 1.2 mp -66.26 117.4 42.93 Favored Pre-proline 0 CA--C 1.566 1.567 0 CA-C-O 118.186 -0.912 . . . . 0.0 109.248 171.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -69.33 142.29 49.4 Favored 'Trans proline' 0 C--N 1.367 1.534 0 C-N-CA 123.224 2.616 . . . . 0.0 112.496 174.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.53 -6.05 19.1 Favored Glycine 0 CA--C 1.549 2.216 0 N-CA-C 117.772 1.869 . . . . 0.0 117.772 -168.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -83.67 -171.63 47.9 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-O 123.409 1.561 . . . . 0.0 112.157 175.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.75 -41.87 82.7 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 -173.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.406 ' HA ' HD13 ' A' ' 68' ' ' LEU . . . -67.59 -26.41 66.26 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 119.719 3.229 . . . . 0.0 119.719 178.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -60.97 -46.03 92.39 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 166.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.56 -55.25 6.55 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 124.548 1.139 . . . . 0.0 113.082 174.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.9 t70 . . . . . 0 N--CA 1.484 1.234 0 C-N-CA 123.959 0.904 . . . . 0.0 112.015 -177.076 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.424 ' O ' ' HA ' ' A' ' 95' ' ' PHE 0.296 15.3 t70 . . . . . 0 C--O 1.213 -0.839 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 66.8 m -100.8 69.41 1.35 Allowed 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.061 1.301 . . . . 0.0 110.424 -173.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 18.0 tt -67.7 124.18 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 CA-C-O 122.1 0.952 . . . . 0.0 109.47 174.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.432 HD23 ' HB3' ' A' ' 149' ' ' MET . 0.0 OUTLIER -117.25 -47.23 2.67 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 113.525 -1.671 . . . . 0.0 114.824 -179.882 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -119.68 141.04 49.73 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.1 t -129.75 110.73 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 102.165 -3.272 . . . . 0.0 102.165 177.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.58 HD22 ' HB3' ' A' ' 140' ' ' ALA 0.32 20.7 m-80 83.21 -83.2 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 123.649 1.69 . . . . 0.0 108.712 178.681 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -153.08 -16.05 0.15 Allowed 'General case' 0 CA--C 1.571 1.781 0 CA-C-N 110.539 -3.028 . . . . 0.0 110.48 178.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.1 t -62.6 136.92 25.16 Favored 'Isoleucine or valine' 0 C--N 1.363 1.156 0 C-N-CA 125.118 1.367 . . . . 0.0 110.088 173.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -100.87 96.91 7.6 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 111.891 -2.413 . . . . 0.0 108.408 178.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . 0.257 0.2 OUTLIER -96.02 -100.35 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 CA-C-O 116.44 -1.743 . . . . 0.0 107.588 179.378 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.498 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.34 29.0 ptt180 50.94 -84.34 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 116.666 2.099 . . . . 0.0 116.666 -177.802 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.498 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 1.9 mt-10 -79.13 69.5 5.33 Favored 'General case' 0 CA--C 1.557 1.226 0 CA-C-O 123.811 1.767 . . . . 0.0 110.486 168.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -147.76 168.57 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 -178.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 28.2 m -60.71 133.67 56.32 Favored 'General case' 0 CA--C 1.562 1.417 0 CA-C-N 114.262 -1.335 . . . . 0.0 110.529 158.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -46.05 -33.86 3.71 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 118.024 2.602 . . . . 0.0 118.024 168.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.6 m -60.84 -38.26 84.87 Favored 'General case' 0 CA--C 1.559 1.316 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 173.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -70.78 -33.3 70.62 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 116.217 1.932 . . . . 0.0 116.217 167.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -74.48 -43.4 56.23 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 172.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.3 p -55.69 -42.41 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 159.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -60.44 -46.36 90.33 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 116.097 -1.906 . . . . 0.0 113.27 170.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.05 -31.66 70.19 Favored 'General case' 0 CA--C 1.559 1.306 0 N-CA-C 116.951 2.204 . . . . 0.0 116.951 173.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 46.7 mt -58.94 -47.89 83.45 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 163.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -65.2 -44.76 87.3 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 168.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -64.03 -17.75 63.66 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 116.533 2.049 . . . . 0.0 116.533 174.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.58 ' HB3' HD22 ' A' ' 121' ' ' ASN . . . -53.5 -20.16 4.55 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 119.667 3.21 . . . . 0.0 119.667 160.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 91.45 -125.93 8.23 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 173.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 39.0 m -90.9 1.59 56.87 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 167.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -150.1 110.74 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -165.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.436 ' HA ' ' HB1' ' A' ' 140' ' ' ALA . 3.3 t -102.9 115.86 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 113.481 -1.69 . . . . 0.0 107.863 -172.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.4 ' HB2' ' HA ' ' A' ' 121' ' ' ASN . 78.4 mtt180 -96.91 101.28 12.83 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 175.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.455 ' HB2' HG12 ' A' ' 66' ' ' ILE . 14.0 mt -95.76 137.35 34.95 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -173.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -125.19 126.1 44.69 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -131.24 122.23 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 177.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' MET . . . . . 0.432 ' HB3' HD23 ' A' ' 118' ' ' LEU . 28.3 ttt . . . . . 0 N--CA 1.472 0.667 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 171.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 2.7 p90 . . . . . 0 CA--C 1.55 0.974 0 CA-C-O 121.399 0.619 . . . . 0.0 110.352 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -130.02 146.89 51.72 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 123.538 1.637 . . . . 0.0 110.418 175.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 10.7 ttpp -107.82 113.7 27.13 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 113.222 -1.808 . . . . 0.0 108.1 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 43.6 m -84.81 137.35 33.23 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 122.029 0.918 . . . . 0.0 109.84 173.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.39 153.91 22.2 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-O 122.711 1.243 . . . . 0.0 110.146 176.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 4.2 p . . . . . 0 C--O 1.25 1.09 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 -171.406 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 20.9 p90 . . . . . 0 CA--C 1.552 1.026 0 CA-C-O 122.708 1.242 . . . . 0.0 109.674 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -104.0 134.71 46.82 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 113.52 -1.673 . . . . 0.0 106.883 -176.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -105.26 118.7 37.22 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 -174.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.5 pt -136.58 104.27 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 N-CA-C 106.39 -1.708 . . . . 0.0 106.39 -168.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.2 m -98.98 126.23 44.63 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 173.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.79 142.38 51.32 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.112 178.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 . . . . . 0 N--CA 1.484 1.268 0 O-C-N 121.446 -0.784 . . . . 0.0 110.795 -177.64 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.9 mp . . . . . 0 N--CA 1.469 0.489 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.48 37.58 3.24 Favored Glycine 0 CA--C 1.532 1.121 0 N-CA-C 116.455 1.342 . . . . 0.0 116.455 -172.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -148.17 159.41 43.98 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-O 124.192 1.949 . . . . 0.0 107.254 168.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.7 m -100.81 155.3 18.0 Favored 'General case' 0 C--N 1.313 -1.013 0 O-C-N 120.459 -1.401 . . . . 0.0 110.717 177.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.4 pt -129.09 132.65 66.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.572 174.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -91.15 -170.43 2.65 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-O 124.249 1.976 . . . . 0.0 108.477 163.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.33 160.18 22.8 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-N 113.12 -1.855 . . . . 0.0 114.915 -142.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -108.45 -158.55 19.47 Favored Glycine 0 CA--C 1.52 0.4 0 CA-C-N 111.542 -2.329 . . . . 0.0 111.852 -175.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 42.2 p -54.73 -39.76 68.57 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 117.627 2.454 . . . . 0.0 117.627 -176.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -73.85 -24.87 59.82 Favored 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 116.268 1.951 . . . . 0.0 116.268 170.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.454 HD21 ' CE1' ' A' ' 130' ' ' HIS . 0.2 OUTLIER -139.97 82.3 17.64 Favored Pre-proline 0 CA--C 1.556 1.177 0 N-CA-C 103.111 -2.922 . . . . 0.0 103.111 -176.119 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -107.5 118.24 0.03 OUTLIER 'Trans proline' 0 CA--C 1.548 1.224 0 CA-C-N 125.165 2.88 . . . . 0.0 111.288 -169.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -178.67 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo . . . . . 0 CA--C 1.549 1.268 0 CA-C-O 122.609 1.004 . . . . 0.0 112.948 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 73.1 m -157.24 134.68 10.55 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 104.4 -2.444 . . . . 0.0 104.4 -177.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 14.0 mm -76.92 121.5 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 -176.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -113.61 151.18 32.05 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 113.714 -1.584 . . . . 0.0 107.492 176.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . 0.29 3.4 mt -93.95 122.77 45.7 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.499 0 N-CA-C 105.094 -2.188 . . . . 0.0 105.094 166.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.5 m -78.98 -54.95 5.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.934 -1.104 . . . . 0.0 112.778 179.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 36.2 mtpt -147.79 162.92 38.24 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 124.27 1.986 . . . . 0.0 111.138 -164.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.88 104.71 17.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 1 N-CA-C 99.742 -4.17 . . . . 0.0 99.742 -170.449 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.283 1.3 mp -65.41 118.75 53.55 Favored Pre-proline 0 CA--C 1.566 1.572 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -176.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -61.19 134.16 50.84 Favored 'Trans proline' 0 C--N 1.364 1.346 0 C-N-CA 122.997 2.465 . . . . 0.0 112.993 173.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.67 -4.81 85.26 Favored Glycine 0 CA--C 1.544 1.874 0 N-CA-C 118.22 2.048 . . . . 0.0 118.22 -172.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -90.23 -173.07 44.83 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-O 123.499 1.61 . . . . 0.0 113.116 174.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.53 -34.52 72.38 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 116.363 1.986 . . . . 0.0 116.363 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -53.11 -42.43 65.98 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 120.126 1.33 . . . . 0.0 114.184 163.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.55 -40.73 65.77 Favored 'General case' 0 CA--C 1.562 1.426 0 N-CA-C 116.305 1.965 . . . . 0.0 116.305 174.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.32 -53.47 14.11 Favored 'General case' 0 CA--C 1.561 1.368 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 174.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.8 t70 . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -167.913 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 . . . . . 0 C--O 1.24 0.584 0 N-CA-C 102.001 -3.333 . . . . 0.0 102.001 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 12.8 m -73.82 86.85 1.73 Allowed 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 113.772 -1.558 . . . . 0.0 110.215 -170.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.3 tp -63.35 116.06 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 CA-C-O 122.11 0.957 . . . . 0.0 110.038 -176.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.1 pp -96.64 -48.04 5.67 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 112.809 -1.996 . . . . 0.0 114.001 174.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -135.42 128.22 31.13 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 -175.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 5.5 p -121.72 122.26 66.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 172.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.445 HD22 ' HB2' ' A' ' 140' ' ' ALA 0.27 45.6 m-80 79.37 -65.3 0.2 Allowed 'General case' 0 N--CA 1.503 2.198 0 CA-C-O 122.818 1.294 . . . . 0.0 111.558 -173.507 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 176.52 -25.28 0.0 OUTLIER 'General case' 0 CA--C 1.573 1.842 0 C-N-CA 128.408 2.683 . . . . 0.0 110.174 -162.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.1 t -70.04 135.83 27.39 Favored 'Isoleucine or valine' 0 C--N 1.361 1.085 0 C-N-CA 125.148 1.379 . . . . 0.0 109.409 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -88.21 100.0 12.64 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 113.209 -1.814 . . . . 0.0 109.841 176.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . 0.251 3.3 m -94.79 -119.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 CA-C-O 116.959 -1.496 . . . . 0.0 107.62 174.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.524 ' HD2' ' H ' ' A' ' 127' ' ' GLU 0.475 1.0 OUTLIER 56.14 -78.43 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -174.283 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.524 ' H ' ' HD2' ' A' ' 126' ' ' ARG . 25.3 tt0 -79.81 67.1 5.49 Favored 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 126.388 1.875 . . . . 0.0 111.288 168.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -153.77 167.92 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 -177.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 27.0 m -64.37 134.1 53.92 Favored 'General case' 0 CA--C 1.561 1.386 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.151 158.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . 0.454 ' CE1' HD21 ' A' ' 85' ' ' ASN . 4.7 p-80 -48.59 -31.51 6.72 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 118.64 2.83 . . . . 0.0 118.64 170.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.4 m -60.73 -38.6 85.67 Favored 'General case' 0 CA--C 1.563 1.465 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 171.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -67.53 -37.95 83.51 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 166.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.88 -52.44 59.97 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 170.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.414 HG21 HG22 ' B' ' 4' ' ' THR . 3.4 p -54.9 -39.93 50.82 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.25 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 168.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -64.72 -40.46 95.37 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 117.058 -1.448 . . . . 0.0 114.181 173.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -67.98 -33.12 74.03 Favored 'General case' 0 CA--C 1.562 1.423 0 N-CA-C 116.539 2.052 . . . . 0.0 116.539 167.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.7 mp -54.24 -49.17 70.1 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 125.391 1.476 . . . . 0.0 113.763 160.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -66.31 -41.66 89.37 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 169.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -65.17 -17.69 64.69 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 116.461 2.023 . . . . 0.0 116.461 172.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.445 ' HB2' HD22 ' A' ' 121' ' ' ASN . . . -52.33 -41.84 63.33 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 117.622 2.453 . . . . 0.0 117.622 164.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 71.0 72.21 0.93 Allowed Glycine 0 C--N 1.339 0.714 0 CA-C-O 118.528 -1.151 . . . . 0.0 114.779 159.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . 0.267 4.5 m 68.5 -3.1 1.43 Allowed 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 117.906 2.558 . . . . 0.0 117.906 -173.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -148.38 103.19 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.251 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 171.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.408 ' HA ' ' HB3' ' A' ' 140' ' ' ALA . 36.0 m -84.99 122.38 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 124.034 0.934 . . . . 0.0 109.233 168.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 50.1 mtt180 -101.92 87.12 3.03 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 171.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 49.7 mt -92.01 136.53 33.1 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-O 122.47 1.129 . . . . 0.0 108.315 -172.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -132.48 118.12 18.89 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 104.359 -2.46 . . . . 0.0 104.359 178.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 33.6 m -126.71 133.0 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -167.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.483 1.18 0 CA-C-O 123.621 1.677 . . . . 0.0 111.657 175.848 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.559 1.292 0 CA-C-O 122.201 1.001 . . . . 0.0 111.695 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -139.33 138.89 37.05 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 123.341 1.543 . . . . 0.0 110.005 173.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -102.86 124.42 48.35 Favored 'General case' 0 CA--C 1.553 1.068 0 CA-C-N 113.452 -1.704 . . . . 0.0 108.294 172.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.414 HG22 HG21 ' A' ' 134' ' ' VAL . 20.1 m -92.68 129.2 38.68 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.243 172.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -103.29 101.55 11.48 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 -174.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 1.4 p . . . . . 0 C--O 1.252 1.208 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.338 -176.2 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 14.1 p90 . . . . . 0 N--CA 1.479 1.012 0 CA-C-O 121.783 0.802 . . . . 0.0 109.304 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -111.91 140.05 46.89 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.173 -178.037 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -115.48 117.13 29.52 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 114.518 -1.219 . . . . 0.0 108.054 -178.76 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.4 mp -134.41 124.89 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 -171.533 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.8 m -97.11 125.1 41.35 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 168.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 mp -123.67 137.85 54.64 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -177.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 . . . . . 0 N--CA 1.482 1.17 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -172.56 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.408 HD12 ' CZ ' ' A' ' 77' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.301 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 . . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.454 ' HA3' ' CA ' ' A' ' 103' ' ' GLY . . . 72.39 42.38 49.27 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 119.577 2.591 . . . . 0.0 119.577 163.054 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.408 ' CZ ' HD12 ' A' ' 75' ' ' LEU . 13.1 p90 -157.87 128.22 6.26 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 176.741 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.1 m -85.19 144.73 27.98 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.789 -1.55 . . . . 0.0 111.663 176.362 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.416 HG22 HD13 ' A' ' 96' ' ' ILE . 2.3 pp -119.2 127.92 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 113.013 -1.903 . . . . 0.0 109.546 -176.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.78 -166.74 0.94 Allowed 'General case' 0 CA--C 1.553 1.091 0 CA-C-O 123.417 1.579 . . . . 0.0 111.024 159.632 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.78 159.24 22.2 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-O 123.936 1.853 . . . . 0.0 115.195 -143.407 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.51 -161.18 23.23 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-N 111.162 -2.519 . . . . 0.0 113.057 179.191 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 71.4 p -53.99 -40.27 66.8 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 -177.638 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -92.88 7.9 41.91 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 116.099 1.889 . . . . 0.0 116.099 175.543 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -161.16 86.67 1.7 Allowed Pre-proline 0 CA--C 1.553 1.092 0 N-CA-C 101.154 -3.647 . . . . 0.0 101.154 178.945 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -108.48 124.53 0.04 OUTLIER 'Trans proline' 0 CA--C 1.549 1.237 0 CA-C-N 124.437 2.62 . . . . 0.0 111.634 -173.023 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 . . . . . 0 N--CA 1.492 1.666 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 176.224 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo . . . . . 0 CA--C 1.552 1.421 0 CA-C-O 121.558 0.566 . . . . 0.0 113.023 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 52.9 m -156.65 109.63 2.59 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 105.512 -2.032 . . . . 0.0 105.512 -173.651 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 8.1 mm -68.95 117.9 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 178.559 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -129.26 140.24 51.52 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 113.459 -1.701 . . . . 0.0 107.514 -163.488 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.416 HD13 HG22 ' A' ' 79' ' ' ILE . 7.4 mm -85.84 107.46 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.346 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 175.365 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 77.0 m -91.11 -35.06 14.81 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 117.4 -1.286 . . . . 0.0 113.74 175.54 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . 0.321 0.0 OUTLIER -144.18 165.14 28.67 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 123.299 1.524 . . . . 0.0 111.72 175.54 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -111.83 126.37 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 -176.451 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.304 1.4 mp -72.25 130.44 86.23 Favored Pre-proline 0 CA--C 1.567 1.606 0 CA-C-O 118.252 -0.88 . . . . 0.0 109.2 169.454 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -58.88 130.6 37.51 Favored 'Trans proline' 0 C--N 1.367 1.511 0 C-N-CA 123.54 2.826 . . . . 0.0 114.521 174.924 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 72.12 20.99 79.34 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 117.153 1.621 . . . . 0.0 117.153 -167.042 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.454 ' CA ' ' HA3' ' A' ' 76' ' ' GLY . . . -85.93 -176.81 50.09 Favored Glycine 0 C--N 1.337 0.636 0 N-CA-C 116.399 1.32 . . . . 0.0 116.399 177.203 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.81 -51.61 63.96 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 178.415 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.49 -38.91 89.04 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 174.167 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.92 -42.03 77.35 Favored 'General case' 0 CA--C 1.565 1.527 0 N-CA-C 115.821 1.786 . . . . 0.0 115.821 170.528 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.67 -51.1 20.83 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.604 1.162 . . . . 0.0 113.877 178.526 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.2 t70 . . . . . 0 N--CA 1.482 1.151 0 C-N-CA 124.38 1.072 . . . . 0.0 112.109 -176.134 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 . . . . . 0 C--O 1.237 0.405 0 N-CA-C 102.831 -3.026 . . . . 0.0 102.831 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.0 m -80.62 93.57 6.15 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.03 -0.986 . . . . 0.0 108.571 -176.517 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.411 HG12 HD11 ' A' ' 137' ' ' LEU . 7.2 tp -59.7 112.94 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 C-N-CA 123.569 0.748 . . . . 0.0 111.306 178.949 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.445 ' HA ' ' HB3' ' A' ' 126' ' ' ARG 0.431 0.0 OUTLIER -105.67 -39.81 5.96 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 115.933 1.827 . . . . 0.0 115.933 -174.306 . . . . . . . . 4 4 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -136.19 135.27 38.99 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 105.019 -2.215 . . . . 0.0 105.019 171.72 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.9 p -123.55 121.95 63.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 170.43 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.5 HD22 ' HB1' ' A' ' 140' ' ' ALA 0.261 3.8 m-80 77.17 -79.73 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 123.332 1.539 . . . . 0.0 108.93 -175.008 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.407 ' H ' ' H ' ' A' ' 123' ' ' VAL . 1.1 tt0 -165.25 -7.77 0.02 OUTLIER 'General case' 0 CA--C 1.576 1.978 0 C-N-CA 127.986 2.514 . . . . 0.0 110.78 -178.833 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.407 ' H ' ' H ' ' A' ' 122' ' ' GLU . 2.1 t -72.46 135.91 26.77 Favored 'Isoleucine or valine' 0 C--N 1.359 1.014 0 C-N-CA 125.443 1.497 . . . . 0.0 109.526 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -77.43 102.19 6.74 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 112.903 -1.953 . . . . 0.0 110.605 171.776 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . 0.261 2.2 m -109.78 -113.13 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-O 116.361 -1.781 . . . . 0.0 107.936 175.254 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.445 ' HB3' ' HA ' ' A' ' 118' ' ' LEU 0.328 0.0 OUTLIER 48.06 -82.72 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 117.753 2.501 . . . . 0.0 117.753 -176.12 . . . . . . . . 4 4 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.432 ' H ' ' HD3' ' A' ' 126' ' ' ARG . 2.9 tm-20 -88.35 70.4 9.09 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-O 123.696 1.712 . . . . 0.0 108.572 171.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.63 167.27 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 -178.689 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 11.6 m -58.45 132.42 53.66 Favored 'General case' 0 CA--C 1.555 1.146 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.206 159.358 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -47.45 -34.16 6.97 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 117.37 2.359 . . . . 0.0 117.37 173.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.2 m -60.38 -40.5 91.06 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 174.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -67.24 -37.75 84.05 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 166.738 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -66.95 -55.86 12.7 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 173.663 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.404 HG21 ' CG2' ' B' ' 6' ' ' VAL . 8.6 p -47.09 -45.71 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 166.567 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.2 -54.15 49.27 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 115.765 -2.064 . . . . 0.0 111.72 174.862 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.97 -34.51 76.27 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 117.527 2.417 . . . . 0.0 117.527 174.074 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.411 HD11 HG12 ' A' ' 117' ' ' ILE . 6.0 mp -57.78 -55.34 36.09 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 125.636 1.575 . . . . 0.0 113.45 165.134 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -65.05 -33.77 76.84 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 115.898 1.814 . . . . 0.0 115.898 171.435 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -68.29 -23.64 64.77 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 117.135 2.272 . . . . 0.0 117.135 170.636 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.5 ' HB1' HD22 ' A' ' 121' ' ' ASN . . . -53.28 -28.46 28.03 Favored 'General case' 0 CA--C 1.56 1.362 0 N-CA-C 116.938 2.199 . . . . 0.0 116.938 156.046 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 91.09 -132.12 11.12 Favored Glycine 0 C--N 1.347 1.193 0 CA-C-O 122.53 1.072 . . . . 0.0 110.753 166.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 13.0 m -78.76 -2.06 37.68 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 169.152 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.05 103.8 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 -172.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.6 m -92.81 117.53 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 113.205 -1.816 . . . . 0.0 108.682 -178.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -89.57 94.22 9.78 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 169.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 82.1 mt -97.05 127.13 42.72 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 -173.521 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -126.12 120.01 29.05 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 102.963 -2.977 . . . . 0.0 102.963 177.178 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 16.8 m -124.65 132.89 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -173.346 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 57.5 ttm . . . . . 0 N--CA 1.484 1.236 0 CA-C-N 119.759 1.163 . . . . 0.0 108.54 168.419 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.558 1.265 0 CA-C-O 122.585 1.184 . . . . 0.0 111.214 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -148.24 120.75 8.52 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 122.517 1.151 . . . . 0.0 108.874 173.402 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 16.7 ttpp -92.1 124.78 36.45 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.42 174.784 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 3.1 m -87.25 143.04 27.46 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 122.174 0.988 . . . . 0.0 109.418 168.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.69 120.31 35.72 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 178.462 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . 0.404 ' CG2' HG21 ' A' ' 134' ' ' VAL . 21.8 t . . . . . 0 N--CA 1.478 0.933 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 -160.84 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 41.3 p90 . . . . . 0 N--CA 1.475 0.778 0 CA-C-O 121.823 0.82 . . . . 0.0 111.656 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -124.91 136.05 53.41 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -176.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.405 ' HB3' ' CE2' ' A' ' 147' ' ' TYR . 9.9 pt-20 -80.39 128.56 33.7 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 114.306 -1.316 . . . . 0.0 111.795 175.42 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 23.4 mt -129.57 118.12 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 -179.3 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.3 m -97.19 122.88 40.71 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 174.248 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.439 ' HB3' ' CG2' ' A' ' 144' ' ' VAL . 1.2 tt -119.85 161.45 20.79 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 113.098 -1.865 . . . . 0.0 106.7 174.902 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 . . . . . 0 N--CA 1.489 1.483 0 O-C-N 120.425 -1.422 . . . . 0.0 108.912 173.622 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.425 HD11 HG13 ' A' ' 144' ' ' VAL . 1.4 tt . . . . . 0 N--CA 1.485 1.32 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 118.02 22.83 3.76 Favored Glycine 0 N--CA 1.478 1.491 0 N-CA-C 118.017 1.967 . . . . 0.0 118.017 178.8 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -145.68 177.17 9.09 Favored 'General case' 0 CA--C 1.557 1.247 0 CA-C-O 123.749 1.738 . . . . 0.0 107.788 171.586 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.8 m -134.91 145.13 47.92 Favored 'General case' 0 C--N 1.318 -0.804 0 O-C-N 119.909 -1.744 . . . . 0.0 107.559 -178.418 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.444 HG21 HG12 ' A' ' 96' ' ' ILE . 5.6 pt -112.22 137.0 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 114.695 -1.138 . . . . 0.0 112.006 -172.847 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.453 ' HB2' ' HG1' ' A' ' 97' ' ' THR . . . -85.57 -174.3 5.1 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-O 123.976 1.846 . . . . 0.0 111.368 160.857 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.82 157.98 21.84 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 113.015 -1.902 . . . . 0.0 115.058 -145.78 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -104.69 -158.6 23.65 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 111.954 -2.123 . . . . 0.0 113.724 179.182 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 34.6 p -54.32 -38.24 65.76 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 116.872 2.175 . . . . 0.0 116.872 -178.0 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -83.25 -10.31 58.63 Favored 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 116.285 1.957 . . . . 0.0 116.285 174.406 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.15 92.29 2.35 Favored Pre-proline 0 CA--C 1.552 1.028 0 N-CA-C 101.095 -3.669 . . . . 0.0 101.095 -173.02 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -93.2 138.46 1.49 Allowed 'Trans proline' 0 CA--C 1.55 1.304 0 CA-C-N 124.879 2.778 . . . . 0.0 111.453 -176.405 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 28.3 t60 . . . . . 0 N--CA 1.493 1.681 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 167.858 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo . . . . . 0 CA--C 1.547 1.159 0 CA-C-O 121.576 0.573 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.4 m -158.19 125.22 4.95 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 -176.541 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 22.1 mm -78.4 123.24 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 178.517 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -116.67 154.67 30.15 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 112.684 -2.053 . . . . 0.0 107.969 177.717 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.444 HG12 HG21 ' A' ' 79' ' ' ILE 0.357 10.3 mt -95.39 123.79 47.7 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.076 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 161.001 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.453 ' HG1' ' HB2' ' A' ' 80' ' ' ALA . 49.6 m -74.3 -60.45 2.26 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.769 -1.207 . . . . 0.0 113.114 171.635 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -147.16 162.21 39.33 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 123.876 1.798 . . . . 0.0 111.48 -163.375 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.87 121.86 55.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 104.427 -2.434 . . . . 0.0 104.427 -175.157 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.259 1.6 mp -73.86 121.14 84.45 Favored Pre-proline 0 CA--C 1.567 1.623 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 173.353 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -61.02 138.1 76.25 Favored 'Trans proline' 0 C--N 1.365 1.425 0 C-N-CA 123.285 2.657 . . . . 0.0 113.701 172.581 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.32 0.58 83.79 Favored Glycine 0 CA--C 1.547 2.09 0 N-CA-C 118.153 2.021 . . . . 0.0 118.153 -170.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -89.96 -177.39 45.05 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-N 119.114 1.457 . . . . 0.0 112.978 174.444 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.37 -32.4 71.43 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 116.821 2.156 . . . . 0.0 116.821 176.631 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.8 -31.91 72.98 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 117.876 -1.059 . . . . 0.0 113.813 168.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -49.44 -43.47 44.79 Favored 'General case' 0 CA--C 1.559 1.319 0 N-CA-C 118.037 2.606 . . . . 0.0 118.037 164.68 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.8 -53.47 9.1 Favored 'General case' 0 CA--C 1.563 1.446 0 C-N-CA 124.466 1.106 . . . . 0.0 113.707 174.916 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.8 t70 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -174.16 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.2 p30 . . . . . 0 C--O 1.243 0.718 0 N-CA-C 100.841 -3.763 . . . . 0.0 100.841 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.1 m -75.18 85.2 2.39 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 114.198 -1.365 . . . . 0.0 109.54 -178.198 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.4 HG12 HD11 ' A' ' 137' ' ' LEU . 6.2 tp -65.63 115.64 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 CA-C-O 122.622 1.201 . . . . 0.0 109.602 179.755 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.1 pp -107.23 -45.12 4.18 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 112.233 -2.258 . . . . 0.0 115.206 179.769 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -130.9 134.78 47.08 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 -179.119 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.4 p -125.62 119.43 54.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 173.248 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.539 HD22 ' CB ' ' A' ' 140' ' ' ALA 0.279 10.5 m-80 76.26 -88.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -174.312 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -148.05 -6.96 0.43 Allowed 'General case' 0 CA--C 1.576 1.953 0 C-N-CA 128.225 2.61 . . . . 0.0 110.71 177.027 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.3 t -69.81 136.5 26.02 Favored 'Isoleucine or valine' 0 C--N 1.359 1.011 0 C-N-CA 125.463 1.505 . . . . 0.0 109.728 178.502 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -89.61 102.21 14.89 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 113.355 -1.748 . . . . 0.0 108.544 175.03 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . 0.258 0.9 OUTLIER -99.71 -97.97 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-O 116.225 -1.845 . . . . 0.0 107.73 173.424 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . 0.301 0.4 OUTLIER 46.7 -87.3 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 117.284 2.328 . . . . 0.0 117.284 179.984 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -85.26 76.11 10.2 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-O 123.408 1.575 . . . . 0.0 108.763 170.232 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.0 p -146.09 168.87 6.57 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 CA-C-N 113.166 -1.834 . . . . 0.0 106.316 -179.784 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.456 HG21 ' H ' ' A' ' 131' ' ' SER . 33.1 m -62.1 137.28 58.23 Favored 'General case' 0 CA--C 1.562 1.407 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.326 158.051 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 10.2 p-80 -46.62 -33.21 4.0 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 117.552 2.427 . . . . 0.0 117.552 168.456 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.456 ' H ' HG21 ' A' ' 129' ' ' THR . 10.9 m -61.02 -41.23 96.16 Favored 'General case' 0 CA--C 1.555 1.159 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 175.109 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -69.0 -35.65 76.94 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 166.851 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -67.2 -53.88 26.2 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 172.634 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.5 p -49.26 -42.86 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 165.827 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -60.15 -55.61 31.69 Favored 'General case' 0 C--N 1.353 0.751 0 CA-C-O 115.799 -2.048 . . . . 0.0 113.24 173.682 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -65.63 -28.31 69.02 Favored 'General case' 0 CA--C 1.564 1.493 0 N-CA-C 117.09 2.255 . . . . 0.0 117.09 175.419 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.4 HD11 HG12 ' A' ' 117' ' ' ILE . 9.8 mp -62.96 -53.93 46.29 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 125.242 1.417 . . . . 0.0 113.876 167.326 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -66.79 -32.73 74.21 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 167.597 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -70.24 -11.5 60.95 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 117.481 2.4 . . . . 0.0 117.481 171.363 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.539 ' CB ' HD22 ' A' ' 121' ' ' ASN . . . -59.13 -1.24 0.17 Allowed 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 118.82 2.896 . . . . 0.0 118.82 163.663 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 93.45 -127.08 8.88 Favored Glycine 0 C--N 1.344 0.989 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 171.395 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.5 m -93.81 -0.5 55.8 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 169.011 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -150.6 111.03 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 -166.188 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.439 ' CG2' ' HB3' ' A' ' 68' ' ' LEU . 34.2 m -90.13 121.04 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 114.528 -1.214 . . . . 0.0 109.119 -179.408 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -103.98 88.24 2.97 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 178.653 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 77.4 mt -89.58 142.22 27.87 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.393 -172.279 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.405 ' CE2' ' HB3' ' A' ' 65' ' ' GLU . 38.4 m-85 -123.69 124.02 41.82 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 103.906 -2.627 . . . . 0.0 103.906 168.748 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 20.0 m -132.49 131.77 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -169.854 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 58.1 ttm . . . . . 0 N--CA 1.477 0.904 0 CA-C-O 123.205 1.479 . . . . 0.0 110.791 177.069 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.558 1.271 0 CA-C-O 122.286 1.041 . . . . 0.0 110.19 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -140.84 124.34 16.83 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 122.986 1.374 . . . . 0.0 108.344 168.144 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.53 129.03 34.96 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 114.175 -1.375 . . . . 0.0 109.646 176.022 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 85.8 m -101.86 132.58 47.55 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.839 175.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -75.28 147.98 39.77 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 122.653 1.216 . . . . 0.0 110.666 174.021 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.6 p . . . . . 0 C--O 1.247 0.927 0 N-CA-C 103.876 -2.638 . . . . 0.0 103.876 -178.895 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 . . . . . 0 N--CA 1.484 1.26 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -126.36 130.48 50.87 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.566 0.698 . . . . 0.0 109.782 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -100.47 136.81 39.77 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.432 -177.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -102.41 116.78 33.33 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.3 mp -130.91 111.96 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 -175.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.3 m -94.25 131.04 40.25 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 168.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.9 tt -134.86 141.87 46.47 Favored 'General case' 0 CA--C 1.556 1.206 0 CA-C-N 113.91 -1.495 . . . . 0.0 108.488 -173.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -81.14 111.24 17.4 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.293 0.637 . . . . 0.0 109.894 177.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 59.9 ttt-85 -70.66 137.78 50.14 Favored 'General case' 0 CA--C 1.563 1.448 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.169 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -62.21 168.78 15.07 Favored Glycine 0 CA--C 1.55 2.277 0 N-CA-C 115.116 0.806 . . . . 0.0 115.116 166.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -61.41 -71.42 0.15 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.108 -1.231 . . . . 0.0 113.792 -167.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.3 m -102.75 -27.38 12.73 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 176.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -123.66 144.49 15.57 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 170.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.1 mp -76.5 -86.88 0.05 OUTLIER 'General case' 0 CA--C 1.558 1.281 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -177.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.464 ' HA3' ' H ' ' A' ' 104' ' ' ALA . . . 140.82 36.17 0.11 Allowed Glycine 0 CA--C 1.546 1.975 0 N-CA-C 116.848 1.499 . . . . 0.0 116.848 -166.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -137.25 175.82 9.26 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 174.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 45.7 m -149.05 119.15 7.19 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 119.919 -1.738 . . . . 0.0 107.775 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 pt -97.22 132.23 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.461 -172.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -79.5 -177.49 5.82 Favored 'General case' 0 CA--C 1.556 1.193 0 CA-C-O 123.478 1.608 . . . . 0.0 111.673 156.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.75 163.03 25.67 Favored Glycine 0 CA--C 1.54 1.599 0 CA-C-N 113.751 -1.568 . . . . 0.0 116.576 -149.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.2 -156.74 20.48 Favored Glycine 0 N--CA 1.471 1.02 0 CA-C-N 112.553 -1.824 . . . . 0.0 114.135 177.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.72 -43.05 76.19 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 115.799 1.778 . . . . 0.0 115.799 177.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -62.33 -38.34 89.1 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 117.536 2.421 . . . . 0.0 117.536 172.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -142.17 89.35 8.7 Favored Pre-proline 0 CA--C 1.553 1.068 1 N-CA-C 99.424 -4.287 . . . . 0.0 99.424 -168.265 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -100.31 130.73 0.16 Allowed 'Trans proline' 0 CA--C 1.548 1.193 0 CA-C-N 124.361 2.593 . . . . 0.0 110.655 -175.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -58.72 -22.5 57.72 Favored 'General case' 0 CA--C 1.582 2.177 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 154.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -157.25 117.38 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.223 0 N-CA-C 104.033 -2.58 . . . . 0.0 104.033 -169.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -77.03 7.58 35.05 Favored Glycine 0 CA--C 1.559 2.799 0 N-CA-C 117.859 1.904 . . . . 0.0 117.859 165.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -97.82 -12.94 21.63 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -155.5 89.89 2.93 Favored Pre-proline 0 CA--C 1.559 1.32 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 176.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -70.49 93.98 0.59 Allowed 'Trans proline' 0 C--N 1.371 1.711 0 C-N-CA 122.821 2.347 . . . . 0.0 110.969 175.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 75.7 m -145.3 128.75 16.95 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 -174.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.498 ' H ' ' HA ' ' A' ' 126' ' ' ARG . 24.6 mm -74.41 115.81 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 -177.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -104.26 155.95 18.31 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 113.044 -1.889 . . . . 0.0 107.446 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . 0.31 97.6 mt -96.28 120.0 45.07 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.688 0 N-CA-C 104.686 -2.339 . . . . 0.0 104.686 160.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 43.4 m -92.42 -25.0 18.68 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 120.57 -1.331 . . . . 0.0 113.486 168.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -138.66 150.74 46.55 Favored 'General case' 0 CA--C 1.56 1.331 0 CA-C-N 120.72 1.6 . . . . 0.0 110.473 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -99.32 126.23 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 104.762 -2.31 . . . . 0.0 104.762 170.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.25 28.7 mm -73.96 120.77 83.0 Favored Pre-proline 0 CA--C 1.571 1.755 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 176.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.64 132.12 22.85 Favored 'Trans proline' 0 C--N 1.368 1.586 0 C-N-CA 123.834 3.022 . . . . 0.0 113.045 -175.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 74.94 0.08 59.32 Favored Glycine 0 CA--C 1.551 2.323 0 N-CA-C 118.59 2.196 . . . . 0.0 118.59 -168.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -88.1 -162.38 38.04 Favored Glycine 0 CA--C 1.544 1.904 0 CA-C-N 119.161 1.481 . . . . 0.0 113.525 177.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.464 ' H ' ' HA3' ' A' ' 76' ' ' GLY . . . -57.24 -58.05 9.94 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -50.47 -45.68 56.36 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 117.843 2.534 . . . . 0.0 117.843 172.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.38 -40.53 73.92 Favored 'General case' 0 CA--C 1.56 1.341 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 177.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . 0.256 0.0 OUTLIER -72.14 -55.49 7.2 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 178.231 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -72.33 -38.3 68.69 Favored 'General case' 0 CA--C 1.557 1.237 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -173.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -141.6 -148.55 5.07 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-O 123.738 1.743 . . . . 0.0 111.164 171.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.88 59.94 0.13 Allowed 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 111.932 -2.134 . . . . 0.0 106.752 -169.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.458 HD22 ' H ' ' A' ' 111' ' ' LEU . 1.5 pt? -79.23 -164.06 0.58 Allowed 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 123.273 1.511 . . . . 0.0 109.128 -174.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.06 157.17 17.06 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 124.594 2.14 . . . . 0.0 106.437 155.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.4 m -58.88 -65.11 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 112.488 -2.142 . . . . 0.0 110.399 171.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -39.54 -18.34 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.256 1 N-CA-C 122.257 4.169 . . . . 0.0 122.257 -177.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -34.92 99.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 125.652 1.581 . . . . 0.0 114.39 163.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.7 m -85.67 104.87 15.79 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 112.568 -2.105 . . . . 0.0 107.455 -161.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . 0.336 11.0 tp -57.93 104.07 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.497 0 CA-C-O 122.339 1.066 . . . . 0.0 112.323 -170.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.428 ' HA ' ' CG ' ' A' ' 126' ' ' ARG 0.317 0.1 OUTLIER -82.9 -63.62 1.33 Allowed 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 112.602 -2.09 . . . . 0.0 110.413 -176.142 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -132.49 135.54 46.08 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 173.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 5.7 p -119.13 112.47 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 105.709 -1.959 . . . . 0.0 105.709 171.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.487 HD22 ' CB ' ' A' ' 140' ' ' ALA 0.27 23.2 m-80 77.7 -78.89 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 122.821 1.296 . . . . 0.0 109.966 -174.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -159.5 -12.94 0.06 Allowed 'General case' 0 CA--C 1.573 1.838 0 C-N-CA 127.399 2.28 . . . . 0.0 110.951 -176.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.4 t -68.25 134.83 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.394 0 C-N-CA 125.376 1.47 . . . . 0.0 110.124 175.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -87.17 97.04 10.54 Favored 'General case' 0 CA--C 1.553 1.068 0 CA-C-N 113.434 -1.712 . . . . 0.0 108.638 177.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . 0.325 2.9 m -97.11 -142.49 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.599 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.498 ' HA ' ' H ' ' A' ' 94' ' ' ILE 0.323 0.9 OUTLIER 71.82 -83.66 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 124.664 1.185 . . . . 0.0 111.2 -173.299 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.56 69.87 10.17 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 123.752 1.739 . . . . 0.0 109.406 177.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.1 m -143.72 166.49 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 -175.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 46.7 m -56.71 129.74 42.46 Favored 'General case' 0 CA--C 1.568 1.666 0 CA-C-N 112.96 -1.927 . . . . 0.0 109.639 150.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -48.49 -32.22 7.55 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 168.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.1 m -57.62 -45.03 85.89 Favored 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 168.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.36 -38.52 84.1 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 169.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -73.23 -44.29 59.79 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 116.914 2.19 . . . . 0.0 116.914 172.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.411 HG23 ' HB ' ' B' ' 6' ' ' VAL . 4.6 p -57.71 -44.93 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 168.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -60.0 -50.8 72.32 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-O 117.089 -1.434 . . . . 0.0 112.055 170.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.63 -31.91 69.94 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 117.939 2.57 . . . . 0.0 117.939 172.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 73.3 mt -59.26 -53.75 54.67 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 125.071 1.348 . . . . 0.0 113.619 164.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -68.6 -35.95 78.03 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 117.358 2.355 . . . . 0.0 117.358 172.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -64.09 -14.28 53.58 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 117.044 2.238 . . . . 0.0 117.044 169.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.487 ' CB ' HD22 ' A' ' 121' ' ' ASN . . . -54.99 -24.0 22.06 Favored 'General case' 0 CA--C 1.561 1.368 0 N-CA-C 118.756 2.873 . . . . 0.0 118.756 160.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 93.61 -125.99 8.45 Favored Glycine 0 N--CA 1.475 1.268 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 168.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.2 m -79.94 -3.36 47.86 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 168.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -149.93 106.8 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -166.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.4 m -81.74 117.55 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 124.192 0.997 . . . . 0.0 110.572 170.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 45.4 mtm180 -99.45 90.59 4.57 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 175.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 42.5 mt -94.25 128.52 40.76 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.322 -169.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -127.49 121.68 31.38 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 103.231 -2.877 . . . . 0.0 103.231 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 18.3 m -131.38 119.44 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 CA-C-N 119.815 1.189 . . . . 0.0 110.923 -163.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 28.1 ttt -91.64 148.07 22.54 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 122.378 1.085 . . . . 0.0 111.256 -176.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -95.12 109.29 21.38 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.632 173.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -118.08 -67.49 0.99 Allowed 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 113.962 -1.472 . . . . 0.0 108.712 178.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? -125.93 84.74 60.57 Favored Pre-proline 0 CA--C 1.555 1.142 0 CA-C-O 118.12 -0.943 . . . . 0.0 109.331 178.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -81.64 115.52 2.81 Favored 'Trans proline' 0 CA--C 1.569 2.228 0 C-N-CA 123.728 2.952 . . . . 0.0 110.864 170.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo . . . . . 0 C--N 1.365 1.436 0 C-N-CA 123.339 2.692 . . . . 0.0 112.121 179.111 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.558 1.273 0 CA-C-O 122.55 1.167 . . . . 0.0 111.406 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -138.31 128.18 25.34 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 170.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 20.7 ttpp -78.97 114.5 17.97 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.551 170.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 85.8 m -88.66 126.54 35.35 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 122.412 1.101 . . . . 0.0 109.059 175.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -80.66 133.8 35.77 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 113.886 -1.506 . . . . 0.0 108.502 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.411 ' HB ' HG23 ' A' ' 134' ' ' VAL . 7.6 p . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 -170.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 . . . . . 0 N--CA 1.479 1.001 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -133.11 133.62 43.17 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 124.676 1.235 . . . . 0.0 109.078 176.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -113.67 141.54 47.1 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.196 -172.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.9 117.7 34.7 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.3 mp -123.76 131.08 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 -174.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.0 m -101.15 127.13 47.85 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 162.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.0 tp -133.79 130.75 38.43 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 113.979 -1.464 . . . . 0.0 107.574 -176.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -77.46 132.28 38.37 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.352 -0.842 . . . . 0.0 109.848 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 33.7 ttt180 -72.98 137.89 45.72 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 119.339 0.972 . . . . 0.0 109.758 174.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -46.86 -82.17 0.03 OUTLIER Glycine 0 CA--C 1.543 1.84 0 CA-C-N 114.734 -1.121 . . . . 0.0 115.866 176.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -166.39 -85.22 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.6 m -88.75 -25.42 22.3 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 125.027 1.331 . . . . 0.0 113.893 173.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -116.79 -174.03 17.05 Favored Glycine 0 CA--C 1.537 1.465 0 CA-C-O 124.801 2.334 . . . . 0.0 110.332 159.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.3 tt -111.25 -44.54 3.54 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 111.705 -2.248 . . . . 0.0 110.101 174.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.414 ' HA3' ' CA ' ' A' ' 103' ' ' GLY . . . 103.75 44.36 1.67 Allowed Glycine 0 CA--C 1.533 1.179 0 N-CA-C 117.392 1.717 . . . . 0.0 117.392 173.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -160.24 168.35 25.56 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.95 1.3 . . . . 0.0 108.487 176.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.0 m -131.81 119.7 21.62 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 120.622 -1.299 . . . . 0.0 111.068 -163.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.7 pt -95.51 129.22 45.93 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.279 -174.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.57 -173.92 4.35 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-O 123.299 1.523 . . . . 0.0 110.243 161.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.47 160.17 22.69 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 123.88 1.822 . . . . 0.0 116.046 -137.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -103.96 -162.0 24.77 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 111.26 -2.47 . . . . 0.0 115.449 -178.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 53.1 p -54.45 -40.16 68.12 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 116.395 1.998 . . . . 0.0 116.395 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -88.49 0.5 56.22 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 116.363 1.986 . . . . 0.0 116.363 175.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -163.27 87.84 1.27 Allowed Pre-proline 0 CA--C 1.557 1.242 0 N-CA-C 101.275 -3.602 . . . . 0.0 101.275 -176.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -97.5 143.19 0.67 Allowed 'Trans proline' 0 CA--C 1.549 1.265 0 CA-C-N 124.043 2.48 . . . . 0.0 111.073 -174.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 57.6 t60 -105.69 -19.38 13.78 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 167.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.501 ' H ' HD12 ' A' ' 88' ' ' ILE . 2.4 mp -94.34 146.7 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 -165.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -64.29 -2.39 7.03 Favored Glycine 0 CA--C 1.559 2.802 0 N-CA-C 119.116 2.407 . . . . 0.0 119.116 167.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -91.65 -11.1 38.0 Favored 'General case' 0 CA--C 1.569 1.697 0 CA-C-O 116.908 -1.52 . . . . 0.0 114.767 163.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.52 19.8 t70 92.59 -88.14 0.0 OUTLIER Pre-proline 0 CA--C 1.569 1.69 0 C-N-CA 126.582 1.953 . . . . 0.0 109.565 -168.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -113.75 103.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.362 1.279 0 CA-C-N 124.455 2.627 . . . . 0.0 112.371 -154.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 67.9 m -154.93 109.52 2.99 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 17.6 mm -74.09 118.85 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 174.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.4 ' HB2' ' O ' ' A' ' 115' ' ' ASP . 2.2 p90 -143.65 134.05 24.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.148 -1.387 . . . . 0.0 108.255 -171.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.449 ' HB ' ' CB ' ' A' ' 114' ' ' ASN . 86.9 mt -83.31 121.75 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 177.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.8 m -96.9 -26.17 15.16 Favored 'General case' 0 CA--C 1.558 1.264 0 CA-C-N 112.659 -2.064 . . . . 0.0 113.501 173.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -132.45 158.37 42.2 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 123.903 1.811 . . . . 0.0 112.121 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -121.92 118.01 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 N-CA-C 102.622 -3.103 . . . . 0.0 102.622 177.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.262 1.6 mp -72.33 131.46 84.91 Favored Pre-proline 0 CA--C 1.567 1.621 0 CA-C-O 118.291 -0.861 . . . . 0.0 108.82 174.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -62.19 134.74 50.57 Favored 'Trans proline' 0 CA--C 1.555 1.547 0 C-N-CA 123.332 2.688 . . . . 0.0 113.531 172.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.18 12.69 84.38 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 117.349 1.7 . . . . 0.0 117.349 -161.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.414 ' CA ' ' HA3' ' A' ' 76' ' ' GLY . . . -93.87 166.52 27.55 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-O 122.203 0.891 . . . . 0.0 113.589 177.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.82 -39.79 76.28 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 116.6 2.074 . . . . 0.0 116.6 -175.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.85 -26.32 65.09 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 172.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.03 -52.39 17.19 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 162.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -58.59 -60.9 3.09 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 125.922 1.689 . . . . 0.0 114.312 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -67.99 -48.27 66.24 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.089 0.955 . . . . 0.0 110.885 175.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.53 80.13 0.24 Allowed Glycine 0 C--N 1.353 1.498 0 CA-C-N 118.719 0.691 . . . . 0.0 112.426 166.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -121.08 -30.54 4.33 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 176.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -138.23 -163.49 1.46 Allowed 'General case' 0 CA--C 1.552 1.026 0 CA-C-O 124.21 1.957 . . . . 0.0 107.048 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -74.41 -146.94 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.465 0 CA-C-O 124.456 2.074 . . . . 0.0 111.271 165.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.411 HG22 ' H ' ' A' ' 114' ' ' ASN 0.371 12.3 m -37.31 -76.48 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 C-N-CA 128.329 2.652 . . . . 0.0 112.847 160.077 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.449 ' CB ' ' HB ' ' A' ' 96' ' ' ILE . 11.7 t-20 -160.72 -16.16 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 112.819 -1.991 . . . . 0.0 109.715 154.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 95' ' ' PHE 0.315 11.9 t70 74.27 -84.69 0.03 OUTLIER 'General case' 0 C--N 1.354 0.801 0 CA-C-O 115.745 -2.074 . . . . 0.0 108.622 -165.163 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 12.6 m -155.23 93.59 1.53 Allowed 'General case' 0 N--CA 1.48 1.037 0 O-C-N 125.47 1.731 . . . . 0.0 107.95 -173.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.4 tp -65.77 127.04 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-O 121.326 0.584 . . . . 0.0 109.967 175.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.517 ' HA ' ' HB3' ' A' ' 126' ' ' ARG 0.338 4.1 pp -96.31 -51.38 4.4 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 116.336 1.976 . . . . 0.0 116.336 171.631 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -135.93 138.56 42.49 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 103.637 -2.727 . . . . 0.0 103.637 -176.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 10.8 p -125.58 121.03 59.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 173.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.521 HD22 ' CB ' ' A' ' 140' ' ' ALA 0.31 38.6 m-80 80.88 -80.65 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 124.181 1.943 . . . . 0.0 109.474 -177.395 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -163.69 -17.37 0.03 OUTLIER 'General case' 0 CA--C 1.568 1.663 0 CA-C-N 110.322 -3.126 . . . . 0.0 109.893 -174.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.4 t -65.46 136.65 26.34 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.268 0 CA-C-O 123.568 1.651 . . . . 0.0 109.647 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -85.25 79.61 9.47 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 111.233 -2.712 . . . . 0.0 110.743 177.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . 0.264 1.2 m -87.03 -106.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 CA-C-O 116.672 -1.633 . . . . 0.0 107.883 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.609 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.254 25.0 ptt180 52.04 -88.87 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 116.604 2.075 . . . . 0.0 116.604 177.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.609 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 25.1 tt0 -86.53 72.77 10.21 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-O 123.259 1.504 . . . . 0.0 108.877 167.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.3 p -139.88 170.25 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 177.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 3.1 m -58.34 136.67 57.45 Favored 'General case' 0 CA--C 1.559 1.29 0 CA-C-N 114.062 -1.426 . . . . 0.0 111.739 159.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . 0.264 2.4 p-80 -46.79 -37.66 8.97 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 117.174 2.287 . . . . 0.0 117.174 171.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 53.6 p -56.33 -52.35 64.88 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 172.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.57 -36.48 78.61 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 173.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.12 -52.53 18.79 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 116.083 1.882 . . . . 0.0 116.083 172.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.9 p -53.43 -44.16 54.53 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.183 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 171.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -63.93 -48.77 75.26 Favored 'General case' 0 C--O 1.212 -0.878 0 CA-C-O 116.038 -1.934 . . . . 0.0 111.807 172.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.77 -28.67 70.14 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 117.384 2.365 . . . . 0.0 117.384 170.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -60.31 -53.98 51.13 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.008 1.323 . . . . 0.0 113.925 166.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -67.91 -39.15 83.63 Favored 'General case' 0 CA--C 1.569 1.691 0 N-CA-C 115.788 1.773 . . . . 0.0 115.788 171.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -74.05 0.31 14.1 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 116.866 2.173 . . . . 0.0 116.866 171.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.521 ' CB ' HD22 ' A' ' 121' ' ' ASN . . . -57.71 -6.75 0.56 Allowed 'General case' 0 CA--C 1.555 1.172 0 N-CA-C 119.317 3.08 . . . . 0.0 119.317 157.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.62 -137.98 16.38 Favored Glycine 0 C--N 1.345 1.072 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 174.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.9 m -79.34 -8.56 59.17 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 169.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -147.76 112.72 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 CA-C-O 123.674 1.702 . . . . 0.0 107.244 -165.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.424 ' HA ' ' HB2' ' A' ' 140' ' ' ALA . 4.3 t -101.55 114.1 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 112.411 -2.177 . . . . 0.0 106.814 -169.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 70.1 mtm180 -96.08 91.79 6.12 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -177.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 45.4 mt -90.88 136.91 32.76 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.033 -173.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -128.49 121.49 29.0 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 104.867 -2.272 . . . . 0.0 104.867 173.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -129.53 122.43 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 -173.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 56.4 ttm -99.68 143.12 30.28 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 124.442 1.088 . . . . 0.0 110.062 164.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -83.37 139.93 32.72 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 122.375 1.083 . . . . 0.0 110.543 168.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 64.6 ttt180 -59.02 148.53 30.49 Favored 'General case' 0 CA--C 1.565 1.554 0 CA-C-N 114.073 -1.421 . . . . 0.0 112.352 177.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.97 -61.03 4.88 Favored Pre-proline 0 N--CA 1.492 1.646 0 CA-C-O 116.027 -1.94 . . . . 0.0 113.532 -178.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.36 139.06 48.44 Favored 'Trans proline' 0 CA--C 1.566 2.106 0 C-N-CA 122.994 2.463 . . . . 0.0 113.494 173.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo . . . . . 0 CA--C 1.554 1.486 0 C-N-CA 123.301 2.667 . . . . 0.0 111.576 173.174 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.562 1.43 0 CA-C-O 122.948 1.356 . . . . 0.0 110.883 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -150.1 113.93 5.05 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 172.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -86.42 125.29 33.59 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.399 175.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 96.7 m -98.85 136.38 38.95 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-O 122.497 1.141 . . . . 0.0 110.008 176.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -84.95 129.19 34.84 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 113.508 -1.678 . . . . 0.0 108.198 173.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 p . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 177.499 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 N--CA 1.481 1.099 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -108.51 132.73 53.53 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 124.08 0.863 . . . . 0.0 109.975 176.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -109.99 131.87 54.67 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 114.389 -1.278 . . . . 0.0 108.223 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.89 126.19 37.86 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 114.362 -1.29 . . . . 0.0 109.294 176.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 40.9 mt -129.26 126.26 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 103.946 -2.613 . . . . 0.0 103.946 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.8 m -109.77 127.6 54.74 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 168.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.453 ' HB3' ' CG2' ' A' ' 144' ' ' VAL . 4.4 tp -127.44 162.11 27.14 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 113.347 -1.752 . . . . 0.0 107.396 175.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -87.52 145.56 26.18 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.432 168.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.4 ttp180 -102.0 124.88 48.37 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 170.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -58.51 149.04 37.02 Favored Glycine 0 CA--C 1.547 2.088 0 CA-C-N 115.42 -0.809 . . . . 0.0 113.773 167.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -54.05 -52.01 62.24 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 -174.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.4 m -83.22 -15.54 49.98 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 116.319 1.97 . . . . 0.0 116.319 175.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 168.67 165.85 26.75 Favored Glycine 0 CA--C 1.535 1.295 0 N-CA-C 107.208 -2.357 . . . . 0.0 107.208 -177.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.8 mp -79.12 -85.43 0.08 Allowed 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 -178.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.424 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 129.97 50.4 0.12 Allowed Glycine 0 CA--C 1.54 1.61 0 C-N-CA 124.08 0.848 . . . . 0.0 114.526 -172.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.445 ' HA ' ' H ' ' A' ' 100' ' ' ILE . 36.8 p90 -151.88 158.36 43.11 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 165.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.1 m -96.05 154.0 17.47 Favored 'General case' 0 C--N 1.316 -0.888 0 O-C-N 119.569 -1.957 . . . . 0.0 110.533 171.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.423 HG21 HD13 ' A' ' 96' ' ' ILE . 2.5 pp -116.39 132.82 64.89 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-N 111.168 -2.742 . . . . 0.0 108.398 168.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.44 -171.3 3.29 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-O 123.613 1.673 . . . . 0.0 109.138 163.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.14 156.44 23.54 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 123.392 1.551 . . . . 0.0 115.251 -142.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.14 -158.58 23.19 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 111.955 -2.123 . . . . 0.0 113.643 -178.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 72.8 p -54.88 -41.55 70.99 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 117.736 2.495 . . . . 0.0 117.736 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -76.54 -13.59 60.07 Favored 'General case' 0 CA--C 1.568 1.663 0 N-CA-C 116.183 1.92 . . . . 0.0 116.183 172.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.31 82.0 6.51 Favored Pre-proline 0 CA--C 1.56 1.345 0 N-CA-C 102.557 -3.127 . . . . 0.0 102.557 -176.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -104.99 120.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.359 1.102 0 CA-C-N 124.976 2.813 . . . . 0.0 110.846 -169.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -107.87 -36.01 6.49 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.44 ' H ' HD12 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -129.13 143.98 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -148.324 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.91 -113.76 4.71 Favored Glycine 0 CA--C 1.536 1.359 0 CA-C-N 114.799 -1.091 . . . . 0.0 112.759 168.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -74.46 -7.81 54.23 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 168.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.454 41.1 m-20 100.79 -81.88 0.0 OUTLIER Pre-proline 0 CA--C 1.566 1.579 0 CA-C-O 115.781 -2.057 . . . . 0.0 106.939 -173.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -86.13 86.92 0.88 Allowed 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 123.442 2.762 . . . . 0.0 112.455 -177.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 66.8 m -155.7 127.65 7.51 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 103.83 -2.655 . . . . 0.0 103.83 -177.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 17.3 mm -76.28 122.3 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -110.02 151.06 27.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 113.057 -1.883 . . . . 0.0 107.936 178.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.423 HD13 HG21 ' A' ' 79' ' ' ILE . 20.6 mm -94.24 100.92 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.205 0 N-CA-C 102.979 -2.971 . . . . 0.0 102.979 165.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.2 t -80.82 -47.35 13.98 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 114.989 1.478 . . . . 0.0 114.989 -176.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.464 ' HA ' HG23 ' A' ' 113' ' ' VAL 0.277 10.4 ptmt -143.75 152.47 41.3 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 121.782 0.801 . . . . 0.0 111.727 -173.593 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.12 123.21 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 N-CA-C 103.886 -2.635 . . . . 0.0 103.886 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.445 ' H ' ' HA ' ' A' ' 77' ' ' PHE 0.267 1.7 mp -72.96 125.88 90.83 Favored Pre-proline 0 CA--C 1.566 1.576 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 173.137 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -60.95 129.52 29.18 Favored 'Trans proline' 0 C--N 1.364 1.367 0 C-N-CA 123.329 2.686 . . . . 0.0 114.296 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.87 5.45 69.81 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 118.481 2.153 . . . . 0.0 118.481 -169.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.424 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -79.08 -175.63 47.21 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 124.31 0.957 . . . . 0.0 114.486 173.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.88 -40.15 94.67 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 116.077 1.88 . . . . 0.0 116.077 -174.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.03 -36.84 80.58 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 173.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.32 -35.21 75.73 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 116.445 2.017 . . . . 0.0 116.445 167.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -70.64 -57.32 4.83 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 125.704 1.602 . . . . 0.0 112.395 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -74.86 -55.57 5.67 Favored 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 123.831 0.853 . . . . 0.0 112.443 -177.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -113.72 -151.75 10.72 Favored Glycine 0 N--CA 1.474 1.208 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 172.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 14.2 mtt-85 -173.82 73.67 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 176.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -104.34 -166.7 1.27 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 124.114 1.912 . . . . 0.0 108.725 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -100.29 128.61 46.32 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 103.133 -2.914 . . . . 0.0 103.133 157.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.464 HG23 ' HA ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -37.34 -64.77 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 110.242 -3.163 . . . . 0.0 116.657 164.026 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -33.48 85.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 125.921 2.013 . . . . 0.0 116.154 -178.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -154.85 131.95 10.95 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 103.717 -2.697 . . . . 0.0 103.717 -177.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 45.0 m -89.98 90.52 8.19 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 113.085 -1.87 . . . . 0.0 108.169 -170.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.5 tp -61.77 121.83 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.009 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.401 ' HA ' ' HB3' ' A' ' 126' ' ' ARG . 1.5 pp -106.33 -50.67 3.1 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 113.16 -1.836 . . . . 0.0 115.91 175.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -123.33 132.75 54.1 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 177.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 5.8 p -122.22 116.39 48.99 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 N-CA-C 104.142 -2.54 . . . . 0.0 104.142 168.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.568 HD22 ' CB ' ' A' ' 140' ' ' ALA 0.282 18.5 m-80 79.83 -74.65 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 CA-C-O 123.348 1.547 . . . . 0.0 110.176 -174.203 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -167.54 -16.74 0.02 OUTLIER 'General case' 0 CA--C 1.578 2.027 0 CA-C-N 111.471 -2.604 . . . . 0.0 109.64 -175.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.0 t -67.66 134.78 29.65 Favored 'Isoleucine or valine' 0 C--N 1.361 1.099 0 CA-C-N 120.415 1.462 . . . . 0.0 110.351 176.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -86.27 99.45 11.58 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 113.419 -1.719 . . . . 0.0 109.046 176.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.3 m -95.93 -101.19 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 CA-C-O 116.401 -1.762 . . . . 0.0 107.381 175.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.49 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.316 18.8 ptt180 50.97 -90.89 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.254 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 177.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.49 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 4.9 tt0 -88.23 65.57 8.12 Favored 'General case' 0 CA--C 1.557 1.225 0 CA-C-O 122.991 1.377 . . . . 0.0 109.54 171.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.7 p -130.36 169.86 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 176.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 33.2 m -61.02 134.87 57.53 Favored 'General case' 0 CA--C 1.56 1.342 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.43 158.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -47.28 -33.41 5.57 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 117.922 2.564 . . . . 0.0 117.922 171.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.7 m -62.06 -38.88 90.46 Favored 'General case' 0 CA--C 1.562 1.439 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 173.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.62 -34.69 76.19 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 115.521 1.675 . . . . 0.0 115.521 166.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -72.44 -49.8 30.84 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 116.234 1.938 . . . . 0.0 116.234 174.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.442 HG23 ' HB ' ' B' ' 6' ' ' VAL . 4.0 p -49.88 -44.24 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.221 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 164.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -64.09 -49.21 73.14 Favored 'General case' 0 C--O 1.216 -0.658 0 CA-C-O 116.075 -1.917 . . . . 0.0 112.556 172.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.47 -32.75 73.68 Favored 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 117.184 2.29 . . . . 0.0 117.184 176.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -58.25 -46.47 85.9 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 162.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -72.36 -37.69 68.74 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 171.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -64.98 -19.95 66.24 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 116.272 1.953 . . . . 0.0 116.272 170.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.568 ' CB ' HD22 ' A' ' 121' ' ' ASN . . . -52.11 -10.66 0.13 Allowed 'General case' 0 CA--C 1.554 1.103 0 N-CA-C 119.246 3.054 . . . . 0.0 119.246 162.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 70.18 -154.51 52.66 Favored Glycine 0 C--N 1.348 1.243 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -175.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.5 m -59.83 -5.09 0.84 Allowed 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 118.506 2.78 . . . . 0.0 118.506 176.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.96 105.79 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 -170.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.453 ' CG2' ' HB3' ' A' ' 68' ' ' LEU . 15.8 m -85.88 123.1 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.07 174.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -108.13 90.22 3.23 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 56.7 mt -90.69 139.27 30.87 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.471 -171.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -135.64 117.88 15.58 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 104.52 -2.4 . . . . 0.0 104.52 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 35.3 m -129.64 118.53 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -164.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 53.2 ttm -118.21 134.15 55.27 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 118.882 0.765 . . . . 0.0 109.746 173.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -82.6 115.18 21.45 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 114.447 -1.251 . . . . 0.0 110.2 171.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 25.9 ttt180 -97.43 99.6 11.03 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 113.628 -1.624 . . . . 0.0 106.665 168.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -68.03 144.63 97.21 Favored Pre-proline 0 CA--C 1.568 1.648 0 CA-C-N 114.088 -1.415 . . . . 0.0 112.457 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -58.38 118.56 5.46 Favored 'Trans proline' 0 CA--C 1.567 2.162 0 C-N-CA 123.45 2.767 . . . . 0.0 114.398 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo . . . . . 0 C--N 1.367 1.516 0 C-N-CA 123.049 2.499 . . . . 0.0 111.703 179.652 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.557 1.212 0 CA-C-O 122.504 1.145 . . . . 0.0 111.285 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -136.24 128.05 29.2 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-O 123.507 1.622 . . . . 0.0 109.328 170.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 10.7 ttpp -97.42 111.27 23.6 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 113.754 -1.566 . . . . 0.0 107.796 172.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.412 HG22 HG22 ' A' ' 134' ' ' VAL . 88.5 m -93.76 144.66 25.21 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.418 -1.265 . . . . 0.0 109.108 173.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -87.19 145.02 26.57 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 113.864 -1.516 . . . . 0.0 108.672 178.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.442 ' HB ' HG23 ' A' ' 134' ' ' VAL . 7.6 p . . . . . 0 C--O 1.248 1.01 0 N-CA-C 104.5 -2.408 . . . . 0.0 104.5 -178.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 . . . . . 0 N--CA 1.481 1.079 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -125.17 134.68 52.31 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 124.833 1.333 . . . . 0.0 110.158 170.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -101.46 133.15 46.54 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.812 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -97.84 128.52 44.51 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.72 170.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.402 HG13 ' HB2' ' A' ' 146' ' ' LEU . 23.5 pt -136.67 111.83 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 -174.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.0 m -91.96 120.24 32.44 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.7 tt -116.52 137.57 52.07 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 175.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -79.58 122.36 26.4 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 120.956 -1.09 . . . . 0.0 111.564 177.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 -62.68 104.79 0.56 Allowed 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 118.855 0.752 . . . . 0.0 110.222 172.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -41.68 -61.49 2.19 Favored Glycine 0 N--CA 1.482 1.743 0 N-CA-C 116.338 1.295 . . . . 0.0 116.338 -173.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -154.43 -100.67 0.04 OUTLIER 'General case' 0 CA--C 1.559 1.316 0 O-C-N 123.994 0.467 . . . . 0.0 109.868 167.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.4 m -73.55 -24.78 60.16 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 168.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -118.15 175.02 15.53 Favored Glycine 0 CA--C 1.543 1.782 0 CA-C-O 125.849 2.916 . . . . 0.0 111.037 162.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.456 ' CD1' HG12 ' A' ' 144' ' ' VAL . 0.1 OUTLIER -119.73 5.29 11.0 Favored 'General case' 0 CA--C 1.558 1.274 0 CA-C-N 110.076 -3.062 . . . . 0.0 112.015 176.499 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 69.4 36.37 77.75 Favored Glycine 0 C--N 1.344 1.014 0 N-CA-C 118.761 2.264 . . . . 0.0 118.761 164.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -150.48 163.51 38.25 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 123.563 1.649 . . . . 0.0 108.489 174.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.5 m -127.25 127.82 45.01 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.582 -169.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.3 pp -101.18 124.03 54.6 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 113.504 -1.68 . . . . 0.0 108.643 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -85.68 -170.86 3.31 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 123.452 1.596 . . . . 0.0 110.051 158.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.1 159.34 24.34 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-O 123.859 1.811 . . . . 0.0 115.604 -136.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -104.24 -162.6 24.58 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 111.082 -2.559 . . . . 0.0 113.742 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 70.2 p -52.83 -41.75 64.5 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 116.67 2.1 . . . . 0.0 116.67 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -80.15 -17.32 52.8 Favored 'General case' 0 CA--C 1.565 1.55 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 175.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.29 96.07 4.27 Favored Pre-proline 0 CA--C 1.552 1.028 0 N-CA-C 101.822 -3.399 . . . . 0.0 101.822 -175.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -96.73 143.41 0.84 Allowed 'Trans proline' 0 CA--C 1.548 1.194 0 CA-C-N 123.688 2.353 . . . . 0.0 111.472 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 16.8 t60 -106.25 -27.85 10.78 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 167.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.432 HG13 ' CE1' ' A' ' 95' ' ' PHE . 0.0 OUTLIER -98.62 162.68 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 125.305 1.442 . . . . 0.0 111.506 179.64 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -83.64 12.57 51.66 Favored Glycine 0 CA--C 1.552 2.358 0 N-CA-C 118.651 2.221 . . . . 0.0 118.651 172.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -81.12 -11.58 59.44 Favored 'General case' 0 CA--C 1.57 1.718 0 CA-C-N 119.151 1.475 . . . . 0.0 114.554 163.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.509 31.8 t70 91.57 -85.32 0.0 OUTLIER Pre-proline 0 CA--C 1.562 1.429 0 CA-C-O 116.089 -1.91 . . . . 0.0 109.017 -169.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -108.39 -139.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.28 0 CA-C-N 125.288 2.924 . . . . 0.0 110.636 -163.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.5 m 78.3 106.87 0.07 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 168.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 11.3 mm -75.55 117.56 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 -173.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.432 ' CE1' HG13 ' A' ' 88' ' ' ILE . 16.9 p90 -128.4 135.44 49.54 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -171.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 89.5 mt -72.5 118.83 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.388 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 175.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.431 ' CG2' ' HG3' ' B' ' 3' ' ' LYS . 14.3 t -87.75 -29.69 20.85 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 169.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -144.25 163.08 34.7 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-O 125.568 2.604 . . . . 0.0 110.343 -174.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.2 pt -115.4 129.17 72.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 111.051 -2.795 . . . . 0.0 103.539 173.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.294 1.5 mp -72.19 123.78 89.95 Favored Pre-proline 0 CA--C 1.57 1.715 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 170.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.93 132.08 42.95 Favored 'Trans proline' 0 C--N 1.367 1.545 0 C-N-CA 123.558 2.838 . . . . 0.0 114.203 172.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 71.52 9.95 69.88 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 118.084 1.994 . . . . 0.0 118.084 -166.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -91.01 -179.29 43.06 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-O 123.033 1.351 . . . . 0.0 112.397 177.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.65 -33.79 66.82 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 117.523 2.416 . . . . 0.0 117.523 -174.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.94 -32.88 72.38 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 117.961 2.578 . . . . 0.0 117.961 165.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.35 -39.41 93.84 Favored 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 167.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.48 -56.02 6.75 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.387 1.075 . . . . 0.0 113.624 175.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -62.0 -39.38 92.06 Favored 'General case' 0 CA--C 1.562 1.415 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -178.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 108.86 38.26 1.9 Allowed Glycine 0 CA--C 1.541 1.67 0 C-N-CA 124.682 1.134 . . . . 0.0 113.649 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -113.61 39.94 2.53 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 122.625 1.202 . . . . 0.0 111.343 173.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -61.01 -23.57 65.51 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 118.114 2.635 . . . . 0.0 118.114 170.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 16.1 mtp-105 -77.91 95.36 4.75 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 125.588 2.613 . . . . 0.0 107.479 163.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.404 HG23 ' H ' ' A' ' 114' ' ' ASN 0.26 17.0 m -56.17 -67.99 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 1 CA-C-N 107.589 -4.369 . . . . 0.0 108.467 -175.834 . . . . . . . . 4 3 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.404 ' H ' HG23 ' A' ' 113' ' ' VAL . 86.3 m-20 -55.3 68.95 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 126.174 2.171 . . . . 0.0 116.714 -175.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -123.91 102.38 7.75 Favored 'General case' 0 C--O 1.239 0.547 1 N-CA-C 100.091 -4.04 . . . . 0.0 100.091 173.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.8 m -75.02 86.93 2.34 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 112.992 -1.913 . . . . 0.0 109.097 -176.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 30.1 pt -64.91 121.22 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 125.065 1.346 . . . . 0.0 111.024 -174.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.841 HD11 ' H ' ' A' ' 149' ' ' MET . 0.0 OUTLIER -101.55 -50.17 3.81 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 112.736 -2.029 . . . . 0.0 112.778 -179.457 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.434 ' H ' HD21 ' A' ' 118' ' ' LEU . 78.4 m-85 -111.4 140.91 45.6 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 169.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.1 p -127.93 120.05 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 104.465 -2.42 . . . . 0.0 104.465 165.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.571 HD22 ' CB ' ' A' ' 140' ' ' ALA 0.27 24.5 m-80 79.67 -74.45 0.05 Allowed 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 123.592 1.663 . . . . 0.0 110.453 -176.162 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -164.49 -10.88 0.03 OUTLIER 'General case' 0 CA--C 1.578 2.038 0 CA-C-N 111.355 -2.657 . . . . 0.0 110.203 177.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.1 t -71.46 134.42 29.98 Favored 'Isoleucine or valine' 0 C--N 1.36 1.03 0 C-N-CA 125.682 1.593 . . . . 0.0 109.745 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -84.67 100.79 11.69 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 113.698 -1.592 . . . . 0.0 109.299 172.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -96.97 -96.86 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 CA-C-O 116.08 -1.914 . . . . 0.0 106.894 171.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.479 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.302 18.9 ptt180 46.79 -89.37 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 -178.374 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.479 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 6.6 mt-10 -85.9 65.95 9.37 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-O 123.672 1.701 . . . . 0.0 109.087 177.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.1 p -138.75 168.38 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 22.9 m -60.33 132.79 55.0 Favored 'General case' 0 CA--C 1.561 1.388 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.884 158.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 10.2 p-80 -46.53 -32.69 3.54 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 118.166 2.654 . . . . 0.0 118.166 170.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.5 m -62.4 -40.37 96.28 Favored 'General case' 0 CA--C 1.561 1.381 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 173.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.74 -37.69 87.07 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 167.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -66.94 -52.18 46.11 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 172.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 4.9 p -53.65 -42.25 50.15 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.421 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 172.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -72.33 -39.82 67.88 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 116.267 -1.825 . . . . 0.0 112.93 174.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.59 -29.19 69.04 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 117.162 2.282 . . . . 0.0 117.162 165.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -62.78 -48.96 76.88 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.819 1.647 . . . . 0.0 114.93 165.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -68.21 -35.71 78.4 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 168.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -64.65 -23.19 67.18 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 116.379 1.992 . . . . 0.0 116.379 171.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.571 ' CB ' HD22 ' A' ' 121' ' ' ASN . . . -54.2 -11.06 0.43 Allowed 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 118.794 2.887 . . . . 0.0 118.794 162.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 89.1 -136.98 13.92 Favored Glycine 0 C--N 1.345 1.066 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 172.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 26.8 m -77.75 -2.96 38.83 Favored 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 170.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.85 106.74 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 -170.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.456 HG12 ' CD1' ' A' ' 75' ' ' LEU . 10.7 m -88.39 116.21 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.324 1.45 . . . . 0.0 109.292 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 56.1 mtm180 -104.01 89.34 3.26 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -176.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.402 ' HB2' HG13 ' A' ' 66' ' ' ILE . 23.9 mt -88.33 138.34 31.52 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.736 0.779 . . . . 0.0 109.0 -170.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -120.97 127.53 51.89 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 5.7 p -133.55 112.45 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 CA-C-O 121.65 0.738 . . . . 0.0 109.85 175.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.841 ' H ' HD11 ' A' ' 118' ' ' LEU . 27.3 ttt -88.63 128.8 35.6 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.343 1.857 . . . . 0.0 110.793 161.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 90.7 mtt-85 -103.7 111.53 24.06 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 114.264 -1.334 . . . . 0.0 107.614 -174.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -96.29 -27.8 14.81 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 112.995 -1.911 . . . . 0.0 113.596 174.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 32.6 tttm -136.29 86.31 24.96 Favored Pre-proline 0 CA--C 1.561 1.403 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -52.18 -49.85 15.99 Favored 'Trans proline' 0 CA--C 1.572 2.405 0 C-N-CA 123.213 2.609 . . . . 0.0 116.977 163.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo . . . . . 0 C--N 1.376 1.997 0 CA-C-N 124.364 2.594 . . . . 0.0 113.045 179.339 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.56 1.356 0 CA-C-O 122.728 1.251 . . . . 0.0 110.899 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -142.0 127.04 18.39 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 123.082 1.42 . . . . 0.0 107.937 170.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.431 ' HG3' ' CG2' ' A' ' 97' ' ' THR . 1.6 tmmt? -89.91 122.13 32.66 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.024 169.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 62.8 m -92.35 135.87 33.67 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 122.715 1.245 . . . . 0.0 108.951 171.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -92.27 133.58 35.7 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 113.855 -1.52 . . . . 0.0 107.865 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . 0.254 11.7 p . . . . . 0 C--O 1.248 1.015 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 -169.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 . . . . . 0 N--CA 1.482 1.175 0 CA-C-O 120.91 0.386 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -123.95 136.98 54.67 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.686 179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -107.43 135.92 48.09 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 114.55 -1.204 . . . . 0.0 108.077 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -95.43 127.59 41.59 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.841 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.409 HG21 HD12 ' A' ' 68' ' ' LEU . 4.2 mp -135.24 122.91 37.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 -177.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.7 m -105.22 122.79 46.66 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 173.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.409 HD12 HG21 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -120.7 132.57 55.15 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 114.305 -1.316 . . . . 0.0 108.581 -175.869 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -105.34 115.47 30.31 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.812 -176.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.424 ' HG2' ' HA ' ' A' ' 75' ' ' LEU . 1.6 tpm_? -116.22 -102.73 0.42 Allowed 'General case' 0 CA--C 1.568 1.65 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.513 166.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.1 54.16 0.81 Allowed Glycine 0 N--CA 1.472 1.083 0 C-N-CA 126.43 1.967 . . . . 0.0 113.729 -165.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -160.7 171.15 19.37 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-O 123.156 1.455 . . . . 0.0 108.937 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.4 m -70.05 -22.42 63.08 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 161.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -105.46 88.74 0.59 Allowed Glycine 0 CA--C 1.543 1.838 0 CA-C-N 119.541 1.064 . . . . 0.0 110.566 164.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.492 ' H ' HD23 ' A' ' 75' ' ' LEU 0.405 0.2 OUTLIER -70.12 -2.06 11.87 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 118.016 2.599 . . . . 0.0 118.016 168.769 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.29 20.44 17.86 Favored Glycine 0 C--O 1.218 -0.855 0 CA-C-O 115.437 -2.868 . . . . 0.0 117.18 168.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -158.46 117.27 3.07 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 121.745 2.773 . . . . 0.0 109.678 -169.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.6 m -87.79 127.0 35.32 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.211 -1.359 . . . . 0.0 110.823 172.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.4 pp -105.74 127.22 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 113.62 -1.627 . . . . 0.0 108.947 -176.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -79.55 -173.05 3.56 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 124.015 1.864 . . . . 0.0 111.321 159.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -101.59 160.57 18.1 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-N 112.937 -1.938 . . . . 0.0 114.95 -142.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.23 -162.22 21.75 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 110.939 -2.631 . . . . 0.0 111.711 -173.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.419 HG22 ' HB2' ' A' ' 92' ' ' PRO . 13.3 p -52.52 -43.1 64.91 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 117.661 2.467 . . . . 0.0 117.661 -173.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -97.99 12.43 34.27 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 174.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -155.17 69.74 5.56 Favored Pre-proline 0 CA--C 1.555 1.151 0 N-CA-C 101.96 -3.348 . . . . 0.0 101.96 174.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -88.79 126.73 1.8 Allowed 'Trans proline' 0 C--N 1.365 1.444 0 CA-C-N 126.659 3.414 . . . . 0.0 112.208 -163.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -56.99 -31.46 65.08 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 115.213 1.561 . . . . 0.0 115.213 157.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -148.83 124.33 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 N-CA-C 103.422 -2.807 . . . . 0.0 103.422 -171.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -77.9 7.75 40.97 Favored Glycine 0 CA--C 1.556 2.639 0 N-CA-C 117.795 1.878 . . . . 0.0 117.795 165.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -105.23 -8.99 17.97 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 125.296 1.438 . . . . 0.0 114.182 177.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -154.51 88.38 3.36 Favored Pre-proline 0 CA--C 1.555 1.163 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.419 ' HB2' HG22 ' A' ' 83' ' ' THR . 14.6 Cg_endo -62.61 96.1 0.16 Allowed 'Trans proline' 0 CA--C 1.557 1.664 0 C-N-CA 122.851 2.367 . . . . 0.0 112.932 170.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.5 t -161.33 159.22 28.16 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 -172.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 12.2 mm -99.61 120.17 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 N-CA-C 105.256 -2.128 . . . . 0.0 105.256 -175.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -111.41 149.68 30.89 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 113.442 -1.708 . . . . 0.0 107.205 -174.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 23.0 mt -94.78 111.27 25.22 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.319 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 165.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 96.8 m -85.81 -30.85 22.66 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 117.264 -1.351 . . . . 0.0 113.431 169.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . 0.282 8.9 ptmm? -141.41 164.08 31.19 Favored 'General case' 0 CA--C 1.557 1.246 0 CA-C-N 120.673 1.579 . . . . 0.0 112.177 173.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.417 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 1.7 tp -115.26 137.51 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 N-CA-C 104.57 -2.381 . . . . 0.0 104.57 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.273 1.6 mp -83.6 116.86 66.71 Favored Pre-proline 0 CA--C 1.57 1.743 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 168.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -63.0 146.01 94.57 Favored 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 123.736 2.957 . . . . 0.0 113.979 172.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.3 -13.65 26.2 Favored Glycine 0 CA--C 1.547 2.073 0 N-CA-C 117.586 1.794 . . . . 0.0 117.586 -169.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -83.19 -169.62 45.02 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 118.911 1.356 . . . . 0.0 113.162 173.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.89 -51.29 27.09 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -170.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.0 -32.86 72.44 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 116.915 2.191 . . . . 0.0 116.915 173.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.07 -51.3 48.2 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 170.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -65.06 -62.22 1.68 Allowed 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 125.313 1.445 . . . . 0.0 112.986 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -64.97 -37.61 88.23 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 -177.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.64 -66.45 0.27 Allowed Glycine 0 N--CA 1.474 1.172 0 CA-C-N 118.955 0.798 . . . . 0.0 113.19 -176.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 58.66 52.33 6.94 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 123.414 1.578 . . . . 0.0 112.239 -157.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.44 HD13 ' H ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -84.28 0.89 47.27 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 112.967 -1.924 . . . . 0.0 115.671 -170.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 40.0 mtt180 65.01 129.3 0.02 OUTLIER 'General case' 0 C--N 1.349 0.544 0 CA-C-O 125.535 2.588 . . . . 0.0 111.608 -168.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.475 ' CG2' ' H ' ' A' ' 114' ' ' ASN 0.281 28.1 m -46.8 -71.09 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.131 1 CA-C-N 108.098 -4.137 . . . . 0.0 111.383 -167.035 . . . . . . . . 4 3 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.475 ' H ' ' CG2' ' A' ' 113' ' ' VAL . 1.5 p-10 -31.11 75.98 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.972 0 O-C-N 127.371 2.92 . . . . 0.0 118.157 166.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -122.56 -164.26 1.16 Allowed 'General case' 0 CA--C 1.558 1.267 0 CA-C-N 110.519 -3.037 . . . . 0.0 104.774 162.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.8 m -144.79 84.27 1.72 Allowed 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 175.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 28.1 pt -56.58 108.63 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 CA-C-O 123.558 1.646 . . . . 0.0 111.042 175.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.3 pp -101.19 -41.37 6.75 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 112.564 -2.107 . . . . 0.0 115.526 178.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -127.59 143.76 51.14 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.401 HG11 HD22 ' A' ' 146' ' ' LEU . 3.3 t -136.56 108.0 6.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 101.294 -3.595 . . . . 0.0 101.294 178.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.608 HD22 ' HB1' ' A' ' 140' ' ' ALA 0.283 25.0 m-80 82.51 -80.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 123.44 1.59 . . . . 0.0 109.504 178.593 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -152.82 -14.07 0.16 Allowed 'General case' 0 CA--C 1.568 1.635 0 CA-C-N 111.815 -2.448 . . . . 0.0 111.196 177.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.2 t -68.86 136.98 25.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 124.893 1.277 . . . . 0.0 109.733 174.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -96.08 101.08 12.7 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 112.574 -2.103 . . . . 0.0 109.018 176.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . 0.261 1.6 m -100.42 -103.84 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 CA-C-O 116.773 -1.584 . . . . 0.0 107.178 178.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.581 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.363 26.9 ptt85 44.21 -92.87 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 125.139 1.376 . . . . 0.0 114.572 -169.9 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.581 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 16.6 tt0 -72.84 74.84 1.15 Allowed 'General case' 0 CA--C 1.555 1.142 0 CA-C-O 124.297 1.998 . . . . 0.0 110.98 170.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.3 p -149.0 166.54 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 CA-C-N 111.993 -2.367 . . . . 0.0 105.232 -178.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.6 122.49 10.71 Favored 'General case' 0 CA--C 1.557 1.224 0 CA-C-N 111.841 -2.436 . . . . 0.0 110.462 154.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -49.48 -31.24 9.59 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 117.436 2.384 . . . . 0.0 117.436 175.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.1 m -58.86 -38.05 77.89 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 115.373 1.619 . . . . 0.0 115.373 171.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.61 -37.06 79.47 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 165.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.19 -54.6 34.96 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 171.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.444 HG22 HG23 ' B' ' 4' ' ' THR . 9.8 p -52.45 -43.43 41.57 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 166.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -58.14 -50.39 73.65 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-O 115.888 -2.006 . . . . 0.0 111.817 171.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.55 -35.43 77.75 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 117.146 2.276 . . . . 0.0 117.146 173.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 9.3 mp -55.82 -52.6 63.43 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 125.04 1.336 . . . . 0.0 114.007 164.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -71.35 -31.82 67.8 Favored 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 174.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -67.16 -30.23 70.15 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 115.332 1.605 . . . . 0.0 115.332 171.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.608 ' HB1' HD22 ' A' ' 121' ' ' ASN . . . -50.27 -33.06 18.52 Favored 'General case' 0 CA--C 1.56 1.332 0 N-CA-C 117.202 2.297 . . . . 0.0 117.202 159.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 91.21 -125.18 7.9 Favored Glycine 0 C--N 1.348 1.229 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 166.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 11.6 m -73.38 -10.36 59.66 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 118.043 2.609 . . . . 0.0 118.043 169.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.2 104.44 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 -170.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.2 m -86.88 118.4 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 113.383 -1.735 . . . . 0.0 109.557 175.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 62.5 mtm180 -97.57 91.79 5.6 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 172.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.401 HD22 HG11 ' A' ' 120' ' ' VAL . 86.2 mt -93.24 138.69 31.39 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.906 0.86 . . . . 0.0 108.985 -173.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -130.67 120.99 24.73 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 177.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 21.2 m -130.77 129.64 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -166.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 23.9 ptt? -90.87 152.48 20.73 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 122.46 1.124 . . . . 0.0 111.587 168.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 46.0 mtp180 -108.19 126.76 53.17 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 113.987 -1.46 . . . . 0.0 108.079 173.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -62.31 -26.16 68.27 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 165.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -99.88 107.84 48.54 Favored Pre-proline 0 CA--C 1.565 1.535 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 165.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -66.32 159.35 50.51 Favored 'Trans proline' 0 CA--C 1.569 2.234 0 C-N-CA 123.013 2.475 . . . . 0.0 114.021 170.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo . . . . . 0 CA--C 1.553 1.436 0 C-N-CA 123.387 2.725 . . . . 0.0 115.137 174.35 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 8.1 p90 . . . . . 0 CA--C 1.55 0.98 0 CA-C-O 122.194 0.997 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -115.06 149.19 37.88 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 123.738 1.733 . . . . 0.0 109.188 173.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 12.0 ttpp -103.97 109.28 20.98 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 113.189 -1.823 . . . . 0.0 107.305 176.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.444 HG23 HG22 ' A' ' 134' ' ' VAL . 0.2 OUTLIER -76.59 131.31 38.84 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.625 175.979 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -85.58 121.92 28.95 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 C--O 1.248 0.977 0 N-CA-C 104.193 -2.521 . . . . 0.0 104.193 -170.314 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 . . . . . 0 N--CA 1.481 1.101 0 CA-C-O 120.988 0.423 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -90.94 133.72 35.04 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-O 122.414 1.102 . . . . 0.0 112.575 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -101.53 129.16 47.56 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 113.354 -1.748 . . . . 0.0 108.254 166.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -116.29 129.27 56.19 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 114.224 -1.353 . . . . 0.0 109.163 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 6.2 pt -135.82 115.36 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 -174.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.3 m -86.43 118.18 25.7 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 171.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.2 tt -124.14 140.46 52.94 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 113.14 -1.845 . . . . 0.0 106.198 -171.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -82.33 131.66 35.23 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 121.431 -0.793 . . . . 0.0 109.378 -176.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 42.4 ttt180 -67.61 92.06 0.31 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.69 -0.631 . . . . 0.0 109.714 175.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 17.89 -94.12 0.01 OUTLIER Glycine 0 N--CA 1.48 1.574 0 N-CA-C 119.243 2.457 . . . . 0.0 119.243 177.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -158.36 -77.85 0.07 Allowed 'General case' 0 CA--C 1.559 1.327 0 CA-C-N 113.925 -1.138 . . . . 0.0 108.725 176.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 27.6 m -81.95 -25.5 34.8 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 175.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -140.54 -146.1 4.74 Favored Glycine 0 CA--C 1.536 1.352 0 N-CA-C 107.406 -2.278 . . . . 0.0 107.406 161.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.9 mp -87.95 -91.66 0.11 Allowed 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 106.349 -1.722 . . . . 0.0 106.349 173.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 127.57 50.39 0.15 Allowed Glycine 0 CA--C 1.543 1.815 0 C-N-CA 124.516 1.055 . . . . 0.0 114.916 -175.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -159.33 149.58 19.15 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 122.998 1.38 . . . . 0.0 109.97 174.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 70.7 m -99.91 116.35 31.75 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.408 -0.807 . . . . 0.0 111.62 -175.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.1 pt -88.46 122.86 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.311 176.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.65 -172.09 3.87 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-O 123.263 1.506 . . . . 0.0 110.644 164.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.43 161.05 22.99 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-O 123.389 1.55 . . . . 0.0 116.341 -136.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.49 -162.58 23.43 Favored Glycine 0 N--CA 1.464 0.564 0 CA-C-N 111.919 -2.14 . . . . 0.0 116.298 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 59.6 p -52.08 -40.53 61.35 Favored 'General case' 0 CA--C 1.567 1.628 0 CA-C-N 112.516 -1.842 . . . . 0.0 115.595 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -78.82 -30.54 45.39 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 172.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -134.52 91.37 21.95 Favored Pre-proline 0 N--CA 1.478 0.972 0 N-CA-C 102.402 -3.185 . . . . 0.0 102.402 -173.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -100.01 147.81 0.44 Allowed 'Trans proline' 0 CA--C 1.549 1.251 0 CA-C-N 124.557 2.663 . . . . 0.0 111.221 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.476 ' HB2' ' CD2' ' B' ' 1' ' ' TYR . 43.3 t60 -110.01 -31.58 7.33 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 166.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.41 ' H ' HD12 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -94.05 153.93 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 CA-C-O 122.912 1.339 . . . . 0.0 110.711 -179.92 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -79.79 12.7 27.81 Favored Glycine 0 CA--C 1.549 2.197 0 N-CA-C 118.304 2.081 . . . . 0.0 118.304 172.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -75.84 -8.97 58.18 Favored 'General case' 0 CA--C 1.569 1.683 0 CA-C-N 119.26 1.53 . . . . 0.0 115.028 162.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.506 31.6 t70 95.17 -78.93 0.0 OUTLIER Pre-proline 0 CA--C 1.565 1.521 0 CA-C-O 115.893 -2.003 . . . . 0.0 109.296 -172.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -116.86 -136.02 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.448 0 CA-C-N 124.661 2.7 . . . . 0.0 110.482 -166.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 39.9 m 79.73 119.31 0.05 Allowed 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 167.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.488 HG13 ' CB ' ' A' ' 133' ' ' ALA . 10.0 mm -96.1 125.67 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 104.905 -2.258 . . . . 0.0 104.905 -172.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.401 ' HB2' ' O ' ' A' ' 115' ' ' ASP . 32.3 p90 -140.67 128.52 21.82 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 112.317 -2.22 . . . . 0.0 106.58 -159.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.447 ' HB ' ' HB2' ' A' ' 114' ' ' ASN . 73.6 mt -87.64 114.93 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.2 t -97.77 -13.85 21.14 Favored 'General case' 0 CA--C 1.559 1.301 0 CA-C-N 113.224 -1.807 . . . . 0.0 114.805 169.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm -141.11 158.11 44.36 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-O 124.832 2.253 . . . . 0.0 109.93 -173.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.29 131.87 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 111.531 -2.577 . . . . 0.0 105.894 -176.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.441 HD12 ' H ' ' B' ' 7' ' ' BAL 0.275 1.6 mp -78.69 131.62 67.2 Favored Pre-proline 0 CA--C 1.57 1.716 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 167.532 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.17 130.56 34.8 Favored 'Trans proline' 0 C--N 1.367 1.517 0 C-N-CA 123.416 2.744 . . . . 0.0 115.132 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 70.48 13.33 70.94 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 118.167 2.027 . . . . 0.0 118.167 -168.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -90.0 -162.11 38.04 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 124.371 0.986 . . . . 0.0 114.675 -175.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.27 -53.85 21.66 Favored 'General case' 0 CA--C 1.557 1.229 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -170.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.05 -24.49 64.18 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 117.286 2.328 . . . . 0.0 117.286 168.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.96 -34.98 71.98 Favored 'General case' 0 CA--C 1.565 1.551 0 N-CA-C 115.964 1.838 . . . . 0.0 115.964 168.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -55.29 6.01 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 124.929 1.292 . . . . 0.0 112.26 174.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -77.03 -48.85 16.77 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.26 0.624 . . . . 0.0 112.612 -174.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -96.07 -140.99 11.46 Favored Glycine 0 CA--C 1.543 1.787 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 160.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 31.7 mtm-85 -156.01 -7.13 0.11 Allowed 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 177.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.8 pp -162.05 -46.69 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.181 -0.949 . . . . 0.0 110.883 -153.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 26.8 mtp180 -78.95 95.73 5.54 Favored 'General case' 0 C--N 1.36 1.024 0 CA-C-O 125.187 2.423 . . . . 0.0 105.297 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . 0.317 11.1 m -32.08 -62.74 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.659 1 CA-C-N 108.194 -4.094 . . . . 0.0 112.316 156.837 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.622 HD22 HD11 ' A' ' 146' ' ' LEU . 0.9 OUTLIER 158.64 -17.7 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 129.859 3.264 . . . . 0.0 110.392 168.16 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 95' ' ' PHE 0.308 6.9 m-20 84.59 -82.28 0.02 OUTLIER 'General case' 0 C--N 1.354 0.77 0 C-N-CA 126.55 1.94 . . . . 0.0 108.248 169.644 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 69.4 m -160.37 102.42 1.39 Allowed 'General case' 0 N--CA 1.473 0.677 0 O-C-N 126.337 2.273 . . . . 0.0 107.352 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -99.0 150.27 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.416 0 CA-C-O 122.617 1.199 . . . . 0.0 108.911 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.732 HD11 ' H ' ' A' ' 149' ' ' MET . 0.0 OUTLIER -120.61 -37.36 3.02 Favored 'General case' 0 N--CA 1.502 2.154 0 C-N-CA 126.504 1.922 . . . . 0.0 111.784 -171.056 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -126.67 150.66 48.85 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-O 122.755 1.264 . . . . 0.0 108.237 173.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.547 ' HB ' HH22 ' A' ' 126' ' ' ARG . 14.6 p -129.65 121.22 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 169.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.468 HD22 ' HB2' ' A' ' 140' ' ' ALA 0.358 12.8 m-80 79.14 -88.67 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 123.595 1.664 . . . . 0.0 107.845 178.626 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -144.21 -16.45 0.58 Allowed 'General case' 0 CA--C 1.568 1.636 0 CA-C-N 110.478 -3.055 . . . . 0.0 110.37 174.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.7 t -66.45 134.54 29.82 Favored 'Isoleucine or valine' 0 C--N 1.36 1.054 0 CA-C-O 123.92 1.819 . . . . 0.0 109.949 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -89.47 57.8 4.12 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 110.254 -3.157 . . . . 0.0 112.923 173.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.401 ' HB ' ' H ' ' A' ' 126' ' ' ARG . 1.8 m -70.86 -163.94 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.333 0 CA-C-O 123.632 1.682 . . . . 0.0 108.496 161.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.547 HH22 ' HB ' ' A' ' 120' ' ' VAL 0.525 4.3 mmt85 86.51 -49.27 0.05 Allowed 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 115.019 1.489 . . . . 0.0 115.019 176.164 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -76.21 51.86 0.71 Allowed 'General case' 0 CA--C 1.571 1.756 0 CA-C-N 114.186 -1.37 . . . . 0.0 113.276 155.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.405 HG23 ' H ' ' A' ' 126' ' ' ARG . 30.4 m -148.58 170.15 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 -170.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 44.6 p -61.73 141.12 58.07 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 113.293 -1.776 . . . . 0.0 111.814 155.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -44.39 -33.74 1.76 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 117.175 2.287 . . . . 0.0 117.175 171.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.1 m -62.78 -40.72 98.19 Favored 'General case' 0 CA--C 1.564 1.489 0 N-CA-C 115.702 1.742 . . . . 0.0 115.702 176.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.06 -37.94 81.87 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 169.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.488 ' CB ' HG13 ' A' ' 94' ' ' ILE . . . -67.8 -47.26 69.58 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 116.152 -1.88 . . . . 0.0 115.968 169.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.419 HG23 HG21 ' B' ' 4' ' ' THR . 13.0 p -53.39 -46.37 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-N 121.351 1.887 . . . . 0.0 113.221 166.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -53.18 -46.91 69.15 Favored 'General case' 0 CA--C 1.555 1.16 0 CA-C-O 117.527 -1.225 . . . . 0.0 113.02 168.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.63 -26.82 67.25 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 117.534 2.42 . . . . 0.0 117.534 170.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.429 ' CD2' HH21 ' A' ' 126' ' ' ARG . 3.5 mm? -68.76 -49.35 59.43 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 125.6 1.56 . . . . 0.0 113.845 171.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -66.22 -34.27 77.65 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 165.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -72.43 -21.65 61.22 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 116.932 2.197 . . . . 0.0 116.932 174.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.468 ' HB2' HD22 ' A' ' 121' ' ' ASN . . . -51.58 -20.8 2.13 Favored 'General case' 0 CA--C 1.563 1.451 0 N-CA-C 117.584 2.438 . . . . 0.0 117.584 155.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.78 -147.29 27.76 Favored Glycine 0 C--N 1.35 1.356 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 174.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 18.5 m -61.84 -6.5 2.76 Favored 'General case' 0 CA--C 1.571 1.783 0 N-CA-C 117.553 2.427 . . . . 0.0 117.553 173.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -146.58 101.68 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 -170.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.42 ' HA ' ' HB3' ' A' ' 140' ' ' ALA . 29.8 m -84.18 116.92 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.293 172.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.435 ' HB2' ' HA ' ' A' ' 121' ' ' ASN . 57.7 mtp85 -94.35 106.12 18.1 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 174.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.622 HD11 HD22 ' A' ' 114' ' ' ASN . 11.3 mt -107.02 124.05 49.08 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 -166.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -116.84 130.14 56.52 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 -174.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.02 127.77 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 176.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.732 ' H ' HD11 ' A' ' 118' ' ' LEU . 67.3 mtt -93.9 113.25 25.23 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.048 1.739 . . . . 0.0 108.671 171.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -97.17 126.2 42.19 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 113.777 -1.556 . . . . 0.0 107.556 174.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -75.89 118.6 18.85 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 114.055 -1.43 . . . . 0.0 108.029 175.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -164.79 -58.62 0.01 OUTLIER Pre-proline 0 CA--C 1.556 1.182 0 CA-C-O 115.59 -2.147 . . . . 0.0 107.642 176.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -73.94 141.54 30.19 Favored 'Trans proline' 0 CA--C 1.566 2.088 0 CA-C-N 124.762 2.736 . . . . 0.0 111.603 177.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo . . . . . 0 CA--C 1.552 1.401 0 C-N-CA 123.104 2.536 . . . . 0.0 113.512 179.183 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' TYR . . . . . 0.476 ' CD2' ' HB2' ' A' ' 87' ' ' HIS . 0.0 OUTLIER . . . . . 0 CA--C 1.557 1.226 0 CA-C-O 122.728 1.251 . . . . 0.0 110.565 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -157.12 151.11 24.72 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 123.351 1.548 . . . . 0.0 109.951 168.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.74 137.16 37.03 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 -176.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.419 HG21 HG23 ' A' ' 134' ' ' VAL . 27.6 m -85.34 133.78 34.13 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 166.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.95 99.98 12.52 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 -177.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 C--O 1.25 1.091 0 N-CA-C 103.042 -2.947 . . . . 0.0 103.042 -165.315 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' BAL . . . . . 0.441 ' H ' HD12 ' A' ' 100' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -123.56 137.42 54.76 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.718 1.207 . . . . 0.0 108.101 -172.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -114.03 136.2 53.18 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 113.697 -1.592 . . . . 0.0 107.71 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -99.63 121.42 41.19 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -172.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 18.2 mt -130.99 114.93 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 104.233 -2.506 . . . . 0.0 104.233 -172.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.0 m -96.6 124.91 40.74 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 169.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.453 ' HB3' ' CG2' ' A' ' 144' ' ' VAL . 5.2 tp -127.86 166.82 17.53 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 113.29 -1.777 . . . . 0.0 107.144 176.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -79.85 144.44 33.46 Favored 'General case' 0 N--CA 1.48 1.074 0 O-C-N 121.352 -0.843 . . . . 0.0 109.392 164.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.3 ttp180 -75.91 79.32 2.81 Favored 'General case' 0 CA--C 1.558 1.256 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 162.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.17 -132.5 41.95 Favored Glycine 0 N--CA 1.479 1.559 0 CA-C-O 122.426 1.015 . . . . 0.0 114.509 170.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -137.73 -59.08 0.67 Allowed 'General case' 0 CA--C 1.555 1.166 0 CA-C-N 112.297 -1.951 . . . . 0.0 109.141 162.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.1 m -97.2 -19.02 18.9 Favored 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 166.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -128.59 -122.61 2.5 Favored Glycine 0 C--N 1.347 1.194 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 171.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.71 -60.8 0.64 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.889 1.276 . . . . 0.0 109.309 -178.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 113.5 43.34 0.83 Allowed Glycine 0 CA--C 1.533 1.179 0 N-CA-C 117.155 1.622 . . . . 0.0 117.155 167.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.404 ' HA ' ' H ' ' A' ' 100' ' ' ILE . 3.8 p90 -156.72 157.7 35.6 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.526 1.131 . . . . 0.0 109.11 172.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 51.1 m -96.66 137.76 35.25 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 120.621 -1.3 . . . . 0.0 110.155 171.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.2 pt -107.21 125.87 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.85 178.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.572 ' HB3' ' HG1' ' A' ' 97' ' ' THR . . . -83.25 -178.46 7.09 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 124.254 1.978 . . . . 0.0 110.001 167.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.51 159.08 25.79 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 112.923 -1.944 . . . . 0.0 115.228 -141.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -109.26 -170.97 20.63 Favored Glycine 0 C--O 1.224 -0.496 0 CA-C-N 110.472 -2.864 . . . . 0.0 113.034 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 29.6 p -43.5 -43.36 5.39 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 118.442 2.756 . . . . 0.0 118.442 -176.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -78.07 -28.64 48.88 Favored 'General case' 0 CA--C 1.561 1.403 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 175.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . 0.258 2.0 t30 -143.81 71.96 17.03 Favored Pre-proline 0 CA--C 1.562 1.404 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -175.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -103.44 145.83 0.17 Allowed 'Trans proline' 0 C--N 1.375 1.937 0 CA-C-N 124.629 2.689 . . . . 0.0 111.652 -171.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -63.05 -26.68 68.95 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 162.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.65 124.08 70.84 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 -170.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -72.39 -11.29 76.06 Favored Glycine 0 CA--C 1.561 2.961 0 N-CA-C 117.686 1.835 . . . . 0.0 117.686 161.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -101.57 -10.73 19.83 Favored 'General case' 0 CA--C 1.565 1.554 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 176.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -142.43 86.1 10.13 Favored Pre-proline 0 CA--C 1.548 0.892 0 CA-C-N 120.438 1.472 . . . . 0.0 107.153 -174.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -65.88 97.4 0.34 Allowed 'Trans proline' 0 CA--C 1.555 1.556 0 C-N-CA 122.145 1.897 . . . . 0.0 112.1 161.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.2 t -161.23 128.35 4.08 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 -173.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.424 HG13 ' HB2' ' A' ' 133' ' ' ALA . 24.3 mm -76.31 121.1 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -133.01 131.66 40.96 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -175.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.407 ' HB ' ' O ' ' A' ' 113' ' ' VAL 0.288 92.8 mt -65.56 127.82 27.31 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.908 0 CA-C-O 122.547 1.165 . . . . 0.0 109.374 179.421 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.572 ' HG1' ' HB3' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -81.34 -48.42 11.99 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.933 1.293 . . . . 0.0 113.63 174.871 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.436 ' HZ3' ' HB2' ' A' ' 98' ' ' LYS 0.286 0.0 OUTLIER -143.42 163.67 32.44 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-O 123.021 1.391 . . . . 0.0 110.573 -176.432 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -108.24 116.56 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 103.607 -2.738 . . . . 0.0 103.607 173.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.404 ' H ' ' HA ' ' A' ' 77' ' ' PHE . 1.4 mp -68.0 129.17 93.24 Favored Pre-proline 0 CA--C 1.57 1.746 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 176.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.19 131.12 35.05 Favored 'Trans proline' 0 CA--C 1.555 1.529 0 C-N-CA 123.468 2.779 . . . . 0.0 114.112 172.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.4 1.27 88.36 Favored Glycine 0 CA--C 1.551 2.292 0 N-CA-C 117.72 1.848 . . . . 0.0 117.72 -164.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -78.33 157.53 44.61 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.281 0.943 . . . . 0.0 114.117 172.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.86 -25.39 67.88 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 117.51 2.411 . . . . 0.0 117.51 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.87 -44.46 89.63 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 173.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.74 -38.67 73.54 Favored 'General case' 0 CA--C 1.563 1.473 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 172.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -67.79 -62.7 1.29 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 125.16 1.384 . . . . 0.0 112.724 173.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -69.91 -51.21 34.91 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.242 1.017 . . . . 0.0 112.709 -171.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -118.22 -161.5 11.93 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-O 123.184 1.436 . . . . 0.0 111.698 171.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 50.2 mtm-85 -156.22 71.15 0.71 Allowed 'General case' 0 N--CA 1.485 1.325 0 CA-C-N 112.881 -1.659 . . . . 0.0 107.166 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.451 HD21 ' H ' ' A' ' 111' ' ' LEU . 1.9 pt? -92.38 -169.11 2.13 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-O 124.586 2.136 . . . . 0.0 108.056 174.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -103.63 167.03 10.06 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 126.986 3.279 . . . . 0.0 106.077 156.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.413 HG22 ' H ' ' A' ' 114' ' ' ASN 0.302 29.8 m -64.06 -69.96 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 108.813 -3.812 . . . . 0.0 108.113 178.123 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.413 ' H ' HG22 ' A' ' 113' ' ' VAL . 16.4 m120 -50.17 75.15 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 124.395 2.045 . . . . 0.0 116.52 174.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -134.08 110.64 9.76 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 100.569 -3.863 . . . . 0.0 100.569 174.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 41.8 m -78.85 93.02 4.93 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 112.932 -1.94 . . . . 0.0 108.846 -168.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.4 tp -58.25 116.77 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.65 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.409 ' HA ' ' HB3' ' A' ' 126' ' ' ARG 0.266 1.9 pp -100.17 -50.42 3.97 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 113.216 -1.811 . . . . 0.0 114.638 175.706 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -126.41 133.09 51.36 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 104.605 -2.368 . . . . 0.0 104.605 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.6 p -123.84 117.45 51.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 170.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.468 HD22 ' HB2' ' A' ' 140' ' ' ALA 0.306 22.4 m-80 80.38 -69.85 0.09 Allowed 'General case' 0 N--CA 1.501 2.121 0 CA-C-O 123.334 1.54 . . . . 0.0 110.681 -174.401 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -172.05 -25.06 0.01 OUTLIER 'General case' 0 CA--C 1.575 1.914 0 C-N-CA 128.537 2.735 . . . . 0.0 109.178 -172.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.2 t -66.48 133.92 30.6 Favored 'Isoleucine or valine' 0 C--N 1.363 1.167 0 C-N-CA 125.298 1.439 . . . . 0.0 110.775 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -83.8 98.94 9.99 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 113.292 -1.776 . . . . 0.0 110.227 174.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 126' ' ' ARG . 2.3 m -86.48 -98.34 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 CA-C-O 115.911 -1.995 . . . . 0.0 107.632 171.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.481 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.274 5.7 ptt180 45.88 -99.58 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 CA-C-N 120.589 1.54 . . . . 0.0 113.638 178.44 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.481 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 1.1 tm-20 -80.05 81.22 6.35 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-O 123.407 1.575 . . . . 0.0 109.006 170.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.58 167.44 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 CA-C-N 112.76 -2.018 . . . . 0.0 106.179 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 25.0 m -60.58 132.49 54.05 Favored 'General case' 0 CA--C 1.561 1.372 0 CA-C-N 114.129 -1.396 . . . . 0.0 110.104 156.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 -46.54 -33.45 4.09 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 117.987 2.588 . . . . 0.0 117.987 171.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 12.0 m -62.97 -38.24 90.31 Favored 'General case' 0 CA--C 1.558 1.268 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 175.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.04 -34.34 77.85 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 165.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.424 ' HB2' HG13 ' A' ' 94' ' ' ILE . . . -70.46 -51.95 25.59 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 116.382 1.993 . . . . 0.0 116.382 173.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.404 HG21 ' HB ' ' B' ' 6' ' ' VAL . 4.3 p -50.05 -43.64 20.96 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.374 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 165.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -64.74 -48.19 75.47 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 116.842 -1.551 . . . . 0.0 113.374 175.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.7 -31.95 71.41 Favored 'General case' 0 CA--C 1.563 1.471 0 N-CA-C 116.561 2.06 . . . . 0.0 116.561 176.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.8 mp -60.3 -52.1 66.7 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 125.32 1.448 . . . . 0.0 114.743 166.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -67.12 -33.95 76.55 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 167.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -65.16 -24.18 67.32 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 173.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.468 ' HB2' HD22 ' A' ' 121' ' ' ASN . . . -50.97 -25.75 5.09 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 118.024 2.601 . . . . 0.0 118.024 163.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 66.96 83.91 0.1 Allowed Glycine 0 C--N 1.351 1.387 0 CA-C-O 118.695 -1.059 . . . . 0.0 113.11 157.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.8 m 75.04 -30.09 0.2 Allowed 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 117.237 2.31 . . . . 0.0 117.237 -175.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.0 108.84 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 -172.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.453 ' CG2' ' HB3' ' A' ' 68' ' ' LEU . 16.9 m -89.55 123.0 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 114.317 -1.31 . . . . 0.0 109.754 176.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -96.27 93.07 6.67 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 172.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 64.6 mt -98.5 133.5 42.77 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -171.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -131.55 115.38 16.05 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 178.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 35.7 m -126.32 129.13 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 -166.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -94.93 141.02 29.14 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-O 121.574 0.702 . . . . 0.0 111.237 169.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 59.5 ttt180 -102.11 124.11 47.14 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 164.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -104.0 95.44 6.0 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.439 -1.255 . . . . 0.0 109.3 -176.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 41.8 tttm -94.34 -57.6 0.21 Allowed Pre-proline 0 CA--C 1.569 1.694 0 CA-C-O 114.806 -2.521 . . . . 0.0 110.227 160.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -71.62 116.49 4.72 Favored 'Trans proline' 0 C--N 1.376 2.016 0 CA-C-N 125.318 2.935 . . . . 0.0 111.59 -175.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo . . . . . 0 C--N 1.364 1.373 0 C-N-CA 122.887 2.391 . . . . 0.0 112.286 -179.825 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 1.6 p90 . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 122.493 1.14 . . . . 0.0 112.31 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -139.33 138.11 36.37 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 113.852 -1.522 . . . . 0.0 107.501 172.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.55 122.26 34.8 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.153 -1.385 . . . . 0.0 108.627 177.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 96.8 m -86.8 133.47 33.64 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 173.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -74.81 142.74 44.19 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.117 173.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.404 ' HB ' HG21 ' A' ' 134' ' ' VAL . 7.4 p . . . . . 0 C--O 1.254 1.29 0 CA-C-N 113.976 -1.465 . . . . 0.0 108.661 169.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 . . . . . 0 N--CA 1.48 1.033 0 CA-C-O 121.432 0.634 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -103.77 136.58 43.19 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 114.338 -1.301 . . . . 0.0 111.646 174.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -110.18 130.25 55.57 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.45 126.79 41.89 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.158 174.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.2 mp -134.24 119.76 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 -176.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.2 m -95.42 122.73 38.44 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 168.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.455 ' HB3' HG21 ' A' ' 144' ' ' VAL . 9.9 tt -125.96 134.94 51.36 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 113.88 -1.509 . . . . 0.0 107.541 -173.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -81.8 115.62 21.11 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 122.209 1.005 . . . . 0.0 109.457 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.44 ' CG ' ' HG ' ' A' ' 75' ' ' LEU . 0.8 OUTLIER -69.59 159.46 33.33 Favored 'General case' 0 CA--C 1.556 1.197 0 CA-C-N 113.071 -1.877 . . . . 0.0 111.814 178.646 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -67.79 -144.26 0.1 OUTLIER Glycine 0 CA--C 1.548 2.116 0 CA-C-N 115.041 -0.982 . . . . 0.0 114.834 174.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -123.65 -69.06 0.83 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -173.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 96.7 p -79.9 -25.45 40.58 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 116.384 1.994 . . . . 0.0 116.384 171.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -143.43 -152.38 5.65 Favored Glycine 0 CA--C 1.534 1.232 0 N-CA-C 107.893 -2.083 . . . . 0.0 107.893 168.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.44 ' HG ' ' CG ' ' A' ' 70' ' ' ARG . 4.7 mp -109.59 -84.7 0.55 Allowed 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 178.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.547 ' HA3' ' H ' ' A' ' 104' ' ' ALA . . . 138.47 39.12 0.11 Allowed Glycine 0 CA--C 1.535 1.284 0 N-CA-C 118.088 1.995 . . . . 0.0 118.088 -175.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -166.5 137.27 3.38 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 124.369 2.033 . . . . 0.0 109.119 -176.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.401 ' HB2' ' HB3' ' A' ' 98' ' ' LYS . 46.1 m -95.0 126.78 40.58 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 113.667 -1.606 . . . . 0.0 112.378 -173.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 96' ' ' ILE . 4.1 pt -93.37 130.51 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 113.945 -1.479 . . . . 0.0 110.856 177.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.15 -171.79 3.66 Favored 'General case' 0 CA--C 1.556 1.176 0 CA-C-O 123.057 1.408 . . . . 0.0 110.522 163.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.76 161.47 28.32 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-O 122.888 1.271 . . . . 0.0 115.802 -146.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -108.73 -162.5 20.39 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 112.47 -1.865 . . . . 0.0 113.502 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 70.3 p -50.07 -40.86 46.77 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 116.699 2.111 . . . . 0.0 116.699 178.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -95.54 7.18 46.99 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -162.79 90.53 1.27 Allowed Pre-proline 0 CA--C 1.561 1.398 0 N-CA-C 101.101 -3.666 . . . . 0.0 101.101 178.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -106.01 125.88 0.05 OUTLIER 'Trans proline' 0 CA--C 1.55 1.323 0 CA-C-N 124.577 2.67 . . . . 0.0 110.799 -177.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -100.43 -21.91 15.22 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 161.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.27 160.97 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 -162.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.4 170.61 43.7 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 124.166 1.981 . . . . 0.0 110.862 -170.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -78.64 -10.59 59.8 Favored 'General case' 0 CA--C 1.571 1.755 0 CA-C-N 112.026 -2.087 . . . . 0.0 114.942 165.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -167.13 -61.28 0.01 OUTLIER Pre-proline 0 CA--C 1.566 1.595 0 CA-C-O 115.516 -2.183 . . . . 0.0 105.516 175.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -117.6 -127.86 0.0 OUTLIER 'Trans proline' 0 C--N 1.375 1.97 0 CA-C-N 124.993 2.819 . . . . 0.0 111.043 -168.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 55.3 m 79.58 119.53 0.05 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.308 1.443 . . . . 0.0 108.161 166.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 26.6 mm -80.89 140.34 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' A' ' 115' ' ' ASP . 13.3 m-85 -123.23 150.86 42.9 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 114.328 -1.305 . . . . 0.0 111.097 175.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 79' ' ' ILE . 53.7 mt -103.21 107.44 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 N-CA-C 103.951 -2.611 . . . . 0.0 103.951 150.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.2 m -95.92 -17.18 21.25 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 174.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.401 ' HB3' ' HB2' ' A' ' 78' ' ' SER 0.273 40.7 tttp -139.26 157.61 45.6 Favored 'General case' 0 CA--C 1.563 1.449 0 CA-C-O 123.818 1.77 . . . . 0.0 110.549 -175.453 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.75 129.9 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 105.299 -2.112 . . . . 0.0 105.299 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.268 1.5 mp -78.51 132.74 64.68 Favored Pre-proline 0 CA--C 1.569 1.705 0 CA-C-O 118.35 -0.833 . . . . 0.0 108.921 169.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -62.9 133.26 40.73 Favored 'Trans proline' 0 C--N 1.367 1.525 0 C-N-CA 123.411 2.741 . . . . 0.0 114.682 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 71.63 4.9 59.19 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 118.383 2.113 . . . . 0.0 118.383 -169.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.409 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -82.79 -172.32 48.23 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.084 0.85 . . . . 0.0 114.119 -179.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.547 ' H ' ' HA3' ' A' ' 76' ' ' GLY . . . -63.27 -48.77 76.75 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -174.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.418 ' HA ' HD11 ' A' ' 68' ' ' LEU . . . -70.05 -30.19 67.39 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 118.026 2.602 . . . . 0.0 118.026 176.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.5 -40.55 93.17 Favored 'General case' 0 CA--C 1.567 1.602 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 163.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.46 -61.47 1.97 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.565 1.546 . . . . 0.0 112.728 177.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -58.66 -40.75 84.39 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 -177.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.07 -140.62 3.15 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 123.326 1.515 . . . . 0.0 111.312 168.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -141.51 50.65 1.58 Allowed 'General case' 0 CA--C 1.563 1.479 0 CA-C-N 111.863 -2.169 . . . . 0.0 108.103 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -82.67 9.88 8.65 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 125.601 1.561 . . . . 0.0 114.638 175.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . 0.303 24.4 mtm180 76.43 166.53 0.26 Allowed 'General case' 0 C--N 1.35 0.61 0 CA-C-O 126.35 2.976 . . . . 0.0 111.047 -171.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.447 HG22 ' H ' ' A' ' 114' ' ' ASN 0.328 35.8 m -28.08 -69.16 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.253 0 CA-C-N 109.495 -3.502 . . . . 0.0 113.237 161.253 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.447 ' H ' HG22 ' A' ' 113' ' ' VAL . 2.5 t-20 157.95 -36.89 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 128.597 2.759 . . . . 0.0 107.665 174.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.413 ' O ' ' HA ' ' A' ' 95' ' ' PHE 0.307 11.0 t70 68.72 -102.02 0.05 Allowed 'General case' 0 C--O 1.213 -0.816 0 C-N-CA 126.42 1.888 . . . . 0.0 107.608 -175.316 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 75.7 m -96.8 69.59 2.45 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 120.38 1.446 . . . . 0.0 110.799 -170.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.5 tp -67.29 115.67 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-O 121.867 0.841 . . . . 0.0 108.785 174.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.1 pp -102.24 -40.57 6.72 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.435 1.642 . . . . 0.0 115.435 177.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -138.97 145.59 39.92 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 -175.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.2 t -132.94 113.42 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 102.753 -3.054 . . . . 0.0 102.753 -176.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.517 HD22 ' HB2' ' A' ' 140' ' ' ALA 0.341 22.0 m-80 84.02 -85.1 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 123.342 1.544 . . . . 0.0 108.726 -179.665 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -156.11 -4.35 0.12 Allowed 'General case' 0 CA--C 1.565 1.522 0 CA-C-N 111.564 -2.562 . . . . 0.0 110.575 173.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.3 t -67.82 139.75 20.31 Favored 'Isoleucine or valine' 0 C--N 1.357 0.93 0 C-N-CA 125.29 1.436 . . . . 0.0 109.282 -178.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -81.74 71.32 8.76 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-N 111.288 -2.687 . . . . 0.0 112.939 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . 0.287 0.6 OUTLIER -82.79 -105.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-O 116.79 -1.576 . . . . 0.0 107.899 178.862 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.641 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.311 27.3 ptt85 49.3 -87.53 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 116.822 2.156 . . . . 0.0 116.822 179.636 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.641 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 27.6 tt0 -81.81 72.53 8.86 Favored 'General case' 0 CA--C 1.555 1.137 0 CA-C-O 123.418 1.58 . . . . 0.0 110.095 167.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.9 p -145.85 167.86 8.01 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 CA-C-N 113.403 -1.726 . . . . 0.0 106.71 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 7.0 m -59.42 132.75 54.93 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 114.044 -1.435 . . . . 0.0 110.2 157.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -48.12 -31.91 6.2 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 117.607 2.447 . . . . 0.0 117.607 169.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 13.9 m -61.91 -38.53 88.71 Favored 'General case' 0 CA--C 1.564 1.486 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 173.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -69.28 -34.14 74.28 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 115.656 1.725 . . . . 0.0 115.656 164.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.18 -52.65 53.61 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 170.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.412 HG23 HG21 ' B' ' 4' ' ' THR . 12.7 p -50.41 -46.43 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 164.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -55.0 -50.42 69.06 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-O 116.68 -1.629 . . . . 0.0 112.606 172.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.88 -31.94 72.26 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 117.148 2.277 . . . . 0.0 117.148 170.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -59.55 -51.69 68.74 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 165.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -66.92 -42.4 85.47 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 171.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -69.59 -12.47 61.67 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 117.431 2.382 . . . . 0.0 117.431 173.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.517 ' HB2' HD22 ' A' ' 121' ' ' ASN . . . -53.49 -19.73 4.03 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 118.661 2.837 . . . . 0.0 118.661 157.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 83.26 -140.17 19.62 Favored Glycine 0 C--N 1.345 1.03 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 11.0 m -70.35 -5.84 31.05 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 116.605 2.076 . . . . 0.0 116.605 173.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -147.8 110.84 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -170.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.455 HG21 ' HB3' ' A' ' 68' ' ' LEU . 11.9 m -84.2 115.97 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 114.071 -1.422 . . . . 0.0 109.401 171.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.412 ' HB3' ' HA ' ' A' ' 121' ' ' ASN . 7.8 tpp180 -90.55 107.23 19.03 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 170.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.41 ' HB3' HD22 ' A' ' 114' ' ' ASN . 79.2 mt -108.27 135.64 49.25 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -172.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -125.54 118.2 25.24 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 177.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.43 121.84 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -177.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 49.6 ttm -102.64 134.85 45.33 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 122.16 0.981 . . . . 0.0 112.671 168.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -99.87 108.49 20.76 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 171.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 26.9 ttp180 -110.79 43.62 1.4 Allowed 'General case' 0 CA--C 1.567 1.607 0 CA-C-N 113.729 -1.578 . . . . 0.0 111.808 173.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -93.5 -53.95 0.25 Allowed Pre-proline 0 CA--C 1.555 1.162 0 CA-C-O 115.132 -2.366 . . . . 0.0 110.225 173.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -48.83 -49.41 15.08 Favored 'Trans proline' 0 CA--C 1.571 2.326 0 CA-C-N 124.677 2.706 . . . . 0.0 116.314 167.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo . . . . . 0 C--N 1.375 1.966 0 C-N-CA 123.707 2.938 . . . . 0.0 111.749 173.506 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.559 1.303 0 CA-C-O 122.68 1.229 . . . . 0.0 111.399 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -136.11 122.14 20.15 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 172.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 13.9 ttpp -95.88 112.78 24.42 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 113.923 -1.49 . . . . 0.0 107.583 173.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.412 HG21 HG23 ' A' ' 134' ' ' VAL . 4.6 m -76.28 131.02 39.0 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 172.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.94 105.46 17.78 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 178.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 11.7 t . . . . . 0 C--O 1.245 0.821 0 N-CA-C 102.363 -3.199 . . . . 0.0 102.363 -165.82 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 . . . . . 0 N--CA 1.483 1.203 0 CA-C-O 120.499 0.19 . . . . 0.0 110.505 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -121.77 140.78 51.92 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 124.41 1.069 . . . . 0.0 110.254 174.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -122.04 133.73 54.79 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 122.617 1.198 . . . . 0.0 108.965 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -104.98 117.11 33.18 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 -176.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.489 HG13 ' HB2' ' A' ' 146' ' ' LEU . 3.1 pt -137.1 115.22 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 -168.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.9 m -94.77 130.26 41.39 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 171.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 105' ' ' ALA . 0.5 OUTLIER -129.68 166.79 19.09 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 113.871 -1.513 . . . . 0.0 109.694 172.911 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -85.36 121.37 27.99 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 122.13 0.966 . . . . 0.0 110.686 175.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.676 ' HD2' ' H ' ' A' ' 142' ' ' SER . 0.9 OUTLIER -78.33 107.92 11.29 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 169.879 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.437 ' H ' ' HA ' ' A' ' 75' ' ' LEU . . . -69.47 134.68 26.56 Favored Glycine 0 CA--C 1.543 1.837 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 165.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -50.13 -54.12 22.81 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 -170.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.4 m -84.5 -19.41 33.34 Favored 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 171.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -174.46 135.99 3.35 Favored Glycine 0 CA--C 1.536 1.363 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.437 ' HA ' ' H ' ' A' ' 71' ' ' GLY . 1.5 mp -74.67 -61.91 1.71 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.248 1.019 . . . . 0.0 110.547 -177.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 136.59 25.91 0.43 Allowed Glycine 0 CA--C 1.542 1.77 0 CA-C-O 117.999 -1.445 . . . . 0.0 114.886 -175.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -129.27 165.84 20.61 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 123.912 1.815 . . . . 0.0 107.72 172.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 35.2 m -111.94 143.98 42.02 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 154.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.4 pp -107.56 128.91 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 113.045 -1.889 . . . . 0.0 108.481 170.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -84.15 -166.26 1.38 Allowed 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 123.915 1.817 . . . . 0.0 108.633 162.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.51 157.78 22.57 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 123.697 1.721 . . . . 0.0 113.835 -138.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -104.88 -163.85 24.08 Favored Glycine 0 CA--C 1.522 0.511 0 CA-C-N 111.349 -2.425 . . . . 0.0 113.0 178.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 61.0 p -51.16 -40.1 57.83 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 116.798 2.147 . . . . 0.0 116.798 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -88.03 -5.72 58.34 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 175.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -149.49 82.88 6.65 Favored Pre-proline 0 CA--C 1.558 1.259 0 N-CA-C 101.747 -3.427 . . . . 0.0 101.747 177.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -106.75 128.52 0.05 OUTLIER 'Trans proline' 0 C--N 1.361 1.193 0 CA-C-N 125.298 2.928 . . . . 0.0 110.943 -173.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -107.71 -55.41 2.36 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.56 0.695 . . . . 0.0 112.355 169.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.517 HD13 ' H ' ' A' ' 88' ' ' ILE . 0.2 OUTLIER -103.55 177.99 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.114 0 CA-C-O 123.663 1.696 . . . . 0.0 108.528 -172.494 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 94.4 -175.95 35.02 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 124.215 2.008 . . . . 0.0 110.431 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -79.45 -8.18 58.94 Favored 'General case' 0 CA--C 1.572 1.804 0 CA-C-N 112.092 -2.054 . . . . 0.0 115.065 162.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 19.2 t70 178.5 -61.92 0.0 OUTLIER Pre-proline 0 CA--C 1.568 1.653 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 175.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -107.66 -120.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.372 1.804 0 CA-C-N 124.749 2.732 . . . . 0.0 110.044 -171.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.9 m 76.15 110.21 0.07 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.058 1.343 . . . . 0.0 108.776 165.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 15.8 mm -73.28 129.53 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -119.2 153.54 34.77 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 112.993 -1.912 . . . . 0.0 108.981 -175.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . 0.258 10.9 mm -98.42 106.58 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.685 0 N-CA-C 100.24 -3.985 . . . . 0.0 100.24 170.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.0 t -93.45 -49.86 5.71 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 -173.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.508 ' HZ2' ' HB2' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -133.94 136.18 44.05 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 169.51 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -79.49 138.4 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 177.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.343 1.5 mp -72.88 115.57 41.44 Favored Pre-proline 0 CA--C 1.568 1.663 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 171.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -68.61 140.95 48.72 Favored 'Trans proline' 0 C--N 1.369 1.634 0 C-N-CA 123.328 2.685 . . . . 0.0 113.067 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.3 7.79 73.36 Favored Glycine 0 CA--C 1.552 2.399 0 N-CA-C 118.177 2.031 . . . . 0.0 118.177 -174.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -99.09 -165.76 30.09 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-N 119.217 1.509 . . . . 0.0 112.719 177.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.03 -30.72 71.16 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 176.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.43 ' HA ' HD12 ' A' ' 68' ' ' LEU . . . -69.21 -40.85 77.77 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 116.873 2.175 . . . . 0.0 116.873 172.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.51 -41.63 96.29 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 170.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -72.96 -52.7 13.53 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 115.019 1.488 . . . . 0.0 115.019 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -62.49 -37.99 88.11 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 176.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 114.75 47.01 0.58 Allowed Glycine 0 CA--C 1.536 1.406 0 C-N-CA 123.745 0.688 . . . . 0.0 113.935 168.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -121.45 24.12 10.04 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 169.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.578 HD11 ' H ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -44.37 -30.68 0.88 Allowed 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 119.958 3.318 . . . . 0.0 119.958 170.285 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 53.6 ttp180 -77.49 88.53 3.84 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 125.11 2.386 . . . . 0.0 107.764 163.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.466 HG12 ' H ' ' A' ' 114' ' ' ASN 0.32 14.6 p -53.21 -65.5 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 109.515 -3.493 . . . . 0.0 113.692 -172.476 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.466 ' H ' HG12 ' A' ' 113' ' ' VAL . 30.9 m-80 -14.98 78.0 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 O-C-N 127.08 2.738 . . . . 0.0 117.959 166.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -147.41 121.0 9.14 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 103.288 -2.856 . . . . 0.0 103.288 -177.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 21.5 m -84.64 82.52 8.38 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 114.414 -1.266 . . . . 0.0 109.508 -175.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.6 tp -64.21 123.09 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 CA-C-O 122.527 1.155 . . . . 0.0 111.441 -174.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -111.96 -53.28 2.72 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 112.334 -2.212 . . . . 0.0 112.053 174.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -122.63 133.66 54.52 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 -170.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.5 t -126.61 111.88 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 103.353 -2.832 . . . . 0.0 103.353 -178.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.535 HD22 ' CB ' ' A' ' 140' ' ' ALA 0.278 10.0 m-80 81.5 -78.4 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 123.371 1.558 . . . . 0.0 109.496 178.318 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -152.18 -22.47 0.18 Allowed 'General case' 0 CA--C 1.576 1.955 0 C-N-CA 128.219 2.607 . . . . 0.0 109.618 175.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.3 t -59.56 137.64 21.7 Favored 'Isoleucine or valine' 0 C--N 1.362 1.145 0 C-N-CA 125.469 1.508 . . . . 0.0 110.911 176.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -105.6 103.35 12.84 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 113.022 -1.899 . . . . 0.0 108.437 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . 0.262 0.5 OUTLIER -97.48 -90.24 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-O 117.012 -1.47 . . . . 0.0 108.166 176.806 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.516 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.32 23.1 ptt180 51.16 -88.37 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 117.351 2.352 . . . . 0.0 117.351 178.601 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.516 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 2.8 mp0 -85.58 67.13 9.98 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 123.505 1.621 . . . . 0.0 109.472 173.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.3 p -137.13 169.17 20.08 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-O 124.263 1.982 . . . . 0.0 105.924 -178.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 5.3 m -59.25 134.94 57.46 Favored 'General case' 0 CA--C 1.56 1.334 0 CA-C-N 112.701 -2.045 . . . . 0.0 110.643 157.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -45.78 -32.9 2.76 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 117.656 2.465 . . . . 0.0 117.656 169.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 9.4 m -63.41 -40.41 97.13 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -69.42 -36.74 76.98 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 168.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -67.23 -50.51 60.38 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 172.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.7 p -52.96 -45.11 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 114.544 1.312 . . . . 0.0 114.544 166.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -60.42 -47.0 88.0 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-O 115.553 -2.165 . . . . 0.0 112.515 173.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.18 -35.97 82.52 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 117.044 2.239 . . . . 0.0 117.044 172.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -50.79 -54.26 25.04 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.299 1.04 . . . . 0.0 113.627 162.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -69.39 -38.45 78.01 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 174.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -63.4 -21.59 66.38 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 172.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.535 ' CB ' HD22 ' A' ' 121' ' ' ASN . . . -53.33 -22.81 7.87 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 118.674 2.842 . . . . 0.0 118.674 168.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 65.7 89.17 0.05 OUTLIER Glycine 0 C--N 1.351 1.384 0 CA-C-N 118.771 0.714 . . . . 0.0 114.5 155.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.676 ' H ' ' HD2' ' A' ' 70' ' ' ARG 0.268 20.4 m 72.17 -30.3 0.21 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 118.02 2.6 . . . . 0.0 118.02 -172.392 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -146.82 110.72 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 -172.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.428 ' CG2' ' HB3' ' A' ' 68' ' ' LEU . 33.5 m -83.57 120.75 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.429 171.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -101.66 91.26 4.34 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 174.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.489 ' HB2' HG13 ' A' ' 66' ' ' ILE . 61.2 mt -95.31 137.9 33.74 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 122.536 1.16 . . . . 0.0 108.361 -172.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -127.67 124.64 38.42 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 175.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 28.6 m -134.13 115.91 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -163.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 32.9 ttm -134.03 121.48 21.62 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 -175.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -97.12 158.05 15.63 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 113.163 -1.835 . . . . 0.0 109.895 166.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 60.96 74.91 0.43 Allowed 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.509 176.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . 0.256 0.0 OUTLIER -116.74 103.64 52.17 Favored Pre-proline 0 CA--C 1.554 1.1 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 -175.668 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -54.33 -49.11 18.06 Favored 'Trans proline' 0 CA--C 1.572 2.393 0 C-N-CA 123.27 2.647 . . . . 0.0 116.385 175.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo . . . . . 0 C--N 1.374 1.895 0 C-N-CA 123.563 2.842 . . . . 0.0 110.969 -177.147 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.56 1.338 0 CA-C-O 122.964 1.364 . . . . 0.0 111.673 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.88 157.92 39.98 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 123.225 1.488 . . . . 0.0 109.904 168.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.04 136.55 42.64 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 113.603 -1.635 . . . . 0.0 106.853 172.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 88.5 m -102.5 136.08 42.98 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 167.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -78.61 140.82 38.4 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-O 123.667 1.699 . . . . 0.0 108.812 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 C--O 1.243 0.731 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 -178.745 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 . . . . . 0 N--CA 1.482 1.134 0 CA-C-O 121.844 0.83 . . . . 0.0 111.313 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -96.16 134.05 39.71 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.967 172.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -110.84 126.75 54.98 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.76 124.99 34.68 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.189 174.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.417 HG13 ' HB2' ' A' ' 146' ' ' LEU . 3.1 pt -137.95 108.28 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 -175.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.8 m -91.39 118.26 30.38 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 172.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.446 ' HB3' ' CG2' ' A' ' 144' ' ' VAL . 3.9 tp -115.42 167.4 10.9 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 113.977 -1.465 . . . . 0.0 108.198 174.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -93.51 138.42 31.81 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 170.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.444 ' HG3' ' HG ' ' A' ' 75' ' ' LEU . 56.7 ttp85 -84.84 111.67 19.85 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 168.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.33 140.19 48.08 Favored Glycine 0 CA--C 1.536 1.354 0 CA-C-N 114.295 -1.32 . . . . 0.0 112.003 169.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -59.26 -50.54 73.62 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -173.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.3 m -77.53 -19.8 55.2 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 171.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -177.19 131.67 1.86 Allowed Glycine 0 CA--C 1.533 1.174 0 N-CA-C 107.23 -2.348 . . . . 0.0 107.23 178.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.444 ' HG ' ' HG3' ' A' ' 70' ' ' ARG . 1.3 tt -48.4 -36.53 14.91 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 169.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 110.91 16.84 9.47 Favored Glycine 0 N--CA 1.478 1.489 0 N-CA-C 117.559 1.783 . . . . 0.0 117.559 169.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.412 ' CE2' HD21 ' A' ' 75' ' ' LEU . 27.7 p90 -143.0 173.0 11.94 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 124.306 2.003 . . . . 0.0 108.5 171.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.7 m -122.12 155.09 36.45 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 123.705 1.717 . . . . 0.0 106.481 176.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.1 pt -121.72 127.05 75.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 111.635 -2.53 . . . . 0.0 109.107 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.37 -168.26 1.29 Allowed 'General case' 0 CA--C 1.556 1.187 0 CA-C-O 123.339 1.542 . . . . 0.0 109.995 159.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.39 159.9 26.48 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 123.409 1.56 . . . . 0.0 115.16 -145.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.37 -160.84 23.31 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-N 111.906 -2.147 . . . . 0.0 113.542 178.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 30.3 p -52.83 -41.2 64.0 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 -178.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -83.04 -8.83 59.5 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 176.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.01 96.98 2.09 Favored Pre-proline 0 CA--C 1.556 1.197 0 N-CA-C 102.32 -3.215 . . . . 0.0 102.32 -173.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -99.15 134.84 0.26 Allowed 'Trans proline' 0 CA--C 1.551 1.338 0 CA-C-N 123.96 2.45 . . . . 0.0 111.543 174.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.449 ' HB2' ' CD2' ' B' ' 1' ' ' TYR . 9.1 t-80 -100.32 -21.02 15.59 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 155.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -151.72 135.27 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 N-CA-C 104.207 -2.516 . . . . 0.0 104.207 -164.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.43 161.48 37.47 Favored Glycine 0 CA--C 1.535 1.322 0 CA-C-O 123.633 1.685 . . . . 0.0 110.939 -165.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -79.63 -6.88 58.03 Favored 'General case' 0 CA--C 1.565 1.536 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 170.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -160.88 -61.4 0.02 OUTLIER Pre-proline 0 CA--C 1.562 1.415 0 CA-C-O 115.259 -2.305 . . . . 0.0 108.961 174.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -121.97 -146.86 0.0 OUTLIER 'Trans proline' 0 C--N 1.372 1.772 0 CA-C-N 125.183 2.887 . . . . 0.0 112.511 -159.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.6 m 78.22 107.67 0.07 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.461 1.104 . . . . 0.0 108.534 166.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 13.0 mm -74.99 127.51 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 106.376 -1.712 . . . . 0.0 106.376 -177.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -115.18 149.42 37.69 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 113.432 -1.713 . . . . 0.0 108.458 -175.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 22.3 mm -97.35 104.23 15.64 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.278 0 N-CA-C 104.388 -2.449 . . . . 0.0 104.388 171.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.427 HG21 ' HG3' ' B' ' 3' ' ' LYS . 12.2 t -79.51 -46.64 17.01 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 -177.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.451 ' HA ' HG23 ' A' ' 113' ' ' VAL . 12.0 ptmt -150.31 146.03 26.51 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.772 0.796 . . . . 0.0 111.099 -170.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.54 135.1 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 178.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.7 mp -82.9 117.62 69.14 Favored Pre-proline 0 CA--C 1.565 1.52 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 172.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.69 135.16 51.01 Favored 'Trans proline' 0 C--N 1.367 1.537 0 C-N-CA 123.442 2.761 . . . . 0.0 113.09 169.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 87.33 -9.97 70.98 Favored Glycine 0 CA--C 1.548 2.156 0 N-CA-C 117.707 1.843 . . . . 0.0 117.707 -169.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -85.91 -179.58 50.01 Favored Glycine 0 CA--C 1.538 1.472 0 CA-C-N 119.44 1.62 . . . . 0.0 113.602 175.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.09 -33.7 72.2 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 117.1 2.259 . . . . 0.0 117.1 -177.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.62 -35.18 68.0 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 118.567 2.803 . . . . 0.0 118.567 169.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.85 -32.04 71.43 Favored 'General case' 0 CA--C 1.558 1.274 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 171.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.02 -53.59 8.14 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 119.706 1.139 . . . . 0.0 112.827 172.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -78.54 -52.36 8.6 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.773 0.829 . . . . 0.0 112.555 -170.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -93.61 -45.5 3.42 Favored Glycine 0 CA--C 1.538 1.482 0 CA-C-O 118.161 -1.355 . . . . 0.0 114.616 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 27.3 ptt85 44.99 47.83 9.43 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -170.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -107.18 -165.56 1.08 Allowed 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 123.94 1.829 . . . . 0.0 108.0 -156.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 10.7 ptt180 -107.85 126.59 52.84 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 102.994 -2.965 . . . . 0.0 102.994 156.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.451 HG23 ' HA ' ' A' ' 98' ' ' LYS . 0.2 OUTLIER -42.26 -64.49 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-N 109.606 -3.452 . . . . 0.0 116.04 170.069 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.444 ' H ' HG21 ' A' ' 113' ' ' VAL . 3.7 m-20 -22.64 81.92 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.182 0 O-C-N 126.82 2.575 . . . . 0.0 116.891 175.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -157.21 128.69 6.93 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 -174.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 64.3 m -88.93 89.92 8.19 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -175.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.407 HG12 HD13 ' A' ' 137' ' ' LEU . 6.7 tp -63.21 128.01 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.073 178.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.416 ' HA ' ' HB3' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -114.93 -54.15 2.59 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 112.422 -2.172 . . . . 0.0 114.421 177.076 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -119.79 134.65 55.16 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 -174.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.1 p -123.94 118.34 53.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 169.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.607 HD22 ' CB ' ' A' ' 140' ' ' ALA 0.298 11.6 m-80 78.5 -81.25 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 122.953 1.359 . . . . 0.0 109.604 -177.213 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -152.91 -20.88 0.16 Allowed 'General case' 0 CA--C 1.568 1.659 0 C-N-CA 127.859 2.464 . . . . 0.0 110.177 -177.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.2 t -64.35 135.19 28.35 Favored 'Isoleucine or valine' 0 C--N 1.362 1.122 0 C-N-CA 125.318 1.447 . . . . 0.0 110.358 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -90.8 97.54 11.24 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 113.072 -1.877 . . . . 0.0 108.307 172.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . 0.282 0.2 OUTLIER -93.48 -93.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-O 116.447 -1.739 . . . . 0.0 107.159 170.263 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.594 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.292 11.3 ptt180 48.39 -88.69 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 117.851 2.538 . . . . 0.0 117.851 178.615 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.594 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 1.7 tt0 -84.1 66.86 9.47 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-O 123.674 1.702 . . . . 0.0 108.804 172.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -139.7 169.96 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 CA-C-N 112.606 -2.088 . . . . 0.0 106.513 178.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 7.7 m -60.5 136.5 58.07 Favored 'General case' 0 CA--C 1.561 1.375 0 CA-C-N 113.439 -1.709 . . . . 0.0 110.843 159.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -45.3 -35.23 3.34 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 118.263 2.69 . . . . 0.0 118.263 170.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 79.0 p -60.31 -42.24 95.15 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 116.786 2.143 . . . . 0.0 116.786 172.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -70.68 -37.78 73.66 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 169.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -59.79 -55.49 33.66 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 169.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.42 ' CG2' ' HB ' ' B' ' 6' ' ' VAL . 2.2 p -53.13 -46.84 55.77 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 170.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -60.55 -45.99 91.84 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 115.838 -2.03 . . . . 0.0 112.844 176.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.7 -34.57 78.61 Favored 'General case' 0 CA--C 1.558 1.278 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 171.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.407 HD13 HG12 ' A' ' 117' ' ' ILE . 9.6 mp -58.65 -46.55 86.9 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 165.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -70.33 -33.06 71.04 Favored 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 170.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -73.26 -14.96 61.42 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 116.455 2.02 . . . . 0.0 116.455 172.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.607 ' CB ' HD22 ' A' ' 121' ' ' ASN . . . -56.91 1.06 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.172 0 N-CA-C 119.227 3.047 . . . . 0.0 119.227 162.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 77.25 -146.51 31.92 Favored Glycine 0 C--N 1.344 1.019 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 176.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.8 m -72.0 -6.95 45.87 Favored 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 173.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -147.49 107.71 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 -165.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.446 ' CG2' ' HB3' ' A' ' 68' ' ' LEU . 23.1 m -92.48 123.91 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 114.073 -1.422 . . . . 0.0 108.612 -174.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -103.15 87.12 2.82 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.417 ' HB2' HG13 ' A' ' 66' ' ' ILE . 73.7 mt -91.33 133.9 35.05 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 -170.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -124.42 121.83 35.97 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 33.3 m -129.56 117.53 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -167.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 27.5 ttt -125.96 142.5 51.49 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -175.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -82.55 108.85 16.26 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 113.38 -1.736 . . . . 0.0 109.914 177.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -70.61 -36.17 73.37 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 113.048 -1.887 . . . . 0.0 114.595 164.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -75.52 124.97 89.17 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-O 118.172 -0.918 . . . . 0.0 109.469 -177.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -62.42 163.44 20.71 Favored 'Trans proline' 0 CA--C 1.57 2.3 0 C-N-CA 122.411 2.074 . . . . 0.0 114.061 174.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo . . . . . 0 CA--C 1.555 1.527 0 C-N-CA 123.646 2.898 . . . . 0.0 116.076 174.88 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' TYR . . . . . 0.449 ' CD2' ' HB2' ' A' ' 87' ' ' HIS . 0.3 OUTLIER . . . . . 0 CA--C 1.559 1.297 0 CA-C-O 122.887 1.327 . . . . 0.0 110.718 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 66.1 tttp -135.15 134.46 40.2 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-O 123.405 1.574 . . . . 0.0 108.205 165.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.427 ' HG3' HG21 ' A' ' 97' ' ' THR . 1.1 tmmt? -104.28 126.91 51.78 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 113.809 -1.541 . . . . 0.0 109.051 173.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 91.1 m -98.2 139.82 33.42 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 114.173 -1.376 . . . . 0.0 109.343 172.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -87.45 128.01 35.22 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 113.926 -1.488 . . . . 0.0 108.936 175.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.42 ' HB ' ' CG2' ' A' ' 134' ' ' VAL . 4.1 p . . . . . 0 C--O 1.248 1.025 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 175.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -129.18 136.21 49.85 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 121.658 0.742 . . . . 0.0 109.599 175.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -124.91 137.65 54.27 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 114.608 -1.178 . . . . 0.0 108.971 -177.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -103.27 132.3 49.64 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.66 175.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 21.0 pt -135.55 127.12 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -175.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.2 m -95.26 121.62 37.1 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 170.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 mp -119.75 126.9 52.18 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.373 -1.285 . . . . 0.0 107.632 -174.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.82 125.45 40.39 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.39 -172.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.402 ' HB2' ' HB1' ' A' ' 104' ' ' ALA . 4.9 tpm_? -152.3 -101.54 0.05 Allowed 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.671 169.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.08 -168.45 54.7 Favored Glycine 0 C--N 1.347 1.151 0 C-N-CA 124.066 0.841 . . . . 0.0 113.306 -167.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 75.67 -87.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 113.827 -1.187 . . . . 0.0 110.634 166.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 56.0 m -81.79 -16.67 50.21 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 172.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 159.75 -139.88 6.44 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 107.291 -2.324 . . . . 0.0 107.291 178.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.39 -30.92 2.57 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 125.615 1.566 . . . . 0.0 111.363 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.06 37.71 2.86 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 117.427 1.731 . . . . 0.0 117.427 162.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -152.33 143.76 23.37 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 -172.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.1 m -106.91 122.25 46.04 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.572 -1.194 . . . . 0.0 108.538 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.1 pt -108.13 129.56 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 CA-C-O 121.674 0.749 . . . . 0.0 109.952 -171.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.57 -171.4 3.52 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-O 123.597 1.665 . . . . 0.0 111.281 158.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.44 159.65 21.15 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-O 123.713 1.73 . . . . 0.0 115.057 -137.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -102.77 -162.14 25.9 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 111.441 -2.38 . . . . 0.0 111.874 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 44.3 p -55.15 -40.38 70.53 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 116.922 2.193 . . . . 0.0 116.922 -174.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -75.51 -21.97 57.54 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 116.353 1.983 . . . . 0.0 116.353 174.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.411 HD21 ' CE1' ' A' ' 130' ' ' HIS . 0.1 OUTLIER -145.28 95.94 4.98 Favored Pre-proline 0 CA--C 1.553 1.075 0 N-CA-C 101.498 -3.519 . . . . 0.0 101.498 -173.916 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -93.32 137.29 1.33 Allowed 'Trans proline' 0 CA--C 1.554 1.475 0 CA-C-N 124.079 2.493 . . . . 0.0 111.646 -177.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -99.69 -24.62 14.66 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 161.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.9 mp -90.86 142.46 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 -166.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.98 -9.78 22.99 Favored Glycine 0 CA--C 1.559 2.794 0 N-CA-C 119.117 2.407 . . . . 0.0 119.117 171.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -85.42 -8.47 58.39 Favored 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 115.351 1.611 . . . . 0.0 115.351 164.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.49 15.8 t70 95.86 -89.28 0.0 OUTLIER Pre-proline 0 CA--C 1.561 1.392 0 C-N-CA 126.161 1.784 . . . . 0.0 109.085 -172.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -94.8 -151.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.223 0 CA-C-N 124.448 2.624 . . . . 0.0 112.113 -159.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 66.8 m 73.17 138.6 0.05 Allowed 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 122.438 1.113 . . . . 0.0 109.323 176.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 15.0 mm -94.43 121.71 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 -169.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -124.57 138.17 54.34 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 -174.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 82.4 mt -82.35 122.98 37.83 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.627 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 169.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 89.3 m -93.57 -33.84 13.57 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 117.627 -1.177 . . . . 0.0 113.907 172.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . 0.354 8.1 ptmm? -140.27 167.75 21.4 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-O 123.534 1.635 . . . . 0.0 110.885 173.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -109.14 129.22 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 103.835 -2.654 . . . . 0.0 103.835 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.314 22.5 mt -83.74 121.76 76.26 Favored Pre-proline 0 CA--C 1.564 1.503 0 CA-C-O 117.915 -1.041 . . . . 0.0 108.789 175.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -55.96 141.18 86.48 Favored 'Trans proline' 0 C--N 1.371 1.746 0 C-N-CA 124.075 3.183 . . . . 0.0 115.581 178.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.95 15.04 79.83 Favored Glycine 0 CA--C 1.547 2.058 0 N-CA-C 117.27 1.668 . . . . 0.0 117.27 -164.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -89.23 176.83 43.9 Favored Glycine 0 C--N 1.34 0.772 0 C-N-CA 124.721 1.153 . . . . 0.0 115.578 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.402 ' HB1' ' HB2' ' A' ' 70' ' ' ARG . . . -64.37 -48.54 75.11 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 177.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.23 -34.0 74.16 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.69 -44.35 81.97 Favored 'General case' 0 CA--C 1.561 1.388 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 168.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.4 -65.4 0.82 Allowed 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 124.637 1.175 . . . . 0.0 111.791 176.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -65.63 -31.86 73.12 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 115.478 1.659 . . . . 0.0 115.478 -174.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.29 -167.61 11.13 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-O 123.839 1.799 . . . . 0.0 112.667 170.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -141.35 59.15 1.51 Allowed 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 112.182 -2.009 . . . . 0.0 107.509 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.7 pp -93.33 -164.31 1.16 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 124.455 2.074 . . . . 0.0 107.709 -165.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -116.03 141.81 47.63 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 104.007 -2.59 . . . . 0.0 104.007 163.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . 0.26 17.9 m -42.65 -65.42 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-N 109.064 -3.698 . . . . 0.0 112.734 172.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -52.5 78.9 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 126.457 1.903 . . . . 0.0 115.119 177.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -130.05 113.9 15.11 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 101.068 -3.678 . . . . 0.0 101.068 175.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.5 m -67.49 79.82 0.17 Allowed 'General case' 0 CA--C 1.554 1.108 0 CA-C-N 113.409 -1.723 . . . . 0.0 111.531 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.6 pt -70.14 100.61 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-O 123.406 1.574 . . . . 0.0 108.8 -176.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.8 pp -96.41 -38.7 9.93 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 112.909 -1.951 . . . . 0.0 114.94 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -125.46 140.55 52.68 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 123.273 1.511 . . . . 0.0 107.067 177.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.5 t -134.0 113.04 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 102.259 -3.238 . . . . 0.0 102.259 -179.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.585 HD22 ' HB1' ' A' ' 140' ' ' ALA 0.32 22.3 m-80 83.97 -78.05 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 123.934 1.826 . . . . 0.0 110.134 179.572 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -156.38 -23.9 0.1 Allowed 'General case' 0 CA--C 1.572 1.791 0 CA-C-N 110.472 -3.058 . . . . 0.0 109.276 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.3 t -61.73 138.78 21.71 Favored 'Isoleucine or valine' 0 C--N 1.361 1.066 0 C-N-CA 125.604 1.561 . . . . 0.0 111.087 -177.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -94.88 87.91 5.13 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 111.348 -2.66 . . . . 0.0 110.81 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . 0.287 0.5 OUTLIER -92.37 -98.52 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 CA-C-O 117.104 -1.427 . . . . 0.0 108.154 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.611 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.315 15.1 ptt180 48.37 -89.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 -179.514 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.611 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 21.9 tt0 -74.68 75.49 2.05 Favored 'General case' 0 CA--C 1.557 1.237 0 CA-C-O 123.738 1.732 . . . . 0.0 110.323 166.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -155.0 164.35 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 -175.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 34.0 m -60.06 132.11 52.92 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-N 113.586 -1.643 . . . . 0.0 109.671 156.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.411 ' CE1' HD21 ' A' ' 85' ' ' ASN . 9.2 p-80 -46.82 -31.45 3.05 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 118.212 2.671 . . . . 0.0 118.212 171.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.6 m -60.09 -38.59 83.37 Favored 'General case' 0 CA--C 1.561 1.375 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 173.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -71.07 -35.93 72.08 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 166.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -59.88 -53.71 54.74 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 168.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 9.7 p -55.99 -41.92 69.73 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.444 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 166.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -57.57 -43.56 84.61 Favored 'General case' 0 CA--C 1.556 1.191 0 CA-C-O 117.626 -1.178 . . . . 0.0 113.458 171.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.14 -33.43 75.45 Favored 'General case' 0 CA--C 1.558 1.263 0 N-CA-C 116.397 1.999 . . . . 0.0 116.397 167.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.65 -50.96 71.85 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 165.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -65.98 -38.33 88.27 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 173.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -65.96 -28.46 68.92 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 116.353 1.983 . . . . 0.0 116.353 171.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.585 ' HB1' HD22 ' A' ' 121' ' ' ASN . . . -52.43 -33.21 43.01 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 117.443 2.386 . . . . 0.0 117.443 161.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 93.62 -120.15 6.19 Favored Glycine 0 C--N 1.345 1.051 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 166.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.3 m -86.71 0.29 54.91 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 117.426 2.38 . . . . 0.0 117.426 168.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.95 101.99 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 -170.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.415 ' HA ' ' HB2' ' A' ' 140' ' ' ALA . 15.5 m -88.02 118.64 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 114.04 -1.436 . . . . 0.0 109.654 176.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 40.8 mtt180 -98.58 87.65 3.87 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 178.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 53.3 mt -90.45 136.52 33.0 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -170.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -122.72 120.39 33.49 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 104.515 -2.402 . . . . 0.0 104.515 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -123.44 120.62 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 -176.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 28.3 ttt -96.65 116.37 29.01 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 124.519 1.137 . . . . 0.0 109.982 162.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -88.35 153.23 21.35 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-O 122.98 1.371 . . . . 0.0 111.082 173.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -117.75 153.92 32.59 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 113.011 -1.904 . . . . 0.0 109.14 167.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -115.72 96.92 47.81 Favored Pre-proline 0 CA--C 1.548 0.904 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 173.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -72.44 138.24 29.51 Favored 'Trans proline' 0 CA--C 1.564 2.011 0 C-N-CA 122.511 2.14 . . . . 0.0 111.624 172.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo . . . . . 0 CA--C 1.552 1.414 0 C-N-CA 123.082 2.522 . . . . 0.0 112.828 173.187 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 1.3 p90 . . . . . 0 CA--C 1.56 1.342 0 CA-C-O 122.569 1.176 . . . . 0.0 110.741 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -132.99 133.99 43.87 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-O 123.017 1.389 . . . . 0.0 108.473 170.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -95.69 124.96 39.95 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 113.782 -1.554 . . . . 0.0 108.736 169.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 4.7 m -83.69 140.41 32.16 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 123.309 1.528 . . . . 0.0 109.21 167.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -98.99 105.79 17.97 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 104.889 -2.263 . . . . 0.0 104.889 -177.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 12.3 t . . . . . 0 C--O 1.256 1.428 0 CA-C-O 123.03 1.395 . . . . 0.0 107.803 -165.983 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 149' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.482 1.154 0 CA-C-O 118.015 -0.993 . . . . 0.0 108.838 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.44 ' HB3' ' HG2' ' A' ' 149' ' ' MET . 13.3 p90 -127.06 139.82 52.73 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.594 0.758 . . . . 0.0 110.353 -176.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -107.77 132.99 52.8 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.562 172.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.22 121.4 43.59 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 113.824 -1.535 . . . . 0.0 108.593 -177.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 13.5 pt -135.32 118.7 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 -174.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.7 m -89.96 124.2 34.53 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 168.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.5 tp -116.05 125.0 51.84 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 114.22 -1.354 . . . . 0.0 109.293 -171.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -90.16 124.28 34.69 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.423 -176.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -165.37 -103.66 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 172.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 62.38 -141.97 47.52 Favored Glycine 0 C--N 1.354 1.568 0 C-N-CA 124.323 0.963 . . . . 0.0 113.421 -177.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . 0.273 24.2 t-20 71.49 -89.08 0.03 OUTLIER 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 123.811 0.844 . . . . 0.0 110.477 176.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.3 m -102.18 -14.7 16.93 Favored 'General case' 0 CA--C 1.564 1.508 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 174.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 158.37 161.74 11.26 Favored Glycine 0 CA--C 1.533 1.182 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -175.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.6 mp -86.46 -97.2 0.08 Allowed 'General case' 0 CA--C 1.56 1.341 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 -175.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 145.71 67.41 0.01 OUTLIER Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 167.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -163.62 141.01 7.32 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 124.292 1.996 . . . . 0.0 108.772 176.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.8 m -92.85 128.22 38.63 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 112.208 -2.269 . . . . 0.0 110.846 -178.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.9 pp -103.63 125.74 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.866 178.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.86 -175.53 2.55 Favored 'General case' 0 CA--C 1.555 1.138 0 CA-C-O 123.624 1.678 . . . . 0.0 111.076 164.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.03 155.73 20.01 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-O 123.591 1.662 . . . . 0.0 115.469 -141.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.13 -160.29 21.51 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 111.37 -2.415 . . . . 0.0 113.891 177.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 38.9 p -58.67 -38.7 78.74 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 115.578 1.695 . . . . 0.0 115.578 -174.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -96.53 12.91 29.85 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 175.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -163.67 76.83 1.71 Allowed Pre-proline 0 N--CA 1.481 1.103 0 N-CA-C 100.868 -3.753 . . . . 0.0 100.868 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -100.12 127.58 0.14 Allowed 'Trans proline' 0 C--N 1.364 1.382 0 CA-C-N 125.198 2.892 . . . . 0.0 111.07 -166.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 41.7 t60 -80.72 -26.18 37.59 Favored 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 162.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.9 mp -106.1 138.01 33.56 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.041 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 -172.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -41.15 -81.25 0.03 OUTLIER Glycine 0 CA--C 1.544 1.853 0 N-CA-C 117.509 1.764 . . . . 0.0 117.509 176.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -113.7 10.45 17.93 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 114.827 1.417 . . . . 0.0 114.827 -178.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -126.53 76.07 74.03 Favored Pre-proline 0 N--CA 1.479 0.99 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -47.62 120.38 4.54 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 123.283 2.655 . . . . 0.0 113.634 162.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.7 m -158.64 122.67 4.0 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 -173.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.405 HG13 ' CB ' ' A' ' 133' ' ' ALA . 21.0 mm -79.42 126.06 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 -173.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 22.8 m-30 -117.72 161.54 19.52 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.646 -1.615 . . . . 0.0 107.32 -176.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.408 ' HB ' ' CB ' ' A' ' 114' ' ' ASN . 89.2 mt -105.8 112.73 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 103.738 -2.69 . . . . 0.0 103.738 149.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.6 m -95.61 -18.64 20.4 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 169.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -136.99 153.62 50.63 Favored 'General case' 0 CA--C 1.556 1.2 0 CA-C-O 124.301 2.0 . . . . 0.0 109.954 178.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.418 HG22 ' HA ' ' A' ' 113' ' ' VAL . 0.6 OUTLIER -113.43 125.63 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-N 112.98 -1.918 . . . . 0.0 105.947 175.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.279 1.4 mp -71.55 127.61 90.86 Favored Pre-proline 0 CA--C 1.567 1.6 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 171.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.57 130.75 41.69 Favored 'Trans proline' 0 C--N 1.365 1.399 0 C-N-CA 123.558 2.838 . . . . 0.0 115.141 176.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 72.98 9.87 76.68 Favored Glycine 0 CA--C 1.551 2.324 0 N-CA-C 118.306 2.082 . . . . 0.0 118.306 -169.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -84.98 -168.71 45.03 Favored Glycine 0 C--N 1.336 0.577 0 N-CA-C 115.625 1.01 . . . . 0.0 115.625 -176.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.81 -52.61 55.86 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.7 -37.46 82.31 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 115.887 -2.006 . . . . 0.0 114.491 173.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.72 -51.18 66.11 Favored 'General case' 0 CA--C 1.562 1.438 0 CA-C-N 121.366 1.894 . . . . 0.0 114.936 173.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.8 -60.93 3.06 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 125.182 1.393 . . . . 0.0 113.25 176.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -69.64 -47.77 62.2 Favored 'General case' 0 CA--C 1.557 1.248 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -173.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -116.09 -71.48 0.47 Allowed Glycine 0 CA--C 1.534 1.227 0 C-N-CA 123.128 0.394 . . . . 0.0 112.755 -174.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 37.3 ttm105 58.65 46.41 14.57 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 123.191 1.472 . . . . 0.0 112.773 -159.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -91.32 -40.75 11.31 Favored 'General case' 0 CA--C 1.56 1.33 0 CA-C-N 113.508 -1.678 . . . . 0.0 112.693 -178.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -175.33 166.04 3.33 Favored 'General case' 0 CA--C 1.553 1.091 0 N-CA-C 101.431 -3.544 . . . . 0.0 101.431 175.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.418 ' HA ' HG22 ' A' ' 99' ' ' ILE 0.386 6.2 m -41.11 -69.08 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.561 1.366 0 CA-C-N 110.713 -2.949 . . . . 0.0 114.47 161.739 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.408 ' CB ' ' HB ' ' A' ' 96' ' ' ILE . 2.4 t30 174.28 -23.86 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 129.163 2.985 . . . . 0.0 107.298 165.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . 0.267 17.2 t70 79.93 -77.74 0.03 OUTLIER 'General case' 0 C--N 1.364 1.211 0 C-N-CA 126.805 2.042 . . . . 0.0 108.432 176.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.8 m -139.33 92.02 2.55 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 -177.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.31 121.66 31.67 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.29 0 CA-C-O 122.445 1.116 . . . . 0.0 109.692 170.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.727 HD12 ' H ' ' A' ' 149' ' ' MET . 0.0 OUTLIER -106.05 -46.98 3.95 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.337 1.055 . . . . 0.0 113.144 179.504 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.455 ' H ' HD23 ' A' ' 118' ' ' LEU . 68.1 m-85 -120.39 141.26 50.27 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 175.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.7 p -128.66 122.17 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 170.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.613 HD22 ' HB2' ' A' ' 140' ' ' ALA 0.314 34.1 m-80 79.19 -76.17 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 123.622 1.677 . . . . 0.0 110.767 -177.379 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -163.47 -20.85 0.04 OUTLIER 'General case' 0 CA--C 1.572 1.794 0 CA-C-N 111.291 -2.686 . . . . 0.0 109.778 -175.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.4 t -64.48 136.21 26.86 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.168 0 C-N-CA 125.334 1.453 . . . . 0.0 110.249 -177.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -88.69 80.92 7.14 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 112.237 -2.256 . . . . 0.0 110.392 175.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -86.3 -89.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-O 117.074 -1.441 . . . . 0.0 107.892 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.671 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.305 11.6 ptt180 46.22 -92.96 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 124.993 1.317 . . . . 0.0 114.393 -177.661 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.671 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 16.3 mt-10 -84.2 66.79 9.49 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 123.866 1.793 . . . . 0.0 111.947 175.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.5 p -133.34 168.09 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 112.607 -2.088 . . . . 0.0 105.918 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 96.6 m -59.66 137.01 58.16 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-N 113.609 -1.632 . . . . 0.0 110.627 157.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -46.91 -37.62 9.19 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 171.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.9 m -56.23 -45.42 79.96 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 177.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.34 -39.06 88.96 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 171.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.405 ' CB ' HG13 ' A' ' 94' ' ' ILE . . . -68.04 -51.1 50.69 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 116.278 1.955 . . . . 0.0 116.278 171.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -59.94 -39.35 79.88 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 N-CA-C 115.888 1.81 . . . . 0.0 115.888 173.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.79 -42.77 97.67 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-O 117.223 -1.37 . . . . 0.0 113.051 167.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.71 -31.36 72.55 Favored 'General case' 0 CA--C 1.565 1.527 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 169.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.5 mp -61.49 -55.48 30.59 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 125.52 1.528 . . . . 0.0 112.322 166.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -64.01 -31.88 73.23 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 116.729 2.122 . . . . 0.0 116.729 170.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -66.44 -27.66 68.0 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 169.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.613 ' HB2' HD22 ' A' ' 121' ' ' ASN . . . -51.81 -42.67 62.68 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 115.826 1.787 . . . . 0.0 115.826 159.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 90.07 -129.03 9.52 Favored Glycine 0 C--N 1.349 1.275 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 165.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.0 t -72.26 -2.04 17.49 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 117.353 2.353 . . . . 0.0 117.353 168.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.97 107.56 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 -173.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.442 ' HA ' ' HB3' ' A' ' 140' ' ' ALA . 4.2 t -113.94 105.85 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 -169.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -89.65 92.11 8.94 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -178.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 22.1 mt -93.96 131.22 39.64 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 -175.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -120.15 128.39 53.38 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 104.686 -2.339 . . . . 0.0 104.686 -178.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -136.64 128.37 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.727 ' H ' HD12 ' A' ' 118' ' ' LEU . 63.9 mtm -103.65 142.34 34.49 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 127.016 2.126 . . . . 0.0 109.465 172.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -108.4 114.91 29.14 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.188 -1.369 . . . . 0.0 107.492 -175.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -126.9 127.13 44.43 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 174.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 86.0 tttt 63.03 81.52 0.23 Allowed Pre-proline 0 CA--C 1.563 1.469 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.879 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -49.7 -45.6 30.95 Favored 'Trans proline' 0 CA--C 1.57 2.309 0 C-N-CA 123.087 2.524 . . . . 0.0 116.384 172.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo . . . . . 0 C--N 1.376 1.985 0 C-N-CA 123.484 2.789 . . . . 0.0 112.586 176.669 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.554 1.098 0 CA-C-O 123.33 1.538 . . . . 0.0 110.398 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 22.7 tptp -151.28 121.94 7.47 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 113.632 -1.622 . . . . 0.0 107.833 170.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 6.0 ptmm? -75.7 109.41 9.26 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 113.918 -1.492 . . . . 0.0 111.26 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 26.3 m -81.43 126.97 32.28 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 123.287 1.518 . . . . 0.0 108.884 -178.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.94 106.17 18.33 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 113.331 -1.759 . . . . 0.0 106.891 -174.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 42.8 t . . . . . 0 C--O 1.251 1.179 0 N-CA-C 105.218 -2.142 . . . . 0.0 105.218 -178.752 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -124.56 136.98 54.42 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.542 -178.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -98.42 126.39 43.93 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.47 125.37 35.15 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 113.368 -1.742 . . . . 0.0 108.199 173.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.449 ' HB ' ' HB2' ' A' ' 146' ' ' LEU . 19.0 mt -126.61 131.83 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 -176.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.3 m -106.6 120.69 42.63 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 171.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.4 tp -124.93 145.57 49.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 113.39 -1.732 . . . . 0.0 107.739 176.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.408 ' HG3' ' HB3' ' A' ' 104' ' ' ALA . 2.7 pt-20 -75.77 144.0 41.67 Favored 'General case' 0 CA--C 1.559 1.314 0 O-C-N 121.218 -0.926 . . . . 0.0 110.71 173.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -85.67 99.7 11.48 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 172.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -67.96 164.45 46.59 Favored Glycine 0 CA--C 1.543 1.814 0 CA-C-O 122.367 0.982 . . . . 0.0 113.373 177.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -65.06 -48.44 73.8 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 114.997 1.48 . . . . 0.0 114.997 -171.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 90.9 p -76.64 -15.41 59.83 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 166.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 150.11 179.42 25.9 Favored Glycine 0 CA--C 1.538 1.469 0 CA-C-O 125.67 2.816 . . . . 0.0 108.459 -172.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.497 HD22 ' H ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -74.92 -14.07 60.61 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 111.462 -2.369 . . . . 0.0 114.798 174.869 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.403 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 76.1 50.48 7.61 Favored Glycine 0 C--N 1.338 0.663 0 N-CA-C 116.229 1.251 . . . . 0.0 116.229 175.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -155.2 149.29 25.8 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 123.172 1.463 . . . . 0.0 108.036 173.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.6 m -97.31 136.07 38.32 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.164 177.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.2 pt -110.13 123.74 66.29 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-O 121.95 0.881 . . . . 0.0 109.576 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.7 177.42 8.14 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-O 124.292 1.996 . . . . 0.0 110.247 157.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -96.75 164.71 22.99 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-O 124.24 2.022 . . . . 0.0 115.582 -140.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -102.78 -166.88 26.19 Favored Glycine 0 CA--C 1.521 0.465 0 CA-C-N 110.543 -2.828 . . . . 0.0 112.364 -175.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 63.1 p -44.57 -42.51 7.38 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 118.014 2.598 . . . . 0.0 118.014 -177.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -88.19 -7.6 56.61 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 115.993 1.849 . . . . 0.0 115.993 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.405 HD22 ' H ' ' B' ' 2' ' ' LYS 0.267 4.4 t30 -151.99 58.59 2.71 Favored Pre-proline 0 CA--C 1.571 1.755 0 CA-C-O 116.667 -1.635 . . . . 0.0 107.632 -178.508 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -97.57 135.04 0.37 Allowed 'Trans proline' 0 C--N 1.373 1.83 0 CA-C-N 126.282 3.279 . . . . 0.0 111.538 -170.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.522 ' HB2' ' CG ' ' B' ' 1' ' ' TYR . 7.9 t-80 -101.91 -21.63 14.5 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 163.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.465 ' H ' HD12 ' A' ' 88' ' ' ILE . 0.3 OUTLIER -138.91 165.19 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 C-N-CA 127.171 2.188 . . . . 0.0 105.261 -164.152 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.54 169.3 34.21 Favored Glycine 0 CA--C 1.525 0.666 0 CA-C-N 112.644 -2.071 . . . . 0.0 110.889 -169.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -77.21 -11.05 59.77 Favored 'General case' 0 CA--C 1.566 1.592 0 CA-C-N 111.834 -2.183 . . . . 0.0 115.592 166.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -170.06 -58.59 0.0 OUTLIER Pre-proline 0 CA--C 1.568 1.65 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 169.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -114.78 -125.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 123.389 2.726 . . . . 0.0 110.403 -175.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 53.1 m 75.71 134.72 0.05 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.991 1.316 . . . . 0.0 109.816 165.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 23.4 mm -96.14 124.44 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 105.812 -1.921 . . . . 0.0 105.812 -172.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -129.6 126.22 37.96 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -175.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.468 ' HB ' ' O ' ' A' ' 113' ' ' VAL 0.349 60.2 mt -66.44 129.6 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.287 0 CA-C-O 122.895 1.331 . . . . 0.0 108.648 174.002 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.4 m -87.69 -41.4 13.38 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 124.846 1.258 . . . . 0.0 113.325 171.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -140.4 160.95 38.86 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 124.174 1.94 . . . . 0.0 110.465 -175.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -114.4 109.93 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 102.365 -3.198 . . . . 0.0 102.365 174.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.254 1.5 mp -66.71 121.28 76.74 Favored Pre-proline 0 CA--C 1.564 1.516 0 CA-C-O 117.774 -1.107 . . . . 0.0 109.395 -177.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -63.22 138.05 64.58 Favored 'Trans proline' 0 C--N 1.364 1.387 0 C-N-CA 123.373 2.715 . . . . 0.0 113.387 172.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.45 -6.83 56.49 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 117.977 1.951 . . . . 0.0 117.977 -168.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.403 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -90.01 176.81 42.64 Favored Glycine 0 CA--C 1.537 1.439 0 CA-C-O 122.435 1.019 . . . . 0.0 113.025 174.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.408 ' HB3' ' HG3' ' A' ' 69' ' ' GLU . . . -67.52 -36.82 81.77 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 117.332 2.345 . . . . 0.0 117.332 -175.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.06 -35.37 78.1 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 116.37 1.989 . . . . 0.0 116.37 168.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.8 -31.72 69.79 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 115.524 1.675 . . . . 0.0 115.524 166.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.34 -61.61 1.77 Allowed 'General case' 0 CA--C 1.566 1.584 0 C-N-CA 124.581 1.152 . . . . 0.0 111.739 171.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -80.96 -56.94 3.78 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 124.901 1.281 . . . . 0.0 112.369 -173.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -81.42 -70.62 1.33 Allowed Glycine 0 CA--C 1.536 1.376 0 N-CA-C 114.302 0.481 . . . . 0.0 114.302 -169.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 48.0 mtt-85 57.04 50.23 12.42 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 125.035 1.334 . . . . 0.0 112.869 -163.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -100.63 -162.12 0.92 Allowed 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 123.533 1.635 . . . . 0.0 108.293 -160.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 4.8 ptt180 -84.63 134.35 34.38 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 125.504 2.573 . . . . 0.0 107.077 162.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.468 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 34.8 m -65.78 -51.57 60.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-N 111.261 -2.699 . . . . 0.0 110.23 168.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -62.3 61.58 0.01 OUTLIER 'General case' 0 CA--C 1.575 1.92 0 CA-C-O 123.846 1.784 . . . . 0.0 115.425 171.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -113.4 112.58 23.89 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 100.292 -3.966 . . . . 0.0 100.292 -178.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.2 m -71.52 78.13 0.79 Allowed 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 113.026 -1.897 . . . . 0.0 109.982 -173.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 5.1 tp -73.86 109.97 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -174.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.402 ' HA ' ' HB3' ' A' ' 126' ' ' ARG . 0.2 OUTLIER -110.0 -47.61 3.3 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 113.171 -1.831 . . . . 0.0 114.157 -175.224 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -116.87 136.5 52.9 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 172.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 14.0 p -124.86 123.73 66.33 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 170.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.435 HD22 ' HB3' ' A' ' 140' ' ' ALA 0.302 28.9 m-80 77.85 -84.46 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 123.757 1.741 . . . . 0.0 108.921 179.971 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -151.57 -22.14 0.2 Allowed 'General case' 0 CA--C 1.574 1.882 0 CA-C-N 110.82 -2.9 . . . . 0.0 109.131 -176.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.3 t -68.41 136.71 25.91 Favored 'Isoleucine or valine' 0 C--N 1.363 1.155 0 C-N-CA 125.781 1.632 . . . . 0.0 110.224 -178.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -89.5 98.98 12.08 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 111.999 -2.364 . . . . 0.0 108.457 170.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . 0.26 0.4 OUTLIER -95.01 -98.36 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 173.233 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.589 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.287 16.1 ptt85 51.7 -92.39 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 116.855 2.169 . . . . 0.0 116.855 176.965 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.589 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 8.5 tt0 -77.65 64.54 2.97 Favored 'General case' 0 CA--C 1.56 1.34 0 CA-C-O 123.648 1.689 . . . . 0.0 110.967 167.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -139.02 167.6 20.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 2.7 m -58.84 134.46 56.91 Favored 'General case' 0 CA--C 1.557 1.222 0 CA-C-N 112.697 -2.047 . . . . 0.0 110.7 157.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -45.41 -32.72 2.23 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 117.499 2.407 . . . . 0.0 117.499 168.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.9 m -60.55 -43.12 97.58 Favored 'General case' 0 CA--C 1.556 1.203 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 175.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -69.67 -37.36 76.64 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 167.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -60.25 -59.27 5.68 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 170.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.435 HG22 HG22 ' B' ' 4' ' ' THR . 0.9 OUTLIER -50.81 -42.44 23.03 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 N-CA-C 116.43 2.011 . . . . 0.0 116.43 171.521 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.65 -48.18 75.75 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 116.317 -1.801 . . . . 0.0 112.607 174.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.51 -28.51 66.11 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 117.23 2.307 . . . . 0.0 117.23 174.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 5.0 mp -54.98 -53.5 54.86 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.159 1.383 . . . . 0.0 113.402 163.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -73.41 -38.58 65.52 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 172.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -65.93 0.11 2.01 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 116.549 2.055 . . . . 0.0 116.549 169.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.448 ' HB1' ' HA ' ' A' ' 144' ' ' VAL . . . -56.8 -9.96 0.93 Allowed 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 120.315 3.45 . . . . 0.0 120.315 162.088 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 102.69 -105.25 2.72 Favored Glycine 0 C--N 1.342 0.886 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 161.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.6 m -113.43 -7.83 13.43 Favored 'General case' 0 CA--C 1.576 1.943 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 163.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.19 111.98 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 -165.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.448 ' HA ' ' HB1' ' A' ' 140' ' ' ALA . 3.4 t -96.94 116.81 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 112.676 -2.056 . . . . 0.0 107.553 -174.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -99.83 91.07 4.66 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 177.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.449 ' HB2' ' HB ' ' A' ' 66' ' ' ILE . 22.9 mt -83.16 135.16 34.9 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -128.55 126.15 39.75 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.3 p -132.48 116.69 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 -173.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 25.2 ttt -93.68 134.76 35.65 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 123.201 1.477 . . . . 0.0 108.516 168.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -82.41 155.88 24.44 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 112.493 -2.14 . . . . 0.0 110.774 173.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -72.95 151.17 41.97 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 112.219 -2.264 . . . . 0.0 109.727 177.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp 69.15 74.51 0.28 Allowed Pre-proline 0 N--CA 1.486 1.366 0 CA-C-O 118.062 -0.971 . . . . 0.0 109.084 -175.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -50.78 -48.15 22.01 Favored 'Trans proline' 0 CA--C 1.567 2.139 0 C-N-CA 122.975 2.45 . . . . 0.0 115.448 174.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo . . . . . 0 C--N 1.374 1.906 0 C-N-CA 123.452 2.768 . . . . 0.0 110.99 174.685 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' TYR . . . . . 0.522 ' CG ' ' HB2' ' A' ' 87' ' ' HIS . 0.4 OUTLIER . . . . . 0 CA--C 1.557 1.224 0 CA-C-O 122.227 1.013 . . . . 0.0 111.548 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.405 ' H ' HD22 ' A' ' 85' ' ' ASN . 4.3 mptp? -127.8 144.97 51.07 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 123.414 1.578 . . . . 0.0 107.707 165.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -101.26 126.69 48.03 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.03 176.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.435 HG22 HG22 ' A' ' 134' ' ' VAL . 98.4 m -97.38 130.94 44.47 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.031 172.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -76.66 138.98 40.38 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 113.964 -1.471 . . . . 0.0 109.564 170.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 6.0 p . . . . . 0 C--O 1.254 1.301 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.012 172.997 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.484 1.263 0 CA-C-O 121.261 0.553 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -119.86 138.7 53.24 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.21 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -109.5 145.53 36.11 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 113.99 -1.459 . . . . 0.0 108.848 176.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -107.52 121.57 44.9 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 112.658 -2.065 . . . . 0.0 106.095 -175.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.6 mp -130.64 128.26 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 -176.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.1 m -100.35 132.56 45.65 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 122.838 1.304 . . . . 0.0 107.547 163.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.404 HD11 ' HA ' ' A' ' 105' ' ' ALA . 9.6 tt -130.05 130.16 44.57 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 113.141 -1.845 . . . . 0.0 107.83 -169.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -83.78 124.04 30.5 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.71 ' HG2' ' H ' ' A' ' 71' ' ' GLY . 29.6 ttt180 -74.39 -166.0 0.39 Allowed 'General case' 0 CA--C 1.573 1.858 0 CA-C-O 122.222 1.011 . . . . 0.0 112.327 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.71 ' H ' ' HG2' ' A' ' 70' ' ' ARG . . . -107.17 -107.64 3.21 Favored Glycine 0 CA--C 1.541 1.699 0 N-CA-C 109.964 -1.255 . . . . 0.0 109.964 168.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -121.9 -82.02 0.64 Allowed 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.53 0.732 . . . . 0.0 109.182 -174.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 89.0 p -100.31 -18.58 16.74 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 125.386 1.474 . . . . 0.0 114.776 173.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -113.68 162.3 12.42 Favored Glycine 0 CA--C 1.544 1.872 0 CA-C-O 125.566 2.759 . . . . 0.0 111.33 167.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.458 HD22 ' HE ' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -117.86 -7.27 10.96 Favored 'General case' 0 CA--C 1.56 1.355 0 CA-C-N 109.41 -3.395 . . . . 0.0 111.465 172.155 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 65.18 51.67 47.94 Favored Glycine 0 C--N 1.346 1.11 0 N-CA-C 117.279 1.671 . . . . 0.0 117.279 166.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -155.3 157.95 38.0 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 112.929 -1.635 . . . . 0.0 107.376 173.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.0 m -122.28 126.87 49.07 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 122.484 1.135 . . . . 0.0 109.341 -173.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 pt -91.33 127.77 43.5 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-N 113.444 -1.707 . . . . 0.0 109.309 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -83.87 -175.54 5.86 Favored 'General case' 0 CA--C 1.555 1.167 0 CA-C-O 123.641 1.686 . . . . 0.0 110.291 156.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.14 157.35 24.08 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 123.161 1.423 . . . . 0.0 116.58 -140.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -108.84 -169.36 20.84 Favored Glycine 0 N--CA 1.466 0.663 0 CA-C-N 111.914 -2.143 . . . . 0.0 114.289 178.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.406 HG22 ' HB2' ' A' ' 92' ' ' PRO . 18.2 p -43.69 -44.59 6.58 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 117.952 2.575 . . . . 0.0 117.952 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -85.55 -15.24 43.32 Favored 'General case' 0 CA--C 1.564 1.506 0 N-CA-C 115.915 1.82 . . . . 0.0 115.915 177.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.444 HD22 ' H ' ' B' ' 2' ' ' LYS . 4.4 t30 -150.64 73.92 8.8 Favored Pre-proline 0 CA--C 1.562 1.41 0 N-CA-C 103.893 -2.632 . . . . 0.0 103.893 -176.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -107.59 144.09 0.07 OUTLIER 'Trans proline' 0 C--N 1.374 1.915 0 CA-C-N 124.656 2.699 . . . . 0.0 112.446 -169.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -65.38 -26.08 67.84 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 114.695 1.369 . . . . 0.0 114.695 161.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -142.74 121.13 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 N-CA-C 105.253 -2.128 . . . . 0.0 105.253 -168.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -80.55 2.64 77.46 Favored Glycine 0 CA--C 1.555 2.59 0 N-CA-C 117.53 1.772 . . . . 0.0 117.53 162.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -87.39 -12.99 44.64 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 175.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -159.61 96.79 1.6 Allowed Pre-proline 0 CA--C 1.553 1.089 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 173.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.406 ' HB2' HG22 ' A' ' 83' ' ' THR . 19.1 Cg_endo -61.34 101.43 0.2 Allowed 'Trans proline' 0 CA--C 1.551 1.341 0 C-N-CA 122.471 2.114 . . . . 0.0 112.503 165.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 74.7 m -150.67 139.33 20.67 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 -179.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.415 HG13 ' HB3' ' A' ' 133' ' ' ALA . 31.5 mm -79.65 129.76 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 175.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.448 ' HA ' ' O ' ' A' ' 115' ' ' ASP 0.276 4.9 p90 -135.49 122.06 20.77 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 113.824 -1.534 . . . . 0.0 110.994 -177.067 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 71.0 mt -74.75 109.86 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 168.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 12.8 m -94.64 -14.62 24.73 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 114.978 -1.01 . . . . 0.0 113.714 172.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 29.5 tttp -139.53 150.12 44.72 Favored 'General case' 0 CA--C 1.557 1.243 0 CA-C-O 124.356 2.027 . . . . 0.0 110.343 -175.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -117.2 125.02 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 N-CA-C 103.924 -2.621 . . . . 0.0 103.924 174.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.5 mp -74.14 133.55 78.24 Favored Pre-proline 0 CA--C 1.566 1.572 0 CA-C-O 118.518 -0.754 . . . . 0.0 109.324 171.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.5 132.87 40.0 Favored 'Trans proline' 0 CA--C 1.554 1.512 0 C-N-CA 123.301 2.668 . . . . 0.0 113.687 171.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.19 11.93 85.08 Favored Glycine 0 CA--C 1.546 2.028 0 N-CA-C 117.383 1.713 . . . . 0.0 117.383 -164.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -84.09 170.75 47.67 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-O 123.086 1.381 . . . . 0.0 114.244 177.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.21 -43.98 89.79 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 112.286 -1.957 . . . . 0.0 115.387 178.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.404 ' HA ' HD11 ' A' ' 68' ' ' LEU . . . -67.17 -32.93 74.35 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 118.496 2.776 . . . . 0.0 118.496 173.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.37 -39.01 91.75 Favored 'General case' 0 CA--C 1.567 1.598 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 165.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -67.32 -60.93 2.18 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.378 1.471 . . . . 0.0 113.042 173.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -58.58 -45.07 89.81 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -172.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -174.65 -136.37 2.24 Favored Glycine 0 C--N 1.34 0.757 0 CA-C-O 122.889 1.271 . . . . 0.0 110.331 166.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -145.27 76.42 1.48 Allowed 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 104.756 -2.313 . . . . 0.0 104.756 -176.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.87 5.83 46.94 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 164.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . 0.351 78.1 mtp180 89.26 168.92 0.04 OUTLIER 'General case' 0 C--N 1.354 0.804 0 CA-C-O 125.385 2.516 . . . . 0.0 110.496 -159.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . 0.344 15.5 m -22.6 -68.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 CA-C-N 111.137 -2.756 . . . . 0.0 114.221 146.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.7 t30 158.76 -28.15 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 129.047 2.939 . . . . 0.0 106.817 168.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.448 ' O ' ' HA ' ' A' ' 95' ' ' PHE 0.278 8.3 t70 46.48 -125.8 1.45 Allowed 'General case' 0 C--N 1.36 1.057 0 C-N-CA 126.111 1.764 . . . . 0.0 109.127 -169.033 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 48.5 m -72.61 74.67 1.08 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.411 1.084 . . . . 0.0 113.246 -169.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.0 tp -67.68 103.95 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 171.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.428 ' HA ' ' HB3' ' A' ' 126' ' ' ARG 0.293 1.0 OUTLIER -91.18 -54.96 3.72 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 113.104 -1.862 . . . . 0.0 113.145 177.632 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.409 ' H ' HD13 ' A' ' 118' ' ' LEU . 20.2 m-85 -118.28 138.92 52.04 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 105.358 -2.089 . . . . 0.0 105.358 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.8 p -127.28 114.9 38.66 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 170.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.544 HD22 ' HB3' ' A' ' 140' ' ' ALA 0.352 14.5 m-80 80.05 -83.03 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 123.489 1.614 . . . . 0.0 109.7 -177.704 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -148.3 -25.68 0.34 Allowed 'General case' 0 CA--C 1.566 1.579 0 CA-C-N 111.126 -2.761 . . . . 0.0 109.411 -178.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.3 t -61.75 135.72 26.02 Favored 'Isoleucine or valine' 0 C--N 1.362 1.119 0 C-N-CA 125.385 1.474 . . . . 0.0 110.286 174.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -97.92 72.29 2.22 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 112.117 -2.311 . . . . 0.0 109.852 175.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -63.21 -86.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 116.243 -1.837 . . . . 0.0 110.401 176.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.744 ' HD2' ' H ' ' A' ' 127' ' ' GLU 0.325 0.1 OUTLIER 49.22 -98.58 0.05 Allowed 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 120.269 1.395 . . . . 0.0 113.353 171.827 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.744 ' H ' ' HD2' ' A' ' 126' ' ' ARG . 10.2 mt-10 -80.64 69.13 7.08 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 126.695 1.998 . . . . 0.0 110.414 174.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.8 p -139.11 169.3 17.61 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 CA-C-N 112.87 -1.968 . . . . 0.0 106.093 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 46.8 m -60.15 135.21 57.65 Favored 'General case' 0 CA--C 1.558 1.288 0 CA-C-N 113.16 -1.836 . . . . 0.0 110.624 157.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 3.6 p-80 -46.15 -35.31 4.94 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 170.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.2 m -62.69 -43.04 99.81 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 125.311 1.444 . . . . 0.0 114.761 176.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.16 -37.33 87.07 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 169.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.415 ' HB3' HG13 ' A' ' 94' ' ' ILE . . . -69.66 -50.93 39.37 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 116.466 2.024 . . . . 0.0 116.466 172.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.419 ' CG2' ' HB ' ' B' ' 6' ' ' VAL . 3.3 p -52.17 -42.67 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.475 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 170.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -72.82 -38.46 67.15 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 115.506 -2.188 . . . . 0.0 113.503 174.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.17 -34.05 77.16 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 116.937 2.199 . . . . 0.0 116.937 170.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.413 ' HB3' HD11 ' A' ' 75' ' ' LEU . 7.8 mp -55.59 -49.13 73.59 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.491 1.516 . . . . 0.0 114.939 162.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -68.05 -35.74 78.73 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 168.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.49 -20.76 66.12 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 173.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.544 ' HB3' HD22 ' A' ' 121' ' ' ASN . . . -52.86 -11.67 0.25 Allowed 'General case' 0 CA--C 1.561 1.377 0 N-CA-C 118.527 2.788 . . . . 0.0 118.527 161.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 79.97 -143.29 25.16 Favored Glycine 0 C--N 1.347 1.188 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 174.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 17.3 m -71.34 -4.52 26.56 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 116.691 2.108 . . . . 0.0 116.691 173.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.07 107.81 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 -170.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.5 t -93.66 114.84 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 113.797 -1.547 . . . . 0.0 108.24 -174.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 75.0 mtt-85 -96.39 94.82 7.65 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 -177.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 34.0 mt -99.58 138.82 36.14 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 122.069 0.938 . . . . 0.0 109.043 -170.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -128.78 115.82 18.54 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.24 129.15 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -173.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 28.0 ttt -91.31 148.69 22.15 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-O 123.307 1.527 . . . . 0.0 112.503 164.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 -97.88 114.44 26.52 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 171.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -93.16 144.25 25.47 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 113.952 -1.476 . . . . 0.0 110.555 -175.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -93.85 106.41 21.63 Favored Pre-proline 0 CA--C 1.56 1.359 0 CA-C-N 113.522 -1.672 . . . . 0.0 107.734 169.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -49.96 -46.06 29.71 Favored 'Trans proline' 0 CA--C 1.57 2.316 0 C-N-CA 123.546 2.831 . . . . 0.0 116.689 171.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 C--N 1.374 1.907 0 C-N-CA 123.55 2.833 . . . . 0.0 111.114 175.295 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 1.1 p90 . . . . . 0 N--CA 1.478 0.961 0 CA-C-O 122.977 1.37 . . . . 0.0 112.828 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.444 ' H ' HD22 ' A' ' 85' ' ' ASN . 0.3 OUTLIER -136.6 144.86 44.34 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 112.738 -2.028 . . . . 0.0 110.888 166.919 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 10.0 ttpp -92.24 109.97 21.35 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 113.534 -1.667 . . . . 0.0 108.481 178.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.402 HG23 HG23 ' A' ' 134' ' ' VAL . 98.7 m -88.38 131.93 34.65 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 122.401 1.096 . . . . 0.0 108.784 175.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.11 155.48 32.36 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 113.848 -1.524 . . . . 0.0 109.971 175.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.419 ' HB ' ' CG2' ' A' ' 134' ' ' VAL . 7.7 p . . . . . 0 C--O 1.247 0.957 0 N-CA-C 104.392 -2.447 . . . . 0.0 104.392 -171.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 . . . . . 0 N--CA 1.481 1.1 0 CA-C-O 121.808 0.813 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -130.05 141.1 50.76 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 124.126 0.97 . . . . 0.0 109.511 168.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -126.66 135.49 51.24 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 122.099 0.952 . . . . 0.0 108.846 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.27 120.62 42.85 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.059 -174.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.6 mp -135.1 125.32 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 -172.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.9 m -98.8 122.53 42.16 Favored 'General case' 0 CA--C 1.557 1.213 0 CA-C-O 122.338 1.066 . . . . 0.0 108.302 173.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 mp -118.26 127.21 53.51 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.576 1.55 . . . . 0.0 108.594 -174.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -100.66 129.09 46.53 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-O 121.223 0.535 . . . . 0.0 110.154 -178.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.52 ' HB2' ' HB3' ' A' ' 104' ' ' ALA . 9.3 tpt180 -157.28 -107.18 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 176.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.451 ' H ' ' HB3' ' A' ' 70' ' ' ARG . . . 74.92 -162.82 54.05 Favored Glycine 0 C--N 1.352 1.42 0 C-N-CA 124.937 1.256 . . . . 0.0 111.614 -168.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 74.57 -89.27 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 113.375 -1.413 . . . . 0.0 111.18 170.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 80.4 p -86.42 -18.19 32.39 Favored 'General case' 0 CA--C 1.561 1.386 0 N-CA-C 116.476 2.028 . . . . 0.0 116.476 174.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 164.03 -146.01 11.03 Favored Glycine 0 CA--C 1.532 1.127 0 N-CA-C 107.475 -2.25 . . . . 0.0 107.475 179.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.29 -34.63 2.27 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 113.556 -1.322 . . . . 0.0 111.753 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.41 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 103.14 41.2 2.29 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 115.848 1.099 . . . . 0.0 115.848 164.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -158.32 127.2 5.56 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 123.425 1.583 . . . . 0.0 107.435 -175.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.3 m -87.56 137.45 32.32 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 121.246 -0.908 . . . . 0.0 111.126 174.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.5 pp -118.02 130.25 73.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 114.403 -1.271 . . . . 0.0 107.978 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -92.38 -169.68 2.29 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-O 123.288 1.518 . . . . 0.0 109.871 160.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.69 159.41 24.78 Favored Glycine 0 CA--C 1.537 1.459 0 CA-C-O 123.551 1.64 . . . . 0.0 115.783 -140.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.11 -162.26 21.87 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 111.606 -2.297 . . . . 0.0 112.316 -176.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 67.8 p -54.02 -41.11 67.65 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 117.373 2.361 . . . . 0.0 117.373 -177.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -75.51 -15.64 60.37 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 116.469 2.025 . . . . 0.0 116.469 173.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.42 HD21 ' CE1' ' A' ' 130' ' ' HIS . 0.1 OUTLIER -152.77 86.05 4.29 Favored Pre-proline 0 CA--C 1.56 1.343 0 N-CA-C 101.585 -3.487 . . . . 0.0 101.585 -177.511 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -99.41 125.02 0.15 Allowed 'Trans proline' 0 CA--C 1.547 1.126 0 CA-C-N 124.241 2.55 . . . . 0.0 110.533 -170.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 60.7 t60 -103.82 -33.64 8.82 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 174.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -156.7 157.9 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 CA-C-O 123.596 1.665 . . . . 0.0 108.338 -152.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 112.32 -129.59 9.11 Favored Glycine 0 C--N 1.337 0.595 0 CA-C-N 112.398 -2.183 . . . . 0.0 109.821 174.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -96.03 -6.43 38.79 Favored 'General case' 0 CA--C 1.572 1.8 0 CA-C-N 113.279 -1.461 . . . . 0.0 114.905 161.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.318 32.7 t70 155.67 -72.63 0.0 OUTLIER Pre-proline 0 CA--C 1.559 1.301 0 N-CA-C 102.698 -3.075 . . . . 0.0 102.698 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -93.45 -141.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.369 1.63 0 C-N-CA 123.338 2.692 . . . . 0.0 110.805 -174.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 43.6 m 70.7 144.04 0.06 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 122.667 1.222 . . . . 0.0 109.204 175.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 10.1 mm -91.78 126.05 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 -174.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -124.83 142.1 51.66 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 -178.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.401 HG22 ' HB ' ' A' ' 113' ' ' VAL 0.254 46.9 mt -85.32 119.52 34.08 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.541 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 175.023 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 91.8 m -85.92 -33.21 21.25 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 117.806 -1.093 . . . . 0.0 113.476 169.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . 0.285 0.0 OUTLIER -141.01 163.66 32.38 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-O 124.779 2.228 . . . . 0.0 111.324 179.218 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -104.18 119.87 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 166.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.415 HD11 ' H ' ' B' ' 7' ' ' BAL . 24.0 mm -65.68 127.77 93.3 Favored Pre-proline 0 CA--C 1.566 1.58 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.164 178.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.74 129.06 32.62 Favored 'Trans proline' 0 C--N 1.365 1.406 0 C-N-CA 123.606 2.871 . . . . 0.0 115.286 -178.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.49 11.39 80.09 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 118.54 2.176 . . . . 0.0 118.54 -170.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.41 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -92.35 -175.92 41.9 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 124.546 1.069 . . . . 0.0 113.937 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.52 ' HB3' ' HB2' ' A' ' 70' ' ' ARG . . . -63.4 -51.96 63.62 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 117.146 2.276 . . . . 0.0 117.146 -171.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.04 -33.19 64.72 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 175.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -67.09 -44.74 79.23 Favored 'General case' 0 CA--C 1.563 1.457 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 169.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.33 -54.55 6.33 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 123.638 0.775 . . . . 0.0 112.306 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -59.54 -42.16 91.7 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -179.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -161.7 -149.24 5.57 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-O 124.296 2.053 . . . . 0.0 113.536 171.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 38.1 mtm105 -146.71 60.7 1.21 Allowed 'General case' 0 CA--C 1.552 1.055 0 CA-C-N 110.446 -2.877 . . . . 0.0 105.797 -177.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.465 ' H ' HD23 ' A' ' 111' ' ' LEU . 1.3 pt? -60.92 -29.17 69.45 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 175.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 18.0 mtp-105 67.63 127.91 0.02 OUTLIER 'General case' 0 C--N 1.351 0.654 0 CA-C-O 124.732 2.206 . . . . 0.0 109.016 -162.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.401 ' HB ' HG22 ' A' ' 96' ' ' ILE 0.264 27.7 m -48.41 -65.86 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 109.178 -3.646 . . . . 0.0 110.56 -168.216 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -63.54 80.97 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.238 0 CA-C-O 124.688 2.185 . . . . 0.0 113.604 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -104.52 -170.07 1.71 Allowed 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 110.264 -3.153 . . . . 0.0 106.128 158.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 40.0 m -127.81 79.61 1.91 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 176.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.5 tp -56.45 116.55 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-O 121.997 0.904 . . . . 0.0 110.666 -178.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.414 ' HB2' ' HD3' ' A' ' 126' ' ' ARG . 3.0 pp -110.19 -47.85 3.25 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 116.785 2.143 . . . . 0.0 116.785 -174.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -126.64 138.07 53.38 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 177.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.1 t -128.44 109.8 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 100.543 -3.873 . . . . 0.0 100.543 175.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.603 HD22 ' HB2' ' A' ' 140' ' ' ALA 0.378 8.9 m-80 83.3 -88.48 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 122.921 1.343 . . . . 0.0 109.389 179.86 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -145.26 -13.82 0.52 Allowed 'General case' 0 CA--C 1.567 1.627 0 CA-C-N 111.401 -2.636 . . . . 0.0 110.59 175.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.3 t -67.58 133.03 32.18 Favored 'Isoleucine or valine' 0 C--N 1.359 0.994 0 C-N-CA 125.431 1.492 . . . . 0.0 109.997 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -84.19 98.09 9.75 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 112.476 -2.147 . . . . 0.0 109.599 172.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . 0.258 2.0 m -97.51 -103.26 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-O 116.281 -1.818 . . . . 0.0 106.97 173.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.563 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.289 13.2 ptt180 50.4 -93.33 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 120.217 1.371 . . . . 0.0 114.237 179.585 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.563 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 2.4 tt0 -79.25 68.68 5.3 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-O 123.425 1.583 . . . . 0.0 111.031 173.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.8 p -144.3 168.89 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.96 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 -173.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 27.4 m -61.76 130.86 47.81 Favored 'General case' 0 CA--C 1.559 1.3 0 CA-C-N 113.119 -1.855 . . . . 0.0 110.038 156.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.42 ' CE1' HD21 ' A' ' 85' ' ' ASN . 2.1 p-80 -47.7 -29.44 3.05 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 118.587 2.81 . . . . 0.0 118.587 169.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.1 m -63.09 -37.91 89.07 Favored 'General case' 0 CA--C 1.565 1.543 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 171.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -70.25 -36.13 74.27 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 165.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.19 -55.61 30.26 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 114.695 1.368 . . . . 0.0 114.695 169.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.3 p -53.1 -40.55 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.162 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 169.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -58.17 -52.19 66.59 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 116.311 -1.804 . . . . 0.0 112.691 168.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.68 -35.62 74.83 Favored 'General case' 0 CA--C 1.561 1.391 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 173.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 9.6 mp -54.46 -53.92 47.86 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 125.296 1.438 . . . . 0.0 113.813 164.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -68.41 -33.54 74.4 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 116.507 2.04 . . . . 0.0 116.507 172.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -64.11 -32.19 73.66 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 115.17 1.544 . . . . 0.0 115.17 171.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.603 ' HB2' HD22 ' A' ' 121' ' ' ASN . . . -52.91 -36.57 59.69 Favored 'General case' 0 CA--C 1.557 1.214 0 N-CA-C 117.234 2.309 . . . . 0.0 117.234 163.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.12 -133.61 12.0 Favored Glycine 0 C--N 1.348 1.214 0 N-CA-C 111.644 -0.582 . . . . 0.0 111.644 167.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.3 t -66.4 -7.97 22.7 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 118.756 2.873 . . . . 0.0 118.756 170.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.32 107.84 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 -172.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.448 ' HA ' ' HB3' ' A' ' 140' ' ' ALA . 4.3 t -106.31 110.47 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 113.006 -1.907 . . . . 0.0 107.539 -173.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -101.77 91.46 4.41 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 78.0 mt -89.43 144.51 26.0 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 113.524 -1.671 . . . . 0.0 108.975 -175.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -133.15 115.97 15.7 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 103.446 -2.798 . . . . 0.0 103.446 173.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 19.6 m -119.57 155.39 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -170.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 60.7 ttp -102.06 132.59 47.84 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 122.494 1.14 . . . . 0.0 110.095 172.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -101.65 114.32 28.26 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 113.521 -1.672 . . . . 0.0 107.106 164.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -80.06 130.92 35.63 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.247 -174.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt 75.96 124.96 0.03 OUTLIER Pre-proline 0 CA--C 1.555 1.152 0 CA-C-N 114.131 -1.395 . . . . 0.0 111.091 176.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -65.01 144.72 83.36 Favored 'Trans proline' 0 CA--C 1.568 2.199 0 C-N-CA 122.362 2.041 . . . . 0.0 113.491 173.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo . . . . . 0 CA--C 1.552 1.396 0 C-N-CA 123.26 2.64 . . . . 0.0 112.641 176.718 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 1.3 p90 . . . . . 0 CA--C 1.562 1.408 0 CA-C-O 122.313 1.054 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -133.72 125.21 28.1 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 123.141 1.448 . . . . 0.0 107.852 171.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 3.0 ttpt -96.76 133.56 41.18 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 113.872 -1.513 . . . . 0.0 108.131 175.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.3 150.14 27.02 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-O 123.121 1.439 . . . . 0.0 109.076 177.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -109.03 126.29 52.99 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 -176.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . 0.321 0.5 OUTLIER . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 173.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' BAL . . . . . 0.415 ' H ' HD11 ' A' ' 100' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 . . . . . 0 N--CA 1.474 0.774 0 CA-C-O 121.689 0.757 . . . . 0.0 111.891 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . 0.251 26.9 p90 -90.05 128.17 36.23 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.077 173.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -124.32 131.07 53.5 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -167.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -83.44 123.99 30.24 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 113.888 -1.505 . . . . 0.0 110.906 171.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.413 HG13 ' HB2' ' A' ' 146' ' ' LEU . 7.9 pt -140.33 118.12 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 -168.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.0 m -97.1 131.18 44.13 Favored 'General case' 0 CA--C 1.554 1.109 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 173.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.3 mp -125.35 131.53 52.98 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.176 179.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -115.92 124.46 50.63 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -174.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.432 ' HB2' ' HB2' ' A' ' 104' ' ' ALA . 15.9 tpt180 -158.16 -109.27 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 176.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.89 -173.49 53.58 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-O 122.429 1.016 . . . . 0.0 113.771 -169.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . 0.267 56.3 t-20 71.6 -93.3 0.03 OUTLIER 'General case' 0 CA--C 1.56 1.365 0 CA-C-N 113.376 -1.412 . . . . 0.0 111.366 174.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.8 m -79.02 -18.75 53.04 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 115.91 1.818 . . . . 0.0 115.91 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 178.8 -151.1 10.04 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 108.454 -1.858 . . . . 0.0 108.454 172.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -134.41 -30.94 1.11 Allowed 'General case' 0 CA--C 1.559 1.32 0 CA-C-N 113.468 -1.366 . . . . 0.0 112.497 169.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.406 ' CA ' ' HA3' ' A' ' 103' ' ' GLY . . . 106.19 15.79 16.8 Favored Glycine 0 N--CA 1.479 1.532 0 N-CA-C 121.118 3.207 . . . . 0.0 121.118 172.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -150.05 143.62 25.25 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 124.483 2.087 . . . . 0.0 108.857 -177.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.0 m -111.91 128.38 56.13 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 112.357 -2.202 . . . . 0.0 108.422 178.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.5 pp -109.2 126.72 66.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.495 -1.23 . . . . 0.0 109.609 -173.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -83.36 -171.89 3.84 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-O 123.401 1.572 . . . . 0.0 110.715 162.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -98.9 163.82 20.5 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-O 123.999 1.888 . . . . 0.0 115.829 -143.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -111.45 -164.06 17.84 Favored Glycine 0 N--CA 1.464 0.553 0 CA-C-N 110.854 -2.673 . . . . 0.0 111.086 -172.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.3 p -51.64 -40.41 59.92 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 117.714 2.487 . . . . 0.0 117.714 -173.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -80.26 -17.54 51.9 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 171.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . 0.303 6.3 t30 -138.2 54.76 7.66 Favored Pre-proline 0 CA--C 1.567 1.633 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -174.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -100.44 124.79 0.12 Allowed 'Trans proline' 0 C--N 1.365 1.442 0 CA-C-N 124.804 2.751 . . . . 0.0 111.312 -157.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -106.85 -35.07 7.05 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 174.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.429 ' H ' HD12 ' A' ' 88' ' ' ILE . 3.2 mp -103.01 135.26 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -153.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.68 -116.36 5.66 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-N 114.311 -1.313 . . . . 0.0 112.29 165.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -89.37 8.08 32.53 Favored 'General case' 0 CA--C 1.563 1.479 0 N-CA-C 116.411 2.004 . . . . 0.0 116.411 172.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.451 21.0 m-20 103.68 -81.19 0.0 OUTLIER Pre-proline 0 CA--C 1.57 1.737 0 C-N-CA 126.224 1.809 . . . . 0.0 109.999 -174.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -92.4 86.36 0.22 Allowed 'Trans proline' 0 C--N 1.366 1.481 0 C-N-CA 123.765 2.976 . . . . 0.0 114.161 -159.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 58.5 m -161.17 132.18 5.36 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 13.9 mm -82.29 124.88 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 -179.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -120.89 155.28 34.52 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 113.91 -1.495 . . . . 0.0 108.78 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.417 ' HB ' ' O ' ' A' ' 113' ' ' VAL . 83.9 mt -92.62 117.39 35.88 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.629 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 158.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.402 ' CG2' ' HG3' ' B' ' 3' ' ' LYS . 10.1 t -86.04 -31.98 21.68 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 115.378 1.621 . . . . 0.0 115.378 169.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.464 ' HZ2' ' HB2' ' A' ' 98' ' ' LYS 0.342 0.0 OUTLIER -143.54 164.4 30.47 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 124.618 2.151 . . . . 0.0 110.707 177.456 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -104.55 132.48 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 174.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.259 43.9 mt -87.75 117.21 68.21 Favored Pre-proline 0 CA--C 1.561 1.397 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 172.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.13 146.61 80.4 Favored 'Trans proline' 0 C--N 1.369 1.654 0 C-N-CA 123.673 2.915 . . . . 0.0 115.722 176.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.76 -8.84 47.45 Favored Glycine 0 CA--C 1.544 1.872 0 N-CA-C 117.649 1.82 . . . . 0.0 117.649 -170.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.406 ' HA3' ' CA ' ' A' ' 76' ' ' GLY . . . -96.54 -168.88 34.11 Favored Glycine 0 CA--C 1.539 1.564 0 CA-C-N 119.171 1.486 . . . . 0.0 115.098 -177.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.432 ' HB2' ' HB2' ' A' ' 70' ' ' ARG . . . -64.28 -47.5 79.29 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -175.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.59 -37.92 88.11 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 178.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.25 -44.85 90.52 Favored 'General case' 0 CA--C 1.564 1.489 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 168.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -66.62 -63.13 1.13 Allowed 'General case' 0 CA--C 1.564 1.498 0 C-N-CA 125.323 1.449 . . . . 0.0 113.136 178.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -65.53 -46.82 78.11 Favored 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 124.651 1.18 . . . . 0.0 113.69 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 123.5 57.6 0.19 Allowed Glycine 0 N--CA 1.479 1.537 0 C-N-CA 123.689 0.661 . . . . 0.0 113.206 174.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -116.51 40.61 2.86 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.703 1.201 . . . . 0.0 112.205 163.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.1 pp -58.54 -28.39 65.43 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 117.739 2.496 . . . . 0.0 117.739 167.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 59.0 ttt180 -80.78 89.91 5.82 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 124.391 2.043 . . . . 0.0 106.833 164.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.417 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 7.1 m -54.99 -60.05 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 110.097 -3.229 . . . . 0.0 111.307 -165.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 -54.27 43.73 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 119.819 3.266 . . . . 0.0 119.819 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -76.91 105.78 8.19 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 165.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.9 m -73.49 90.63 1.74 Allowed 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 113.912 -1.494 . . . . 0.0 108.784 -172.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.1 tp -66.76 118.18 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 CA-C-O 122.295 1.045 . . . . 0.0 110.312 -171.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.424 ' HA ' ' HB3' ' A' ' 126' ' ' ARG 0.328 3.1 pp -99.41 -51.31 3.82 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 112.424 -2.171 . . . . 0.0 115.046 178.29 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -133.76 140.84 47.21 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 -176.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.7 t -128.87 110.06 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 102.774 -3.047 . . . . 0.0 102.774 -178.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.636 HD22 ' HB3' ' A' ' 140' ' ' ALA 0.295 8.2 m-80 82.26 -79.04 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 123.3 1.524 . . . . 0.0 108.935 178.08 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.41 ' H ' ' H ' ' A' ' 123' ' ' VAL . 5.6 tp10 -154.27 -9.03 0.14 Allowed 'General case' 0 CA--C 1.568 1.668 0 CA-C-N 111.712 -2.495 . . . . 0.0 111.782 171.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.41 ' H ' ' H ' ' A' ' 122' ' ' GLU . 2.4 t -68.17 137.03 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.189 0 CA-C-O 123.492 1.615 . . . . 0.0 109.871 -179.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -86.86 98.11 11.03 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 111.316 -2.675 . . . . 0.0 109.869 177.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . 0.28 2.7 m -108.77 -110.53 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 CA-C-O 116.356 -1.783 . . . . 0.0 107.464 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.471 ' HD3' ' H ' ' A' ' 127' ' ' GLU 0.362 0.0 OUTLIER 53.57 -82.68 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -179.533 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.471 ' H ' ' HD3' ' A' ' 126' ' ' ARG . 19.6 mt-10 -86.28 68.86 10.38 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-O 123.356 1.551 . . . . 0.0 109.308 171.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.6 p -143.06 167.08 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 CA-C-O 123.849 1.785 . . . . 0.0 107.061 -178.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 11.6 m -56.38 129.1 39.09 Favored 'General case' 0 CA--C 1.558 1.257 0 CA-C-N 113.289 -1.778 . . . . 0.0 110.217 157.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -47.94 -31.95 5.84 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 117.701 2.482 . . . . 0.0 117.701 173.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.8 m -59.32 -41.51 89.26 Favored 'General case' 0 CA--C 1.559 1.305 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 172.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -70.51 -36.41 73.76 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 167.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.58 -56.08 23.77 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 170.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.412 ' CG2' HG23 ' B' ' 6' ' ' VAL . 0.5 OUTLIER -55.4 -39.86 54.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 N-CA-C 115.891 1.812 . . . . 0.0 115.891 167.854 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.99 -54.84 33.43 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 115.383 -2.246 . . . . 0.0 111.272 168.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.76 -35.0 73.71 Favored 'General case' 0 CA--C 1.561 1.373 0 N-CA-C 117.565 2.431 . . . . 0.0 117.565 172.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.6 mp -57.74 -49.61 75.98 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 165.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -73.31 -34.94 65.99 Favored 'General case' 0 CA--C 1.564 1.511 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 175.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.19 -28.69 67.48 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 115.921 1.823 . . . . 0.0 115.921 171.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.636 ' HB3' HD22 ' A' ' 121' ' ' ASN . . . -51.62 -36.7 46.9 Favored 'General case' 0 CA--C 1.56 1.339 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 158.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 91.39 -131.68 10.9 Favored Glycine 0 C--N 1.349 1.286 0 CA-C-O 122.488 1.049 . . . . 0.0 110.518 167.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.5 m -76.63 -2.19 31.45 Favored 'General case' 0 CA--C 1.557 1.244 0 N-CA-C 117.148 2.277 . . . . 0.0 117.148 168.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.09 108.18 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 -171.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.46 ' HA ' ' HB1' ' A' ' 140' ' ' ALA . 6.7 t -116.04 116.33 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 113.834 -1.53 . . . . 0.0 107.348 -165.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.401 ' HB2' ' HA ' ' A' ' 121' ' ' ASN . 1.9 mpp_? -93.59 91.66 7.18 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 174.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.413 ' HB2' HG13 ' A' ' 66' ' ' ILE . 78.3 mt -91.45 141.38 28.81 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 176.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -132.86 113.82 13.33 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 103.562 -2.755 . . . . 0.0 103.562 176.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 32.2 m -127.68 139.51 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -165.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 26.1 ptm -95.44 127.56 41.58 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 122.341 1.067 . . . . 0.0 110.427 170.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -101.33 125.42 47.96 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 174.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 30.2 mtp-105 -79.22 66.84 4.78 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.261 168.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -85.61 112.42 44.43 Favored Pre-proline 0 CA--C 1.555 1.167 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 -178.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -74.88 151.44 40.18 Favored 'Trans proline' 0 CA--C 1.566 2.123 0 C-N-CA 122.427 2.085 . . . . 0.0 112.896 176.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo . . . . . 0 CA--C 1.555 1.538 0 C-N-CA 123.858 3.039 . . . . 0.0 116.996 177.906 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 2.8 p90 . . . . . 0 CA--C 1.557 1.234 0 CA-C-O 122.436 1.112 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -120.49 149.46 42.37 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-O 124.162 1.934 . . . . 0.0 108.267 167.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.402 ' HG3' ' CG2' ' A' ' 97' ' ' THR . 0.5 OUTLIER -103.5 130.04 50.79 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 113.434 -1.712 . . . . 0.0 109.001 168.616 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 1.3 m -86.94 147.2 25.86 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 122.456 1.122 . . . . 0.0 109.877 168.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -114.53 113.34 24.29 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -171.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.412 HG23 ' CG2' ' A' ' 134' ' ' VAL . 62.0 t . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 -169.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 . . . . . 0 N--CA 1.479 0.983 0 CA-C-O 121.733 0.778 . . . . 0.0 111.255 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -118.75 138.36 52.72 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 114.117 -1.401 . . . . 0.0 110.865 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -129.19 141.84 51.04 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 123.011 1.386 . . . . 0.0 109.37 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -97.73 121.9 40.18 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 112.905 -1.952 . . . . 0.0 108.559 173.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.428 HG13 ' HB2' ' A' ' 146' ' ' LEU . 8.8 pt -131.46 109.42 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 -172.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.7 m -93.49 124.29 37.39 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 122.337 1.065 . . . . 0.0 108.391 175.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.3 mp -110.33 131.05 55.4 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 113.471 -1.695 . . . . 0.0 107.49 177.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -103.51 114.86 29.46 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -170.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.419 ' HB2' ' HB3' ' A' ' 104' ' ' ALA . 13.9 tpt180 -143.08 -106.64 0.13 Allowed 'General case' 0 CA--C 1.55 0.98 0 O-C-N 121.509 -0.744 . . . . 0.0 112.128 174.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.74 -152.41 23.09 Favored Glycine 0 C--N 1.342 0.904 0 C-N-CA 124.712 1.148 . . . . 0.0 111.954 -166.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . 0.256 16.6 m120 73.19 -92.02 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 114.356 -0.922 . . . . 0.0 110.853 177.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.2 m -103.87 -17.22 15.12 Favored 'General case' 0 CA--C 1.562 1.432 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 175.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 177.17 -139.32 4.32 Favored Glycine 0 CA--C 1.533 1.191 0 N-CA-C 108.293 -1.923 . . . . 0.0 108.293 178.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.404 ' HA ' ' HB3' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -130.87 -38.86 1.25 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 125.486 1.515 . . . . 0.0 111.139 -171.969 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.428 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 102.07 55.19 0.88 Allowed Glycine 0 N--CA 1.464 0.52 0 C-N-CA 124.176 0.893 . . . . 0.0 113.703 166.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -158.92 138.87 12.0 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-O 123.315 1.531 . . . . 0.0 111.152 178.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.0 m -100.0 120.16 39.39 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 122.854 1.311 . . . . 0.0 110.622 176.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.7 pt -95.45 136.09 27.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-N 113.087 -1.87 . . . . 0.0 109.876 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.04 -178.39 6.53 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-O 123.782 1.754 . . . . 0.0 109.698 157.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -103.85 166.46 15.72 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-O 124.059 1.922 . . . . 0.0 116.319 -136.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -99.23 -162.07 29.45 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 111.242 -2.479 . . . . 0.0 112.499 -172.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 45.7 p -51.97 -43.09 63.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 116.517 2.043 . . . . 0.0 116.517 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -83.0 -13.73 55.37 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 116.277 1.954 . . . . 0.0 116.277 173.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.495 HD22 ' H ' ' B' ' 2' ' ' LYS 0.289 9.0 t30 -139.15 55.46 7.48 Favored Pre-proline 0 CA--C 1.565 1.529 0 CA-C-O 117.065 -1.445 . . . . 0.0 107.534 -172.905 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -83.63 132.3 5.7 Favored 'Trans proline' 0 C--N 1.365 1.412 0 CA-C-N 126.051 3.197 . . . . 0.0 112.648 -162.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -99.66 -23.68 14.96 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 166.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.6 mp -92.32 142.98 12.31 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 -157.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -64.31 -1.66 6.03 Favored Glycine 0 CA--C 1.556 2.627 0 N-CA-C 119.435 2.534 . . . . 0.0 119.435 174.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -90.14 -8.57 50.94 Favored 'General case' 0 CA--C 1.568 1.648 0 CA-C-O 117.035 -1.46 . . . . 0.0 114.459 164.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.467 0.3 OUTLIER 89.27 -85.46 0.0 OUTLIER Pre-proline 0 CA--C 1.563 1.48 0 C-N-CA 127.458 2.303 . . . . 0.0 109.815 -170.279 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -114.04 93.76 0.01 OUTLIER 'Trans proline' 0 C--N 1.367 1.527 0 CA-C-N 124.328 2.582 . . . . 0.0 112.141 -160.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.8 m -155.81 130.0 8.78 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 -177.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 15.6 mm -83.32 110.06 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 -177.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.414 ' CZ ' ' HA ' ' A' ' 114' ' ' ASN . 72.7 t80 -130.18 130.83 45.2 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 -167.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.481 ' HB ' ' O ' ' A' ' 113' ' ' VAL 0.298 82.5 mt -81.73 120.11 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.736 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 176.178 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 12.3 t -89.72 -28.88 19.11 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 168.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.7 ptmm? -144.4 161.68 38.4 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-O 122.659 1.219 . . . . 0.0 109.777 172.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.484 ' HB ' HG12 ' A' ' 113' ' ' VAL . 0.2 OUTLIER -123.02 139.27 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 177.791 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.279 1.5 mp -79.14 124.93 84.37 Favored Pre-proline 0 CA--C 1.57 1.743 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.331 -179.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -67.35 146.99 77.07 Favored 'Trans proline' 0 CA--C 1.56 1.79 0 C-N-CA 123.398 2.732 . . . . 0.0 113.107 166.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.451 ' H ' ' CB ' ' A' ' 106' ' ' ALA . . . 85.76 -14.06 53.7 Favored Glycine 0 CA--C 1.548 2.122 0 N-CA-C 117.245 1.658 . . . . 0.0 117.245 -164.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.428 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -96.23 -166.3 33.99 Favored Glycine 0 CA--C 1.539 1.541 0 CA-C-N 118.914 1.357 . . . . 0.0 115.82 177.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.419 ' HB3' ' HB2' ' A' ' 70' ' ' ARG . . . -58.61 -51.19 70.95 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -177.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.48 -38.39 80.7 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 124.573 1.17 . . . . 0.0 114.075 169.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.451 ' CB ' ' H ' ' A' ' 102' ' ' GLY . . . -46.19 -40.14 10.81 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 117.538 2.421 . . . . 0.0 117.538 166.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.403 HE21 ' HB2' ' A' ' 107' ' ' GLN . 0.0 OUTLIER -82.38 -53.17 6.22 Favored 'General case' 0 CA--C 1.568 1.642 0 C-N-CA 123.734 0.813 . . . . 0.0 112.665 173.946 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -79.02 -52.95 7.53 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -172.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -161.9 97.2 0.15 Allowed Glycine 0 CA--C 1.532 1.132 0 N-CA-C 108.369 -1.892 . . . . 0.0 108.369 -178.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.459 ' HA ' HG21 ' A' ' 99' ' ' ILE . 15.7 ptt-85 -85.65 19.3 2.48 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 119.822 3.268 . . . . 0.0 119.822 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.51 -21.7 0.82 Allowed 'General case' 0 CA--C 1.564 1.496 0 C-N-CA 128.003 2.521 . . . . 0.0 111.335 -164.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -78.38 18.73 0.52 Allowed 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 116.232 1.938 . . . . 0.0 116.232 179.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.484 HG12 ' HB ' ' A' ' 99' ' ' ILE 0.25 2.4 m -39.61 -59.36 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 127.665 2.386 . . . . 0.0 110.109 179.379 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.425 ' H ' ' CG2' ' A' ' 113' ' ' VAL . 63.2 m-20 -51.79 37.85 0.0 OUTLIER 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 121.799 3.999 . . . . 0.0 121.799 166.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -102.35 110.67 22.68 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 165.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 65.9 p -67.51 89.32 0.23 Allowed 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 113.408 -1.724 . . . . 0.0 111.147 169.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.414 HD12 HD12 ' A' ' 137' ' ' LEU . 27.6 pt -74.27 101.19 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 123.683 1.706 . . . . 0.0 108.854 -176.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.422 ' HA ' ' HB3' ' A' ' 126' ' ' ARG . 1.4 pp -79.95 -39.1 30.9 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 112.58 -2.1 . . . . 0.0 115.578 177.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -132.89 150.46 52.16 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 175.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.4 p -131.2 124.11 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 172.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.573 HD22 ' HB1' ' A' ' 140' ' ' ALA 0.272 31.0 m-80 78.77 -70.2 0.11 Allowed 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 123.26 1.505 . . . . 0.0 111.554 -178.039 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -177.93 -10.65 0.01 OUTLIER 'General case' 0 CA--C 1.583 2.213 0 C-N-CA 129.229 3.011 . . . . 0.0 109.391 -177.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.1 t -64.67 137.89 24.11 Favored 'Isoleucine or valine' 0 C--N 1.364 1.204 0 C-N-CA 125.801 1.641 . . . . 0.0 109.987 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -82.04 94.15 7.13 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 112.545 -2.116 . . . . 0.0 109.979 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . 0.339 0.8 OUTLIER -110.5 -112.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 CA-C-O 117.546 -1.216 . . . . 0.0 108.593 179.781 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.563 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.315 17.3 ptt180 55.15 -86.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 -174.982 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.563 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 32.9 mt-10 -82.06 69.47 8.78 Favored 'General case' 0 CA--C 1.555 1.156 0 CA-C-O 123.92 1.819 . . . . 0.0 109.986 172.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.7 m -137.0 166.34 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 112.627 -2.079 . . . . 0.0 105.677 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 25.8 p -55.83 135.69 51.76 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 113.12 -1.855 . . . . 0.0 111.301 149.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -50.04 -29.8 9.48 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 116.66 2.096 . . . . 0.0 116.66 167.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.1 m -57.09 -56.05 26.81 Favored 'General case' 0 CA--C 1.559 1.315 0 C-N-CA 124.432 1.093 . . . . 0.0 112.348 169.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -57.5 -38.7 75.04 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 173.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -62.15 -55.78 25.35 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 115.883 1.809 . . . . 0.0 115.883 166.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.7 p -57.74 -40.37 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 176.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -61.36 -44.38 97.26 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 116.657 -1.639 . . . . 0.0 112.999 168.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.59 -31.84 73.23 Favored 'General case' 0 CA--C 1.563 1.48 0 N-CA-C 117.628 2.455 . . . . 0.0 117.628 169.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.414 HD12 HD12 ' A' ' 117' ' ' ILE . 6.5 mp -60.07 -48.76 80.38 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 125.752 1.621 . . . . 0.0 113.29 166.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -69.67 -32.83 71.69 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 168.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -67.71 -22.83 65.24 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 116.278 1.955 . . . . 0.0 116.278 171.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.573 ' HB1' HD22 ' A' ' 121' ' ' ASN . . . -51.9 -27.73 13.86 Favored 'General case' 0 CA--C 1.555 1.155 0 N-CA-C 118.072 2.619 . . . . 0.0 118.072 157.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 97.08 -116.15 5.43 Favored Glycine 0 C--N 1.344 1.025 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 166.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.6 m -92.5 1.27 57.34 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 116.413 2.005 . . . . 0.0 116.413 166.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.37 102.1 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 -171.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 1.4 m -85.09 116.33 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-N 113.72 -1.582 . . . . 0.0 109.821 173.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 31.8 mtp180 -100.79 87.79 3.41 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 122.443 1.116 . . . . 0.0 108.103 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.428 ' HB2' HG13 ' A' ' 66' ' ' ILE . 32.6 mt -87.5 133.94 33.69 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -170.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -118.9 119.57 34.74 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.4 p -127.05 121.65 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -176.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 52.3 ttm -100.47 136.25 40.65 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 122.816 1.293 . . . . 0.0 110.286 163.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 14.7 mmt180 -94.64 113.47 25.28 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 112.83 -1.987 . . . . 0.0 106.847 172.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 24.2 ttt180 -58.74 -55.3 36.88 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.478 157.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.416 ' HZ1' ' HB3' ' A' ' 152' ' ' LYS . 9.6 mtpm? -97.89 123.78 50.25 Favored Pre-proline 0 CA--C 1.551 1.013 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -175.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.13 136.33 74.18 Favored 'Trans proline' 0 CA--C 1.565 2.058 0 C-N-CA 122.909 2.406 . . . . 0.0 114.271 178.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo . . . . . 0 CA--C 1.553 1.474 0 C-N-CA 123.042 2.495 . . . . 0.0 113.01 179.033 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 1.1 p90 . . . . . 0 CA--C 1.555 1.17 0 CA-C-O 122.02 0.914 . . . . 0.0 111.352 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.495 ' H ' HD22 ' A' ' 85' ' ' ASN . 4.6 mptp? -138.81 145.54 40.23 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 113.401 -1.727 . . . . 0.0 108.4 172.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 7.4 ttpp -100.0 111.25 23.56 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 114.109 -1.405 . . . . 0.0 107.878 175.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 87.3 m -89.79 131.18 35.87 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 114.565 -1.198 . . . . 0.0 108.864 175.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.66 147.02 35.74 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 113.724 -1.58 . . . . 0.0 109.199 173.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.256 1.402 0 CA-C-N 113.652 -1.613 . . . . 0.0 109.836 172.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 N--CA 1.483 1.209 0 CA-C-O 121.902 0.858 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.418 ' HB3' ' HB2' ' A' ' 149' ' ' MET . 32.4 p90 -107.08 138.1 43.89 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 114.22 -1.355 . . . . 0.0 110.65 176.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -115.61 129.81 56.64 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.055 175.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -88.47 127.15 35.51 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 113.679 -1.6 . . . . 0.0 110.944 175.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 20.8 mm -130.73 126.7 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 -177.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.6 m -88.9 132.79 34.53 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-O 123.561 1.648 . . . . 0.0 108.175 167.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.6 tp -136.01 150.17 49.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 112.263 -2.244 . . . . 0.0 107.931 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -80.11 140.42 36.43 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 122.065 0.936 . . . . 0.0 110.419 173.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.668 ' HD2' ' H ' ' A' ' 142' ' ' SER . 2.4 tmt_? -92.52 114.72 27.34 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 172.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.72 116.02 8.69 Favored Glycine 0 CA--C 1.541 1.706 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.318 164.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -61.5 -42.17 98.4 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 -168.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 57.1 m -83.55 -17.1 42.96 Favored 'General case' 0 CA--C 1.564 1.496 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 167.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -179.29 126.01 1.02 Allowed Glycine 0 C--N 1.343 0.936 0 N-CA-C 108.177 -1.969 . . . . 0.0 108.177 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.6 mp -66.76 -74.73 0.11 Allowed 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.698 0.799 . . . . 0.0 108.944 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.417 ' HA3' ' CA ' ' A' ' 103' ' ' GLY . . . 120.41 45.07 0.41 Allowed Glycine 0 CA--C 1.535 1.307 0 C-N-CA 124.476 1.036 . . . . 0.0 115.408 178.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -157.2 138.89 14.09 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 123.4 1.571 . . . . 0.0 109.472 -178.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.6 m -106.67 113.8 27.51 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.431 -1.259 . . . . 0.0 112.395 -166.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.1 pt -92.39 123.58 44.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.041 -175.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -83.34 -170.86 3.26 Favored 'General case' 0 CA--C 1.557 1.24 0 CA-C-O 123.5 1.619 . . . . 0.0 110.043 159.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.72 160.65 23.48 Favored Glycine 0 CA--C 1.539 1.54 0 CA-C-O 123.715 1.73 . . . . 0.0 117.126 -138.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -109.62 -161.47 19.14 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-N 111.289 -2.456 . . . . 0.0 114.251 178.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 43.1 p -54.26 -41.87 69.31 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 117.222 2.304 . . . . 0.0 117.222 178.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -81.44 -19.28 42.77 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 116.371 1.989 . . . . 0.0 116.371 172.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -141.27 84.04 13.09 Favored Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 102.587 -3.116 . . . . 0.0 102.587 -171.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -99.27 123.1 0.13 Allowed 'Trans proline' 0 CA--C 1.548 1.221 0 CA-C-N 124.385 2.602 . . . . 0.0 109.733 -175.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 39.1 t-80 -74.89 -29.1 60.89 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 162.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -109.84 172.28 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 C-N-CA 126.248 1.819 . . . . 0.0 109.93 -178.213 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.15 -109.77 0.01 OUTLIER Glycine 0 CA--C 1.543 1.796 0 N-CA-C 115.98 1.152 . . . . 0.0 115.98 -176.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -99.65 24.21 8.57 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -173.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.47 75.03 8.79 Favored Pre-proline 0 CA--C 1.549 0.94 0 CA-C-N 119.312 0.96 . . . . 0.0 110.49 169.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -63.96 104.3 0.47 Allowed 'Trans proline' 0 C--N 1.369 1.632 0 C-N-CA 122.97 2.447 . . . . 0.0 112.791 171.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 63.0 m -160.5 124.79 3.65 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 -176.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.433 HG13 ' HB3' ' A' ' 133' ' ' ALA . 11.1 mm -69.86 131.94 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -170.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.417 ' HB2' ' O ' ' A' ' 115' ' ' ASP . 21.2 p90 -140.38 128.82 22.68 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.405 -1.271 . . . . 0.0 108.297 -168.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.417 ' HB ' ' CB ' ' A' ' 114' ' ' ASN . 70.2 mt -85.25 112.02 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 173.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 23.2 m -85.86 -28.56 24.34 Favored 'General case' 0 CA--C 1.556 1.199 0 CA-C-N 113.667 -1.606 . . . . 0.0 113.191 169.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -134.73 159.01 42.64 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 123.486 1.613 . . . . 0.0 111.203 -173.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -120.57 124.79 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 103.316 -2.846 . . . . 0.0 103.316 177.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.287 1.2 mp -66.51 130.72 94.14 Favored Pre-proline 0 CA--C 1.573 1.854 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.304 170.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.94 132.09 40.44 Favored 'Trans proline' 0 CA--C 1.554 1.493 0 C-N-CA 123.432 2.754 . . . . 0.0 114.156 173.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.46 14.17 82.77 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 117.249 1.66 . . . . 0.0 117.249 -163.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.417 ' CA ' ' HA3' ' A' ' 76' ' ' GLY . . . -89.92 171.07 37.03 Favored Glycine 0 C--N 1.337 0.638 0 CA-C-O 122.672 1.151 . . . . 0.0 114.388 -177.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.62 -38.0 70.84 Favored 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -172.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.28 -38.71 88.42 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 172.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.86 -42.71 76.71 Favored 'General case' 0 CA--C 1.562 1.421 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 170.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -72.54 -52.12 17.0 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.202 1.001 . . . . 0.0 113.685 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -69.0 -50.01 52.67 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.512 1.125 . . . . 0.0 112.351 -176.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.04 -146.48 5.14 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 124.657 2.254 . . . . 0.0 111.373 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.401 ' C ' ' H ' ' A' ' 112' ' ' ARG . 0.0 OUTLIER -160.71 26.91 0.15 Allowed 'General case' 0 CA--C 1.567 1.622 0 CA-C-N 110.478 -2.861 . . . . 0.0 111.71 -172.334 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.564 HD12 ' H ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -76.0 31.38 0.11 Allowed 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 126.127 1.771 . . . . 0.0 114.238 177.9 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.401 ' H ' ' C ' ' A' ' 110' ' ' ARG 0.308 67.0 mtp180 71.7 -178.63 0.21 Allowed 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 126.082 2.848 . . . . 0.0 111.108 -167.926 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.411 HG23 ' H ' ' A' ' 114' ' ' ASN 0.374 17.2 m -25.03 -69.48 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.581 0 CA-C-N 110.534 -3.03 . . . . 0.0 114.406 146.822 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.417 ' CB ' ' HB ' ' A' ' 96' ' ' ILE . 8.6 t-20 172.38 -33.1 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 129.142 2.977 . . . . 0.0 106.685 168.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.423 ' CG ' ' HE ' ' A' ' 150' ' ' ARG 0.289 35.1 t70 81.87 -70.38 0.07 Allowed 'General case' 0 C--N 1.354 0.792 0 C-N-CA 126.053 1.741 . . . . 0.0 111.258 -177.434 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 45.4 m -155.78 77.57 0.97 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 -170.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.0 tp -66.65 124.39 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-O 121.667 0.746 . . . . 0.0 109.261 171.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.436 ' HA ' ' HB3' ' A' ' 126' ' ' ARG 0.259 0.8 OUTLIER -108.38 -43.97 4.21 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 174.699 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -129.85 133.68 47.07 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 104.786 -2.302 . . . . 0.0 104.786 177.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.7 p -123.76 123.49 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 174.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . 0.32 32.7 m-80 80.77 -72.2 0.06 Allowed 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 123.954 1.835 . . . . 0.0 110.37 -175.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.414 ' H ' ' H ' ' A' ' 123' ' ' VAL . 6.3 tp10 -177.11 -17.57 0.01 OUTLIER 'General case' 0 CA--C 1.576 1.959 0 C-N-CA 129.006 2.923 . . . . 0.0 109.247 -173.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.414 ' H ' ' H ' ' A' ' 122' ' ' GLU . 2.2 t -64.9 135.56 28.02 Favored 'Isoleucine or valine' 0 C--N 1.363 1.173 0 C-N-CA 125.69 1.596 . . . . 0.0 110.131 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -78.84 86.41 4.75 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 111.131 -2.759 . . . . 0.0 111.226 173.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -94.99 -105.12 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 176.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.619 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.285 14.0 ptt85 47.42 -98.68 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.674 1.189 . . . . 0.0 113.85 -176.549 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.619 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 1.5 tt0 -71.46 72.95 0.72 Allowed 'General case' 0 CA--C 1.555 1.146 0 CA-C-O 124.227 1.965 . . . . 0.0 111.885 168.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.7 p -147.34 167.41 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 CA-C-N 112.141 -2.299 . . . . 0.0 105.153 -174.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 34.9 p -57.2 130.85 48.01 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 112.579 -2.1 . . . . 0.0 112.051 156.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -48.16 -33.1 7.86 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 116.845 2.165 . . . . 0.0 116.845 168.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 13.2 m -63.61 -38.94 93.04 Favored 'General case' 0 CA--C 1.559 1.301 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 172.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.11 -32.93 73.58 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 167.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.433 ' HB3' HG13 ' A' ' 94' ' ' ILE . . . -73.18 -47.81 40.57 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 171.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.434 HG23 HG21 ' B' ' 4' ' ' THR . 11.3 p -52.07 -44.82 40.54 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.532 0 CA-C-N 120.47 1.486 . . . . 0.0 113.87 162.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -53.98 -52.02 62.05 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-O 115.989 -1.958 . . . . 0.0 112.23 170.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.24 -29.86 68.78 Favored 'General case' 0 CA--C 1.558 1.266 0 N-CA-C 118.108 2.633 . . . . 0.0 118.108 175.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 7.0 mp -55.49 -52.88 62.2 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.161 1.384 . . . . 0.0 112.821 162.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -69.33 -41.24 76.93 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 171.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -66.86 -4.65 9.83 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 116.524 2.046 . . . . 0.0 116.524 169.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -52.0 -36.08 48.68 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 117.018 2.229 . . . . 0.0 117.018 158.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 64.97 79.01 0.19 Allowed Glycine 0 C--N 1.348 1.233 0 O-C-N 123.849 0.718 . . . . 0.0 113.115 163.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.668 ' H ' ' HD2' ' A' ' 70' ' ' ARG 0.267 15.7 m 73.81 -27.08 0.19 Allowed 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 117.561 2.43 . . . . 0.0 117.561 -172.937 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -145.88 107.98 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -171.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 1.6 t -91.14 115.16 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 125.846 1.658 . . . . 0.0 107.324 175.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 5.2 ttp180 -97.3 100.16 11.61 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 172.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 36.8 mt -90.75 142.41 27.79 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.532 -175.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -131.17 113.57 14.04 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 173.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.72 123.73 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -175.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.418 ' HB2' ' HB3' ' A' ' 63' ' ' TYR . 25.7 ttt -111.12 134.2 52.9 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 124.366 1.041 . . . . 0.0 111.208 165.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.423 ' HE ' ' CG ' ' A' ' 115' ' ' ASP . 22.6 mtp180 -93.22 136.6 33.33 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.046 -1.433 . . . . 0.0 109.6 169.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -87.06 122.16 30.51 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 113.954 -1.475 . . . . 0.0 109.513 -179.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -63.99 -55.19 34.43 Favored Pre-proline 0 N--CA 1.486 1.33 0 CA-C-O 115.311 -2.281 . . . . 0.0 112.756 170.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -63.45 123.92 12.9 Favored 'Trans proline' 0 CA--C 1.568 2.178 0 CA-C-N 124.16 2.521 . . . . 0.0 112.163 173.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo . . . . . 0 C--N 1.366 1.462 0 C-N-CA 123.11 2.54 . . . . 0.0 112.874 -179.271 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.561 1.367 0 CA-C-O 123.699 1.714 . . . . 0.0 110.835 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -161.6 123.0 2.81 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 172.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -82.17 122.94 28.52 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 114.201 -1.363 . . . . 0.0 109.054 175.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.434 HG21 HG23 ' A' ' 134' ' ' VAL . 2.9 m -81.91 127.3 32.88 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 122.177 0.989 . . . . 0.0 108.389 170.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.0 103.53 16.24 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 9.5 t . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -169.53 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 . . . . . 0 N--CA 1.485 1.306 0 CA-C-O 121.66 0.743 . . . . 0.0 112.289 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -111.65 136.1 51.34 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 114.3 -1.318 . . . . 0.0 111.04 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -102.26 138.46 39.17 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.14 176.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -107.07 125.41 51.01 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.455 HG12 ' HB2' ' A' ' 146' ' ' LEU . 0.1 OUTLIER -141.72 111.69 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 -174.501 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 86.3 m -84.67 129.81 34.79 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 122.224 1.012 . . . . 0.0 108.352 170.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 105' ' ' ALA . 0.9 OUTLIER -137.62 128.14 26.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 113.317 -1.765 . . . . 0.0 107.085 -176.189 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -72.32 130.69 41.34 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 121.943 -0.473 . . . . 0.0 110.303 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 27.8 ttt-85 -75.21 123.81 25.95 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 173.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -64.96 155.52 48.53 Favored Glycine 0 CA--C 1.539 1.576 0 CA-C-N 113.968 -1.469 . . . . 0.0 112.78 171.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 57.7 m-80 -64.14 -51.94 61.47 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 113.512 -1.344 . . . . 0.0 113.233 -176.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 45.9 m -99.66 -16.56 18.15 Favored 'General case' 0 CA--C 1.561 1.403 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 175.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -154.38 119.85 0.97 Allowed Glycine 0 C--N 1.349 1.254 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.7 tt -63.02 -34.72 78.16 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 167.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.28 41.69 2.35 Favored Glycine 0 N--CA 1.475 1.259 0 O-C-N 120.434 -1.416 . . . . 0.0 116.376 168.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -151.76 165.95 32.85 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 122.643 1.211 . . . . 0.0 110.883 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.32 121.75 20.52 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 168.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 96' ' ' ILE . 6.4 pt -90.97 133.69 31.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 113.331 -1.758 . . . . 0.0 111.006 -177.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.36 -174.81 4.77 Favored 'General case' 0 CA--C 1.558 1.274 0 CA-C-O 123.258 1.504 . . . . 0.0 110.055 158.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -96.18 159.45 21.98 Favored Glycine 0 CA--C 1.539 1.568 0 CA-C-O 123.2 1.444 . . . . 0.0 116.059 -144.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -108.35 -164.19 20.99 Favored Glycine 0 N--CA 1.47 0.933 0 CA-C-N 112.276 -1.962 . . . . 0.0 112.226 -176.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 43.5 p -50.49 -39.11 47.5 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 118.355 2.724 . . . . 0.0 118.355 -177.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -73.8 -23.87 59.74 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 171.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -139.37 74.89 34.15 Favored Pre-proline 0 CA--C 1.567 1.622 0 N-CA-C 104.209 -2.515 . . . . 0.0 104.209 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -107.98 115.59 0.03 OUTLIER 'Trans proline' 0 C--N 1.364 1.386 0 CA-C-N 125.26 2.914 . . . . 0.0 111.092 -164.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -107.45 -43.97 4.41 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.546 HD13 ' H ' ' A' ' 88' ' ' ILE . 0.8 OUTLIER -105.95 140.94 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -147.774 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.94 -111.58 3.49 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.766 170.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -80.46 -4.59 54.34 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 169.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.457 33.4 m-20 103.32 -80.75 0.0 OUTLIER Pre-proline 0 CA--C 1.562 1.418 0 C-N-CA 126.561 1.944 . . . . 0.0 107.77 -172.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -94.15 89.01 0.13 Allowed 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 123.676 2.917 . . . . 0.0 112.533 -168.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 58.7 m -158.61 140.15 13.46 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 177.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 21.7 mm -81.46 130.07 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 -177.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.424 ' HA ' ' O ' ' A' ' 115' ' ' ASP . 40.4 m-85 -119.4 149.82 41.21 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 113.484 -1.689 . . . . 0.0 110.509 175.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 79' ' ' ILE . 72.6 mt -106.06 114.55 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 104.381 -2.451 . . . . 0.0 104.381 148.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.9 t -98.74 -6.38 29.58 Favored 'General case' 0 CA--C 1.564 1.496 0 N-CA-C 115.386 1.625 . . . . 0.0 115.386 168.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -141.82 147.51 37.35 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-O 123.774 1.75 . . . . 0.0 108.963 -177.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.33 123.55 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 N-CA-C 103.224 -2.88 . . . . 0.0 103.224 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.368 1.2 mp -66.26 117.4 42.93 Favored Pre-proline 0 CA--C 1.566 1.567 0 CA-C-O 118.186 -0.912 . . . . 0.0 109.248 171.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -69.33 142.29 49.4 Favored 'Trans proline' 0 C--N 1.367 1.534 0 C-N-CA 123.224 2.616 . . . . 0.0 112.496 174.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.53 -6.05 19.1 Favored Glycine 0 CA--C 1.549 2.216 0 N-CA-C 117.772 1.869 . . . . 0.0 117.772 -168.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -83.67 -171.63 47.9 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-O 123.409 1.561 . . . . 0.0 112.157 175.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.75 -41.87 82.7 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 -173.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.406 ' HA ' HD13 ' A' ' 68' ' ' LEU . . . -67.59 -26.41 66.26 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 119.719 3.229 . . . . 0.0 119.719 178.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -60.97 -46.03 92.39 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 166.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.56 -55.25 6.55 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 124.548 1.139 . . . . 0.0 113.082 174.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -60.09 -43.59 95.4 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.959 0.904 . . . . 0.0 112.015 -177.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 59.65 66.85 2.48 Favored Glycine 0 C--N 1.353 1.499 0 O-C-N 124.022 0.826 . . . . 0.0 112.979 164.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -106.61 -38.23 6.2 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 113.768 -1.216 . . . . 0.0 112.54 -174.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -143.34 -163.15 1.58 Allowed 'General case' 0 CA--C 1.553 1.077 0 CA-C-O 124.819 2.247 . . . . 0.0 107.058 -173.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.424 ' HB3' ' H ' ' A' ' 113' ' ' VAL 0.266 6.0 mmt180 -75.1 -148.58 0.02 OUTLIER 'General case' 0 CA--C 1.559 1.301 0 CA-C-O 124.503 2.097 . . . . 0.0 111.968 164.561 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.466 HG21 ' H ' ' A' ' 114' ' ' ASN 0.294 30.4 m -37.72 -67.91 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.737 0 CA-C-N 112.696 -2.047 . . . . 0.0 112.326 150.452 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.466 ' H ' HG21 ' A' ' 113' ' ' VAL 0.311 0.6 OUTLIER 159.31 -39.32 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 128.077 2.551 . . . . 0.0 107.864 179.728 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.424 ' O ' ' HA ' ' A' ' 95' ' ' PHE 0.296 15.3 t70 67.72 -102.77 0.07 Allowed 'General case' 0 C--O 1.213 -0.839 0 C-N-CA 126.246 1.818 . . . . 0.0 106.737 178.65 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 66.8 m -100.8 69.41 1.35 Allowed 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.061 1.301 . . . . 0.0 110.424 -173.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 18.0 tt -67.7 124.18 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 CA-C-O 122.1 0.952 . . . . 0.0 109.47 174.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.432 HD23 ' HB3' ' A' ' 149' ' ' MET . 0.0 OUTLIER -117.25 -47.23 2.67 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 113.525 -1.671 . . . . 0.0 114.824 -179.882 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -119.68 141.04 49.73 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.1 t -129.75 110.73 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 102.165 -3.272 . . . . 0.0 102.165 177.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.58 HD22 ' HB3' ' A' ' 140' ' ' ALA 0.32 20.7 m-80 83.21 -83.2 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 123.649 1.69 . . . . 0.0 108.712 178.681 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -153.08 -16.05 0.15 Allowed 'General case' 0 CA--C 1.571 1.781 0 CA-C-N 110.539 -3.028 . . . . 0.0 110.48 178.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.1 t -62.6 136.92 25.16 Favored 'Isoleucine or valine' 0 C--N 1.363 1.156 0 C-N-CA 125.118 1.367 . . . . 0.0 110.088 173.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -100.87 96.91 7.6 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 111.891 -2.413 . . . . 0.0 108.408 178.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . 0.257 0.2 OUTLIER -96.02 -100.35 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 CA-C-O 116.44 -1.743 . . . . 0.0 107.588 179.378 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.498 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.34 29.0 ptt180 50.94 -84.34 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 116.666 2.099 . . . . 0.0 116.666 -177.802 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.498 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 1.9 mt-10 -79.13 69.5 5.33 Favored 'General case' 0 CA--C 1.557 1.226 0 CA-C-O 123.811 1.767 . . . . 0.0 110.486 168.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -147.76 168.57 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 -178.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 28.2 m -60.71 133.67 56.32 Favored 'General case' 0 CA--C 1.562 1.417 0 CA-C-N 114.262 -1.335 . . . . 0.0 110.529 158.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -46.05 -33.86 3.71 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 118.024 2.602 . . . . 0.0 118.024 168.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.6 m -60.84 -38.26 84.87 Favored 'General case' 0 CA--C 1.559 1.316 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 173.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -70.78 -33.3 70.62 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 116.217 1.932 . . . . 0.0 116.217 167.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -74.48 -43.4 56.23 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 172.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.3 p -55.69 -42.41 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 159.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -60.44 -46.36 90.33 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 116.097 -1.906 . . . . 0.0 113.27 170.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.05 -31.66 70.19 Favored 'General case' 0 CA--C 1.559 1.306 0 N-CA-C 116.951 2.204 . . . . 0.0 116.951 173.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 46.7 mt -58.94 -47.89 83.45 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 163.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -65.2 -44.76 87.3 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 168.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -64.03 -17.75 63.66 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 116.533 2.049 . . . . 0.0 116.533 174.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.58 ' HB3' HD22 ' A' ' 121' ' ' ASN . . . -53.5 -20.16 4.55 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 119.667 3.21 . . . . 0.0 119.667 160.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 91.45 -125.93 8.23 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 173.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 39.0 m -90.9 1.59 56.87 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 167.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -150.1 110.74 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -165.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.436 ' HA ' ' HB1' ' A' ' 140' ' ' ALA . 3.3 t -102.9 115.86 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 113.481 -1.69 . . . . 0.0 107.863 -172.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.4 ' HB2' ' HA ' ' A' ' 121' ' ' ASN . 78.4 mtt180 -96.91 101.28 12.83 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 175.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.455 ' HB2' HG12 ' A' ' 66' ' ' ILE . 14.0 mt -95.76 137.35 34.95 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -173.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -125.19 126.1 44.69 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -131.24 122.23 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 177.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.432 ' HB3' HD23 ' A' ' 118' ' ' LEU . 28.3 ttt -114.3 125.65 54.13 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 171.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -94.47 115.4 27.58 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 113.891 -1.504 . . . . 0.0 107.266 -177.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.93 153.46 8.65 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.952 166.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.22 123.66 89.36 Favored Pre-proline 0 CA--C 1.553 1.094 0 CA-C-O 117.489 -1.243 . . . . 0.0 109.253 -178.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.57 120.56 8.03 Favored 'Trans proline' 0 CA--C 1.565 2.033 0 C-N-CA 123.462 2.775 . . . . 0.0 113.67 -176.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo . . . . . 0 C--N 1.367 1.502 0 C-N-CA 123.027 2.485 . . . . 0.0 113.156 -176.086 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 2.7 p90 . . . . . 0 CA--C 1.55 0.974 0 CA-C-O 121.399 0.619 . . . . 0.0 110.352 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -130.02 146.89 51.72 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 123.538 1.637 . . . . 0.0 110.418 175.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 10.7 ttpp -107.82 113.7 27.13 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 113.222 -1.808 . . . . 0.0 108.1 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 43.6 m -84.81 137.35 33.23 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 122.029 0.918 . . . . 0.0 109.84 173.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.39 153.91 22.2 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-O 122.711 1.243 . . . . 0.0 110.146 176.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 4.2 p . . . . . 0 C--O 1.25 1.09 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 -171.406 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -128.72 139.41 52.23 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-O 122.708 1.242 . . . . 0.0 109.674 178.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -104.0 134.71 46.82 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 113.52 -1.673 . . . . 0.0 106.883 -176.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -105.26 118.7 37.22 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 -174.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.5 pt -136.58 104.27 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 N-CA-C 106.39 -1.708 . . . . 0.0 106.39 -168.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.2 m -98.98 126.23 44.63 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 173.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.79 142.38 51.32 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.112 178.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -86.73 99.22 11.61 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 121.446 -0.784 . . . . 0.0 110.795 -177.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -177.54 178.18 1.06 Allowed 'General case' 0 CA--C 1.558 1.288 0 CA-C-O 122.518 1.152 . . . . 0.0 111.874 -178.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 129.33 -159.12 22.32 Favored Glycine 0 N--CA 1.463 0.441 0 N-CA-C 107.958 -2.057 . . . . 0.0 107.958 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . 0.273 19.6 t-20 75.85 -90.64 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.165 0 CA-C-N 112.024 -2.088 . . . . 0.0 108.821 173.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 67.9 m -107.08 -17.85 14.06 Favored 'General case' 0 CA--C 1.56 1.358 0 CA-C-N 113.594 -1.639 . . . . 0.0 114.512 176.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -162.24 128.75 1.94 Allowed Glycine 0 C--N 1.348 1.217 0 CA-C-O 123.228 1.46 . . . . 0.0 110.429 -174.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.9 mp -106.76 -65.82 1.06 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 112.122 -2.039 . . . . 0.0 107.597 176.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.48 37.58 3.24 Favored Glycine 0 CA--C 1.532 1.121 0 N-CA-C 116.455 1.342 . . . . 0.0 116.455 -172.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -148.17 159.41 43.98 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-O 124.192 1.949 . . . . 0.0 107.254 168.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.417 ' HG ' ' C ' ' B' ' 7' ' ' BAL . 8.7 m -100.81 155.3 18.0 Favored 'General case' 0 C--N 1.313 -1.013 0 O-C-N 120.459 -1.401 . . . . 0.0 110.717 177.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.4 pt -129.09 132.65 66.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.572 174.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -91.15 -170.43 2.65 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-O 124.249 1.976 . . . . 0.0 108.477 163.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.33 160.18 22.8 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-N 113.12 -1.855 . . . . 0.0 114.915 -142.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -108.45 -158.55 19.47 Favored Glycine 0 CA--C 1.52 0.4 0 CA-C-N 111.542 -2.329 . . . . 0.0 111.852 -175.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 42.2 p -54.73 -39.76 68.57 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 117.627 2.454 . . . . 0.0 117.627 -176.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -73.85 -24.87 59.82 Favored 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 116.268 1.951 . . . . 0.0 116.268 170.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.454 HD21 ' CE1' ' A' ' 130' ' ' HIS . 0.2 OUTLIER -139.97 82.3 17.64 Favored Pre-proline 0 CA--C 1.556 1.177 0 N-CA-C 103.111 -2.922 . . . . 0.0 103.111 -176.119 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -107.5 118.24 0.03 OUTLIER 'Trans proline' 0 CA--C 1.548 1.224 0 CA-C-N 125.165 2.88 . . . . 0.0 111.288 -169.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -106.28 -38.71 6.15 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.549 HD13 ' H ' ' A' ' 88' ' ' ILE . 0.6 OUTLIER -115.19 133.09 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 -147.795 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.75 -109.47 2.86 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-N 115.021 -0.991 . . . . 0.0 112.959 167.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -76.78 -9.25 58.55 Favored 'General case' 0 CA--C 1.562 1.406 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 171.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.455 5.5 m-20 101.68 -84.53 0.0 OUTLIER Pre-proline 0 CA--C 1.566 1.575 0 C-N-CA 126.102 1.761 . . . . 0.0 107.617 -176.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -92.47 80.77 0.29 Allowed 'Trans proline' 0 C--N 1.367 1.522 0 C-N-CA 123.859 3.039 . . . . 0.0 112.948 -165.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 73.1 m -157.24 134.68 10.55 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 104.4 -2.444 . . . . 0.0 104.4 -177.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 14.0 mm -76.92 121.5 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 -176.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -113.61 151.18 32.05 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 113.714 -1.584 . . . . 0.0 107.492 176.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.434 ' HB ' ' O ' ' A' ' 113' ' ' VAL 0.29 3.4 mt -93.95 122.77 45.7 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.499 0 N-CA-C 105.094 -2.188 . . . . 0.0 105.094 166.147 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.5 m -78.98 -54.95 5.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.934 -1.104 . . . . 0.0 112.778 179.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.419 ' HA ' HG22 ' A' ' 113' ' ' VAL . 36.2 mtpt -147.79 162.92 38.24 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 124.27 1.986 . . . . 0.0 111.138 -164.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.88 104.71 17.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 1 N-CA-C 99.742 -4.17 . . . . 0.0 99.742 -170.449 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.283 1.3 mp -65.41 118.75 53.55 Favored Pre-proline 0 CA--C 1.566 1.572 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -176.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -61.19 134.16 50.84 Favored 'Trans proline' 0 C--N 1.364 1.346 0 C-N-CA 122.997 2.465 . . . . 0.0 112.993 173.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.67 -4.81 85.26 Favored Glycine 0 CA--C 1.544 1.874 0 N-CA-C 118.22 2.048 . . . . 0.0 118.22 -172.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -90.23 -173.07 44.83 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-O 123.499 1.61 . . . . 0.0 113.116 174.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.53 -34.52 72.38 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 116.363 1.986 . . . . 0.0 116.363 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -53.11 -42.43 65.98 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 120.126 1.33 . . . . 0.0 114.184 163.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.55 -40.73 65.77 Favored 'General case' 0 CA--C 1.562 1.426 0 N-CA-C 116.305 1.965 . . . . 0.0 116.305 174.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.32 -53.47 14.11 Favored 'General case' 0 CA--C 1.561 1.368 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 174.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -94.78 -28.68 15.15 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -167.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.33 86.63 0.09 OUTLIER Glycine 0 CA--C 1.532 1.129 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 176.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 29.1 ttm105 -89.73 69.57 7.69 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 122.057 0.932 . . . . 0.0 110.818 -175.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -162.35 -178.23 6.17 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 121.609 0.719 . . . . 0.0 110.294 -177.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 30.8 ptt180 50.81 26.83 2.77 Favored 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 118.891 2.922 . . . . 0.0 118.891 154.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.434 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 0.4 OUTLIER -47.98 -59.13 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-O 114.795 -2.526 . . . . 0.0 112.02 -179.803 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -43.58 71.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 117.88 2.548 . . . . 0.0 117.88 164.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.46 ' HA ' HH22 ' A' ' 150' ' ' ARG . 16.1 m-20 -142.51 118.16 10.41 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 102.001 -3.333 . . . . 0.0 102.001 -171.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 12.8 m -73.82 86.85 1.73 Allowed 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 113.772 -1.558 . . . . 0.0 110.215 -170.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.3 tp -63.35 116.06 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 CA-C-O 122.11 0.957 . . . . 0.0 110.038 -176.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.1 pp -96.64 -48.04 5.67 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 112.809 -1.996 . . . . 0.0 114.001 174.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -135.42 128.22 31.13 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 -175.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 5.5 p -121.72 122.26 66.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 172.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.445 HD22 ' HB2' ' A' ' 140' ' ' ALA 0.27 45.6 m-80 79.37 -65.3 0.2 Allowed 'General case' 0 N--CA 1.503 2.198 0 CA-C-O 122.818 1.294 . . . . 0.0 111.558 -173.507 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 176.52 -25.28 0.0 OUTLIER 'General case' 0 CA--C 1.573 1.842 0 C-N-CA 128.408 2.683 . . . . 0.0 110.174 -162.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.1 t -70.04 135.83 27.39 Favored 'Isoleucine or valine' 0 C--N 1.361 1.085 0 C-N-CA 125.148 1.379 . . . . 0.0 109.409 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -88.21 100.0 12.64 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 113.209 -1.814 . . . . 0.0 109.841 176.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . 0.251 3.3 m -94.79 -119.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 CA-C-O 116.959 -1.496 . . . . 0.0 107.62 174.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.524 ' HD2' ' H ' ' A' ' 127' ' ' GLU 0.475 1.0 OUTLIER 56.14 -78.43 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -174.283 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.524 ' H ' ' HD2' ' A' ' 126' ' ' ARG . 25.3 tt0 -79.81 67.1 5.49 Favored 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 126.388 1.875 . . . . 0.0 111.288 168.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -153.77 167.92 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 -177.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 27.0 m -64.37 134.1 53.92 Favored 'General case' 0 CA--C 1.561 1.386 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.151 158.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.454 ' CE1' HD21 ' A' ' 85' ' ' ASN . 4.7 p-80 -48.59 -31.51 6.72 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 118.64 2.83 . . . . 0.0 118.64 170.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.4 m -60.73 -38.6 85.67 Favored 'General case' 0 CA--C 1.563 1.465 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 171.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -67.53 -37.95 83.51 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 166.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.88 -52.44 59.97 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 170.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.414 HG21 HG22 ' B' ' 4' ' ' THR . 3.4 p -54.9 -39.93 50.82 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.25 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 168.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -64.72 -40.46 95.37 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 117.058 -1.448 . . . . 0.0 114.181 173.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -67.98 -33.12 74.03 Favored 'General case' 0 CA--C 1.562 1.423 0 N-CA-C 116.539 2.052 . . . . 0.0 116.539 167.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.7 mp -54.24 -49.17 70.1 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 125.391 1.476 . . . . 0.0 113.763 160.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -66.31 -41.66 89.37 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 169.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -65.17 -17.69 64.69 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 116.461 2.023 . . . . 0.0 116.461 172.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.445 ' HB2' HD22 ' A' ' 121' ' ' ASN . . . -52.33 -41.84 63.33 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 117.622 2.453 . . . . 0.0 117.622 164.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 71.0 72.21 0.93 Allowed Glycine 0 C--N 1.339 0.714 0 CA-C-O 118.528 -1.151 . . . . 0.0 114.779 159.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . 0.267 4.5 m 68.5 -3.1 1.43 Allowed 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 117.906 2.558 . . . . 0.0 117.906 -173.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -148.38 103.19 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.251 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 171.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.408 ' HA ' ' HB3' ' A' ' 140' ' ' ALA . 36.0 m -84.99 122.38 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 124.034 0.934 . . . . 0.0 109.233 168.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 50.1 mtt180 -101.92 87.12 3.03 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 171.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 49.7 mt -92.01 136.53 33.1 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-O 122.47 1.129 . . . . 0.0 108.315 -172.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -132.48 118.12 18.89 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 104.359 -2.46 . . . . 0.0 104.359 178.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 33.6 m -126.71 133.0 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -167.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 26.7 ttt -92.17 148.45 22.15 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 123.621 1.677 . . . . 0.0 111.657 175.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.556 ' HA ' ' HE ' ' A' ' 150' ' ' ARG . 0.4 OUTLIER -93.88 123.87 37.51 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 112.698 -2.047 . . . . 0.0 108.455 163.42 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -53.15 -57.72 9.5 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 114.262 -1.335 . . . . 0.0 113.637 172.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 13.0 tptm -174.84 122.18 0.36 Allowed Pre-proline 0 CA--C 1.557 1.247 0 CA-C-O 116.936 -1.507 . . . . 0.0 108.974 -178.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -74.67 117.23 4.87 Favored 'Trans proline' 0 CA--C 1.568 2.204 0 C-N-CA 123.301 2.668 . . . . 0.0 111.749 173.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo . . . . . 0 C--N 1.366 1.458 0 C-N-CA 123.219 2.613 . . . . 0.0 112.261 177.658 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.559 1.292 0 CA-C-O 122.201 1.001 . . . . 0.0 111.695 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -139.33 138.89 37.05 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 123.341 1.543 . . . . 0.0 110.005 173.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -102.86 124.42 48.35 Favored 'General case' 0 CA--C 1.553 1.068 0 CA-C-N 113.452 -1.704 . . . . 0.0 108.294 172.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.414 HG22 HG21 ' A' ' 134' ' ' VAL . 20.1 m -92.68 129.2 38.68 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.243 172.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -103.29 101.55 11.48 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 -174.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 1.4 p . . . . . 0 C--O 1.252 1.208 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.338 -176.2 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' BAL . . . . . 0.417 ' C ' ' HG ' ' A' ' 78' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 N--CA 1.48 1.031 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -130.27 133.76 46.73 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 124.048 0.842 . . . . 0.0 109.304 -178.54 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -111.91 140.05 46.89 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.173 -178.037 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -115.48 117.13 29.52 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 114.518 -1.219 . . . . 0.0 108.054 -178.76 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.4 mp -134.41 124.89 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 -171.533 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.8 m -97.11 125.1 41.35 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 168.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 mp -123.67 137.85 54.64 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -177.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -112.56 131.78 55.44 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -172.56 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -157.48 -112.19 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.942 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.97 173.271 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 95.21 -154.08 20.99 Favored Glycine 0 C--N 1.341 0.842 0 C-N-CA 124.424 1.012 . . . . 0.0 111.753 -172.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . 0.278 25.9 t-20 73.08 -91.69 0.02 OUTLIER 'General case' 0 CA--C 1.562 1.405 0 CA-C-N 114.046 -1.077 . . . . 0.0 110.413 -179.648 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 64.9 m -105.1 -16.83 14.68 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 177.476 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -177.08 -149.49 7.78 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-O 124.875 2.375 . . . . 0.0 109.895 176.416 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.408 HD12 ' CZ ' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -129.51 -4.31 4.79 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 111.438 -2.381 . . . . 0.0 112.247 -179.968 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.454 ' HA3' ' CA ' ' A' ' 103' ' ' GLY . . . 72.39 42.38 49.27 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 119.577 2.591 . . . . 0.0 119.577 163.054 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.408 ' CZ ' HD12 ' A' ' 75' ' ' LEU . 13.1 p90 -157.87 128.22 6.26 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 176.741 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.1 m -85.19 144.73 27.98 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.789 -1.55 . . . . 0.0 111.663 176.362 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.416 HG22 HD13 ' A' ' 96' ' ' ILE . 2.3 pp -119.2 127.92 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 113.013 -1.903 . . . . 0.0 109.546 -176.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.78 -166.74 0.94 Allowed 'General case' 0 CA--C 1.553 1.091 0 CA-C-O 123.417 1.579 . . . . 0.0 111.024 159.632 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.78 159.24 22.2 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-O 123.936 1.853 . . . . 0.0 115.195 -143.407 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.51 -161.18 23.23 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-N 111.162 -2.519 . . . . 0.0 113.057 179.191 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 71.4 p -53.99 -40.27 66.8 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 -177.638 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -92.88 7.9 41.91 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 116.099 1.889 . . . . 0.0 116.099 175.543 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -161.16 86.67 1.7 Allowed Pre-proline 0 CA--C 1.553 1.092 0 N-CA-C 101.154 -3.647 . . . . 0.0 101.154 178.945 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -108.48 124.53 0.04 OUTLIER 'Trans proline' 0 CA--C 1.549 1.237 0 CA-C-N 124.437 2.62 . . . . 0.0 111.634 -173.023 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -109.03 -34.59 6.56 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 176.224 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -148.0 161.7 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 CA-C-O 123.268 1.508 . . . . 0.0 109.592 -151.802 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.45 -111.08 3.21 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-N 113.365 -1.743 . . . . 0.0 109.822 177.081 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -103.39 5.33 37.08 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 112.978 -1.611 . . . . 0.0 114.518 168.002 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.428 75.9 m-20 100.93 -76.49 0.0 OUTLIER Pre-proline 0 CA--C 1.568 1.66 0 CA-C-O 116.262 -1.828 . . . . 0.0 108.711 -165.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -88.56 80.9 0.94 Allowed 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 123.409 2.74 . . . . 0.0 113.023 -176.338 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 52.9 m -156.65 109.63 2.59 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 105.512 -2.032 . . . . 0.0 105.512 -173.651 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 8.1 mm -68.95 117.9 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 178.559 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -129.26 140.24 51.52 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 113.459 -1.701 . . . . 0.0 107.514 -163.488 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.416 HD13 HG22 ' A' ' 79' ' ' ILE . 7.4 mm -85.84 107.46 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.346 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 175.365 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 77.0 m -91.11 -35.06 14.81 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 117.4 -1.286 . . . . 0.0 113.74 175.54 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . 0.321 0.0 OUTLIER -144.18 165.14 28.67 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 123.299 1.524 . . . . 0.0 111.72 175.54 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -111.83 126.37 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 -176.451 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.304 1.4 mp -72.25 130.44 86.23 Favored Pre-proline 0 CA--C 1.567 1.606 0 CA-C-O 118.252 -0.88 . . . . 0.0 109.2 169.454 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -58.88 130.6 37.51 Favored 'Trans proline' 0 C--N 1.367 1.511 0 C-N-CA 123.54 2.826 . . . . 0.0 114.521 174.924 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 72.12 20.99 79.34 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 117.153 1.621 . . . . 0.0 117.153 -167.042 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.454 ' CA ' ' HA3' ' A' ' 76' ' ' GLY . . . -85.93 -176.81 50.09 Favored Glycine 0 C--N 1.337 0.636 0 N-CA-C 116.399 1.32 . . . . 0.0 116.399 177.203 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.81 -51.61 63.96 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 178.415 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.49 -38.91 89.04 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 174.167 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.92 -42.03 77.35 Favored 'General case' 0 CA--C 1.565 1.527 0 N-CA-C 115.821 1.786 . . . . 0.0 115.821 170.528 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.67 -51.1 20.83 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.604 1.162 . . . . 0.0 113.877 178.526 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -71.48 -49.85 37.25 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.38 1.072 . . . . 0.0 112.109 -176.134 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.45 -164.11 10.87 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 124.32 2.067 . . . . 0.0 112.498 179.082 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -139.6 56.49 1.65 Allowed 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 110.902 -2.649 . . . . 0.0 108.084 -177.606 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.481 HD22 ' H ' ' A' ' 111' ' ' LEU . 1.4 pt? -88.59 -160.99 0.7 Allowed 'General case' 0 CA--C 1.547 0.864 0 CA-C-O 125.18 2.419 . . . . 0.0 107.591 -174.107 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.94 149.77 42.13 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 102.718 -3.068 . . . . 0.0 102.718 162.667 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.439 HG23 ' H ' ' A' ' 114' ' ' ASN 0.266 14.4 m -45.99 -69.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 110.451 -3.068 . . . . 0.0 111.999 172.673 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.439 ' H ' HG23 ' A' ' 113' ' ' VAL . 25.0 m-80 -20.35 74.64 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 119.27 3.063 . . . . 0.0 119.27 172.949 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -151.97 117.93 5.5 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 102.831 -3.026 . . . . 0.0 102.831 -176.367 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.0 m -80.62 93.57 6.15 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.03 -0.986 . . . . 0.0 108.571 -176.517 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.411 HG12 HD11 ' A' ' 137' ' ' LEU . 7.2 tp -59.7 112.94 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 C-N-CA 123.569 0.748 . . . . 0.0 111.306 178.949 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.445 ' HA ' ' HB3' ' A' ' 126' ' ' ARG 0.431 0.0 OUTLIER -105.67 -39.81 5.96 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 115.933 1.827 . . . . 0.0 115.933 -174.306 . . . . . . . . 4 4 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -136.19 135.27 38.99 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 105.019 -2.215 . . . . 0.0 105.019 171.72 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.9 p -123.55 121.95 63.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 170.43 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.5 HD22 ' HB1' ' A' ' 140' ' ' ALA 0.261 3.8 m-80 77.17 -79.73 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 123.332 1.539 . . . . 0.0 108.93 -175.008 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.407 ' H ' ' H ' ' A' ' 123' ' ' VAL . 1.1 tt0 -165.25 -7.77 0.02 OUTLIER 'General case' 0 CA--C 1.576 1.978 0 C-N-CA 127.986 2.514 . . . . 0.0 110.78 -178.833 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.407 ' H ' ' H ' ' A' ' 122' ' ' GLU . 2.1 t -72.46 135.91 26.77 Favored 'Isoleucine or valine' 0 C--N 1.359 1.014 0 C-N-CA 125.443 1.497 . . . . 0.0 109.526 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -77.43 102.19 6.74 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 112.903 -1.953 . . . . 0.0 110.605 171.776 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . 0.261 2.2 m -109.78 -113.13 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-O 116.361 -1.781 . . . . 0.0 107.936 175.254 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.445 ' HB3' ' HA ' ' A' ' 118' ' ' LEU 0.328 0.0 OUTLIER 48.06 -82.72 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 117.753 2.501 . . . . 0.0 117.753 -176.12 . . . . . . . . 4 4 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.432 ' H ' ' HD3' ' A' ' 126' ' ' ARG . 2.9 tm-20 -88.35 70.4 9.09 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-O 123.696 1.712 . . . . 0.0 108.572 171.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.63 167.27 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 -178.689 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 11.6 m -58.45 132.42 53.66 Favored 'General case' 0 CA--C 1.555 1.146 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.206 159.358 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -47.45 -34.16 6.97 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 117.37 2.359 . . . . 0.0 117.37 173.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.2 m -60.38 -40.5 91.06 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 174.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -67.24 -37.75 84.05 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 166.738 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -66.95 -55.86 12.7 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 173.663 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.404 HG21 ' CG2' ' B' ' 6' ' ' VAL . 8.6 p -47.09 -45.71 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 166.567 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.2 -54.15 49.27 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 115.765 -2.064 . . . . 0.0 111.72 174.862 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.97 -34.51 76.27 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 117.527 2.417 . . . . 0.0 117.527 174.074 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.411 HD11 HG12 ' A' ' 117' ' ' ILE . 6.0 mp -57.78 -55.34 36.09 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 125.636 1.575 . . . . 0.0 113.45 165.134 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -65.05 -33.77 76.84 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 115.898 1.814 . . . . 0.0 115.898 171.435 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -68.29 -23.64 64.77 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 117.135 2.272 . . . . 0.0 117.135 170.636 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.5 ' HB1' HD22 ' A' ' 121' ' ' ASN . . . -53.28 -28.46 28.03 Favored 'General case' 0 CA--C 1.56 1.362 0 N-CA-C 116.938 2.199 . . . . 0.0 116.938 156.046 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 91.09 -132.12 11.12 Favored Glycine 0 C--N 1.347 1.193 0 CA-C-O 122.53 1.072 . . . . 0.0 110.753 166.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 13.0 m -78.76 -2.06 37.68 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 169.152 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.05 103.8 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 -172.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.6 m -92.81 117.53 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 113.205 -1.816 . . . . 0.0 108.682 -178.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -89.57 94.22 9.78 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 169.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 82.1 mt -97.05 127.13 42.72 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 -173.521 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -126.12 120.01 29.05 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 102.963 -2.977 . . . . 0.0 102.963 177.178 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 16.8 m -124.65 132.89 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -173.346 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 57.5 ttm -100.27 112.38 24.7 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 119.759 1.163 . . . . 0.0 108.54 168.419 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -88.31 125.56 34.73 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 -178.541 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -56.59 -29.22 61.83 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 116.761 2.134 . . . . 0.0 116.761 169.581 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt 74.71 164.74 0.14 Allowed Pre-proline 0 CA--C 1.56 1.332 0 C-N-CA 124.326 1.05 . . . . 0.0 112.825 175.162 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -87.04 107.85 0.71 Allowed 'Trans proline' 0 CA--C 1.568 2.2 0 C-N-CA 123.161 2.574 . . . . 0.0 109.895 168.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo . . . . . 0 C--N 1.369 1.635 0 C-N-CA 123.233 2.622 . . . . 0.0 111.388 179.687 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.558 1.265 0 CA-C-O 122.585 1.184 . . . . 0.0 111.214 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -148.24 120.75 8.52 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 122.517 1.151 . . . . 0.0 108.874 173.402 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 16.7 ttpp -92.1 124.78 36.45 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.42 174.784 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 3.1 m -87.25 143.04 27.46 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 122.174 0.988 . . . . 0.0 109.418 168.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.69 120.31 35.72 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 178.462 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.404 ' CG2' HG21 ' A' ' 134' ' ' VAL . 21.8 t . . . . . 0 N--CA 1.478 0.933 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 -160.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 121.802 0.811 . . . . 0.0 109.92 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -106.15 134.68 48.89 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.656 176.414 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -124.91 136.05 53.41 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -176.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.405 ' HB3' ' CE2' ' A' ' 147' ' ' TYR . 9.9 pt-20 -80.39 128.56 33.7 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 114.306 -1.316 . . . . 0.0 111.795 175.42 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 23.4 mt -129.57 118.12 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 -179.3 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.3 m -97.19 122.88 40.71 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 174.248 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.439 ' HB3' ' CG2' ' A' ' 144' ' ' VAL . 1.2 tt -119.85 161.45 20.79 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 113.098 -1.865 . . . . 0.0 106.7 174.902 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -83.09 142.16 31.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.425 -1.422 . . . . 0.0 108.912 173.622 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.426 ' HG2' ' HG ' ' A' ' 75' ' ' LEU . 4.2 tmt_? -79.86 82.27 5.98 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 120.001 -1.687 . . . . 0.0 109.153 168.098 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 31.07 -118.88 0.1 Allowed Glycine 0 N--CA 1.482 1.725 0 C-N-CA 125.911 1.72 . . . . 0.0 117.093 171.271 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.9 t30 -154.22 -67.47 0.14 Allowed 'General case' 0 CA--C 1.556 1.2 0 CA-C-N 112.976 -1.612 . . . . 0.0 107.294 170.307 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.3 m -83.64 -21.83 32.35 Favored 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 114.881 1.438 . . . . 0.0 114.881 168.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -138.8 -133.17 3.03 Favored Glycine 0 CA--C 1.535 1.307 0 N-CA-C 107.911 -2.076 . . . . 0.0 107.911 168.367 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.426 ' HG ' ' HG2' ' A' ' 70' ' ' ARG . 1.4 tt -121.46 -54.26 1.98 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.028 0.931 . . . . 0.0 109.643 179.702 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 118.02 22.83 3.76 Favored Glycine 0 N--CA 1.478 1.491 0 N-CA-C 118.017 1.967 . . . . 0.0 118.017 178.8 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -145.68 177.17 9.09 Favored 'General case' 0 CA--C 1.557 1.247 0 CA-C-O 123.749 1.738 . . . . 0.0 107.788 171.586 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.8 m -134.91 145.13 47.92 Favored 'General case' 0 C--N 1.318 -0.804 0 O-C-N 119.909 -1.744 . . . . 0.0 107.559 -178.418 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.444 HG21 HG12 ' A' ' 96' ' ' ILE . 5.6 pt -112.22 137.0 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 114.695 -1.138 . . . . 0.0 112.006 -172.847 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.453 ' HB2' ' HG1' ' A' ' 97' ' ' THR . . . -85.57 -174.3 5.1 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-O 123.976 1.846 . . . . 0.0 111.368 160.857 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.82 157.98 21.84 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 113.015 -1.902 . . . . 0.0 115.058 -145.78 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -104.69 -158.6 23.65 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 111.954 -2.123 . . . . 0.0 113.724 179.182 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 34.6 p -54.32 -38.24 65.76 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 116.872 2.175 . . . . 0.0 116.872 -178.0 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -83.25 -10.31 58.63 Favored 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 116.285 1.957 . . . . 0.0 116.285 174.406 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.15 92.29 2.35 Favored Pre-proline 0 CA--C 1.552 1.028 0 N-CA-C 101.095 -3.669 . . . . 0.0 101.095 -173.02 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -93.2 138.46 1.49 Allowed 'Trans proline' 0 CA--C 1.55 1.304 0 CA-C-N 124.879 2.778 . . . . 0.0 111.453 -176.405 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -100.72 -31.31 11.26 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 167.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -98.95 153.12 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 125.051 1.34 . . . . 0.0 109.974 -168.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -74.71 13.34 5.26 Favored Glycine 0 CA--C 1.549 2.167 0 N-CA-C 118.938 2.335 . . . . 0.0 118.938 176.572 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -92.7 -10.41 37.28 Favored 'General case' 0 CA--C 1.568 1.669 0 CA-C-O 117.178 -1.391 . . . . 0.0 114.403 162.321 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.519 12.7 t70 88.28 -84.37 0.0 OUTLIER Pre-proline 0 CA--C 1.568 1.643 0 CA-C-O 115.85 -2.024 . . . . 0.0 109.616 -169.764 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -116.71 98.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.367 1.507 0 CA-C-N 125.458 2.985 . . . . 0.0 112.473 -164.827 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.4 m -158.19 125.22 4.95 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 -176.541 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 22.1 mm -78.4 123.24 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 178.517 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -116.67 154.67 30.15 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 112.684 -2.053 . . . . 0.0 107.969 177.717 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.473 ' HB ' ' O ' ' A' ' 113' ' ' VAL 0.357 10.3 mt -95.39 123.79 47.7 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.076 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 161.001 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.453 ' HG1' ' HB2' ' A' ' 80' ' ' ALA . 49.6 m -74.3 -60.45 2.26 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.769 -1.207 . . . . 0.0 113.114 171.635 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -147.16 162.21 39.33 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 123.876 1.798 . . . . 0.0 111.48 -163.375 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.87 121.86 55.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 104.427 -2.434 . . . . 0.0 104.427 -175.157 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.259 1.6 mp -73.86 121.14 84.45 Favored Pre-proline 0 CA--C 1.567 1.623 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 173.353 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -61.02 138.1 76.25 Favored 'Trans proline' 0 C--N 1.365 1.425 0 C-N-CA 123.285 2.657 . . . . 0.0 113.701 172.581 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.32 0.58 83.79 Favored Glycine 0 CA--C 1.547 2.09 0 N-CA-C 118.153 2.021 . . . . 0.0 118.153 -170.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -89.96 -177.39 45.05 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-N 119.114 1.457 . . . . 0.0 112.978 174.444 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.37 -32.4 71.43 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 116.821 2.156 . . . . 0.0 116.821 176.631 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.8 -31.91 72.98 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 117.876 -1.059 . . . . 0.0 113.813 168.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -49.44 -43.47 44.79 Favored 'General case' 0 CA--C 1.559 1.319 0 N-CA-C 118.037 2.606 . . . . 0.0 118.037 164.68 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.8 -53.47 9.1 Favored 'General case' 0 CA--C 1.563 1.446 0 C-N-CA 124.466 1.106 . . . . 0.0 113.707 174.916 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -72.3 -52.13 17.64 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -174.16 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -166.94 92.51 0.1 Allowed Glycine 0 CA--C 1.529 0.907 0 N-CA-C 108.287 -1.925 . . . . 0.0 108.287 176.444 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 37.8 ttp180 -77.83 48.08 0.67 Allowed 'General case' 0 CA--C 1.573 1.851 0 N-CA-C 115.775 1.769 . . . . 0.0 115.775 179.548 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.96 -23.56 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 119.748 -1.845 . . . . 0.0 115.392 -159.62 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -96.8 3.88 52.04 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 117.956 2.576 . . . . 0.0 117.956 -167.221 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.473 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 2.5 m -38.01 -62.03 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.592 0 C-N-CA 127.048 2.139 . . . . 0.0 113.32 -169.371 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -54.52 79.5 0.0 OUTLIER 'General case' 0 CA--C 1.566 1.559 0 CA-C-O 124.464 2.078 . . . . 0.0 114.516 167.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -141.73 124.25 15.83 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 100.841 -3.763 . . . . 0.0 100.841 -177.376 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.1 m -75.18 85.2 2.39 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 114.198 -1.365 . . . . 0.0 109.54 -178.198 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.4 HG12 HD11 ' A' ' 137' ' ' LEU . 6.2 tp -65.63 115.64 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 CA-C-O 122.622 1.201 . . . . 0.0 109.602 179.755 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.1 pp -107.23 -45.12 4.18 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 112.233 -2.258 . . . . 0.0 115.206 179.769 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -130.9 134.78 47.08 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 -179.119 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.4 p -125.62 119.43 54.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 173.248 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.539 HD22 ' CB ' ' A' ' 140' ' ' ALA 0.279 10.5 m-80 76.26 -88.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -174.312 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -148.05 -6.96 0.43 Allowed 'General case' 0 CA--C 1.576 1.953 0 C-N-CA 128.225 2.61 . . . . 0.0 110.71 177.027 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.3 t -69.81 136.5 26.02 Favored 'Isoleucine or valine' 0 C--N 1.359 1.011 0 C-N-CA 125.463 1.505 . . . . 0.0 109.728 178.502 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -89.61 102.21 14.89 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 113.355 -1.748 . . . . 0.0 108.544 175.03 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . 0.258 0.9 OUTLIER -99.71 -97.97 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-O 116.225 -1.845 . . . . 0.0 107.73 173.424 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . 0.301 0.4 OUTLIER 46.7 -87.3 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 117.284 2.328 . . . . 0.0 117.284 179.984 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -85.26 76.11 10.2 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-O 123.408 1.575 . . . . 0.0 108.763 170.232 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.0 p -146.09 168.87 6.57 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 CA-C-N 113.166 -1.834 . . . . 0.0 106.316 -179.784 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.456 HG21 ' H ' ' A' ' 131' ' ' SER . 33.1 m -62.1 137.28 58.23 Favored 'General case' 0 CA--C 1.562 1.407 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.326 158.051 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 10.2 p-80 -46.62 -33.21 4.0 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 117.552 2.427 . . . . 0.0 117.552 168.456 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.456 ' H ' HG21 ' A' ' 129' ' ' THR . 10.9 m -61.02 -41.23 96.16 Favored 'General case' 0 CA--C 1.555 1.159 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 175.109 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -69.0 -35.65 76.94 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 166.851 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -67.2 -53.88 26.2 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 172.634 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.5 p -49.26 -42.86 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 165.827 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -60.15 -55.61 31.69 Favored 'General case' 0 C--N 1.353 0.751 0 CA-C-O 115.799 -2.048 . . . . 0.0 113.24 173.682 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -65.63 -28.31 69.02 Favored 'General case' 0 CA--C 1.564 1.493 0 N-CA-C 117.09 2.255 . . . . 0.0 117.09 175.419 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.4 HD11 HG12 ' A' ' 117' ' ' ILE . 9.8 mp -62.96 -53.93 46.29 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 125.242 1.417 . . . . 0.0 113.876 167.326 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -66.79 -32.73 74.21 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 167.597 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -70.24 -11.5 60.95 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 117.481 2.4 . . . . 0.0 117.481 171.363 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.539 ' CB ' HD22 ' A' ' 121' ' ' ASN . . . -59.13 -1.24 0.17 Allowed 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 118.82 2.896 . . . . 0.0 118.82 163.663 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 93.45 -127.08 8.88 Favored Glycine 0 C--N 1.344 0.989 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 171.395 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.5 m -93.81 -0.5 55.8 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 169.011 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -150.6 111.03 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 -166.188 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.439 ' CG2' ' HB3' ' A' ' 68' ' ' LEU . 34.2 m -90.13 121.04 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 114.528 -1.214 . . . . 0.0 109.119 -179.408 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -103.98 88.24 2.97 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 178.653 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 77.4 mt -89.58 142.22 27.87 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.393 -172.279 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.405 ' CE2' ' HB3' ' A' ' 65' ' ' GLU . 38.4 m-85 -123.69 124.02 41.82 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 103.906 -2.627 . . . . 0.0 103.906 168.748 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 20.0 m -132.49 131.77 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -169.854 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 58.1 ttm -95.7 135.62 37.16 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 123.205 1.479 . . . . 0.0 110.791 177.069 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -102.01 138.61 38.74 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 113.37 -1.741 . . . . 0.0 108.742 161.088 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 62.68 70.04 0.57 Allowed 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.353 0.661 . . . . 0.0 110.903 175.647 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -76.26 115.92 51.43 Favored Pre-proline 0 CA--C 1.56 1.347 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -174.28 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -77.29 132.01 12.18 Favored 'Trans proline' 0 CA--C 1.563 1.955 0 C-N-CA 122.623 2.215 . . . . 0.0 111.881 -176.046 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo . . . . . 0 CA--C 1.553 1.437 0 C-N-CA 123.144 2.562 . . . . 0.0 113.588 169.959 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.558 1.271 0 CA-C-O 122.286 1.041 . . . . 0.0 110.19 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -140.84 124.34 16.83 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 122.986 1.374 . . . . 0.0 108.344 168.144 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.53 129.03 34.96 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 114.175 -1.375 . . . . 0.0 109.646 176.022 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 85.8 m -101.86 132.58 47.55 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.839 175.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -75.28 147.98 39.77 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 122.653 1.216 . . . . 0.0 110.666 174.021 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.6 p . . . . . 0 C--O 1.247 0.927 0 N-CA-C 103.876 -2.638 . . . . 0.0 103.876 -178.895 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.7 p90 . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 121.566 0.698 . . . . 0.0 109.782 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -100.47 136.81 39.77 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.432 -177.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -102.41 116.78 33.33 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.3 mp -130.91 111.96 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 -175.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.3 m -94.25 131.04 40.25 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 168.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.561 HD11 ' HA ' ' A' ' 105' ' ' ALA . 8.9 tt -134.86 141.87 46.47 Favored 'General case' 0 CA--C 1.556 1.206 0 CA-C-N 113.91 -1.495 . . . . 0.0 108.488 -173.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 . . . . . 0 N--CA 1.488 1.444 0 C-N-CA 123.293 0.637 . . . . 0.0 109.894 177.834 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 CA--C 1.558 1.281 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 140.82 36.17 0.11 Allowed Glycine 0 CA--C 1.546 1.975 0 N-CA-C 116.848 1.499 . . . . 0.0 116.848 -166.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.439 ' CD2' ' HB2' ' A' ' 105' ' ' ALA . 0.3 OUTLIER -137.25 175.82 9.26 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 174.814 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 45.7 m -149.05 119.15 7.19 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 119.919 -1.738 . . . . 0.0 107.775 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.405 HD11 ' HB ' ' A' ' 134' ' ' VAL . 5.3 pt -97.22 132.23 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.461 -172.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -79.5 -177.49 5.82 Favored 'General case' 0 CA--C 1.556 1.193 0 CA-C-O 123.478 1.608 . . . . 0.0 111.673 156.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.75 163.03 25.67 Favored Glycine 0 CA--C 1.54 1.599 0 CA-C-N 113.751 -1.568 . . . . 0.0 116.576 -149.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.2 -156.74 20.48 Favored Glycine 0 N--CA 1.471 1.02 0 CA-C-N 112.553 -1.824 . . . . 0.0 114.135 177.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.72 -43.05 76.19 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 115.799 1.778 . . . . 0.0 115.799 177.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -62.33 -38.34 89.1 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 117.536 2.421 . . . . 0.0 117.536 172.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -142.17 89.35 8.7 Favored Pre-proline 0 CA--C 1.553 1.068 1 N-CA-C 99.424 -4.287 . . . . 0.0 99.424 -168.265 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -100.31 130.73 0.16 Allowed 'Trans proline' 0 CA--C 1.548 1.193 0 CA-C-N 124.361 2.593 . . . . 0.0 110.655 -175.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 72.0 t60 . . . . . 0 CA--C 1.582 2.177 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 154.274 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo . . . . . 0 CA--C 1.548 1.225 0 CA-C-O 122.534 0.973 . . . . 0.0 110.969 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 75.7 m -145.3 128.75 16.95 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 -174.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.443 ' H ' ' HA ' ' A' ' 126' ' ' ARG . 24.6 mm -74.41 115.81 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 -177.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -104.26 155.95 18.31 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 113.044 -1.889 . . . . 0.0 107.446 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . 0.31 97.6 mt -96.28 120.0 45.07 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.688 0 N-CA-C 104.686 -2.339 . . . . 0.0 104.686 160.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 43.4 m -92.42 -25.0 18.68 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 120.57 -1.331 . . . . 0.0 113.486 168.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -138.66 150.74 46.55 Favored 'General case' 0 CA--C 1.56 1.331 0 CA-C-N 120.72 1.6 . . . . 0.0 110.473 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -99.32 126.23 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 104.762 -2.31 . . . . 0.0 104.762 170.121 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.25 28.7 mm -73.96 120.77 83.0 Favored Pre-proline 0 CA--C 1.571 1.755 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 176.018 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.64 132.12 22.85 Favored 'Trans proline' 0 C--N 1.368 1.586 0 C-N-CA 123.834 3.022 . . . . 0.0 113.045 -175.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 74.94 0.08 59.32 Favored Glycine 0 CA--C 1.551 2.323 0 N-CA-C 118.59 2.196 . . . . 0.0 118.59 -168.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -88.1 -162.38 38.04 Favored Glycine 0 CA--C 1.544 1.904 0 CA-C-N 119.161 1.481 . . . . 0.0 113.525 177.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.24 -58.05 9.94 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.561 ' HA ' HD11 ' A' ' 68' ' ' LEU . . . -50.47 -45.68 56.36 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 117.843 2.534 . . . . 0.0 117.843 172.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.38 -40.53 73.92 Favored 'General case' 0 CA--C 1.56 1.341 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 177.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . 0.256 0.0 OUTLIER -72.14 -55.49 7.2 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 178.231 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.6 t70 . . . . . 0 CA--C 1.557 1.237 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -173.519 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 122.76 1.267 . . . . 0.0 114.39 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.7 m -85.67 104.87 15.79 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 112.568 -2.105 . . . . 0.0 107.455 -161.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . 0.336 11.0 tp -57.93 104.07 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.497 0 CA-C-O 122.339 1.066 . . . . 0.0 112.323 -170.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.439 ' HG ' ' HB2' ' A' ' 149' ' ' MET 0.317 0.1 OUTLIER -82.9 -63.62 1.33 Allowed 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 112.602 -2.09 . . . . 0.0 110.413 -176.142 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -132.49 135.54 46.08 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 173.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 5.7 p -119.13 112.47 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 105.709 -1.959 . . . . 0.0 105.709 171.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . 0.27 12.8 m120 77.7 -78.89 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 122.821 1.296 . . . . 0.0 109.966 -174.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -159.5 -12.94 0.06 Allowed 'General case' 0 CA--C 1.573 1.838 0 C-N-CA 127.399 2.28 . . . . 0.0 110.951 -176.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.657 HG12 HG13 ' A' ' 125' ' ' VAL . 2.4 t -68.25 134.83 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.394 0 C-N-CA 125.376 1.47 . . . . 0.0 110.124 175.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -87.17 97.04 10.54 Favored 'General case' 0 CA--C 1.553 1.068 0 CA-C-N 113.434 -1.712 . . . . 0.0 108.638 177.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.657 HG13 HG12 ' A' ' 123' ' ' VAL 0.325 2.9 m -97.11 -142.49 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.599 179.616 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.443 ' HA ' ' H ' ' A' ' 94' ' ' ILE 0.323 0.9 OUTLIER 71.82 -83.66 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 124.664 1.185 . . . . 0.0 111.2 -173.299 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.56 69.87 10.17 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 123.752 1.739 . . . . 0.0 109.406 177.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.1 m -143.72 166.49 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 -175.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 46.7 m -56.71 129.74 42.46 Favored 'General case' 0 CA--C 1.568 1.666 0 CA-C-N 112.96 -1.927 . . . . 0.0 109.639 150.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -48.49 -32.22 7.55 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 168.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.543 ' HA ' HG12 ' A' ' 134' ' ' VAL . 16.1 m -57.62 -45.03 85.89 Favored 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 168.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.36 -38.52 84.1 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 169.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.474 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -73.23 -44.29 59.79 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 116.914 2.19 . . . . 0.0 116.914 172.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.543 HG12 ' HA ' ' A' ' 131' ' ' SER . 4.6 p -57.71 -44.93 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 168.101 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -60.0 -50.8 72.32 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-O 117.089 -1.434 . . . . 0.0 112.055 170.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.63 -31.91 69.94 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 117.939 2.57 . . . . 0.0 117.939 172.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 73.3 mt -59.26 -53.75 54.67 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 125.071 1.348 . . . . 0.0 113.619 164.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -68.6 -35.95 78.03 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 117.358 2.355 . . . . 0.0 117.358 172.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -64.09 -14.28 53.58 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 117.044 2.238 . . . . 0.0 117.044 169.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.411 ' HB1' ' HA ' ' A' ' 144' ' ' VAL . . . -54.99 -24.0 22.06 Favored 'General case' 0 CA--C 1.561 1.368 0 N-CA-C 118.756 2.873 . . . . 0.0 118.756 160.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 93.61 -125.99 8.45 Favored Glycine 0 N--CA 1.475 1.268 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 168.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.2 m -79.94 -3.36 47.86 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 168.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -149.93 106.8 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -166.133 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.513 HG23 ' HB3' ' A' ' 68' ' ' LEU . 2.4 m -81.74 117.55 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 124.192 0.997 . . . . 0.0 110.572 170.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 45.4 mtm180 -99.45 90.59 4.57 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 175.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 42.5 mt -94.25 128.52 40.76 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.322 -169.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -127.49 121.68 31.38 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 103.231 -2.877 . . . . 0.0 103.231 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 18.3 m -131.38 119.44 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 CA-C-N 119.815 1.189 . . . . 0.0 110.923 -163.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' MET . . . . . 0.439 ' HB2' ' HG ' ' A' ' 118' ' ' LEU . 28.1 ttt . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 122.378 1.085 . . . . 0.0 111.256 -176.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.558 1.273 0 CA-C-O 122.55 1.167 . . . . 0.0 111.406 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -138.31 128.18 25.34 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 170.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 20.7 ttpp -78.97 114.5 17.97 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.551 170.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 85.8 m -88.66 126.54 35.35 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 122.412 1.101 . . . . 0.0 109.059 175.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -80.66 133.8 35.77 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 113.886 -1.506 . . . . 0.0 108.502 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.417 ' HB ' HG23 ' A' ' 134' ' ' VAL . 7.6 p . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 -170.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 26.8 p90 . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -113.67 141.54 47.1 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.196 -172.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.9 117.7 34.7 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.3 mp -123.76 131.08 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 -174.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.0 m -101.15 127.13 47.85 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 162.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.0 tp -133.79 130.75 38.43 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 113.979 -1.464 . . . . 0.0 107.574 -176.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 . . . . . 0 N--CA 1.485 1.307 0 O-C-N 121.352 -0.842 . . . . 0.0 109.848 178.494 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.558 HD11 HG21 ' A' ' 144' ' ' VAL . 1.3 tt . . . . . 0 N--CA 1.48 1.075 0 CA-C-O 118.119 -0.943 . . . . 0.0 110.101 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.445 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 103.75 44.36 1.67 Allowed Glycine 0 CA--C 1.533 1.179 0 N-CA-C 117.392 1.717 . . . . 0.0 117.392 173.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.46 ' CD1' HD13 ' A' ' 96' ' ' ILE . 0.1 OUTLIER -160.24 168.35 25.56 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.95 1.3 . . . . 0.0 108.487 176.252 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.468 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 3.0 m -131.81 119.7 21.62 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 120.622 -1.299 . . . . 0.0 111.068 -163.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.593 HG22 HG12 ' A' ' 96' ' ' ILE . 1.7 pt -95.51 129.22 45.93 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.279 -174.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.57 -173.92 4.35 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-O 123.299 1.523 . . . . 0.0 110.243 161.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.47 160.17 22.69 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 123.88 1.822 . . . . 0.0 116.046 -137.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -103.96 -162.0 24.77 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 111.26 -2.47 . . . . 0.0 115.449 -178.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 53.1 p -54.45 -40.16 68.12 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 116.395 1.998 . . . . 0.0 116.395 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.421 ' HB2' HG23 ' A' ' 129' ' ' THR . 9.6 m-20 -88.49 0.5 56.22 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 116.363 1.986 . . . . 0.0 116.363 175.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -163.27 87.84 1.27 Allowed Pre-proline 0 CA--C 1.557 1.242 0 N-CA-C 101.275 -3.602 . . . . 0.0 101.275 -176.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -97.5 143.19 0.67 Allowed 'Trans proline' 0 CA--C 1.549 1.265 0 CA-C-N 124.043 2.48 . . . . 0.0 111.073 -174.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 57.6 t60 . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 167.158 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo . . . . . 0 CA--C 1.545 1.039 0 CA-C-O 121.159 0.399 . . . . 0.0 112.371 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 67.9 m -154.93 109.52 2.99 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.497 HD12 ' HA ' ' A' ' 130' ' ' HIS . 17.6 mm -74.09 118.85 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 174.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.481 ' HB2' ' HA ' ' A' ' 116' ' ' SER . 2.2 p90 -143.65 134.05 24.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.148 -1.387 . . . . 0.0 108.255 -171.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.593 HG12 HG22 ' A' ' 79' ' ' ILE . 86.9 mt -83.31 121.75 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 177.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.8 m -96.9 -26.17 15.16 Favored 'General case' 0 CA--C 1.558 1.264 0 CA-C-N 112.659 -2.064 . . . . 0.0 113.501 173.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.468 ' HB2' ' HB2' ' A' ' 78' ' ' SER . 63.8 mttm -132.45 158.37 42.2 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 123.903 1.811 . . . . 0.0 112.121 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -121.92 118.01 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 N-CA-C 102.622 -3.103 . . . . 0.0 102.622 177.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.262 1.6 mp -72.33 131.46 84.91 Favored Pre-proline 0 CA--C 1.567 1.621 0 CA-C-O 118.291 -0.861 . . . . 0.0 108.82 174.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -62.19 134.74 50.57 Favored 'Trans proline' 0 CA--C 1.555 1.547 0 C-N-CA 123.332 2.688 . . . . 0.0 113.531 172.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.18 12.69 84.38 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 117.349 1.7 . . . . 0.0 117.349 -161.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.445 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -93.87 166.52 27.55 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-O 122.203 0.891 . . . . 0.0 113.589 177.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.463 ' HB3' HD23 ' A' ' 75' ' ' LEU . . . -69.82 -39.79 76.28 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 116.6 2.074 . . . . 0.0 116.6 -175.306 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.85 -26.32 65.09 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 172.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.03 -52.39 17.19 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 162.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -58.59 -60.9 3.09 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 125.922 1.689 . . . . 0.0 114.312 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.8 t70 . . . . . 0 CA--C 1.552 1.027 0 C-N-CA 124.089 0.955 . . . . 0.0 110.885 175.789 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . 0.315 11.9 t70 . . . . . 0 CA--C 1.535 0.385 0 CA-C-O 115.745 -2.074 . . . . 0.0 108.622 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.481 ' HA ' ' HB2' ' A' ' 95' ' ' PHE . 12.6 m -155.23 93.59 1.53 Allowed 'General case' 0 N--CA 1.48 1.037 0 O-C-N 125.47 1.731 . . . . 0.0 107.95 -173.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.4 tp -65.77 127.04 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-O 121.326 0.584 . . . . 0.0 109.967 175.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.58 ' HA ' ' HB3' ' A' ' 126' ' ' ARG 0.338 4.1 pp -96.31 -51.38 4.4 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 116.336 1.976 . . . . 0.0 116.336 171.631 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -135.93 138.56 42.49 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 103.637 -2.727 . . . . 0.0 103.637 -176.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 10.8 p -125.58 121.03 59.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 173.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.403 ' HA ' ' HB2' ' A' ' 145' ' ' ARG 0.31 16.0 m120 80.88 -80.65 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 124.181 1.943 . . . . 0.0 109.474 -177.395 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -163.69 -17.37 0.03 OUTLIER 'General case' 0 CA--C 1.568 1.663 0 CA-C-N 110.322 -3.126 . . . . 0.0 109.893 -174.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.689 HG12 HG13 ' A' ' 125' ' ' VAL . 2.4 t -65.46 136.65 26.34 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.268 0 CA-C-O 123.568 1.651 . . . . 0.0 109.647 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -85.25 79.61 9.47 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 111.233 -2.712 . . . . 0.0 110.743 177.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.689 HG13 HG12 ' A' ' 123' ' ' VAL 0.264 1.2 m -87.03 -106.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 CA-C-O 116.672 -1.633 . . . . 0.0 107.883 -179.497 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.58 ' HB3' ' HA ' ' A' ' 118' ' ' LEU 0.254 25.0 ptt180 52.04 -88.87 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 116.604 2.075 . . . . 0.0 116.604 177.987 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.565 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 25.1 tt0 -86.53 72.77 10.21 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-O 123.259 1.504 . . . . 0.0 108.877 167.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.3 p -139.88 170.25 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 177.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.421 HG23 ' HB2' ' A' ' 84' ' ' ASP . 3.1 m -58.34 136.67 57.45 Favored 'General case' 0 CA--C 1.559 1.29 0 CA-C-N 114.062 -1.426 . . . . 0.0 111.739 159.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' HIS . . . . . 0.497 ' HA ' HD12 ' A' ' 94' ' ' ILE 0.264 2.4 p-80 -46.79 -37.66 8.97 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 117.174 2.287 . . . . 0.0 117.174 171.339 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.438 ' HA ' HG12 ' A' ' 134' ' ' VAL . 53.6 p -56.33 -52.35 64.88 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 172.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.57 -36.48 78.61 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 173.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.624 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -71.12 -52.53 18.79 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 116.083 1.882 . . . . 0.0 116.083 172.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.438 HG12 ' HA ' ' A' ' 131' ' ' SER . 1.9 p -53.43 -44.16 54.53 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.183 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 171.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 139' ' ' GLU . 65.7 mm-40 -63.93 -48.77 75.26 Favored 'General case' 0 C--O 1.212 -0.878 0 CA-C-O 116.038 -1.934 . . . . 0.0 111.807 172.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.77 -28.67 70.14 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 117.384 2.365 . . . . 0.0 117.384 170.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -60.31 -53.98 51.13 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.008 1.323 . . . . 0.0 113.925 166.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -67.91 -39.15 83.63 Favored 'General case' 0 CA--C 1.569 1.691 0 N-CA-C 115.788 1.773 . . . . 0.0 115.788 171.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 135' ' ' GLU . 1.2 mm-40 -74.05 0.31 14.1 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 116.866 2.173 . . . . 0.0 116.866 171.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.511 ' HB1' ' HA ' ' A' ' 144' ' ' VAL . . . -57.71 -6.75 0.56 Allowed 'General case' 0 CA--C 1.555 1.172 0 N-CA-C 119.317 3.08 . . . . 0.0 119.317 157.173 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.62 -137.98 16.38 Favored Glycine 0 C--N 1.345 1.072 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 174.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.9 m -79.34 -8.56 59.17 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 169.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -147.76 112.72 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 CA-C-O 123.674 1.702 . . . . 0.0 107.244 -165.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.558 HG21 HD11 ' A' ' 75' ' ' LEU . 4.3 t -101.55 114.1 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 112.411 -2.177 . . . . 0.0 106.814 -169.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.403 ' HB2' ' HA ' ' A' ' 121' ' ' ASN . 70.1 mtm180 -96.08 91.79 6.12 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -177.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 45.4 mt -90.88 136.91 32.76 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.033 -173.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -128.49 121.49 29.0 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 104.867 -2.272 . . . . 0.0 104.867 173.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -129.53 122.43 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 -173.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' MET . . . . . 0.409 ' HB2' ' CD2' ' A' ' 118' ' ' LEU . 56.4 ttm . . . . . 0 N--CA 1.477 0.916 0 O-C-N 124.442 1.088 . . . . 0.0 110.062 164.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.562 1.43 0 CA-C-O 122.948 1.356 . . . . 0.0 110.883 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -150.1 113.93 5.05 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 172.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -86.42 125.29 33.59 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.399 175.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 96.7 m -98.85 136.38 38.95 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-O 122.497 1.141 . . . . 0.0 110.008 176.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -84.95 129.19 34.84 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 113.508 -1.678 . . . . 0.0 108.198 173.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 p . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 177.499 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 33.3 p90 . . . . . 0 N--CA 1.48 1.057 0 CA-C-O 121.869 0.842 . . . . 0.0 109.975 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -109.99 131.87 54.67 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 114.389 -1.278 . . . . 0.0 108.223 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.89 126.19 37.86 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 114.362 -1.29 . . . . 0.0 109.294 176.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 40.9 mt -129.26 126.26 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 103.946 -2.613 . . . . 0.0 103.946 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.8 m -109.77 127.6 54.74 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 168.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.488 HD11 ' HA ' ' A' ' 105' ' ' ALA . 4.4 tp -127.44 162.11 27.14 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 113.347 -1.752 . . . . 0.0 107.396 175.277 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.402 ' O ' ' HB1' ' A' ' 104' ' ' ALA . 5.9 mt-10 . . . . . 0 N--CA 1.481 1.104 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.432 168.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.632 HD13 HG22 ' B' ' 6' ' ' VAL . 1.8 mp . . . . . 0 N--CA 1.48 1.054 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.615 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 129.97 50.4 0.12 Allowed Glycine 0 CA--C 1.54 1.61 0 C-N-CA 124.08 0.848 . . . . 0.0 114.526 -172.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.418 ' HA ' ' H ' ' A' ' 100' ' ' ILE . 36.8 p90 -151.88 158.36 43.11 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 165.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.454 ' HB2' ' HG2' ' A' ' 98' ' ' LYS . 67.1 m -96.05 154.0 17.47 Favored 'General case' 0 C--N 1.316 -0.888 0 O-C-N 119.569 -1.957 . . . . 0.0 110.533 171.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.478 HG22 HD13 ' A' ' 96' ' ' ILE . 2.5 pp -116.39 132.82 64.89 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-N 111.168 -2.742 . . . . 0.0 108.398 168.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.44 -171.3 3.29 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-O 123.613 1.673 . . . . 0.0 109.138 163.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.14 156.44 23.54 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 123.392 1.551 . . . . 0.0 115.251 -142.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.14 -158.58 23.19 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 111.955 -2.123 . . . . 0.0 113.643 -178.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.545 HG22 ' HB2' ' A' ' 92' ' ' PRO . 72.8 p -54.88 -41.55 70.99 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 117.736 2.495 . . . . 0.0 117.736 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -76.54 -13.59 60.07 Favored 'General case' 0 CA--C 1.568 1.663 0 N-CA-C 116.183 1.92 . . . . 0.0 116.183 172.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.31 82.0 6.51 Favored Pre-proline 0 CA--C 1.56 1.345 0 N-CA-C 102.557 -3.127 . . . . 0.0 102.557 -176.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -104.99 120.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.359 1.102 0 CA-C-N 124.976 2.813 . . . . 0.0 110.846 -169.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -179.447 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.545 ' HB2' HG22 ' A' ' 83' ' ' THR . 91.2 Cg_endo . . . . . 0 CA--C 1.547 1.169 0 CA-C-O 122.507 0.961 . . . . 0.0 112.455 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 66.8 m -155.7 127.65 7.51 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 103.83 -2.655 . . . . 0.0 103.83 -177.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.459 HG13 ' HB2' ' A' ' 133' ' ' ALA . 17.3 mm -76.28 122.3 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -110.02 151.06 27.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 113.057 -1.883 . . . . 0.0 107.936 178.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.478 HD13 HG22 ' A' ' 79' ' ' ILE . 20.6 mm -94.24 100.92 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.205 0 N-CA-C 102.979 -2.971 . . . . 0.0 102.979 165.299 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.2 t -80.82 -47.35 13.98 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 114.989 1.478 . . . . 0.0 114.989 -176.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.454 ' HG2' ' HB2' ' A' ' 78' ' ' SER 0.277 10.4 ptmt -143.75 152.47 41.3 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 121.782 0.801 . . . . 0.0 111.727 -173.593 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.12 123.21 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 N-CA-C 103.886 -2.635 . . . . 0.0 103.886 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.418 ' H ' ' HA ' ' A' ' 77' ' ' PHE 0.267 1.7 mp -72.96 125.88 90.83 Favored Pre-proline 0 CA--C 1.566 1.576 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 173.137 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -60.95 129.52 29.18 Favored 'Trans proline' 0 C--N 1.364 1.367 0 C-N-CA 123.329 2.686 . . . . 0.0 114.296 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.87 5.45 69.81 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 118.481 2.153 . . . . 0.0 118.481 -169.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.615 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -79.08 -175.63 47.21 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 124.31 0.957 . . . . 0.0 114.486 173.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.402 ' HB1' ' O ' ' A' ' 69' ' ' GLU . . . -64.88 -40.15 94.67 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 116.077 1.88 . . . . 0.0 116.077 -174.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.488 ' HA ' HD11 ' A' ' 68' ' ' LEU . . . -68.03 -36.84 80.58 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 173.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.32 -35.21 75.73 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 116.445 2.017 . . . . 0.0 116.445 167.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -70.64 -57.32 4.83 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 125.704 1.602 . . . . 0.0 112.395 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.0 t70 . . . . . 0 CA--C 1.557 1.225 0 C-N-CA 123.831 0.853 . . . . 0.0 112.443 -177.146 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 C--O 1.238 0.495 0 N-CA-C 103.717 -2.697 . . . . 0.0 103.717 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 45.0 m -89.98 90.52 8.19 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 113.085 -1.87 . . . . 0.0 108.169 -170.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.5 tp -61.77 121.83 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.009 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.536 ' HA ' ' HB3' ' A' ' 126' ' ' ARG . 1.5 pp -106.33 -50.67 3.1 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 113.16 -1.836 . . . . 0.0 115.91 175.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.42 ' H ' HD12 ' A' ' 118' ' ' LEU . 41.6 m-85 -123.33 132.75 54.1 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 177.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 5.8 p -122.22 116.39 48.99 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 N-CA-C 104.142 -2.54 . . . . 0.0 104.142 168.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . 0.282 10.5 m120 79.83 -74.65 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 CA-C-O 123.348 1.547 . . . . 0.0 110.176 -174.203 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -167.54 -16.74 0.02 OUTLIER 'General case' 0 CA--C 1.578 2.027 0 CA-C-N 111.471 -2.604 . . . . 0.0 109.64 -175.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.405 HG12 HG13 ' A' ' 125' ' ' VAL . 2.0 t -67.66 134.78 29.65 Favored 'Isoleucine or valine' 0 C--N 1.361 1.099 0 CA-C-N 120.415 1.462 . . . . 0.0 110.351 176.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -86.27 99.45 11.58 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 113.419 -1.719 . . . . 0.0 109.046 176.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.504 HG11 ' HA ' ' A' ' 133' ' ' ALA . 1.3 m -95.93 -101.19 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 CA-C-O 116.401 -1.762 . . . . 0.0 107.381 175.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.536 ' HB3' ' HA ' ' A' ' 118' ' ' LEU 0.316 18.8 ptt180 50.97 -90.89 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.254 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 177.99 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.422 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 4.9 tt0 -88.23 65.57 8.12 Favored 'General case' 0 CA--C 1.557 1.225 0 CA-C-O 122.991 1.377 . . . . 0.0 109.54 171.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.7 p -130.36 169.86 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 176.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 33.2 m -61.02 134.87 57.53 Favored 'General case' 0 CA--C 1.56 1.342 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.43 158.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' HIS . . . . . 0.424 ' HA ' HD12 ' A' ' 94' ' ' ILE . 9.1 p-80 -47.28 -33.41 5.57 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 117.922 2.564 . . . . 0.0 117.922 171.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.552 ' HA ' HG12 ' A' ' 134' ' ' VAL . 16.7 m -62.06 -38.88 90.46 Favored 'General case' 0 CA--C 1.562 1.439 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 173.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.62 -34.69 76.19 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 115.521 1.675 . . . . 0.0 115.521 166.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.504 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -72.44 -49.8 30.84 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 116.234 1.938 . . . . 0.0 116.234 174.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.633 HG23 ' HB ' ' B' ' 6' ' ' VAL . 4.0 p -49.88 -44.24 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.221 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 164.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -64.09 -49.21 73.14 Favored 'General case' 0 C--O 1.216 -0.658 0 CA-C-O 116.075 -1.917 . . . . 0.0 112.556 172.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.47 -32.75 73.68 Favored 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 117.184 2.29 . . . . 0.0 117.184 176.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -58.25 -46.47 85.9 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 162.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -72.36 -37.69 68.74 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 171.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -64.98 -19.95 66.24 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 116.272 1.953 . . . . 0.0 116.272 170.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.444 ' HB1' ' HA ' ' A' ' 144' ' ' VAL . . . -52.11 -10.66 0.13 Allowed 'General case' 0 CA--C 1.554 1.103 0 N-CA-C 119.246 3.054 . . . . 0.0 119.246 162.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 70.18 -154.51 52.66 Favored Glycine 0 C--N 1.348 1.243 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -175.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.5 m -59.83 -5.09 0.84 Allowed 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 118.506 2.78 . . . . 0.0 118.506 176.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.96 105.79 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 -170.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.468 HG11 HD21 ' A' ' 75' ' ' LEU . 15.8 m -85.88 123.1 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.07 174.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -108.13 90.22 3.23 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 56.7 mt -90.69 139.27 30.87 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.471 -171.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -135.64 117.88 15.58 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 104.52 -2.4 . . . . 0.0 104.52 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 35.3 m -129.64 118.53 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -164.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 53.2 ttm . . . . . 0 N--CA 1.489 1.518 0 CA-C-N 118.882 0.765 . . . . 0.0 109.746 173.498 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.557 1.212 0 CA-C-O 122.504 1.145 . . . . 0.0 111.285 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -136.24 128.05 29.2 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-O 123.507 1.622 . . . . 0.0 109.328 170.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 10.7 ttpp -97.42 111.27 23.6 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 113.754 -1.566 . . . . 0.0 107.796 172.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 88.5 m -93.76 144.66 25.21 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.418 -1.265 . . . . 0.0 109.108 173.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -87.19 145.02 26.57 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 113.864 -1.516 . . . . 0.0 108.672 178.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.633 ' HB ' HG23 ' A' ' 134' ' ' VAL . 7.6 p . . . . . 0 C--O 1.248 1.01 0 N-CA-C 104.5 -2.408 . . . . 0.0 104.5 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 27.0 p90 . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 121.609 0.719 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -101.46 133.15 46.54 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.812 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -97.84 128.52 44.51 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.72 170.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.533 HG13 ' HB2' ' A' ' 146' ' ' LEU . 23.5 pt -136.67 111.83 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 -174.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.0 m -91.96 120.24 32.44 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.42 ' HB3' ' CG2' ' A' ' 144' ' ' VAL . 6.7 tt -116.52 137.57 52.07 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 175.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 . . . . . 0 N--CA 1.483 1.222 0 O-C-N 120.956 -1.09 . . . . 0.0 111.564 177.17 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.568 HD21 HG22 ' B' ' 6' ' ' VAL . 0.1 OUTLIER . . . . . 0 CA--C 1.558 1.274 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.522 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 69.4 36.37 77.75 Favored Glycine 0 C--N 1.344 1.014 0 N-CA-C 118.761 2.264 . . . . 0.0 118.761 164.076 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -150.48 163.51 38.25 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 123.563 1.649 . . . . 0.0 108.489 174.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.5 m -127.25 127.82 45.01 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.582 -169.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.3 pp -101.18 124.03 54.6 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 113.504 -1.68 . . . . 0.0 108.643 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -85.68 -170.86 3.31 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 123.452 1.596 . . . . 0.0 110.051 158.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.1 159.34 24.34 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-O 123.859 1.811 . . . . 0.0 115.604 -136.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -104.24 -162.6 24.58 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 111.082 -2.559 . . . . 0.0 113.742 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.446 HG22 ' HB3' ' A' ' 92' ' ' PRO . 70.2 p -52.83 -41.75 64.5 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 116.67 2.1 . . . . 0.0 116.67 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -80.15 -17.32 52.8 Favored 'General case' 0 CA--C 1.565 1.55 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 175.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.29 96.07 4.27 Favored Pre-proline 0 CA--C 1.552 1.028 0 N-CA-C 101.822 -3.399 . . . . 0.0 101.822 -175.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -96.73 143.41 0.84 Allowed 'Trans proline' 0 CA--C 1.548 1.194 0 CA-C-N 123.688 2.353 . . . . 0.0 111.472 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 16.8 t60 . . . . . 0 CA--C 1.565 1.532 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 167.271 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.446 ' HB3' HG22 ' A' ' 83' ' ' THR . 1.4 Cg_endo . . . . . 0 CA--C 1.549 1.256 0 N-CA-C 110.636 -0.563 . . . . 0.0 110.636 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.5 m 78.3 106.87 0.07 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 168.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.487 HG13 ' HB2' ' A' ' 133' ' ' ALA . 11.3 mm -75.55 117.56 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 -173.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -128.4 135.44 49.54 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -171.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 89.5 mt -72.5 118.83 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.388 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 175.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.44 ' CG2' ' HG3' ' B' ' 3' ' ' LYS . 14.3 t -87.75 -29.69 20.85 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 169.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -144.25 163.08 34.7 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-O 125.568 2.604 . . . . 0.0 110.343 -174.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.479 HG22 ' HB3' ' A' ' 105' ' ' ALA . 1.2 pt -115.4 129.17 72.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 111.051 -2.795 . . . . 0.0 103.539 173.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.294 1.5 mp -72.19 123.78 89.95 Favored Pre-proline 0 CA--C 1.57 1.715 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 170.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.93 132.08 42.95 Favored 'Trans proline' 0 C--N 1.367 1.545 0 C-N-CA 123.558 2.838 . . . . 0.0 114.203 172.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 71.52 9.95 69.88 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 118.084 1.994 . . . . 0.0 118.084 -166.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.522 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -91.01 -179.29 43.06 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-O 123.033 1.351 . . . . 0.0 112.397 177.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.65 -33.79 66.82 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 117.523 2.416 . . . . 0.0 117.523 -174.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.479 ' HB3' HG22 ' A' ' 99' ' ' ILE . . . -60.94 -32.88 72.38 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 117.961 2.578 . . . . 0.0 117.961 165.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.35 -39.41 93.84 Favored 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 167.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.48 -56.02 6.75 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.387 1.075 . . . . 0.0 113.624 175.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.7 t70 . . . . . 0 CA--C 1.562 1.415 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -178.17 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 . . . . . 0 C--O 1.239 0.547 1 N-CA-C 100.091 -4.04 . . . . 0.0 100.091 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.8 m -75.02 86.93 2.34 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 112.992 -1.913 . . . . 0.0 109.097 -176.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.571 HD12 HD21 ' A' ' 137' ' ' LEU . 30.1 pt -64.91 121.22 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 125.065 1.346 . . . . 0.0 111.024 -174.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.869 HD11 ' H ' ' A' ' 149' ' ' MET . 0.0 OUTLIER -101.55 -50.17 3.81 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 112.736 -2.029 . . . . 0.0 112.778 -179.457 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -111.4 140.91 45.6 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 169.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.521 HG23 HD23 ' A' ' 146' ' ' LEU . 7.1 p -127.93 120.05 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 104.465 -2.42 . . . . 0.0 104.465 165.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . 0.27 12.2 m120 79.67 -74.45 0.05 Allowed 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 123.592 1.663 . . . . 0.0 110.453 -176.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -164.49 -10.88 0.03 OUTLIER 'General case' 0 CA--C 1.578 2.038 0 CA-C-N 111.355 -2.657 . . . . 0.0 110.203 177.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.1 t -71.46 134.42 29.98 Favored 'Isoleucine or valine' 0 C--N 1.36 1.03 0 C-N-CA 125.682 1.593 . . . . 0.0 109.745 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -84.67 100.79 11.69 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 113.698 -1.592 . . . . 0.0 109.299 172.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.555 HG11 ' HA ' ' A' ' 133' ' ' ALA . 0.7 OUTLIER -96.97 -96.86 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 CA-C-O 116.08 -1.914 . . . . 0.0 106.894 171.517 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.552 ' HB3' ' HA ' ' A' ' 118' ' ' LEU 0.302 18.9 ptt180 46.79 -89.37 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 -178.374 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.421 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 6.6 mt-10 -85.9 65.95 9.37 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-O 123.672 1.701 . . . . 0.0 109.087 177.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.1 p -138.75 168.38 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 22.9 m -60.33 132.79 55.0 Favored 'General case' 0 CA--C 1.561 1.388 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.884 158.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' HIS . . . . . 0.46 ' HA ' HD12 ' A' ' 94' ' ' ILE . 10.2 p-80 -46.53 -32.69 3.54 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 118.166 2.654 . . . . 0.0 118.166 170.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.505 ' HA ' HG12 ' A' ' 134' ' ' VAL . 16.5 m -62.4 -40.37 96.28 Favored 'General case' 0 CA--C 1.561 1.381 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 173.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.74 -37.69 87.07 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 167.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.555 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -66.94 -52.18 46.11 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 172.306 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.505 HG12 ' HA ' ' A' ' 131' ' ' SER . 4.9 p -53.65 -42.25 50.15 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.421 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 172.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -72.33 -39.82 67.88 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 116.267 -1.825 . . . . 0.0 112.93 174.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.436 ' HA ' ' HB3' ' A' ' 139' ' ' GLU . . . -60.59 -29.19 69.04 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 117.162 2.282 . . . . 0.0 117.162 165.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.593 HD11 HD21 ' A' ' 146' ' ' LEU . 2.8 mm? -62.78 -48.96 76.88 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.819 1.647 . . . . 0.0 114.93 165.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -68.21 -35.71 78.4 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 168.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.436 ' HB3' ' HA ' ' A' ' 136' ' ' ALA . 29.6 tt0 -64.65 -23.19 67.18 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 116.379 1.992 . . . . 0.0 116.379 171.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.466 ' HB1' ' HA ' ' A' ' 144' ' ' VAL . . . -54.2 -11.06 0.43 Allowed 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 118.794 2.887 . . . . 0.0 118.794 162.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 89.1 -136.98 13.92 Favored Glycine 0 C--N 1.345 1.066 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 172.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 26.8 m -77.75 -2.96 38.83 Favored 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 170.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.85 106.74 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 -170.159 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.491 HG11 ' CD1' ' A' ' 75' ' ' LEU . 10.7 m -88.39 116.21 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.324 1.45 . . . . 0.0 109.292 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 56.1 mtm180 -104.01 89.34 3.26 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -176.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.593 HD21 HD11 ' A' ' 137' ' ' LEU . 23.9 mt -88.33 138.34 31.52 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.736 0.779 . . . . 0.0 109.0 -170.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -120.97 127.53 51.89 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 5.7 p -133.55 112.45 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 CA-C-O 121.65 0.738 . . . . 0.0 109.85 175.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' MET . . . . . 0.869 ' H ' HD11 ' A' ' 118' ' ' LEU . 27.3 ttt . . . . . 0 CA--C 1.544 0.739 0 C-N-CA 126.343 1.857 . . . . 0.0 110.793 161.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.56 1.356 0 CA-C-O 122.728 1.251 . . . . 0.0 110.899 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -142.0 127.04 18.39 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 123.082 1.42 . . . . 0.0 107.937 170.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.44 ' HG3' ' CG2' ' A' ' 97' ' ' THR . 1.6 tmmt? -89.91 122.13 32.66 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.024 169.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 62.8 m -92.35 135.87 33.67 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 122.715 1.245 . . . . 0.0 108.951 171.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -92.27 133.58 35.7 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 113.855 -1.52 . . . . 0.0 107.865 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.568 HG22 HD21 ' A' ' 75' ' ' LEU 0.254 11.7 p . . . . . 0 C--O 1.248 1.015 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 -169.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.457 ' HB3' HD21 ' A' ' 118' ' ' LEU . 40.9 p90 . . . . . 0 N--CA 1.478 0.955 0 CA-C-O 121.917 0.865 . . . . 0.0 110.686 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -107.43 135.92 48.09 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 114.55 -1.204 . . . . 0.0 108.077 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -95.43 127.59 41.59 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.841 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.495 HG22 HD13 ' A' ' 68' ' ' LEU . 4.2 mp -135.24 122.91 37.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 -177.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.7 m -105.22 122.79 46.66 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 173.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.495 HD13 HG22 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -120.7 132.57 55.15 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 114.305 -1.316 . . . . 0.0 108.581 -175.869 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 . . . . . 0 CA--C 1.547 0.842 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.812 -176.598 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.476 HD12 HG11 ' A' ' 144' ' ' VAL 0.405 0.2 OUTLIER . . . . . 0 N--CA 1.499 2.008 0 N-CA-C 118.016 2.599 . . . . 0.0 118.016 . . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.429 ' O ' HG13 ' A' ' 99' ' ' ILE . . . 99.29 20.44 17.86 Favored Glycine 0 C--O 1.218 -0.855 0 CA-C-O 115.437 -2.868 . . . . 0.0 117.18 168.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.42 ' O ' ' HB ' ' B' ' 6' ' ' VAL . 2.0 p90 -158.46 117.27 3.07 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 121.745 2.773 . . . . 0.0 109.678 -169.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.6 m -87.79 127.0 35.32 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.211 -1.359 . . . . 0.0 110.823 172.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.537 HG22 HG12 ' A' ' 96' ' ' ILE . 2.4 pp -105.74 127.22 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 113.62 -1.627 . . . . 0.0 108.947 -176.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -79.55 -173.05 3.56 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 124.015 1.864 . . . . 0.0 111.321 159.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' A' ' 85' ' ' ASN . . . -101.59 160.57 18.1 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-N 112.937 -1.938 . . . . 0.0 114.95 -142.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.456 ' H ' ' HB3' ' A' ' 130' ' ' HIS . . . -107.23 -162.22 21.75 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 110.939 -2.631 . . . . 0.0 111.711 -173.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.606 HG22 ' HB2' ' A' ' 92' ' ' PRO . 13.3 p -52.52 -43.1 64.91 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 117.661 2.467 . . . . 0.0 117.661 -173.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.514 ' HB3' HG23 ' A' ' 129' ' ' THR . 24.0 t70 -97.99 12.43 34.27 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 174.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.488 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 5.6 t30 -155.17 69.74 5.56 Favored Pre-proline 0 CA--C 1.555 1.151 0 N-CA-C 101.96 -3.348 . . . . 0.0 101.96 174.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -88.79 126.73 1.8 Allowed 'Trans proline' 0 C--N 1.365 1.444 0 CA-C-N 126.659 3.414 . . . . 0.0 112.208 -163.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 84.5 t60 . . . . . 0 N--CA 1.5 2.048 0 N-CA-C 115.213 1.561 . . . . 0.0 115.213 157.921 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.606 ' HB2' HG22 ' A' ' 83' ' ' THR . 14.6 Cg_endo . . . . . 0 CA--C 1.557 1.664 0 CA-C-O 122.732 1.055 . . . . 0.0 112.932 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.5 t -161.33 159.22 28.16 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 -172.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.526 HG13 ' HB2' ' A' ' 133' ' ' ALA . 12.2 mm -99.61 120.17 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 N-CA-C 105.256 -2.128 . . . . 0.0 105.256 -175.103 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -111.41 149.68 30.89 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 113.442 -1.708 . . . . 0.0 107.205 -174.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.537 HG12 HG22 ' A' ' 79' ' ' ILE . 23.0 mt -94.78 111.27 25.22 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.319 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 165.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 96.8 m -85.81 -30.85 22.66 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 117.264 -1.351 . . . . 0.0 113.431 169.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . 0.282 8.9 ptmm? -141.41 164.08 31.19 Favored 'General case' 0 CA--C 1.557 1.246 0 CA-C-N 120.673 1.579 . . . . 0.0 112.177 173.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 76' ' ' GLY . 1.7 tp -115.26 137.51 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 N-CA-C 104.57 -2.381 . . . . 0.0 104.57 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.273 1.6 mp -83.6 116.86 66.71 Favored Pre-proline 0 CA--C 1.57 1.743 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 168.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -63.0 146.01 94.57 Favored 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 123.736 2.957 . . . . 0.0 113.979 172.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.3 -13.65 26.2 Favored Glycine 0 CA--C 1.547 2.073 0 N-CA-C 117.586 1.794 . . . . 0.0 117.586 -169.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -83.19 -169.62 45.02 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 118.911 1.356 . . . . 0.0 113.162 173.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.89 -51.29 27.09 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -170.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.0 -32.86 72.44 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 116.915 2.191 . . . . 0.0 116.915 173.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.07 -51.3 48.2 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 170.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -65.06 -62.22 1.68 Allowed 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 125.313 1.445 . . . . 0.0 112.986 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 . . . . . 0 N--CA 1.486 1.348 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 -177.772 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.2 p30 . . . . . 0 CA--C 1.558 1.267 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.8 m -144.79 84.27 1.72 Allowed 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 175.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.563 HD12 HD11 ' A' ' 137' ' ' LEU . 28.1 pt -56.58 108.63 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 CA-C-O 123.558 1.646 . . . . 0.0 111.042 175.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.457 HD21 ' HB3' ' A' ' 63' ' ' TYR . 3.3 pp -101.19 -41.37 6.75 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 112.564 -2.107 . . . . 0.0 115.526 178.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -127.59 143.76 51.14 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.553 HG21 HD12 ' A' ' 137' ' ' LEU . 3.3 t -136.56 108.0 6.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 101.294 -3.595 . . . . 0.0 101.294 178.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . 0.283 12.8 m120 82.51 -80.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 123.44 1.59 . . . . 0.0 109.504 178.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -152.82 -14.07 0.16 Allowed 'General case' 0 CA--C 1.568 1.635 0 CA-C-N 111.815 -2.448 . . . . 0.0 111.196 177.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.2 t -68.86 136.98 25.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 124.893 1.277 . . . . 0.0 109.733 174.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -96.08 101.08 12.7 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 112.574 -2.103 . . . . 0.0 109.018 176.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.548 HG11 ' HA ' ' A' ' 133' ' ' ALA 0.261 1.6 m -100.42 -103.84 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 CA-C-O 116.773 -1.584 . . . . 0.0 107.178 178.49 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.455 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.363 26.9 ptt85 44.21 -92.87 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 125.139 1.376 . . . . 0.0 114.572 -169.9 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.455 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 16.6 tt0 -72.84 74.84 1.15 Allowed 'General case' 0 CA--C 1.555 1.142 0 CA-C-O 124.297 1.998 . . . . 0.0 110.98 170.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.3 p -149.0 166.54 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 CA-C-N 111.993 -2.367 . . . . 0.0 105.232 -178.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.514 HG23 ' HB3' ' A' ' 84' ' ' ASP . 0.2 OUTLIER -54.6 122.49 10.71 Favored 'General case' 0 CA--C 1.557 1.224 0 CA-C-N 111.841 -2.436 . . . . 0.0 110.462 154.552 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 130' ' ' HIS . . . . . 0.456 ' HB3' ' H ' ' A' ' 82' ' ' GLY . 1.6 p-80 -49.48 -31.24 9.59 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 117.436 2.384 . . . . 0.0 117.436 175.049 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.58 ' HA ' HG12 ' A' ' 134' ' ' VAL . 7.1 m -58.86 -38.05 77.89 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 115.373 1.619 . . . . 0.0 115.373 171.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.61 -37.06 79.47 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 165.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.548 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -63.19 -54.6 34.96 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 171.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.58 HG12 ' HA ' ' A' ' 131' ' ' SER . 9.8 p -52.45 -43.43 41.57 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 166.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -58.14 -50.39 73.65 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-O 115.888 -2.006 . . . . 0.0 111.817 171.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.55 -35.43 77.75 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 117.146 2.276 . . . . 0.0 117.146 173.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.563 HD11 HD12 ' A' ' 117' ' ' ILE . 9.3 mp -55.82 -52.6 63.43 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 125.04 1.336 . . . . 0.0 114.007 164.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -71.35 -31.82 67.8 Favored 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 174.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -67.16 -30.23 70.15 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 115.332 1.605 . . . . 0.0 115.332 171.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.492 ' HB1' ' HA ' ' A' ' 144' ' ' VAL . . . -50.27 -33.06 18.52 Favored 'General case' 0 CA--C 1.56 1.332 0 N-CA-C 117.202 2.297 . . . . 0.0 117.202 159.296 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 91.21 -125.18 7.9 Favored Glycine 0 C--N 1.348 1.229 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 166.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 11.6 m -73.38 -10.36 59.66 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 118.043 2.609 . . . . 0.0 118.043 169.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.2 104.44 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 -170.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.492 ' HA ' ' HB1' ' A' ' 140' ' ' ALA . 5.2 m -86.88 118.4 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 113.383 -1.735 . . . . 0.0 109.557 175.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 62.5 mtm180 -97.57 91.79 5.6 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 172.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.426 HD23 HG13 ' A' ' 120' ' ' VAL . 86.2 mt -93.24 138.69 31.39 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.906 0.86 . . . . 0.0 108.985 -173.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -130.67 120.99 24.73 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 177.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 21.2 m -130.77 129.64 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -166.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 23.9 ptt? . . . . . 0 N--CA 1.48 1.044 0 CA-C-O 122.46 1.124 . . . . 0.0 111.587 168.991 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 8.1 p90 . . . . . 0 CA--C 1.55 0.98 0 CA-C-O 122.194 0.997 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -115.06 149.19 37.88 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 123.738 1.733 . . . . 0.0 109.188 173.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 12.0 ttpp -103.97 109.28 20.98 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 113.189 -1.823 . . . . 0.0 107.305 176.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.59 131.31 38.84 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.625 175.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -85.58 121.92 28.95 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.42 ' HB ' ' O ' ' A' ' 77' ' ' PHE . 2.7 t . . . . . 0 C--O 1.248 0.977 0 N-CA-C 104.193 -2.521 . . . . 0.0 104.193 -170.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 34.0 p90 . . . . . 0 CA--C 1.551 1.008 0 CA-C-O 122.414 1.102 . . . . 0.0 112.575 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -101.53 129.16 47.56 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 113.354 -1.748 . . . . 0.0 108.254 166.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -116.29 129.27 56.19 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 114.224 -1.353 . . . . 0.0 109.163 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.454 HG13 ' HB2' ' A' ' 146' ' ' LEU . 6.2 pt -135.82 115.36 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 -174.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.3 m -86.43 118.18 25.7 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 171.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.495 HD21 ' HB1' ' A' ' 104' ' ' ALA . 8.2 tt -124.14 140.46 52.94 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 113.14 -1.845 . . . . 0.0 106.198 -171.063 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 . . . . . 0 N--CA 1.483 1.218 0 O-C-N 121.431 -0.793 . . . . 0.0 109.378 -176.455 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.416 HD13 HG12 ' B' ' 6' ' ' VAL . 6.9 mp . . . . . 0 CA--C 1.555 1.137 0 N-CA-C 106.349 -1.722 . . . . 0.0 106.349 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.537 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 127.57 50.39 0.15 Allowed Glycine 0 CA--C 1.543 1.815 0 C-N-CA 124.516 1.055 . . . . 0.0 114.916 -175.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.457 ' CD1' HD13 ' A' ' 96' ' ' ILE . 0.3 OUTLIER -159.33 149.58 19.15 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 122.998 1.38 . . . . 0.0 109.97 174.186 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.515 ' HB2' ' HB3' ' A' ' 98' ' ' LYS . 70.7 m -99.91 116.35 31.75 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.408 -0.807 . . . . 0.0 111.62 -175.101 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.616 HG22 HG12 ' A' ' 96' ' ' ILE . 1.1 pt -88.46 122.86 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.311 176.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.65 -172.09 3.87 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-O 123.263 1.506 . . . . 0.0 110.644 164.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' A' ' 85' ' ' ASN . . . -95.43 161.05 22.99 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-O 123.389 1.55 . . . . 0.0 116.341 -136.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.49 -162.58 23.43 Favored Glycine 0 N--CA 1.464 0.564 0 CA-C-N 111.919 -2.14 . . . . 0.0 116.298 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.449 HG22 ' HB3' ' A' ' 92' ' ' PRO . 59.6 p -52.08 -40.53 61.35 Favored 'General case' 0 CA--C 1.567 1.628 0 CA-C-N 112.516 -1.842 . . . . 0.0 115.595 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.42 ' HB2' HG22 ' A' ' 129' ' ' THR . 31.5 t70 -78.82 -30.54 45.39 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 172.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.401 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 0.1 OUTLIER -134.52 91.37 21.95 Favored Pre-proline 0 N--CA 1.478 0.972 0 N-CA-C 102.402 -3.185 . . . . 0.0 102.402 -173.824 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -100.01 147.81 0.44 Allowed 'Trans proline' 0 CA--C 1.549 1.251 0 CA-C-N 124.557 2.663 . . . . 0.0 111.221 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.488 ' HB2' ' CD2' ' B' ' 1' ' ' TYR . 43.3 t60 . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 166.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.449 ' HB3' HG22 ' A' ' 83' ' ' THR . 0.5 OUTLIER . . . . . 0 CA--C 1.553 1.448 0 N-CA-C 110.482 -0.622 . . . . 0.0 110.482 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 39.9 m 79.73 119.31 0.05 Allowed 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 167.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.549 HG13 ' CB ' ' A' ' 133' ' ' ALA . 10.0 mm -96.1 125.67 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 104.905 -2.258 . . . . 0.0 104.905 -172.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.435 ' HZ ' ' HB3' ' A' ' 87' ' ' HIS . 32.3 p90 -140.67 128.52 21.82 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 112.317 -2.22 . . . . 0.0 106.58 -159.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.616 HG12 HG22 ' A' ' 79' ' ' ILE . 73.6 mt -87.64 114.93 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.2 t -97.77 -13.85 21.14 Favored 'General case' 0 CA--C 1.559 1.301 0 CA-C-N 113.224 -1.807 . . . . 0.0 114.805 169.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 78' ' ' SER . 19.2 ttmm -141.11 158.11 44.36 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-O 124.832 2.253 . . . . 0.0 109.93 -173.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.29 131.87 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 111.531 -2.577 . . . . 0.0 105.894 -176.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.275 1.6 mp -78.69 131.62 67.2 Favored Pre-proline 0 CA--C 1.57 1.716 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 167.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.17 130.56 34.8 Favored 'Trans proline' 0 C--N 1.367 1.517 0 C-N-CA 123.416 2.744 . . . . 0.0 115.132 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 70.48 13.33 70.94 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 118.167 2.027 . . . . 0.0 118.167 -168.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.537 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -90.0 -162.11 38.04 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 124.371 0.986 . . . . 0.0 114.675 -175.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.495 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -68.27 -53.85 21.66 Favored 'General case' 0 CA--C 1.557 1.229 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -170.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.05 -24.49 64.18 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 117.286 2.328 . . . . 0.0 117.286 168.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.96 -34.98 71.98 Favored 'General case' 0 CA--C 1.565 1.551 0 N-CA-C 115.964 1.838 . . . . 0.0 115.964 168.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -55.29 6.01 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 124.929 1.292 . . . . 0.0 112.26 174.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.9 t70 . . . . . 0 N--CA 1.487 1.405 0 C-N-CA 123.26 0.624 . . . . 0.0 112.612 -174.964 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 95' ' ' PHE 0.308 6.9 m-20 . . . . . 0 N--CA 1.466 0.327 0 CA-C-O 116.728 -1.606 . . . . 0.0 108.248 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 69.4 m -160.37 102.42 1.39 Allowed 'General case' 0 N--CA 1.473 0.677 0 O-C-N 126.337 2.273 . . . . 0.0 107.352 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.445 HD13 ' H ' ' A' ' 117' ' ' ILE . 0.2 OUTLIER -99.0 150.27 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.416 0 CA-C-O 122.617 1.199 . . . . 0.0 108.911 179.465 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.908 HD11 ' H ' ' A' ' 149' ' ' MET . 0.0 OUTLIER -120.61 -37.36 3.02 Favored 'General case' 0 N--CA 1.502 2.154 0 C-N-CA 126.504 1.922 . . . . 0.0 111.784 -171.056 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -126.67 150.66 48.85 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-O 122.755 1.264 . . . . 0.0 108.237 173.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.49 ' HB ' HH22 ' A' ' 126' ' ' ARG . 14.6 p -129.65 121.22 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 169.222 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.481 ' HA ' ' HB2' ' A' ' 145' ' ' ARG 0.358 8.6 m120 79.14 -88.67 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 123.595 1.664 . . . . 0.0 107.845 178.626 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -144.21 -16.45 0.58 Allowed 'General case' 0 CA--C 1.568 1.636 0 CA-C-N 110.478 -3.055 . . . . 0.0 110.37 174.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.7 t -66.45 134.54 29.82 Favored 'Isoleucine or valine' 0 C--N 1.36 1.054 0 CA-C-O 123.92 1.819 . . . . 0.0 109.949 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -89.47 57.8 4.12 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 110.254 -3.157 . . . . 0.0 112.923 173.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.8 m -70.86 -163.94 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.333 0 CA-C-O 123.632 1.682 . . . . 0.0 108.496 161.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.615 ' H ' HG22 ' A' ' 128' ' ' VAL 0.525 4.3 mmt85 86.51 -49.27 0.05 Allowed 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 115.019 1.489 . . . . 0.0 115.019 176.164 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -76.21 51.86 0.71 Allowed 'General case' 0 CA--C 1.571 1.756 0 CA-C-N 114.186 -1.37 . . . . 0.0 113.276 155.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.615 HG22 ' H ' ' A' ' 126' ' ' ARG . 30.4 m -148.58 170.15 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 -170.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.42 HG22 ' HB2' ' A' ' 84' ' ' ASP . 44.6 p -61.73 141.12 58.07 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 113.293 -1.776 . . . . 0.0 111.814 155.148 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' HIS . . . . . 0.41 ' HA ' HD12 ' A' ' 94' ' ' ILE . 3.4 p80 -44.39 -33.74 1.76 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 117.175 2.287 . . . . 0.0 117.175 171.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.602 ' HA ' HG12 ' A' ' 134' ' ' VAL . 16.1 m -62.78 -40.72 98.19 Favored 'General case' 0 CA--C 1.564 1.489 0 N-CA-C 115.702 1.742 . . . . 0.0 115.702 176.136 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.06 -37.94 81.87 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 169.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.549 ' CB ' HG13 ' A' ' 94' ' ' ILE . . . -67.8 -47.26 69.58 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 116.152 -1.88 . . . . 0.0 115.968 169.28 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.602 HG12 ' HA ' ' A' ' 131' ' ' SER . 13.0 p -53.39 -46.37 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-N 121.351 1.887 . . . . 0.0 113.221 166.268 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -53.18 -46.91 69.15 Favored 'General case' 0 CA--C 1.555 1.16 0 CA-C-O 117.527 -1.225 . . . . 0.0 113.02 168.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.63 -26.82 67.25 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 117.534 2.42 . . . . 0.0 117.534 170.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.476 ' CD2' HH21 ' A' ' 126' ' ' ARG . 3.5 mm? -68.76 -49.35 59.43 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 125.6 1.56 . . . . 0.0 113.845 171.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -66.22 -34.27 77.65 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 165.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -72.43 -21.65 61.22 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 116.932 2.197 . . . . 0.0 116.932 174.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.508 ' HB1' ' HA ' ' A' ' 144' ' ' VAL . . . -51.58 -20.8 2.13 Favored 'General case' 0 CA--C 1.563 1.451 0 N-CA-C 117.584 2.438 . . . . 0.0 117.584 155.163 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.78 -147.29 27.76 Favored Glycine 0 C--N 1.35 1.356 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 174.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 18.5 m -61.84 -6.5 2.76 Favored 'General case' 0 CA--C 1.571 1.783 0 N-CA-C 117.553 2.427 . . . . 0.0 117.553 173.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -146.58 101.68 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 -170.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.508 ' HA ' ' HB1' ' A' ' 140' ' ' ALA . 29.8 m -84.18 116.92 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.293 172.28 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.481 ' HB2' ' HA ' ' A' ' 121' ' ' ASN . 57.7 mtp85 -94.35 106.12 18.1 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 174.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.454 ' HB2' HG13 ' A' ' 66' ' ' ILE . 11.3 mt -107.02 124.05 49.08 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 -166.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -116.84 130.14 56.52 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 -174.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.02 127.77 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 176.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' MET . . . . . 0.908 ' H ' HD11 ' A' ' 118' ' ' LEU . 67.3 mtt . . . . . 0 N--CA 1.475 0.799 0 C-N-CA 126.048 1.739 . . . . 0.0 108.671 171.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 1' ' ' TYR . . . . . 0.488 ' CD2' ' HB2' ' A' ' 87' ' ' HIS . 0.0 OUTLIER . . . . . 0 CA--C 1.557 1.226 0 CA-C-O 122.728 1.251 . . . . 0.0 110.565 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -157.12 151.11 24.72 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 123.351 1.548 . . . . 0.0 109.951 168.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.74 137.16 37.03 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 -176.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 27.6 m -85.34 133.78 34.13 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 166.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.95 99.98 12.52 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 -177.245 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.416 HG12 HD13 ' A' ' 75' ' ' LEU . 21.9 t . . . . . 0 C--O 1.25 1.091 0 N-CA-C 103.042 -2.947 . . . . 0.0 103.042 -165.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 17.8 p90 . . . . . 0 N--CA 1.475 0.792 0 CA-C-O 122.38 1.086 . . . . 0.0 108.101 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -114.03 136.2 53.18 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 113.697 -1.592 . . . . 0.0 107.71 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -99.63 121.42 41.19 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -172.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 18.2 mt -130.99 114.93 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 104.233 -2.506 . . . . 0.0 104.233 -172.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.0 m -96.6 124.91 40.74 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 169.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.468 ' HB3' ' CG2' ' A' ' 144' ' ' VAL . 5.2 tp -127.86 166.82 17.53 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 113.29 -1.777 . . . . 0.0 107.144 176.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 . . . . . 0 N--CA 1.48 1.074 0 O-C-N 121.352 -0.843 . . . . 0.0 109.392 164.456 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.567 HD11 HG11 ' A' ' 144' ' ' VAL . 1.0 OUTLIER . . . . . 0 N--CA 1.481 1.1 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.477 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 113.5 43.34 0.83 Allowed Glycine 0 CA--C 1.533 1.179 0 N-CA-C 117.155 1.622 . . . . 0.0 117.155 167.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.486 ' HE1' HD23 ' A' ' 137' ' ' LEU . 3.8 p90 -156.72 157.7 35.6 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.526 1.131 . . . . 0.0 109.11 172.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 51.1 m -96.66 137.76 35.25 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 120.621 -1.3 . . . . 0.0 110.155 171.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.42 HG22 HG12 ' A' ' 96' ' ' ILE . 1.2 pt -107.21 125.87 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.85 178.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -83.25 -178.46 7.09 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 124.254 1.978 . . . . 0.0 110.001 167.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 85' ' ' ASN . . . -91.51 159.08 25.79 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 112.923 -1.944 . . . . 0.0 115.228 -141.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -109.26 -170.97 20.63 Favored Glycine 0 C--O 1.224 -0.496 0 CA-C-N 110.472 -2.864 . . . . 0.0 113.034 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.563 HG22 ' HB2' ' A' ' 92' ' ' PRO . 29.6 p -43.5 -43.36 5.39 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 118.442 2.756 . . . . 0.0 118.442 -176.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -78.07 -28.64 48.88 Favored 'General case' 0 CA--C 1.561 1.403 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 175.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.419 ' O ' ' HA3' ' A' ' 81' ' ' GLY 0.258 2.0 t30 -143.81 71.96 17.03 Favored Pre-proline 0 CA--C 1.562 1.404 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -175.754 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -103.44 145.83 0.17 Allowed 'Trans proline' 0 C--N 1.375 1.937 0 CA-C-N 124.629 2.689 . . . . 0.0 111.652 -171.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 . . . . . 0 N--CA 1.495 1.812 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 162.71 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.563 ' HB2' HG22 ' A' ' 83' ' ' THR . 26.5 Cg_endo . . . . . 0 CA--C 1.555 1.556 0 CA-C-O 121.962 0.734 . . . . 0.0 112.1 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.2 t -161.23 128.35 4.08 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 -173.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.509 HG13 ' HB2' ' A' ' 133' ' ' ALA . 24.3 mm -76.31 121.1 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -133.01 131.66 40.96 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -175.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.42 HG12 HG22 ' A' ' 79' ' ' ILE 0.288 92.8 mt -65.56 127.82 27.31 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.908 0 CA-C-O 122.547 1.165 . . . . 0.0 109.374 179.421 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.34 -48.42 11.99 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.933 1.293 . . . . 0.0 113.63 174.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . 0.286 0.0 OUTLIER -143.42 163.67 32.44 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-O 123.021 1.391 . . . . 0.0 110.573 -176.432 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -108.24 116.56 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 103.607 -2.738 . . . . 0.0 103.607 173.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.422 ' H ' ' HA ' ' A' ' 77' ' ' PHE . 1.4 mp -68.0 129.17 93.24 Favored Pre-proline 0 CA--C 1.57 1.746 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 176.322 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.19 131.12 35.05 Favored 'Trans proline' 0 CA--C 1.555 1.529 0 C-N-CA 123.468 2.779 . . . . 0.0 114.112 172.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.4 1.27 88.36 Favored Glycine 0 CA--C 1.551 2.292 0 N-CA-C 117.72 1.848 . . . . 0.0 117.72 -164.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.477 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -78.33 157.53 44.61 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.281 0.943 . . . . 0.0 114.117 172.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.86 -25.39 67.88 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 117.51 2.411 . . . . 0.0 117.51 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.429 ' HA ' HD11 ' A' ' 68' ' ' LEU . . . -64.87 -44.46 89.63 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 173.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.74 -38.67 73.54 Favored 'General case' 0 CA--C 1.563 1.473 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 172.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -67.79 -62.7 1.29 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 125.16 1.384 . . . . 0.0 112.724 173.057 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.9 t70 . . . . . 0 N--CA 1.485 1.318 0 C-N-CA 124.242 1.017 . . . . 0.0 112.709 -171.526 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 . . . . . 0 C--O 1.241 0.626 0 N-CA-C 100.569 -3.863 . . . . 0.0 100.569 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 41.8 m -78.85 93.02 4.93 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 112.932 -1.94 . . . . 0.0 108.846 -168.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.4 tp -58.25 116.77 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.65 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.58 ' HA ' ' HB3' ' A' ' 126' ' ' ARG 0.266 1.9 pp -100.17 -50.42 3.97 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 113.216 -1.811 . . . . 0.0 114.638 175.706 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.408 ' H ' HD12 ' A' ' 118' ' ' LEU . 62.3 m-85 -126.41 133.09 51.36 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 104.605 -2.368 . . . . 0.0 104.605 177.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.426 HG23 HD23 ' A' ' 146' ' ' LEU . 7.6 p -123.84 117.45 51.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 170.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . 0.306 12.2 m120 80.38 -69.85 0.09 Allowed 'General case' 0 N--CA 1.501 2.121 0 CA-C-O 123.334 1.54 . . . . 0.0 110.681 -174.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -172.05 -25.06 0.01 OUTLIER 'General case' 0 CA--C 1.575 1.914 0 C-N-CA 128.537 2.735 . . . . 0.0 109.178 -172.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.2 t -66.48 133.92 30.6 Favored 'Isoleucine or valine' 0 C--N 1.363 1.167 0 C-N-CA 125.298 1.439 . . . . 0.0 110.775 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -83.8 98.94 9.99 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 113.292 -1.776 . . . . 0.0 110.227 174.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.57 HG11 ' HA ' ' A' ' 133' ' ' ALA . 2.3 m -86.48 -98.34 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 CA-C-O 115.911 -1.995 . . . . 0.0 107.632 171.016 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.58 ' HB3' ' HA ' ' A' ' 118' ' ' LEU 0.274 5.7 ptt180 45.88 -99.58 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 CA-C-N 120.589 1.54 . . . . 0.0 113.638 178.44 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -80.05 81.22 6.35 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-O 123.407 1.575 . . . . 0.0 109.006 170.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.58 167.44 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 CA-C-N 112.76 -2.018 . . . . 0.0 106.179 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 25.0 m -60.58 132.49 54.05 Favored 'General case' 0 CA--C 1.561 1.372 0 CA-C-N 114.129 -1.396 . . . . 0.0 110.104 156.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' HIS . . . . . 0.406 ' HA ' HD12 ' A' ' 94' ' ' ILE . 7.3 p-80 -46.54 -33.45 4.09 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 117.987 2.588 . . . . 0.0 117.987 171.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.493 ' HA ' HG12 ' A' ' 134' ' ' VAL . 12.0 m -62.97 -38.24 90.31 Favored 'General case' 0 CA--C 1.558 1.268 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 175.129 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.04 -34.34 77.85 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 165.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.57 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -70.46 -51.95 25.59 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 116.382 1.993 . . . . 0.0 116.382 173.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.493 HG12 ' HA ' ' A' ' 131' ' ' SER . 4.3 p -50.05 -43.64 20.96 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.374 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 165.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -64.74 -48.19 75.47 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 116.842 -1.551 . . . . 0.0 113.374 175.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.415 ' HA ' ' HB3' ' A' ' 139' ' ' GLU . . . -68.7 -31.95 71.41 Favored 'General case' 0 CA--C 1.563 1.471 0 N-CA-C 116.561 2.06 . . . . 0.0 116.561 176.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.486 HD23 ' HE1' ' A' ' 77' ' ' PHE . 8.8 mp -60.3 -52.1 66.7 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 125.32 1.448 . . . . 0.0 114.743 166.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -67.12 -33.95 76.55 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 167.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.415 ' HB3' ' HA ' ' A' ' 136' ' ' ALA . 9.1 tp10 -65.16 -24.18 67.32 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 173.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.491 ' HB3' HG12 ' A' ' 144' ' ' VAL . . . -50.97 -25.75 5.09 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 118.024 2.601 . . . . 0.0 118.024 163.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 66.96 83.91 0.1 Allowed Glycine 0 C--N 1.351 1.387 0 CA-C-O 118.695 -1.059 . . . . 0.0 113.11 157.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.8 m 75.04 -30.09 0.2 Allowed 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 117.237 2.31 . . . . 0.0 117.237 -175.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.0 108.84 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 -172.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.567 HG11 HD11 ' A' ' 75' ' ' LEU . 16.9 m -89.55 123.0 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 114.317 -1.31 . . . . 0.0 109.754 176.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -96.27 93.07 6.67 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 172.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.426 HD23 HG23 ' A' ' 120' ' ' VAL . 64.6 mt -98.5 133.5 42.77 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -171.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -131.55 115.38 16.05 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 178.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 35.7 m -126.32 129.13 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 -166.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.483 1.183 0 CA-C-O 121.574 0.702 . . . . 0.0 111.237 169.929 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 1.6 p90 . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 122.493 1.14 . . . . 0.0 112.31 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -139.33 138.11 36.37 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 113.852 -1.522 . . . . 0.0 107.501 172.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.55 122.26 34.8 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.153 -1.385 . . . . 0.0 108.627 177.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 96.8 m -86.8 133.47 33.64 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 173.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -74.81 142.74 44.19 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.117 173.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.426 ' HB ' HG23 ' A' ' 134' ' ' VAL . 7.4 p . . . . . 0 C--O 1.254 1.29 0 CA-C-N 113.976 -1.465 . . . . 0.0 108.661 169.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 32.9 p90 . . . . . 0 N--CA 1.477 0.921 0 CA-C-O 122.332 1.063 . . . . 0.0 111.646 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -110.18 130.25 55.57 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.45 126.79 41.89 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.158 174.09 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.2 mp -134.24 119.76 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 -176.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.2 m -95.42 122.73 38.44 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 168.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.561 ' HB3' HG23 ' A' ' 144' ' ' VAL . 9.9 tt -125.96 134.94 51.36 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 113.88 -1.509 . . . . 0.0 107.541 -173.066 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 . . . . . 0 N--CA 1.478 0.967 0 CA-C-O 122.209 1.005 . . . . 0.0 109.457 179.113 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.483 HD13 HG12 ' B' ' 6' ' ' VAL . 4.7 mp . . . . . 0 N--CA 1.477 0.913 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.642 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 138.47 39.12 0.11 Allowed Glycine 0 CA--C 1.535 1.284 0 N-CA-C 118.088 1.995 . . . . 0.0 118.088 -175.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.476 ' CD1' HD13 ' A' ' 96' ' ' ILE . 5.8 p90 -166.5 137.27 3.38 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 124.369 2.033 . . . . 0.0 109.119 -176.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.546 ' HB2' ' HB3' ' A' ' 98' ' ' LYS . 46.1 m -95.0 126.78 40.58 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 113.667 -1.606 . . . . 0.0 112.378 -173.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.712 HG22 HG12 ' A' ' 96' ' ' ILE . 4.1 pt -93.37 130.51 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 113.945 -1.479 . . . . 0.0 110.856 177.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.15 -171.79 3.66 Favored 'General case' 0 CA--C 1.556 1.176 0 CA-C-O 123.057 1.408 . . . . 0.0 110.522 163.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.76 161.47 28.32 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-O 122.888 1.271 . . . . 0.0 115.802 -146.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -108.73 -162.5 20.39 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 112.47 -1.865 . . . . 0.0 113.502 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.445 HG22 ' HB3' ' A' ' 92' ' ' PRO . 70.3 p -50.07 -40.86 46.77 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 116.699 2.111 . . . . 0.0 116.699 178.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -95.54 7.18 46.99 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.4 HD22 ' CE1' ' A' ' 130' ' ' HIS . 0.0 OUTLIER -162.79 90.53 1.27 Allowed Pre-proline 0 CA--C 1.561 1.398 0 N-CA-C 101.101 -3.666 . . . . 0.0 101.101 178.031 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -106.01 125.88 0.05 OUTLIER 'Trans proline' 0 CA--C 1.55 1.323 0 CA-C-N 124.577 2.67 . . . . 0.0 110.799 -177.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 . . . . . 0 N--CA 1.496 1.859 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 161.902 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.445 ' HB3' HG22 ' A' ' 83' ' ' THR . 15.6 Cg_endo . . . . . 0 CA--C 1.554 1.523 0 N-CA-C 111.043 -0.407 . . . . 0.0 111.043 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 55.3 m 79.58 119.53 0.05 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.308 1.443 . . . . 0.0 108.161 166.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.46 HG13 ' HB2' ' A' ' 133' ' ' ALA . 26.6 mm -80.89 140.34 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.482 ' HA ' ' O ' ' A' ' 115' ' ' ASP . 13.3 m-85 -123.23 150.86 42.9 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 114.328 -1.305 . . . . 0.0 111.097 175.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.712 HG12 HG22 ' A' ' 79' ' ' ILE . 53.7 mt -103.21 107.44 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 N-CA-C 103.951 -2.611 . . . . 0.0 103.951 150.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.2 m -95.92 -17.18 21.25 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 174.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.546 ' HB3' ' HB2' ' A' ' 78' ' ' SER 0.273 40.7 tttp -139.26 157.61 45.6 Favored 'General case' 0 CA--C 1.563 1.449 0 CA-C-O 123.818 1.77 . . . . 0.0 110.549 -175.453 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.75 129.9 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 105.299 -2.112 . . . . 0.0 105.299 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.268 1.5 mp -78.51 132.74 64.68 Favored Pre-proline 0 CA--C 1.569 1.705 0 CA-C-O 118.35 -0.833 . . . . 0.0 108.921 169.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -62.9 133.26 40.73 Favored 'Trans proline' 0 C--N 1.367 1.525 0 C-N-CA 123.411 2.741 . . . . 0.0 114.682 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 71.63 4.9 59.19 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 118.383 2.113 . . . . 0.0 118.383 -169.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.642 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -82.79 -172.32 48.23 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.084 0.85 . . . . 0.0 114.119 -179.235 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.27 -48.77 76.75 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -174.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.443 ' HA ' HD11 ' A' ' 68' ' ' LEU . . . -70.05 -30.19 67.39 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 118.026 2.602 . . . . 0.0 118.026 176.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.5 -40.55 93.17 Favored 'General case' 0 CA--C 1.567 1.602 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 163.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.46 -61.47 1.97 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.565 1.546 . . . . 0.0 112.728 177.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.7 t70 . . . . . 0 N--CA 1.482 1.162 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 -177.869 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.482 ' O ' ' HA ' ' A' ' 95' ' ' PHE 0.307 11.0 t70 . . . . . 0 C--O 1.213 -0.816 0 CA-C-O 117.226 -1.368 . . . . 0.0 107.608 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 75.7 m -96.8 69.59 2.45 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 120.38 1.446 . . . . 0.0 110.799 -170.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.5 tp -67.29 115.67 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-O 121.867 0.841 . . . . 0.0 108.785 174.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.418 HD21 ' HB2' ' A' ' 149' ' ' MET . 3.1 pp -102.24 -40.57 6.72 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.435 1.642 . . . . 0.0 115.435 177.021 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -138.97 145.59 39.92 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 -175.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.572 HG21 HD22 ' A' ' 137' ' ' LEU . 4.2 t -132.94 113.42 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 102.753 -3.054 . . . . 0.0 102.753 -176.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.444 ' HA ' ' HB3' ' A' ' 145' ' ' ARG 0.341 11.3 m120 84.02 -85.1 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 123.342 1.544 . . . . 0.0 108.726 -179.665 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -156.11 -4.35 0.12 Allowed 'General case' 0 CA--C 1.565 1.522 0 CA-C-N 111.564 -2.562 . . . . 0.0 110.575 173.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.518 HG12 HG13 ' A' ' 125' ' ' VAL . 2.3 t -67.82 139.75 20.31 Favored 'Isoleucine or valine' 0 C--N 1.357 0.93 0 C-N-CA 125.29 1.436 . . . . 0.0 109.282 -178.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -81.74 71.32 8.76 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-N 111.288 -2.687 . . . . 0.0 112.939 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.539 HG11 ' HA ' ' A' ' 133' ' ' ALA 0.287 0.6 OUTLIER -82.79 -105.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-O 116.79 -1.576 . . . . 0.0 107.899 178.862 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.581 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.311 27.3 ptt85 49.3 -87.53 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 116.822 2.156 . . . . 0.0 116.822 179.636 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.581 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 27.6 tt0 -81.81 72.53 8.86 Favored 'General case' 0 CA--C 1.555 1.137 0 CA-C-O 123.418 1.58 . . . . 0.0 110.095 167.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.9 p -145.85 167.86 8.01 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 CA-C-N 113.403 -1.726 . . . . 0.0 106.71 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 7.0 m -59.42 132.75 54.93 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 114.044 -1.435 . . . . 0.0 110.2 157.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' HIS . . . . . 0.4 ' CE1' HD22 ' A' ' 85' ' ' ASN . 2.9 p-80 -48.12 -31.91 6.2 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 117.607 2.447 . . . . 0.0 117.607 169.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.57 ' HA ' HG12 ' A' ' 134' ' ' VAL . 13.9 m -61.91 -38.53 88.71 Favored 'General case' 0 CA--C 1.564 1.486 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 173.253 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -69.28 -34.14 74.28 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 115.656 1.725 . . . . 0.0 115.656 164.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.539 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -65.18 -52.65 53.61 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 170.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.57 HG12 ' HA ' ' A' ' 131' ' ' SER . 12.7 p -50.41 -46.43 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 164.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -55.0 -50.42 69.06 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-O 116.68 -1.629 . . . . 0.0 112.606 172.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.88 -31.94 72.26 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 117.148 2.277 . . . . 0.0 117.148 170.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.572 HD22 HG21 ' A' ' 120' ' ' VAL . 3.1 mm? -59.55 -51.69 68.74 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 165.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -66.92 -42.4 85.47 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 171.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -69.59 -12.47 61.67 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 117.431 2.382 . . . . 0.0 117.431 173.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.425 ' HB1' ' HA ' ' A' ' 144' ' ' VAL . . . -53.49 -19.73 4.03 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 118.661 2.837 . . . . 0.0 118.661 157.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 83.26 -140.17 19.62 Favored Glycine 0 C--N 1.345 1.03 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 11.0 m -70.35 -5.84 31.05 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 116.605 2.076 . . . . 0.0 116.605 173.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -147.8 110.84 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -170.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.561 HG23 ' HB3' ' A' ' 68' ' ' LEU . 11.9 m -84.2 115.97 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 114.071 -1.422 . . . . 0.0 109.401 171.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.444 ' HB3' ' HA ' ' A' ' 121' ' ' ASN . 7.8 tpp180 -90.55 107.23 19.03 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 170.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 79.2 mt -108.27 135.64 49.25 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -172.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -125.54 118.2 25.24 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 177.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.43 121.84 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -177.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' MET . . . . . 0.418 ' HB2' HD21 ' A' ' 118' ' ' LEU . 49.6 ttm . . . . . 0 N--CA 1.481 1.107 0 CA-C-O 122.16 0.981 . . . . 0.0 112.671 168.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.559 1.303 0 CA-C-O 122.68 1.229 . . . . 0.0 111.399 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -136.11 122.14 20.15 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 172.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 13.9 ttpp -95.88 112.78 24.42 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 113.923 -1.49 . . . . 0.0 107.583 173.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 4.6 m -76.28 131.02 39.0 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 172.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.94 105.46 17.78 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 178.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.483 HG12 HD13 ' A' ' 75' ' ' LEU . 11.7 t . . . . . 0 C--O 1.245 0.821 0 N-CA-C 102.363 -3.199 . . . . 0.0 102.363 -165.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.412 ' HB3' ' HB2' ' A' ' 149' ' ' MET . 26.3 p90 . . . . . 0 N--CA 1.481 1.091 0 CA-C-O 120.862 0.363 . . . . 0.0 110.254 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -122.04 133.73 54.79 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 122.617 1.198 . . . . 0.0 108.965 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -104.98 117.11 33.18 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 -176.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.606 HG13 ' HB2' ' A' ' 146' ' ' LEU . 3.1 pt -137.1 115.22 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 -168.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.9 m -94.77 130.26 41.39 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 171.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.6 HD11 ' HA ' ' A' ' 105' ' ' ALA . 0.5 OUTLIER -129.68 166.79 19.09 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 113.871 -1.513 . . . . 0.0 109.694 172.911 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 . . . . . 0 N--CA 1.478 0.958 0 CA-C-O 122.13 0.966 . . . . 0.0 110.686 175.178 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.527 HD23 HG11 ' A' ' 144' ' ' VAL . 1.5 mp . . . . . 0 N--CA 1.482 1.153 0 N-CA-C 110.547 -0.168 . . . . 0.0 110.547 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 136.59 25.91 0.43 Allowed Glycine 0 CA--C 1.542 1.77 0 CA-C-O 117.999 -1.445 . . . . 0.0 114.886 -175.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.497 ' HD1' HD11 ' A' ' 99' ' ' ILE . 0.0 OUTLIER -129.27 165.84 20.61 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 123.912 1.815 . . . . 0.0 107.72 172.744 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 35.2 m -111.94 143.98 42.02 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 154.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.723 HG22 HD13 ' A' ' 96' ' ' ILE . 2.4 pp -107.56 128.91 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 113.045 -1.889 . . . . 0.0 108.481 170.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -84.15 -166.26 1.38 Allowed 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 123.915 1.817 . . . . 0.0 108.633 162.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 85' ' ' ASN . . . -94.51 157.78 22.57 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 123.697 1.721 . . . . 0.0 113.835 -138.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -104.88 -163.85 24.08 Favored Glycine 0 CA--C 1.522 0.511 0 CA-C-N 111.349 -2.425 . . . . 0.0 113.0 178.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 61.0 p -51.16 -40.1 57.83 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 116.798 2.147 . . . . 0.0 116.798 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -88.03 -5.72 58.34 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 175.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.441 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 0.1 OUTLIER -149.49 82.88 6.65 Favored Pre-proline 0 CA--C 1.558 1.259 0 N-CA-C 101.747 -3.427 . . . . 0.0 101.747 177.308 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -106.75 128.52 0.05 OUTLIER 'Trans proline' 0 C--N 1.361 1.193 0 CA-C-N 125.298 2.928 . . . . 0.0 110.943 -173.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.4 ' HB2' ' CG ' ' B' ' 1' ' ' TYR . 10.6 t-160 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.56 0.695 . . . . 0.0 112.355 169.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo . . . . . 0 CA--C 1.555 1.556 0 N-CA-C 110.044 -0.791 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.9 m 76.15 110.21 0.07 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.058 1.343 . . . . 0.0 108.776 165.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.498 HG13 ' HB2' ' A' ' 133' ' ' ALA . 15.8 mm -73.28 129.53 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -119.2 153.54 34.77 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 112.993 -1.912 . . . . 0.0 108.981 -175.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.723 HD13 HG22 ' A' ' 79' ' ' ILE 0.258 10.9 mm -98.42 106.58 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.685 0 N-CA-C 100.24 -3.985 . . . . 0.0 100.24 170.39 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.543 HG21 ' HG2' ' B' ' 3' ' ' LYS . 10.0 t -93.45 -49.86 5.71 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 -173.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.94 136.18 44.05 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 169.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.497 HD11 ' HD1' ' A' ' 77' ' ' PHE . 0.9 OUTLIER -79.49 138.4 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 177.496 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.343 1.5 mp -72.88 115.57 41.44 Favored Pre-proline 0 CA--C 1.568 1.663 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 171.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -68.61 140.95 48.72 Favored 'Trans proline' 0 C--N 1.369 1.634 0 C-N-CA 123.328 2.685 . . . . 0.0 113.067 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.3 7.79 73.36 Favored Glycine 0 CA--C 1.552 2.399 0 N-CA-C 118.177 2.031 . . . . 0.0 118.177 -174.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -99.09 -165.76 30.09 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-N 119.217 1.509 . . . . 0.0 112.719 177.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 75' ' ' LEU . . . -62.03 -30.72 71.16 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 176.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.6 ' HA ' HD11 ' A' ' 68' ' ' LEU . . . -69.21 -40.85 77.77 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 116.873 2.175 . . . . 0.0 116.873 172.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.51 -41.63 96.29 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 170.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -72.96 -52.7 13.53 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 115.019 1.488 . . . . 0.0 115.019 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.0 t70 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 176.979 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.605 ' HB3' HG11 ' A' ' 148' ' ' VAL . 58.5 m-20 . . . . . 0 C--O 1.235 0.337 0 N-CA-C 103.288 -2.856 . . . . 0.0 103.288 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 21.5 m -84.64 82.52 8.38 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 114.414 -1.266 . . . . 0.0 109.508 -175.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.6 tp -64.21 123.09 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 CA-C-O 122.527 1.155 . . . . 0.0 111.441 -174.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.591 HD21 ' HB3' ' A' ' 149' ' ' MET . 0.0 OUTLIER -111.96 -53.28 2.72 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 112.334 -2.212 . . . . 0.0 112.053 174.896 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -122.63 133.66 54.52 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 -170.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.425 HG13 HD23 ' A' ' 146' ' ' LEU . 2.5 t -126.61 111.88 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 103.353 -2.832 . . . . 0.0 103.353 -178.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . 0.278 9.2 m120 81.5 -78.4 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 123.371 1.558 . . . . 0.0 109.496 178.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -152.18 -22.47 0.18 Allowed 'General case' 0 CA--C 1.576 1.955 0 C-N-CA 128.219 2.607 . . . . 0.0 109.618 175.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.3 t -59.56 137.64 21.7 Favored 'Isoleucine or valine' 0 C--N 1.362 1.145 0 C-N-CA 125.469 1.508 . . . . 0.0 110.911 176.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -105.6 103.35 12.84 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 113.022 -1.899 . . . . 0.0 108.437 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.426 HG11 ' HA ' ' A' ' 133' ' ' ALA 0.262 0.5 OUTLIER -97.48 -90.24 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-O 117.012 -1.47 . . . . 0.0 108.166 176.806 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.464 ' HB3' ' HB3' ' A' ' 118' ' ' LEU 0.32 23.1 ptt180 51.16 -88.37 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 117.351 2.352 . . . . 0.0 117.351 178.601 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.431 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 2.8 mp0 -85.58 67.13 9.98 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 123.505 1.621 . . . . 0.0 109.472 173.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.3 p -137.13 169.17 20.08 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-O 124.263 1.982 . . . . 0.0 105.924 -178.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 5.3 m -59.25 134.94 57.46 Favored 'General case' 0 CA--C 1.56 1.334 0 CA-C-N 112.701 -2.045 . . . . 0.0 110.643 157.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' HIS . . . . . 0.455 ' HA ' HD12 ' A' ' 94' ' ' ILE . 9.7 p-80 -45.78 -32.9 2.76 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 117.656 2.465 . . . . 0.0 117.656 169.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.475 ' HA ' HG12 ' A' ' 134' ' ' VAL . 9.4 m -63.41 -40.41 97.13 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 177.152 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -69.42 -36.74 76.98 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 168.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.498 ' HB2' HG13 ' A' ' 94' ' ' ILE . . . -67.23 -50.51 60.38 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 172.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.475 HG12 ' HA ' ' A' ' 131' ' ' SER . 2.7 p -52.96 -45.11 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 114.544 1.312 . . . . 0.0 114.544 166.197 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -60.42 -47.0 88.0 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-O 115.553 -2.165 . . . . 0.0 112.515 173.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.18 -35.97 82.52 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 117.044 2.239 . . . . 0.0 117.044 172.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.442 ' HB3' HG21 ' B' ' 6' ' ' VAL . 3.8 mm? -50.79 -54.26 25.04 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.299 1.04 . . . . 0.0 113.627 162.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -69.39 -38.45 78.01 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 174.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -63.4 -21.59 66.38 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 172.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.471 ' HB1' ' HA ' ' A' ' 144' ' ' VAL . . . -53.33 -22.81 7.87 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 118.674 2.842 . . . . 0.0 118.674 168.412 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 65.7 89.17 0.05 OUTLIER Glycine 0 C--N 1.351 1.384 0 CA-C-N 118.771 0.714 . . . . 0.0 114.5 155.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . 0.268 20.4 m 72.17 -30.3 0.21 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 118.02 2.6 . . . . 0.0 118.02 -172.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -146.82 110.72 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 -172.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.527 HG11 HD23 ' A' ' 75' ' ' LEU . 33.5 m -83.57 120.75 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.429 171.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -101.66 91.26 4.34 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 174.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.606 ' HB2' HG13 ' A' ' 66' ' ' ILE . 61.2 mt -95.31 137.9 33.74 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 122.536 1.16 . . . . 0.0 108.361 -172.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -127.67 124.64 38.42 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 175.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.605 HG11 ' HB3' ' A' ' 115' ' ' ASP . 28.6 m -134.13 115.91 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -163.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' MET . . . . . 0.591 ' HB3' HD21 ' A' ' 118' ' ' LEU . 32.9 ttm . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 -175.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 1' ' ' TYR . . . . . 0.4 ' CG ' ' HB2' ' A' ' 87' ' ' HIS . 1.0 OUTLIER . . . . . 0 CA--C 1.56 1.338 0 CA-C-O 122.964 1.364 . . . . 0.0 111.673 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.88 157.92 39.98 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 123.225 1.488 . . . . 0.0 109.904 168.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.543 ' HG2' HG21 ' A' ' 97' ' ' THR . 0.2 OUTLIER -103.04 136.55 42.64 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 113.603 -1.635 . . . . 0.0 106.853 172.131 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 88.5 m -102.5 136.08 42.98 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 167.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -78.61 140.82 38.4 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-O 123.667 1.699 . . . . 0.0 108.812 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.442 HG21 ' HB3' ' A' ' 137' ' ' LEU . 7.5 p . . . . . 0 C--O 1.243 0.731 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.494 ' HB3' ' HB2' ' A' ' 149' ' ' MET . 20.9 p90 . . . . . 0 CA--C 1.552 1.028 0 CA-C-O 121.491 0.663 . . . . 0.0 110.967 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -110.84 126.75 54.98 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.76 124.99 34.68 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.189 174.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.477 HG13 ' HB2' ' A' ' 146' ' ' LEU . 3.1 pt -137.95 108.28 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 -175.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.8 m -91.39 118.26 30.38 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 172.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.449 ' HB3' ' CG2' ' A' ' 144' ' ' VAL . 3.9 tp -115.42 167.4 10.9 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 113.977 -1.465 . . . . 0.0 108.198 174.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 . . . . . 0 N--CA 1.482 1.125 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 170.125 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.713 HD11 HG11 ' A' ' 144' ' ' VAL . 1.3 tt . . . . . 0 CA--C 1.573 1.829 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 110.91 16.84 9.47 Favored Glycine 0 N--CA 1.478 1.489 0 N-CA-C 117.559 1.783 . . . . 0.0 117.559 169.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.432 ' CE2' HD22 ' A' ' 75' ' ' LEU . 27.7 p90 -143.0 173.0 11.94 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 124.306 2.003 . . . . 0.0 108.5 171.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.7 m -122.12 155.09 36.45 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 123.705 1.717 . . . . 0.0 106.481 176.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.569 HG22 HD13 ' A' ' 96' ' ' ILE . 1.1 pt -121.72 127.05 75.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 111.635 -2.53 . . . . 0.0 109.107 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.37 -168.26 1.29 Allowed 'General case' 0 CA--C 1.556 1.187 0 CA-C-O 123.339 1.542 . . . . 0.0 109.995 159.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.39 159.9 26.48 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 123.409 1.56 . . . . 0.0 115.16 -145.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.37 -160.84 23.31 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-N 111.906 -2.147 . . . . 0.0 113.542 178.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.501 HG22 ' HB3' ' A' ' 92' ' ' PRO . 30.3 p -52.83 -41.2 64.0 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 -178.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -83.04 -8.83 59.5 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 176.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.01 96.98 2.09 Favored Pre-proline 0 CA--C 1.556 1.197 0 N-CA-C 102.32 -3.215 . . . . 0.0 102.32 -173.126 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -99.15 134.84 0.26 Allowed 'Trans proline' 0 CA--C 1.551 1.338 0 CA-C-N 123.96 2.45 . . . . 0.0 111.543 174.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.448 ' HB2' ' CD2' ' B' ' 1' ' ' TYR . 9.1 t-80 . . . . . 0 N--CA 1.498 1.926 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 155.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.501 ' HB3' HG22 ' A' ' 83' ' ' THR . 3.2 Cg_endo . . . . . 0 CA--C 1.547 1.141 0 CA-C-O 121.339 0.475 . . . . 0.0 112.511 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.6 m 78.22 107.67 0.07 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.461 1.104 . . . . 0.0 108.534 166.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.514 HG13 ' HB2' ' A' ' 133' ' ' ALA . 13.0 mm -74.99 127.51 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 106.376 -1.712 . . . . 0.0 106.376 -177.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -115.18 149.42 37.69 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 113.432 -1.713 . . . . 0.0 108.458 -175.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.569 HD13 HG22 ' A' ' 79' ' ' ILE . 22.3 mm -97.35 104.23 15.64 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.278 0 N-CA-C 104.388 -2.449 . . . . 0.0 104.388 171.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.545 HG21 ' HG3' ' B' ' 3' ' ' LYS . 12.2 t -79.51 -46.64 17.01 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 -177.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.0 ptmt -150.31 146.03 26.51 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.772 0.796 . . . . 0.0 111.099 -170.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.54 135.1 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 178.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.7 mp -82.9 117.62 69.14 Favored Pre-proline 0 CA--C 1.565 1.52 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 172.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.69 135.16 51.01 Favored 'Trans proline' 0 C--N 1.367 1.537 0 C-N-CA 123.442 2.761 . . . . 0.0 113.09 169.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 87.33 -9.97 70.98 Favored Glycine 0 CA--C 1.548 2.156 0 N-CA-C 117.707 1.843 . . . . 0.0 117.707 -169.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -85.91 -179.58 50.01 Favored Glycine 0 CA--C 1.538 1.472 0 CA-C-N 119.44 1.62 . . . . 0.0 113.602 175.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.09 -33.7 72.2 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 117.1 2.259 . . . . 0.0 117.1 -177.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.62 -35.18 68.0 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 118.567 2.803 . . . . 0.0 118.567 169.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.85 -32.04 71.43 Favored 'General case' 0 CA--C 1.558 1.274 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 171.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.02 -53.59 8.14 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 119.706 1.139 . . . . 0.0 112.827 172.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.2 t70 . . . . . 0 N--CA 1.484 1.24 0 C-N-CA 123.773 0.829 . . . . 0.0 112.555 -170.927 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 . . . . . 0 CA--C 1.535 0.382 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 64.3 m -88.93 89.92 8.19 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -175.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.486 HG12 HD11 ' A' ' 137' ' ' LEU . 6.7 tp -63.21 128.01 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.073 178.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.746 HD21 ' HB3' ' A' ' 149' ' ' MET . 0.0 OUTLIER -114.93 -54.15 2.59 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 112.422 -2.172 . . . . 0.0 114.421 177.076 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -119.79 134.65 55.16 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 -174.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.431 HG23 HD23 ' A' ' 146' ' ' LEU . 9.1 p -123.94 118.34 53.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 169.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . 0.298 9.1 m120 78.5 -81.25 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 122.953 1.359 . . . . 0.0 109.604 -177.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -152.91 -20.88 0.16 Allowed 'General case' 0 CA--C 1.568 1.659 0 C-N-CA 127.859 2.464 . . . . 0.0 110.177 -177.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.2 t -64.35 135.19 28.35 Favored 'Isoleucine or valine' 0 C--N 1.362 1.122 0 C-N-CA 125.318 1.447 . . . . 0.0 110.358 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -90.8 97.54 11.24 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 113.072 -1.877 . . . . 0.0 108.307 172.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.472 HG11 ' HA ' ' A' ' 133' ' ' ALA 0.282 0.2 OUTLIER -93.48 -93.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-O 116.447 -1.739 . . . . 0.0 107.159 170.263 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.554 ' HB3' ' HA ' ' A' ' 118' ' ' LEU 0.292 11.3 ptt180 48.39 -88.69 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 117.851 2.538 . . . . 0.0 117.851 178.615 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.521 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 1.7 tt0 -84.1 66.86 9.47 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-O 123.674 1.702 . . . . 0.0 108.804 172.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -139.7 169.96 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 CA-C-N 112.606 -2.088 . . . . 0.0 106.513 178.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 7.7 m -60.5 136.5 58.07 Favored 'General case' 0 CA--C 1.561 1.375 0 CA-C-N 113.439 -1.709 . . . . 0.0 110.843 159.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' HIS . . . . . 0.408 ' HA ' HD12 ' A' ' 94' ' ' ILE . 8.8 p-80 -45.3 -35.23 3.34 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 118.263 2.69 . . . . 0.0 118.263 170.308 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.477 ' HA ' HG12 ' A' ' 134' ' ' VAL . 79.0 p -60.31 -42.24 95.15 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 116.786 2.143 . . . . 0.0 116.786 172.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -70.68 -37.78 73.66 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 169.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.514 ' HB2' HG13 ' A' ' 94' ' ' ILE . . . -59.79 -55.49 33.66 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 169.036 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.477 HG12 ' HA ' ' A' ' 131' ' ' SER . 2.2 p -53.13 -46.84 55.77 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 170.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -60.55 -45.99 91.84 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 115.838 -2.03 . . . . 0.0 112.844 176.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.7 -34.57 78.61 Favored 'General case' 0 CA--C 1.558 1.278 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 171.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.486 HD11 HG12 ' A' ' 117' ' ' ILE . 9.6 mp -58.65 -46.55 86.9 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 165.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -70.33 -33.06 71.04 Favored 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 170.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -73.26 -14.96 61.42 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 116.455 2.02 . . . . 0.0 116.455 172.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.546 ' HB3' HG12 ' A' ' 144' ' ' VAL . . . -56.91 1.06 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.172 0 N-CA-C 119.227 3.047 . . . . 0.0 119.227 162.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 77.25 -146.51 31.92 Favored Glycine 0 C--N 1.344 1.019 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 176.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.8 m -72.0 -6.95 45.87 Favored 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 173.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -147.49 107.71 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 -165.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.713 HG11 HD11 ' A' ' 75' ' ' LEU . 23.1 m -92.48 123.91 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 114.073 -1.422 . . . . 0.0 108.612 -174.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -103.15 87.12 2.82 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.477 ' HB2' HG13 ' A' ' 66' ' ' ILE . 73.7 mt -91.33 133.9 35.05 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 -170.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -124.42 121.83 35.97 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 33.3 m -129.56 117.53 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -167.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' MET . . . . . 0.746 ' HB3' HD21 ' A' ' 118' ' ' LEU . 27.5 ttt . . . . . 0 N--CA 1.482 1.165 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -175.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 1' ' ' TYR . . . . . 0.448 ' CD2' ' HB2' ' A' ' 87' ' ' HIS . 0.3 OUTLIER . . . . . 0 CA--C 1.559 1.297 0 CA-C-O 122.887 1.327 . . . . 0.0 110.718 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 66.1 tttp -135.15 134.46 40.2 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-O 123.405 1.574 . . . . 0.0 108.205 165.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.545 ' HG3' HG21 ' A' ' 97' ' ' THR . 1.1 tmmt? -104.28 126.91 51.78 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 113.809 -1.541 . . . . 0.0 109.051 173.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.428 HG21 HG11 ' A' ' 134' ' ' VAL . 91.1 m -98.2 139.82 33.42 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 114.173 -1.376 . . . . 0.0 109.343 172.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -87.45 128.01 35.22 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 113.926 -1.488 . . . . 0.0 108.936 175.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.468 ' HB ' HG23 ' A' ' 134' ' ' VAL . 4.1 p . . . . . 0 C--O 1.248 1.025 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 175.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 8.8 p90 . . . . . 0 N--CA 1.481 1.078 0 CA-C-O 121.658 0.742 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -124.91 137.65 54.27 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 114.608 -1.178 . . . . 0.0 108.971 -177.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -103.27 132.3 49.64 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.66 175.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 21.0 pt -135.55 127.12 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -175.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.2 m -95.26 121.62 37.1 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 170.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 mp -119.75 126.9 52.18 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.373 -1.285 . . . . 0.0 107.632 -174.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.548 0.873 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.39 -172.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.606 HD23 HG12 ' B' ' 6' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.484 1.265 0 CA-C-O 118.558 -0.734 . . . . 0.0 111.363 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.553 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 104.06 37.71 2.86 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 117.427 1.731 . . . . 0.0 117.427 162.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.472 ' O ' ' HB ' ' B' ' 6' ' ' VAL . 0.0 OUTLIER -152.33 143.76 23.37 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 -172.42 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.464 ' CB ' ' HG2' ' A' ' 98' ' ' LYS . 50.1 m -106.91 122.25 46.04 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.572 -1.194 . . . . 0.0 108.538 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.555 HG22 HG12 ' A' ' 96' ' ' ILE . 5.1 pt -108.13 129.56 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 CA-C-O 121.674 0.749 . . . . 0.0 109.952 -171.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.434 ' HB1' ' CB ' ' A' ' 87' ' ' HIS . . . -86.57 -171.4 3.52 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-O 123.597 1.665 . . . . 0.0 111.281 158.291 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.44 159.65 21.15 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-O 123.713 1.73 . . . . 0.0 115.057 -137.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -102.77 -162.14 25.9 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 111.441 -2.38 . . . . 0.0 111.874 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 44.3 p -55.15 -40.38 70.53 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 116.922 2.193 . . . . 0.0 116.922 -174.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -75.51 -21.97 57.54 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 116.353 1.983 . . . . 0.0 116.353 174.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -145.28 95.94 4.98 Favored Pre-proline 0 CA--C 1.553 1.075 0 N-CA-C 101.498 -3.519 . . . . 0.0 101.498 -173.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -93.32 137.29 1.33 Allowed 'Trans proline' 0 CA--C 1.554 1.475 0 CA-C-N 124.079 2.493 . . . . 0.0 111.646 -177.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.434 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 23.2 t-80 . . . . . 0 N--CA 1.495 1.783 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 161.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo . . . . . 0 CA--C 1.545 1.056 0 CA-C-O 120.946 0.311 . . . . 0.0 112.113 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 66.8 m 73.17 138.6 0.05 Allowed 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 122.438 1.113 . . . . 0.0 109.323 176.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.428 HG13 ' HB2' ' A' ' 133' ' ' ALA . 15.0 mm -94.43 121.71 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 -169.039 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -124.57 138.17 54.34 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 -174.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.555 HG12 HG22 ' A' ' 79' ' ' ILE . 82.4 mt -82.35 122.98 37.83 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.627 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 169.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 89.3 m -93.57 -33.84 13.57 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 117.627 -1.177 . . . . 0.0 113.907 172.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.464 ' HG2' ' CB ' ' A' ' 78' ' ' SER 0.354 8.1 ptmm? -140.27 167.75 21.4 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-O 123.534 1.635 . . . . 0.0 110.885 173.351 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -109.14 129.22 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 103.835 -2.654 . . . . 0.0 103.835 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.427 ' HA ' ' HD2' ' A' ' 101' ' ' PRO 0.314 22.5 mt -83.74 121.76 76.26 Favored Pre-proline 0 CA--C 1.564 1.503 0 CA-C-O 117.915 -1.041 . . . . 0.0 108.789 175.142 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 100' ' ' ILE . 11.6 Cg_endo -55.96 141.18 86.48 Favored 'Trans proline' 0 C--N 1.371 1.746 0 C-N-CA 124.075 3.183 . . . . 0.0 115.581 178.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.95 15.04 79.83 Favored Glycine 0 CA--C 1.547 2.058 0 N-CA-C 117.27 1.668 . . . . 0.0 117.27 -164.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.553 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -89.23 176.83 43.9 Favored Glycine 0 C--N 1.34 0.772 0 C-N-CA 124.721 1.153 . . . . 0.0 115.578 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.37 -48.54 75.11 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 177.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.23 -34.0 74.16 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.69 -44.35 81.97 Favored 'General case' 0 CA--C 1.561 1.388 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 168.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.4 -65.4 0.82 Allowed 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 124.637 1.175 . . . . 0.0 111.791 176.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.2 t70 . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 115.478 1.659 . . . . 0.0 115.478 -174.142 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.3 p30 . . . . . 0 CA--C 1.542 0.651 0 N-CA-C 101.068 -3.678 . . . . 0.0 101.068 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.5 m -67.49 79.82 0.17 Allowed 'General case' 0 CA--C 1.554 1.108 0 CA-C-N 113.409 -1.723 . . . . 0.0 111.531 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.6 pt -70.14 100.61 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-O 123.406 1.574 . . . . 0.0 108.8 -176.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.8 pp -96.41 -38.7 9.93 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 112.909 -1.951 . . . . 0.0 114.94 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.445 ' HB2' ' HB2' ' A' ' 147' ' ' TYR . 20.9 m-85 -125.46 140.55 52.68 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 123.273 1.511 . . . . 0.0 107.067 177.144 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.462 HG21 HD22 ' A' ' 137' ' ' LEU . 3.5 t -134.0 113.04 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 102.259 -3.238 . . . . 0.0 102.259 -179.1 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . 0.32 11.4 m120 83.97 -78.05 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 123.934 1.826 . . . . 0.0 110.134 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -156.38 -23.9 0.1 Allowed 'General case' 0 CA--C 1.572 1.791 0 CA-C-N 110.472 -3.058 . . . . 0.0 109.276 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.3 t -61.73 138.78 21.71 Favored 'Isoleucine or valine' 0 C--N 1.361 1.066 0 C-N-CA 125.604 1.561 . . . . 0.0 111.087 -177.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -94.88 87.91 5.13 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 111.348 -2.66 . . . . 0.0 110.81 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.47 HG11 ' HA ' ' A' ' 133' ' ' ALA 0.287 0.5 OUTLIER -92.37 -98.52 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 CA-C-O 117.104 -1.427 . . . . 0.0 108.154 -179.942 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.546 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.315 15.1 ptt180 48.37 -89.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 -179.514 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.546 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 21.9 tt0 -74.68 75.49 2.05 Favored 'General case' 0 CA--C 1.557 1.237 0 CA-C-O 123.738 1.732 . . . . 0.0 110.323 166.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -155.0 164.35 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 -175.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 34.0 m -60.06 132.11 52.92 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-N 113.586 -1.643 . . . . 0.0 109.671 156.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -46.82 -31.45 3.05 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 118.212 2.671 . . . . 0.0 118.212 171.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.544 ' HA ' HG12 ' A' ' 134' ' ' VAL . 14.6 m -60.09 -38.59 83.37 Favored 'General case' 0 CA--C 1.561 1.375 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 173.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -71.07 -35.93 72.08 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 166.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.47 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -59.88 -53.71 54.74 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 168.146 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.544 HG12 ' HA ' ' A' ' 131' ' ' SER . 9.7 p -55.99 -41.92 69.73 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.444 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 166.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -57.57 -43.56 84.61 Favored 'General case' 0 CA--C 1.556 1.191 0 CA-C-O 117.626 -1.178 . . . . 0.0 113.458 171.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.14 -33.43 75.45 Favored 'General case' 0 CA--C 1.558 1.263 0 N-CA-C 116.397 1.999 . . . . 0.0 116.397 167.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.462 HD22 HG21 ' A' ' 120' ' ' VAL . 4.3 mm? -59.65 -50.96 71.85 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 165.451 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -65.98 -38.33 88.27 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 173.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -65.96 -28.46 68.92 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 116.353 1.983 . . . . 0.0 116.353 171.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.499 ' HB1' ' HA ' ' A' ' 144' ' ' VAL . . . -52.43 -33.21 43.01 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 117.443 2.386 . . . . 0.0 117.443 161.339 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 93.62 -120.15 6.19 Favored Glycine 0 C--N 1.345 1.051 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 166.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.3 m -86.71 0.29 54.91 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 117.426 2.38 . . . . 0.0 117.426 168.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.95 101.99 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 -170.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.499 ' HA ' ' HB1' ' A' ' 140' ' ' ALA . 15.5 m -88.02 118.64 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 114.04 -1.436 . . . . 0.0 109.654 176.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 40.8 mtt180 -98.58 87.65 3.87 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 178.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 53.3 mt -90.45 136.52 33.0 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -170.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.445 ' HB2' ' HB2' ' A' ' 119' ' ' PHE . 41.6 m-85 -122.72 120.39 33.49 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 104.515 -2.402 . . . . 0.0 104.515 178.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -123.44 120.62 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 -176.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 28.3 ttt . . . . . 0 N--CA 1.476 0.835 0 O-C-N 124.519 1.137 . . . . 0.0 109.982 162.449 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 1.3 p90 . . . . . 0 CA--C 1.56 1.342 0 CA-C-O 122.569 1.176 . . . . 0.0 110.741 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -132.99 133.99 43.87 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-O 123.017 1.389 . . . . 0.0 108.473 170.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -95.69 124.96 39.95 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 113.782 -1.554 . . . . 0.0 108.736 169.054 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 4.7 m -83.69 140.41 32.16 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 123.309 1.528 . . . . 0.0 109.21 167.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -98.99 105.79 17.97 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 104.889 -2.263 . . . . 0.0 104.889 -177.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.606 HG12 HD23 ' A' ' 75' ' ' LEU . 12.3 t . . . . . 0 C--O 1.256 1.428 0 CA-C-O 123.03 1.395 . . . . 0.0 107.803 -165.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.59 ' HB3' ' HG2' ' A' ' 149' ' ' MET . 13.3 p90 . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 121.368 0.604 . . . . 0.0 110.353 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -107.77 132.99 52.8 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.562 172.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.22 121.4 43.59 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 113.824 -1.535 . . . . 0.0 108.593 -177.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 13.5 pt -135.32 118.7 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 -174.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.7 m -89.96 124.2 34.53 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 168.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.534 HD21 ' HA ' ' A' ' 105' ' ' ALA . 1.5 tp -116.05 125.0 51.84 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 114.22 -1.354 . . . . 0.0 109.293 -171.435 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 . . . . . 0 N--CA 1.471 0.594 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.423 -176.094 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.49 HD22 HG12 ' B' ' 6' ' ' VAL . 1.6 mp . . . . . 0 CA--C 1.56 1.341 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.558 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 145.71 67.41 0.01 OUTLIER Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 167.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.45 ' CZ ' HD23 ' A' ' 75' ' ' LEU . 2.7 p90 -163.62 141.01 7.32 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 124.292 1.996 . . . . 0.0 108.772 176.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.416 ' HB2' ' HB3' ' A' ' 98' ' ' LYS . 15.8 m -92.85 128.22 38.63 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 112.208 -2.269 . . . . 0.0 110.846 -178.253 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.467 HG12 HG23 ' A' ' 134' ' ' VAL . 1.9 pp -103.63 125.74 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.866 178.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.552 ' HB3' ' HB2' ' A' ' 95' ' ' PHE . . . -74.86 -175.53 2.55 Favored 'General case' 0 CA--C 1.555 1.138 0 CA-C-O 123.624 1.678 . . . . 0.0 111.076 164.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 85' ' ' ASN . . . -99.03 155.73 20.01 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-O 123.591 1.662 . . . . 0.0 115.469 -141.019 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.13 -160.29 21.51 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 111.37 -2.415 . . . . 0.0 113.891 177.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 38.9 p -58.67 -38.7 78.74 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 115.578 1.695 . . . . 0.0 115.578 -174.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.561 ' HB3' HG23 ' A' ' 129' ' ' THR . 11.2 t70 -96.53 12.91 29.85 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 175.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.405 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 0.8 OUTLIER -163.67 76.83 1.71 Allowed Pre-proline 0 N--CA 1.481 1.103 0 N-CA-C 100.868 -3.753 . . . . 0.0 100.868 -179.756 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -100.12 127.58 0.14 Allowed 'Trans proline' 0 C--N 1.364 1.382 0 CA-C-N 125.198 2.892 . . . . 0.0 111.07 -166.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 41.7 t60 . . . . . 0 CA--C 1.566 1.593 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 162.412 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo . . . . . 0 CA--C 1.54 0.783 0 N-CA-C 113.634 0.59 . . . . 0.0 113.634 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.7 m -158.64 122.67 4.0 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 -173.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.46 HG13 ' CB ' ' A' ' 133' ' ' ALA . 21.0 mm -79.42 126.06 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 -173.315 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.552 ' HB2' ' HB3' ' A' ' 80' ' ' ALA . 22.8 m-30 -117.72 161.54 19.52 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.646 -1.615 . . . . 0.0 107.32 -176.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 89.2 mt -105.8 112.73 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 103.738 -2.69 . . . . 0.0 103.738 149.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.6 m -95.61 -18.64 20.4 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 169.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.416 ' HB3' ' HB2' ' A' ' 78' ' ' SER . 53.2 tttp -136.99 153.62 50.63 Favored 'General case' 0 CA--C 1.556 1.2 0 CA-C-O 124.301 2.0 . . . . 0.0 109.954 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.433 HG22 ' HB3' ' A' ' 105' ' ' ALA . 0.6 OUTLIER -113.43 125.63 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-N 112.98 -1.918 . . . . 0.0 105.947 175.959 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.279 1.4 mp -71.55 127.61 90.86 Favored Pre-proline 0 CA--C 1.567 1.6 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 171.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.57 130.75 41.69 Favored 'Trans proline' 0 C--N 1.365 1.399 0 C-N-CA 123.558 2.838 . . . . 0.0 115.141 176.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 72.98 9.87 76.68 Favored Glycine 0 CA--C 1.551 2.324 0 N-CA-C 118.306 2.082 . . . . 0.0 118.306 -169.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.558 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -84.98 -168.71 45.03 Favored Glycine 0 C--N 1.336 0.577 0 N-CA-C 115.625 1.01 . . . . 0.0 115.625 -176.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.81 -52.61 55.86 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.534 ' HA ' HD21 ' A' ' 68' ' ' LEU . . . -67.7 -37.46 82.31 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 115.887 -2.006 . . . . 0.0 114.491 173.361 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.72 -51.18 66.11 Favored 'General case' 0 CA--C 1.562 1.438 0 CA-C-N 121.366 1.894 . . . . 0.0 114.936 173.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.8 -60.93 3.06 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 125.182 1.393 . . . . 0.0 113.25 176.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.2 t70 . . . . . 0 CA--C 1.557 1.248 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -173.815 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . 0.267 17.2 t70 . . . . . 0 N--CA 1.468 0.448 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.8 m -139.33 92.02 2.55 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 -177.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.505 HD11 ' HB ' ' A' ' 120' ' ' VAL . 0.0 OUTLIER -78.31 121.66 31.67 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.29 0 CA-C-O 122.445 1.116 . . . . 0.0 109.692 170.277 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.911 HD11 ' H ' ' A' ' 149' ' ' MET . 0.0 OUTLIER -106.05 -46.98 3.95 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.337 1.055 . . . . 0.0 113.144 179.504 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.465 ' HD1' HD23 ' A' ' 118' ' ' LEU . 68.1 m-85 -120.39 141.26 50.27 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 175.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.505 ' HB ' HD11 ' A' ' 117' ' ' ILE . 7.7 p -128.66 122.17 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 170.184 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.432 ' HA ' ' HB2' ' A' ' 145' ' ' ARG 0.314 15.0 m120 79.19 -76.17 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 123.622 1.677 . . . . 0.0 110.767 -177.379 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -163.47 -20.85 0.04 OUTLIER 'General case' 0 CA--C 1.572 1.794 0 CA-C-N 111.291 -2.686 . . . . 0.0 109.778 -175.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.542 HG12 HG13 ' A' ' 125' ' ' VAL . 2.4 t -64.48 136.21 26.86 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.168 0 C-N-CA 125.334 1.453 . . . . 0.0 110.249 -177.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -88.69 80.92 7.14 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 112.237 -2.256 . . . . 0.0 110.392 175.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.546 HG11 ' HA ' ' A' ' 133' ' ' ALA . 0.2 OUTLIER -86.3 -89.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-O 117.074 -1.441 . . . . 0.0 107.892 179.735 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.595 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.305 11.6 ptt180 46.22 -92.96 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 124.993 1.317 . . . . 0.0 114.393 -177.661 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.595 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 16.3 mt-10 -84.2 66.79 9.49 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 123.866 1.793 . . . . 0.0 111.947 175.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.5 p -133.34 168.09 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 112.607 -2.088 . . . . 0.0 105.918 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.561 HG23 ' HB3' ' A' ' 84' ' ' ASP . 96.6 m -59.66 137.01 58.16 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-N 113.609 -1.632 . . . . 0.0 110.627 157.168 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' HIS . . . . . 0.433 ' HA ' HD12 ' A' ' 94' ' ' ILE . 3.4 p-80 -46.91 -37.62 9.19 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 171.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.458 ' H ' HG22 ' A' ' 129' ' ' THR . 7.9 m -56.23 -45.42 79.96 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 177.019 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.34 -39.06 88.96 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 171.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.546 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -68.04 -51.1 50.69 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 116.278 1.955 . . . . 0.0 116.278 171.356 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.818 HG22 HG21 ' B' ' 6' ' ' VAL . 0.3 OUTLIER -59.94 -39.35 79.88 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 N-CA-C 115.888 1.81 . . . . 0.0 115.888 173.035 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.409 ' HA ' ' HG2' ' A' ' 138' ' ' LYS . 1.0 OUTLIER -63.79 -42.77 97.67 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-O 117.223 -1.37 . . . . 0.0 113.051 167.123 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.71 -31.36 72.55 Favored 'General case' 0 CA--C 1.565 1.527 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 169.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.501 ' O ' ' HB3' ' A' ' 140' ' ' ALA . 8.5 mp -61.49 -55.48 30.59 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 125.52 1.528 . . . . 0.0 112.322 166.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.409 ' HG2' ' HA ' ' A' ' 135' ' ' GLU . 17.7 ptpt -64.01 -31.88 73.23 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 116.729 2.122 . . . . 0.0 116.729 170.337 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -66.44 -27.66 68.0 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 169.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.593 ' HB1' ' HA ' ' A' ' 144' ' ' VAL . . . -51.81 -42.67 62.68 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 115.826 1.787 . . . . 0.0 115.826 159.238 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 90.07 -129.03 9.52 Favored Glycine 0 C--N 1.349 1.275 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 165.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.0 t -72.26 -2.04 17.49 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 117.353 2.353 . . . . 0.0 117.353 168.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.97 107.56 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 -173.018 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.593 ' HA ' ' HB1' ' A' ' 140' ' ' ALA . 4.2 t -113.94 105.85 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 -169.375 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.432 ' HB2' ' HA ' ' A' ' 121' ' ' ASN . 99.2 mtt180 -89.65 92.11 8.94 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -178.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 22.1 mt -93.96 131.22 39.64 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 -175.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.428 ' O ' HD22 ' A' ' 118' ' ' LEU . 79.5 m-85 -120.15 128.39 53.38 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 104.686 -2.339 . . . . 0.0 104.686 -178.019 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -136.64 128.37 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' MET . . . . . 0.911 ' H ' HD11 ' A' ' 118' ' ' LEU . 63.9 mtm . . . . . 0 C--O 1.239 0.519 0 C-N-CA 127.016 2.126 . . . . 0.0 109.465 172.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.554 1.098 0 CA-C-O 123.33 1.538 . . . . 0.0 110.398 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 22.7 tptp -151.28 121.94 7.47 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 113.632 -1.622 . . . . 0.0 107.833 170.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 6.0 ptmm? -75.7 109.41 9.26 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 113.918 -1.492 . . . . 0.0 111.26 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 26.3 m -81.43 126.97 32.28 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 123.287 1.518 . . . . 0.0 108.884 -178.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.94 106.17 18.33 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 113.331 -1.759 . . . . 0.0 106.891 -174.082 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.818 HG21 HG22 ' A' ' 134' ' ' VAL . 42.8 t . . . . . 0 C--O 1.251 1.179 0 N-CA-C 105.218 -2.142 . . . . 0.0 105.218 -178.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 21.8 p90 . . . . . 0 N--CA 1.477 0.884 0 CA-C-O 121.857 0.837 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -98.42 126.39 43.93 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.47 125.37 35.15 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 113.368 -1.742 . . . . 0.0 108.199 173.253 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.474 ' HB ' ' HB2' ' A' ' 146' ' ' LEU . 19.0 mt -126.61 131.83 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 -176.222 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.3 m -106.6 120.69 42.63 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 171.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.4 tp -124.93 145.57 49.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 113.39 -1.732 . . . . 0.0 107.739 176.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.517 ' HG3' ' HB1' ' A' ' 104' ' ' ALA . 2.7 pt-20 . . . . . 0 CA--C 1.559 1.314 0 O-C-N 121.218 -0.926 . . . . 0.0 110.71 173.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.542 HD12 HG21 ' A' ' 144' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.51 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 76.1 50.48 7.61 Favored Glycine 0 C--N 1.338 0.663 0 N-CA-C 116.229 1.251 . . . . 0.0 116.229 175.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.489 ' HE1' HD23 ' A' ' 137' ' ' LEU . 17.8 p90 -155.2 149.29 25.8 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 123.172 1.463 . . . . 0.0 108.036 173.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.431 ' O ' HG23 ' A' ' 96' ' ' ILE . 3.6 m -97.31 136.07 38.32 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.164 177.41 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.409 HD11 ' HB ' ' A' ' 134' ' ' VAL . 1.2 pt -110.13 123.74 66.29 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-O 121.95 0.881 . . . . 0.0 109.576 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.417 ' HB2' ' OG1' ' A' ' 97' ' ' THR . . . -77.7 177.42 8.14 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-O 124.292 1.996 . . . . 0.0 110.247 157.096 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' A' ' 85' ' ' ASN . . . -96.75 164.71 22.99 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-O 124.24 2.022 . . . . 0.0 115.582 -140.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -102.78 -166.88 26.19 Favored Glycine 0 CA--C 1.521 0.465 0 CA-C-N 110.543 -2.828 . . . . 0.0 112.364 -175.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.443 HG22 ' HB3' ' A' ' 92' ' ' PRO . 63.1 p -44.57 -42.51 7.38 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 118.014 2.598 . . . . 0.0 118.014 -177.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -88.19 -7.6 56.61 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 115.993 1.849 . . . . 0.0 115.993 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.409 ' O ' ' HA3' ' A' ' 81' ' ' GLY 0.267 4.4 t30 -151.99 58.59 2.71 Favored Pre-proline 0 CA--C 1.571 1.755 0 CA-C-O 116.667 -1.635 . . . . 0.0 107.632 -178.508 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -97.57 135.04 0.37 Allowed 'Trans proline' 0 C--N 1.373 1.83 0 CA-C-N 126.282 3.279 . . . . 0.0 111.538 -170.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.554 ' HB2' ' CG ' ' B' ' 1' ' ' TYR . 7.9 t-80 . . . . . 0 N--CA 1.502 2.169 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 163.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.443 ' HB3' HG22 ' A' ' 83' ' ' THR . 23.6 Cg_endo . . . . . 0 CA--C 1.558 1.708 0 N-CA-C 110.403 -0.653 . . . . 0.0 110.403 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 53.1 m 75.71 134.72 0.05 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.991 1.316 . . . . 0.0 109.816 165.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.404 HG13 ' HB2' ' A' ' 133' ' ' ALA . 23.4 mm -96.14 124.44 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 105.812 -1.921 . . . . 0.0 105.812 -172.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -129.6 126.22 37.96 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -175.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.431 HG23 ' O ' ' A' ' 78' ' ' SER 0.349 60.2 mt -66.44 129.6 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.287 0 CA-C-O 122.895 1.331 . . . . 0.0 108.648 174.002 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.417 ' OG1' ' HB2' ' A' ' 80' ' ' ALA . 4.4 m -87.69 -41.4 13.38 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 124.846 1.258 . . . . 0.0 113.325 171.217 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -140.4 160.95 38.86 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 124.174 1.94 . . . . 0.0 110.465 -175.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -114.4 109.93 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 102.365 -3.198 . . . . 0.0 102.365 174.111 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.254 1.5 mp -66.71 121.28 76.74 Favored Pre-proline 0 CA--C 1.564 1.516 0 CA-C-O 117.774 -1.107 . . . . 0.0 109.395 -177.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -63.22 138.05 64.58 Favored 'Trans proline' 0 C--N 1.364 1.387 0 C-N-CA 123.373 2.715 . . . . 0.0 113.387 172.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.45 -6.83 56.49 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 117.977 1.951 . . . . 0.0 117.977 -168.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.51 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -90.01 176.81 42.64 Favored Glycine 0 CA--C 1.537 1.439 0 CA-C-O 122.435 1.019 . . . . 0.0 113.025 174.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.517 ' HB1' ' HG3' ' A' ' 69' ' ' GLU . . . -67.52 -36.82 81.77 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 117.332 2.345 . . . . 0.0 117.332 -175.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.402 ' HB2' ' HD2' ' A' ' 77' ' ' PHE . . . -68.06 -35.37 78.1 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 116.37 1.989 . . . . 0.0 116.37 168.085 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.8 -31.72 69.79 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 115.524 1.675 . . . . 0.0 115.524 166.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.34 -61.61 1.77 Allowed 'General case' 0 CA--C 1.566 1.584 0 C-N-CA 124.581 1.152 . . . . 0.0 111.739 171.064 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.8 t70 . . . . . 0 CA--C 1.556 1.209 0 C-N-CA 124.901 1.281 . . . . 0.0 112.369 -173.723 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 20.4 t70 . . . . . 0 C--O 1.24 0.581 0 N-CA-C 100.292 -3.966 . . . . 0.0 100.292 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.2 m -71.52 78.13 0.79 Allowed 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 113.026 -1.897 . . . . 0.0 109.982 -173.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 5.1 tp -73.86 109.97 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -174.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.733 HD21 ' HB3' ' A' ' 149' ' ' MET . 0.2 OUTLIER -110.0 -47.61 3.3 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 113.171 -1.831 . . . . 0.0 114.157 -175.224 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -116.87 136.5 52.9 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 172.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 14.0 p -124.86 123.73 66.33 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 170.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . 0.302 13.0 m120 77.85 -84.46 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 123.757 1.741 . . . . 0.0 108.921 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -151.57 -22.14 0.2 Allowed 'General case' 0 CA--C 1.574 1.882 0 CA-C-N 110.82 -2.9 . . . . 0.0 109.131 -176.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.416 HG12 HG13 ' A' ' 125' ' ' VAL . 2.3 t -68.41 136.71 25.91 Favored 'Isoleucine or valine' 0 C--N 1.363 1.155 0 C-N-CA 125.781 1.632 . . . . 0.0 110.224 -178.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -89.5 98.98 12.08 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 111.999 -2.364 . . . . 0.0 108.457 170.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.543 HG11 ' HA ' ' A' ' 133' ' ' ALA 0.26 0.4 OUTLIER -95.01 -98.36 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 173.233 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.513 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.287 16.1 ptt85 51.7 -92.39 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 116.855 2.169 . . . . 0.0 116.855 176.965 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.513 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 8.5 tt0 -77.65 64.54 2.97 Favored 'General case' 0 CA--C 1.56 1.34 0 CA-C-O 123.648 1.689 . . . . 0.0 110.967 167.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -139.02 167.6 20.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 2.7 m -58.84 134.46 56.91 Favored 'General case' 0 CA--C 1.557 1.222 0 CA-C-N 112.697 -2.047 . . . . 0.0 110.7 157.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -45.41 -32.72 2.23 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 117.499 2.407 . . . . 0.0 117.499 168.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.9 m -60.55 -43.12 97.58 Favored 'General case' 0 CA--C 1.556 1.203 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 175.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -69.67 -37.36 76.64 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 167.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.543 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -60.25 -59.27 5.68 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 170.418 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.409 ' HB ' HD11 ' A' ' 79' ' ' ILE . 0.9 OUTLIER -50.81 -42.44 23.03 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 N-CA-C 116.43 2.011 . . . . 0.0 116.43 171.521 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.65 -48.18 75.75 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 116.317 -1.801 . . . . 0.0 112.607 174.279 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.51 -28.51 66.11 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 117.23 2.307 . . . . 0.0 117.23 174.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.489 HD23 ' HE1' ' A' ' 77' ' ' PHE . 5.0 mp -54.98 -53.5 54.86 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.159 1.383 . . . . 0.0 113.402 163.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -73.41 -38.58 65.52 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 172.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -65.93 0.11 2.01 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 116.549 2.055 . . . . 0.0 116.549 169.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.527 ' HB1' ' HA ' ' A' ' 144' ' ' VAL . . . -56.8 -9.96 0.93 Allowed 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 120.315 3.45 . . . . 0.0 120.315 162.088 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 102.69 -105.25 2.72 Favored Glycine 0 C--N 1.342 0.886 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 161.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.6 m -113.43 -7.83 13.43 Favored 'General case' 0 CA--C 1.576 1.943 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 163.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.19 111.98 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 -165.269 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.542 HG21 HD12 ' A' ' 75' ' ' LEU . 3.4 t -96.94 116.81 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 112.676 -2.056 . . . . 0.0 107.553 -174.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -99.83 91.07 4.66 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 177.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.474 ' HB2' ' HB ' ' A' ' 66' ' ' ILE . 22.9 mt -83.16 135.16 34.9 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -128.55 126.15 39.75 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.3 p -132.48 116.69 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 -173.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' MET . . . . . 0.733 ' HB3' HD21 ' A' ' 118' ' ' LEU . 25.2 ttt . . . . . 0 N--CA 1.474 0.726 0 CA-C-O 123.201 1.477 . . . . 0.0 108.516 168.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 1' ' ' TYR . . . . . 0.554 ' CG ' ' HB2' ' A' ' 87' ' ' HIS . 0.4 OUTLIER . . . . . 0 CA--C 1.557 1.224 0 CA-C-O 122.227 1.013 . . . . 0.0 111.548 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -127.8 144.97 51.07 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 123.414 1.578 . . . . 0.0 107.707 165.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -101.26 126.69 48.03 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.03 176.529 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 98.4 m -97.38 130.94 44.47 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.031 172.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -76.66 138.98 40.38 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 113.964 -1.471 . . . . 0.0 109.564 170.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 6.0 p . . . . . 0 C--O 1.254 1.301 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.012 172.997 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 25.1 p90 . . . . . 0 N--CA 1.479 1.012 0 CA-C-O 121.995 0.902 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -109.5 145.53 36.11 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 113.99 -1.459 . . . . 0.0 108.848 176.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -107.52 121.57 44.9 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 112.658 -2.065 . . . . 0.0 106.095 -175.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.6 mp -130.64 128.26 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 -176.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.1 m -100.35 132.56 45.65 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 122.838 1.304 . . . . 0.0 107.547 163.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.444 HD11 ' HA ' ' A' ' 105' ' ' ALA . 9.6 tt -130.05 130.16 44.57 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 113.141 -1.845 . . . . 0.0 107.83 -169.241 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 . . . . . 0 N--CA 1.481 1.109 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 177.912 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.615 HD21 HG22 ' B' ' 6' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.56 1.355 0 CA-C-O 119.342 -0.361 . . . . 0.0 111.465 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.443 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 65.18 51.67 47.94 Favored Glycine 0 C--N 1.346 1.11 0 N-CA-C 117.279 1.671 . . . . 0.0 117.279 166.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.482 ' CD1' HD13 ' A' ' 96' ' ' ILE . 1.7 p90 -155.3 157.95 38.0 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 112.929 -1.635 . . . . 0.0 107.376 173.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.431 ' HB2' ' HB3' ' A' ' 98' ' ' LYS . 4.0 m -122.28 126.87 49.07 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 122.484 1.135 . . . . 0.0 109.341 -173.196 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.622 HG22 HG12 ' A' ' 96' ' ' ILE . 2.0 pt -91.33 127.77 43.5 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-N 113.444 -1.707 . . . . 0.0 109.309 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -83.87 -175.54 5.86 Favored 'General case' 0 CA--C 1.555 1.167 0 CA-C-O 123.641 1.686 . . . . 0.0 110.291 156.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.14 157.35 24.08 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 123.161 1.423 . . . . 0.0 116.58 -140.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -108.84 -169.36 20.84 Favored Glycine 0 N--CA 1.466 0.663 0 CA-C-N 111.914 -2.143 . . . . 0.0 114.289 178.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.585 HG22 ' HB2' ' A' ' 92' ' ' PRO . 18.2 p -43.69 -44.59 6.58 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 117.952 2.575 . . . . 0.0 117.952 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.412 ' HB3' HG23 ' A' ' 129' ' ' THR . 35.6 t70 -85.55 -15.24 43.32 Favored 'General case' 0 CA--C 1.564 1.506 0 N-CA-C 115.915 1.82 . . . . 0.0 115.915 177.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -150.64 73.92 8.8 Favored Pre-proline 0 CA--C 1.562 1.41 0 N-CA-C 103.893 -2.632 . . . . 0.0 103.893 -176.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -107.59 144.09 0.07 OUTLIER 'Trans proline' 0 C--N 1.374 1.915 0 CA-C-N 124.656 2.699 . . . . 0.0 112.446 -169.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 15.1 t60 . . . . . 0 N--CA 1.498 1.961 0 N-CA-C 114.695 1.369 . . . . 0.0 114.695 161.216 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.585 ' HB2' HG22 ' A' ' 83' ' ' THR . 19.1 Cg_endo . . . . . 0 CA--C 1.551 1.341 0 CA-C-O 121.593 0.58 . . . . 0.0 112.503 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 74.7 m -150.67 139.33 20.67 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 -179.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.49 HG13 ' HB2' ' A' ' 133' ' ' ALA . 31.5 mm -79.65 129.76 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 175.059 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.484 ' HA ' ' O ' ' A' ' 115' ' ' ASP 0.276 4.9 p90 -135.49 122.06 20.77 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 113.824 -1.534 . . . . 0.0 110.994 -177.067 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.622 HG12 HG22 ' A' ' 79' ' ' ILE . 71.0 mt -74.75 109.86 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 168.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 12.8 m -94.64 -14.62 24.73 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 114.978 -1.01 . . . . 0.0 113.714 172.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.431 ' HB3' ' HB2' ' A' ' 78' ' ' SER . 29.5 tttp -139.53 150.12 44.72 Favored 'General case' 0 CA--C 1.557 1.243 0 CA-C-O 124.356 2.027 . . . . 0.0 110.343 -175.247 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -117.2 125.02 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 N-CA-C 103.924 -2.621 . . . . 0.0 103.924 174.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.5 mp -74.14 133.55 78.24 Favored Pre-proline 0 CA--C 1.566 1.572 0 CA-C-O 118.518 -0.754 . . . . 0.0 109.324 171.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.5 132.87 40.0 Favored 'Trans proline' 0 CA--C 1.554 1.512 0 C-N-CA 123.301 2.668 . . . . 0.0 113.687 171.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.19 11.93 85.08 Favored Glycine 0 CA--C 1.546 2.028 0 N-CA-C 117.383 1.713 . . . . 0.0 117.383 -164.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.443 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -84.09 170.75 47.67 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-O 123.086 1.381 . . . . 0.0 114.244 177.049 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.21 -43.98 89.79 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 112.286 -1.957 . . . . 0.0 115.387 178.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.444 ' HA ' HD11 ' A' ' 68' ' ' LEU . . . -67.17 -32.93 74.35 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 118.496 2.776 . . . . 0.0 118.496 173.459 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.37 -39.01 91.75 Favored 'General case' 0 CA--C 1.567 1.598 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 165.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -67.32 -60.93 2.18 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.378 1.471 . . . . 0.0 113.042 173.51 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 N--CA 1.487 1.413 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -172.795 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.484 ' O ' ' HA ' ' A' ' 95' ' ' PHE 0.278 8.3 t70 . . . . . 0 N--CA 1.474 0.749 0 CA-C-O 117.729 -1.129 . . . . 0.0 109.127 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 48.5 m -72.61 74.67 1.08 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.411 1.084 . . . . 0.0 113.246 -169.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.0 tp -67.68 103.95 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 171.024 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.568 ' HA ' ' HB3' ' A' ' 126' ' ' ARG 0.293 1.0 OUTLIER -91.18 -54.96 3.72 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 113.104 -1.862 . . . . 0.0 113.145 177.632 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.427 ' H ' HD12 ' A' ' 118' ' ' LEU . 20.2 m-85 -118.28 138.92 52.04 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 105.358 -2.089 . . . . 0.0 105.358 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.8 p -127.28 114.9 38.66 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 170.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.456 ' HA ' ' HB2' ' A' ' 145' ' ' ARG 0.352 9.8 m120 80.05 -83.03 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 123.489 1.614 . . . . 0.0 109.7 -177.704 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -148.3 -25.68 0.34 Allowed 'General case' 0 CA--C 1.566 1.579 0 CA-C-N 111.126 -2.761 . . . . 0.0 109.411 -178.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.426 ' CG1' HG13 ' A' ' 125' ' ' VAL . 2.3 t -61.75 135.72 26.02 Favored 'Isoleucine or valine' 0 C--N 1.362 1.119 0 C-N-CA 125.385 1.474 . . . . 0.0 110.286 174.054 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -97.92 72.29 2.22 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 112.117 -2.311 . . . . 0.0 109.852 175.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.586 HG11 ' HA ' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -63.21 -86.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 116.243 -1.837 . . . . 0.0 110.401 176.73 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.786 ' HD2' ' H ' ' A' ' 127' ' ' GLU 0.325 0.1 OUTLIER 49.22 -98.58 0.05 Allowed 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 120.269 1.395 . . . . 0.0 113.353 171.827 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.786 ' H ' ' HD2' ' A' ' 126' ' ' ARG . 10.2 mt-10 -80.64 69.13 7.08 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 126.695 1.998 . . . . 0.0 110.414 174.207 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.8 p -139.11 169.3 17.61 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 CA-C-N 112.87 -1.968 . . . . 0.0 106.093 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.422 HG22 ' H ' ' A' ' 131' ' ' SER . 46.8 m -60.15 135.21 57.65 Favored 'General case' 0 CA--C 1.558 1.288 0 CA-C-N 113.16 -1.836 . . . . 0.0 110.624 157.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' HIS . . . . . 0.456 ' HA ' HD12 ' A' ' 94' ' ' ILE . 3.6 p-80 -46.15 -35.31 4.94 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 170.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.467 ' HA ' HG12 ' A' ' 134' ' ' VAL . 5.2 m -62.69 -43.04 99.81 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 125.311 1.444 . . . . 0.0 114.761 176.244 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.16 -37.33 87.07 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 169.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.586 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -69.66 -50.93 39.37 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 116.466 2.024 . . . . 0.0 116.466 172.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.467 HG12 ' HA ' ' A' ' 131' ' ' SER . 3.3 p -52.17 -42.67 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.475 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 170.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -72.82 -38.46 67.15 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 115.506 -2.188 . . . . 0.0 113.503 174.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.17 -34.05 77.16 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 116.937 2.199 . . . . 0.0 116.937 170.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.448 HD21 HD11 ' A' ' 96' ' ' ILE . 7.8 mp -55.59 -49.13 73.59 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.491 1.516 . . . . 0.0 114.939 162.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -68.05 -35.74 78.73 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 168.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.49 -20.76 66.12 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 173.114 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.556 ' HB1' ' HA ' ' A' ' 144' ' ' VAL . . . -52.86 -11.67 0.25 Allowed 'General case' 0 CA--C 1.561 1.377 0 N-CA-C 118.527 2.788 . . . . 0.0 118.527 161.257 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 79.97 -143.29 25.16 Favored Glycine 0 C--N 1.347 1.188 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 174.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 17.3 m -71.34 -4.52 26.56 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 116.691 2.108 . . . . 0.0 116.691 173.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.07 107.81 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 -170.315 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.556 ' HA ' ' HB1' ' A' ' 140' ' ' ALA . 3.5 t -93.66 114.84 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 113.797 -1.547 . . . . 0.0 108.24 -174.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.456 ' HB2' ' HA ' ' A' ' 121' ' ' ASN . 75.0 mtt-85 -96.39 94.82 7.65 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 -177.214 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 34.0 mt -99.58 138.82 36.14 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 122.069 0.938 . . . . 0.0 109.043 -170.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -128.78 115.82 18.54 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.24 129.15 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -173.356 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' MET . . . . . 0.426 ' HB2' HD21 ' A' ' 118' ' ' LEU . 28.0 ttt . . . . . 0 CA--C 1.548 0.879 0 CA-C-O 123.307 1.527 . . . . 0.0 112.503 164.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 1.1 p90 . . . . . 0 N--CA 1.478 0.961 0 CA-C-O 122.977 1.37 . . . . 0.0 112.828 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 2' ' ' LYS . . . . . 0.554 ' HA ' ' HE3' ' B' ' 2' ' ' LYS . 0.3 OUTLIER -136.6 144.86 44.34 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 112.738 -2.028 . . . . 0.0 110.888 166.919 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.415 ' HB3' ' HE3' ' B' ' 3' ' ' LYS . 10.0 ttpp -92.24 109.97 21.35 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 113.534 -1.667 . . . . 0.0 108.481 178.397 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 98.7 m -88.38 131.93 34.65 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 122.401 1.096 . . . . 0.0 108.784 175.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.11 155.48 32.36 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 113.848 -1.524 . . . . 0.0 109.971 175.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.615 HG22 HD21 ' A' ' 75' ' ' LEU . 7.7 p . . . . . 0 C--O 1.247 0.957 0 N-CA-C 104.392 -2.447 . . . . 0.0 104.392 -171.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 14.5 p90 . . . . . 0 CA--C 1.558 1.258 0 CA-C-O 121.272 0.558 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -126.66 135.49 51.24 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 122.099 0.952 . . . . 0.0 108.846 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.27 120.62 42.85 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.059 -174.269 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.6 mp -135.1 125.32 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 -172.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.9 m -98.8 122.53 42.16 Favored 'General case' 0 CA--C 1.557 1.213 0 CA-C-O 122.338 1.066 . . . . 0.0 108.302 173.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 mp -118.26 127.21 53.51 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.576 1.55 . . . . 0.0 108.594 -174.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 . . . . . 0 N--CA 1.476 0.875 0 CA-C-O 121.223 0.535 . . . . 0.0 110.154 -178.837 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.607 ' HB2' HG13 ' B' ' 6' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 119.319 -0.372 . . . . 0.0 111.753 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.553 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 103.14 41.2 2.29 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 115.848 1.099 . . . . 0.0 115.848 164.027 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -158.32 127.2 5.56 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 123.425 1.583 . . . . 0.0 107.435 -175.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.3 m -87.56 137.45 32.32 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 121.246 -0.908 . . . . 0.0 111.126 174.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.451 HD11 ' HB ' ' A' ' 134' ' ' VAL . 2.5 pp -118.02 130.25 73.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 114.403 -1.271 . . . . 0.0 107.978 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -92.38 -169.68 2.29 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-O 123.288 1.518 . . . . 0.0 109.871 160.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.69 159.41 24.78 Favored Glycine 0 CA--C 1.537 1.459 0 CA-C-O 123.551 1.64 . . . . 0.0 115.783 -140.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.11 -162.26 21.87 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 111.606 -2.297 . . . . 0.0 112.316 -176.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 67.8 p -54.02 -41.11 67.65 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 117.373 2.361 . . . . 0.0 117.373 -177.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -75.51 -15.64 60.37 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 116.469 2.025 . . . . 0.0 116.469 173.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -152.77 86.05 4.29 Favored Pre-proline 0 CA--C 1.56 1.343 0 N-CA-C 101.585 -3.487 . . . . 0.0 101.585 -177.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -99.41 125.02 0.15 Allowed 'Trans proline' 0 CA--C 1.547 1.126 0 CA-C-N 124.241 2.55 . . . . 0.0 110.533 -170.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 60.7 t60 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 174.279 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo . . . . . 0 CA--C 1.551 1.36 0 N-CA-C 110.805 -0.498 . . . . 0.0 110.805 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 43.6 m 70.7 144.04 0.06 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 122.667 1.222 . . . . 0.0 109.204 175.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.545 HG13 ' HB2' ' A' ' 133' ' ' ALA . 10.1 mm -91.78 126.05 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 -174.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -124.83 142.1 51.66 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 -178.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.418 HG12 HG22 ' A' ' 79' ' ' ILE 0.254 46.9 mt -85.32 119.52 34.08 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.541 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 175.023 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 91.8 m -85.92 -33.21 21.25 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 117.806 -1.093 . . . . 0.0 113.476 169.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . 0.285 0.0 OUTLIER -141.01 163.66 32.38 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-O 124.779 2.228 . . . . 0.0 111.324 179.218 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.495 HG22 ' HB3' ' A' ' 105' ' ' ALA . 0.9 OUTLIER -104.18 119.87 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 166.323 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 24.0 mm -65.68 127.77 93.3 Favored Pre-proline 0 CA--C 1.566 1.58 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.164 178.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.74 129.06 32.62 Favored 'Trans proline' 0 C--N 1.365 1.406 0 C-N-CA 123.606 2.871 . . . . 0.0 115.286 -178.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.49 11.39 80.09 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 118.54 2.176 . . . . 0.0 118.54 -170.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.553 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -92.35 -175.92 41.9 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 124.546 1.069 . . . . 0.0 113.937 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.4 -51.96 63.62 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 117.146 2.276 . . . . 0.0 117.146 -171.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.495 ' HB3' HG22 ' A' ' 99' ' ' ILE . . . -56.04 -33.19 64.72 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 175.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -67.09 -44.74 79.23 Favored 'General case' 0 CA--C 1.563 1.457 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 169.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.33 -54.55 6.33 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 123.638 0.775 . . . . 0.0 112.306 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 . . . . . 0 N--CA 1.486 1.358 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -179.051 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 2.7 p30 . . . . . 0 CA--C 1.552 1.056 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.401 ' HB2' ' HB3' ' A' ' 149' ' ' MET . 40.0 m -127.81 79.61 1.91 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 176.649 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.42 HG23 ' HB ' ' A' ' 94' ' ' ILE . 7.5 tp -56.45 116.55 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-O 121.997 0.904 . . . . 0.0 110.666 -178.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.608 HD23 ' HB2' ' A' ' 149' ' ' MET . 3.0 pp -110.19 -47.85 3.25 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 116.785 2.143 . . . . 0.0 116.785 -174.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.453 ' HB2' ' HB2' ' A' ' 147' ' ' TYR . 47.9 m-85 -126.64 138.07 53.38 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 177.122 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.465 HG21 HD12 ' A' ' 137' ' ' LEU . 3.1 t -128.44 109.8 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 100.543 -3.873 . . . . 0.0 100.543 175.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.522 ' HA ' ' HG3' ' A' ' 145' ' ' ARG 0.378 9.2 m120 83.3 -88.48 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 122.921 1.343 . . . . 0.0 109.389 179.86 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -145.26 -13.82 0.52 Allowed 'General case' 0 CA--C 1.567 1.627 0 CA-C-N 111.401 -2.636 . . . . 0.0 110.59 175.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.509 HG12 HG13 ' A' ' 125' ' ' VAL . 2.3 t -67.58 133.03 32.18 Favored 'Isoleucine or valine' 0 C--N 1.359 0.994 0 C-N-CA 125.431 1.492 . . . . 0.0 109.997 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -84.19 98.09 9.75 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 112.476 -2.147 . . . . 0.0 109.599 172.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.601 HG11 ' HA ' ' A' ' 133' ' ' ALA 0.258 2.0 m -97.51 -103.26 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-O 116.281 -1.818 . . . . 0.0 106.97 173.173 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.536 ' HB3' ' HA ' ' A' ' 118' ' ' LEU 0.289 13.2 ptt180 50.4 -93.33 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 120.217 1.371 . . . . 0.0 114.237 179.585 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.479 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 2.4 tt0 -79.25 68.68 5.3 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-O 123.425 1.583 . . . . 0.0 111.031 173.189 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.8 p -144.3 168.89 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.96 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 -173.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.419 HG22 ' H ' ' A' ' 131' ' ' SER . 27.4 m -61.76 130.86 47.81 Favored 'General case' 0 CA--C 1.559 1.3 0 CA-C-N 113.119 -1.855 . . . . 0.0 110.038 156.334 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' HIS . . . . . 0.419 ' HA ' HD12 ' A' ' 94' ' ' ILE . 2.5 p80 -47.7 -29.44 3.05 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 118.587 2.81 . . . . 0.0 118.587 169.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.519 ' HA ' HG12 ' A' ' 134' ' ' VAL . 8.1 m -63.09 -37.91 89.07 Favored 'General case' 0 CA--C 1.565 1.543 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 171.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -70.25 -36.13 74.27 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 165.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.601 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -61.19 -55.61 30.26 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 114.695 1.368 . . . . 0.0 114.695 169.581 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.519 HG12 ' HA ' ' A' ' 131' ' ' SER . 2.3 p -53.1 -40.55 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.162 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 169.056 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -58.17 -52.19 66.59 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 116.311 -1.804 . . . . 0.0 112.691 168.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.68 -35.62 74.83 Favored 'General case' 0 CA--C 1.561 1.391 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 173.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.513 HD23 HG11 ' B' ' 6' ' ' VAL . 9.6 mp -54.46 -53.92 47.86 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 125.296 1.438 . . . . 0.0 113.813 164.315 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.437 ' HA ' HD21 ' A' ' 75' ' ' LEU . 88.6 mttt -68.41 -33.54 74.4 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 116.507 2.04 . . . . 0.0 116.507 172.464 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -64.11 -32.19 73.66 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 115.17 1.544 . . . . 0.0 115.17 171.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.593 ' HB1' ' HA ' ' A' ' 144' ' ' VAL . . . -52.91 -36.57 59.69 Favored 'General case' 0 CA--C 1.557 1.214 0 N-CA-C 117.234 2.309 . . . . 0.0 117.234 163.216 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.12 -133.61 12.0 Favored Glycine 0 C--N 1.348 1.214 0 N-CA-C 111.644 -0.582 . . . . 0.0 111.644 167.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.3 t -66.4 -7.97 22.7 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 118.756 2.873 . . . . 0.0 118.756 170.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.32 107.84 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 -172.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.593 ' HA ' ' HB1' ' A' ' 140' ' ' ALA . 4.3 t -106.31 110.47 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 113.006 -1.907 . . . . 0.0 107.539 -173.105 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.522 ' HG3' ' HA ' ' A' ' 121' ' ' ASN . 9.8 ptt180 -101.77 91.46 4.41 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.422 HD23 HG13 ' A' ' 120' ' ' VAL . 78.0 mt -89.43 144.51 26.0 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 113.524 -1.671 . . . . 0.0 108.975 -175.399 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.453 ' HB2' ' HB2' ' A' ' 119' ' ' PHE . 88.9 m-85 -133.15 115.97 15.7 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 103.446 -2.798 . . . . 0.0 103.446 173.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 19.6 m -119.57 155.39 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -170.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' MET . . . . . 0.608 ' HB2' HD23 ' A' ' 118' ' ' LEU . 60.7 ttp . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 122.494 1.14 . . . . 0.0 110.095 172.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 1.3 p90 . . . . . 0 CA--C 1.562 1.408 0 CA-C-O 122.313 1.054 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -133.72 125.21 28.1 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 123.141 1.448 . . . . 0.0 107.852 171.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 3.0 ttpt -96.76 133.56 41.18 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 113.872 -1.513 . . . . 0.0 108.131 175.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.3 150.14 27.02 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-O 123.121 1.439 . . . . 0.0 109.076 177.544 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -109.03 126.29 52.99 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 -176.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.607 HG13 ' HB2' ' A' ' 75' ' ' LEU 0.321 0.5 OUTLIER . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 173.7 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . 0.251 26.9 p90 . . . . . 0 CA--C 1.551 0.984 0 CA-C-O 121.652 0.739 . . . . 0.0 111.077 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -124.32 131.07 53.5 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -167.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -83.44 123.99 30.24 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 113.888 -1.505 . . . . 0.0 110.906 171.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.485 HG13 ' HB2' ' A' ' 146' ' ' LEU . 7.9 pt -140.33 118.12 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 -168.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.0 m -97.1 131.18 44.13 Favored 'General case' 0 CA--C 1.554 1.109 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 173.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.423 ' HG ' ' HB1' ' A' ' 104' ' ' ALA . 1.3 mp -125.35 131.53 52.98 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.176 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 . . . . . 0 N--CA 1.485 1.307 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -174.185 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.502 HD21 HG21 ' A' ' 144' ' ' VAL . 0.8 OUTLIER . . . . . 0 CA--C 1.559 1.32 0 CA-C-O 118.635 -0.697 . . . . 0.0 112.497 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.436 ' CA ' ' HA3' ' A' ' 103' ' ' GLY . . . 106.19 15.79 16.8 Favored Glycine 0 N--CA 1.479 1.532 0 N-CA-C 121.118 3.207 . . . . 0.0 121.118 172.473 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -150.05 143.62 25.25 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 124.483 2.087 . . . . 0.0 108.857 -177.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.0 m -111.91 128.38 56.13 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 112.357 -2.202 . . . . 0.0 108.422 178.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.5 pp -109.2 126.72 66.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.495 -1.23 . . . . 0.0 109.609 -173.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -83.36 -171.89 3.84 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-O 123.401 1.572 . . . . 0.0 110.715 162.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -98.9 163.82 20.5 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-O 123.999 1.888 . . . . 0.0 115.829 -143.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -111.45 -164.06 17.84 Favored Glycine 0 N--CA 1.464 0.553 0 CA-C-N 110.854 -2.673 . . . . 0.0 111.086 -172.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.495 HG22 ' HB2' ' A' ' 92' ' ' PRO . 11.3 p -51.64 -40.41 59.92 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 117.714 2.487 . . . . 0.0 117.714 -173.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -80.26 -17.54 51.9 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 171.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . 0.303 6.3 t30 -138.2 54.76 7.66 Favored Pre-proline 0 CA--C 1.567 1.633 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -174.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -100.44 124.79 0.12 Allowed 'Trans proline' 0 C--N 1.365 1.442 0 CA-C-N 124.804 2.751 . . . . 0.0 111.312 -157.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 . . . . . 0 N--CA 1.487 1.412 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 174.633 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.495 ' HB2' HG22 ' A' ' 83' ' ' THR . 85.9 Cg_endo . . . . . 0 CA--C 1.547 1.147 0 N-CA-C 114.161 0.793 . . . . 0.0 114.161 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 58.5 m -161.17 132.18 5.36 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.467 HG13 ' HB2' ' A' ' 133' ' ' ALA . 13.9 mm -82.29 124.88 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 -179.218 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -120.89 155.28 34.52 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 113.91 -1.495 . . . . 0.0 108.78 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 83.9 mt -92.62 117.39 35.88 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.629 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 158.043 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.407 ' CG2' ' HG3' ' B' ' 3' ' ' LYS . 10.1 t -86.04 -31.98 21.68 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 115.378 1.621 . . . . 0.0 115.378 169.219 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . 0.342 0.0 OUTLIER -143.54 164.4 30.47 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 124.618 2.151 . . . . 0.0 110.707 177.456 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -104.55 132.48 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 174.362 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.259 43.9 mt -87.75 117.21 68.21 Favored Pre-proline 0 CA--C 1.561 1.397 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 172.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.13 146.61 80.4 Favored 'Trans proline' 0 C--N 1.369 1.654 0 C-N-CA 123.673 2.915 . . . . 0.0 115.722 176.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.76 -8.84 47.45 Favored Glycine 0 CA--C 1.544 1.872 0 N-CA-C 117.649 1.82 . . . . 0.0 117.649 -170.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.436 ' HA3' ' CA ' ' A' ' 76' ' ' GLY . . . -96.54 -168.88 34.11 Favored Glycine 0 CA--C 1.539 1.564 0 CA-C-N 119.171 1.486 . . . . 0.0 115.098 -177.175 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.423 ' HB1' ' HG ' ' A' ' 68' ' ' LEU . . . -64.28 -47.5 79.29 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -175.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.59 -37.92 88.11 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 178.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.25 -44.85 90.52 Favored 'General case' 0 CA--C 1.564 1.489 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 168.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -66.62 -63.13 1.13 Allowed 'General case' 0 CA--C 1.564 1.498 0 C-N-CA 125.323 1.449 . . . . 0.0 113.136 178.296 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 CA--C 1.561 1.382 0 C-N-CA 124.651 1.18 . . . . 0.0 113.69 -179.201 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.5 ' HB3' HG11 ' A' ' 148' ' ' VAL . 41.2 m-20 . . . . . 0 CA--C 1.542 0.64 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.9 m -73.49 90.63 1.74 Allowed 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 113.912 -1.494 . . . . 0.0 108.784 -172.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.1 tp -66.76 118.18 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 CA-C-O 122.295 1.045 . . . . 0.0 110.312 -171.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.592 ' HA ' ' HB3' ' A' ' 126' ' ' ARG 0.328 3.1 pp -99.41 -51.31 3.82 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 112.424 -2.171 . . . . 0.0 115.046 178.29 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -133.76 140.84 47.21 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 -176.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.442 HG21 HD12 ' A' ' 137' ' ' LEU . 2.7 t -128.87 110.06 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 102.774 -3.047 . . . . 0.0 102.774 -178.299 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.846 HD21 ' HB2' ' A' ' 140' ' ' ALA 0.295 8.2 m-80 82.26 -79.04 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 123.3 1.524 . . . . 0.0 108.935 178.08 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -154.27 -9.03 0.14 Allowed 'General case' 0 CA--C 1.568 1.668 0 CA-C-N 111.712 -2.495 . . . . 0.0 111.782 171.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.54 HG12 HG13 ' A' ' 125' ' ' VAL . 2.4 t -68.17 137.03 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.189 0 CA-C-O 123.492 1.615 . . . . 0.0 109.871 -179.394 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -86.86 98.11 11.03 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 111.316 -2.675 . . . . 0.0 109.869 177.081 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.61 HG11 ' HA ' ' A' ' 133' ' ' ALA 0.28 2.7 m -108.77 -110.53 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 CA-C-O 116.356 -1.783 . . . . 0.0 107.464 179.691 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.592 ' HB3' ' HA ' ' A' ' 118' ' ' LEU 0.362 0.0 OUTLIER 53.57 -82.68 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -179.533 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.554 ' H ' ' HD3' ' A' ' 126' ' ' ARG . 19.6 mt-10 -86.28 68.86 10.38 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-O 123.356 1.551 . . . . 0.0 109.308 171.055 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.6 p -143.06 167.08 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 CA-C-O 123.849 1.785 . . . . 0.0 107.061 -178.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 11.6 m -56.38 129.1 39.09 Favored 'General case' 0 CA--C 1.558 1.257 0 CA-C-N 113.289 -1.778 . . . . 0.0 110.217 157.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -47.94 -31.95 5.84 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 117.701 2.482 . . . . 0.0 117.701 173.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.478 ' HA ' HG12 ' A' ' 134' ' ' VAL . 6.8 m -59.32 -41.51 89.26 Favored 'General case' 0 CA--C 1.559 1.305 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 172.033 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -70.51 -36.41 73.76 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 167.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.61 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -61.58 -56.08 23.77 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 170.338 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.478 HG12 ' HA ' ' A' ' 131' ' ' SER . 0.5 OUTLIER -55.4 -39.86 54.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 N-CA-C 115.891 1.812 . . . . 0.0 115.891 167.854 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.99 -54.84 33.43 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 115.383 -2.246 . . . . 0.0 111.272 168.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.76 -35.0 73.71 Favored 'General case' 0 CA--C 1.561 1.373 0 N-CA-C 117.565 2.431 . . . . 0.0 117.565 172.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.442 HD12 HG21 ' A' ' 120' ' ' VAL . 8.6 mp -57.74 -49.61 75.98 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 165.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -73.31 -34.94 65.99 Favored 'General case' 0 CA--C 1.564 1.511 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 175.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.19 -28.69 67.48 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 115.921 1.823 . . . . 0.0 115.921 171.097 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.846 ' HB2' HD21 ' A' ' 121' ' ' ASN . . . -51.62 -36.7 46.9 Favored 'General case' 0 CA--C 1.56 1.339 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 158.253 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 91.39 -131.68 10.9 Favored Glycine 0 C--N 1.349 1.286 0 CA-C-O 122.488 1.049 . . . . 0.0 110.518 167.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.5 m -76.63 -2.19 31.45 Favored 'General case' 0 CA--C 1.557 1.244 0 N-CA-C 117.148 2.277 . . . . 0.0 117.148 168.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.09 108.18 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 -171.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.54 ' HA ' ' HB1' ' A' ' 140' ' ' ALA . 6.7 t -116.04 116.33 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 113.834 -1.53 . . . . 0.0 107.348 -165.4 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.417 ' HB2' ' HA ' ' A' ' 121' ' ' ASN . 1.9 mpp_? -93.59 91.66 7.18 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 174.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.485 ' HB2' HG13 ' A' ' 66' ' ' ILE . 78.3 mt -91.45 141.38 28.81 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 176.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -132.86 113.82 13.33 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 103.562 -2.755 . . . . 0.0 103.562 176.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.5 HG11 ' HB3' ' A' ' 115' ' ' ASP . 32.2 m -127.68 139.51 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -165.147 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 26.1 ptm . . . . . 0 N--CA 1.479 0.993 0 CA-C-O 122.341 1.067 . . . . 0.0 110.427 170.681 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 2.8 p90 . . . . . 0 CA--C 1.557 1.234 0 CA-C-O 122.436 1.112 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -120.49 149.46 42.37 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-O 124.162 1.934 . . . . 0.0 108.267 167.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.407 ' HG3' ' CG2' ' A' ' 97' ' ' THR . 0.5 OUTLIER -103.5 130.04 50.79 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 113.434 -1.712 . . . . 0.0 109.001 168.616 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 1.3 m -86.94 147.2 25.86 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 122.456 1.122 . . . . 0.0 109.877 168.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -114.53 113.34 24.29 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -171.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.47 HG21 ' CG2' ' A' ' 134' ' ' VAL . 62.0 t . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 -169.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 37.7 p90 . . . . . 0 N--CA 1.477 0.912 0 CA-C-O 121.649 0.737 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -129.19 141.84 51.04 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 123.011 1.386 . . . . 0.0 109.37 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -97.73 121.9 40.18 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 112.905 -1.952 . . . . 0.0 108.559 173.225 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.485 HG13 ' HB2' ' A' ' 146' ' ' LEU . 8.8 pt -131.46 109.42 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 -172.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.7 m -93.49 124.29 37.39 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 122.337 1.065 . . . . 0.0 108.391 175.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.407 ' HB2' HG23 ' A' ' 144' ' ' VAL . 1.3 mp -110.33 131.05 55.4 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 113.471 -1.695 . . . . 0.0 107.49 177.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -170.71 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.472 HD21 ' HA ' ' A' ' 138' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 119.495 -0.288 . . . . 0.0 111.139 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.46 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 102.07 55.19 0.88 Allowed Glycine 0 N--CA 1.464 0.52 0 C-N-CA 124.176 0.893 . . . . 0.0 113.703 166.291 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.413 ' HB3' ' CG1' ' A' ' 99' ' ' ILE . 1.1 p90 -158.92 138.87 12.0 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-O 123.315 1.531 . . . . 0.0 111.152 178.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.473 ' HB2' ' HG2' ' A' ' 98' ' ' LYS . 5.0 m -100.0 120.16 39.39 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 122.854 1.311 . . . . 0.0 110.622 176.274 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.548 HD11 ' HB ' ' A' ' 134' ' ' VAL . 8.7 pt -95.45 136.09 27.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-N 113.087 -1.87 . . . . 0.0 109.876 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.04 -178.39 6.53 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-O 123.782 1.754 . . . . 0.0 109.698 157.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.433 ' HA3' ' O ' ' A' ' 85' ' ' ASN . . . -103.85 166.46 15.72 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-O 124.059 1.922 . . . . 0.0 116.319 -136.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -99.23 -162.07 29.45 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 111.242 -2.479 . . . . 0.0 112.499 -172.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.452 HG22 ' CB ' ' A' ' 92' ' ' PRO . 45.7 p -51.97 -43.09 63.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 116.517 2.043 . . . . 0.0 116.517 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -83.0 -13.73 55.37 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 116.277 1.954 . . . . 0.0 116.277 173.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.433 ' O ' ' HA3' ' A' ' 81' ' ' GLY 0.289 9.0 t30 -139.15 55.46 7.48 Favored Pre-proline 0 CA--C 1.565 1.529 0 CA-C-O 117.065 -1.445 . . . . 0.0 107.534 -172.905 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -83.63 132.3 5.7 Favored 'Trans proline' 0 C--N 1.365 1.412 0 CA-C-N 126.051 3.197 . . . . 0.0 112.648 -162.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 166.606 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.452 ' CB ' HG22 ' A' ' 83' ' ' THR . 88.7 Cg_endo . . . . . 0 CA--C 1.547 1.163 0 CA-C-O 120.886 0.286 . . . . 0.0 112.141 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.8 m -155.81 130.0 8.78 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 -177.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.442 HG13 ' HB2' ' A' ' 133' ' ' ALA . 15.6 mm -83.32 110.06 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 -177.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -130.18 130.83 45.2 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 -167.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.539 HG12 HG22 ' A' ' 79' ' ' ILE 0.298 82.5 mt -81.73 120.11 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.736 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 176.178 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.451 ' CG2' ' HD3' ' B' ' 3' ' ' LYS . 12.3 t -89.72 -28.88 19.11 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 168.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.473 ' HG2' ' HB2' ' A' ' 78' ' ' SER . 7.7 ptmm? -144.4 161.68 38.4 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-O 122.659 1.219 . . . . 0.0 109.777 172.016 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.413 ' CG1' ' HB3' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -123.02 139.27 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 177.791 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.403 ' HA ' ' HD2' ' A' ' 101' ' ' PRO 0.279 1.5 mp -79.14 124.93 84.37 Favored Pre-proline 0 CA--C 1.57 1.743 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.331 -179.03 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.596 ' HA ' ' HB2' ' A' ' 106' ' ' ALA . 60.1 Cg_endo -67.35 146.99 77.07 Favored 'Trans proline' 0 CA--C 1.56 1.79 0 C-N-CA 123.398 2.732 . . . . 0.0 113.107 166.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.76 -14.06 53.7 Favored Glycine 0 CA--C 1.548 2.122 0 N-CA-C 117.245 1.658 . . . . 0.0 117.245 -164.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.46 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -96.23 -166.3 33.99 Favored Glycine 0 CA--C 1.539 1.541 0 CA-C-N 118.914 1.357 . . . . 0.0 115.82 177.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.61 -51.19 70.95 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -177.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.407 ' HB1' HD13 ' A' ' 99' ' ' ILE . . . -59.48 -38.39 80.7 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 124.573 1.17 . . . . 0.0 114.075 169.23 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.596 ' HB2' ' HA ' ' A' ' 101' ' ' PRO . . . -46.19 -40.14 10.81 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 117.538 2.421 . . . . 0.0 117.538 166.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.38 -53.17 6.22 Favored 'General case' 0 CA--C 1.568 1.642 0 C-N-CA 123.734 0.813 . . . . 0.0 112.665 173.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.9 t70 . . . . . 0 N--CA 1.487 1.393 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -172.354 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 . . . . . 0 CA--C 1.542 0.645 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 65.9 p -67.51 89.32 0.23 Allowed 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 113.408 -1.724 . . . . 0.0 111.147 169.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.566 HD12 HD11 ' A' ' 137' ' ' LEU . 27.6 pt -74.27 101.19 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 123.683 1.706 . . . . 0.0 108.854 -176.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.484 ' HA ' ' HB3' ' A' ' 126' ' ' ARG . 1.4 pp -79.95 -39.1 30.9 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 112.58 -2.1 . . . . 0.0 115.578 177.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -132.89 150.46 52.16 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 175.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.512 HG23 HD23 ' A' ' 146' ' ' LEU . 9.4 p -131.2 124.11 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 172.408 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . 0.272 13.6 m120 78.77 -70.2 0.11 Allowed 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 123.26 1.505 . . . . 0.0 111.554 -178.039 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.423 ' H ' ' H ' ' A' ' 123' ' ' VAL . 2.1 tt0 -177.93 -10.65 0.01 OUTLIER 'General case' 0 CA--C 1.583 2.213 0 C-N-CA 129.229 3.011 . . . . 0.0 109.391 -177.063 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.423 ' H ' ' H ' ' A' ' 122' ' ' GLU . 2.1 t -64.67 137.89 24.11 Favored 'Isoleucine or valine' 0 C--N 1.364 1.204 0 C-N-CA 125.801 1.641 . . . . 0.0 109.987 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -82.04 94.15 7.13 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 112.545 -2.116 . . . . 0.0 109.979 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.46 HG11 ' HA ' ' A' ' 133' ' ' ALA 0.339 0.8 OUTLIER -110.5 -112.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 CA-C-O 117.546 -1.216 . . . . 0.0 108.593 179.781 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.541 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.315 17.3 ptt180 55.15 -86.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 -174.982 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.541 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 32.9 mt-10 -82.06 69.47 8.78 Favored 'General case' 0 CA--C 1.555 1.156 0 CA-C-O 123.92 1.819 . . . . 0.0 109.986 172.234 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.7 m -137.0 166.34 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 112.627 -2.079 . . . . 0.0 105.677 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 25.8 p -55.83 135.69 51.76 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 113.12 -1.855 . . . . 0.0 111.301 149.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -50.04 -29.8 9.48 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 116.66 2.096 . . . . 0.0 116.66 167.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.465 ' HA ' HG12 ' A' ' 134' ' ' VAL . 5.1 m -57.09 -56.05 26.81 Favored 'General case' 0 CA--C 1.559 1.315 0 C-N-CA 124.432 1.093 . . . . 0.0 112.348 169.509 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -57.5 -38.7 75.04 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 173.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.46 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -62.15 -55.78 25.35 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 115.883 1.809 . . . . 0.0 115.883 166.06 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.548 ' HB ' HD11 ' A' ' 79' ' ' ILE . 3.7 p -57.74 -40.37 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 176.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -61.36 -44.38 97.26 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 116.657 -1.639 . . . . 0.0 112.999 168.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.59 -31.84 73.23 Favored 'General case' 0 CA--C 1.563 1.48 0 N-CA-C 117.628 2.455 . . . . 0.0 117.628 169.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.566 HD11 HD12 ' A' ' 117' ' ' ILE . 6.5 mp -60.07 -48.76 80.38 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 125.752 1.621 . . . . 0.0 113.29 166.085 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.472 ' HA ' HD21 ' A' ' 75' ' ' LEU . 53.2 mtmt -69.67 -32.83 71.69 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 168.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -67.71 -22.83 65.24 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 116.278 1.955 . . . . 0.0 116.278 171.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.455 ' HB1' ' HA ' ' A' ' 144' ' ' VAL . . . -51.9 -27.73 13.86 Favored 'General case' 0 CA--C 1.555 1.155 0 N-CA-C 118.072 2.619 . . . . 0.0 118.072 157.362 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 97.08 -116.15 5.43 Favored Glycine 0 C--N 1.344 1.025 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 166.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.6 m -92.5 1.27 57.34 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 116.413 2.005 . . . . 0.0 116.413 166.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.37 102.1 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 -171.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.455 ' HA ' ' HB1' ' A' ' 140' ' ' ALA . 1.4 m -85.09 116.33 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-N 113.72 -1.582 . . . . 0.0 109.821 173.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 31.8 mtp180 -100.79 87.79 3.41 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 122.443 1.116 . . . . 0.0 108.103 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.512 HD23 HG23 ' A' ' 120' ' ' VAL . 32.6 mt -87.5 133.94 33.69 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -170.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -118.9 119.57 34.74 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.4 p -127.05 121.65 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -176.241 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 52.3 ttm . . . . . 0 N--CA 1.477 0.888 0 CA-C-O 122.816 1.293 . . . . 0.0 110.286 163.342 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 1.1 p90 . . . . . 0 CA--C 1.555 1.17 0 CA-C-O 122.02 0.914 . . . . 0.0 111.352 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 2' ' ' LYS . . . . . 0.432 ' H ' HD21 ' A' ' 85' ' ' ASN . 4.6 mptp? -138.81 145.54 40.23 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 113.401 -1.727 . . . . 0.0 108.4 172.184 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.451 ' HD3' ' CG2' ' A' ' 97' ' ' THR . 7.4 ttpp -100.0 111.25 23.56 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 114.109 -1.405 . . . . 0.0 107.878 175.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 87.3 m -89.79 131.18 35.87 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 114.565 -1.198 . . . . 0.0 108.864 175.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.66 147.02 35.74 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 113.724 -1.58 . . . . 0.0 109.199 173.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.46 HG11 HD23 ' A' ' 137' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.256 1.402 0 CA-C-N 113.652 -1.613 . . . . 0.0 109.836 172.159 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.478 ' HB3' ' HB2' ' A' ' 149' ' ' MET . 32.4 p90 . . . . . 0 CA--C 1.551 0.999 0 CA-C-O 121.929 0.871 . . . . 0.0 110.65 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -115.61 129.81 56.64 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.055 175.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -88.47 127.15 35.51 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 113.679 -1.6 . . . . 0.0 110.944 175.51 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 20.8 mm -130.73 126.7 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 -177.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.6 m -88.9 132.79 34.53 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-O 123.561 1.648 . . . . 0.0 108.175 167.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.48 HD11 ' HA ' ' A' ' 105' ' ' ALA . 3.6 tp -136.01 150.17 49.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 112.263 -2.244 . . . . 0.0 107.931 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 122.065 0.936 . . . . 0.0 110.419 173.426 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.448 HD23 ' CZ ' ' A' ' 77' ' ' PHE . 6.6 mp . . . . . 0 N--CA 1.485 1.277 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.431 ' HA3' ' CA ' ' A' ' 103' ' ' GLY . . . 120.41 45.07 0.41 Allowed Glycine 0 CA--C 1.535 1.307 0 C-N-CA 124.476 1.036 . . . . 0.0 115.408 178.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.448 ' CZ ' HD23 ' A' ' 75' ' ' LEU . 0.8 OUTLIER -157.2 138.89 14.09 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 123.4 1.571 . . . . 0.0 109.472 -178.551 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.409 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 2.6 m -106.67 113.8 27.51 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.431 -1.259 . . . . 0.0 112.395 -166.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.56 HG22 HG12 ' A' ' 96' ' ' ILE . 1.1 pt -92.39 123.58 44.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.041 -175.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -83.34 -170.86 3.26 Favored 'General case' 0 CA--C 1.557 1.24 0 CA-C-O 123.5 1.619 . . . . 0.0 110.043 159.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 85' ' ' ASN . . . -94.72 160.65 23.48 Favored Glycine 0 CA--C 1.539 1.54 0 CA-C-O 123.715 1.73 . . . . 0.0 117.126 -138.32 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -109.62 -161.47 19.14 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-N 111.289 -2.456 . . . . 0.0 114.251 178.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 43.1 p -54.26 -41.87 69.31 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 117.222 2.304 . . . . 0.0 117.222 178.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -81.44 -19.28 42.77 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 116.371 1.989 . . . . 0.0 116.371 172.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.402 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 1.0 OUTLIER -141.27 84.04 13.09 Favored Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 102.587 -3.116 . . . . 0.0 102.587 -171.544 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -99.27 123.1 0.13 Allowed 'Trans proline' 0 CA--C 1.548 1.221 0 CA-C-N 124.385 2.602 . . . . 0.0 109.733 -175.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 39.1 t-80 . . . . . 0 N--CA 1.495 1.808 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 162.553 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo . . . . . 0 CA--C 1.542 0.913 0 CA-C-O 121.888 0.703 . . . . 0.0 112.791 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 63.0 m -160.5 124.79 3.65 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 -176.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.539 HG13 ' HB2' ' A' ' 133' ' ' ALA . 11.1 mm -69.86 131.94 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -170.164 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.483 ' HB2' ' O ' ' A' ' 115' ' ' ASP . 21.2 p90 -140.38 128.82 22.68 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.405 -1.271 . . . . 0.0 108.297 -168.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.56 HG12 HG22 ' A' ' 79' ' ' ILE . 70.2 mt -85.25 112.02 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 173.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 23.2 m -85.86 -28.56 24.34 Favored 'General case' 0 CA--C 1.556 1.199 0 CA-C-N 113.667 -1.606 . . . . 0.0 113.191 169.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.409 ' HB2' ' HB2' ' A' ' 78' ' ' SER . 27.4 mtpp -134.73 159.01 42.64 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 123.486 1.613 . . . . 0.0 111.203 -173.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -120.57 124.79 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 103.316 -2.846 . . . . 0.0 103.316 177.399 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.287 1.2 mp -66.51 130.72 94.14 Favored Pre-proline 0 CA--C 1.573 1.854 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.304 170.181 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.94 132.09 40.44 Favored 'Trans proline' 0 CA--C 1.554 1.493 0 C-N-CA 123.432 2.754 . . . . 0.0 114.156 173.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.46 14.17 82.77 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 117.249 1.66 . . . . 0.0 117.249 -163.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.431 ' CA ' ' HA3' ' A' ' 76' ' ' GLY . . . -89.92 171.07 37.03 Favored Glycine 0 C--N 1.337 0.638 0 CA-C-O 122.672 1.151 . . . . 0.0 114.388 -177.016 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.62 -38.0 70.84 Favored 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -172.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.48 ' HA ' HD11 ' A' ' 68' ' ' LEU . . . -66.28 -38.71 88.42 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 172.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.86 -42.71 76.71 Favored 'General case' 0 CA--C 1.562 1.421 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 170.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -72.54 -52.12 17.0 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.202 1.001 . . . . 0.0 113.685 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.1 t70 . . . . . 0 N--CA 1.48 1.054 0 C-N-CA 124.512 1.125 . . . . 0.0 112.351 -176.932 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.483 ' O ' ' HB2' ' A' ' 95' ' ' PHE 0.289 35.1 t70 . . . . . 0 C--O 1.222 -0.361 0 CA-C-O 117.069 -1.444 . . . . 0.0 111.258 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 45.4 m -155.78 77.57 0.97 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 -170.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.0 tp -66.65 124.39 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-O 121.667 0.746 . . . . 0.0 109.261 171.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.459 ' HA ' ' HB3' ' A' ' 126' ' ' ARG 0.259 0.8 OUTLIER -108.38 -43.97 4.21 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 174.699 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -129.85 133.68 47.07 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 104.786 -2.302 . . . . 0.0 104.786 177.258 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.7 p -123.76 123.49 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 174.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . 0.32 32.7 m-80 80.77 -72.2 0.06 Allowed 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 123.954 1.835 . . . . 0.0 110.37 -175.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -177.11 -17.57 0.01 OUTLIER 'General case' 0 CA--C 1.576 1.959 0 C-N-CA 129.006 2.923 . . . . 0.0 109.247 -173.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.412 HG12 HG13 ' A' ' 125' ' ' VAL . 2.2 t -64.9 135.56 28.02 Favored 'Isoleucine or valine' 0 C--N 1.363 1.173 0 C-N-CA 125.69 1.596 . . . . 0.0 110.131 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -78.84 86.41 4.75 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 111.131 -2.759 . . . . 0.0 111.226 173.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.414 HG11 ' HA ' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -94.99 -105.12 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 176.127 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.469 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.285 14.0 ptt85 47.42 -98.68 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.674 1.189 . . . . 0.0 113.85 -176.549 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.469 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 1.5 tt0 -71.46 72.95 0.72 Allowed 'General case' 0 CA--C 1.555 1.146 0 CA-C-O 124.227 1.965 . . . . 0.0 111.885 168.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.7 p -147.34 167.41 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 CA-C-N 112.141 -2.299 . . . . 0.0 105.153 -174.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 34.9 p -57.2 130.85 48.01 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 112.579 -2.1 . . . . 0.0 112.051 156.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' HIS . . . . . 0.448 ' HA ' HD12 ' A' ' 94' ' ' ILE . 2.1 p-80 -48.16 -33.1 7.86 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 116.845 2.165 . . . . 0.0 116.845 168.096 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.562 ' HA ' HG12 ' A' ' 134' ' ' VAL . 13.2 m -63.61 -38.94 93.04 Favored 'General case' 0 CA--C 1.559 1.301 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 172.488 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.11 -32.93 73.58 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 167.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.539 ' HB2' HG13 ' A' ' 94' ' ' ILE . . . -73.18 -47.81 40.57 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 171.287 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.562 HG12 ' HA ' ' A' ' 131' ' ' SER . 11.3 p -52.07 -44.82 40.54 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.532 0 CA-C-N 120.47 1.486 . . . . 0.0 113.87 162.453 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -53.98 -52.02 62.05 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-O 115.989 -1.958 . . . . 0.0 112.23 170.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.24 -29.86 68.78 Favored 'General case' 0 CA--C 1.558 1.266 0 N-CA-C 118.108 2.633 . . . . 0.0 118.108 175.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 7.0 mp -55.49 -52.88 62.2 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.161 1.384 . . . . 0.0 112.821 162.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -69.33 -41.24 76.93 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 171.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -66.86 -4.65 9.83 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 116.524 2.046 . . . . 0.0 116.524 169.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.44 ' HB1' ' HA ' ' A' ' 144' ' ' VAL . . . -52.0 -36.08 48.68 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 117.018 2.229 . . . . 0.0 117.018 158.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 64.97 79.01 0.19 Allowed Glycine 0 C--N 1.348 1.233 0 O-C-N 123.849 0.718 . . . . 0.0 113.115 163.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . 0.267 15.7 m 73.81 -27.08 0.19 Allowed 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 117.561 2.43 . . . . 0.0 117.561 -172.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -145.88 107.98 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -171.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.44 ' HA ' ' HB1' ' A' ' 140' ' ' ALA . 1.6 t -91.14 115.16 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 125.846 1.658 . . . . 0.0 107.324 175.382 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 5.2 ttp180 -97.3 100.16 11.61 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 172.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 36.8 mt -90.75 142.41 27.79 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.532 -175.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -131.17 113.57 14.04 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 173.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.72 123.73 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -175.17 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' MET . . . . . 0.478 ' HB2' ' HB3' ' A' ' 63' ' ' TYR . 25.7 ttt . . . . . 0 N--CA 1.479 0.98 0 O-C-N 124.366 1.041 . . . . 0.0 111.208 165.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.561 1.367 0 CA-C-O 123.699 1.714 . . . . 0.0 110.835 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -161.6 123.0 2.81 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 172.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -82.17 122.94 28.52 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 114.201 -1.363 . . . . 0.0 109.054 175.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 2.9 m -81.91 127.3 32.88 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 122.177 0.989 . . . . 0.0 108.389 170.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.0 103.53 16.24 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.422 ' HB ' ' O ' ' A' ' 77' ' ' PHE . 9.5 t . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -169.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.492 ' HB3' ' HB2' ' A' ' 149' ' ' MET . 43.0 p90 . . . . . 0 N--CA 1.478 0.955 0 CA-C-O 121.816 0.817 . . . . 0.0 111.04 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -102.26 138.46 39.17 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.14 176.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -107.07 125.41 51.01 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.541 HG12 ' HB2' ' A' ' 146' ' ' LEU . 0.1 OUTLIER -141.72 111.69 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 -174.501 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 86.3 m -84.67 129.81 34.79 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 122.224 1.012 . . . . 0.0 108.352 170.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.463 HD11 ' HA ' ' A' ' 105' ' ' ALA . 0.9 OUTLIER -137.62 128.14 26.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 113.317 -1.765 . . . . 0.0 107.085 -176.189 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 . . . . . 0 N--CA 1.481 1.122 0 O-C-N 121.943 -0.473 . . . . 0.0 110.303 179.528 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.446 HD21 HG21 ' A' ' 144' ' ' VAL . 2.7 tt . . . . . 0 CA--C 1.569 1.681 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.28 41.69 2.35 Favored Glycine 0 N--CA 1.475 1.259 0 O-C-N 120.434 -1.416 . . . . 0.0 116.376 168.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.473 ' HB2' HG13 ' B' ' 6' ' ' VAL . 72.4 m-85 -151.76 165.95 32.85 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 122.643 1.211 . . . . 0.0 110.883 179.34 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.32 121.75 20.52 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 168.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.72 HG22 HG12 ' A' ' 96' ' ' ILE . 6.4 pt -90.97 133.69 31.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 113.331 -1.758 . . . . 0.0 111.006 -177.054 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.36 -174.81 4.77 Favored 'General case' 0 CA--C 1.558 1.274 0 CA-C-O 123.258 1.504 . . . . 0.0 110.055 158.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -96.18 159.45 21.98 Favored Glycine 0 CA--C 1.539 1.568 0 CA-C-O 123.2 1.444 . . . . 0.0 116.059 -144.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -108.35 -164.19 20.99 Favored Glycine 0 N--CA 1.47 0.933 0 CA-C-N 112.276 -1.962 . . . . 0.0 112.226 -176.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.533 HG22 ' HB2' ' A' ' 92' ' ' PRO . 43.5 p -50.49 -39.11 47.5 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 118.355 2.724 . . . . 0.0 118.355 -177.269 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -73.8 -23.87 59.74 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 171.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -139.37 74.89 34.15 Favored Pre-proline 0 CA--C 1.567 1.622 0 N-CA-C 104.209 -2.515 . . . . 0.0 104.209 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -107.98 115.59 0.03 OUTLIER 'Trans proline' 0 C--N 1.364 1.386 0 CA-C-N 125.26 2.914 . . . . 0.0 111.092 -164.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 179.846 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.533 ' HB2' HG22 ' A' ' 83' ' ' THR . 46.2 Cg_endo . . . . . 0 CA--C 1.546 1.101 0 CA-C-O 122.779 1.075 . . . . 0.0 112.533 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 58.7 m -158.61 140.15 13.46 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 177.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.463 HD12 ' HA ' ' A' ' 130' ' ' HIS . 21.7 mm -81.46 130.07 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 -177.13 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.478 ' HA ' ' O ' ' A' ' 115' ' ' ASP . 40.4 m-85 -119.4 149.82 41.21 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 113.484 -1.689 . . . . 0.0 110.509 175.074 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.72 HG12 HG22 ' A' ' 79' ' ' ILE . 72.6 mt -106.06 114.55 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 104.381 -2.451 . . . . 0.0 104.381 148.363 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.9 t -98.74 -6.38 29.58 Favored 'General case' 0 CA--C 1.564 1.496 0 N-CA-C 115.386 1.625 . . . . 0.0 115.386 168.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -141.82 147.51 37.35 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-O 123.774 1.75 . . . . 0.0 108.963 -177.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.33 123.55 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 N-CA-C 103.224 -2.88 . . . . 0.0 103.224 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.368 1.2 mp -66.26 117.4 42.93 Favored Pre-proline 0 CA--C 1.566 1.567 0 CA-C-O 118.186 -0.912 . . . . 0.0 109.248 171.468 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -69.33 142.29 49.4 Favored 'Trans proline' 0 C--N 1.367 1.534 0 C-N-CA 123.224 2.616 . . . . 0.0 112.496 174.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.53 -6.05 19.1 Favored Glycine 0 CA--C 1.549 2.216 0 N-CA-C 117.772 1.869 . . . . 0.0 117.772 -168.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -83.67 -171.63 47.9 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-O 123.409 1.561 . . . . 0.0 112.157 175.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 75' ' ' LEU . . . -67.75 -41.87 82.7 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 -173.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.463 ' HA ' HD11 ' A' ' 68' ' ' LEU . . . -67.59 -26.41 66.26 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 119.719 3.229 . . . . 0.0 119.719 178.244 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -60.97 -46.03 92.39 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 166.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.56 -55.25 6.55 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 124.548 1.139 . . . . 0.0 113.082 174.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.9 t70 . . . . . 0 N--CA 1.484 1.234 0 C-N-CA 123.959 0.904 . . . . 0.0 112.015 -177.076 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 95' ' ' PHE 0.296 15.3 t70 . . . . . 0 C--O 1.213 -0.839 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 66.8 m -100.8 69.41 1.35 Allowed 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.061 1.301 . . . . 0.0 110.424 -173.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.487 HD11 HG22 ' A' ' 120' ' ' VAL . 18.0 tt -67.7 124.18 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 CA-C-O 122.1 0.952 . . . . 0.0 109.47 174.281 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.723 HD21 ' HB3' ' A' ' 149' ' ' MET . 0.0 OUTLIER -117.25 -47.23 2.67 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 113.525 -1.671 . . . . 0.0 114.824 -179.882 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -119.68 141.04 49.73 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.487 HG22 HD11 ' A' ' 117' ' ' ILE . 2.1 t -129.75 110.73 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 102.165 -3.272 . . . . 0.0 102.165 177.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . 0.32 10.4 m120 83.21 -83.2 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 123.649 1.69 . . . . 0.0 108.712 178.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -153.08 -16.05 0.15 Allowed 'General case' 0 CA--C 1.571 1.781 0 CA-C-N 110.539 -3.028 . . . . 0.0 110.48 178.139 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.1 t -62.6 136.92 25.16 Favored 'Isoleucine or valine' 0 C--N 1.363 1.156 0 C-N-CA 125.118 1.367 . . . . 0.0 110.088 173.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -100.87 96.91 7.6 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 111.891 -2.413 . . . . 0.0 108.408 178.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . 0.257 0.2 OUTLIER -96.02 -100.35 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 CA-C-O 116.44 -1.743 . . . . 0.0 107.588 179.378 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.539 ' HD3' ' HB3' ' A' ' 118' ' ' LEU 0.34 29.0 ptt180 50.94 -84.34 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 116.666 2.099 . . . . 0.0 116.666 -177.802 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.441 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 1.9 mt-10 -79.13 69.5 5.33 Favored 'General case' 0 CA--C 1.557 1.226 0 CA-C-O 123.811 1.767 . . . . 0.0 110.486 168.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -147.76 168.57 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 -178.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.404 HG22 ' H ' ' A' ' 131' ' ' SER . 28.2 m -60.71 133.67 56.32 Favored 'General case' 0 CA--C 1.562 1.417 0 CA-C-N 114.262 -1.335 . . . . 0.0 110.529 158.14 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' HIS . . . . . 0.463 ' HA ' HD12 ' A' ' 94' ' ' ILE . 7.7 p-80 -46.05 -33.86 3.71 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 118.024 2.602 . . . . 0.0 118.024 168.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.564 ' HA ' HG12 ' A' ' 134' ' ' VAL . 7.6 m -60.84 -38.26 84.87 Favored 'General case' 0 CA--C 1.559 1.316 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 173.242 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -70.78 -33.3 70.62 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 116.217 1.932 . . . . 0.0 116.217 167.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.457 ' HB2' HG13 ' A' ' 94' ' ' ILE . . . -74.48 -43.4 56.23 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 172.64 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.564 HG12 ' HA ' ' A' ' 131' ' ' SER . 2.3 p -55.69 -42.41 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 159.012 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -60.44 -46.36 90.33 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 116.097 -1.906 . . . . 0.0 113.27 170.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.05 -31.66 70.19 Favored 'General case' 0 CA--C 1.559 1.306 0 N-CA-C 116.951 2.204 . . . . 0.0 116.951 173.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.468 HD12 ' HA ' ' A' ' 134' ' ' VAL . 46.7 mt -58.94 -47.89 83.45 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 163.494 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -65.2 -44.76 87.3 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 168.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -64.03 -17.75 63.66 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 116.533 2.049 . . . . 0.0 116.533 174.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.461 ' HB1' ' HA ' ' A' ' 144' ' ' VAL . . . -53.5 -20.16 4.55 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 119.667 3.21 . . . . 0.0 119.667 160.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 91.45 -125.93 8.23 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 173.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 39.0 m -90.9 1.59 56.87 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 167.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -150.1 110.74 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -165.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.461 ' HA ' ' HB1' ' A' ' 140' ' ' ALA . 3.3 t -102.9 115.86 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 113.481 -1.69 . . . . 0.0 107.863 -172.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 78.4 mtt180 -96.91 101.28 12.83 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 175.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.541 ' HB2' HG12 ' A' ' 66' ' ' ILE . 14.0 mt -95.76 137.35 34.95 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -173.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -125.19 126.1 44.69 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -131.24 122.23 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 177.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' MET . . . . . 0.723 ' HB3' HD21 ' A' ' 118' ' ' LEU . 28.3 ttt . . . . . 0 N--CA 1.472 0.667 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 171.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 2.7 p90 . . . . . 0 CA--C 1.55 0.974 0 CA-C-O 121.399 0.619 . . . . 0.0 110.352 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -130.02 146.89 51.72 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 123.538 1.637 . . . . 0.0 110.418 175.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 10.7 ttpp -107.82 113.7 27.13 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 113.222 -1.808 . . . . 0.0 108.1 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 43.6 m -84.81 137.35 33.23 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 122.029 0.918 . . . . 0.0 109.84 173.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.39 153.91 22.2 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-O 122.711 1.243 . . . . 0.0 110.146 176.178 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.473 HG13 ' HB2' ' A' ' 77' ' ' PHE . 4.2 p . . . . . 0 C--O 1.25 1.09 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 -171.406 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 20.9 p90 . . . . . 0 CA--C 1.552 1.026 0 CA-C-O 122.708 1.242 . . . . 0.0 109.674 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -104.0 134.71 46.82 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 113.52 -1.673 . . . . 0.0 106.883 -176.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -105.26 118.7 37.22 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 -174.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.485 HG13 ' HB2' ' A' ' 146' ' ' LEU . 2.5 pt -136.58 104.27 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 N-CA-C 106.39 -1.708 . . . . 0.0 106.39 -168.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.2 m -98.98 126.23 44.63 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 173.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.79 142.38 51.32 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.112 178.228 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 . . . . . 0 N--CA 1.484 1.268 0 O-C-N 121.446 -0.784 . . . . 0.0 110.795 -177.64 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.624 HD13 HG22 ' B' ' 6' ' ' VAL . 5.9 mp . . . . . 0 N--CA 1.469 0.489 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.404 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 102.48 37.58 3.24 Favored Glycine 0 CA--C 1.532 1.121 0 N-CA-C 116.455 1.342 . . . . 0.0 116.455 -172.291 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -148.17 159.41 43.98 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-O 124.192 1.949 . . . . 0.0 107.254 168.173 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.536 ' O ' HG23 ' A' ' 96' ' ' ILE . 8.7 m -100.81 155.3 18.0 Favored 'General case' 0 C--N 1.313 -1.013 0 O-C-N 120.459 -1.401 . . . . 0.0 110.717 177.467 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.57 HD11 ' HB ' ' A' ' 134' ' ' VAL . 4.4 pt -129.09 132.65 66.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.572 174.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -91.15 -170.43 2.65 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-O 124.249 1.976 . . . . 0.0 108.477 163.183 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 85' ' ' ASN . . . -95.33 160.18 22.8 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-N 113.12 -1.855 . . . . 0.0 114.915 -142.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -108.45 -158.55 19.47 Favored Glycine 0 CA--C 1.52 0.4 0 CA-C-N 111.542 -2.329 . . . . 0.0 111.852 -175.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.533 HG22 ' HB2' ' A' ' 92' ' ' PRO . 42.2 p -54.73 -39.76 68.57 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 117.627 2.454 . . . . 0.0 117.627 -176.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -73.85 -24.87 59.82 Favored 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 116.268 1.951 . . . . 0.0 116.268 170.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.424 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 0.2 OUTLIER -139.97 82.3 17.64 Favored Pre-proline 0 CA--C 1.556 1.177 0 N-CA-C 103.111 -2.922 . . . . 0.0 103.111 -176.119 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -107.5 118.24 0.03 OUTLIER 'Trans proline' 0 CA--C 1.548 1.224 0 CA-C-N 125.165 2.88 . . . . 0.0 111.288 -169.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -178.67 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.533 ' HB2' HG22 ' A' ' 83' ' ' THR . 30.5 Cg_endo . . . . . 0 CA--C 1.549 1.268 0 CA-C-O 122.609 1.004 . . . . 0.0 112.948 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 73.1 m -157.24 134.68 10.55 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 104.4 -2.444 . . . . 0.0 104.4 -177.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.456 HD12 ' HA ' ' A' ' 130' ' ' HIS . 14.0 mm -76.92 121.5 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 -176.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -113.61 151.18 32.05 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 113.714 -1.584 . . . . 0.0 107.492 176.189 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.55 HG12 HG22 ' A' ' 79' ' ' ILE 0.29 3.4 mt -93.95 122.77 45.7 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.499 0 N-CA-C 105.094 -2.188 . . . . 0.0 105.094 166.147 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.5 m -78.98 -54.95 5.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.934 -1.104 . . . . 0.0 112.778 179.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 36.2 mtpt -147.79 162.92 38.24 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 124.27 1.986 . . . . 0.0 111.138 -164.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.88 104.71 17.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 1 N-CA-C 99.742 -4.17 . . . . 0.0 99.742 -170.449 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.283 1.3 mp -65.41 118.75 53.55 Favored Pre-proline 0 CA--C 1.566 1.572 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -176.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -61.19 134.16 50.84 Favored 'Trans proline' 0 C--N 1.364 1.346 0 C-N-CA 122.997 2.465 . . . . 0.0 112.993 173.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.67 -4.81 85.26 Favored Glycine 0 CA--C 1.544 1.874 0 N-CA-C 118.22 2.048 . . . . 0.0 118.22 -172.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.404 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -90.23 -173.07 44.83 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-O 123.499 1.61 . . . . 0.0 113.116 174.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.53 -34.52 72.38 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 116.363 1.986 . . . . 0.0 116.363 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -53.11 -42.43 65.98 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 120.126 1.33 . . . . 0.0 114.184 163.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.55 -40.73 65.77 Favored 'General case' 0 CA--C 1.562 1.426 0 N-CA-C 116.305 1.965 . . . . 0.0 116.305 174.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.32 -53.47 14.11 Favored 'General case' 0 CA--C 1.561 1.368 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 174.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.8 t70 . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -167.913 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 . . . . . 0 C--O 1.24 0.584 0 N-CA-C 102.001 -3.333 . . . . 0.0 102.001 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 12.8 m -73.82 86.85 1.73 Allowed 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 113.772 -1.558 . . . . 0.0 110.215 -170.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.3 tp -63.35 116.06 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 CA-C-O 122.11 0.957 . . . . 0.0 110.038 -176.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.513 HD23 ' HB2' ' A' ' 149' ' ' MET . 3.1 pp -96.64 -48.04 5.67 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 112.809 -1.996 . . . . 0.0 114.001 174.24 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -135.42 128.22 31.13 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 -175.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.512 HG23 HD23 ' A' ' 146' ' ' LEU . 5.5 p -121.72 122.26 66.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 172.644 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.618 HD22 ' HA ' ' A' ' 140' ' ' ALA 0.27 17.0 m120 79.37 -65.3 0.2 Allowed 'General case' 0 N--CA 1.503 2.198 0 CA-C-O 122.818 1.294 . . . . 0.0 111.558 -173.507 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 176.52 -25.28 0.0 OUTLIER 'General case' 0 CA--C 1.573 1.842 0 C-N-CA 128.408 2.683 . . . . 0.0 110.174 -162.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.467 HG12 HG13 ' A' ' 125' ' ' VAL . 2.1 t -70.04 135.83 27.39 Favored 'Isoleucine or valine' 0 C--N 1.361 1.085 0 C-N-CA 125.148 1.379 . . . . 0.0 109.409 179.047 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -88.21 100.0 12.64 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 113.209 -1.814 . . . . 0.0 109.841 176.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.605 HG11 ' HA ' ' A' ' 133' ' ' ALA 0.251 3.3 m -94.79 -119.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 CA-C-O 116.959 -1.496 . . . . 0.0 107.62 174.902 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.696 ' HD2' ' H ' ' A' ' 127' ' ' GLU 0.475 1.0 OUTLIER 56.14 -78.43 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -174.283 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.696 ' H ' ' HD2' ' A' ' 126' ' ' ARG . 25.3 tt0 -79.81 67.1 5.49 Favored 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 126.388 1.875 . . . . 0.0 111.288 168.445 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -153.77 167.92 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 -177.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 27.0 m -64.37 134.1 53.92 Favored 'General case' 0 CA--C 1.561 1.386 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.151 158.095 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' HIS . . . . . 0.456 ' HA ' HD12 ' A' ' 94' ' ' ILE . 3.7 p80 -48.59 -31.51 6.72 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 118.64 2.83 . . . . 0.0 118.64 170.118 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.519 ' HA ' HG12 ' A' ' 134' ' ' VAL . 6.4 m -60.73 -38.6 85.67 Favored 'General case' 0 CA--C 1.563 1.465 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 171.529 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -67.53 -37.95 83.51 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 166.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.605 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -63.88 -52.44 59.97 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 170.719 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.57 ' HB ' HD11 ' A' ' 79' ' ' ILE . 3.4 p -54.9 -39.93 50.82 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.25 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 168.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -64.72 -40.46 95.37 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 117.058 -1.448 . . . . 0.0 114.181 173.035 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -67.98 -33.12 74.03 Favored 'General case' 0 CA--C 1.562 1.423 0 N-CA-C 116.539 2.052 . . . . 0.0 116.539 167.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.482 HD12 HG21 ' A' ' 120' ' ' VAL . 8.7 mp -54.24 -49.17 70.1 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 125.391 1.476 . . . . 0.0 113.763 160.441 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -66.31 -41.66 89.37 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 169.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -65.17 -17.69 64.69 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 116.461 2.023 . . . . 0.0 116.461 172.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.618 ' HA ' HD22 ' A' ' 121' ' ' ASN . . . -52.33 -41.84 63.33 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 117.622 2.453 . . . . 0.0 117.622 164.175 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 71.0 72.21 0.93 Allowed Glycine 0 C--N 1.339 0.714 0 CA-C-O 118.528 -1.151 . . . . 0.0 114.779 159.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . 0.267 4.5 m 68.5 -3.1 1.43 Allowed 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 117.906 2.558 . . . . 0.0 117.906 -173.078 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -148.38 103.19 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.251 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 171.35 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.441 ' HA ' ' HB1' ' A' ' 140' ' ' ALA . 36.0 m -84.99 122.38 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 124.034 0.934 . . . . 0.0 109.233 168.243 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 50.1 mtt180 -101.92 87.12 3.03 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 171.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.512 HD23 HG23 ' A' ' 120' ' ' VAL . 49.7 mt -92.01 136.53 33.1 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-O 122.47 1.129 . . . . 0.0 108.315 -172.155 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -132.48 118.12 18.89 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 104.359 -2.46 . . . . 0.0 104.359 178.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 33.6 m -126.71 133.0 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -167.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' MET . . . . . 0.513 ' HB2' HD23 ' A' ' 118' ' ' LEU . 26.7 ttt . . . . . 0 N--CA 1.483 1.18 0 CA-C-O 123.621 1.677 . . . . 0.0 111.657 175.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.559 1.292 0 CA-C-O 122.201 1.001 . . . . 0.0 111.695 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -139.33 138.89 37.05 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 123.341 1.543 . . . . 0.0 110.005 173.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -102.86 124.42 48.35 Favored 'General case' 0 CA--C 1.553 1.068 0 CA-C-N 113.452 -1.704 . . . . 0.0 108.294 172.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.43 HG21 HG11 ' A' ' 134' ' ' VAL . 20.1 m -92.68 129.2 38.68 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.243 172.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -103.29 101.55 11.48 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 -174.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.624 HG22 HD13 ' A' ' 75' ' ' LEU . 1.4 p . . . . . 0 C--O 1.252 1.208 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.338 -176.2 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 14.1 p90 . . . . . 0 N--CA 1.479 1.012 0 CA-C-O 121.783 0.802 . . . . 0.0 109.304 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -111.91 140.05 46.89 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.173 -178.037 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -115.48 117.13 29.52 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 114.518 -1.219 . . . . 0.0 108.054 -178.76 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.4 mp -134.41 124.89 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 -171.533 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.8 m -97.11 125.1 41.35 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 168.983 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 mp -123.67 137.85 54.64 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -177.848 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 . . . . . 0 N--CA 1.482 1.17 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -172.56 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.486 HD23 ' N ' ' A' ' 75' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.301 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 . . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.594 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 72.39 42.38 49.27 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 119.577 2.591 . . . . 0.0 119.577 163.054 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.449 ' CZ ' HD12 ' A' ' 75' ' ' LEU . 13.1 p90 -157.87 128.22 6.26 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 176.741 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.476 ' HB3' ' HD2' ' B' ' 3' ' ' LYS . 48.1 m -85.19 144.73 27.98 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.789 -1.55 . . . . 0.0 111.663 176.362 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.531 HG22 HD13 ' A' ' 96' ' ' ILE . 2.3 pp -119.2 127.92 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 113.013 -1.903 . . . . 0.0 109.546 -176.907 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.78 -166.74 0.94 Allowed 'General case' 0 CA--C 1.553 1.091 0 CA-C-O 123.417 1.579 . . . . 0.0 111.024 159.632 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.78 159.24 22.2 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-O 123.936 1.853 . . . . 0.0 115.195 -143.407 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.51 -161.18 23.23 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-N 111.162 -2.519 . . . . 0.0 113.057 179.191 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.405 HG22 ' HB2' ' A' ' 92' ' ' PRO . 71.4 p -53.99 -40.27 66.8 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 -177.638 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.451 ' HB2' HG23 ' A' ' 129' ' ' THR . 5.9 m-20 -92.88 7.9 41.91 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 116.099 1.889 . . . . 0.0 116.099 175.543 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -161.16 86.67 1.7 Allowed Pre-proline 0 CA--C 1.553 1.092 0 N-CA-C 101.154 -3.647 . . . . 0.0 101.154 178.945 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -108.48 124.53 0.04 OUTLIER 'Trans proline' 0 CA--C 1.549 1.237 0 CA-C-N 124.437 2.62 . . . . 0.0 111.634 -173.023 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 . . . . . 0 N--CA 1.492 1.666 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 176.224 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.405 ' HB2' HG22 ' A' ' 83' ' ' THR . 81.2 Cg_endo . . . . . 0 CA--C 1.552 1.421 0 CA-C-O 121.558 0.566 . . . . 0.0 113.023 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 52.9 m -156.65 109.63 2.59 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 105.512 -2.032 . . . . 0.0 105.512 -173.651 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.484 HD12 ' HA ' ' A' ' 130' ' ' HIS . 8.1 mm -68.95 117.9 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 178.559 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -129.26 140.24 51.52 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 113.459 -1.701 . . . . 0.0 107.514 -163.488 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.531 HD13 HG22 ' A' ' 79' ' ' ILE . 7.4 mm -85.84 107.46 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.346 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 175.365 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 77.0 m -91.11 -35.06 14.81 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 117.4 -1.286 . . . . 0.0 113.74 175.54 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . 0.321 0.0 OUTLIER -144.18 165.14 28.67 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 123.299 1.524 . . . . 0.0 111.72 175.54 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -111.83 126.37 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 -176.451 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.304 1.4 mp -72.25 130.44 86.23 Favored Pre-proline 0 CA--C 1.567 1.606 0 CA-C-O 118.252 -0.88 . . . . 0.0 109.2 169.454 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -58.88 130.6 37.51 Favored 'Trans proline' 0 C--N 1.367 1.511 0 C-N-CA 123.54 2.826 . . . . 0.0 114.521 174.924 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 72.12 20.99 79.34 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 117.153 1.621 . . . . 0.0 117.153 -167.042 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.594 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -85.93 -176.81 50.09 Favored Glycine 0 C--N 1.337 0.636 0 N-CA-C 116.399 1.32 . . . . 0.0 116.399 177.203 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.81 -51.61 63.96 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 178.415 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.49 -38.91 89.04 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 174.167 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.92 -42.03 77.35 Favored 'General case' 0 CA--C 1.565 1.527 0 N-CA-C 115.821 1.786 . . . . 0.0 115.821 170.528 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.67 -51.1 20.83 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.604 1.162 . . . . 0.0 113.877 178.526 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.2 t70 . . . . . 0 N--CA 1.482 1.151 0 C-N-CA 124.38 1.072 . . . . 0.0 112.109 -176.134 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.461 ' HB3' HG11 ' A' ' 148' ' ' VAL . 47.2 m-20 . . . . . 0 C--O 1.237 0.405 0 N-CA-C 102.831 -3.026 . . . . 0.0 102.831 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.0 m -80.62 93.57 6.15 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.03 -0.986 . . . . 0.0 108.571 -176.517 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.466 HG12 HD11 ' A' ' 137' ' ' LEU . 7.2 tp -59.7 112.94 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 C-N-CA 123.569 0.748 . . . . 0.0 111.306 178.949 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.629 ' HA ' ' HB3' ' A' ' 126' ' ' ARG 0.431 0.0 OUTLIER -105.67 -39.81 5.96 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 115.933 1.827 . . . . 0.0 115.933 -174.306 . . . . . . . . 4 4 . 1 . 021 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -136.19 135.27 38.99 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 105.019 -2.215 . . . . 0.0 105.019 171.72 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.457 HG11 HD12 ' A' ' 137' ' ' LEU . 9.9 p -123.55 121.95 63.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 170.43 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.576 HD22 ' HA ' ' A' ' 140' ' ' ALA 0.261 9.0 m120 77.17 -79.73 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 123.332 1.539 . . . . 0.0 108.93 -175.008 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.402 ' H ' ' H ' ' A' ' 123' ' ' VAL . 1.1 tt0 -165.25 -7.77 0.02 OUTLIER 'General case' 0 CA--C 1.576 1.978 0 C-N-CA 127.986 2.514 . . . . 0.0 110.78 -178.833 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.526 HG12 HG13 ' A' ' 125' ' ' VAL . 2.1 t -72.46 135.91 26.77 Favored 'Isoleucine or valine' 0 C--N 1.359 1.014 0 C-N-CA 125.443 1.497 . . . . 0.0 109.526 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -77.43 102.19 6.74 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 112.903 -1.953 . . . . 0.0 110.605 171.776 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.57 HG11 ' HA ' ' A' ' 133' ' ' ALA 0.261 2.2 m -109.78 -113.13 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-O 116.361 -1.781 . . . . 0.0 107.936 175.254 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.629 ' HB3' ' HA ' ' A' ' 118' ' ' LEU 0.328 0.0 OUTLIER 48.06 -82.72 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 117.753 2.501 . . . . 0.0 117.753 -176.12 . . . . . . . . 4 4 . 1 . 021 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.566 ' H ' ' HD3' ' A' ' 126' ' ' ARG . 2.9 tm-20 -88.35 70.4 9.09 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-O 123.696 1.712 . . . . 0.0 108.572 171.981 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.63 167.27 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 -178.689 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.451 HG23 ' HB2' ' A' ' 84' ' ' ASP . 11.6 m -58.45 132.42 53.66 Favored 'General case' 0 CA--C 1.555 1.146 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.206 159.358 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 130' ' ' HIS . . . . . 0.484 ' HA ' HD12 ' A' ' 94' ' ' ILE . 2.7 p-80 -47.45 -34.16 6.97 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 117.37 2.359 . . . . 0.0 117.37 173.706 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.581 ' HA ' HG12 ' A' ' 134' ' ' VAL . 5.2 m -60.38 -40.5 91.06 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 174.925 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -67.24 -37.75 84.05 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 166.738 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.57 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -66.95 -55.86 12.7 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 173.663 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.606 HG23 HG22 ' B' ' 6' ' ' VAL . 8.6 p -47.09 -45.71 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 166.567 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.2 -54.15 49.27 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 115.765 -2.064 . . . . 0.0 111.72 174.862 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.97 -34.51 76.27 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 117.527 2.417 . . . . 0.0 117.527 174.074 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.466 HD11 HG12 ' A' ' 117' ' ' ILE . 6.0 mp -57.78 -55.34 36.09 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 125.636 1.575 . . . . 0.0 113.45 165.134 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -65.05 -33.77 76.84 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 115.898 1.814 . . . . 0.0 115.898 171.435 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -68.29 -23.64 64.77 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 117.135 2.272 . . . . 0.0 117.135 170.636 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.576 ' HA ' HD22 ' A' ' 121' ' ' ASN . . . -53.28 -28.46 28.03 Favored 'General case' 0 CA--C 1.56 1.362 0 N-CA-C 116.938 2.199 . . . . 0.0 116.938 156.046 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 91.09 -132.12 11.12 Favored Glycine 0 C--N 1.347 1.193 0 CA-C-O 122.53 1.072 . . . . 0.0 110.753 166.879 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 13.0 m -78.76 -2.06 37.68 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 169.152 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.05 103.8 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 -172.915 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.484 HG11 ' CD1' ' A' ' 75' ' ' LEU . 16.6 m -92.81 117.53 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 113.205 -1.816 . . . . 0.0 108.682 -178.985 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -89.57 94.22 9.78 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 169.837 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 82.1 mt -97.05 127.13 42.72 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 -173.521 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -126.12 120.01 29.05 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 102.963 -2.977 . . . . 0.0 102.963 177.178 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.461 HG11 ' HB3' ' A' ' 115' ' ' ASP . 16.8 m -124.65 132.89 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -173.346 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 57.5 ttm . . . . . 0 N--CA 1.484 1.236 0 CA-C-N 119.759 1.163 . . . . 0.0 108.54 168.419 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.558 1.265 0 CA-C-O 122.585 1.184 . . . . 0.0 111.214 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -148.24 120.75 8.52 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 122.517 1.151 . . . . 0.0 108.874 173.402 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.476 ' HD2' ' HB3' ' A' ' 78' ' ' SER . 16.7 ttpp -92.1 124.78 36.45 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.42 174.784 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.569 HG21 HG21 ' A' ' 134' ' ' VAL . 3.1 m -87.25 143.04 27.46 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 122.174 0.988 . . . . 0.0 109.418 168.98 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.69 120.31 35.72 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 178.462 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.606 HG22 HG23 ' A' ' 134' ' ' VAL . 21.8 t . . . . . 0 N--CA 1.478 0.933 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 -160.84 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 41.3 p90 . . . . . 0 N--CA 1.475 0.778 0 CA-C-O 121.823 0.82 . . . . 0.0 111.656 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -124.91 136.05 53.41 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -176.83 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.407 ' HB3' ' CE2' ' A' ' 147' ' ' TYR . 9.9 pt-20 -80.39 128.56 33.7 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 114.306 -1.316 . . . . 0.0 111.795 175.42 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 23.4 mt -129.57 118.12 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 -179.3 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.3 m -97.19 122.88 40.71 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 174.248 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.455 ' HB3' ' CG2' ' A' ' 144' ' ' VAL . 1.2 tt -119.85 161.45 20.79 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 113.098 -1.865 . . . . 0.0 106.7 174.902 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 . . . . . 0 N--CA 1.489 1.483 0 O-C-N 120.425 -1.422 . . . . 0.0 108.912 173.622 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.71 HD11 HG11 ' A' ' 144' ' ' VAL . 1.4 tt . . . . . 0 N--CA 1.485 1.32 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 118.02 22.83 3.76 Favored Glycine 0 N--CA 1.478 1.491 0 N-CA-C 118.017 1.967 . . . . 0.0 118.017 178.8 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -145.68 177.17 9.09 Favored 'General case' 0 CA--C 1.557 1.247 0 CA-C-O 123.749 1.738 . . . . 0.0 107.788 171.586 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.408 ' O ' HG23 ' A' ' 96' ' ' ILE . 1.8 m -134.91 145.13 47.92 Favored 'General case' 0 C--N 1.318 -0.804 0 O-C-N 119.909 -1.744 . . . . 0.0 107.559 -178.418 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.58 HG22 HG12 ' A' ' 96' ' ' ILE . 5.6 pt -112.22 137.0 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 114.695 -1.138 . . . . 0.0 112.006 -172.847 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.416 ' HB1' ' CB ' ' A' ' 87' ' ' HIS . . . -85.57 -174.3 5.1 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-O 123.976 1.846 . . . . 0.0 111.368 160.857 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.82 157.98 21.84 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 113.015 -1.902 . . . . 0.0 115.058 -145.78 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -104.69 -158.6 23.65 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 111.954 -2.123 . . . . 0.0 113.724 179.182 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.467 HG22 ' CB ' ' A' ' 92' ' ' PRO . 34.6 p -54.32 -38.24 65.76 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 116.872 2.175 . . . . 0.0 116.872 -178.0 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -83.25 -10.31 58.63 Favored 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 116.285 1.957 . . . . 0.0 116.285 174.406 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.15 92.29 2.35 Favored Pre-proline 0 CA--C 1.552 1.028 0 N-CA-C 101.095 -3.669 . . . . 0.0 101.095 -173.02 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -93.2 138.46 1.49 Allowed 'Trans proline' 0 CA--C 1.55 1.304 0 CA-C-N 124.879 2.778 . . . . 0.0 111.453 -176.405 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.416 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 28.3 t60 . . . . . 0 N--CA 1.493 1.681 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 167.858 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.467 ' CB ' HG22 ' A' ' 83' ' ' THR . 84.6 Cg_endo . . . . . 0 CA--C 1.547 1.159 0 CA-C-O 121.576 0.573 . . . . 0.0 112.473 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.4 m -158.19 125.22 4.95 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 -176.541 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.46 HG21 ' HB1' ' A' ' 133' ' ' ALA . 22.1 mm -78.4 123.24 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 178.517 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -116.67 154.67 30.15 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 112.684 -2.053 . . . . 0.0 107.969 177.717 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.58 HG12 HG22 ' A' ' 79' ' ' ILE 0.357 10.3 mt -95.39 123.79 47.7 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.076 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 161.001 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 49.6 m -74.3 -60.45 2.26 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.769 -1.207 . . . . 0.0 113.114 171.635 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -147.16 162.21 39.33 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 123.876 1.798 . . . . 0.0 111.48 -163.375 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.87 121.86 55.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 104.427 -2.434 . . . . 0.0 104.427 -175.157 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.259 1.6 mp -73.86 121.14 84.45 Favored Pre-proline 0 CA--C 1.567 1.623 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 173.353 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -61.02 138.1 76.25 Favored 'Trans proline' 0 C--N 1.365 1.425 0 C-N-CA 123.285 2.657 . . . . 0.0 113.701 172.581 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.32 0.58 83.79 Favored Glycine 0 CA--C 1.547 2.09 0 N-CA-C 118.153 2.021 . . . . 0.0 118.153 -170.936 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -89.96 -177.39 45.05 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-N 119.114 1.457 . . . . 0.0 112.978 174.444 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.37 -32.4 71.43 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 116.821 2.156 . . . . 0.0 116.821 176.631 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.8 -31.91 72.98 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 117.876 -1.059 . . . . 0.0 113.813 168.91 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -49.44 -43.47 44.79 Favored 'General case' 0 CA--C 1.559 1.319 0 N-CA-C 118.037 2.606 . . . . 0.0 118.037 164.68 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.8 -53.47 9.1 Favored 'General case' 0 CA--C 1.563 1.446 0 C-N-CA 124.466 1.106 . . . . 0.0 113.707 174.916 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.8 t70 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -174.16 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.2 p30 . . . . . 0 C--O 1.243 0.718 0 N-CA-C 100.841 -3.763 . . . . 0.0 100.841 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.1 m -75.18 85.2 2.39 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 114.198 -1.365 . . . . 0.0 109.54 -178.198 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.481 HG12 HD11 ' A' ' 137' ' ' LEU . 6.2 tp -65.63 115.64 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 CA-C-O 122.622 1.201 . . . . 0.0 109.602 179.755 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.487 ' HA ' ' HB3' ' A' ' 126' ' ' ARG . 3.1 pp -107.23 -45.12 4.18 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 112.233 -2.258 . . . . 0.0 115.206 179.769 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -130.9 134.78 47.08 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 -179.119 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.48 HG23 HD23 ' A' ' 146' ' ' LEU . 7.4 p -125.62 119.43 54.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 173.248 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . 0.279 9.6 m120 76.26 -88.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -174.312 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -148.05 -6.96 0.43 Allowed 'General case' 0 CA--C 1.576 1.953 0 C-N-CA 128.225 2.61 . . . . 0.0 110.71 177.027 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.3 t -69.81 136.5 26.02 Favored 'Isoleucine or valine' 0 C--N 1.359 1.011 0 C-N-CA 125.463 1.505 . . . . 0.0 109.728 178.502 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -89.61 102.21 14.89 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 113.355 -1.748 . . . . 0.0 108.544 175.03 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.524 HG11 ' HA ' ' A' ' 133' ' ' ALA 0.258 0.9 OUTLIER -99.71 -97.97 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-O 116.225 -1.845 . . . . 0.0 107.73 173.424 . . . . . . . . 4 4 . 1 . 022 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.487 ' HB3' ' HA ' ' A' ' 118' ' ' LEU 0.301 0.4 OUTLIER 46.7 -87.3 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 117.284 2.328 . . . . 0.0 117.284 179.984 . . . . . . . . 4 4 . 1 . 022 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -85.26 76.11 10.2 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-O 123.408 1.575 . . . . 0.0 108.763 170.232 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.0 p -146.09 168.87 6.57 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 CA-C-N 113.166 -1.834 . . . . 0.0 106.316 -179.784 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.487 HG22 ' H ' ' A' ' 131' ' ' SER . 33.1 m -62.1 137.28 58.23 Favored 'General case' 0 CA--C 1.562 1.407 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.326 158.051 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 10.2 p-80 -46.62 -33.21 4.0 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 117.552 2.427 . . . . 0.0 117.552 168.456 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.487 ' H ' HG22 ' A' ' 129' ' ' THR . 10.9 m -61.02 -41.23 96.16 Favored 'General case' 0 CA--C 1.555 1.159 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 175.109 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -69.0 -35.65 76.94 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 166.851 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.524 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -67.2 -53.88 26.2 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 172.634 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.538 ' HB ' HD11 ' A' ' 79' ' ' ILE . 2.5 p -49.26 -42.86 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 165.827 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -60.15 -55.61 31.69 Favored 'General case' 0 C--N 1.353 0.751 0 CA-C-O 115.799 -2.048 . . . . 0.0 113.24 173.682 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -65.63 -28.31 69.02 Favored 'General case' 0 CA--C 1.564 1.493 0 N-CA-C 117.09 2.255 . . . . 0.0 117.09 175.419 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.481 HD11 HG12 ' A' ' 117' ' ' ILE . 9.8 mp -62.96 -53.93 46.29 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 125.242 1.417 . . . . 0.0 113.876 167.326 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -66.79 -32.73 74.21 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 167.597 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -70.24 -11.5 60.95 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 117.481 2.4 . . . . 0.0 117.481 171.363 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.511 ' HB3' HG12 ' A' ' 144' ' ' VAL . . . -59.13 -1.24 0.17 Allowed 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 118.82 2.896 . . . . 0.0 118.82 163.663 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 93.45 -127.08 8.88 Favored Glycine 0 C--N 1.344 0.989 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 171.395 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.5 m -93.81 -0.5 55.8 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 169.011 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -150.6 111.03 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 -166.188 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.71 HG11 HD11 ' A' ' 75' ' ' LEU . 34.2 m -90.13 121.04 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 114.528 -1.214 . . . . 0.0 109.119 -179.408 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -103.98 88.24 2.97 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 178.653 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.48 HD23 HG23 ' A' ' 120' ' ' VAL . 77.4 mt -89.58 142.22 27.87 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.393 -172.279 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.407 ' CE2' ' HB3' ' A' ' 65' ' ' GLU . 38.4 m-85 -123.69 124.02 41.82 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 103.906 -2.627 . . . . 0.0 103.906 168.748 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 20.0 m -132.49 131.77 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -169.854 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 149' ' ' MET . . . . . 0.419 ' HB2' ' CD2' ' A' ' 118' ' ' LEU . 58.1 ttm . . . . . 0 N--CA 1.477 0.904 0 CA-C-O 123.205 1.479 . . . . 0.0 110.791 177.069 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.558 1.271 0 CA-C-O 122.286 1.041 . . . . 0.0 110.19 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -140.84 124.34 16.83 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 122.986 1.374 . . . . 0.0 108.344 168.144 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.53 129.03 34.96 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 114.175 -1.375 . . . . 0.0 109.646 176.022 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 85.8 m -101.86 132.58 47.55 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.839 175.953 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -75.28 147.98 39.77 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 122.653 1.216 . . . . 0.0 110.666 174.021 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.41 ' O ' ' HB3' ' A' ' 75' ' ' LEU . 2.6 p . . . . . 0 C--O 1.247 0.927 0 N-CA-C 103.876 -2.638 . . . . 0.0 103.876 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 . . . . . 0 N--CA 1.484 1.26 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -126.36 130.48 50.87 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.566 0.698 . . . . 0.0 109.782 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -100.47 136.81 39.77 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.432 -177.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -102.41 116.78 33.33 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.3 mp -130.91 111.96 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 -175.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.3 m -94.25 131.04 40.25 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 168.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.561 HD11 ' HA ' ' A' ' 105' ' ' ALA . 8.9 tt -134.86 141.87 46.47 Favored 'General case' 0 CA--C 1.556 1.206 0 CA-C-N 113.91 -1.495 . . . . 0.0 108.488 -173.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -81.14 111.24 17.4 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.293 0.637 . . . . 0.0 109.894 177.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.425 ' HG3' ' HG ' ' A' ' 75' ' ' LEU . 59.9 ttt-85 -70.66 137.78 50.14 Favored 'General case' 0 CA--C 1.563 1.448 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.169 178.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -62.21 168.78 15.07 Favored Glycine 0 CA--C 1.55 2.277 0 N-CA-C 115.116 0.806 . . . . 0.0 115.116 166.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -61.41 -71.42 0.15 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.108 -1.231 . . . . 0.0 113.792 -167.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.3 m -102.75 -27.38 12.73 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 176.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -123.66 144.49 15.57 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 170.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.425 ' HG ' ' HG3' ' A' ' 70' ' ' ARG . 1.1 mp -76.5 -86.88 0.05 OUTLIER 'General case' 0 CA--C 1.558 1.281 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -177.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 140.82 36.17 0.11 Allowed Glycine 0 CA--C 1.546 1.975 0 N-CA-C 116.848 1.499 . . . . 0.0 116.848 -166.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.439 ' CD2' ' HB2' ' A' ' 105' ' ' ALA . 0.3 OUTLIER -137.25 175.82 9.26 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 174.814 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 45.7 m -149.05 119.15 7.19 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 119.919 -1.738 . . . . 0.0 107.775 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.405 HD11 ' HB ' ' A' ' 134' ' ' VAL . 5.3 pt -97.22 132.23 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.461 -172.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -79.5 -177.49 5.82 Favored 'General case' 0 CA--C 1.556 1.193 0 CA-C-O 123.478 1.608 . . . . 0.0 111.673 156.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.75 163.03 25.67 Favored Glycine 0 CA--C 1.54 1.599 0 CA-C-N 113.751 -1.568 . . . . 0.0 116.576 -149.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.2 -156.74 20.48 Favored Glycine 0 N--CA 1.471 1.02 0 CA-C-N 112.553 -1.824 . . . . 0.0 114.135 177.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.72 -43.05 76.19 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 115.799 1.778 . . . . 0.0 115.799 177.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -62.33 -38.34 89.1 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 117.536 2.421 . . . . 0.0 117.536 172.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -142.17 89.35 8.7 Favored Pre-proline 0 CA--C 1.553 1.068 1 N-CA-C 99.424 -4.287 . . . . 0.0 99.424 -168.265 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -100.31 130.73 0.16 Allowed 'Trans proline' 0 CA--C 1.548 1.193 0 CA-C-N 124.361 2.593 . . . . 0.0 110.655 -175.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -58.72 -22.5 57.72 Favored 'General case' 0 CA--C 1.582 2.177 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 154.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.418 HD11 ' HE2' ' A' ' 95' ' ' PHE . 0.4 OUTLIER -157.25 117.38 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.223 0 N-CA-C 104.033 -2.58 . . . . 0.0 104.033 -169.809 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -77.03 7.58 35.05 Favored Glycine 0 CA--C 1.559 2.799 0 N-CA-C 117.859 1.904 . . . . 0.0 117.859 165.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -97.82 -12.94 21.63 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -155.5 89.89 2.93 Favored Pre-proline 0 CA--C 1.559 1.32 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 176.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -70.49 93.98 0.59 Allowed 'Trans proline' 0 C--N 1.371 1.711 0 C-N-CA 122.821 2.347 . . . . 0.0 110.969 175.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 75.7 m -145.3 128.75 16.95 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 -174.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.443 ' H ' ' HA ' ' A' ' 126' ' ' ARG . 24.6 mm -74.41 115.81 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 -177.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.418 ' HE2' HD11 ' A' ' 88' ' ' ILE . 31.5 m-85 -104.26 155.95 18.31 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 113.044 -1.889 . . . . 0.0 107.446 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.427 ' HB ' ' O ' ' A' ' 113' ' ' VAL 0.31 97.6 mt -96.28 120.0 45.07 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.688 0 N-CA-C 104.686 -2.339 . . . . 0.0 104.686 160.03 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 43.4 m -92.42 -25.0 18.68 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 120.57 -1.331 . . . . 0.0 113.486 168.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -138.66 150.74 46.55 Favored 'General case' 0 CA--C 1.56 1.331 0 CA-C-N 120.72 1.6 . . . . 0.0 110.473 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -99.32 126.23 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 104.762 -2.31 . . . . 0.0 104.762 170.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.25 28.7 mm -73.96 120.77 83.0 Favored Pre-proline 0 CA--C 1.571 1.755 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 176.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.64 132.12 22.85 Favored 'Trans proline' 0 C--N 1.368 1.586 0 C-N-CA 123.834 3.022 . . . . 0.0 113.045 -175.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 74.94 0.08 59.32 Favored Glycine 0 CA--C 1.551 2.323 0 N-CA-C 118.59 2.196 . . . . 0.0 118.59 -168.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -88.1 -162.38 38.04 Favored Glycine 0 CA--C 1.544 1.904 0 CA-C-N 119.161 1.481 . . . . 0.0 113.525 177.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.24 -58.05 9.94 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.561 ' HA ' HD11 ' A' ' 68' ' ' LEU . . . -50.47 -45.68 56.36 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 117.843 2.534 . . . . 0.0 117.843 172.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.38 -40.53 73.92 Favored 'General case' 0 CA--C 1.56 1.341 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 177.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . 0.256 0.0 OUTLIER -72.14 -55.49 7.2 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 178.231 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -72.33 -38.3 68.69 Favored 'General case' 0 CA--C 1.557 1.237 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -173.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -141.6 -148.55 5.07 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-O 123.738 1.743 . . . . 0.0 111.164 171.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.88 59.94 0.13 Allowed 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 111.932 -2.134 . . . . 0.0 106.752 -169.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.634 ' H ' HD23 ' A' ' 111' ' ' LEU . 1.5 pt? -79.23 -164.06 0.58 Allowed 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 123.273 1.511 . . . . 0.0 109.128 -174.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.06 157.17 17.06 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 124.594 2.14 . . . . 0.0 106.437 155.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.427 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 33.4 m -58.88 -65.11 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 112.488 -2.142 . . . . 0.0 110.399 171.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -39.54 -18.34 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.256 1 N-CA-C 122.257 4.169 . . . . 0.0 122.257 -177.07 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -34.92 99.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 125.652 1.581 . . . . 0.0 114.39 163.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.7 m -85.67 104.87 15.79 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 112.568 -2.105 . . . . 0.0 107.455 -161.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . 0.336 11.0 tp -57.93 104.07 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.497 0 CA-C-O 122.339 1.066 . . . . 0.0 112.323 -170.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.439 ' HG ' ' HB2' ' A' ' 149' ' ' MET 0.317 0.1 OUTLIER -82.9 -63.62 1.33 Allowed 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 112.602 -2.09 . . . . 0.0 110.413 -176.142 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -132.49 135.54 46.08 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 173.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 5.7 p -119.13 112.47 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 105.709 -1.959 . . . . 0.0 105.709 171.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . 0.27 12.8 m120 77.7 -78.89 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 122.821 1.296 . . . . 0.0 109.966 -174.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -159.5 -12.94 0.06 Allowed 'General case' 0 CA--C 1.573 1.838 0 C-N-CA 127.399 2.28 . . . . 0.0 110.951 -176.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.657 HG12 HG13 ' A' ' 125' ' ' VAL . 2.4 t -68.25 134.83 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.394 0 C-N-CA 125.376 1.47 . . . . 0.0 110.124 175.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -87.17 97.04 10.54 Favored 'General case' 0 CA--C 1.553 1.068 0 CA-C-N 113.434 -1.712 . . . . 0.0 108.638 177.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.657 HG13 HG12 ' A' ' 123' ' ' VAL 0.325 2.9 m -97.11 -142.49 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.599 179.616 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.443 ' HA ' ' H ' ' A' ' 94' ' ' ILE 0.323 0.9 OUTLIER 71.82 -83.66 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 124.664 1.185 . . . . 0.0 111.2 -173.299 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.56 69.87 10.17 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 123.752 1.739 . . . . 0.0 109.406 177.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.1 m -143.72 166.49 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 -175.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 46.7 m -56.71 129.74 42.46 Favored 'General case' 0 CA--C 1.568 1.666 0 CA-C-N 112.96 -1.927 . . . . 0.0 109.639 150.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -48.49 -32.22 7.55 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 168.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.543 ' HA ' HG12 ' A' ' 134' ' ' VAL . 16.1 m -57.62 -45.03 85.89 Favored 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 168.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.36 -38.52 84.1 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 169.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.474 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -73.23 -44.29 59.79 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 116.914 2.19 . . . . 0.0 116.914 172.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.543 HG12 ' HA ' ' A' ' 131' ' ' SER . 4.6 p -57.71 -44.93 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 168.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -60.0 -50.8 72.32 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-O 117.089 -1.434 . . . . 0.0 112.055 170.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.63 -31.91 69.94 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 117.939 2.57 . . . . 0.0 117.939 172.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 73.3 mt -59.26 -53.75 54.67 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 125.071 1.348 . . . . 0.0 113.619 164.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -68.6 -35.95 78.03 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 117.358 2.355 . . . . 0.0 117.358 172.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -64.09 -14.28 53.58 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 117.044 2.238 . . . . 0.0 117.044 169.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.411 ' HB1' ' HA ' ' A' ' 144' ' ' VAL . . . -54.99 -24.0 22.06 Favored 'General case' 0 CA--C 1.561 1.368 0 N-CA-C 118.756 2.873 . . . . 0.0 118.756 160.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 93.61 -125.99 8.45 Favored Glycine 0 N--CA 1.475 1.268 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 168.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.2 m -79.94 -3.36 47.86 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 168.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -149.93 106.8 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -166.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.513 HG23 ' HB3' ' A' ' 68' ' ' LEU . 2.4 m -81.74 117.55 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 124.192 0.997 . . . . 0.0 110.572 170.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 45.4 mtm180 -99.45 90.59 4.57 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 175.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 42.5 mt -94.25 128.52 40.76 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.322 -169.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -127.49 121.68 31.38 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 103.231 -2.877 . . . . 0.0 103.231 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 18.3 m -131.38 119.44 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 CA-C-N 119.815 1.189 . . . . 0.0 110.923 -163.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.439 ' HB2' ' HG ' ' A' ' 118' ' ' LEU . 28.1 ttt -91.64 148.07 22.54 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 122.378 1.085 . . . . 0.0 111.256 -176.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -95.12 109.29 21.38 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.632 173.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -118.08 -67.49 0.99 Allowed 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 113.962 -1.472 . . . . 0.0 108.712 178.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.429 ' HA ' ' HE2' ' A' ' 152' ' ' LYS . 6.7 mmpt? -125.93 84.74 60.57 Favored Pre-proline 0 CA--C 1.555 1.142 0 CA-C-O 118.12 -0.943 . . . . 0.0 109.331 178.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -81.64 115.52 2.81 Favored 'Trans proline' 0 CA--C 1.569 2.228 0 C-N-CA 123.728 2.952 . . . . 0.0 110.864 170.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo . . . . . 0 C--N 1.365 1.436 0 C-N-CA 123.339 2.692 . . . . 0.0 112.121 179.111 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.558 1.273 0 CA-C-O 122.55 1.167 . . . . 0.0 111.406 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -138.31 128.18 25.34 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 170.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 20.7 ttpp -78.97 114.5 17.97 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.551 170.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 85.8 m -88.66 126.54 35.35 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 122.412 1.101 . . . . 0.0 109.059 175.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -80.66 133.8 35.77 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 113.886 -1.506 . . . . 0.0 108.502 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.417 ' HB ' HG23 ' A' ' 134' ' ' VAL . 7.6 p . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 -170.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 . . . . . 0 N--CA 1.479 1.001 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -133.11 133.62 43.17 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 124.676 1.235 . . . . 0.0 109.078 176.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -113.67 141.54 47.1 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.196 -172.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.9 117.7 34.7 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.3 mp -123.76 131.08 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 -174.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.0 m -101.15 127.13 47.85 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 162.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.0 tp -133.79 130.75 38.43 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 113.979 -1.464 . . . . 0.0 107.574 -176.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -77.46 132.28 38.37 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.352 -0.842 . . . . 0.0 109.848 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.413 ' HG3' ' HG ' ' A' ' 75' ' ' LEU . 33.7 ttt180 -72.98 137.89 45.72 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 119.339 0.972 . . . . 0.0 109.758 174.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -46.86 -82.17 0.03 OUTLIER Glycine 0 CA--C 1.543 1.84 0 CA-C-N 114.734 -1.121 . . . . 0.0 115.866 176.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -166.39 -85.22 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.6 m -88.75 -25.42 22.3 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 125.027 1.331 . . . . 0.0 113.893 173.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -116.79 -174.03 17.05 Favored Glycine 0 CA--C 1.537 1.465 0 CA-C-O 124.801 2.334 . . . . 0.0 110.332 159.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.558 HD11 HG21 ' A' ' 144' ' ' VAL . 1.3 tt -111.25 -44.54 3.54 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 111.705 -2.248 . . . . 0.0 110.101 174.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.445 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 103.75 44.36 1.67 Allowed Glycine 0 CA--C 1.533 1.179 0 N-CA-C 117.392 1.717 . . . . 0.0 117.392 173.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.46 ' CD1' HD13 ' A' ' 96' ' ' ILE . 0.1 OUTLIER -160.24 168.35 25.56 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.95 1.3 . . . . 0.0 108.487 176.252 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.468 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 3.0 m -131.81 119.7 21.62 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 120.622 -1.299 . . . . 0.0 111.068 -163.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.593 HG22 HG12 ' A' ' 96' ' ' ILE . 1.7 pt -95.51 129.22 45.93 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.279 -174.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.57 -173.92 4.35 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-O 123.299 1.523 . . . . 0.0 110.243 161.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.47 160.17 22.69 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 123.88 1.822 . . . . 0.0 116.046 -137.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -103.96 -162.0 24.77 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 111.26 -2.47 . . . . 0.0 115.449 -178.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 53.1 p -54.45 -40.16 68.12 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 116.395 1.998 . . . . 0.0 116.395 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.421 ' HB2' HG23 ' A' ' 129' ' ' THR . 9.6 m-20 -88.49 0.5 56.22 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 116.363 1.986 . . . . 0.0 116.363 175.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -163.27 87.84 1.27 Allowed Pre-proline 0 CA--C 1.557 1.242 0 N-CA-C 101.275 -3.602 . . . . 0.0 101.275 -176.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -97.5 143.19 0.67 Allowed 'Trans proline' 0 CA--C 1.549 1.265 0 CA-C-N 124.043 2.48 . . . . 0.0 111.073 -174.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 57.6 t60 -105.69 -19.38 13.78 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 167.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.423 ' H ' HD12 ' A' ' 88' ' ' ILE . 2.4 mp -94.34 146.7 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 -165.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -64.29 -2.39 7.03 Favored Glycine 0 CA--C 1.559 2.802 0 N-CA-C 119.116 2.407 . . . . 0.0 119.116 167.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -91.65 -11.1 38.0 Favored 'General case' 0 CA--C 1.569 1.697 0 CA-C-O 116.908 -1.52 . . . . 0.0 114.767 163.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.471 ' HB3' ' HD3' ' A' ' 92' ' ' PRO 0.52 19.8 t70 92.59 -88.14 0.0 OUTLIER Pre-proline 0 CA--C 1.569 1.69 0 C-N-CA 126.582 1.953 . . . . 0.0 109.565 -168.685 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.471 ' HD3' ' HB3' ' A' ' 91' ' ' ASP . 70.9 Cg_endo -113.75 103.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.362 1.279 0 CA-C-N 124.455 2.627 . . . . 0.0 112.371 -154.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 67.9 m -154.93 109.52 2.99 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.497 HD12 ' HA ' ' A' ' 130' ' ' HIS . 17.6 mm -74.09 118.85 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 174.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.481 ' HB2' ' HA ' ' A' ' 116' ' ' SER . 2.2 p90 -143.65 134.05 24.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.148 -1.387 . . . . 0.0 108.255 -171.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.595 HD12 ' HB2' ' A' ' 114' ' ' ASN . 86.9 mt -83.31 121.75 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 177.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.8 m -96.9 -26.17 15.16 Favored 'General case' 0 CA--C 1.558 1.264 0 CA-C-N 112.659 -2.064 . . . . 0.0 113.501 173.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.468 ' HB2' ' HB2' ' A' ' 78' ' ' SER . 63.8 mttm -132.45 158.37 42.2 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 123.903 1.811 . . . . 0.0 112.121 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -121.92 118.01 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 N-CA-C 102.622 -3.103 . . . . 0.0 102.622 177.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.262 1.6 mp -72.33 131.46 84.91 Favored Pre-proline 0 CA--C 1.567 1.621 0 CA-C-O 118.291 -0.861 . . . . 0.0 108.82 174.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -62.19 134.74 50.57 Favored 'Trans proline' 0 CA--C 1.555 1.547 0 C-N-CA 123.332 2.688 . . . . 0.0 113.531 172.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.18 12.69 84.38 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 117.349 1.7 . . . . 0.0 117.349 -161.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.445 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -93.87 166.52 27.55 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-O 122.203 0.891 . . . . 0.0 113.589 177.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.463 ' HB3' HD23 ' A' ' 75' ' ' LEU . . . -69.82 -39.79 76.28 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 116.6 2.074 . . . . 0.0 116.6 -175.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.85 -26.32 65.09 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 172.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.03 -52.39 17.19 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 162.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -58.59 -60.9 3.09 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 125.922 1.689 . . . . 0.0 114.312 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -67.99 -48.27 66.24 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.089 0.955 . . . . 0.0 110.885 175.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.53 80.13 0.24 Allowed Glycine 0 C--N 1.353 1.498 0 CA-C-N 118.719 0.691 . . . . 0.0 112.426 166.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -121.08 -30.54 4.33 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 176.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -138.23 -163.49 1.46 Allowed 'General case' 0 CA--C 1.552 1.026 0 CA-C-O 124.21 1.957 . . . . 0.0 107.048 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -74.41 -146.94 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.465 0 CA-C-O 124.456 2.074 . . . . 0.0 111.271 165.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.516 ' HB ' HG22 ' A' ' 96' ' ' ILE 0.371 12.3 m -37.31 -76.48 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 C-N-CA 128.329 2.652 . . . . 0.0 112.847 160.077 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.595 ' HB2' HD12 ' A' ' 96' ' ' ILE . 11.7 t-20 -160.72 -16.16 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 112.819 -1.991 . . . . 0.0 109.715 154.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.41 ' H ' ' H ' ' A' ' 114' ' ' ASN 0.315 11.9 t70 74.27 -84.69 0.03 OUTLIER 'General case' 0 C--N 1.354 0.801 0 CA-C-O 115.745 -2.074 . . . . 0.0 108.622 -165.163 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.481 ' HA ' ' HB2' ' A' ' 95' ' ' PHE . 12.6 m -155.23 93.59 1.53 Allowed 'General case' 0 N--CA 1.48 1.037 0 O-C-N 125.47 1.731 . . . . 0.0 107.95 -173.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.4 tp -65.77 127.04 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-O 121.326 0.584 . . . . 0.0 109.967 175.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.58 ' HA ' ' HB3' ' A' ' 126' ' ' ARG 0.338 4.1 pp -96.31 -51.38 4.4 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 116.336 1.976 . . . . 0.0 116.336 171.631 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -135.93 138.56 42.49 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 103.637 -2.727 . . . . 0.0 103.637 -176.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 10.8 p -125.58 121.03 59.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 173.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.403 ' HA ' ' HB2' ' A' ' 145' ' ' ARG 0.31 16.0 m120 80.88 -80.65 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 124.181 1.943 . . . . 0.0 109.474 -177.395 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -163.69 -17.37 0.03 OUTLIER 'General case' 0 CA--C 1.568 1.663 0 CA-C-N 110.322 -3.126 . . . . 0.0 109.893 -174.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.689 HG12 HG13 ' A' ' 125' ' ' VAL . 2.4 t -65.46 136.65 26.34 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.268 0 CA-C-O 123.568 1.651 . . . . 0.0 109.647 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -85.25 79.61 9.47 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 111.233 -2.712 . . . . 0.0 110.743 177.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.689 HG13 HG12 ' A' ' 123' ' ' VAL 0.264 1.2 m -87.03 -106.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 CA-C-O 116.672 -1.633 . . . . 0.0 107.883 -179.497 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.58 ' HB3' ' HA ' ' A' ' 118' ' ' LEU 0.254 25.0 ptt180 52.04 -88.87 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 116.604 2.075 . . . . 0.0 116.604 177.987 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.565 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 25.1 tt0 -86.53 72.77 10.21 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-O 123.259 1.504 . . . . 0.0 108.877 167.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.3 p -139.88 170.25 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 177.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.421 HG23 ' HB2' ' A' ' 84' ' ' ASP . 3.1 m -58.34 136.67 57.45 Favored 'General case' 0 CA--C 1.559 1.29 0 CA-C-N 114.062 -1.426 . . . . 0.0 111.739 159.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.497 ' HA ' HD12 ' A' ' 94' ' ' ILE 0.264 2.4 p-80 -46.79 -37.66 8.97 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 117.174 2.287 . . . . 0.0 117.174 171.339 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.438 ' HA ' HG12 ' A' ' 134' ' ' VAL . 53.6 p -56.33 -52.35 64.88 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 172.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.57 -36.48 78.61 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 173.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.624 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -71.12 -52.53 18.79 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 116.083 1.882 . . . . 0.0 116.083 172.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.438 HG12 ' HA ' ' A' ' 131' ' ' SER . 1.9 p -53.43 -44.16 54.53 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.183 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 171.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 139' ' ' GLU . 65.7 mm-40 -63.93 -48.77 75.26 Favored 'General case' 0 C--O 1.212 -0.878 0 CA-C-O 116.038 -1.934 . . . . 0.0 111.807 172.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.77 -28.67 70.14 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 117.384 2.365 . . . . 0.0 117.384 170.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -60.31 -53.98 51.13 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.008 1.323 . . . . 0.0 113.925 166.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -67.91 -39.15 83.63 Favored 'General case' 0 CA--C 1.569 1.691 0 N-CA-C 115.788 1.773 . . . . 0.0 115.788 171.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 135' ' ' GLU . 1.2 mm-40 -74.05 0.31 14.1 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 116.866 2.173 . . . . 0.0 116.866 171.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.511 ' HB1' ' HA ' ' A' ' 144' ' ' VAL . . . -57.71 -6.75 0.56 Allowed 'General case' 0 CA--C 1.555 1.172 0 N-CA-C 119.317 3.08 . . . . 0.0 119.317 157.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.62 -137.98 16.38 Favored Glycine 0 C--N 1.345 1.072 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 174.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.9 m -79.34 -8.56 59.17 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 169.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -147.76 112.72 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 CA-C-O 123.674 1.702 . . . . 0.0 107.244 -165.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.558 HG21 HD11 ' A' ' 75' ' ' LEU . 4.3 t -101.55 114.1 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 112.411 -2.177 . . . . 0.0 106.814 -169.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.403 ' HB2' ' HA ' ' A' ' 121' ' ' ASN . 70.1 mtm180 -96.08 91.79 6.12 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -177.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 45.4 mt -90.88 136.91 32.76 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.033 -173.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -128.49 121.49 29.0 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 104.867 -2.272 . . . . 0.0 104.867 173.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.424 HG21 ' O ' ' A' ' 114' ' ' ASN . 0.1 OUTLIER -129.53 122.43 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 -173.328 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.409 ' HB2' ' CD2' ' A' ' 118' ' ' LEU . 56.4 ttm -99.68 143.12 30.28 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 124.442 1.088 . . . . 0.0 110.062 164.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -83.37 139.93 32.72 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 122.375 1.083 . . . . 0.0 110.543 168.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.416 ' HG2' ' HD2' ' A' ' 153' ' ' PRO . 64.6 ttt180 -59.02 148.53 30.49 Favored 'General case' 0 CA--C 1.565 1.554 0 CA-C-N 114.073 -1.421 . . . . 0.0 112.352 177.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.97 -61.03 4.88 Favored Pre-proline 0 N--CA 1.492 1.646 0 CA-C-O 116.027 -1.94 . . . . 0.0 113.532 -178.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.45 ' HA ' ' HD3' ' A' ' 154' ' ' PRO . 59.0 Cg_endo -67.36 139.06 48.44 Favored 'Trans proline' 0 CA--C 1.566 2.106 0 C-N-CA 122.994 2.463 . . . . 0.0 113.494 173.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 153' ' ' PRO . 7.7 Cg_exo . . . . . 0 CA--C 1.554 1.486 0 C-N-CA 123.301 2.667 . . . . 0.0 111.576 173.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.562 1.43 0 CA-C-O 122.948 1.356 . . . . 0.0 110.883 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -150.1 113.93 5.05 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 172.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -86.42 125.29 33.59 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.399 175.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 96.7 m -98.85 136.38 38.95 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-O 122.497 1.141 . . . . 0.0 110.008 176.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -84.95 129.19 34.84 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 113.508 -1.678 . . . . 0.0 108.198 173.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 p . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 177.499 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 N--CA 1.481 1.099 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -108.51 132.73 53.53 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 124.08 0.863 . . . . 0.0 109.975 176.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -109.99 131.87 54.67 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 114.389 -1.278 . . . . 0.0 108.223 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.89 126.19 37.86 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 114.362 -1.29 . . . . 0.0 109.294 176.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 40.9 mt -129.26 126.26 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 103.946 -2.613 . . . . 0.0 103.946 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.8 m -109.77 127.6 54.74 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 168.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.488 HD11 ' HA ' ' A' ' 105' ' ' ALA . 4.4 tp -127.44 162.11 27.14 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 113.347 -1.752 . . . . 0.0 107.396 175.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.402 ' O ' ' HB1' ' A' ' 104' ' ' ALA . 5.9 mt-10 -87.52 145.56 26.18 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.432 168.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.486 ' HG3' ' HG ' ' A' ' 75' ' ' LEU . 16.4 ttp180 -102.0 124.88 48.37 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 170.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -58.51 149.04 37.02 Favored Glycine 0 CA--C 1.547 2.088 0 CA-C-N 115.42 -0.809 . . . . 0.0 113.773 167.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -54.05 -52.01 62.24 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 -174.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.4 m -83.22 -15.54 49.98 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 116.319 1.97 . . . . 0.0 116.319 175.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 168.67 165.85 26.75 Favored Glycine 0 CA--C 1.535 1.295 0 N-CA-C 107.208 -2.357 . . . . 0.0 107.208 -177.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.632 HD13 HG22 ' B' ' 6' ' ' VAL . 1.8 mp -79.12 -85.43 0.08 Allowed 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 -178.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.615 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 129.97 50.4 0.12 Allowed Glycine 0 CA--C 1.54 1.61 0 C-N-CA 124.08 0.848 . . . . 0.0 114.526 -172.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.418 ' HA ' ' H ' ' A' ' 100' ' ' ILE . 36.8 p90 -151.88 158.36 43.11 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 165.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.454 ' HB2' ' HG2' ' A' ' 98' ' ' LYS . 67.1 m -96.05 154.0 17.47 Favored 'General case' 0 C--N 1.316 -0.888 0 O-C-N 119.569 -1.957 . . . . 0.0 110.533 171.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.478 HG22 HD13 ' A' ' 96' ' ' ILE . 2.5 pp -116.39 132.82 64.89 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-N 111.168 -2.742 . . . . 0.0 108.398 168.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.44 -171.3 3.29 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-O 123.613 1.673 . . . . 0.0 109.138 163.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.14 156.44 23.54 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 123.392 1.551 . . . . 0.0 115.251 -142.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.14 -158.58 23.19 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 111.955 -2.123 . . . . 0.0 113.643 -178.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.545 HG22 ' HB2' ' A' ' 92' ' ' PRO . 72.8 p -54.88 -41.55 70.99 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 117.736 2.495 . . . . 0.0 117.736 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -76.54 -13.59 60.07 Favored 'General case' 0 CA--C 1.568 1.663 0 N-CA-C 116.183 1.92 . . . . 0.0 116.183 172.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.31 82.0 6.51 Favored Pre-proline 0 CA--C 1.56 1.345 0 N-CA-C 102.557 -3.127 . . . . 0.0 102.557 -176.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -104.99 120.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.359 1.102 0 CA-C-N 124.976 2.813 . . . . 0.0 110.846 -169.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -107.87 -36.01 6.49 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.13 143.98 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -148.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.91 -113.76 4.71 Favored Glycine 0 CA--C 1.536 1.359 0 CA-C-N 114.799 -1.091 . . . . 0.0 112.759 168.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -74.46 -7.81 54.23 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 168.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.467 ' HB2' ' HD3' ' A' ' 92' ' ' PRO 0.454 41.1 m-20 100.79 -81.88 0.0 OUTLIER Pre-proline 0 CA--C 1.566 1.579 0 CA-C-O 115.781 -2.057 . . . . 0.0 106.939 -173.578 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.545 ' HB2' HG22 ' A' ' 83' ' ' THR . 91.2 Cg_endo -86.13 86.92 0.88 Allowed 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 123.442 2.762 . . . . 0.0 112.455 -177.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 66.8 m -155.7 127.65 7.51 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 103.83 -2.655 . . . . 0.0 103.83 -177.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.459 HG13 ' HB2' ' A' ' 133' ' ' ALA . 17.3 mm -76.28 122.3 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -110.02 151.06 27.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 113.057 -1.883 . . . . 0.0 107.936 178.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.478 HD13 HG22 ' A' ' 79' ' ' ILE . 20.6 mm -94.24 100.92 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.205 0 N-CA-C 102.979 -2.971 . . . . 0.0 102.979 165.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.2 t -80.82 -47.35 13.98 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 114.989 1.478 . . . . 0.0 114.989 -176.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.598 ' HA ' HG21 ' A' ' 113' ' ' VAL 0.277 10.4 ptmt -143.75 152.47 41.3 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 121.782 0.801 . . . . 0.0 111.727 -173.593 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.12 123.21 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 N-CA-C 103.886 -2.635 . . . . 0.0 103.886 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.418 ' H ' ' HA ' ' A' ' 77' ' ' PHE 0.267 1.7 mp -72.96 125.88 90.83 Favored Pre-proline 0 CA--C 1.566 1.576 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 173.137 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -60.95 129.52 29.18 Favored 'Trans proline' 0 C--N 1.364 1.367 0 C-N-CA 123.329 2.686 . . . . 0.0 114.296 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.87 5.45 69.81 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 118.481 2.153 . . . . 0.0 118.481 -169.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.615 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -79.08 -175.63 47.21 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 124.31 0.957 . . . . 0.0 114.486 173.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.402 ' HB1' ' O ' ' A' ' 69' ' ' GLU . . . -64.88 -40.15 94.67 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 116.077 1.88 . . . . 0.0 116.077 -174.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.488 ' HA ' HD11 ' A' ' 68' ' ' LEU . . . -68.03 -36.84 80.58 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 173.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.32 -35.21 75.73 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 116.445 2.017 . . . . 0.0 116.445 167.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -70.64 -57.32 4.83 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 125.704 1.602 . . . . 0.0 112.395 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -74.86 -55.57 5.67 Favored 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 123.831 0.853 . . . . 0.0 112.443 -177.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -113.72 -151.75 10.72 Favored Glycine 0 N--CA 1.474 1.208 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 172.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 14.2 mtt-85 -173.82 73.67 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 176.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.525 HD23 ' H ' ' A' ' 111' ' ' LEU . 2.5 pt? -104.34 -166.7 1.27 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 124.114 1.912 . . . . 0.0 108.725 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -100.29 128.61 46.32 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 103.133 -2.914 . . . . 0.0 103.133 157.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.598 HG21 ' HA ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -37.34 -64.77 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 110.242 -3.163 . . . . 0.0 116.657 164.026 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -33.48 85.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 125.921 2.013 . . . . 0.0 116.154 -178.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -154.85 131.95 10.95 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 103.717 -2.697 . . . . 0.0 103.717 -177.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 45.0 m -89.98 90.52 8.19 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 113.085 -1.87 . . . . 0.0 108.169 -170.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.5 tp -61.77 121.83 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.009 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.536 ' HA ' ' HB3' ' A' ' 126' ' ' ARG . 1.5 pp -106.33 -50.67 3.1 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 113.16 -1.836 . . . . 0.0 115.91 175.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.42 ' H ' HD12 ' A' ' 118' ' ' LEU . 41.6 m-85 -123.33 132.75 54.1 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 177.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 5.8 p -122.22 116.39 48.99 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 N-CA-C 104.142 -2.54 . . . . 0.0 104.142 168.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . 0.282 10.5 m120 79.83 -74.65 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 CA-C-O 123.348 1.547 . . . . 0.0 110.176 -174.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -167.54 -16.74 0.02 OUTLIER 'General case' 0 CA--C 1.578 2.027 0 CA-C-N 111.471 -2.604 . . . . 0.0 109.64 -175.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.405 HG12 HG13 ' A' ' 125' ' ' VAL . 2.0 t -67.66 134.78 29.65 Favored 'Isoleucine or valine' 0 C--N 1.361 1.099 0 CA-C-N 120.415 1.462 . . . . 0.0 110.351 176.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -86.27 99.45 11.58 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 113.419 -1.719 . . . . 0.0 109.046 176.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.504 HG11 ' HA ' ' A' ' 133' ' ' ALA . 1.3 m -95.93 -101.19 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 CA-C-O 116.401 -1.762 . . . . 0.0 107.381 175.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.536 ' HB3' ' HA ' ' A' ' 118' ' ' LEU 0.316 18.8 ptt180 50.97 -90.89 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.254 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 177.99 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.422 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 4.9 tt0 -88.23 65.57 8.12 Favored 'General case' 0 CA--C 1.557 1.225 0 CA-C-O 122.991 1.377 . . . . 0.0 109.54 171.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.7 p -130.36 169.86 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 176.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 33.2 m -61.02 134.87 57.53 Favored 'General case' 0 CA--C 1.56 1.342 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.43 158.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.424 ' HA ' HD12 ' A' ' 94' ' ' ILE . 9.1 p-80 -47.28 -33.41 5.57 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 117.922 2.564 . . . . 0.0 117.922 171.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.552 ' HA ' HG12 ' A' ' 134' ' ' VAL . 16.7 m -62.06 -38.88 90.46 Favored 'General case' 0 CA--C 1.562 1.439 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 173.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.62 -34.69 76.19 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 115.521 1.675 . . . . 0.0 115.521 166.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.504 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -72.44 -49.8 30.84 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 116.234 1.938 . . . . 0.0 116.234 174.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.633 HG23 ' HB ' ' B' ' 6' ' ' VAL . 4.0 p -49.88 -44.24 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.221 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 164.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -64.09 -49.21 73.14 Favored 'General case' 0 C--O 1.216 -0.658 0 CA-C-O 116.075 -1.917 . . . . 0.0 112.556 172.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.47 -32.75 73.68 Favored 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 117.184 2.29 . . . . 0.0 117.184 176.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -58.25 -46.47 85.9 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 162.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -72.36 -37.69 68.74 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 171.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -64.98 -19.95 66.24 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 116.272 1.953 . . . . 0.0 116.272 170.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.444 ' HB1' ' HA ' ' A' ' 144' ' ' VAL . . . -52.11 -10.66 0.13 Allowed 'General case' 0 CA--C 1.554 1.103 0 N-CA-C 119.246 3.054 . . . . 0.0 119.246 162.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 70.18 -154.51 52.66 Favored Glycine 0 C--N 1.348 1.243 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -175.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.5 m -59.83 -5.09 0.84 Allowed 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 118.506 2.78 . . . . 0.0 118.506 176.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.96 105.79 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 -170.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.468 HG11 HD21 ' A' ' 75' ' ' LEU . 15.8 m -85.88 123.1 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.07 174.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -108.13 90.22 3.23 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 56.7 mt -90.69 139.27 30.87 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.471 -171.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -135.64 117.88 15.58 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 104.52 -2.4 . . . . 0.0 104.52 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 35.3 m -129.64 118.53 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -164.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 53.2 ttm -118.21 134.15 55.27 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 118.882 0.765 . . . . 0.0 109.746 173.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -82.6 115.18 21.45 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 114.447 -1.251 . . . . 0.0 110.2 171.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 25.9 ttt180 -97.43 99.6 11.03 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 113.628 -1.624 . . . . 0.0 106.665 168.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -68.03 144.63 97.21 Favored Pre-proline 0 CA--C 1.568 1.648 0 CA-C-N 114.088 -1.415 . . . . 0.0 112.457 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -58.38 118.56 5.46 Favored 'Trans proline' 0 CA--C 1.567 2.162 0 C-N-CA 123.45 2.767 . . . . 0.0 114.398 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo . . . . . 0 C--N 1.367 1.516 0 C-N-CA 123.049 2.499 . . . . 0.0 111.703 179.652 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.557 1.212 0 CA-C-O 122.504 1.145 . . . . 0.0 111.285 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -136.24 128.05 29.2 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-O 123.507 1.622 . . . . 0.0 109.328 170.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 10.7 ttpp -97.42 111.27 23.6 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 113.754 -1.566 . . . . 0.0 107.796 172.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 88.5 m -93.76 144.66 25.21 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.418 -1.265 . . . . 0.0 109.108 173.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -87.19 145.02 26.57 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 113.864 -1.516 . . . . 0.0 108.672 178.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.633 ' HB ' HG23 ' A' ' 134' ' ' VAL . 7.6 p . . . . . 0 C--O 1.248 1.01 0 N-CA-C 104.5 -2.408 . . . . 0.0 104.5 -178.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' BAL . . . . . 0.408 ' HB3' HD11 ' A' ' 100' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 . . . . . 0 N--CA 1.481 1.079 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -125.17 134.68 52.31 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 124.833 1.333 . . . . 0.0 110.158 170.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -101.46 133.15 46.54 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.812 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -97.84 128.52 44.51 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.72 170.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.533 HG13 ' HB2' ' A' ' 146' ' ' LEU . 23.5 pt -136.67 111.83 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 -174.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.0 m -91.96 120.24 32.44 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.42 ' HB3' ' CG2' ' A' ' 144' ' ' VAL . 6.7 tt -116.52 137.57 52.07 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 175.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -79.58 122.36 26.4 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 120.956 -1.09 . . . . 0.0 111.564 177.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 -62.68 104.79 0.56 Allowed 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 118.855 0.752 . . . . 0.0 110.222 172.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -41.68 -61.49 2.19 Favored Glycine 0 N--CA 1.482 1.743 0 N-CA-C 116.338 1.295 . . . . 0.0 116.338 -173.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -154.43 -100.67 0.04 OUTLIER 'General case' 0 CA--C 1.559 1.316 0 O-C-N 123.994 0.467 . . . . 0.0 109.868 167.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.4 m -73.55 -24.78 60.16 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 168.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -118.15 175.02 15.53 Favored Glycine 0 CA--C 1.543 1.782 0 CA-C-O 125.849 2.916 . . . . 0.0 111.037 162.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.568 HD21 HG22 ' B' ' 6' ' ' VAL . 0.1 OUTLIER -119.73 5.29 11.0 Favored 'General case' 0 CA--C 1.558 1.274 0 CA-C-N 110.076 -3.062 . . . . 0.0 112.015 176.499 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.522 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 69.4 36.37 77.75 Favored Glycine 0 C--N 1.344 1.014 0 N-CA-C 118.761 2.264 . . . . 0.0 118.761 164.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -150.48 163.51 38.25 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 123.563 1.649 . . . . 0.0 108.489 174.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.5 m -127.25 127.82 45.01 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.582 -169.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.3 pp -101.18 124.03 54.6 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 113.504 -1.68 . . . . 0.0 108.643 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -85.68 -170.86 3.31 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 123.452 1.596 . . . . 0.0 110.051 158.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.1 159.34 24.34 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-O 123.859 1.811 . . . . 0.0 115.604 -136.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -104.24 -162.6 24.58 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 111.082 -2.559 . . . . 0.0 113.742 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.446 HG22 ' HB3' ' A' ' 92' ' ' PRO . 70.2 p -52.83 -41.75 64.5 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 116.67 2.1 . . . . 0.0 116.67 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -80.15 -17.32 52.8 Favored 'General case' 0 CA--C 1.565 1.55 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 175.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.29 96.07 4.27 Favored Pre-proline 0 CA--C 1.552 1.028 0 N-CA-C 101.822 -3.399 . . . . 0.0 101.822 -175.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -96.73 143.41 0.84 Allowed 'Trans proline' 0 CA--C 1.548 1.194 0 CA-C-N 123.688 2.353 . . . . 0.0 111.472 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 16.8 t60 -106.25 -27.85 10.78 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 167.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.532 ' H ' HD12 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -98.62 162.68 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 125.305 1.442 . . . . 0.0 111.506 179.64 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -83.64 12.57 51.66 Favored Glycine 0 CA--C 1.552 2.358 0 N-CA-C 118.651 2.221 . . . . 0.0 118.651 172.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -81.12 -11.58 59.44 Favored 'General case' 0 CA--C 1.57 1.718 0 CA-C-N 119.151 1.475 . . . . 0.0 114.554 163.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.431 ' HB3' ' HD3' ' A' ' 92' ' ' PRO 0.509 31.8 t70 91.57 -85.32 0.0 OUTLIER Pre-proline 0 CA--C 1.562 1.429 0 CA-C-O 116.089 -1.91 . . . . 0.0 109.017 -169.019 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.446 ' HB3' HG22 ' A' ' 83' ' ' THR . 1.4 Cg_endo -108.39 -139.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.28 0 CA-C-N 125.288 2.924 . . . . 0.0 110.636 -163.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.5 m 78.3 106.87 0.07 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 168.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.487 HG13 ' HB2' ' A' ' 133' ' ' ALA . 11.3 mm -75.55 117.56 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 -173.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.427 ' CE1' HG13 ' A' ' 88' ' ' ILE . 16.9 p90 -128.4 135.44 49.54 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -171.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.414 ' HB ' ' O ' ' A' ' 113' ' ' VAL . 89.5 mt -72.5 118.83 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.388 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 175.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.44 ' CG2' ' HG3' ' B' ' 3' ' ' LYS . 14.3 t -87.75 -29.69 20.85 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 169.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -144.25 163.08 34.7 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-O 125.568 2.604 . . . . 0.0 110.343 -174.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.674 HG21 ' HA ' ' A' ' 111' ' ' LEU . 1.2 pt -115.4 129.17 72.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 111.051 -2.795 . . . . 0.0 103.539 173.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.294 1.5 mp -72.19 123.78 89.95 Favored Pre-proline 0 CA--C 1.57 1.715 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 170.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.93 132.08 42.95 Favored 'Trans proline' 0 C--N 1.367 1.545 0 C-N-CA 123.558 2.838 . . . . 0.0 114.203 172.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 71.52 9.95 69.88 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 118.084 1.994 . . . . 0.0 118.084 -166.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.522 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -91.01 -179.29 43.06 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-O 123.033 1.351 . . . . 0.0 112.397 177.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.65 -33.79 66.82 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 117.523 2.416 . . . . 0.0 117.523 -174.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.479 ' HB3' HG22 ' A' ' 99' ' ' ILE . . . -60.94 -32.88 72.38 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 117.961 2.578 . . . . 0.0 117.961 165.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.35 -39.41 93.84 Favored 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 167.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.48 -56.02 6.75 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.387 1.075 . . . . 0.0 113.624 175.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -62.0 -39.38 92.06 Favored 'General case' 0 CA--C 1.562 1.415 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -178.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 108.86 38.26 1.9 Allowed Glycine 0 CA--C 1.541 1.67 0 C-N-CA 124.682 1.134 . . . . 0.0 113.649 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -113.61 39.94 2.53 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 122.625 1.202 . . . . 0.0 111.343 173.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.674 ' HA ' HG21 ' A' ' 99' ' ' ILE . 1.7 pt? -61.01 -23.57 65.51 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 118.114 2.635 . . . . 0.0 118.114 170.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 16.1 mtp-105 -77.91 95.36 4.75 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 125.588 2.613 . . . . 0.0 107.479 163.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.414 ' O ' ' HB ' ' A' ' 96' ' ' ILE 0.26 17.0 m -56.17 -67.99 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 1 CA-C-N 107.589 -4.369 . . . . 0.0 108.467 -175.834 . . . . . . . . 4 3 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -55.3 68.95 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 126.174 2.171 . . . . 0.0 116.714 -175.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -123.91 102.38 7.75 Favored 'General case' 0 C--O 1.239 0.547 1 N-CA-C 100.091 -4.04 . . . . 0.0 100.091 173.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.8 m -75.02 86.93 2.34 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 112.992 -1.913 . . . . 0.0 109.097 -176.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.571 HD12 HD21 ' A' ' 137' ' ' LEU . 30.1 pt -64.91 121.22 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 125.065 1.346 . . . . 0.0 111.024 -174.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.869 HD11 ' H ' ' A' ' 149' ' ' MET . 0.0 OUTLIER -101.55 -50.17 3.81 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 112.736 -2.029 . . . . 0.0 112.778 -179.457 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -111.4 140.91 45.6 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 169.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.521 HG23 HD23 ' A' ' 146' ' ' LEU . 7.1 p -127.93 120.05 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 104.465 -2.42 . . . . 0.0 104.465 165.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . 0.27 12.2 m120 79.67 -74.45 0.05 Allowed 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 123.592 1.663 . . . . 0.0 110.453 -176.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -164.49 -10.88 0.03 OUTLIER 'General case' 0 CA--C 1.578 2.038 0 CA-C-N 111.355 -2.657 . . . . 0.0 110.203 177.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.1 t -71.46 134.42 29.98 Favored 'Isoleucine or valine' 0 C--N 1.36 1.03 0 C-N-CA 125.682 1.593 . . . . 0.0 109.745 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -84.67 100.79 11.69 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 113.698 -1.592 . . . . 0.0 109.299 172.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.555 HG11 ' HA ' ' A' ' 133' ' ' ALA . 0.7 OUTLIER -96.97 -96.86 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 CA-C-O 116.08 -1.914 . . . . 0.0 106.894 171.517 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.552 ' HB3' ' HA ' ' A' ' 118' ' ' LEU 0.302 18.9 ptt180 46.79 -89.37 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 -178.374 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.421 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 6.6 mt-10 -85.9 65.95 9.37 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-O 123.672 1.701 . . . . 0.0 109.087 177.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.1 p -138.75 168.38 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 22.9 m -60.33 132.79 55.0 Favored 'General case' 0 CA--C 1.561 1.388 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.884 158.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.46 ' HA ' HD12 ' A' ' 94' ' ' ILE . 10.2 p-80 -46.53 -32.69 3.54 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 118.166 2.654 . . . . 0.0 118.166 170.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.505 ' HA ' HG12 ' A' ' 134' ' ' VAL . 16.5 m -62.4 -40.37 96.28 Favored 'General case' 0 CA--C 1.561 1.381 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 173.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.74 -37.69 87.07 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 167.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.555 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -66.94 -52.18 46.11 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 172.306 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.505 HG12 ' HA ' ' A' ' 131' ' ' SER . 4.9 p -53.65 -42.25 50.15 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.421 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 172.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -72.33 -39.82 67.88 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 116.267 -1.825 . . . . 0.0 112.93 174.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.436 ' HA ' ' HB3' ' A' ' 139' ' ' GLU . . . -60.59 -29.19 69.04 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 117.162 2.282 . . . . 0.0 117.162 165.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.593 HD11 HD21 ' A' ' 146' ' ' LEU . 2.8 mm? -62.78 -48.96 76.88 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.819 1.647 . . . . 0.0 114.93 165.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -68.21 -35.71 78.4 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 168.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.436 ' HB3' ' HA ' ' A' ' 136' ' ' ALA . 29.6 tt0 -64.65 -23.19 67.18 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 116.379 1.992 . . . . 0.0 116.379 171.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.466 ' HB1' ' HA ' ' A' ' 144' ' ' VAL . . . -54.2 -11.06 0.43 Allowed 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 118.794 2.887 . . . . 0.0 118.794 162.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 89.1 -136.98 13.92 Favored Glycine 0 C--N 1.345 1.066 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 172.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 26.8 m -77.75 -2.96 38.83 Favored 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 170.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.85 106.74 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 -170.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.491 HG11 ' CD1' ' A' ' 75' ' ' LEU . 10.7 m -88.39 116.21 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.324 1.45 . . . . 0.0 109.292 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 56.1 mtm180 -104.01 89.34 3.26 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -176.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.593 HD21 HD11 ' A' ' 137' ' ' LEU . 23.9 mt -88.33 138.34 31.52 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.736 0.779 . . . . 0.0 109.0 -170.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -120.97 127.53 51.89 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 5.7 p -133.55 112.45 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 CA-C-O 121.65 0.738 . . . . 0.0 109.85 175.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.869 ' H ' HD11 ' A' ' 118' ' ' LEU . 27.3 ttt -88.63 128.8 35.6 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.343 1.857 . . . . 0.0 110.793 161.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 90.7 mtt-85 -103.7 111.53 24.06 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 114.264 -1.334 . . . . 0.0 107.614 -174.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -96.29 -27.8 14.81 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 112.995 -1.911 . . . . 0.0 113.596 174.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 32.6 tttm -136.29 86.31 24.96 Favored Pre-proline 0 CA--C 1.561 1.403 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -52.18 -49.85 15.99 Favored 'Trans proline' 0 CA--C 1.572 2.405 0 C-N-CA 123.213 2.609 . . . . 0.0 116.977 163.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo . . . . . 0 C--N 1.376 1.997 0 CA-C-N 124.364 2.594 . . . . 0.0 113.045 179.339 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.56 1.356 0 CA-C-O 122.728 1.251 . . . . 0.0 110.899 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -142.0 127.04 18.39 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 123.082 1.42 . . . . 0.0 107.937 170.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.44 ' HG3' ' CG2' ' A' ' 97' ' ' THR . 1.6 tmmt? -89.91 122.13 32.66 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.024 169.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 62.8 m -92.35 135.87 33.67 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 122.715 1.245 . . . . 0.0 108.951 171.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -92.27 133.58 35.7 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 113.855 -1.52 . . . . 0.0 107.865 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.568 HG22 HD21 ' A' ' 75' ' ' LEU 0.254 11.7 p . . . . . 0 C--O 1.248 1.015 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 -169.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 . . . . . 0 N--CA 1.482 1.175 0 CA-C-O 120.91 0.386 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.457 ' HB3' HD21 ' A' ' 118' ' ' LEU . 40.9 p90 -123.95 136.98 54.67 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.686 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -107.43 135.92 48.09 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 114.55 -1.204 . . . . 0.0 108.077 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -95.43 127.59 41.59 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.841 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.495 HG22 HD13 ' A' ' 68' ' ' LEU . 4.2 mp -135.24 122.91 37.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 -177.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.7 m -105.22 122.79 46.66 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 173.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.495 HD13 HG22 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -120.7 132.57 55.15 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 114.305 -1.316 . . . . 0.0 108.581 -175.869 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -105.34 115.47 30.31 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.812 -176.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.573 ' HG2' ' HA ' ' A' ' 75' ' ' LEU . 1.6 tpm_? -116.22 -102.73 0.42 Allowed 'General case' 0 CA--C 1.568 1.65 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.513 166.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.1 54.16 0.81 Allowed Glycine 0 N--CA 1.472 1.083 0 C-N-CA 126.43 1.967 . . . . 0.0 113.729 -165.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -160.7 171.15 19.37 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-O 123.156 1.455 . . . . 0.0 108.937 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.4 m -70.05 -22.42 63.08 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 161.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -105.46 88.74 0.59 Allowed Glycine 0 CA--C 1.543 1.838 0 CA-C-N 119.541 1.064 . . . . 0.0 110.566 164.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.821 ' H ' HD23 ' A' ' 75' ' ' LEU 0.405 0.2 OUTLIER -70.12 -2.06 11.87 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 118.016 2.599 . . . . 0.0 118.016 168.769 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.429 ' O ' HG13 ' A' ' 99' ' ' ILE . . . 99.29 20.44 17.86 Favored Glycine 0 C--O 1.218 -0.855 0 CA-C-O 115.437 -2.868 . . . . 0.0 117.18 168.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.42 ' O ' ' HB ' ' B' ' 6' ' ' VAL . 2.0 p90 -158.46 117.27 3.07 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 121.745 2.773 . . . . 0.0 109.678 -169.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.6 m -87.79 127.0 35.32 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.211 -1.359 . . . . 0.0 110.823 172.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.537 HG22 HG12 ' A' ' 96' ' ' ILE . 2.4 pp -105.74 127.22 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 113.62 -1.627 . . . . 0.0 108.947 -176.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -79.55 -173.05 3.56 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 124.015 1.864 . . . . 0.0 111.321 159.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' A' ' 85' ' ' ASN . . . -101.59 160.57 18.1 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-N 112.937 -1.938 . . . . 0.0 114.95 -142.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.456 ' H ' ' HB3' ' A' ' 130' ' ' HIS . . . -107.23 -162.22 21.75 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 110.939 -2.631 . . . . 0.0 111.711 -173.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.606 HG22 ' HB2' ' A' ' 92' ' ' PRO . 13.3 p -52.52 -43.1 64.91 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 117.661 2.467 . . . . 0.0 117.661 -173.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.514 ' HB3' HG23 ' A' ' 129' ' ' THR . 24.0 t70 -97.99 12.43 34.27 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 174.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.488 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 5.6 t30 -155.17 69.74 5.56 Favored Pre-proline 0 CA--C 1.555 1.151 0 N-CA-C 101.96 -3.348 . . . . 0.0 101.96 174.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -88.79 126.73 1.8 Allowed 'Trans proline' 0 C--N 1.365 1.444 0 CA-C-N 126.659 3.414 . . . . 0.0 112.208 -163.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -56.99 -31.46 65.08 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 115.213 1.561 . . . . 0.0 115.213 157.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -148.83 124.33 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 N-CA-C 103.422 -2.807 . . . . 0.0 103.422 -171.008 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -77.9 7.75 40.97 Favored Glycine 0 CA--C 1.556 2.639 0 N-CA-C 117.795 1.878 . . . . 0.0 117.795 165.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -105.23 -8.99 17.97 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 125.296 1.438 . . . . 0.0 114.182 177.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -154.51 88.38 3.36 Favored Pre-proline 0 CA--C 1.555 1.163 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.606 ' HB2' HG22 ' A' ' 83' ' ' THR . 14.6 Cg_endo -62.61 96.1 0.16 Allowed 'Trans proline' 0 CA--C 1.557 1.664 0 C-N-CA 122.851 2.367 . . . . 0.0 112.932 170.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.5 t -161.33 159.22 28.16 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 -172.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.526 HG13 ' HB2' ' A' ' 133' ' ' ALA . 12.2 mm -99.61 120.17 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 N-CA-C 105.256 -2.128 . . . . 0.0 105.256 -175.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -111.41 149.68 30.89 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 113.442 -1.708 . . . . 0.0 107.205 -174.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.537 HG12 HG22 ' A' ' 79' ' ' ILE . 23.0 mt -94.78 111.27 25.22 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.319 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 165.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 96.8 m -85.81 -30.85 22.66 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 117.264 -1.351 . . . . 0.0 113.431 169.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.514 ' HA ' HG11 ' A' ' 113' ' ' VAL 0.282 8.9 ptmm? -141.41 164.08 31.19 Favored 'General case' 0 CA--C 1.557 1.246 0 CA-C-N 120.673 1.579 . . . . 0.0 112.177 173.522 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.594 ' HB ' HG12 ' A' ' 113' ' ' VAL . 1.7 tp -115.26 137.51 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 N-CA-C 104.57 -2.381 . . . . 0.0 104.57 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.273 1.6 mp -83.6 116.86 66.71 Favored Pre-proline 0 CA--C 1.57 1.743 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 168.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -63.0 146.01 94.57 Favored 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 123.736 2.957 . . . . 0.0 113.979 172.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.3 -13.65 26.2 Favored Glycine 0 CA--C 1.547 2.073 0 N-CA-C 117.586 1.794 . . . . 0.0 117.586 -169.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -83.19 -169.62 45.02 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 118.911 1.356 . . . . 0.0 113.162 173.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.531 ' HB2' ' HB2' ' A' ' 70' ' ' ARG . . . -70.89 -51.29 27.09 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -170.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.0 -32.86 72.44 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 116.915 2.191 . . . . 0.0 116.915 173.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.07 -51.3 48.2 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 170.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -65.06 -62.22 1.68 Allowed 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 125.313 1.445 . . . . 0.0 112.986 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -64.97 -37.61 88.23 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 -177.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.64 -66.45 0.27 Allowed Glycine 0 N--CA 1.474 1.172 0 CA-C-N 118.955 0.798 . . . . 0.0 113.19 -176.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 58.66 52.33 6.94 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 123.414 1.578 . . . . 0.0 112.239 -157.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.609 ' H ' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -84.28 0.89 47.27 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 112.967 -1.924 . . . . 0.0 115.671 -170.985 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 40.0 mtt180 65.01 129.3 0.02 OUTLIER 'General case' 0 C--N 1.349 0.544 0 CA-C-O 125.535 2.588 . . . . 0.0 111.608 -168.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.598 HG23 ' H ' ' A' ' 114' ' ' ASN 0.281 28.1 m -46.8 -71.09 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.131 1 CA-C-N 108.098 -4.137 . . . . 0.0 111.383 -167.035 . . . . . . . . 4 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.598 ' H ' HG23 ' A' ' 113' ' ' VAL . 1.5 p-10 -31.11 75.98 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.972 0 O-C-N 127.371 2.92 . . . . 0.0 118.157 166.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -122.56 -164.26 1.16 Allowed 'General case' 0 CA--C 1.558 1.267 0 CA-C-N 110.519 -3.037 . . . . 0.0 104.774 162.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.8 m -144.79 84.27 1.72 Allowed 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 175.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.563 HD12 HD11 ' A' ' 137' ' ' LEU . 28.1 pt -56.58 108.63 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 CA-C-O 123.558 1.646 . . . . 0.0 111.042 175.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.457 HD21 ' HB3' ' A' ' 63' ' ' TYR . 3.3 pp -101.19 -41.37 6.75 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 112.564 -2.107 . . . . 0.0 115.526 178.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -127.59 143.76 51.14 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.553 HG21 HD12 ' A' ' 137' ' ' LEU . 3.3 t -136.56 108.0 6.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 101.294 -3.595 . . . . 0.0 101.294 178.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . 0.283 12.8 m120 82.51 -80.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 123.44 1.59 . . . . 0.0 109.504 178.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -152.82 -14.07 0.16 Allowed 'General case' 0 CA--C 1.568 1.635 0 CA-C-N 111.815 -2.448 . . . . 0.0 111.196 177.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.2 t -68.86 136.98 25.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 124.893 1.277 . . . . 0.0 109.733 174.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -96.08 101.08 12.7 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 112.574 -2.103 . . . . 0.0 109.018 176.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.548 HG11 ' HA ' ' A' ' 133' ' ' ALA 0.261 1.6 m -100.42 -103.84 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 CA-C-O 116.773 -1.584 . . . . 0.0 107.178 178.49 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.455 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.363 26.9 ptt85 44.21 -92.87 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 125.139 1.376 . . . . 0.0 114.572 -169.9 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.455 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 16.6 tt0 -72.84 74.84 1.15 Allowed 'General case' 0 CA--C 1.555 1.142 0 CA-C-O 124.297 1.998 . . . . 0.0 110.98 170.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.3 p -149.0 166.54 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 CA-C-N 111.993 -2.367 . . . . 0.0 105.232 -178.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.514 HG23 ' HB3' ' A' ' 84' ' ' ASP . 0.2 OUTLIER -54.6 122.49 10.71 Favored 'General case' 0 CA--C 1.557 1.224 0 CA-C-N 111.841 -2.436 . . . . 0.0 110.462 154.552 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.456 ' HB3' ' H ' ' A' ' 82' ' ' GLY . 1.6 p-80 -49.48 -31.24 9.59 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 117.436 2.384 . . . . 0.0 117.436 175.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.58 ' HA ' HG12 ' A' ' 134' ' ' VAL . 7.1 m -58.86 -38.05 77.89 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 115.373 1.619 . . . . 0.0 115.373 171.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.61 -37.06 79.47 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 165.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.548 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -63.19 -54.6 34.96 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 171.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.58 HG12 ' HA ' ' A' ' 131' ' ' SER . 9.8 p -52.45 -43.43 41.57 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 166.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -58.14 -50.39 73.65 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-O 115.888 -2.006 . . . . 0.0 111.817 171.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.55 -35.43 77.75 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 117.146 2.276 . . . . 0.0 117.146 173.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.563 HD11 HD12 ' A' ' 117' ' ' ILE . 9.3 mp -55.82 -52.6 63.43 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 125.04 1.336 . . . . 0.0 114.007 164.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -71.35 -31.82 67.8 Favored 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 174.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -67.16 -30.23 70.15 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 115.332 1.605 . . . . 0.0 115.332 171.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.492 ' HB1' ' HA ' ' A' ' 144' ' ' VAL . . . -50.27 -33.06 18.52 Favored 'General case' 0 CA--C 1.56 1.332 0 N-CA-C 117.202 2.297 . . . . 0.0 117.202 159.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 91.21 -125.18 7.9 Favored Glycine 0 C--N 1.348 1.229 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 166.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 11.6 m -73.38 -10.36 59.66 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 118.043 2.609 . . . . 0.0 118.043 169.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.2 104.44 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 -170.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.492 ' HA ' ' HB1' ' A' ' 140' ' ' ALA . 5.2 m -86.88 118.4 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 113.383 -1.735 . . . . 0.0 109.557 175.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 62.5 mtm180 -97.57 91.79 5.6 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 172.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.426 HD23 HG13 ' A' ' 120' ' ' VAL . 86.2 mt -93.24 138.69 31.39 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.906 0.86 . . . . 0.0 108.985 -173.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -130.67 120.99 24.73 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 177.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 21.2 m -130.77 129.64 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -166.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 23.9 ptt? -90.87 152.48 20.73 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 122.46 1.124 . . . . 0.0 111.587 168.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 46.0 mtp180 -108.19 126.76 53.17 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 113.987 -1.46 . . . . 0.0 108.079 173.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -62.31 -26.16 68.27 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 165.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -99.88 107.84 48.54 Favored Pre-proline 0 CA--C 1.565 1.535 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 165.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -66.32 159.35 50.51 Favored 'Trans proline' 0 CA--C 1.569 2.234 0 C-N-CA 123.013 2.475 . . . . 0.0 114.021 170.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo . . . . . 0 CA--C 1.553 1.436 0 C-N-CA 123.387 2.725 . . . . 0.0 115.137 174.35 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 8.1 p90 . . . . . 0 CA--C 1.55 0.98 0 CA-C-O 122.194 0.997 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -115.06 149.19 37.88 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 123.738 1.733 . . . . 0.0 109.188 173.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 12.0 ttpp -103.97 109.28 20.98 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 113.189 -1.823 . . . . 0.0 107.305 176.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.59 131.31 38.84 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.625 175.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -85.58 121.92 28.95 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.42 ' HB ' ' O ' ' A' ' 77' ' ' PHE . 2.7 t . . . . . 0 C--O 1.248 0.977 0 N-CA-C 104.193 -2.521 . . . . 0.0 104.193 -170.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 . . . . . 0 N--CA 1.481 1.101 0 CA-C-O 120.988 0.423 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -90.94 133.72 35.04 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-O 122.414 1.102 . . . . 0.0 112.575 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -101.53 129.16 47.56 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 113.354 -1.748 . . . . 0.0 108.254 166.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -116.29 129.27 56.19 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 114.224 -1.353 . . . . 0.0 109.163 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.454 HG13 ' HB2' ' A' ' 146' ' ' LEU . 6.2 pt -135.82 115.36 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 -174.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.3 m -86.43 118.18 25.7 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 171.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.495 HD21 ' HB1' ' A' ' 104' ' ' ALA . 8.2 tt -124.14 140.46 52.94 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 113.14 -1.845 . . . . 0.0 106.198 -171.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -82.33 131.66 35.23 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 121.431 -0.793 . . . . 0.0 109.378 -176.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.528 ' HG3' ' HG ' ' A' ' 75' ' ' LEU . 42.4 ttt180 -67.61 92.06 0.31 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.69 -0.631 . . . . 0.0 109.714 175.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.431 ' H ' ' HB2' ' A' ' 104' ' ' ALA . . . 17.89 -94.12 0.01 OUTLIER Glycine 0 N--CA 1.48 1.574 0 N-CA-C 119.243 2.457 . . . . 0.0 119.243 177.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -158.36 -77.85 0.07 Allowed 'General case' 0 CA--C 1.559 1.327 0 CA-C-N 113.925 -1.138 . . . . 0.0 108.725 176.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 27.6 m -81.95 -25.5 34.8 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 175.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -140.54 -146.1 4.74 Favored Glycine 0 CA--C 1.536 1.352 0 N-CA-C 107.406 -2.278 . . . . 0.0 107.406 161.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.528 ' HG ' ' HG3' ' A' ' 70' ' ' ARG . 6.9 mp -87.95 -91.66 0.11 Allowed 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 106.349 -1.722 . . . . 0.0 106.349 173.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.537 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 127.57 50.39 0.15 Allowed Glycine 0 CA--C 1.543 1.815 0 C-N-CA 124.516 1.055 . . . . 0.0 114.916 -175.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.457 ' CD1' HD13 ' A' ' 96' ' ' ILE . 0.3 OUTLIER -159.33 149.58 19.15 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 122.998 1.38 . . . . 0.0 109.97 174.186 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.515 ' HB2' ' HB3' ' A' ' 98' ' ' LYS . 70.7 m -99.91 116.35 31.75 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.408 -0.807 . . . . 0.0 111.62 -175.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.616 HG22 HG12 ' A' ' 96' ' ' ILE . 1.1 pt -88.46 122.86 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.311 176.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.65 -172.09 3.87 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-O 123.263 1.506 . . . . 0.0 110.644 164.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' A' ' 85' ' ' ASN . . . -95.43 161.05 22.99 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-O 123.389 1.55 . . . . 0.0 116.341 -136.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.49 -162.58 23.43 Favored Glycine 0 N--CA 1.464 0.564 0 CA-C-N 111.919 -2.14 . . . . 0.0 116.298 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.449 HG22 ' HB3' ' A' ' 92' ' ' PRO . 59.6 p -52.08 -40.53 61.35 Favored 'General case' 0 CA--C 1.567 1.628 0 CA-C-N 112.516 -1.842 . . . . 0.0 115.595 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.42 ' HB2' HG22 ' A' ' 129' ' ' THR . 31.5 t70 -78.82 -30.54 45.39 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 172.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.401 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 0.1 OUTLIER -134.52 91.37 21.95 Favored Pre-proline 0 N--CA 1.478 0.972 0 N-CA-C 102.402 -3.185 . . . . 0.0 102.402 -173.824 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -100.01 147.81 0.44 Allowed 'Trans proline' 0 CA--C 1.549 1.251 0 CA-C-N 124.557 2.663 . . . . 0.0 111.221 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.488 ' HB2' ' CD2' ' B' ' 1' ' ' TYR . 43.3 t60 -110.01 -31.58 7.33 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 166.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.506 ' H ' HD12 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -94.05 153.93 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 CA-C-O 122.912 1.339 . . . . 0.0 110.711 -179.92 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -79.79 12.7 27.81 Favored Glycine 0 CA--C 1.549 2.197 0 N-CA-C 118.304 2.081 . . . . 0.0 118.304 172.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -75.84 -8.97 58.18 Favored 'General case' 0 CA--C 1.569 1.683 0 CA-C-N 119.26 1.53 . . . . 0.0 115.028 162.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.434 ' HB3' ' HD3' ' A' ' 92' ' ' PRO 0.506 31.6 t70 95.17 -78.93 0.0 OUTLIER Pre-proline 0 CA--C 1.565 1.521 0 CA-C-O 115.893 -2.003 . . . . 0.0 109.296 -172.718 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.485 ' O ' HD11 ' A' ' 88' ' ' ILE . 0.5 OUTLIER -116.86 -136.02 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.448 0 CA-C-N 124.661 2.7 . . . . 0.0 110.482 -166.638 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 39.9 m 79.73 119.31 0.05 Allowed 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 167.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.549 HG13 ' CB ' ' A' ' 133' ' ' ALA . 10.0 mm -96.1 125.67 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 104.905 -2.258 . . . . 0.0 104.905 -172.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.435 ' HZ ' ' HB3' ' A' ' 87' ' ' HIS . 32.3 p90 -140.67 128.52 21.82 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 112.317 -2.22 . . . . 0.0 106.58 -159.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.616 HG12 HG22 ' A' ' 79' ' ' ILE . 73.6 mt -87.64 114.93 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.2 t -97.77 -13.85 21.14 Favored 'General case' 0 CA--C 1.559 1.301 0 CA-C-N 113.224 -1.807 . . . . 0.0 114.805 169.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 78' ' ' SER . 19.2 ttmm -141.11 158.11 44.36 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-O 124.832 2.253 . . . . 0.0 109.93 -173.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.29 131.87 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 111.531 -2.577 . . . . 0.0 105.894 -176.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.275 1.6 mp -78.69 131.62 67.2 Favored Pre-proline 0 CA--C 1.57 1.716 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 167.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.17 130.56 34.8 Favored 'Trans proline' 0 C--N 1.367 1.517 0 C-N-CA 123.416 2.744 . . . . 0.0 115.132 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 70.48 13.33 70.94 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 118.167 2.027 . . . . 0.0 118.167 -168.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.537 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -90.0 -162.11 38.04 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 124.371 0.986 . . . . 0.0 114.675 -175.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.495 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -68.27 -53.85 21.66 Favored 'General case' 0 CA--C 1.557 1.229 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -170.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.05 -24.49 64.18 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 117.286 2.328 . . . . 0.0 117.286 168.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.96 -34.98 71.98 Favored 'General case' 0 CA--C 1.565 1.551 0 N-CA-C 115.964 1.838 . . . . 0.0 115.964 168.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -55.29 6.01 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 124.929 1.292 . . . . 0.0 112.26 174.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -77.03 -48.85 16.77 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.26 0.624 . . . . 0.0 112.612 -174.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -96.07 -140.99 11.46 Favored Glycine 0 CA--C 1.543 1.787 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 160.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 31.7 mtm-85 -156.01 -7.13 0.11 Allowed 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 177.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.8 pp -162.05 -46.69 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.181 -0.949 . . . . 0.0 110.883 -153.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 26.8 mtp180 -78.95 95.73 5.54 Favored 'General case' 0 C--N 1.36 1.024 0 CA-C-O 125.187 2.423 . . . . 0.0 105.297 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.442 ' HB ' HG22 ' A' ' 96' ' ' ILE 0.317 11.1 m -32.08 -62.74 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.659 1 CA-C-N 108.194 -4.094 . . . . 0.0 112.316 156.837 . . . . . . . . 4 3 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.568 ' HB2' ' HB ' ' A' ' 96' ' ' ILE . 0.9 OUTLIER 158.64 -17.7 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 129.859 3.264 . . . . 0.0 110.392 168.16 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 95' ' ' PHE 0.308 6.9 m-20 84.59 -82.28 0.02 OUTLIER 'General case' 0 C--N 1.354 0.77 0 C-N-CA 126.55 1.94 . . . . 0.0 108.248 169.644 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 69.4 m -160.37 102.42 1.39 Allowed 'General case' 0 N--CA 1.473 0.677 0 O-C-N 126.337 2.273 . . . . 0.0 107.352 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.445 HD13 ' H ' ' A' ' 117' ' ' ILE . 0.2 OUTLIER -99.0 150.27 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.416 0 CA-C-O 122.617 1.199 . . . . 0.0 108.911 179.465 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.908 HD11 ' H ' ' A' ' 149' ' ' MET . 0.0 OUTLIER -120.61 -37.36 3.02 Favored 'General case' 0 N--CA 1.502 2.154 0 C-N-CA 126.504 1.922 . . . . 0.0 111.784 -171.056 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -126.67 150.66 48.85 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-O 122.755 1.264 . . . . 0.0 108.237 173.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.49 ' HB ' HH22 ' A' ' 126' ' ' ARG . 14.6 p -129.65 121.22 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 169.222 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.481 ' HA ' ' HB2' ' A' ' 145' ' ' ARG 0.358 8.6 m120 79.14 -88.67 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 123.595 1.664 . . . . 0.0 107.845 178.626 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -144.21 -16.45 0.58 Allowed 'General case' 0 CA--C 1.568 1.636 0 CA-C-N 110.478 -3.055 . . . . 0.0 110.37 174.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.7 t -66.45 134.54 29.82 Favored 'Isoleucine or valine' 0 C--N 1.36 1.054 0 CA-C-O 123.92 1.819 . . . . 0.0 109.949 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -89.47 57.8 4.12 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 110.254 -3.157 . . . . 0.0 112.923 173.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.8 m -70.86 -163.94 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.333 0 CA-C-O 123.632 1.682 . . . . 0.0 108.496 161.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.615 ' H ' HG22 ' A' ' 128' ' ' VAL 0.525 4.3 mmt85 86.51 -49.27 0.05 Allowed 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 115.019 1.489 . . . . 0.0 115.019 176.164 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -76.21 51.86 0.71 Allowed 'General case' 0 CA--C 1.571 1.756 0 CA-C-N 114.186 -1.37 . . . . 0.0 113.276 155.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.615 HG22 ' H ' ' A' ' 126' ' ' ARG . 30.4 m -148.58 170.15 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 -170.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.42 HG22 ' HB2' ' A' ' 84' ' ' ASP . 44.6 p -61.73 141.12 58.07 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 113.293 -1.776 . . . . 0.0 111.814 155.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.41 ' HA ' HD12 ' A' ' 94' ' ' ILE . 3.4 p80 -44.39 -33.74 1.76 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 117.175 2.287 . . . . 0.0 117.175 171.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.602 ' HA ' HG12 ' A' ' 134' ' ' VAL . 16.1 m -62.78 -40.72 98.19 Favored 'General case' 0 CA--C 1.564 1.489 0 N-CA-C 115.702 1.742 . . . . 0.0 115.702 176.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.06 -37.94 81.87 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 169.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.549 ' CB ' HG13 ' A' ' 94' ' ' ILE . . . -67.8 -47.26 69.58 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 116.152 -1.88 . . . . 0.0 115.968 169.28 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.602 HG12 ' HA ' ' A' ' 131' ' ' SER . 13.0 p -53.39 -46.37 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-N 121.351 1.887 . . . . 0.0 113.221 166.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -53.18 -46.91 69.15 Favored 'General case' 0 CA--C 1.555 1.16 0 CA-C-O 117.527 -1.225 . . . . 0.0 113.02 168.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.63 -26.82 67.25 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 117.534 2.42 . . . . 0.0 117.534 170.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.476 ' CD2' HH21 ' A' ' 126' ' ' ARG . 3.5 mm? -68.76 -49.35 59.43 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 125.6 1.56 . . . . 0.0 113.845 171.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -66.22 -34.27 77.65 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 165.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -72.43 -21.65 61.22 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 116.932 2.197 . . . . 0.0 116.932 174.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.508 ' HB1' ' HA ' ' A' ' 144' ' ' VAL . . . -51.58 -20.8 2.13 Favored 'General case' 0 CA--C 1.563 1.451 0 N-CA-C 117.584 2.438 . . . . 0.0 117.584 155.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.78 -147.29 27.76 Favored Glycine 0 C--N 1.35 1.356 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 174.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.487 ' HA ' ' HB3' ' A' ' 70' ' ' ARG . 18.5 m -61.84 -6.5 2.76 Favored 'General case' 0 CA--C 1.571 1.783 0 N-CA-C 117.553 2.427 . . . . 0.0 117.553 173.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -146.58 101.68 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 -170.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.508 ' HA ' ' HB1' ' A' ' 140' ' ' ALA . 29.8 m -84.18 116.92 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.293 172.28 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.481 ' HB2' ' HA ' ' A' ' 121' ' ' ASN . 57.7 mtp85 -94.35 106.12 18.1 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 174.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.555 HD13 HD21 ' A' ' 114' ' ' ASN . 11.3 mt -107.02 124.05 49.08 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 -166.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -116.84 130.14 56.52 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 -174.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.02 127.77 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 176.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.908 ' H ' HD11 ' A' ' 118' ' ' LEU . 67.3 mtt -93.9 113.25 25.23 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.048 1.739 . . . . 0.0 108.671 171.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -97.17 126.2 42.19 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 113.777 -1.556 . . . . 0.0 107.556 174.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -75.89 118.6 18.85 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 114.055 -1.43 . . . . 0.0 108.029 175.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.414 ' HB3' ' HD3' ' A' ' 153' ' ' PRO . 22.7 ttpp -164.79 -58.62 0.01 OUTLIER Pre-proline 0 CA--C 1.556 1.182 0 CA-C-O 115.59 -2.147 . . . . 0.0 107.642 176.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.414 ' HD3' ' HB3' ' A' ' 152' ' ' LYS . 3.0 Cg_exo -73.94 141.54 30.19 Favored 'Trans proline' 0 CA--C 1.566 2.088 0 CA-C-N 124.762 2.736 . . . . 0.0 111.603 177.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo . . . . . 0 CA--C 1.552 1.401 0 C-N-CA 123.104 2.536 . . . . 0.0 113.512 179.183 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' TYR . . . . . 0.488 ' CD2' ' HB2' ' A' ' 87' ' ' HIS . 0.0 OUTLIER . . . . . 0 CA--C 1.557 1.226 0 CA-C-O 122.728 1.251 . . . . 0.0 110.565 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -157.12 151.11 24.72 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 123.351 1.548 . . . . 0.0 109.951 168.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.74 137.16 37.03 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 -176.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 27.6 m -85.34 133.78 34.13 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 166.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.95 99.98 12.52 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 -177.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.416 HG12 HD13 ' A' ' 75' ' ' LEU . 21.9 t . . . . . 0 C--O 1.25 1.091 0 N-CA-C 103.042 -2.947 . . . . 0.0 103.042 -165.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -123.56 137.42 54.76 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.718 1.207 . . . . 0.0 108.101 -172.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -114.03 136.2 53.18 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 113.697 -1.592 . . . . 0.0 107.71 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -99.63 121.42 41.19 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -172.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 18.2 mt -130.99 114.93 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 104.233 -2.506 . . . . 0.0 104.233 -172.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.0 m -96.6 124.91 40.74 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 169.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.468 ' HB3' ' CG2' ' A' ' 144' ' ' VAL . 5.2 tp -127.86 166.82 17.53 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 113.29 -1.777 . . . . 0.0 107.144 176.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -79.85 144.44 33.46 Favored 'General case' 0 N--CA 1.48 1.074 0 O-C-N 121.352 -0.843 . . . . 0.0 109.392 164.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.447 ' HA ' ' HG ' ' A' ' 75' ' ' LEU . 7.3 ttp180 -75.91 79.32 2.81 Favored 'General case' 0 CA--C 1.558 1.256 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 162.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.17 -132.5 41.95 Favored Glycine 0 N--CA 1.479 1.559 0 CA-C-O 122.426 1.015 . . . . 0.0 114.509 170.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -137.73 -59.08 0.67 Allowed 'General case' 0 CA--C 1.555 1.166 0 CA-C-N 112.297 -1.951 . . . . 0.0 109.141 162.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.1 m -97.2 -19.02 18.9 Favored 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 166.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -128.59 -122.61 2.5 Favored Glycine 0 C--N 1.347 1.194 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 171.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.567 HD11 HG11 ' A' ' 144' ' ' VAL . 1.0 OUTLIER -137.71 -60.8 0.64 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.889 1.276 . . . . 0.0 109.309 -178.192 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.477 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 113.5 43.34 0.83 Allowed Glycine 0 CA--C 1.533 1.179 0 N-CA-C 117.155 1.622 . . . . 0.0 117.155 167.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.486 ' HE1' HD23 ' A' ' 137' ' ' LEU . 3.8 p90 -156.72 157.7 35.6 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.526 1.131 . . . . 0.0 109.11 172.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 51.1 m -96.66 137.76 35.25 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 120.621 -1.3 . . . . 0.0 110.155 171.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.42 HG22 HG12 ' A' ' 96' ' ' ILE . 1.2 pt -107.21 125.87 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.85 178.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -83.25 -178.46 7.09 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 124.254 1.978 . . . . 0.0 110.001 167.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 85' ' ' ASN . . . -91.51 159.08 25.79 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 112.923 -1.944 . . . . 0.0 115.228 -141.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -109.26 -170.97 20.63 Favored Glycine 0 C--O 1.224 -0.496 0 CA-C-N 110.472 -2.864 . . . . 0.0 113.034 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.563 HG22 ' HB2' ' A' ' 92' ' ' PRO . 29.6 p -43.5 -43.36 5.39 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 118.442 2.756 . . . . 0.0 118.442 -176.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -78.07 -28.64 48.88 Favored 'General case' 0 CA--C 1.561 1.403 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 175.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.419 ' O ' ' HA3' ' A' ' 81' ' ' GLY 0.258 2.0 t30 -143.81 71.96 17.03 Favored Pre-proline 0 CA--C 1.562 1.404 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -175.754 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -103.44 145.83 0.17 Allowed 'Trans proline' 0 C--N 1.375 1.937 0 CA-C-N 124.629 2.689 . . . . 0.0 111.652 -171.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -63.05 -26.68 68.95 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 162.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.65 124.08 70.84 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 -170.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -72.39 -11.29 76.06 Favored Glycine 0 CA--C 1.561 2.961 0 N-CA-C 117.686 1.835 . . . . 0.0 117.686 161.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -101.57 -10.73 19.83 Favored 'General case' 0 CA--C 1.565 1.554 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 176.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -142.43 86.1 10.13 Favored Pre-proline 0 CA--C 1.548 0.892 0 CA-C-N 120.438 1.472 . . . . 0.0 107.153 -174.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.563 ' HB2' HG22 ' A' ' 83' ' ' THR . 26.5 Cg_endo -65.88 97.4 0.34 Allowed 'Trans proline' 0 CA--C 1.555 1.556 0 C-N-CA 122.145 1.897 . . . . 0.0 112.1 161.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.2 t -161.23 128.35 4.08 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 -173.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.509 HG13 ' HB2' ' A' ' 133' ' ' ALA . 24.3 mm -76.31 121.1 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -133.01 131.66 40.96 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -175.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.428 ' HB ' ' O ' ' A' ' 113' ' ' VAL 0.288 92.8 mt -65.56 127.82 27.31 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.908 0 CA-C-O 122.547 1.165 . . . . 0.0 109.374 179.421 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.34 -48.42 11.99 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.933 1.293 . . . . 0.0 113.63 174.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.543 ' HA ' HG11 ' A' ' 113' ' ' VAL 0.286 0.0 OUTLIER -143.42 163.67 32.44 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-O 123.021 1.391 . . . . 0.0 110.573 -176.432 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -108.24 116.56 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 103.607 -2.738 . . . . 0.0 103.607 173.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.422 ' H ' ' HA ' ' A' ' 77' ' ' PHE . 1.4 mp -68.0 129.17 93.24 Favored Pre-proline 0 CA--C 1.57 1.746 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 176.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.19 131.12 35.05 Favored 'Trans proline' 0 CA--C 1.555 1.529 0 C-N-CA 123.468 2.779 . . . . 0.0 114.112 172.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.4 1.27 88.36 Favored Glycine 0 CA--C 1.551 2.292 0 N-CA-C 117.72 1.848 . . . . 0.0 117.72 -164.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.477 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -78.33 157.53 44.61 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.281 0.943 . . . . 0.0 114.117 172.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.86 -25.39 67.88 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 117.51 2.411 . . . . 0.0 117.51 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.429 ' HA ' HD11 ' A' ' 68' ' ' LEU . . . -64.87 -44.46 89.63 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 173.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.74 -38.67 73.54 Favored 'General case' 0 CA--C 1.563 1.473 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 172.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -67.79 -62.7 1.29 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 125.16 1.384 . . . . 0.0 112.724 173.057 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -69.91 -51.21 34.91 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.242 1.017 . . . . 0.0 112.709 -171.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -118.22 -161.5 11.93 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-O 123.184 1.436 . . . . 0.0 111.698 171.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 50.2 mtm-85 -156.22 71.15 0.71 Allowed 'General case' 0 N--CA 1.485 1.325 0 CA-C-N 112.881 -1.659 . . . . 0.0 107.166 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.641 HD23 ' H ' ' A' ' 111' ' ' LEU . 1.9 pt? -92.38 -169.11 2.13 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-O 124.586 2.136 . . . . 0.0 108.056 174.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -103.63 167.03 10.06 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 126.986 3.279 . . . . 0.0 106.077 156.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.543 HG11 ' HA ' ' A' ' 98' ' ' LYS 0.302 29.8 m -64.06 -69.96 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 108.813 -3.812 . . . . 0.0 108.113 178.123 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.418 ' H ' HG23 ' A' ' 113' ' ' VAL . 16.4 m120 -50.17 75.15 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 124.395 2.045 . . . . 0.0 116.52 174.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -134.08 110.64 9.76 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 100.569 -3.863 . . . . 0.0 100.569 174.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 41.8 m -78.85 93.02 4.93 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 112.932 -1.94 . . . . 0.0 108.846 -168.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.4 tp -58.25 116.77 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.65 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.58 ' HA ' ' HB3' ' A' ' 126' ' ' ARG 0.266 1.9 pp -100.17 -50.42 3.97 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 113.216 -1.811 . . . . 0.0 114.638 175.706 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.408 ' H ' HD12 ' A' ' 118' ' ' LEU . 62.3 m-85 -126.41 133.09 51.36 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 104.605 -2.368 . . . . 0.0 104.605 177.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.426 HG23 HD23 ' A' ' 146' ' ' LEU . 7.6 p -123.84 117.45 51.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 170.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . 0.306 12.2 m120 80.38 -69.85 0.09 Allowed 'General case' 0 N--CA 1.501 2.121 0 CA-C-O 123.334 1.54 . . . . 0.0 110.681 -174.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -172.05 -25.06 0.01 OUTLIER 'General case' 0 CA--C 1.575 1.914 0 C-N-CA 128.537 2.735 . . . . 0.0 109.178 -172.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.2 t -66.48 133.92 30.6 Favored 'Isoleucine or valine' 0 C--N 1.363 1.167 0 C-N-CA 125.298 1.439 . . . . 0.0 110.775 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -83.8 98.94 9.99 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 113.292 -1.776 . . . . 0.0 110.227 174.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.57 HG11 ' HA ' ' A' ' 133' ' ' ALA . 2.3 m -86.48 -98.34 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 CA-C-O 115.911 -1.995 . . . . 0.0 107.632 171.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.58 ' HB3' ' HA ' ' A' ' 118' ' ' LEU 0.274 5.7 ptt180 45.88 -99.58 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 CA-C-N 120.589 1.54 . . . . 0.0 113.638 178.44 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -80.05 81.22 6.35 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-O 123.407 1.575 . . . . 0.0 109.006 170.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.58 167.44 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 CA-C-N 112.76 -2.018 . . . . 0.0 106.179 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 25.0 m -60.58 132.49 54.05 Favored 'General case' 0 CA--C 1.561 1.372 0 CA-C-N 114.129 -1.396 . . . . 0.0 110.104 156.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.406 ' HA ' HD12 ' A' ' 94' ' ' ILE . 7.3 p-80 -46.54 -33.45 4.09 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 117.987 2.588 . . . . 0.0 117.987 171.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.493 ' HA ' HG12 ' A' ' 134' ' ' VAL . 12.0 m -62.97 -38.24 90.31 Favored 'General case' 0 CA--C 1.558 1.268 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 175.129 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.04 -34.34 77.85 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 165.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.57 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -70.46 -51.95 25.59 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 116.382 1.993 . . . . 0.0 116.382 173.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.493 HG12 ' HA ' ' A' ' 131' ' ' SER . 4.3 p -50.05 -43.64 20.96 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.374 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 165.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -64.74 -48.19 75.47 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 116.842 -1.551 . . . . 0.0 113.374 175.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.415 ' HA ' ' HB3' ' A' ' 139' ' ' GLU . . . -68.7 -31.95 71.41 Favored 'General case' 0 CA--C 1.563 1.471 0 N-CA-C 116.561 2.06 . . . . 0.0 116.561 176.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.486 HD23 ' HE1' ' A' ' 77' ' ' PHE . 8.8 mp -60.3 -52.1 66.7 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 125.32 1.448 . . . . 0.0 114.743 166.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -67.12 -33.95 76.55 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 167.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.415 ' HB3' ' HA ' ' A' ' 136' ' ' ALA . 9.1 tp10 -65.16 -24.18 67.32 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 173.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.491 ' HB3' HG12 ' A' ' 144' ' ' VAL . . . -50.97 -25.75 5.09 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 118.024 2.601 . . . . 0.0 118.024 163.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 66.96 83.91 0.1 Allowed Glycine 0 C--N 1.351 1.387 0 CA-C-O 118.695 -1.059 . . . . 0.0 113.11 157.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.8 m 75.04 -30.09 0.2 Allowed 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 117.237 2.31 . . . . 0.0 117.237 -175.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.0 108.84 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 -172.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.567 HG11 HD11 ' A' ' 75' ' ' LEU . 16.9 m -89.55 123.0 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 114.317 -1.31 . . . . 0.0 109.754 176.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -96.27 93.07 6.67 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 172.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.426 HD23 HG23 ' A' ' 120' ' ' VAL . 64.6 mt -98.5 133.5 42.77 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -171.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -131.55 115.38 16.05 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 178.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 35.7 m -126.32 129.13 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 -166.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -94.93 141.02 29.14 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-O 121.574 0.702 . . . . 0.0 111.237 169.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 59.5 ttt180 -102.11 124.11 47.14 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 164.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -104.0 95.44 6.0 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.439 -1.255 . . . . 0.0 109.3 -176.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 41.8 tttm -94.34 -57.6 0.21 Allowed Pre-proline 0 CA--C 1.569 1.694 0 CA-C-O 114.806 -2.521 . . . . 0.0 110.227 160.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -71.62 116.49 4.72 Favored 'Trans proline' 0 C--N 1.376 2.016 0 CA-C-N 125.318 2.935 . . . . 0.0 111.59 -175.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo . . . . . 0 C--N 1.364 1.373 0 C-N-CA 122.887 2.391 . . . . 0.0 112.286 -179.825 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 1.6 p90 . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 122.493 1.14 . . . . 0.0 112.31 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -139.33 138.11 36.37 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 113.852 -1.522 . . . . 0.0 107.501 172.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.55 122.26 34.8 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.153 -1.385 . . . . 0.0 108.627 177.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 96.8 m -86.8 133.47 33.64 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 173.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -74.81 142.74 44.19 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.117 173.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.426 ' HB ' HG23 ' A' ' 134' ' ' VAL . 7.4 p . . . . . 0 C--O 1.254 1.29 0 CA-C-N 113.976 -1.465 . . . . 0.0 108.661 169.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 . . . . . 0 N--CA 1.48 1.033 0 CA-C-O 121.432 0.634 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -103.77 136.58 43.19 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 114.338 -1.301 . . . . 0.0 111.646 174.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -110.18 130.25 55.57 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.45 126.79 41.89 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.158 174.09 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.2 mp -134.24 119.76 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 -176.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.2 m -95.42 122.73 38.44 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 168.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.561 ' HB3' HG23 ' A' ' 144' ' ' VAL . 9.9 tt -125.96 134.94 51.36 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 113.88 -1.509 . . . . 0.0 107.541 -173.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -81.8 115.62 21.11 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 122.209 1.005 . . . . 0.0 109.457 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.467 ' CG ' ' HG ' ' A' ' 75' ' ' LEU . 0.8 OUTLIER -69.59 159.46 33.33 Favored 'General case' 0 CA--C 1.556 1.197 0 CA-C-N 113.071 -1.877 . . . . 0.0 111.814 178.646 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -67.79 -144.26 0.1 OUTLIER Glycine 0 CA--C 1.548 2.116 0 CA-C-N 115.041 -0.982 . . . . 0.0 114.834 174.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -123.65 -69.06 0.83 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -173.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 96.7 p -79.9 -25.45 40.58 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 116.384 1.994 . . . . 0.0 116.384 171.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -143.43 -152.38 5.65 Favored Glycine 0 CA--C 1.534 1.232 0 N-CA-C 107.893 -2.083 . . . . 0.0 107.893 168.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.483 HD13 HG12 ' B' ' 6' ' ' VAL . 4.7 mp -109.59 -84.7 0.55 Allowed 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 178.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.642 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 138.47 39.12 0.11 Allowed Glycine 0 CA--C 1.535 1.284 0 N-CA-C 118.088 1.995 . . . . 0.0 118.088 -175.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.476 ' CD1' HD13 ' A' ' 96' ' ' ILE . 5.8 p90 -166.5 137.27 3.38 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 124.369 2.033 . . . . 0.0 109.119 -176.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.546 ' HB2' ' HB3' ' A' ' 98' ' ' LYS . 46.1 m -95.0 126.78 40.58 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 113.667 -1.606 . . . . 0.0 112.378 -173.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.712 HG22 HG12 ' A' ' 96' ' ' ILE . 4.1 pt -93.37 130.51 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 113.945 -1.479 . . . . 0.0 110.856 177.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.15 -171.79 3.66 Favored 'General case' 0 CA--C 1.556 1.176 0 CA-C-O 123.057 1.408 . . . . 0.0 110.522 163.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.76 161.47 28.32 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-O 122.888 1.271 . . . . 0.0 115.802 -146.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -108.73 -162.5 20.39 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 112.47 -1.865 . . . . 0.0 113.502 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.445 HG22 ' HB3' ' A' ' 92' ' ' PRO . 70.3 p -50.07 -40.86 46.77 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 116.699 2.111 . . . . 0.0 116.699 178.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -95.54 7.18 46.99 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.4 HD22 ' CE1' ' A' ' 130' ' ' HIS . 0.0 OUTLIER -162.79 90.53 1.27 Allowed Pre-proline 0 CA--C 1.561 1.398 0 N-CA-C 101.101 -3.666 . . . . 0.0 101.101 178.031 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -106.01 125.88 0.05 OUTLIER 'Trans proline' 0 CA--C 1.55 1.323 0 CA-C-N 124.577 2.67 . . . . 0.0 110.799 -177.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -100.43 -21.91 15.22 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 161.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.404 HD13 ' CD1' ' A' ' 95' ' ' PHE . 0.0 OUTLIER -146.27 160.97 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 -162.457 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.4 170.61 43.7 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 124.166 1.981 . . . . 0.0 110.862 -170.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -78.64 -10.59 59.8 Favored 'General case' 0 CA--C 1.571 1.755 0 CA-C-N 112.026 -2.087 . . . . 0.0 114.942 165.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.463 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 19.9 t70 -167.13 -61.28 0.01 OUTLIER Pre-proline 0 CA--C 1.566 1.595 0 CA-C-O 115.516 -2.183 . . . . 0.0 105.516 175.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.463 ' HD3' ' HB3' ' A' ' 91' ' ' ASP . 15.6 Cg_endo -117.6 -127.86 0.0 OUTLIER 'Trans proline' 0 C--N 1.375 1.97 0 CA-C-N 124.993 2.819 . . . . 0.0 111.043 -168.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 55.3 m 79.58 119.53 0.05 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.308 1.443 . . . . 0.0 108.161 166.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.46 HG13 ' HB2' ' A' ' 133' ' ' ALA . 26.6 mm -80.89 140.34 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.482 ' HA ' ' O ' ' A' ' 115' ' ' ASP . 13.3 m-85 -123.23 150.86 42.9 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 114.328 -1.305 . . . . 0.0 111.097 175.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.712 HG12 HG22 ' A' ' 79' ' ' ILE . 53.7 mt -103.21 107.44 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 N-CA-C 103.951 -2.611 . . . . 0.0 103.951 150.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.2 m -95.92 -17.18 21.25 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 174.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.546 ' HB3' ' HB2' ' A' ' 78' ' ' SER 0.273 40.7 tttp -139.26 157.61 45.6 Favored 'General case' 0 CA--C 1.563 1.449 0 CA-C-O 123.818 1.77 . . . . 0.0 110.549 -175.453 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.75 129.9 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 105.299 -2.112 . . . . 0.0 105.299 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.268 1.5 mp -78.51 132.74 64.68 Favored Pre-proline 0 CA--C 1.569 1.705 0 CA-C-O 118.35 -0.833 . . . . 0.0 108.921 169.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -62.9 133.26 40.73 Favored 'Trans proline' 0 C--N 1.367 1.525 0 C-N-CA 123.411 2.741 . . . . 0.0 114.682 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 71.63 4.9 59.19 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 118.383 2.113 . . . . 0.0 118.383 -169.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.642 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -82.79 -172.32 48.23 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.084 0.85 . . . . 0.0 114.119 -179.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.27 -48.77 76.75 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -174.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.443 ' HA ' HD11 ' A' ' 68' ' ' LEU . . . -70.05 -30.19 67.39 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 118.026 2.602 . . . . 0.0 118.026 176.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.5 -40.55 93.17 Favored 'General case' 0 CA--C 1.567 1.602 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 163.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.46 -61.47 1.97 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.565 1.546 . . . . 0.0 112.728 177.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -58.66 -40.75 84.39 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 -177.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.07 -140.62 3.15 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 123.326 1.515 . . . . 0.0 111.312 168.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -141.51 50.65 1.58 Allowed 'General case' 0 CA--C 1.563 1.479 0 CA-C-N 111.863 -2.169 . . . . 0.0 108.103 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.55 ' H ' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -82.67 9.88 8.65 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 125.601 1.561 . . . . 0.0 114.638 175.716 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . 0.303 24.4 mtm180 76.43 166.53 0.26 Allowed 'General case' 0 C--N 1.35 0.61 0 CA-C-O 126.35 2.976 . . . . 0.0 111.047 -171.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . 0.328 35.8 m -28.08 -69.16 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.253 0 CA-C-N 109.495 -3.502 . . . . 0.0 113.237 161.253 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.493 ' HB2' HD12 ' A' ' 96' ' ' ILE . 2.5 t-20 157.95 -36.89 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 128.597 2.759 . . . . 0.0 107.665 174.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.482 ' O ' ' HA ' ' A' ' 95' ' ' PHE 0.307 11.0 t70 68.72 -102.02 0.05 Allowed 'General case' 0 C--O 1.213 -0.816 0 C-N-CA 126.42 1.888 . . . . 0.0 107.608 -175.316 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 75.7 m -96.8 69.59 2.45 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 120.38 1.446 . . . . 0.0 110.799 -170.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.5 tp -67.29 115.67 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-O 121.867 0.841 . . . . 0.0 108.785 174.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.418 HD21 ' HB2' ' A' ' 149' ' ' MET . 3.1 pp -102.24 -40.57 6.72 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.435 1.642 . . . . 0.0 115.435 177.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -138.97 145.59 39.92 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 -175.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.572 HG21 HD22 ' A' ' 137' ' ' LEU . 4.2 t -132.94 113.42 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 102.753 -3.054 . . . . 0.0 102.753 -176.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.444 ' HA ' ' HB3' ' A' ' 145' ' ' ARG 0.341 11.3 m120 84.02 -85.1 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 123.342 1.544 . . . . 0.0 108.726 -179.665 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -156.11 -4.35 0.12 Allowed 'General case' 0 CA--C 1.565 1.522 0 CA-C-N 111.564 -2.562 . . . . 0.0 110.575 173.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.518 HG12 HG13 ' A' ' 125' ' ' VAL . 2.3 t -67.82 139.75 20.31 Favored 'Isoleucine or valine' 0 C--N 1.357 0.93 0 C-N-CA 125.29 1.436 . . . . 0.0 109.282 -178.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -81.74 71.32 8.76 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-N 111.288 -2.687 . . . . 0.0 112.939 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.539 HG11 ' HA ' ' A' ' 133' ' ' ALA 0.287 0.6 OUTLIER -82.79 -105.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-O 116.79 -1.576 . . . . 0.0 107.899 178.862 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.581 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.311 27.3 ptt85 49.3 -87.53 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 116.822 2.156 . . . . 0.0 116.822 179.636 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.581 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 27.6 tt0 -81.81 72.53 8.86 Favored 'General case' 0 CA--C 1.555 1.137 0 CA-C-O 123.418 1.58 . . . . 0.0 110.095 167.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.9 p -145.85 167.86 8.01 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 CA-C-N 113.403 -1.726 . . . . 0.0 106.71 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 7.0 m -59.42 132.75 54.93 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 114.044 -1.435 . . . . 0.0 110.2 157.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.4 ' CE1' HD22 ' A' ' 85' ' ' ASN . 2.9 p-80 -48.12 -31.91 6.2 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 117.607 2.447 . . . . 0.0 117.607 169.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.57 ' HA ' HG12 ' A' ' 134' ' ' VAL . 13.9 m -61.91 -38.53 88.71 Favored 'General case' 0 CA--C 1.564 1.486 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 173.253 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -69.28 -34.14 74.28 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 115.656 1.725 . . . . 0.0 115.656 164.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.539 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -65.18 -52.65 53.61 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 170.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.57 HG12 ' HA ' ' A' ' 131' ' ' SER . 12.7 p -50.41 -46.43 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 164.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -55.0 -50.42 69.06 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-O 116.68 -1.629 . . . . 0.0 112.606 172.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.88 -31.94 72.26 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 117.148 2.277 . . . . 0.0 117.148 170.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.572 HD22 HG21 ' A' ' 120' ' ' VAL . 3.1 mm? -59.55 -51.69 68.74 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 165.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -66.92 -42.4 85.47 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 171.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -69.59 -12.47 61.67 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 117.431 2.382 . . . . 0.0 117.431 173.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.425 ' HB1' ' HA ' ' A' ' 144' ' ' VAL . . . -53.49 -19.73 4.03 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 118.661 2.837 . . . . 0.0 118.661 157.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 83.26 -140.17 19.62 Favored Glycine 0 C--N 1.345 1.03 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 11.0 m -70.35 -5.84 31.05 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 116.605 2.076 . . . . 0.0 116.605 173.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -147.8 110.84 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -170.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.561 HG23 ' HB3' ' A' ' 68' ' ' LEU . 11.9 m -84.2 115.97 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 114.071 -1.422 . . . . 0.0 109.401 171.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.444 ' HB3' ' HA ' ' A' ' 121' ' ' ASN . 7.8 tpp180 -90.55 107.23 19.03 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 170.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 79.2 mt -108.27 135.64 49.25 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -172.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -125.54 118.2 25.24 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 177.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.43 121.84 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -177.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.418 ' HB2' HD21 ' A' ' 118' ' ' LEU . 49.6 ttm -102.64 134.85 45.33 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 122.16 0.981 . . . . 0.0 112.671 168.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -99.87 108.49 20.76 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 171.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 26.9 ttp180 -110.79 43.62 1.4 Allowed 'General case' 0 CA--C 1.567 1.607 0 CA-C-N 113.729 -1.578 . . . . 0.0 111.808 173.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.413 ' HB2' ' HD3' ' A' ' 153' ' ' PRO . 61.9 mttp -93.5 -53.95 0.25 Allowed Pre-proline 0 CA--C 1.555 1.162 0 CA-C-O 115.132 -2.366 . . . . 0.0 110.225 173.023 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.413 ' HD3' ' HB2' ' A' ' 152' ' ' LYS . 17.9 Cg_exo -48.83 -49.41 15.08 Favored 'Trans proline' 0 CA--C 1.571 2.326 0 CA-C-N 124.677 2.706 . . . . 0.0 116.314 167.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo . . . . . 0 C--N 1.375 1.966 0 C-N-CA 123.707 2.938 . . . . 0.0 111.749 173.506 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.559 1.303 0 CA-C-O 122.68 1.229 . . . . 0.0 111.399 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -136.11 122.14 20.15 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 172.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 13.9 ttpp -95.88 112.78 24.42 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 113.923 -1.49 . . . . 0.0 107.583 173.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 4.6 m -76.28 131.02 39.0 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 172.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.94 105.46 17.78 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 178.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.483 HG12 HD13 ' A' ' 75' ' ' LEU . 11.7 t . . . . . 0 C--O 1.245 0.821 0 N-CA-C 102.363 -3.199 . . . . 0.0 102.363 -165.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 . . . . . 0 N--CA 1.483 1.203 0 CA-C-O 120.499 0.19 . . . . 0.0 110.505 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.412 ' HB3' ' HB2' ' A' ' 149' ' ' MET . 26.3 p90 -121.77 140.78 51.92 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 124.41 1.069 . . . . 0.0 110.254 174.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -122.04 133.73 54.79 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 122.617 1.198 . . . . 0.0 108.965 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -104.98 117.11 33.18 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 -176.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.606 HG13 ' HB2' ' A' ' 146' ' ' LEU . 3.1 pt -137.1 115.22 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 -168.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.9 m -94.77 130.26 41.39 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 171.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.6 HD11 ' HA ' ' A' ' 105' ' ' ALA . 0.5 OUTLIER -129.68 166.79 19.09 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 113.871 -1.513 . . . . 0.0 109.694 172.911 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -85.36 121.37 27.99 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 122.13 0.966 . . . . 0.0 110.686 175.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.65 ' HD2' ' H ' ' A' ' 142' ' ' SER . 0.9 OUTLIER -78.33 107.92 11.29 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 169.879 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.415 ' H ' ' HA ' ' A' ' 75' ' ' LEU . . . -69.47 134.68 26.56 Favored Glycine 0 CA--C 1.543 1.837 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 165.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -50.13 -54.12 22.81 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 -170.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.4 m -84.5 -19.41 33.34 Favored 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 171.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -174.46 135.99 3.35 Favored Glycine 0 CA--C 1.536 1.363 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.527 HD23 HG11 ' A' ' 144' ' ' VAL . 1.5 mp -74.67 -61.91 1.71 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.248 1.019 . . . . 0.0 110.547 -177.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 136.59 25.91 0.43 Allowed Glycine 0 CA--C 1.542 1.77 0 CA-C-O 117.999 -1.445 . . . . 0.0 114.886 -175.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.497 ' HD1' HD11 ' A' ' 99' ' ' ILE . 0.0 OUTLIER -129.27 165.84 20.61 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 123.912 1.815 . . . . 0.0 107.72 172.744 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 35.2 m -111.94 143.98 42.02 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 154.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.723 HG22 HD13 ' A' ' 96' ' ' ILE . 2.4 pp -107.56 128.91 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 113.045 -1.889 . . . . 0.0 108.481 170.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -84.15 -166.26 1.38 Allowed 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 123.915 1.817 . . . . 0.0 108.633 162.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 85' ' ' ASN . . . -94.51 157.78 22.57 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 123.697 1.721 . . . . 0.0 113.835 -138.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -104.88 -163.85 24.08 Favored Glycine 0 CA--C 1.522 0.511 0 CA-C-N 111.349 -2.425 . . . . 0.0 113.0 178.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 61.0 p -51.16 -40.1 57.83 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 116.798 2.147 . . . . 0.0 116.798 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -88.03 -5.72 58.34 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 175.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.441 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 0.1 OUTLIER -149.49 82.88 6.65 Favored Pre-proline 0 CA--C 1.558 1.259 0 N-CA-C 101.747 -3.427 . . . . 0.0 101.747 177.308 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -106.75 128.52 0.05 OUTLIER 'Trans proline' 0 C--N 1.361 1.193 0 CA-C-N 125.298 2.928 . . . . 0.0 110.943 -173.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.4 ' HB2' ' CG ' ' B' ' 1' ' ' TYR . 10.6 t-160 -107.71 -55.41 2.36 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.56 0.695 . . . . 0.0 112.355 169.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.612 HD13 ' H ' ' A' ' 88' ' ' ILE . 0.2 OUTLIER -103.55 177.99 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.114 0 CA-C-O 123.663 1.696 . . . . 0.0 108.528 -172.494 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 94.4 -175.95 35.02 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 124.215 2.008 . . . . 0.0 110.431 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -79.45 -8.18 58.94 Favored 'General case' 0 CA--C 1.572 1.804 0 CA-C-N 112.092 -2.054 . . . . 0.0 115.065 162.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.421 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 19.2 t70 178.5 -61.92 0.0 OUTLIER Pre-proline 0 CA--C 1.568 1.653 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 175.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.421 ' HD3' ' HB3' ' A' ' 91' ' ' ASP . 15.6 Cg_endo -107.66 -120.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.372 1.804 0 CA-C-N 124.749 2.732 . . . . 0.0 110.044 -171.299 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.9 m 76.15 110.21 0.07 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.058 1.343 . . . . 0.0 108.776 165.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.498 HG13 ' HB2' ' A' ' 133' ' ' ALA . 15.8 mm -73.28 129.53 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -119.2 153.54 34.77 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 112.993 -1.912 . . . . 0.0 108.981 -175.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.792 HG22 ' CG2' ' A' ' 113' ' ' VAL 0.258 10.9 mm -98.42 106.58 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.685 0 N-CA-C 100.24 -3.985 . . . . 0.0 100.24 170.39 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.543 HG21 ' HG2' ' B' ' 3' ' ' LYS . 10.0 t -93.45 -49.86 5.71 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 -173.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.52 ' HA ' HG11 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -133.94 136.18 44.05 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 169.51 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.497 HD11 ' HD1' ' A' ' 77' ' ' PHE . 0.9 OUTLIER -79.49 138.4 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 177.496 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.343 1.5 mp -72.88 115.57 41.44 Favored Pre-proline 0 CA--C 1.568 1.663 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 171.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -68.61 140.95 48.72 Favored 'Trans proline' 0 C--N 1.369 1.634 0 C-N-CA 123.328 2.685 . . . . 0.0 113.067 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.3 7.79 73.36 Favored Glycine 0 CA--C 1.552 2.399 0 N-CA-C 118.177 2.031 . . . . 0.0 118.177 -174.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -99.09 -165.76 30.09 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-N 119.217 1.509 . . . . 0.0 112.719 177.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 75' ' ' LEU . . . -62.03 -30.72 71.16 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 176.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.6 ' HA ' HD11 ' A' ' 68' ' ' LEU . . . -69.21 -40.85 77.77 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 116.873 2.175 . . . . 0.0 116.873 172.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.51 -41.63 96.29 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 170.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -72.96 -52.7 13.53 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 115.019 1.488 . . . . 0.0 115.019 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -62.49 -37.99 88.11 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 176.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 114.75 47.01 0.58 Allowed Glycine 0 CA--C 1.536 1.406 0 C-N-CA 123.745 0.688 . . . . 0.0 113.935 168.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -121.45 24.12 10.04 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 169.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.627 ' H ' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -44.37 -30.68 0.88 Allowed 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 119.958 3.318 . . . . 0.0 119.958 170.285 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.446 ' H ' HD22 ' A' ' 111' ' ' LEU . 53.6 ttp180 -77.49 88.53 3.84 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 125.11 2.386 . . . . 0.0 107.764 163.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.792 ' CG2' HG22 ' A' ' 96' ' ' ILE 0.32 14.6 p -53.21 -65.5 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 109.515 -3.493 . . . . 0.0 113.692 -172.476 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.526 ' H ' HG13 ' A' ' 113' ' ' VAL . 30.9 m-80 -14.98 78.0 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 O-C-N 127.08 2.738 . . . . 0.0 117.959 166.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.605 ' HB3' HG11 ' A' ' 148' ' ' VAL . 58.5 m-20 -147.41 121.0 9.14 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 103.288 -2.856 . . . . 0.0 103.288 -177.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 21.5 m -84.64 82.52 8.38 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 114.414 -1.266 . . . . 0.0 109.508 -175.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.6 tp -64.21 123.09 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 CA-C-O 122.527 1.155 . . . . 0.0 111.441 -174.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.591 HD21 ' HB3' ' A' ' 149' ' ' MET . 0.0 OUTLIER -111.96 -53.28 2.72 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 112.334 -2.212 . . . . 0.0 112.053 174.896 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -122.63 133.66 54.52 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 -170.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.425 HG13 HD23 ' A' ' 146' ' ' LEU . 2.5 t -126.61 111.88 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 103.353 -2.832 . . . . 0.0 103.353 -178.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . 0.278 9.2 m120 81.5 -78.4 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 123.371 1.558 . . . . 0.0 109.496 178.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -152.18 -22.47 0.18 Allowed 'General case' 0 CA--C 1.576 1.955 0 C-N-CA 128.219 2.607 . . . . 0.0 109.618 175.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.3 t -59.56 137.64 21.7 Favored 'Isoleucine or valine' 0 C--N 1.362 1.145 0 C-N-CA 125.469 1.508 . . . . 0.0 110.911 176.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -105.6 103.35 12.84 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 113.022 -1.899 . . . . 0.0 108.437 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.426 HG11 ' HA ' ' A' ' 133' ' ' ALA 0.262 0.5 OUTLIER -97.48 -90.24 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-O 117.012 -1.47 . . . . 0.0 108.166 176.806 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.464 ' HB3' ' HB3' ' A' ' 118' ' ' LEU 0.32 23.1 ptt180 51.16 -88.37 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 117.351 2.352 . . . . 0.0 117.351 178.601 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.431 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 2.8 mp0 -85.58 67.13 9.98 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 123.505 1.621 . . . . 0.0 109.472 173.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.3 p -137.13 169.17 20.08 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-O 124.263 1.982 . . . . 0.0 105.924 -178.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 5.3 m -59.25 134.94 57.46 Favored 'General case' 0 CA--C 1.56 1.334 0 CA-C-N 112.701 -2.045 . . . . 0.0 110.643 157.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.455 ' HA ' HD12 ' A' ' 94' ' ' ILE . 9.7 p-80 -45.78 -32.9 2.76 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 117.656 2.465 . . . . 0.0 117.656 169.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.475 ' HA ' HG12 ' A' ' 134' ' ' VAL . 9.4 m -63.41 -40.41 97.13 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 177.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -69.42 -36.74 76.98 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 168.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.498 ' HB2' HG13 ' A' ' 94' ' ' ILE . . . -67.23 -50.51 60.38 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 172.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.475 HG12 ' HA ' ' A' ' 131' ' ' SER . 2.7 p -52.96 -45.11 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 114.544 1.312 . . . . 0.0 114.544 166.197 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -60.42 -47.0 88.0 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-O 115.553 -2.165 . . . . 0.0 112.515 173.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.18 -35.97 82.52 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 117.044 2.239 . . . . 0.0 117.044 172.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.442 ' HB3' HG21 ' B' ' 6' ' ' VAL . 3.8 mm? -50.79 -54.26 25.04 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.299 1.04 . . . . 0.0 113.627 162.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -69.39 -38.45 78.01 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 174.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -63.4 -21.59 66.38 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 172.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.471 ' HB1' ' HA ' ' A' ' 144' ' ' VAL . . . -53.33 -22.81 7.87 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 118.674 2.842 . . . . 0.0 118.674 168.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 65.7 89.17 0.05 OUTLIER Glycine 0 C--N 1.351 1.384 0 CA-C-N 118.771 0.714 . . . . 0.0 114.5 155.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.65 ' H ' ' HD2' ' A' ' 70' ' ' ARG 0.268 20.4 m 72.17 -30.3 0.21 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 118.02 2.6 . . . . 0.0 118.02 -172.392 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -146.82 110.72 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 -172.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.527 HG11 HD23 ' A' ' 75' ' ' LEU . 33.5 m -83.57 120.75 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.429 171.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -101.66 91.26 4.34 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 174.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.606 ' HB2' HG13 ' A' ' 66' ' ' ILE . 61.2 mt -95.31 137.9 33.74 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 122.536 1.16 . . . . 0.0 108.361 -172.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -127.67 124.64 38.42 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 175.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.605 HG11 ' HB3' ' A' ' 115' ' ' ASP . 28.6 m -134.13 115.91 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -163.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.591 ' HB3' HD21 ' A' ' 118' ' ' LEU . 32.9 ttm -134.03 121.48 21.62 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 -175.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -97.12 158.05 15.63 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 113.163 -1.835 . . . . 0.0 109.895 166.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 60.96 74.91 0.43 Allowed 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.509 176.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . 0.256 0.0 OUTLIER -116.74 103.64 52.17 Favored Pre-proline 0 CA--C 1.554 1.1 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 -175.668 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -54.33 -49.11 18.06 Favored 'Trans proline' 0 CA--C 1.572 2.393 0 C-N-CA 123.27 2.647 . . . . 0.0 116.385 175.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo . . . . . 0 C--N 1.374 1.895 0 C-N-CA 123.563 2.842 . . . . 0.0 110.969 -177.147 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' TYR . . . . . 0.4 ' CG ' ' HB2' ' A' ' 87' ' ' HIS . 1.0 OUTLIER . . . . . 0 CA--C 1.56 1.338 0 CA-C-O 122.964 1.364 . . . . 0.0 111.673 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.88 157.92 39.98 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 123.225 1.488 . . . . 0.0 109.904 168.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.543 ' HG2' HG21 ' A' ' 97' ' ' THR . 0.2 OUTLIER -103.04 136.55 42.64 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 113.603 -1.635 . . . . 0.0 106.853 172.131 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 88.5 m -102.5 136.08 42.98 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 167.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -78.61 140.82 38.4 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-O 123.667 1.699 . . . . 0.0 108.812 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.442 HG21 ' HB3' ' A' ' 137' ' ' LEU . 7.5 p . . . . . 0 C--O 1.243 0.731 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 . . . . . 0 N--CA 1.482 1.134 0 CA-C-O 121.844 0.83 . . . . 0.0 111.313 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.494 ' HB3' ' HB2' ' A' ' 149' ' ' MET . 20.9 p90 -96.16 134.05 39.71 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.967 172.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -110.84 126.75 54.98 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.76 124.99 34.68 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.189 174.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.477 HG13 ' HB2' ' A' ' 146' ' ' LEU . 3.1 pt -137.95 108.28 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 -175.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.8 m -91.39 118.26 30.38 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 172.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.449 ' HB3' ' CG2' ' A' ' 144' ' ' VAL . 3.9 tp -115.42 167.4 10.9 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 113.977 -1.465 . . . . 0.0 108.198 174.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -93.51 138.42 31.81 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 170.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.565 ' HG3' ' HG ' ' A' ' 75' ' ' LEU . 56.7 ttp85 -84.84 111.67 19.85 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 168.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.33 140.19 48.08 Favored Glycine 0 CA--C 1.536 1.354 0 CA-C-N 114.295 -1.32 . . . . 0.0 112.003 169.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -59.26 -50.54 73.62 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -173.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.3 m -77.53 -19.8 55.2 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 171.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -177.19 131.67 1.86 Allowed Glycine 0 CA--C 1.533 1.174 0 N-CA-C 107.23 -2.348 . . . . 0.0 107.23 178.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.713 HD11 HG11 ' A' ' 144' ' ' VAL . 1.3 tt -48.4 -36.53 14.91 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 169.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 110.91 16.84 9.47 Favored Glycine 0 N--CA 1.478 1.489 0 N-CA-C 117.559 1.783 . . . . 0.0 117.559 169.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.432 ' CE2' HD22 ' A' ' 75' ' ' LEU . 27.7 p90 -143.0 173.0 11.94 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 124.306 2.003 . . . . 0.0 108.5 171.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.7 m -122.12 155.09 36.45 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 123.705 1.717 . . . . 0.0 106.481 176.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.569 HG22 HD13 ' A' ' 96' ' ' ILE . 1.1 pt -121.72 127.05 75.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 111.635 -2.53 . . . . 0.0 109.107 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.37 -168.26 1.29 Allowed 'General case' 0 CA--C 1.556 1.187 0 CA-C-O 123.339 1.542 . . . . 0.0 109.995 159.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.39 159.9 26.48 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 123.409 1.56 . . . . 0.0 115.16 -145.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.37 -160.84 23.31 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-N 111.906 -2.147 . . . . 0.0 113.542 178.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.501 HG22 ' HB3' ' A' ' 92' ' ' PRO . 30.3 p -52.83 -41.2 64.0 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 -178.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -83.04 -8.83 59.5 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 176.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.01 96.98 2.09 Favored Pre-proline 0 CA--C 1.556 1.197 0 N-CA-C 102.32 -3.215 . . . . 0.0 102.32 -173.126 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -99.15 134.84 0.26 Allowed 'Trans proline' 0 CA--C 1.551 1.338 0 CA-C-N 123.96 2.45 . . . . 0.0 111.543 174.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.448 ' HB2' ' CD2' ' B' ' 1' ' ' TYR . 9.1 t-80 -100.32 -21.02 15.59 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 155.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -151.72 135.27 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 N-CA-C 104.207 -2.516 . . . . 0.0 104.207 -164.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.43 161.48 37.47 Favored Glycine 0 CA--C 1.535 1.322 0 CA-C-O 123.633 1.685 . . . . 0.0 110.939 -165.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -79.63 -6.88 58.03 Favored 'General case' 0 CA--C 1.565 1.536 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 170.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.42 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 26.1 t70 -160.88 -61.4 0.02 OUTLIER Pre-proline 0 CA--C 1.562 1.415 0 CA-C-O 115.259 -2.305 . . . . 0.0 108.961 174.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.501 ' HB3' HG22 ' A' ' 83' ' ' THR . 3.2 Cg_endo -121.97 -146.86 0.0 OUTLIER 'Trans proline' 0 C--N 1.372 1.772 0 CA-C-N 125.183 2.887 . . . . 0.0 112.511 -159.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.6 m 78.22 107.67 0.07 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.461 1.104 . . . . 0.0 108.534 166.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.514 HG13 ' HB2' ' A' ' 133' ' ' ALA . 13.0 mm -74.99 127.51 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 106.376 -1.712 . . . . 0.0 106.376 -177.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -115.18 149.42 37.69 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 113.432 -1.713 . . . . 0.0 108.458 -175.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.569 HD13 HG22 ' A' ' 79' ' ' ILE . 22.3 mm -97.35 104.23 15.64 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.278 0 N-CA-C 104.388 -2.449 . . . . 0.0 104.388 171.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.545 HG21 ' HG3' ' B' ' 3' ' ' LYS . 12.2 t -79.51 -46.64 17.01 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 -177.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.637 ' HA ' HG21 ' A' ' 113' ' ' VAL . 12.0 ptmt -150.31 146.03 26.51 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.772 0.796 . . . . 0.0 111.099 -170.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.54 135.1 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 178.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.7 mp -82.9 117.62 69.14 Favored Pre-proline 0 CA--C 1.565 1.52 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 172.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.69 135.16 51.01 Favored 'Trans proline' 0 C--N 1.367 1.537 0 C-N-CA 123.442 2.761 . . . . 0.0 113.09 169.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 87.33 -9.97 70.98 Favored Glycine 0 CA--C 1.548 2.156 0 N-CA-C 117.707 1.843 . . . . 0.0 117.707 -169.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -85.91 -179.58 50.01 Favored Glycine 0 CA--C 1.538 1.472 0 CA-C-N 119.44 1.62 . . . . 0.0 113.602 175.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.09 -33.7 72.2 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 117.1 2.259 . . . . 0.0 117.1 -177.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.62 -35.18 68.0 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 118.567 2.803 . . . . 0.0 118.567 169.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.85 -32.04 71.43 Favored 'General case' 0 CA--C 1.558 1.274 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 171.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.02 -53.59 8.14 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 119.706 1.139 . . . . 0.0 112.827 172.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -78.54 -52.36 8.6 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.773 0.829 . . . . 0.0 112.555 -170.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -93.61 -45.5 3.42 Favored Glycine 0 CA--C 1.538 1.482 0 CA-C-O 118.161 -1.355 . . . . 0.0 114.616 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 27.3 ptt85 44.99 47.83 9.43 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -170.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -107.18 -165.56 1.08 Allowed 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 123.94 1.829 . . . . 0.0 108.0 -156.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 10.7 ptt180 -107.85 126.59 52.84 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 102.994 -2.965 . . . . 0.0 102.994 156.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.637 HG21 ' HA ' ' A' ' 98' ' ' LYS . 0.2 OUTLIER -42.26 -64.49 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-N 109.606 -3.452 . . . . 0.0 116.04 170.069 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -22.64 81.92 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.182 0 O-C-N 126.82 2.575 . . . . 0.0 116.891 175.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -157.21 128.69 6.93 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 -174.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 64.3 m -88.93 89.92 8.19 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -175.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.486 HG12 HD11 ' A' ' 137' ' ' LEU . 6.7 tp -63.21 128.01 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.073 178.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.746 HD21 ' HB3' ' A' ' 149' ' ' MET . 0.0 OUTLIER -114.93 -54.15 2.59 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 112.422 -2.172 . . . . 0.0 114.421 177.076 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -119.79 134.65 55.16 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 -174.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.431 HG23 HD23 ' A' ' 146' ' ' LEU . 9.1 p -123.94 118.34 53.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 169.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . 0.298 9.1 m120 78.5 -81.25 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 122.953 1.359 . . . . 0.0 109.604 -177.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -152.91 -20.88 0.16 Allowed 'General case' 0 CA--C 1.568 1.659 0 C-N-CA 127.859 2.464 . . . . 0.0 110.177 -177.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.2 t -64.35 135.19 28.35 Favored 'Isoleucine or valine' 0 C--N 1.362 1.122 0 C-N-CA 125.318 1.447 . . . . 0.0 110.358 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -90.8 97.54 11.24 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 113.072 -1.877 . . . . 0.0 108.307 172.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.472 HG11 ' HA ' ' A' ' 133' ' ' ALA 0.282 0.2 OUTLIER -93.48 -93.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-O 116.447 -1.739 . . . . 0.0 107.159 170.263 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.554 ' HB3' ' HA ' ' A' ' 118' ' ' LEU 0.292 11.3 ptt180 48.39 -88.69 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 117.851 2.538 . . . . 0.0 117.851 178.615 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.521 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 1.7 tt0 -84.1 66.86 9.47 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-O 123.674 1.702 . . . . 0.0 108.804 172.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -139.7 169.96 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 CA-C-N 112.606 -2.088 . . . . 0.0 106.513 178.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 7.7 m -60.5 136.5 58.07 Favored 'General case' 0 CA--C 1.561 1.375 0 CA-C-N 113.439 -1.709 . . . . 0.0 110.843 159.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.408 ' HA ' HD12 ' A' ' 94' ' ' ILE . 8.8 p-80 -45.3 -35.23 3.34 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 118.263 2.69 . . . . 0.0 118.263 170.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.477 ' HA ' HG12 ' A' ' 134' ' ' VAL . 79.0 p -60.31 -42.24 95.15 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 116.786 2.143 . . . . 0.0 116.786 172.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -70.68 -37.78 73.66 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 169.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.514 ' HB2' HG13 ' A' ' 94' ' ' ILE . . . -59.79 -55.49 33.66 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 169.036 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.477 HG12 ' HA ' ' A' ' 131' ' ' SER . 2.2 p -53.13 -46.84 55.77 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 170.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -60.55 -45.99 91.84 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 115.838 -2.03 . . . . 0.0 112.844 176.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.7 -34.57 78.61 Favored 'General case' 0 CA--C 1.558 1.278 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 171.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.486 HD11 HG12 ' A' ' 117' ' ' ILE . 9.6 mp -58.65 -46.55 86.9 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 165.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -70.33 -33.06 71.04 Favored 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 170.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -73.26 -14.96 61.42 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 116.455 2.02 . . . . 0.0 116.455 172.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.546 ' HB3' HG12 ' A' ' 144' ' ' VAL . . . -56.91 1.06 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.172 0 N-CA-C 119.227 3.047 . . . . 0.0 119.227 162.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 77.25 -146.51 31.92 Favored Glycine 0 C--N 1.344 1.019 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 176.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.8 m -72.0 -6.95 45.87 Favored 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 173.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -147.49 107.71 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 -165.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.713 HG11 HD11 ' A' ' 75' ' ' LEU . 23.1 m -92.48 123.91 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 114.073 -1.422 . . . . 0.0 108.612 -174.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -103.15 87.12 2.82 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.477 ' HB2' HG13 ' A' ' 66' ' ' ILE . 73.7 mt -91.33 133.9 35.05 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 -170.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -124.42 121.83 35.97 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 33.3 m -129.56 117.53 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -167.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.746 ' HB3' HD21 ' A' ' 118' ' ' LEU . 27.5 ttt -125.96 142.5 51.49 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -175.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -82.55 108.85 16.26 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 113.38 -1.736 . . . . 0.0 109.914 177.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -70.61 -36.17 73.37 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 113.048 -1.887 . . . . 0.0 114.595 164.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -75.52 124.97 89.17 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-O 118.172 -0.918 . . . . 0.0 109.469 -177.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -62.42 163.44 20.71 Favored 'Trans proline' 0 CA--C 1.57 2.3 0 C-N-CA 122.411 2.074 . . . . 0.0 114.061 174.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo . . . . . 0 CA--C 1.555 1.527 0 C-N-CA 123.646 2.898 . . . . 0.0 116.076 174.88 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' TYR . . . . . 0.448 ' CD2' ' HB2' ' A' ' 87' ' ' HIS . 0.3 OUTLIER . . . . . 0 CA--C 1.559 1.297 0 CA-C-O 122.887 1.327 . . . . 0.0 110.718 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 66.1 tttp -135.15 134.46 40.2 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-O 123.405 1.574 . . . . 0.0 108.205 165.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.545 ' HG3' HG21 ' A' ' 97' ' ' THR . 1.1 tmmt? -104.28 126.91 51.78 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 113.809 -1.541 . . . . 0.0 109.051 173.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.428 HG21 HG11 ' A' ' 134' ' ' VAL . 91.1 m -98.2 139.82 33.42 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 114.173 -1.376 . . . . 0.0 109.343 172.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -87.45 128.01 35.22 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 113.926 -1.488 . . . . 0.0 108.936 175.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.468 ' HB ' HG23 ' A' ' 134' ' ' VAL . 4.1 p . . . . . 0 C--O 1.248 1.025 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 175.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -129.18 136.21 49.85 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 121.658 0.742 . . . . 0.0 109.599 175.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -124.91 137.65 54.27 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 114.608 -1.178 . . . . 0.0 108.971 -177.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -103.27 132.3 49.64 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.66 175.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 21.0 pt -135.55 127.12 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -175.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.2 m -95.26 121.62 37.1 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 170.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 mp -119.75 126.9 52.18 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.373 -1.285 . . . . 0.0 107.632 -174.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.82 125.45 40.39 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.39 -172.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.558 ' HB2' ' HB2' ' A' ' 104' ' ' ALA . 4.9 tpm_? -152.3 -101.54 0.05 Allowed 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.671 169.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.08 -168.45 54.7 Favored Glycine 0 C--N 1.347 1.151 0 C-N-CA 124.066 0.841 . . . . 0.0 113.306 -167.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 75.67 -87.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 113.827 -1.187 . . . . 0.0 110.634 166.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 56.0 m -81.79 -16.67 50.21 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 172.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 159.75 -139.88 6.44 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 107.291 -2.324 . . . . 0.0 107.291 178.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.606 HD23 HG12 ' B' ' 6' ' ' VAL . 0.3 OUTLIER -127.39 -30.92 2.57 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 125.615 1.566 . . . . 0.0 111.363 -179.684 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.553 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 104.06 37.71 2.86 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 117.427 1.731 . . . . 0.0 117.427 162.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.472 ' O ' ' HB ' ' B' ' 6' ' ' VAL . 0.0 OUTLIER -152.33 143.76 23.37 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 -172.42 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.464 ' CB ' ' HG2' ' A' ' 98' ' ' LYS . 50.1 m -106.91 122.25 46.04 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.572 -1.194 . . . . 0.0 108.538 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.555 HG22 HG12 ' A' ' 96' ' ' ILE . 5.1 pt -108.13 129.56 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 CA-C-O 121.674 0.749 . . . . 0.0 109.952 -171.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.434 ' HB1' ' CB ' ' A' ' 87' ' ' HIS . . . -86.57 -171.4 3.52 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-O 123.597 1.665 . . . . 0.0 111.281 158.291 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.44 159.65 21.15 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-O 123.713 1.73 . . . . 0.0 115.057 -137.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -102.77 -162.14 25.9 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 111.441 -2.38 . . . . 0.0 111.874 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 44.3 p -55.15 -40.38 70.53 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 116.922 2.193 . . . . 0.0 116.922 -174.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -75.51 -21.97 57.54 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 116.353 1.983 . . . . 0.0 116.353 174.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -145.28 95.94 4.98 Favored Pre-proline 0 CA--C 1.553 1.075 0 N-CA-C 101.498 -3.519 . . . . 0.0 101.498 -173.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -93.32 137.29 1.33 Allowed 'Trans proline' 0 CA--C 1.554 1.475 0 CA-C-N 124.079 2.493 . . . . 0.0 111.646 -177.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.434 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 23.2 t-80 -99.69 -24.62 14.66 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 161.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.462 HG22 ' H ' ' A' ' 90' ' ' ASP . 4.9 mp -90.86 142.46 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 -166.256 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.98 -9.78 22.99 Favored Glycine 0 CA--C 1.559 2.794 0 N-CA-C 119.117 2.407 . . . . 0.0 119.117 171.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.462 ' H ' HG22 ' A' ' 88' ' ' ILE . 37.5 t70 -85.42 -8.47 58.39 Favored 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 115.351 1.611 . . . . 0.0 115.351 164.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.442 ' HB3' ' HD3' ' A' ' 92' ' ' PRO 0.49 15.8 t70 95.86 -89.28 0.0 OUTLIER Pre-proline 0 CA--C 1.561 1.392 0 C-N-CA 126.161 1.784 . . . . 0.0 109.085 -172.712 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.442 ' HD3' ' HB3' ' A' ' 91' ' ' ASP . 14.0 Cg_endo -94.8 -151.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.223 0 CA-C-N 124.448 2.624 . . . . 0.0 112.113 -159.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 66.8 m 73.17 138.6 0.05 Allowed 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 122.438 1.113 . . . . 0.0 109.323 176.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.428 HG13 ' HB2' ' A' ' 133' ' ' ALA . 15.0 mm -94.43 121.71 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 -169.039 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -124.57 138.17 54.34 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 -174.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.555 HG12 HG22 ' A' ' 79' ' ' ILE . 82.4 mt -82.35 122.98 37.83 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.627 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 169.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 89.3 m -93.57 -33.84 13.57 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 117.627 -1.177 . . . . 0.0 113.907 172.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.512 ' HA ' HG11 ' A' ' 113' ' ' VAL 0.354 8.1 ptmm? -140.27 167.75 21.4 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-O 123.534 1.635 . . . . 0.0 110.885 173.351 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -109.14 129.22 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 103.835 -2.654 . . . . 0.0 103.835 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.427 ' HA ' ' HD2' ' A' ' 101' ' ' PRO 0.314 22.5 mt -83.74 121.76 76.26 Favored Pre-proline 0 CA--C 1.564 1.503 0 CA-C-O 117.915 -1.041 . . . . 0.0 108.789 175.142 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 100' ' ' ILE . 11.6 Cg_endo -55.96 141.18 86.48 Favored 'Trans proline' 0 C--N 1.371 1.746 0 C-N-CA 124.075 3.183 . . . . 0.0 115.581 178.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.95 15.04 79.83 Favored Glycine 0 CA--C 1.547 2.058 0 N-CA-C 117.27 1.668 . . . . 0.0 117.27 -164.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.553 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -89.23 176.83 43.9 Favored Glycine 0 C--N 1.34 0.772 0 C-N-CA 124.721 1.153 . . . . 0.0 115.578 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.558 ' HB2' ' HB2' ' A' ' 70' ' ' ARG . . . -64.37 -48.54 75.11 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 177.029 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.483 ' HB1' HD11 ' A' ' 111' ' ' LEU . . . -69.23 -34.0 74.16 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.69 -44.35 81.97 Favored 'General case' 0 CA--C 1.561 1.388 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 168.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.4 -65.4 0.82 Allowed 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 124.637 1.175 . . . . 0.0 111.791 176.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -65.63 -31.86 73.12 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 115.478 1.659 . . . . 0.0 115.478 -174.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.29 -167.61 11.13 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-O 123.839 1.799 . . . . 0.0 112.667 170.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -141.35 59.15 1.51 Allowed 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 112.182 -2.009 . . . . 0.0 107.509 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.483 HD11 ' HB1' ' A' ' 105' ' ' ALA . 1.7 pp -93.33 -164.31 1.16 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 124.455 2.074 . . . . 0.0 107.709 -165.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -116.03 141.81 47.63 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 104.007 -2.59 . . . . 0.0 104.007 163.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.512 HG11 ' HA ' ' A' ' 98' ' ' LYS 0.26 17.9 m -42.65 -65.42 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-N 109.064 -3.698 . . . . 0.0 112.734 172.163 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -52.5 78.9 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 126.457 1.903 . . . . 0.0 115.119 177.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -130.05 113.9 15.11 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 101.068 -3.678 . . . . 0.0 101.068 175.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.5 m -67.49 79.82 0.17 Allowed 'General case' 0 CA--C 1.554 1.108 0 CA-C-N 113.409 -1.723 . . . . 0.0 111.531 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.6 pt -70.14 100.61 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-O 123.406 1.574 . . . . 0.0 108.8 -176.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.8 pp -96.41 -38.7 9.93 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 112.909 -1.951 . . . . 0.0 114.94 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.445 ' HB2' ' HB2' ' A' ' 147' ' ' TYR . 20.9 m-85 -125.46 140.55 52.68 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 123.273 1.511 . . . . 0.0 107.067 177.144 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.462 HG21 HD22 ' A' ' 137' ' ' LEU . 3.5 t -134.0 113.04 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 102.259 -3.238 . . . . 0.0 102.259 -179.1 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . 0.32 11.4 m120 83.97 -78.05 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 123.934 1.826 . . . . 0.0 110.134 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -156.38 -23.9 0.1 Allowed 'General case' 0 CA--C 1.572 1.791 0 CA-C-N 110.472 -3.058 . . . . 0.0 109.276 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.3 t -61.73 138.78 21.71 Favored 'Isoleucine or valine' 0 C--N 1.361 1.066 0 C-N-CA 125.604 1.561 . . . . 0.0 111.087 -177.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -94.88 87.91 5.13 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 111.348 -2.66 . . . . 0.0 110.81 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.47 HG11 ' HA ' ' A' ' 133' ' ' ALA 0.287 0.5 OUTLIER -92.37 -98.52 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 CA-C-O 117.104 -1.427 . . . . 0.0 108.154 -179.942 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.546 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.315 15.1 ptt180 48.37 -89.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 -179.514 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.546 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 21.9 tt0 -74.68 75.49 2.05 Favored 'General case' 0 CA--C 1.557 1.237 0 CA-C-O 123.738 1.732 . . . . 0.0 110.323 166.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -155.0 164.35 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 -175.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 34.0 m -60.06 132.11 52.92 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-N 113.586 -1.643 . . . . 0.0 109.671 156.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -46.82 -31.45 3.05 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 118.212 2.671 . . . . 0.0 118.212 171.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.544 ' HA ' HG12 ' A' ' 134' ' ' VAL . 14.6 m -60.09 -38.59 83.37 Favored 'General case' 0 CA--C 1.561 1.375 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 173.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -71.07 -35.93 72.08 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 166.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.47 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -59.88 -53.71 54.74 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 168.146 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.544 HG12 ' HA ' ' A' ' 131' ' ' SER . 9.7 p -55.99 -41.92 69.73 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.444 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 166.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -57.57 -43.56 84.61 Favored 'General case' 0 CA--C 1.556 1.191 0 CA-C-O 117.626 -1.178 . . . . 0.0 113.458 171.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.14 -33.43 75.45 Favored 'General case' 0 CA--C 1.558 1.263 0 N-CA-C 116.397 1.999 . . . . 0.0 116.397 167.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.462 HD22 HG21 ' A' ' 120' ' ' VAL . 4.3 mm? -59.65 -50.96 71.85 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 165.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -65.98 -38.33 88.27 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 173.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -65.96 -28.46 68.92 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 116.353 1.983 . . . . 0.0 116.353 171.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.499 ' HB1' ' HA ' ' A' ' 144' ' ' VAL . . . -52.43 -33.21 43.01 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 117.443 2.386 . . . . 0.0 117.443 161.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 93.62 -120.15 6.19 Favored Glycine 0 C--N 1.345 1.051 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 166.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.3 m -86.71 0.29 54.91 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 117.426 2.38 . . . . 0.0 117.426 168.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.95 101.99 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 -170.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.499 ' HA ' ' HB1' ' A' ' 140' ' ' ALA . 15.5 m -88.02 118.64 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 114.04 -1.436 . . . . 0.0 109.654 176.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 40.8 mtt180 -98.58 87.65 3.87 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 178.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 53.3 mt -90.45 136.52 33.0 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -170.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.445 ' HB2' ' HB2' ' A' ' 119' ' ' PHE . 41.6 m-85 -122.72 120.39 33.49 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 104.515 -2.402 . . . . 0.0 104.515 178.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -123.44 120.62 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 -176.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 28.3 ttt -96.65 116.37 29.01 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 124.519 1.137 . . . . 0.0 109.982 162.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -88.35 153.23 21.35 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-O 122.98 1.371 . . . . 0.0 111.082 173.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -117.75 153.92 32.59 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 113.011 -1.904 . . . . 0.0 109.14 167.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -115.72 96.92 47.81 Favored Pre-proline 0 CA--C 1.548 0.904 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 173.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -72.44 138.24 29.51 Favored 'Trans proline' 0 CA--C 1.564 2.011 0 C-N-CA 122.511 2.14 . . . . 0.0 111.624 172.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo . . . . . 0 CA--C 1.552 1.414 0 C-N-CA 123.082 2.522 . . . . 0.0 112.828 173.187 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 1.3 p90 . . . . . 0 CA--C 1.56 1.342 0 CA-C-O 122.569 1.176 . . . . 0.0 110.741 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -132.99 133.99 43.87 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-O 123.017 1.389 . . . . 0.0 108.473 170.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -95.69 124.96 39.95 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 113.782 -1.554 . . . . 0.0 108.736 169.054 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 4.7 m -83.69 140.41 32.16 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 123.309 1.528 . . . . 0.0 109.21 167.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -98.99 105.79 17.97 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 104.889 -2.263 . . . . 0.0 104.889 -177.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.606 HG12 HD23 ' A' ' 75' ' ' LEU . 12.3 t . . . . . 0 C--O 1.256 1.428 0 CA-C-O 123.03 1.395 . . . . 0.0 107.803 -165.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 149' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.482 1.154 0 CA-C-O 118.015 -0.993 . . . . 0.0 108.838 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.59 ' HB3' ' HG2' ' A' ' 149' ' ' MET . 13.3 p90 -127.06 139.82 52.73 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.594 0.758 . . . . 0.0 110.353 -176.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -107.77 132.99 52.8 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.562 172.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.22 121.4 43.59 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 113.824 -1.535 . . . . 0.0 108.593 -177.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 13.5 pt -135.32 118.7 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 -174.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.7 m -89.96 124.2 34.53 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 168.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.534 HD21 ' HA ' ' A' ' 105' ' ' ALA . 1.5 tp -116.05 125.0 51.84 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 114.22 -1.354 . . . . 0.0 109.293 -171.435 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -90.16 124.28 34.69 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.423 -176.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.401 ' CB ' ' HB2' ' A' ' 104' ' ' ALA . 9.8 tpt180 -165.37 -103.66 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 172.099 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 62.38 -141.97 47.52 Favored Glycine 0 C--N 1.354 1.568 0 C-N-CA 124.323 0.963 . . . . 0.0 113.421 -177.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . 0.273 24.2 t-20 71.49 -89.08 0.03 OUTLIER 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 123.811 0.844 . . . . 0.0 110.477 176.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.3 m -102.18 -14.7 16.93 Favored 'General case' 0 CA--C 1.564 1.508 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 174.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 158.37 161.74 11.26 Favored Glycine 0 CA--C 1.533 1.182 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -175.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.49 HD22 HG12 ' B' ' 6' ' ' VAL . 1.6 mp -86.46 -97.2 0.08 Allowed 'General case' 0 CA--C 1.56 1.341 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 -175.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.558 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 145.71 67.41 0.01 OUTLIER Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 167.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.45 ' CZ ' HD23 ' A' ' 75' ' ' LEU . 2.7 p90 -163.62 141.01 7.32 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 124.292 1.996 . . . . 0.0 108.772 176.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.416 ' HB2' ' HB3' ' A' ' 98' ' ' LYS . 15.8 m -92.85 128.22 38.63 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 112.208 -2.269 . . . . 0.0 110.846 -178.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.467 HG12 HG23 ' A' ' 134' ' ' VAL . 1.9 pp -103.63 125.74 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.866 178.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.552 ' HB3' ' HB2' ' A' ' 95' ' ' PHE . . . -74.86 -175.53 2.55 Favored 'General case' 0 CA--C 1.555 1.138 0 CA-C-O 123.624 1.678 . . . . 0.0 111.076 164.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 85' ' ' ASN . . . -99.03 155.73 20.01 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-O 123.591 1.662 . . . . 0.0 115.469 -141.019 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.13 -160.29 21.51 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 111.37 -2.415 . . . . 0.0 113.891 177.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 38.9 p -58.67 -38.7 78.74 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 115.578 1.695 . . . . 0.0 115.578 -174.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.561 ' HB3' HG23 ' A' ' 129' ' ' THR . 11.2 t70 -96.53 12.91 29.85 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 175.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.405 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 0.8 OUTLIER -163.67 76.83 1.71 Allowed Pre-proline 0 N--CA 1.481 1.103 0 N-CA-C 100.868 -3.753 . . . . 0.0 100.868 -179.756 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -100.12 127.58 0.14 Allowed 'Trans proline' 0 C--N 1.364 1.382 0 CA-C-N 125.198 2.892 . . . . 0.0 111.07 -166.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 41.7 t60 -80.72 -26.18 37.59 Favored 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 162.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.9 mp -106.1 138.01 33.56 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.041 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 -172.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -41.15 -81.25 0.03 OUTLIER Glycine 0 CA--C 1.544 1.853 0 N-CA-C 117.509 1.764 . . . . 0.0 117.509 176.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -113.7 10.45 17.93 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 114.827 1.417 . . . . 0.0 114.827 -178.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -126.53 76.07 74.03 Favored Pre-proline 0 N--CA 1.479 0.99 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -47.62 120.38 4.54 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 123.283 2.655 . . . . 0.0 113.634 162.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.7 m -158.64 122.67 4.0 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 -173.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.46 HG13 ' CB ' ' A' ' 133' ' ' ALA . 21.0 mm -79.42 126.06 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 -173.315 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.552 ' HB2' ' HB3' ' A' ' 80' ' ' ALA . 22.8 m-30 -117.72 161.54 19.52 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.646 -1.615 . . . . 0.0 107.32 -176.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.505 HD12 ' HB2' ' A' ' 114' ' ' ASN . 89.2 mt -105.8 112.73 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 103.738 -2.69 . . . . 0.0 103.738 149.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.6 m -95.61 -18.64 20.4 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 169.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.416 ' HB3' ' HB2' ' A' ' 78' ' ' SER . 53.2 tttp -136.99 153.62 50.63 Favored 'General case' 0 CA--C 1.556 1.2 0 CA-C-O 124.301 2.0 . . . . 0.0 109.954 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.433 HG22 ' HB3' ' A' ' 105' ' ' ALA . 0.6 OUTLIER -113.43 125.63 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-N 112.98 -1.918 . . . . 0.0 105.947 175.959 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.279 1.4 mp -71.55 127.61 90.86 Favored Pre-proline 0 CA--C 1.567 1.6 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 171.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.57 130.75 41.69 Favored 'Trans proline' 0 C--N 1.365 1.399 0 C-N-CA 123.558 2.838 . . . . 0.0 115.141 176.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 72.98 9.87 76.68 Favored Glycine 0 CA--C 1.551 2.324 0 N-CA-C 118.306 2.082 . . . . 0.0 118.306 -169.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.558 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -84.98 -168.71 45.03 Favored Glycine 0 C--N 1.336 0.577 0 N-CA-C 115.625 1.01 . . . . 0.0 115.625 -176.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.401 ' HB2' ' CB ' ' A' ' 70' ' ' ARG . . . -64.81 -52.61 55.86 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -177.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.534 ' HA ' HD21 ' A' ' 68' ' ' LEU . . . -67.7 -37.46 82.31 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 115.887 -2.006 . . . . 0.0 114.491 173.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.72 -51.18 66.11 Favored 'General case' 0 CA--C 1.562 1.438 0 CA-C-N 121.366 1.894 . . . . 0.0 114.936 173.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.8 -60.93 3.06 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 125.182 1.393 . . . . 0.0 113.25 176.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -69.64 -47.77 62.2 Favored 'General case' 0 CA--C 1.557 1.248 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -173.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -116.09 -71.48 0.47 Allowed Glycine 0 CA--C 1.534 1.227 0 C-N-CA 123.128 0.394 . . . . 0.0 112.755 -174.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 37.3 ttm105 58.65 46.41 14.57 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 123.191 1.472 . . . . 0.0 112.773 -159.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -91.32 -40.75 11.31 Favored 'General case' 0 CA--C 1.56 1.33 0 CA-C-N 113.508 -1.678 . . . . 0.0 112.693 -178.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -175.33 166.04 3.33 Favored 'General case' 0 CA--C 1.553 1.091 0 N-CA-C 101.431 -3.544 . . . . 0.0 101.431 175.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.422 ' HB ' HG22 ' A' ' 96' ' ' ILE 0.386 6.2 m -41.11 -69.08 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.561 1.366 0 CA-C-N 110.713 -2.949 . . . . 0.0 114.47 161.739 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.505 ' HB2' HD12 ' A' ' 96' ' ' ILE . 2.4 t30 174.28 -23.86 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 129.163 2.985 . . . . 0.0 107.298 165.014 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . 0.267 17.2 t70 79.93 -77.74 0.03 OUTLIER 'General case' 0 C--N 1.364 1.211 0 C-N-CA 126.805 2.042 . . . . 0.0 108.432 176.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.8 m -139.33 92.02 2.55 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 -177.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.505 HD11 ' HB ' ' A' ' 120' ' ' VAL . 0.0 OUTLIER -78.31 121.66 31.67 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.29 0 CA-C-O 122.445 1.116 . . . . 0.0 109.692 170.277 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.911 HD11 ' H ' ' A' ' 149' ' ' MET . 0.0 OUTLIER -106.05 -46.98 3.95 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.337 1.055 . . . . 0.0 113.144 179.504 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.465 ' HD1' HD23 ' A' ' 118' ' ' LEU . 68.1 m-85 -120.39 141.26 50.27 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 175.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.505 ' HB ' HD11 ' A' ' 117' ' ' ILE . 7.7 p -128.66 122.17 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 170.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.432 ' HA ' ' HB2' ' A' ' 145' ' ' ARG 0.314 15.0 m120 79.19 -76.17 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 123.622 1.677 . . . . 0.0 110.767 -177.379 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -163.47 -20.85 0.04 OUTLIER 'General case' 0 CA--C 1.572 1.794 0 CA-C-N 111.291 -2.686 . . . . 0.0 109.778 -175.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.542 HG12 HG13 ' A' ' 125' ' ' VAL . 2.4 t -64.48 136.21 26.86 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.168 0 C-N-CA 125.334 1.453 . . . . 0.0 110.249 -177.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -88.69 80.92 7.14 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 112.237 -2.256 . . . . 0.0 110.392 175.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.546 HG11 ' HA ' ' A' ' 133' ' ' ALA . 0.2 OUTLIER -86.3 -89.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-O 117.074 -1.441 . . . . 0.0 107.892 179.735 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.595 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.305 11.6 ptt180 46.22 -92.96 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 124.993 1.317 . . . . 0.0 114.393 -177.661 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.595 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 16.3 mt-10 -84.2 66.79 9.49 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 123.866 1.793 . . . . 0.0 111.947 175.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.5 p -133.34 168.09 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 112.607 -2.088 . . . . 0.0 105.918 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.561 HG23 ' HB3' ' A' ' 84' ' ' ASP . 96.6 m -59.66 137.01 58.16 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-N 113.609 -1.632 . . . . 0.0 110.627 157.168 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.433 ' HA ' HD12 ' A' ' 94' ' ' ILE . 3.4 p-80 -46.91 -37.62 9.19 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 171.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.458 ' H ' HG22 ' A' ' 129' ' ' THR . 7.9 m -56.23 -45.42 79.96 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 177.019 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.34 -39.06 88.96 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 171.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.546 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -68.04 -51.1 50.69 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 116.278 1.955 . . . . 0.0 116.278 171.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.818 HG22 HG21 ' B' ' 6' ' ' VAL . 0.3 OUTLIER -59.94 -39.35 79.88 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 N-CA-C 115.888 1.81 . . . . 0.0 115.888 173.035 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.409 ' HA ' ' HG2' ' A' ' 138' ' ' LYS . 1.0 OUTLIER -63.79 -42.77 97.67 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-O 117.223 -1.37 . . . . 0.0 113.051 167.123 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.71 -31.36 72.55 Favored 'General case' 0 CA--C 1.565 1.527 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 169.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.501 ' O ' ' HB3' ' A' ' 140' ' ' ALA . 8.5 mp -61.49 -55.48 30.59 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 125.52 1.528 . . . . 0.0 112.322 166.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.409 ' HG2' ' HA ' ' A' ' 135' ' ' GLU . 17.7 ptpt -64.01 -31.88 73.23 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 116.729 2.122 . . . . 0.0 116.729 170.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -66.44 -27.66 68.0 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 169.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.593 ' HB1' ' HA ' ' A' ' 144' ' ' VAL . . . -51.81 -42.67 62.68 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 115.826 1.787 . . . . 0.0 115.826 159.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 90.07 -129.03 9.52 Favored Glycine 0 C--N 1.349 1.275 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 165.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.0 t -72.26 -2.04 17.49 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 117.353 2.353 . . . . 0.0 117.353 168.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.97 107.56 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 -173.018 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.593 ' HA ' ' HB1' ' A' ' 140' ' ' ALA . 4.2 t -113.94 105.85 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 -169.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.432 ' HB2' ' HA ' ' A' ' 121' ' ' ASN . 99.2 mtt180 -89.65 92.11 8.94 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -178.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 22.1 mt -93.96 131.22 39.64 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 -175.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.428 ' O ' HD22 ' A' ' 118' ' ' LEU . 79.5 m-85 -120.15 128.39 53.38 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 104.686 -2.339 . . . . 0.0 104.686 -178.019 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -136.64 128.37 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.911 ' H ' HD11 ' A' ' 118' ' ' LEU . 63.9 mtm -103.65 142.34 34.49 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 127.016 2.126 . . . . 0.0 109.465 172.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -108.4 114.91 29.14 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.188 -1.369 . . . . 0.0 107.492 -175.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -126.9 127.13 44.43 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 174.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 86.0 tttt 63.03 81.52 0.23 Allowed Pre-proline 0 CA--C 1.563 1.469 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.879 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -49.7 -45.6 30.95 Favored 'Trans proline' 0 CA--C 1.57 2.309 0 C-N-CA 123.087 2.524 . . . . 0.0 116.384 172.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo . . . . . 0 C--N 1.376 1.985 0 C-N-CA 123.484 2.789 . . . . 0.0 112.586 176.669 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.554 1.098 0 CA-C-O 123.33 1.538 . . . . 0.0 110.398 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 22.7 tptp -151.28 121.94 7.47 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 113.632 -1.622 . . . . 0.0 107.833 170.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 6.0 ptmm? -75.7 109.41 9.26 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 113.918 -1.492 . . . . 0.0 111.26 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 26.3 m -81.43 126.97 32.28 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 123.287 1.518 . . . . 0.0 108.884 -178.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.94 106.17 18.33 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 113.331 -1.759 . . . . 0.0 106.891 -174.082 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.818 HG21 HG22 ' A' ' 134' ' ' VAL . 42.8 t . . . . . 0 C--O 1.251 1.179 0 N-CA-C 105.218 -2.142 . . . . 0.0 105.218 -178.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -124.56 136.98 54.42 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.542 -178.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -98.42 126.39 43.93 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.47 125.37 35.15 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 113.368 -1.742 . . . . 0.0 108.199 173.253 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.474 ' HB ' ' HB2' ' A' ' 146' ' ' LEU . 19.0 mt -126.61 131.83 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 -176.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.3 m -106.6 120.69 42.63 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 171.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.4 tp -124.93 145.57 49.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 113.39 -1.732 . . . . 0.0 107.739 176.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.517 ' HG3' ' HB1' ' A' ' 104' ' ' ALA . 2.7 pt-20 -75.77 144.0 41.67 Favored 'General case' 0 CA--C 1.559 1.314 0 O-C-N 121.218 -0.926 . . . . 0.0 110.71 173.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -85.67 99.7 11.48 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 172.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -67.96 164.45 46.59 Favored Glycine 0 CA--C 1.543 1.814 0 CA-C-O 122.367 0.982 . . . . 0.0 113.373 177.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -65.06 -48.44 73.8 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 114.997 1.48 . . . . 0.0 114.997 -171.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 90.9 p -76.64 -15.41 59.83 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 166.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 150.11 179.42 25.9 Favored Glycine 0 CA--C 1.538 1.469 0 CA-C-O 125.67 2.816 . . . . 0.0 108.459 -172.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.763 ' H ' HD22 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -74.92 -14.07 60.61 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 111.462 -2.369 . . . . 0.0 114.798 174.869 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.51 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 76.1 50.48 7.61 Favored Glycine 0 C--N 1.338 0.663 0 N-CA-C 116.229 1.251 . . . . 0.0 116.229 175.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.489 ' HE1' HD23 ' A' ' 137' ' ' LEU . 17.8 p90 -155.2 149.29 25.8 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 123.172 1.463 . . . . 0.0 108.036 173.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.431 ' O ' HG23 ' A' ' 96' ' ' ILE . 3.6 m -97.31 136.07 38.32 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.164 177.41 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.409 HD11 ' HB ' ' A' ' 134' ' ' VAL . 1.2 pt -110.13 123.74 66.29 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-O 121.95 0.881 . . . . 0.0 109.576 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.417 ' HB2' ' OG1' ' A' ' 97' ' ' THR . . . -77.7 177.42 8.14 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-O 124.292 1.996 . . . . 0.0 110.247 157.096 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' A' ' 85' ' ' ASN . . . -96.75 164.71 22.99 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-O 124.24 2.022 . . . . 0.0 115.582 -140.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -102.78 -166.88 26.19 Favored Glycine 0 CA--C 1.521 0.465 0 CA-C-N 110.543 -2.828 . . . . 0.0 112.364 -175.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.443 HG22 ' HB3' ' A' ' 92' ' ' PRO . 63.1 p -44.57 -42.51 7.38 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 118.014 2.598 . . . . 0.0 118.014 -177.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -88.19 -7.6 56.61 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 115.993 1.849 . . . . 0.0 115.993 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.409 ' O ' ' HA3' ' A' ' 81' ' ' GLY 0.267 4.4 t30 -151.99 58.59 2.71 Favored Pre-proline 0 CA--C 1.571 1.755 0 CA-C-O 116.667 -1.635 . . . . 0.0 107.632 -178.508 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -97.57 135.04 0.37 Allowed 'Trans proline' 0 C--N 1.373 1.83 0 CA-C-N 126.282 3.279 . . . . 0.0 111.538 -170.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.554 ' HB2' ' CG ' ' B' ' 1' ' ' TYR . 7.9 t-80 -101.91 -21.63 14.5 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 163.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.427 ' H ' HD12 ' A' ' 88' ' ' ILE . 0.3 OUTLIER -138.91 165.19 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 C-N-CA 127.171 2.188 . . . . 0.0 105.261 -164.152 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.54 169.3 34.21 Favored Glycine 0 CA--C 1.525 0.666 0 CA-C-N 112.644 -2.071 . . . . 0.0 110.889 -169.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -77.21 -11.05 59.77 Favored 'General case' 0 CA--C 1.566 1.592 0 CA-C-N 111.834 -2.183 . . . . 0.0 115.592 166.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.488 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 18.5 t70 -170.06 -58.59 0.0 OUTLIER Pre-proline 0 CA--C 1.568 1.65 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 169.41 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.488 ' HD3' ' HB3' ' A' ' 91' ' ' ASP . 23.6 Cg_endo -114.78 -125.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 123.389 2.726 . . . . 0.0 110.403 -175.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 53.1 m 75.71 134.72 0.05 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.991 1.316 . . . . 0.0 109.816 165.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.404 HG13 ' HB2' ' A' ' 133' ' ' ALA . 23.4 mm -96.14 124.44 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 105.812 -1.921 . . . . 0.0 105.812 -172.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -129.6 126.22 37.96 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -175.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.584 ' HB ' ' O ' ' A' ' 113' ' ' VAL 0.349 60.2 mt -66.44 129.6 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.287 0 CA-C-O 122.895 1.331 . . . . 0.0 108.648 174.002 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.417 ' OG1' ' HB2' ' A' ' 80' ' ' ALA . 4.4 m -87.69 -41.4 13.38 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 124.846 1.258 . . . . 0.0 113.325 171.217 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.439 ' HA ' HG11 ' A' ' 113' ' ' VAL . 94.3 mttt -140.4 160.95 38.86 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 124.174 1.94 . . . . 0.0 110.465 -175.03 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -114.4 109.93 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 102.365 -3.198 . . . . 0.0 102.365 174.111 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.254 1.5 mp -66.71 121.28 76.74 Favored Pre-proline 0 CA--C 1.564 1.516 0 CA-C-O 117.774 -1.107 . . . . 0.0 109.395 -177.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -63.22 138.05 64.58 Favored 'Trans proline' 0 C--N 1.364 1.387 0 C-N-CA 123.373 2.715 . . . . 0.0 113.387 172.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.45 -6.83 56.49 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 117.977 1.951 . . . . 0.0 117.977 -168.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.51 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -90.01 176.81 42.64 Favored Glycine 0 CA--C 1.537 1.439 0 CA-C-O 122.435 1.019 . . . . 0.0 113.025 174.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.517 ' HB1' ' HG3' ' A' ' 69' ' ' GLU . . . -67.52 -36.82 81.77 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 117.332 2.345 . . . . 0.0 117.332 -175.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.402 ' HB2' ' HD2' ' A' ' 77' ' ' PHE . . . -68.06 -35.37 78.1 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 116.37 1.989 . . . . 0.0 116.37 168.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.8 -31.72 69.79 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 115.524 1.675 . . . . 0.0 115.524 166.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.34 -61.61 1.77 Allowed 'General case' 0 CA--C 1.566 1.584 0 C-N-CA 124.581 1.152 . . . . 0.0 111.739 171.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -80.96 -56.94 3.78 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 124.901 1.281 . . . . 0.0 112.369 -173.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -81.42 -70.62 1.33 Allowed Glycine 0 CA--C 1.536 1.376 0 N-CA-C 114.302 0.481 . . . . 0.0 114.302 -169.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 48.0 mtt-85 57.04 50.23 12.42 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 125.035 1.334 . . . . 0.0 112.869 -163.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.423 HD23 ' H ' ' A' ' 111' ' ' LEU . 2.2 pt? -100.63 -162.12 0.92 Allowed 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 123.533 1.635 . . . . 0.0 108.293 -160.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 4.8 ptt180 -84.63 134.35 34.38 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 125.504 2.573 . . . . 0.0 107.077 162.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.584 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 34.8 m -65.78 -51.57 60.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-N 111.261 -2.699 . . . . 0.0 110.23 168.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -62.3 61.58 0.01 OUTLIER 'General case' 0 CA--C 1.575 1.92 0 CA-C-O 123.846 1.784 . . . . 0.0 115.425 171.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -113.4 112.58 23.89 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 100.292 -3.966 . . . . 0.0 100.292 -178.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.2 m -71.52 78.13 0.79 Allowed 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 113.026 -1.897 . . . . 0.0 109.982 -173.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 5.1 tp -73.86 109.97 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -174.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.733 HD21 ' HB3' ' A' ' 149' ' ' MET . 0.2 OUTLIER -110.0 -47.61 3.3 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 113.171 -1.831 . . . . 0.0 114.157 -175.224 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -116.87 136.5 52.9 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 172.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 14.0 p -124.86 123.73 66.33 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 170.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . 0.302 13.0 m120 77.85 -84.46 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 123.757 1.741 . . . . 0.0 108.921 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -151.57 -22.14 0.2 Allowed 'General case' 0 CA--C 1.574 1.882 0 CA-C-N 110.82 -2.9 . . . . 0.0 109.131 -176.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.416 HG12 HG13 ' A' ' 125' ' ' VAL . 2.3 t -68.41 136.71 25.91 Favored 'Isoleucine or valine' 0 C--N 1.363 1.155 0 C-N-CA 125.781 1.632 . . . . 0.0 110.224 -178.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -89.5 98.98 12.08 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 111.999 -2.364 . . . . 0.0 108.457 170.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.543 HG11 ' HA ' ' A' ' 133' ' ' ALA 0.26 0.4 OUTLIER -95.01 -98.36 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 173.233 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.513 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.287 16.1 ptt85 51.7 -92.39 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 116.855 2.169 . . . . 0.0 116.855 176.965 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.513 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 8.5 tt0 -77.65 64.54 2.97 Favored 'General case' 0 CA--C 1.56 1.34 0 CA-C-O 123.648 1.689 . . . . 0.0 110.967 167.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -139.02 167.6 20.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 2.7 m -58.84 134.46 56.91 Favored 'General case' 0 CA--C 1.557 1.222 0 CA-C-N 112.697 -2.047 . . . . 0.0 110.7 157.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -45.41 -32.72 2.23 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 117.499 2.407 . . . . 0.0 117.499 168.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.9 m -60.55 -43.12 97.58 Favored 'General case' 0 CA--C 1.556 1.203 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 175.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -69.67 -37.36 76.64 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 167.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.543 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -60.25 -59.27 5.68 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 170.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.409 ' HB ' HD11 ' A' ' 79' ' ' ILE . 0.9 OUTLIER -50.81 -42.44 23.03 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 N-CA-C 116.43 2.011 . . . . 0.0 116.43 171.521 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.65 -48.18 75.75 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 116.317 -1.801 . . . . 0.0 112.607 174.279 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.51 -28.51 66.11 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 117.23 2.307 . . . . 0.0 117.23 174.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.489 HD23 ' HE1' ' A' ' 77' ' ' PHE . 5.0 mp -54.98 -53.5 54.86 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.159 1.383 . . . . 0.0 113.402 163.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -73.41 -38.58 65.52 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 172.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -65.93 0.11 2.01 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 116.549 2.055 . . . . 0.0 116.549 169.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.527 ' HB1' ' HA ' ' A' ' 144' ' ' VAL . . . -56.8 -9.96 0.93 Allowed 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 120.315 3.45 . . . . 0.0 120.315 162.088 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 102.69 -105.25 2.72 Favored Glycine 0 C--N 1.342 0.886 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 161.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.6 m -113.43 -7.83 13.43 Favored 'General case' 0 CA--C 1.576 1.943 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 163.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.19 111.98 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 -165.269 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.542 HG21 HD12 ' A' ' 75' ' ' LEU . 3.4 t -96.94 116.81 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 112.676 -2.056 . . . . 0.0 107.553 -174.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -99.83 91.07 4.66 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 177.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.474 ' HB2' ' HB ' ' A' ' 66' ' ' ILE . 22.9 mt -83.16 135.16 34.9 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -128.55 126.15 39.75 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.3 p -132.48 116.69 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 -173.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.733 ' HB3' HD21 ' A' ' 118' ' ' LEU . 25.2 ttt -93.68 134.76 35.65 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 123.201 1.477 . . . . 0.0 108.516 168.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -82.41 155.88 24.44 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 112.493 -2.14 . . . . 0.0 110.774 173.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -72.95 151.17 41.97 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 112.219 -2.264 . . . . 0.0 109.727 177.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp 69.15 74.51 0.28 Allowed Pre-proline 0 N--CA 1.486 1.366 0 CA-C-O 118.062 -0.971 . . . . 0.0 109.084 -175.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -50.78 -48.15 22.01 Favored 'Trans proline' 0 CA--C 1.567 2.139 0 C-N-CA 122.975 2.45 . . . . 0.0 115.448 174.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo . . . . . 0 C--N 1.374 1.906 0 C-N-CA 123.452 2.768 . . . . 0.0 110.99 174.685 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' TYR . . . . . 0.554 ' CG ' ' HB2' ' A' ' 87' ' ' HIS . 0.4 OUTLIER . . . . . 0 CA--C 1.557 1.224 0 CA-C-O 122.227 1.013 . . . . 0.0 111.548 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -127.8 144.97 51.07 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 123.414 1.578 . . . . 0.0 107.707 165.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -101.26 126.69 48.03 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.03 176.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 98.4 m -97.38 130.94 44.47 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.031 172.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -76.66 138.98 40.38 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 113.964 -1.471 . . . . 0.0 109.564 170.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 6.0 p . . . . . 0 C--O 1.254 1.301 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.012 172.997 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.484 1.263 0 CA-C-O 121.261 0.553 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -119.86 138.7 53.24 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.21 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -109.5 145.53 36.11 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 113.99 -1.459 . . . . 0.0 108.848 176.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -107.52 121.57 44.9 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 112.658 -2.065 . . . . 0.0 106.095 -175.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.413 HG21 HD22 ' A' ' 111' ' ' LEU . 4.6 mp -130.64 128.26 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 -176.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.1 m -100.35 132.56 45.65 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 122.838 1.304 . . . . 0.0 107.547 163.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.444 HD11 ' HA ' ' A' ' 105' ' ' ALA . 9.6 tt -130.05 130.16 44.57 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 113.141 -1.845 . . . . 0.0 107.83 -169.241 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -83.78 124.04 30.5 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.613 ' HG3' ' HB3' ' A' ' 75' ' ' LEU . 29.6 ttt180 -74.39 -166.0 0.39 Allowed 'General case' 0 CA--C 1.573 1.858 0 CA-C-O 122.222 1.011 . . . . 0.0 112.327 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.559 ' H ' ' HG2' ' A' ' 70' ' ' ARG . . . -107.17 -107.64 3.21 Favored Glycine 0 CA--C 1.541 1.699 0 N-CA-C 109.964 -1.255 . . . . 0.0 109.964 168.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -121.9 -82.02 0.64 Allowed 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.53 0.732 . . . . 0.0 109.182 -174.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 89.0 p -100.31 -18.58 16.74 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 125.386 1.474 . . . . 0.0 114.776 173.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -113.68 162.3 12.42 Favored Glycine 0 CA--C 1.544 1.872 0 CA-C-O 125.566 2.759 . . . . 0.0 111.33 167.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.615 HD21 HG22 ' B' ' 6' ' ' VAL . 0.0 OUTLIER -117.86 -7.27 10.96 Favored 'General case' 0 CA--C 1.56 1.355 0 CA-C-N 109.41 -3.395 . . . . 0.0 111.465 172.155 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.443 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 65.18 51.67 47.94 Favored Glycine 0 C--N 1.346 1.11 0 N-CA-C 117.279 1.671 . . . . 0.0 117.279 166.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.482 ' CD1' HD13 ' A' ' 96' ' ' ILE . 1.7 p90 -155.3 157.95 38.0 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 112.929 -1.635 . . . . 0.0 107.376 173.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.431 ' HB2' ' HB3' ' A' ' 98' ' ' LYS . 4.0 m -122.28 126.87 49.07 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 122.484 1.135 . . . . 0.0 109.341 -173.196 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.622 HG22 HG12 ' A' ' 96' ' ' ILE . 2.0 pt -91.33 127.77 43.5 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-N 113.444 -1.707 . . . . 0.0 109.309 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -83.87 -175.54 5.86 Favored 'General case' 0 CA--C 1.555 1.167 0 CA-C-O 123.641 1.686 . . . . 0.0 110.291 156.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.14 157.35 24.08 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 123.161 1.423 . . . . 0.0 116.58 -140.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -108.84 -169.36 20.84 Favored Glycine 0 N--CA 1.466 0.663 0 CA-C-N 111.914 -2.143 . . . . 0.0 114.289 178.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.585 HG22 ' HB2' ' A' ' 92' ' ' PRO . 18.2 p -43.69 -44.59 6.58 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 117.952 2.575 . . . . 0.0 117.952 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.412 ' HB3' HG23 ' A' ' 129' ' ' THR . 35.6 t70 -85.55 -15.24 43.32 Favored 'General case' 0 CA--C 1.564 1.506 0 N-CA-C 115.915 1.82 . . . . 0.0 115.915 177.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -150.64 73.92 8.8 Favored Pre-proline 0 CA--C 1.562 1.41 0 N-CA-C 103.893 -2.632 . . . . 0.0 103.893 -176.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -107.59 144.09 0.07 OUTLIER 'Trans proline' 0 C--N 1.374 1.915 0 CA-C-N 124.656 2.699 . . . . 0.0 112.446 -169.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -65.38 -26.08 67.84 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 114.695 1.369 . . . . 0.0 114.695 161.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -142.74 121.13 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 N-CA-C 105.253 -2.128 . . . . 0.0 105.253 -168.004 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -80.55 2.64 77.46 Favored Glycine 0 CA--C 1.555 2.59 0 N-CA-C 117.53 1.772 . . . . 0.0 117.53 162.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -87.39 -12.99 44.64 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 175.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -159.61 96.79 1.6 Allowed Pre-proline 0 CA--C 1.553 1.089 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 173.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.585 ' HB2' HG22 ' A' ' 83' ' ' THR . 19.1 Cg_endo -61.34 101.43 0.2 Allowed 'Trans proline' 0 CA--C 1.551 1.341 0 C-N-CA 122.471 2.114 . . . . 0.0 112.503 165.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 74.7 m -150.67 139.33 20.67 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 -179.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.49 HG13 ' HB2' ' A' ' 133' ' ' ALA . 31.5 mm -79.65 129.76 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 175.059 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.484 ' HA ' ' O ' ' A' ' 115' ' ' ASP 0.276 4.9 p90 -135.49 122.06 20.77 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 113.824 -1.534 . . . . 0.0 110.994 -177.067 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.622 HG12 HG22 ' A' ' 79' ' ' ILE . 71.0 mt -74.75 109.86 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 168.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 12.8 m -94.64 -14.62 24.73 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 114.978 -1.01 . . . . 0.0 113.714 172.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.431 ' HB3' ' HB2' ' A' ' 78' ' ' SER . 29.5 tttp -139.53 150.12 44.72 Favored 'General case' 0 CA--C 1.557 1.243 0 CA-C-O 124.356 2.027 . . . . 0.0 110.343 -175.247 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -117.2 125.02 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 N-CA-C 103.924 -2.621 . . . . 0.0 103.924 174.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.408 HD11 ' HB3' ' B' ' 7' ' ' BAL . 1.5 mp -74.14 133.55 78.24 Favored Pre-proline 0 CA--C 1.566 1.572 0 CA-C-O 118.518 -0.754 . . . . 0.0 109.324 171.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.5 132.87 40.0 Favored 'Trans proline' 0 CA--C 1.554 1.512 0 C-N-CA 123.301 2.668 . . . . 0.0 113.687 171.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.19 11.93 85.08 Favored Glycine 0 CA--C 1.546 2.028 0 N-CA-C 117.383 1.713 . . . . 0.0 117.383 -164.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.443 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -84.09 170.75 47.67 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-O 123.086 1.381 . . . . 0.0 114.244 177.049 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.21 -43.98 89.79 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 112.286 -1.957 . . . . 0.0 115.387 178.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.444 ' HA ' HD11 ' A' ' 68' ' ' LEU . . . -67.17 -32.93 74.35 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 118.496 2.776 . . . . 0.0 118.496 173.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.37 -39.01 91.75 Favored 'General case' 0 CA--C 1.567 1.598 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 165.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -67.32 -60.93 2.18 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.378 1.471 . . . . 0.0 113.042 173.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -58.58 -45.07 89.81 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -172.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -174.65 -136.37 2.24 Favored Glycine 0 C--N 1.34 0.757 0 CA-C-O 122.889 1.271 . . . . 0.0 110.331 166.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -145.27 76.42 1.48 Allowed 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 104.756 -2.313 . . . . 0.0 104.756 -176.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.413 HD22 HG21 ' A' ' 66' ' ' ILE . 0.7 OUTLIER -90.87 5.83 46.94 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 164.689 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . 0.351 78.1 mtp180 89.26 168.92 0.04 OUTLIER 'General case' 0 C--N 1.354 0.804 0 CA-C-O 125.385 2.516 . . . . 0.0 110.496 -159.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.433 ' HB ' HG22 ' A' ' 96' ' ' ILE 0.344 15.5 m -22.6 -68.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 CA-C-N 111.137 -2.756 . . . . 0.0 114.221 146.813 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.483 ' HB2' HD12 ' A' ' 96' ' ' ILE . 2.7 t30 158.76 -28.15 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 129.047 2.939 . . . . 0.0 106.817 168.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.484 ' O ' ' HA ' ' A' ' 95' ' ' PHE 0.278 8.3 t70 46.48 -125.8 1.45 Allowed 'General case' 0 C--N 1.36 1.057 0 C-N-CA 126.111 1.764 . . . . 0.0 109.127 -169.033 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 48.5 m -72.61 74.67 1.08 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.411 1.084 . . . . 0.0 113.246 -169.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.0 tp -67.68 103.95 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 171.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.568 ' HA ' ' HB3' ' A' ' 126' ' ' ARG 0.293 1.0 OUTLIER -91.18 -54.96 3.72 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 113.104 -1.862 . . . . 0.0 113.145 177.632 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.427 ' H ' HD12 ' A' ' 118' ' ' LEU . 20.2 m-85 -118.28 138.92 52.04 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 105.358 -2.089 . . . . 0.0 105.358 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.8 p -127.28 114.9 38.66 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 170.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.456 ' HA ' ' HB2' ' A' ' 145' ' ' ARG 0.352 9.8 m120 80.05 -83.03 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 123.489 1.614 . . . . 0.0 109.7 -177.704 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -148.3 -25.68 0.34 Allowed 'General case' 0 CA--C 1.566 1.579 0 CA-C-N 111.126 -2.761 . . . . 0.0 109.411 -178.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.426 ' CG1' HG13 ' A' ' 125' ' ' VAL . 2.3 t -61.75 135.72 26.02 Favored 'Isoleucine or valine' 0 C--N 1.362 1.119 0 C-N-CA 125.385 1.474 . . . . 0.0 110.286 174.054 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -97.92 72.29 2.22 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 112.117 -2.311 . . . . 0.0 109.852 175.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.586 HG11 ' HA ' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -63.21 -86.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 116.243 -1.837 . . . . 0.0 110.401 176.73 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.786 ' HD2' ' H ' ' A' ' 127' ' ' GLU 0.325 0.1 OUTLIER 49.22 -98.58 0.05 Allowed 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 120.269 1.395 . . . . 0.0 113.353 171.827 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.786 ' H ' ' HD2' ' A' ' 126' ' ' ARG . 10.2 mt-10 -80.64 69.13 7.08 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 126.695 1.998 . . . . 0.0 110.414 174.207 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.8 p -139.11 169.3 17.61 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 CA-C-N 112.87 -1.968 . . . . 0.0 106.093 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.422 HG22 ' H ' ' A' ' 131' ' ' SER . 46.8 m -60.15 135.21 57.65 Favored 'General case' 0 CA--C 1.558 1.288 0 CA-C-N 113.16 -1.836 . . . . 0.0 110.624 157.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.456 ' HA ' HD12 ' A' ' 94' ' ' ILE . 3.6 p-80 -46.15 -35.31 4.94 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 170.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.467 ' HA ' HG12 ' A' ' 134' ' ' VAL . 5.2 m -62.69 -43.04 99.81 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 125.311 1.444 . . . . 0.0 114.761 176.244 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.16 -37.33 87.07 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 169.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.586 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -69.66 -50.93 39.37 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 116.466 2.024 . . . . 0.0 116.466 172.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.467 HG12 ' HA ' ' A' ' 131' ' ' SER . 3.3 p -52.17 -42.67 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.475 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 170.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -72.82 -38.46 67.15 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 115.506 -2.188 . . . . 0.0 113.503 174.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.17 -34.05 77.16 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 116.937 2.199 . . . . 0.0 116.937 170.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.448 HD21 HD11 ' A' ' 96' ' ' ILE . 7.8 mp -55.59 -49.13 73.59 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.491 1.516 . . . . 0.0 114.939 162.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -68.05 -35.74 78.73 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 168.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.49 -20.76 66.12 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 173.114 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.556 ' HB1' ' HA ' ' A' ' 144' ' ' VAL . . . -52.86 -11.67 0.25 Allowed 'General case' 0 CA--C 1.561 1.377 0 N-CA-C 118.527 2.788 . . . . 0.0 118.527 161.257 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.504 ' O ' ' HD3' ' A' ' 70' ' ' ARG . . . 79.97 -143.29 25.16 Favored Glycine 0 C--N 1.347 1.188 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 174.224 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 17.3 m -71.34 -4.52 26.56 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 116.691 2.108 . . . . 0.0 116.691 173.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.07 107.81 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 -170.315 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.556 ' HA ' ' HB1' ' A' ' 140' ' ' ALA . 3.5 t -93.66 114.84 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 113.797 -1.547 . . . . 0.0 108.24 -174.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.456 ' HB2' ' HA ' ' A' ' 121' ' ' ASN . 75.0 mtt-85 -96.39 94.82 7.65 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 -177.214 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 34.0 mt -99.58 138.82 36.14 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 122.069 0.938 . . . . 0.0 109.043 -170.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -128.78 115.82 18.54 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.24 129.15 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -173.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.426 ' HB2' HD21 ' A' ' 118' ' ' LEU . 28.0 ttt -91.31 148.69 22.15 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-O 123.307 1.527 . . . . 0.0 112.503 164.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 -97.88 114.44 26.52 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 171.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -93.16 144.25 25.47 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 113.952 -1.476 . . . . 0.0 110.555 -175.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -93.85 106.41 21.63 Favored Pre-proline 0 CA--C 1.56 1.359 0 CA-C-N 113.522 -1.672 . . . . 0.0 107.734 169.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -49.96 -46.06 29.71 Favored 'Trans proline' 0 CA--C 1.57 2.316 0 C-N-CA 123.546 2.831 . . . . 0.0 116.689 171.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 C--N 1.374 1.907 0 C-N-CA 123.55 2.833 . . . . 0.0 111.114 175.295 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 1.1 p90 . . . . . 0 N--CA 1.478 0.961 0 CA-C-O 122.977 1.37 . . . . 0.0 112.828 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.554 ' HA ' ' HE3' ' B' ' 2' ' ' LYS . 0.3 OUTLIER -136.6 144.86 44.34 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 112.738 -2.028 . . . . 0.0 110.888 166.919 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.415 ' HB3' ' HE3' ' B' ' 3' ' ' LYS . 10.0 ttpp -92.24 109.97 21.35 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 113.534 -1.667 . . . . 0.0 108.481 178.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 98.7 m -88.38 131.93 34.65 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 122.401 1.096 . . . . 0.0 108.784 175.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.11 155.48 32.36 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 113.848 -1.524 . . . . 0.0 109.971 175.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.615 HG22 HD21 ' A' ' 75' ' ' LEU . 7.7 p . . . . . 0 C--O 1.247 0.957 0 N-CA-C 104.392 -2.447 . . . . 0.0 104.392 -171.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 7' ' ' BAL . . . . . 0.408 ' HB3' HD11 ' A' ' 100' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 . . . . . 0 N--CA 1.481 1.1 0 CA-C-O 121.808 0.813 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -130.05 141.1 50.76 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 124.126 0.97 . . . . 0.0 109.511 168.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -126.66 135.49 51.24 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 122.099 0.952 . . . . 0.0 108.846 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.27 120.62 42.85 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.059 -174.269 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.6 mp -135.1 125.32 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 -172.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.9 m -98.8 122.53 42.16 Favored 'General case' 0 CA--C 1.557 1.213 0 CA-C-O 122.338 1.066 . . . . 0.0 108.302 173.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 mp -118.26 127.21 53.51 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.576 1.55 . . . . 0.0 108.594 -174.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -100.66 129.09 46.53 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-O 121.223 0.535 . . . . 0.0 110.154 -178.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.751 ' HB2' ' HB2' ' A' ' 104' ' ' ALA . 9.3 tpt180 -157.28 -107.18 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 176.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.92 -162.82 54.05 Favored Glycine 0 C--N 1.352 1.42 0 C-N-CA 124.937 1.256 . . . . 0.0 111.614 -168.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 74.57 -89.27 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 113.375 -1.413 . . . . 0.0 111.18 170.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 80.4 p -86.42 -18.19 32.39 Favored 'General case' 0 CA--C 1.561 1.386 0 N-CA-C 116.476 2.028 . . . . 0.0 116.476 174.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 164.03 -146.01 11.03 Favored Glycine 0 CA--C 1.532 1.127 0 N-CA-C 107.475 -2.25 . . . . 0.0 107.475 179.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.607 ' HB2' HG13 ' B' ' 6' ' ' VAL . 0.0 OUTLIER -127.29 -34.63 2.27 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 113.556 -1.322 . . . . 0.0 111.753 -179.476 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.553 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 103.14 41.2 2.29 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 115.848 1.099 . . . . 0.0 115.848 164.027 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -158.32 127.2 5.56 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 123.425 1.583 . . . . 0.0 107.435 -175.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.3 m -87.56 137.45 32.32 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 121.246 -0.908 . . . . 0.0 111.126 174.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.451 HD11 ' HB ' ' A' ' 134' ' ' VAL . 2.5 pp -118.02 130.25 73.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 114.403 -1.271 . . . . 0.0 107.978 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -92.38 -169.68 2.29 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-O 123.288 1.518 . . . . 0.0 109.871 160.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.69 159.41 24.78 Favored Glycine 0 CA--C 1.537 1.459 0 CA-C-O 123.551 1.64 . . . . 0.0 115.783 -140.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.11 -162.26 21.87 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 111.606 -2.297 . . . . 0.0 112.316 -176.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 67.8 p -54.02 -41.11 67.65 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 117.373 2.361 . . . . 0.0 117.373 -177.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -75.51 -15.64 60.37 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 116.469 2.025 . . . . 0.0 116.469 173.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -152.77 86.05 4.29 Favored Pre-proline 0 CA--C 1.56 1.343 0 N-CA-C 101.585 -3.487 . . . . 0.0 101.585 -177.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -99.41 125.02 0.15 Allowed 'Trans proline' 0 CA--C 1.547 1.126 0 CA-C-N 124.241 2.55 . . . . 0.0 110.533 -170.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 60.7 t60 -103.82 -33.64 8.82 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 174.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.66 HD13 ' HB2' ' A' ' 95' ' ' PHE . 0.2 OUTLIER -156.7 157.9 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 CA-C-O 123.596 1.665 . . . . 0.0 108.338 -152.334 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 112.32 -129.59 9.11 Favored Glycine 0 C--N 1.337 0.595 0 CA-C-N 112.398 -2.183 . . . . 0.0 109.821 174.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -96.03 -6.43 38.79 Favored 'General case' 0 CA--C 1.572 1.8 0 CA-C-N 113.279 -1.461 . . . . 0.0 114.905 161.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.451 ' HB3' ' HD3' ' A' ' 92' ' ' PRO 0.318 32.7 t70 155.67 -72.63 0.0 OUTLIER Pre-proline 0 CA--C 1.559 1.301 0 N-CA-C 102.698 -3.075 . . . . 0.0 102.698 -179.171 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.451 ' HD3' ' HB3' ' A' ' 91' ' ' ASP . 92.2 Cg_endo -93.45 -141.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.369 1.63 0 C-N-CA 123.338 2.692 . . . . 0.0 110.805 -174.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 43.6 m 70.7 144.04 0.06 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 122.667 1.222 . . . . 0.0 109.204 175.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.545 HG13 ' HB2' ' A' ' 133' ' ' ALA . 10.1 mm -91.78 126.05 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 -174.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.66 ' HB2' HD13 ' A' ' 88' ' ' ILE . 29.5 m-85 -124.83 142.1 51.66 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 -178.017 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.429 HG22 ' HB ' ' A' ' 113' ' ' VAL 0.254 46.9 mt -85.32 119.52 34.08 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.541 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 175.023 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 91.8 m -85.92 -33.21 21.25 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 117.806 -1.093 . . . . 0.0 113.476 169.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . 0.285 0.0 OUTLIER -141.01 163.66 32.38 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-O 124.779 2.228 . . . . 0.0 111.324 179.218 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.495 HG22 ' HB3' ' A' ' 105' ' ' ALA . 0.9 OUTLIER -104.18 119.87 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 166.323 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 24.0 mm -65.68 127.77 93.3 Favored Pre-proline 0 CA--C 1.566 1.58 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.164 178.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.74 129.06 32.62 Favored 'Trans proline' 0 C--N 1.365 1.406 0 C-N-CA 123.606 2.871 . . . . 0.0 115.286 -178.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.49 11.39 80.09 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 118.54 2.176 . . . . 0.0 118.54 -170.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.553 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -92.35 -175.92 41.9 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 124.546 1.069 . . . . 0.0 113.937 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.751 ' HB2' ' HB2' ' A' ' 70' ' ' ARG . . . -63.4 -51.96 63.62 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 117.146 2.276 . . . . 0.0 117.146 -171.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.495 ' HB3' HG22 ' A' ' 99' ' ' ILE . . . -56.04 -33.19 64.72 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 175.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -67.09 -44.74 79.23 Favored 'General case' 0 CA--C 1.563 1.457 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 169.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.33 -54.55 6.33 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 123.638 0.775 . . . . 0.0 112.306 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -59.54 -42.16 91.7 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -179.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -161.7 -149.24 5.57 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-O 124.296 2.053 . . . . 0.0 113.536 171.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 38.1 mtm105 -146.71 60.7 1.21 Allowed 'General case' 0 CA--C 1.552 1.055 0 CA-C-N 110.446 -2.877 . . . . 0.0 105.797 -177.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.509 HD23 ' H ' ' A' ' 111' ' ' LEU . 1.3 pt? -60.92 -29.17 69.45 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 175.199 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 18.0 mtp-105 67.63 127.91 0.02 OUTLIER 'General case' 0 C--N 1.351 0.654 0 CA-C-O 124.732 2.206 . . . . 0.0 109.016 -162.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.429 ' HB ' HG22 ' A' ' 96' ' ' ILE 0.264 27.7 m -48.41 -65.86 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 109.178 -3.646 . . . . 0.0 110.56 -168.216 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -63.54 80.97 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.238 0 CA-C-O 124.688 2.185 . . . . 0.0 113.604 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -104.52 -170.07 1.71 Allowed 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 110.264 -3.153 . . . . 0.0 106.128 158.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.401 ' HB2' ' HB3' ' A' ' 149' ' ' MET . 40.0 m -127.81 79.61 1.91 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 176.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.42 HG23 ' HB ' ' A' ' 94' ' ' ILE . 7.5 tp -56.45 116.55 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-O 121.997 0.904 . . . . 0.0 110.666 -178.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.608 HD23 ' HB2' ' A' ' 149' ' ' MET . 3.0 pp -110.19 -47.85 3.25 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 116.785 2.143 . . . . 0.0 116.785 -174.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.453 ' HB2' ' HB2' ' A' ' 147' ' ' TYR . 47.9 m-85 -126.64 138.07 53.38 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 177.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.465 HG21 HD12 ' A' ' 137' ' ' LEU . 3.1 t -128.44 109.8 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 100.543 -3.873 . . . . 0.0 100.543 175.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.522 ' HA ' ' HG3' ' A' ' 145' ' ' ARG 0.378 9.2 m120 83.3 -88.48 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 122.921 1.343 . . . . 0.0 109.389 179.86 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -145.26 -13.82 0.52 Allowed 'General case' 0 CA--C 1.567 1.627 0 CA-C-N 111.401 -2.636 . . . . 0.0 110.59 175.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.509 HG12 HG13 ' A' ' 125' ' ' VAL . 2.3 t -67.58 133.03 32.18 Favored 'Isoleucine or valine' 0 C--N 1.359 0.994 0 C-N-CA 125.431 1.492 . . . . 0.0 109.997 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -84.19 98.09 9.75 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 112.476 -2.147 . . . . 0.0 109.599 172.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.601 HG11 ' HA ' ' A' ' 133' ' ' ALA 0.258 2.0 m -97.51 -103.26 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-O 116.281 -1.818 . . . . 0.0 106.97 173.173 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.536 ' HB3' ' HA ' ' A' ' 118' ' ' LEU 0.289 13.2 ptt180 50.4 -93.33 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 120.217 1.371 . . . . 0.0 114.237 179.585 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.479 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 2.4 tt0 -79.25 68.68 5.3 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-O 123.425 1.583 . . . . 0.0 111.031 173.189 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.8 p -144.3 168.89 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.96 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 -173.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.419 HG22 ' H ' ' A' ' 131' ' ' SER . 27.4 m -61.76 130.86 47.81 Favored 'General case' 0 CA--C 1.559 1.3 0 CA-C-N 113.119 -1.855 . . . . 0.0 110.038 156.334 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.419 ' HA ' HD12 ' A' ' 94' ' ' ILE . 2.5 p80 -47.7 -29.44 3.05 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 118.587 2.81 . . . . 0.0 118.587 169.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.519 ' HA ' HG12 ' A' ' 134' ' ' VAL . 8.1 m -63.09 -37.91 89.07 Favored 'General case' 0 CA--C 1.565 1.543 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 171.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -70.25 -36.13 74.27 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 165.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.601 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -61.19 -55.61 30.26 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 114.695 1.368 . . . . 0.0 114.695 169.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.519 HG12 ' HA ' ' A' ' 131' ' ' SER . 2.3 p -53.1 -40.55 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.162 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 169.056 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -58.17 -52.19 66.59 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 116.311 -1.804 . . . . 0.0 112.691 168.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.68 -35.62 74.83 Favored 'General case' 0 CA--C 1.561 1.391 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 173.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.513 HD23 HG11 ' B' ' 6' ' ' VAL . 9.6 mp -54.46 -53.92 47.86 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 125.296 1.438 . . . . 0.0 113.813 164.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.437 ' HA ' HD21 ' A' ' 75' ' ' LEU . 88.6 mttt -68.41 -33.54 74.4 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 116.507 2.04 . . . . 0.0 116.507 172.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -64.11 -32.19 73.66 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 115.17 1.544 . . . . 0.0 115.17 171.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.593 ' HB1' ' HA ' ' A' ' 144' ' ' VAL . . . -52.91 -36.57 59.69 Favored 'General case' 0 CA--C 1.557 1.214 0 N-CA-C 117.234 2.309 . . . . 0.0 117.234 163.216 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.12 -133.61 12.0 Favored Glycine 0 C--N 1.348 1.214 0 N-CA-C 111.644 -0.582 . . . . 0.0 111.644 167.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.3 t -66.4 -7.97 22.7 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 118.756 2.873 . . . . 0.0 118.756 170.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.32 107.84 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 -172.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.593 ' HA ' ' HB1' ' A' ' 140' ' ' ALA . 4.3 t -106.31 110.47 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 113.006 -1.907 . . . . 0.0 107.539 -173.105 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.522 ' HG3' ' HA ' ' A' ' 121' ' ' ASN . 9.8 ptt180 -101.77 91.46 4.41 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.422 HD23 HG13 ' A' ' 120' ' ' VAL . 78.0 mt -89.43 144.51 26.0 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 113.524 -1.671 . . . . 0.0 108.975 -175.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.453 ' HB2' ' HB2' ' A' ' 119' ' ' PHE . 88.9 m-85 -133.15 115.97 15.7 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 103.446 -2.798 . . . . 0.0 103.446 173.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 19.6 m -119.57 155.39 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -170.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.608 ' HB2' HD23 ' A' ' 118' ' ' LEU . 60.7 ttp -102.06 132.59 47.84 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 122.494 1.14 . . . . 0.0 110.095 172.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -101.65 114.32 28.26 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 113.521 -1.672 . . . . 0.0 107.106 164.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -80.06 130.92 35.63 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.247 -174.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt 75.96 124.96 0.03 OUTLIER Pre-proline 0 CA--C 1.555 1.152 0 CA-C-N 114.131 -1.395 . . . . 0.0 111.091 176.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -65.01 144.72 83.36 Favored 'Trans proline' 0 CA--C 1.568 2.199 0 C-N-CA 122.362 2.041 . . . . 0.0 113.491 173.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo . . . . . 0 CA--C 1.552 1.396 0 C-N-CA 123.26 2.64 . . . . 0.0 112.641 176.718 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 1.3 p90 . . . . . 0 CA--C 1.562 1.408 0 CA-C-O 122.313 1.054 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -133.72 125.21 28.1 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 123.141 1.448 . . . . 0.0 107.852 171.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 3.0 ttpt -96.76 133.56 41.18 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 113.872 -1.513 . . . . 0.0 108.131 175.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.3 150.14 27.02 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-O 123.121 1.439 . . . . 0.0 109.076 177.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -109.03 126.29 52.99 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 -176.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.607 HG13 ' HB2' ' A' ' 75' ' ' LEU 0.321 0.5 OUTLIER . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 173.7 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 . . . . . 0 N--CA 1.474 0.774 0 CA-C-O 121.689 0.757 . . . . 0.0 111.891 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . 0.251 26.9 p90 -90.05 128.17 36.23 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.077 173.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -124.32 131.07 53.5 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -167.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -83.44 123.99 30.24 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 113.888 -1.505 . . . . 0.0 110.906 171.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.485 HG13 ' HB2' ' A' ' 146' ' ' LEU . 7.9 pt -140.33 118.12 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 -168.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.0 m -97.1 131.18 44.13 Favored 'General case' 0 CA--C 1.554 1.109 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 173.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.423 ' HG ' ' HB1' ' A' ' 104' ' ' ALA . 1.3 mp -125.35 131.53 52.98 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.176 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -115.92 124.46 50.63 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -174.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.684 ' HB2' ' HB2' ' A' ' 104' ' ' ALA . 15.9 tpt180 -158.16 -109.27 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 176.255 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.89 -173.49 53.58 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-O 122.429 1.016 . . . . 0.0 113.771 -169.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . 0.267 56.3 t-20 71.6 -93.3 0.03 OUTLIER 'General case' 0 CA--C 1.56 1.365 0 CA-C-N 113.376 -1.412 . . . . 0.0 111.366 174.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.8 m -79.02 -18.75 53.04 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 115.91 1.818 . . . . 0.0 115.91 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 178.8 -151.1 10.04 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 108.454 -1.858 . . . . 0.0 108.454 172.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.502 HD21 HG21 ' A' ' 144' ' ' VAL . 0.8 OUTLIER -134.41 -30.94 1.11 Allowed 'General case' 0 CA--C 1.559 1.32 0 CA-C-N 113.468 -1.366 . . . . 0.0 112.497 169.927 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.436 ' CA ' ' HA3' ' A' ' 103' ' ' GLY . . . 106.19 15.79 16.8 Favored Glycine 0 N--CA 1.479 1.532 0 N-CA-C 121.118 3.207 . . . . 0.0 121.118 172.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -150.05 143.62 25.25 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 124.483 2.087 . . . . 0.0 108.857 -177.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.0 m -111.91 128.38 56.13 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 112.357 -2.202 . . . . 0.0 108.422 178.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.5 pp -109.2 126.72 66.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.495 -1.23 . . . . 0.0 109.609 -173.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -83.36 -171.89 3.84 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-O 123.401 1.572 . . . . 0.0 110.715 162.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -98.9 163.82 20.5 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-O 123.999 1.888 . . . . 0.0 115.829 -143.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -111.45 -164.06 17.84 Favored Glycine 0 N--CA 1.464 0.553 0 CA-C-N 110.854 -2.673 . . . . 0.0 111.086 -172.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.495 HG22 ' HB2' ' A' ' 92' ' ' PRO . 11.3 p -51.64 -40.41 59.92 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 117.714 2.487 . . . . 0.0 117.714 -173.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -80.26 -17.54 51.9 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 171.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . 0.303 6.3 t30 -138.2 54.76 7.66 Favored Pre-proline 0 CA--C 1.567 1.633 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -174.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -100.44 124.79 0.12 Allowed 'Trans proline' 0 C--N 1.365 1.442 0 CA-C-N 124.804 2.751 . . . . 0.0 111.312 -157.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -106.85 -35.07 7.05 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 174.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.2 mp -103.01 135.26 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -153.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.68 -116.36 5.66 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-N 114.311 -1.313 . . . . 0.0 112.29 165.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -89.37 8.08 32.53 Favored 'General case' 0 CA--C 1.563 1.479 0 N-CA-C 116.411 2.004 . . . . 0.0 116.411 172.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.43 ' HB2' ' HD3' ' A' ' 92' ' ' PRO 0.451 21.0 m-20 103.68 -81.19 0.0 OUTLIER Pre-proline 0 CA--C 1.57 1.737 0 C-N-CA 126.224 1.809 . . . . 0.0 109.999 -174.869 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.495 ' HB2' HG22 ' A' ' 83' ' ' THR . 85.9 Cg_endo -92.4 86.36 0.22 Allowed 'Trans proline' 0 C--N 1.366 1.481 0 C-N-CA 123.765 2.976 . . . . 0.0 114.161 -159.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 58.5 m -161.17 132.18 5.36 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.467 HG13 ' HB2' ' A' ' 133' ' ' ALA . 13.9 mm -82.29 124.88 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 -179.218 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -120.89 155.28 34.52 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 113.91 -1.495 . . . . 0.0 108.78 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.437 ' HB ' ' O ' ' A' ' 113' ' ' VAL . 83.9 mt -92.62 117.39 35.88 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.629 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 158.043 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.407 ' CG2' ' HG3' ' B' ' 3' ' ' LYS . 10.1 t -86.04 -31.98 21.68 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 115.378 1.621 . . . . 0.0 115.378 169.219 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.544 ' HA ' HG11 ' A' ' 113' ' ' VAL 0.342 0.0 OUTLIER -143.54 164.4 30.47 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 124.618 2.151 . . . . 0.0 110.707 177.456 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.6 HD13 ' HA ' ' A' ' 111' ' ' LEU . 0.8 OUTLIER -104.55 132.48 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 174.362 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.259 43.9 mt -87.75 117.21 68.21 Favored Pre-proline 0 CA--C 1.561 1.397 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 172.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.13 146.61 80.4 Favored 'Trans proline' 0 C--N 1.369 1.654 0 C-N-CA 123.673 2.915 . . . . 0.0 115.722 176.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.76 -8.84 47.45 Favored Glycine 0 CA--C 1.544 1.872 0 N-CA-C 117.649 1.82 . . . . 0.0 117.649 -170.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.436 ' HA3' ' CA ' ' A' ' 76' ' ' GLY . . . -96.54 -168.88 34.11 Favored Glycine 0 CA--C 1.539 1.564 0 CA-C-N 119.171 1.486 . . . . 0.0 115.098 -177.175 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.684 ' HB2' ' HB2' ' A' ' 70' ' ' ARG . . . -64.28 -47.5 79.29 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -175.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.59 -37.92 88.11 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 178.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.25 -44.85 90.52 Favored 'General case' 0 CA--C 1.564 1.489 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 168.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -66.62 -63.13 1.13 Allowed 'General case' 0 CA--C 1.564 1.498 0 C-N-CA 125.323 1.449 . . . . 0.0 113.136 178.296 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -65.53 -46.82 78.11 Favored 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 124.651 1.18 . . . . 0.0 113.69 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 123.5 57.6 0.19 Allowed Glycine 0 N--CA 1.479 1.537 0 C-N-CA 123.689 0.661 . . . . 0.0 113.206 174.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -116.51 40.61 2.86 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.703 1.201 . . . . 0.0 112.205 163.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.6 ' HA ' HD13 ' A' ' 99' ' ' ILE . 3.1 pp -58.54 -28.39 65.43 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 117.739 2.496 . . . . 0.0 117.739 167.14 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 59.0 ttt180 -80.78 89.91 5.82 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 124.391 2.043 . . . . 0.0 106.833 164.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.544 HG11 ' HA ' ' A' ' 98' ' ' LYS . 7.1 m -54.99 -60.05 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 110.097 -3.229 . . . . 0.0 111.307 -165.165 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 -54.27 43.73 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 119.819 3.266 . . . . 0.0 119.819 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.5 ' HB3' HG11 ' A' ' 148' ' ' VAL . 41.2 m-20 -76.91 105.78 8.19 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 165.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.9 m -73.49 90.63 1.74 Allowed 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 113.912 -1.494 . . . . 0.0 108.784 -172.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.1 tp -66.76 118.18 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 CA-C-O 122.295 1.045 . . . . 0.0 110.312 -171.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.592 ' HA ' ' HB3' ' A' ' 126' ' ' ARG 0.328 3.1 pp -99.41 -51.31 3.82 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 112.424 -2.171 . . . . 0.0 115.046 178.29 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -133.76 140.84 47.21 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 -176.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.442 HG21 HD12 ' A' ' 137' ' ' LEU . 2.7 t -128.87 110.06 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 102.774 -3.047 . . . . 0.0 102.774 -178.299 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.846 HD21 ' HB2' ' A' ' 140' ' ' ALA 0.295 8.2 m-80 82.26 -79.04 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 123.3 1.524 . . . . 0.0 108.935 178.08 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -154.27 -9.03 0.14 Allowed 'General case' 0 CA--C 1.568 1.668 0 CA-C-N 111.712 -2.495 . . . . 0.0 111.782 171.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.54 HG12 HG13 ' A' ' 125' ' ' VAL . 2.4 t -68.17 137.03 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.189 0 CA-C-O 123.492 1.615 . . . . 0.0 109.871 -179.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -86.86 98.11 11.03 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 111.316 -2.675 . . . . 0.0 109.869 177.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.61 HG11 ' HA ' ' A' ' 133' ' ' ALA 0.28 2.7 m -108.77 -110.53 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 CA-C-O 116.356 -1.783 . . . . 0.0 107.464 179.691 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.592 ' HB3' ' HA ' ' A' ' 118' ' ' LEU 0.362 0.0 OUTLIER 53.57 -82.68 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -179.533 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.554 ' H ' ' HD3' ' A' ' 126' ' ' ARG . 19.6 mt-10 -86.28 68.86 10.38 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-O 123.356 1.551 . . . . 0.0 109.308 171.055 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.6 p -143.06 167.08 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 CA-C-O 123.849 1.785 . . . . 0.0 107.061 -178.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 11.6 m -56.38 129.1 39.09 Favored 'General case' 0 CA--C 1.558 1.257 0 CA-C-N 113.289 -1.778 . . . . 0.0 110.217 157.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -47.94 -31.95 5.84 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 117.701 2.482 . . . . 0.0 117.701 173.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.478 ' HA ' HG12 ' A' ' 134' ' ' VAL . 6.8 m -59.32 -41.51 89.26 Favored 'General case' 0 CA--C 1.559 1.305 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 172.033 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -70.51 -36.41 73.76 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 167.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.61 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -61.58 -56.08 23.77 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 170.338 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.478 HG12 ' HA ' ' A' ' 131' ' ' SER . 0.5 OUTLIER -55.4 -39.86 54.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 N-CA-C 115.891 1.812 . . . . 0.0 115.891 167.854 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.99 -54.84 33.43 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 115.383 -2.246 . . . . 0.0 111.272 168.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.76 -35.0 73.71 Favored 'General case' 0 CA--C 1.561 1.373 0 N-CA-C 117.565 2.431 . . . . 0.0 117.565 172.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.442 HD12 HG21 ' A' ' 120' ' ' VAL . 8.6 mp -57.74 -49.61 75.98 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 165.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -73.31 -34.94 65.99 Favored 'General case' 0 CA--C 1.564 1.511 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 175.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.19 -28.69 67.48 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 115.921 1.823 . . . . 0.0 115.921 171.097 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.846 ' HB2' HD21 ' A' ' 121' ' ' ASN . . . -51.62 -36.7 46.9 Favored 'General case' 0 CA--C 1.56 1.339 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 158.253 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 91.39 -131.68 10.9 Favored Glycine 0 C--N 1.349 1.286 0 CA-C-O 122.488 1.049 . . . . 0.0 110.518 167.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.5 m -76.63 -2.19 31.45 Favored 'General case' 0 CA--C 1.557 1.244 0 N-CA-C 117.148 2.277 . . . . 0.0 117.148 168.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.09 108.18 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 -171.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.54 ' HA ' ' HB1' ' A' ' 140' ' ' ALA . 6.7 t -116.04 116.33 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 113.834 -1.53 . . . . 0.0 107.348 -165.4 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.417 ' HB2' ' HA ' ' A' ' 121' ' ' ASN . 1.9 mpp_? -93.59 91.66 7.18 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 174.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.485 ' HB2' HG13 ' A' ' 66' ' ' ILE . 78.3 mt -91.45 141.38 28.81 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 176.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -132.86 113.82 13.33 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 103.562 -2.755 . . . . 0.0 103.562 176.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.5 HG11 ' HB3' ' A' ' 115' ' ' ASP . 32.2 m -127.68 139.51 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -165.147 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 26.1 ptm -95.44 127.56 41.58 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 122.341 1.067 . . . . 0.0 110.427 170.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -101.33 125.42 47.96 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 174.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 30.2 mtp-105 -79.22 66.84 4.78 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.261 168.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -85.61 112.42 44.43 Favored Pre-proline 0 CA--C 1.555 1.167 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 -178.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -74.88 151.44 40.18 Favored 'Trans proline' 0 CA--C 1.566 2.123 0 C-N-CA 122.427 2.085 . . . . 0.0 112.896 176.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo . . . . . 0 CA--C 1.555 1.538 0 C-N-CA 123.858 3.039 . . . . 0.0 116.996 177.906 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 2.8 p90 . . . . . 0 CA--C 1.557 1.234 0 CA-C-O 122.436 1.112 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -120.49 149.46 42.37 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-O 124.162 1.934 . . . . 0.0 108.267 167.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.407 ' HG3' ' CG2' ' A' ' 97' ' ' THR . 0.5 OUTLIER -103.5 130.04 50.79 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 113.434 -1.712 . . . . 0.0 109.001 168.616 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 1.3 m -86.94 147.2 25.86 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 122.456 1.122 . . . . 0.0 109.877 168.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -114.53 113.34 24.29 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -171.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.47 HG21 ' CG2' ' A' ' 134' ' ' VAL . 62.0 t . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 -169.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 . . . . . 0 N--CA 1.479 0.983 0 CA-C-O 121.733 0.778 . . . . 0.0 111.255 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -118.75 138.36 52.72 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 114.117 -1.401 . . . . 0.0 110.865 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -129.19 141.84 51.04 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 123.011 1.386 . . . . 0.0 109.37 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -97.73 121.9 40.18 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 112.905 -1.952 . . . . 0.0 108.559 173.225 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.485 HG13 ' HB2' ' A' ' 146' ' ' LEU . 8.8 pt -131.46 109.42 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 -172.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.7 m -93.49 124.29 37.39 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 122.337 1.065 . . . . 0.0 108.391 175.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.407 ' HB2' HG23 ' A' ' 144' ' ' VAL . 1.3 mp -110.33 131.05 55.4 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 113.471 -1.695 . . . . 0.0 107.49 177.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -103.51 114.86 29.46 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -170.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.679 ' HB2' ' HB2' ' A' ' 104' ' ' ALA . 13.9 tpt180 -143.08 -106.64 0.13 Allowed 'General case' 0 CA--C 1.55 0.98 0 O-C-N 121.509 -0.744 . . . . 0.0 112.128 174.316 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.74 -152.41 23.09 Favored Glycine 0 C--N 1.342 0.904 0 C-N-CA 124.712 1.148 . . . . 0.0 111.954 -166.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . 0.256 16.6 m120 73.19 -92.02 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 114.356 -0.922 . . . . 0.0 110.853 177.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.2 m -103.87 -17.22 15.12 Favored 'General case' 0 CA--C 1.562 1.432 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 175.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 177.17 -139.32 4.32 Favored Glycine 0 CA--C 1.533 1.191 0 N-CA-C 108.293 -1.923 . . . . 0.0 108.293 178.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.472 HD21 ' HA ' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -130.87 -38.86 1.25 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 125.486 1.515 . . . . 0.0 111.139 -171.969 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.46 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 102.07 55.19 0.88 Allowed Glycine 0 N--CA 1.464 0.52 0 C-N-CA 124.176 0.893 . . . . 0.0 113.703 166.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.413 ' HB3' ' CG1' ' A' ' 99' ' ' ILE . 1.1 p90 -158.92 138.87 12.0 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-O 123.315 1.531 . . . . 0.0 111.152 178.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.473 ' HB2' ' HG2' ' A' ' 98' ' ' LYS . 5.0 m -100.0 120.16 39.39 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 122.854 1.311 . . . . 0.0 110.622 176.274 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.548 HD11 ' HB ' ' A' ' 134' ' ' VAL . 8.7 pt -95.45 136.09 27.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-N 113.087 -1.87 . . . . 0.0 109.876 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.04 -178.39 6.53 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-O 123.782 1.754 . . . . 0.0 109.698 157.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.433 ' HA3' ' O ' ' A' ' 85' ' ' ASN . . . -103.85 166.46 15.72 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-O 124.059 1.922 . . . . 0.0 116.319 -136.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -99.23 -162.07 29.45 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 111.242 -2.479 . . . . 0.0 112.499 -172.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.452 HG22 ' CB ' ' A' ' 92' ' ' PRO . 45.7 p -51.97 -43.09 63.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 116.517 2.043 . . . . 0.0 116.517 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -83.0 -13.73 55.37 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 116.277 1.954 . . . . 0.0 116.277 173.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.433 ' O ' ' HA3' ' A' ' 81' ' ' GLY 0.289 9.0 t30 -139.15 55.46 7.48 Favored Pre-proline 0 CA--C 1.565 1.529 0 CA-C-O 117.065 -1.445 . . . . 0.0 107.534 -172.905 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -83.63 132.3 5.7 Favored 'Trans proline' 0 C--N 1.365 1.412 0 CA-C-N 126.051 3.197 . . . . 0.0 112.648 -162.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -99.66 -23.68 14.96 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 166.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.487 HG22 ' H ' ' A' ' 90' ' ' ASP . 3.6 mp -92.32 142.98 12.31 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 -157.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -64.31 -1.66 6.03 Favored Glycine 0 CA--C 1.556 2.627 0 N-CA-C 119.435 2.534 . . . . 0.0 119.435 174.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.487 ' H ' HG22 ' A' ' 88' ' ' ILE . 7.4 m-20 -90.14 -8.57 50.94 Favored 'General case' 0 CA--C 1.568 1.648 0 CA-C-O 117.035 -1.46 . . . . 0.0 114.459 164.107 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.438 ' HB3' ' HD3' ' A' ' 92' ' ' PRO 0.467 0.3 OUTLIER 89.27 -85.46 0.0 OUTLIER Pre-proline 0 CA--C 1.563 1.48 0 C-N-CA 127.458 2.303 . . . . 0.0 109.815 -170.279 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.452 ' CB ' HG22 ' A' ' 83' ' ' THR . 88.7 Cg_endo -114.04 93.76 0.01 OUTLIER 'Trans proline' 0 C--N 1.367 1.527 0 CA-C-N 124.328 2.582 . . . . 0.0 112.141 -160.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.8 m -155.81 130.0 8.78 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 -177.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.442 HG13 ' HB2' ' A' ' 133' ' ' ALA . 15.6 mm -83.32 110.06 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 -177.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.444 ' HB3' HD11 ' A' ' 88' ' ' ILE . 72.7 t80 -130.18 130.83 45.2 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 -167.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.564 ' HB ' ' O ' ' A' ' 113' ' ' VAL 0.298 82.5 mt -81.73 120.11 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.736 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 176.178 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.451 ' CG2' ' HD3' ' B' ' 3' ' ' LYS . 12.3 t -89.72 -28.88 19.11 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 168.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.473 ' HG2' ' HB2' ' A' ' 78' ' ' SER . 7.7 ptmm? -144.4 161.68 38.4 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-O 122.659 1.219 . . . . 0.0 109.777 172.016 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.771 ' HB ' HG12 ' A' ' 113' ' ' VAL . 0.2 OUTLIER -123.02 139.27 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 177.791 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.403 ' HA ' ' HD2' ' A' ' 101' ' ' PRO 0.279 1.5 mp -79.14 124.93 84.37 Favored Pre-proline 0 CA--C 1.57 1.743 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.331 -179.03 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.596 ' HA ' ' HB2' ' A' ' 106' ' ' ALA . 60.1 Cg_endo -67.35 146.99 77.07 Favored 'Trans proline' 0 CA--C 1.56 1.79 0 C-N-CA 123.398 2.732 . . . . 0.0 113.107 166.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.76 -14.06 53.7 Favored Glycine 0 CA--C 1.548 2.122 0 N-CA-C 117.245 1.658 . . . . 0.0 117.245 -164.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.46 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -96.23 -166.3 33.99 Favored Glycine 0 CA--C 1.539 1.541 0 CA-C-N 118.914 1.357 . . . . 0.0 115.82 177.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.679 ' HB2' ' HB2' ' A' ' 70' ' ' ARG . . . -58.61 -51.19 70.95 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -177.173 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.407 ' HB1' HD13 ' A' ' 99' ' ' ILE . . . -59.48 -38.39 80.7 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 124.573 1.17 . . . . 0.0 114.075 169.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.596 ' HB2' ' HA ' ' A' ' 101' ' ' PRO . . . -46.19 -40.14 10.81 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 117.538 2.421 . . . . 0.0 117.538 166.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.38 -53.17 6.22 Favored 'General case' 0 CA--C 1.568 1.642 0 C-N-CA 123.734 0.813 . . . . 0.0 112.665 173.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -79.02 -52.95 7.53 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -172.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -161.9 97.2 0.15 Allowed Glycine 0 CA--C 1.532 1.132 0 N-CA-C 108.369 -1.892 . . . . 0.0 108.369 -178.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.585 ' HA ' HG21 ' A' ' 99' ' ' ILE . 15.7 ptt-85 -85.65 19.3 2.48 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 119.822 3.268 . . . . 0.0 119.822 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.419 HD22 ' N ' ' A' ' 112' ' ' ARG . 0.0 OUTLIER -140.51 -21.7 0.82 Allowed 'General case' 0 CA--C 1.564 1.496 0 C-N-CA 128.003 2.521 . . . . 0.0 111.335 -164.246 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.419 ' N ' HD22 ' A' ' 111' ' ' LEU . 3.8 ptp180 -78.38 18.73 0.52 Allowed 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 116.232 1.938 . . . . 0.0 116.232 179.347 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.771 HG12 ' HB ' ' A' ' 99' ' ' ILE 0.25 2.4 m -39.61 -59.36 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 127.665 2.386 . . . . 0.0 110.109 179.379 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 63.2 m-20 -51.79 37.85 0.0 OUTLIER 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 121.799 3.999 . . . . 0.0 121.799 166.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -102.35 110.67 22.68 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 165.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 65.9 p -67.51 89.32 0.23 Allowed 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 113.408 -1.724 . . . . 0.0 111.147 169.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.566 HD12 HD11 ' A' ' 137' ' ' LEU . 27.6 pt -74.27 101.19 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 123.683 1.706 . . . . 0.0 108.854 -176.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.484 ' HA ' ' HB3' ' A' ' 126' ' ' ARG . 1.4 pp -79.95 -39.1 30.9 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 112.58 -2.1 . . . . 0.0 115.578 177.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -132.89 150.46 52.16 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 175.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.512 HG23 HD23 ' A' ' 146' ' ' LEU . 9.4 p -131.2 124.11 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 172.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . 0.272 13.6 m120 78.77 -70.2 0.11 Allowed 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 123.26 1.505 . . . . 0.0 111.554 -178.039 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.423 ' H ' ' H ' ' A' ' 123' ' ' VAL . 2.1 tt0 -177.93 -10.65 0.01 OUTLIER 'General case' 0 CA--C 1.583 2.213 0 C-N-CA 129.229 3.011 . . . . 0.0 109.391 -177.063 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.423 ' H ' ' H ' ' A' ' 122' ' ' GLU . 2.1 t -64.67 137.89 24.11 Favored 'Isoleucine or valine' 0 C--N 1.364 1.204 0 C-N-CA 125.801 1.641 . . . . 0.0 109.987 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -82.04 94.15 7.13 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 112.545 -2.116 . . . . 0.0 109.979 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.46 HG11 ' HA ' ' A' ' 133' ' ' ALA 0.339 0.8 OUTLIER -110.5 -112.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 CA-C-O 117.546 -1.216 . . . . 0.0 108.593 179.781 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.541 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.315 17.3 ptt180 55.15 -86.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 -174.982 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.541 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 32.9 mt-10 -82.06 69.47 8.78 Favored 'General case' 0 CA--C 1.555 1.156 0 CA-C-O 123.92 1.819 . . . . 0.0 109.986 172.234 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.7 m -137.0 166.34 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 112.627 -2.079 . . . . 0.0 105.677 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 25.8 p -55.83 135.69 51.76 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 113.12 -1.855 . . . . 0.0 111.301 149.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -50.04 -29.8 9.48 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 116.66 2.096 . . . . 0.0 116.66 167.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.465 ' HA ' HG12 ' A' ' 134' ' ' VAL . 5.1 m -57.09 -56.05 26.81 Favored 'General case' 0 CA--C 1.559 1.315 0 C-N-CA 124.432 1.093 . . . . 0.0 112.348 169.509 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -57.5 -38.7 75.04 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 173.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.46 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -62.15 -55.78 25.35 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 115.883 1.809 . . . . 0.0 115.883 166.06 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.548 ' HB ' HD11 ' A' ' 79' ' ' ILE . 3.7 p -57.74 -40.37 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 176.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -61.36 -44.38 97.26 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 116.657 -1.639 . . . . 0.0 112.999 168.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.59 -31.84 73.23 Favored 'General case' 0 CA--C 1.563 1.48 0 N-CA-C 117.628 2.455 . . . . 0.0 117.628 169.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.566 HD11 HD12 ' A' ' 117' ' ' ILE . 6.5 mp -60.07 -48.76 80.38 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 125.752 1.621 . . . . 0.0 113.29 166.085 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.472 ' HA ' HD21 ' A' ' 75' ' ' LEU . 53.2 mtmt -69.67 -32.83 71.69 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 168.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -67.71 -22.83 65.24 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 116.278 1.955 . . . . 0.0 116.278 171.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.455 ' HB1' ' HA ' ' A' ' 144' ' ' VAL . . . -51.9 -27.73 13.86 Favored 'General case' 0 CA--C 1.555 1.155 0 N-CA-C 118.072 2.619 . . . . 0.0 118.072 157.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 97.08 -116.15 5.43 Favored Glycine 0 C--N 1.344 1.025 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 166.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.6 m -92.5 1.27 57.34 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 116.413 2.005 . . . . 0.0 116.413 166.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.37 102.1 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 -171.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.455 ' HA ' ' HB1' ' A' ' 140' ' ' ALA . 1.4 m -85.09 116.33 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-N 113.72 -1.582 . . . . 0.0 109.821 173.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 31.8 mtp180 -100.79 87.79 3.41 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 122.443 1.116 . . . . 0.0 108.103 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.512 HD23 HG23 ' A' ' 120' ' ' VAL . 32.6 mt -87.5 133.94 33.69 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -170.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -118.9 119.57 34.74 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.4 p -127.05 121.65 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -176.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 52.3 ttm -100.47 136.25 40.65 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 122.816 1.293 . . . . 0.0 110.286 163.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 14.7 mmt180 -94.64 113.47 25.28 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 112.83 -1.987 . . . . 0.0 106.847 172.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 24.2 ttt180 -58.74 -55.3 36.88 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.478 157.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -97.89 123.78 50.25 Favored Pre-proline 0 CA--C 1.551 1.013 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -175.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.437 ' HA ' ' HD3' ' A' ' 154' ' ' PRO . 32.5 Cg_exo -58.13 136.33 74.18 Favored 'Trans proline' 0 CA--C 1.565 2.058 0 C-N-CA 122.909 2.406 . . . . 0.0 114.271 178.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 153' ' ' PRO . 20.3 Cg_exo . . . . . 0 CA--C 1.553 1.474 0 C-N-CA 123.042 2.495 . . . . 0.0 113.01 179.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 1.1 p90 . . . . . 0 CA--C 1.555 1.17 0 CA-C-O 122.02 0.914 . . . . 0.0 111.352 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.432 ' H ' HD21 ' A' ' 85' ' ' ASN . 4.6 mptp? -138.81 145.54 40.23 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 113.401 -1.727 . . . . 0.0 108.4 172.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.451 ' HD3' ' CG2' ' A' ' 97' ' ' THR . 7.4 ttpp -100.0 111.25 23.56 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 114.109 -1.405 . . . . 0.0 107.878 175.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 87.3 m -89.79 131.18 35.87 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 114.565 -1.198 . . . . 0.0 108.864 175.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.66 147.02 35.74 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 113.724 -1.58 . . . . 0.0 109.199 173.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.46 HG11 HD23 ' A' ' 137' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.256 1.402 0 CA-C-N 113.652 -1.613 . . . . 0.0 109.836 172.159 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 N--CA 1.483 1.209 0 CA-C-O 121.902 0.858 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.478 ' HB3' ' HB2' ' A' ' 149' ' ' MET . 32.4 p90 -107.08 138.1 43.89 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 114.22 -1.355 . . . . 0.0 110.65 176.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -115.61 129.81 56.64 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.055 175.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -88.47 127.15 35.51 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 113.679 -1.6 . . . . 0.0 110.944 175.51 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.434 HG21 HD12 ' A' ' 111' ' ' LEU . 20.8 mm -130.73 126.7 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 -177.116 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.6 m -88.9 132.79 34.53 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-O 123.561 1.648 . . . . 0.0 108.175 167.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.48 HD11 ' HA ' ' A' ' 105' ' ' ALA . 3.6 tp -136.01 150.17 49.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 112.263 -2.244 . . . . 0.0 107.931 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -80.11 140.42 36.43 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 122.065 0.936 . . . . 0.0 110.419 173.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.657 ' HD2' ' H ' ' A' ' 142' ' ' SER . 2.4 tmt_? -92.52 114.72 27.34 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 172.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.72 116.02 8.69 Favored Glycine 0 CA--C 1.541 1.706 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.318 164.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -61.5 -42.17 98.4 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 -168.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 57.1 m -83.55 -17.1 42.96 Favored 'General case' 0 CA--C 1.564 1.496 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 167.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -179.29 126.01 1.02 Allowed Glycine 0 C--N 1.343 0.936 0 N-CA-C 108.177 -1.969 . . . . 0.0 108.177 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.448 HD23 ' CZ ' ' A' ' 77' ' ' PHE . 6.6 mp -66.76 -74.73 0.11 Allowed 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.698 0.799 . . . . 0.0 108.944 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.431 ' HA3' ' CA ' ' A' ' 103' ' ' GLY . . . 120.41 45.07 0.41 Allowed Glycine 0 CA--C 1.535 1.307 0 C-N-CA 124.476 1.036 . . . . 0.0 115.408 178.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.448 ' CZ ' HD23 ' A' ' 75' ' ' LEU . 0.8 OUTLIER -157.2 138.89 14.09 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 123.4 1.571 . . . . 0.0 109.472 -178.551 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.409 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 2.6 m -106.67 113.8 27.51 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.431 -1.259 . . . . 0.0 112.395 -166.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.56 HG22 HG12 ' A' ' 96' ' ' ILE . 1.1 pt -92.39 123.58 44.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.041 -175.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -83.34 -170.86 3.26 Favored 'General case' 0 CA--C 1.557 1.24 0 CA-C-O 123.5 1.619 . . . . 0.0 110.043 159.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 85' ' ' ASN . . . -94.72 160.65 23.48 Favored Glycine 0 CA--C 1.539 1.54 0 CA-C-O 123.715 1.73 . . . . 0.0 117.126 -138.32 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -109.62 -161.47 19.14 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-N 111.289 -2.456 . . . . 0.0 114.251 178.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 43.1 p -54.26 -41.87 69.31 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 117.222 2.304 . . . . 0.0 117.222 178.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -81.44 -19.28 42.77 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 116.371 1.989 . . . . 0.0 116.371 172.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.402 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 1.0 OUTLIER -141.27 84.04 13.09 Favored Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 102.587 -3.116 . . . . 0.0 102.587 -171.544 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -99.27 123.1 0.13 Allowed 'Trans proline' 0 CA--C 1.548 1.221 0 CA-C-N 124.385 2.602 . . . . 0.0 109.733 -175.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 39.1 t-80 -74.89 -29.1 60.89 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 162.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.46 ' H ' HD12 ' A' ' 88' ' ' ILE . 0.3 OUTLIER -109.84 172.28 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 C-N-CA 126.248 1.819 . . . . 0.0 109.93 -178.213 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.15 -109.77 0.01 OUTLIER Glycine 0 CA--C 1.543 1.796 0 N-CA-C 115.98 1.152 . . . . 0.0 115.98 -176.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -99.65 24.21 8.57 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -173.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.47 75.03 8.79 Favored Pre-proline 0 CA--C 1.549 0.94 0 CA-C-N 119.312 0.96 . . . . 0.0 110.49 169.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -63.96 104.3 0.47 Allowed 'Trans proline' 0 C--N 1.369 1.632 0 C-N-CA 122.97 2.447 . . . . 0.0 112.791 171.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 63.0 m -160.5 124.79 3.65 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 -176.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.539 HG13 ' HB2' ' A' ' 133' ' ' ALA . 11.1 mm -69.86 131.94 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -170.164 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.483 ' HB2' ' O ' ' A' ' 115' ' ' ASP . 21.2 p90 -140.38 128.82 22.68 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.405 -1.271 . . . . 0.0 108.297 -168.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.573 HD12 ' HB2' ' A' ' 114' ' ' ASN . 70.2 mt -85.25 112.02 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 173.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 23.2 m -85.86 -28.56 24.34 Favored 'General case' 0 CA--C 1.556 1.199 0 CA-C-N 113.667 -1.606 . . . . 0.0 113.191 169.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.409 ' HB2' ' HB2' ' A' ' 78' ' ' SER . 27.4 mtpp -134.73 159.01 42.64 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 123.486 1.613 . . . . 0.0 111.203 -173.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -120.57 124.79 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 103.316 -2.846 . . . . 0.0 103.316 177.399 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.287 1.2 mp -66.51 130.72 94.14 Favored Pre-proline 0 CA--C 1.573 1.854 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.304 170.181 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.94 132.09 40.44 Favored 'Trans proline' 0 CA--C 1.554 1.493 0 C-N-CA 123.432 2.754 . . . . 0.0 114.156 173.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.46 14.17 82.77 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 117.249 1.66 . . . . 0.0 117.249 -163.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.431 ' CA ' ' HA3' ' A' ' 76' ' ' GLY . . . -89.92 171.07 37.03 Favored Glycine 0 C--N 1.337 0.638 0 CA-C-O 122.672 1.151 . . . . 0.0 114.388 -177.016 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.62 -38.0 70.84 Favored 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -172.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.48 ' HA ' HD11 ' A' ' 68' ' ' LEU . . . -66.28 -38.71 88.42 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 172.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.86 -42.71 76.71 Favored 'General case' 0 CA--C 1.562 1.421 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 170.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -72.54 -52.12 17.0 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.202 1.001 . . . . 0.0 113.685 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -69.0 -50.01 52.67 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.512 1.125 . . . . 0.0 112.351 -176.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.04 -146.48 5.14 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 124.657 2.254 . . . . 0.0 111.373 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.71 26.91 0.15 Allowed 'General case' 0 CA--C 1.567 1.622 0 CA-C-N 110.478 -2.861 . . . . 0.0 111.71 -172.334 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.868 ' H ' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -76.0 31.38 0.11 Allowed 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 126.127 1.771 . . . . 0.0 114.238 177.9 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . 0.308 67.0 mtp180 71.7 -178.63 0.21 Allowed 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 126.082 2.848 . . . . 0.0 111.108 -167.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.502 ' HB ' HG22 ' A' ' 96' ' ' ILE 0.374 17.2 m -25.03 -69.48 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.581 0 CA-C-N 110.534 -3.03 . . . . 0.0 114.406 146.822 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.573 ' HB2' HD12 ' A' ' 96' ' ' ILE . 8.6 t-20 172.38 -33.1 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 129.142 2.977 . . . . 0.0 106.685 168.179 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.483 ' O ' ' HB2' ' A' ' 95' ' ' PHE 0.289 35.1 t70 81.87 -70.38 0.07 Allowed 'General case' 0 C--N 1.354 0.792 0 C-N-CA 126.053 1.741 . . . . 0.0 111.258 -177.434 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 45.4 m -155.78 77.57 0.97 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 -170.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.0 tp -66.65 124.39 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-O 121.667 0.746 . . . . 0.0 109.261 171.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.459 ' HA ' ' HB3' ' A' ' 126' ' ' ARG 0.259 0.8 OUTLIER -108.38 -43.97 4.21 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 174.699 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -129.85 133.68 47.07 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 104.786 -2.302 . . . . 0.0 104.786 177.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.7 p -123.76 123.49 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 174.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . 0.32 32.7 m-80 80.77 -72.2 0.06 Allowed 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 123.954 1.835 . . . . 0.0 110.37 -175.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -177.11 -17.57 0.01 OUTLIER 'General case' 0 CA--C 1.576 1.959 0 C-N-CA 129.006 2.923 . . . . 0.0 109.247 -173.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.412 HG12 HG13 ' A' ' 125' ' ' VAL . 2.2 t -64.9 135.56 28.02 Favored 'Isoleucine or valine' 0 C--N 1.363 1.173 0 C-N-CA 125.69 1.596 . . . . 0.0 110.131 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -78.84 86.41 4.75 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 111.131 -2.759 . . . . 0.0 111.226 173.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.414 HG11 ' HA ' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -94.99 -105.12 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 176.127 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.469 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.285 14.0 ptt85 47.42 -98.68 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.674 1.189 . . . . 0.0 113.85 -176.549 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.469 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 1.5 tt0 -71.46 72.95 0.72 Allowed 'General case' 0 CA--C 1.555 1.146 0 CA-C-O 124.227 1.965 . . . . 0.0 111.885 168.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.7 p -147.34 167.41 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 CA-C-N 112.141 -2.299 . . . . 0.0 105.153 -174.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 34.9 p -57.2 130.85 48.01 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 112.579 -2.1 . . . . 0.0 112.051 156.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.448 ' HA ' HD12 ' A' ' 94' ' ' ILE . 2.1 p-80 -48.16 -33.1 7.86 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 116.845 2.165 . . . . 0.0 116.845 168.096 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.562 ' HA ' HG12 ' A' ' 134' ' ' VAL . 13.2 m -63.61 -38.94 93.04 Favored 'General case' 0 CA--C 1.559 1.301 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 172.488 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.11 -32.93 73.58 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 167.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.539 ' HB2' HG13 ' A' ' 94' ' ' ILE . . . -73.18 -47.81 40.57 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 171.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.562 HG12 ' HA ' ' A' ' 131' ' ' SER . 11.3 p -52.07 -44.82 40.54 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.532 0 CA-C-N 120.47 1.486 . . . . 0.0 113.87 162.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -53.98 -52.02 62.05 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-O 115.989 -1.958 . . . . 0.0 112.23 170.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.24 -29.86 68.78 Favored 'General case' 0 CA--C 1.558 1.266 0 N-CA-C 118.108 2.633 . . . . 0.0 118.108 175.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 7.0 mp -55.49 -52.88 62.2 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.161 1.384 . . . . 0.0 112.821 162.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -69.33 -41.24 76.93 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 171.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -66.86 -4.65 9.83 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 116.524 2.046 . . . . 0.0 116.524 169.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.44 ' HB1' ' HA ' ' A' ' 144' ' ' VAL . . . -52.0 -36.08 48.68 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 117.018 2.229 . . . . 0.0 117.018 158.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 64.97 79.01 0.19 Allowed Glycine 0 C--N 1.348 1.233 0 O-C-N 123.849 0.718 . . . . 0.0 113.115 163.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.657 ' H ' ' HD2' ' A' ' 70' ' ' ARG 0.267 15.7 m 73.81 -27.08 0.19 Allowed 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 117.561 2.43 . . . . 0.0 117.561 -172.937 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -145.88 107.98 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -171.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.44 ' HA ' ' HB1' ' A' ' 140' ' ' ALA . 1.6 t -91.14 115.16 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 125.846 1.658 . . . . 0.0 107.324 175.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 5.2 ttp180 -97.3 100.16 11.61 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 172.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 36.8 mt -90.75 142.41 27.79 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.532 -175.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -131.17 113.57 14.04 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 173.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.72 123.73 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -175.17 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.478 ' HB2' ' HB3' ' A' ' 63' ' ' TYR . 25.7 ttt -111.12 134.2 52.9 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 124.366 1.041 . . . . 0.0 111.208 165.253 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.402 ' HE ' ' CG ' ' A' ' 115' ' ' ASP . 22.6 mtp180 -93.22 136.6 33.33 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.046 -1.433 . . . . 0.0 109.6 169.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -87.06 122.16 30.51 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 113.954 -1.475 . . . . 0.0 109.513 -179.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -63.99 -55.19 34.43 Favored Pre-proline 0 N--CA 1.486 1.33 0 CA-C-O 115.311 -2.281 . . . . 0.0 112.756 170.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.418 ' HA ' ' HD3' ' A' ' 154' ' ' PRO . 32.9 Cg_endo -63.45 123.92 12.9 Favored 'Trans proline' 0 CA--C 1.568 2.178 0 CA-C-N 124.16 2.521 . . . . 0.0 112.163 173.312 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 153' ' ' PRO . 19.3 Cg_exo . . . . . 0 C--N 1.366 1.462 0 C-N-CA 123.11 2.54 . . . . 0.0 112.874 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.561 1.367 0 CA-C-O 123.699 1.714 . . . . 0.0 110.835 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -161.6 123.0 2.81 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 172.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -82.17 122.94 28.52 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 114.201 -1.363 . . . . 0.0 109.054 175.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 2.9 m -81.91 127.3 32.88 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 122.177 0.989 . . . . 0.0 108.389 170.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.0 103.53 16.24 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.422 ' HB ' ' O ' ' A' ' 77' ' ' PHE . 9.5 t . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -169.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 . . . . . 0 N--CA 1.485 1.306 0 CA-C-O 121.66 0.743 . . . . 0.0 112.289 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.492 ' HB3' ' HB2' ' A' ' 149' ' ' MET . 43.0 p90 -111.65 136.1 51.34 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 114.3 -1.318 . . . . 0.0 111.04 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -102.26 138.46 39.17 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.14 176.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -107.07 125.41 51.01 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.541 HG12 ' HB2' ' A' ' 146' ' ' LEU . 0.1 OUTLIER -141.72 111.69 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 -174.501 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 86.3 m -84.67 129.81 34.79 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 122.224 1.012 . . . . 0.0 108.352 170.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.463 HD11 ' HA ' ' A' ' 105' ' ' ALA . 0.9 OUTLIER -137.62 128.14 26.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 113.317 -1.765 . . . . 0.0 107.085 -176.189 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -72.32 130.69 41.34 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 121.943 -0.473 . . . . 0.0 110.303 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 27.8 ttt-85 -75.21 123.81 25.95 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 173.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -64.96 155.52 48.53 Favored Glycine 0 CA--C 1.539 1.576 0 CA-C-N 113.968 -1.469 . . . . 0.0 112.78 171.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 57.7 m-80 -64.14 -51.94 61.47 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 113.512 -1.344 . . . . 0.0 113.233 -176.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 45.9 m -99.66 -16.56 18.15 Favored 'General case' 0 CA--C 1.561 1.403 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 175.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -154.38 119.85 0.97 Allowed Glycine 0 C--N 1.349 1.254 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.446 HD21 HG21 ' A' ' 144' ' ' VAL . 2.7 tt -63.02 -34.72 78.16 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 167.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.28 41.69 2.35 Favored Glycine 0 N--CA 1.475 1.259 0 O-C-N 120.434 -1.416 . . . . 0.0 116.376 168.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.473 ' HB2' HG13 ' B' ' 6' ' ' VAL . 72.4 m-85 -151.76 165.95 32.85 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 122.643 1.211 . . . . 0.0 110.883 179.34 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.32 121.75 20.52 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 168.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.72 HG22 HG12 ' A' ' 96' ' ' ILE . 6.4 pt -90.97 133.69 31.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 113.331 -1.758 . . . . 0.0 111.006 -177.054 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.56 ' HB1' HD11 ' A' ' 88' ' ' ILE . . . -88.36 -174.81 4.77 Favored 'General case' 0 CA--C 1.558 1.274 0 CA-C-O 123.258 1.504 . . . . 0.0 110.055 158.394 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -96.18 159.45 21.98 Favored Glycine 0 CA--C 1.539 1.568 0 CA-C-O 123.2 1.444 . . . . 0.0 116.059 -144.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -108.35 -164.19 20.99 Favored Glycine 0 N--CA 1.47 0.933 0 CA-C-N 112.276 -1.962 . . . . 0.0 112.226 -176.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.533 HG22 ' HB2' ' A' ' 92' ' ' PRO . 43.5 p -50.49 -39.11 47.5 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 118.355 2.724 . . . . 0.0 118.355 -177.269 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -73.8 -23.87 59.74 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 171.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -139.37 74.89 34.15 Favored Pre-proline 0 CA--C 1.567 1.622 0 N-CA-C 104.209 -2.515 . . . . 0.0 104.209 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -107.98 115.59 0.03 OUTLIER 'Trans proline' 0 C--N 1.364 1.386 0 CA-C-N 125.26 2.914 . . . . 0.0 111.092 -164.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -107.45 -43.97 4.41 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.56 HD11 ' HB1' ' A' ' 80' ' ' ALA . 0.8 OUTLIER -105.95 140.94 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -147.774 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.94 -111.58 3.49 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.766 170.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -80.46 -4.59 54.34 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 169.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.427 ' HB2' ' HD3' ' A' ' 92' ' ' PRO 0.457 33.4 m-20 103.32 -80.75 0.0 OUTLIER Pre-proline 0 CA--C 1.562 1.418 0 C-N-CA 126.561 1.944 . . . . 0.0 107.77 -172.122 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.533 ' HB2' HG22 ' A' ' 83' ' ' THR . 46.2 Cg_endo -94.15 89.01 0.13 Allowed 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 123.676 2.917 . . . . 0.0 112.533 -168.031 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 58.7 m -158.61 140.15 13.46 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 177.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.463 HD12 ' HA ' ' A' ' 130' ' ' HIS . 21.7 mm -81.46 130.07 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 -177.13 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.478 ' HA ' ' O ' ' A' ' 115' ' ' ASP . 40.4 m-85 -119.4 149.82 41.21 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 113.484 -1.689 . . . . 0.0 110.509 175.074 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.72 HG12 HG22 ' A' ' 79' ' ' ILE . 72.6 mt -106.06 114.55 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 104.381 -2.451 . . . . 0.0 104.381 148.363 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.9 t -98.74 -6.38 29.58 Favored 'General case' 0 CA--C 1.564 1.496 0 N-CA-C 115.386 1.625 . . . . 0.0 115.386 168.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -141.82 147.51 37.35 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-O 123.774 1.75 . . . . 0.0 108.963 -177.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.33 123.55 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 N-CA-C 103.224 -2.88 . . . . 0.0 103.224 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.368 1.2 mp -66.26 117.4 42.93 Favored Pre-proline 0 CA--C 1.566 1.567 0 CA-C-O 118.186 -0.912 . . . . 0.0 109.248 171.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -69.33 142.29 49.4 Favored 'Trans proline' 0 C--N 1.367 1.534 0 C-N-CA 123.224 2.616 . . . . 0.0 112.496 174.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.53 -6.05 19.1 Favored Glycine 0 CA--C 1.549 2.216 0 N-CA-C 117.772 1.869 . . . . 0.0 117.772 -168.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -83.67 -171.63 47.9 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-O 123.409 1.561 . . . . 0.0 112.157 175.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 75' ' ' LEU . . . -67.75 -41.87 82.7 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 -173.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.463 ' HA ' HD11 ' A' ' 68' ' ' LEU . . . -67.59 -26.41 66.26 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 119.719 3.229 . . . . 0.0 119.719 178.244 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -60.97 -46.03 92.39 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 166.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.56 -55.25 6.55 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 124.548 1.139 . . . . 0.0 113.082 174.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -60.09 -43.59 95.4 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.959 0.904 . . . . 0.0 112.015 -177.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 59.65 66.85 2.48 Favored Glycine 0 C--N 1.353 1.499 0 O-C-N 124.022 0.826 . . . . 0.0 112.979 164.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -106.61 -38.23 6.2 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 113.768 -1.216 . . . . 0.0 112.54 -174.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.471 HD13 HG13 ' A' ' 66' ' ' ILE . 2.0 pt? -143.34 -163.15 1.58 Allowed 'General case' 0 CA--C 1.553 1.077 0 CA-C-O 124.819 2.247 . . . . 0.0 107.058 -173.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . 0.266 6.0 mmt180 -75.1 -148.58 0.02 OUTLIER 'General case' 0 CA--C 1.559 1.301 0 CA-C-O 124.503 2.097 . . . . 0.0 111.968 164.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.439 ' HB ' HG22 ' A' ' 96' ' ' ILE 0.294 30.4 m -37.72 -67.91 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.737 0 CA-C-N 112.696 -2.047 . . . . 0.0 112.326 150.452 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.526 ' HB2' ' HB ' ' A' ' 96' ' ' ILE 0.311 0.2 OUTLIER 159.31 -39.32 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 128.077 2.551 . . . . 0.0 107.864 179.728 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 95' ' ' PHE 0.296 15.3 t70 67.72 -102.77 0.07 Allowed 'General case' 0 C--O 1.213 -0.839 0 C-N-CA 126.246 1.818 . . . . 0.0 106.737 178.65 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 66.8 m -100.8 69.41 1.35 Allowed 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.061 1.301 . . . . 0.0 110.424 -173.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.487 HD11 HG22 ' A' ' 120' ' ' VAL . 18.0 tt -67.7 124.18 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 CA-C-O 122.1 0.952 . . . . 0.0 109.47 174.281 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.723 HD21 ' HB3' ' A' ' 149' ' ' MET . 0.0 OUTLIER -117.25 -47.23 2.67 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 113.525 -1.671 . . . . 0.0 114.824 -179.882 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -119.68 141.04 49.73 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.487 HG22 HD11 ' A' ' 117' ' ' ILE . 2.1 t -129.75 110.73 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 102.165 -3.272 . . . . 0.0 102.165 177.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . 0.32 10.4 m120 83.21 -83.2 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 123.649 1.69 . . . . 0.0 108.712 178.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -153.08 -16.05 0.15 Allowed 'General case' 0 CA--C 1.571 1.781 0 CA-C-N 110.539 -3.028 . . . . 0.0 110.48 178.139 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.1 t -62.6 136.92 25.16 Favored 'Isoleucine or valine' 0 C--N 1.363 1.156 0 C-N-CA 125.118 1.367 . . . . 0.0 110.088 173.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -100.87 96.91 7.6 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 111.891 -2.413 . . . . 0.0 108.408 178.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . 0.257 0.2 OUTLIER -96.02 -100.35 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 CA-C-O 116.44 -1.743 . . . . 0.0 107.588 179.378 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.539 ' HD3' ' HB3' ' A' ' 118' ' ' LEU 0.34 29.0 ptt180 50.94 -84.34 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 116.666 2.099 . . . . 0.0 116.666 -177.802 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.441 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 1.9 mt-10 -79.13 69.5 5.33 Favored 'General case' 0 CA--C 1.557 1.226 0 CA-C-O 123.811 1.767 . . . . 0.0 110.486 168.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -147.76 168.57 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 -178.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.404 HG22 ' H ' ' A' ' 131' ' ' SER . 28.2 m -60.71 133.67 56.32 Favored 'General case' 0 CA--C 1.562 1.417 0 CA-C-N 114.262 -1.335 . . . . 0.0 110.529 158.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.463 ' HA ' HD12 ' A' ' 94' ' ' ILE . 7.7 p-80 -46.05 -33.86 3.71 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 118.024 2.602 . . . . 0.0 118.024 168.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.564 ' HA ' HG12 ' A' ' 134' ' ' VAL . 7.6 m -60.84 -38.26 84.87 Favored 'General case' 0 CA--C 1.559 1.316 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 173.242 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -70.78 -33.3 70.62 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 116.217 1.932 . . . . 0.0 116.217 167.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.457 ' HB2' HG13 ' A' ' 94' ' ' ILE . . . -74.48 -43.4 56.23 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 172.64 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.564 HG12 ' HA ' ' A' ' 131' ' ' SER . 2.3 p -55.69 -42.41 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 159.012 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -60.44 -46.36 90.33 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 116.097 -1.906 . . . . 0.0 113.27 170.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.05 -31.66 70.19 Favored 'General case' 0 CA--C 1.559 1.306 0 N-CA-C 116.951 2.204 . . . . 0.0 116.951 173.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.468 HD12 ' HA ' ' A' ' 134' ' ' VAL . 46.7 mt -58.94 -47.89 83.45 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 163.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -65.2 -44.76 87.3 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 168.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -64.03 -17.75 63.66 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 116.533 2.049 . . . . 0.0 116.533 174.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.461 ' HB1' ' HA ' ' A' ' 144' ' ' VAL . . . -53.5 -20.16 4.55 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 119.667 3.21 . . . . 0.0 119.667 160.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 91.45 -125.93 8.23 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 173.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 39.0 m -90.9 1.59 56.87 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 167.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -150.1 110.74 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -165.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.461 ' HA ' ' HB1' ' A' ' 140' ' ' ALA . 3.3 t -102.9 115.86 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 113.481 -1.69 . . . . 0.0 107.863 -172.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 78.4 mtt180 -96.91 101.28 12.83 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 175.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.541 ' HB2' HG12 ' A' ' 66' ' ' ILE . 14.0 mt -95.76 137.35 34.95 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -173.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -125.19 126.1 44.69 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -131.24 122.23 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 177.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.723 ' HB3' HD21 ' A' ' 118' ' ' LEU . 28.3 ttt -114.3 125.65 54.13 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 171.29 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -94.47 115.4 27.58 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 113.891 -1.504 . . . . 0.0 107.266 -177.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.93 153.46 8.65 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.952 166.144 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.22 123.66 89.36 Favored Pre-proline 0 CA--C 1.553 1.094 0 CA-C-O 117.489 -1.243 . . . . 0.0 109.253 -178.497 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.41 ' HA ' ' HD3' ' A' ' 154' ' ' PRO . 10.2 Cg_endo -53.57 120.56 8.03 Favored 'Trans proline' 0 CA--C 1.565 2.033 0 C-N-CA 123.462 2.775 . . . . 0.0 113.67 -176.307 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 153' ' ' PRO . 21.8 Cg_exo . . . . . 0 C--N 1.367 1.502 0 C-N-CA 123.027 2.485 . . . . 0.0 113.156 -176.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 2.7 p90 . . . . . 0 CA--C 1.55 0.974 0 CA-C-O 121.399 0.619 . . . . 0.0 110.352 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -130.02 146.89 51.72 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 123.538 1.637 . . . . 0.0 110.418 175.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 10.7 ttpp -107.82 113.7 27.13 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 113.222 -1.808 . . . . 0.0 108.1 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 43.6 m -84.81 137.35 33.23 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 122.029 0.918 . . . . 0.0 109.84 173.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.39 153.91 22.2 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-O 122.711 1.243 . . . . 0.0 110.146 176.178 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.473 HG13 ' HB2' ' A' ' 77' ' ' PHE . 4.2 p . . . . . 0 C--O 1.25 1.09 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 -171.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -128.72 139.41 52.23 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-O 122.708 1.242 . . . . 0.0 109.674 178.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -104.0 134.71 46.82 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 113.52 -1.673 . . . . 0.0 106.883 -176.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -105.26 118.7 37.22 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 -174.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.485 HG13 ' HB2' ' A' ' 146' ' ' LEU . 2.5 pt -136.58 104.27 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 N-CA-C 106.39 -1.708 . . . . 0.0 106.39 -168.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.2 m -98.98 126.23 44.63 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 173.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.679 HD22 ' HD2' ' A' ' 70' ' ' ARG . 0.8 OUTLIER -127.79 142.38 51.32 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.112 178.228 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -86.73 99.22 11.61 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 121.446 -0.784 . . . . 0.0 110.795 -177.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.679 ' HD2' HD22 ' A' ' 68' ' ' LEU . 0.7 OUTLIER -177.54 178.18 1.06 Allowed 'General case' 0 CA--C 1.558 1.288 0 CA-C-O 122.518 1.152 . . . . 0.0 111.874 -178.713 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 129.33 -159.12 22.32 Favored Glycine 0 N--CA 1.463 0.441 0 N-CA-C 107.958 -2.057 . . . . 0.0 107.958 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . 0.273 19.6 t-20 75.85 -90.64 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.165 0 CA-C-N 112.024 -2.088 . . . . 0.0 108.821 173.615 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 67.9 m -107.08 -17.85 14.06 Favored 'General case' 0 CA--C 1.56 1.358 0 CA-C-N 113.594 -1.639 . . . . 0.0 114.512 176.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -162.24 128.75 1.94 Allowed Glycine 0 C--N 1.348 1.217 0 CA-C-O 123.228 1.46 . . . . 0.0 110.429 -174.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.624 HD13 HG22 ' B' ' 6' ' ' VAL . 5.9 mp -106.76 -65.82 1.06 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 112.122 -2.039 . . . . 0.0 107.597 176.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.404 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 102.48 37.58 3.24 Favored Glycine 0 CA--C 1.532 1.121 0 N-CA-C 116.455 1.342 . . . . 0.0 116.455 -172.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -148.17 159.41 43.98 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-O 124.192 1.949 . . . . 0.0 107.254 168.173 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.536 ' O ' HG23 ' A' ' 96' ' ' ILE . 8.7 m -100.81 155.3 18.0 Favored 'General case' 0 C--N 1.313 -1.013 0 O-C-N 120.459 -1.401 . . . . 0.0 110.717 177.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.57 HD11 ' HB ' ' A' ' 134' ' ' VAL . 4.4 pt -129.09 132.65 66.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.572 174.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.435 ' CB ' HD11 ' A' ' 88' ' ' ILE . . . -91.15 -170.43 2.65 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-O 124.249 1.976 . . . . 0.0 108.477 163.183 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 85' ' ' ASN . . . -95.33 160.18 22.8 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-N 113.12 -1.855 . . . . 0.0 114.915 -142.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -108.45 -158.55 19.47 Favored Glycine 0 CA--C 1.52 0.4 0 CA-C-N 111.542 -2.329 . . . . 0.0 111.852 -175.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.533 HG22 ' HB2' ' A' ' 92' ' ' PRO . 42.2 p -54.73 -39.76 68.57 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 117.627 2.454 . . . . 0.0 117.627 -176.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -73.85 -24.87 59.82 Favored 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 116.268 1.951 . . . . 0.0 116.268 170.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.424 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 0.2 OUTLIER -139.97 82.3 17.64 Favored Pre-proline 0 CA--C 1.556 1.177 0 N-CA-C 103.111 -2.922 . . . . 0.0 103.111 -176.119 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.43 ' HB2' ' HB3' ' A' ' 91' ' ' ASP . 85.3 Cg_endo -107.5 118.24 0.03 OUTLIER 'Trans proline' 0 CA--C 1.548 1.224 0 CA-C-N 125.165 2.88 . . . . 0.0 111.288 -169.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -106.28 -38.71 6.15 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.435 HD11 ' CB ' ' A' ' 80' ' ' ALA . 0.6 OUTLIER -115.19 133.09 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 -147.795 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.75 -109.47 2.86 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-N 115.021 -0.991 . . . . 0.0 112.959 167.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -76.78 -9.25 58.55 Favored 'General case' 0 CA--C 1.562 1.406 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 171.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.455 ' HB2' ' HD3' ' A' ' 92' ' ' PRO 0.455 5.5 m-20 101.68 -84.53 0.0 OUTLIER Pre-proline 0 CA--C 1.566 1.575 0 C-N-CA 126.102 1.761 . . . . 0.0 107.617 -176.92 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.533 ' HB2' HG22 ' A' ' 83' ' ' THR . 30.5 Cg_endo -92.47 80.77 0.29 Allowed 'Trans proline' 0 C--N 1.367 1.522 0 C-N-CA 123.859 3.039 . . . . 0.0 112.948 -165.197 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 73.1 m -157.24 134.68 10.55 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 104.4 -2.444 . . . . 0.0 104.4 -177.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.456 HD12 ' HA ' ' A' ' 130' ' ' HIS . 14.0 mm -76.92 121.5 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 -176.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -113.61 151.18 32.05 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 113.714 -1.584 . . . . 0.0 107.492 176.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.55 HG12 HG22 ' A' ' 79' ' ' ILE 0.29 3.4 mt -93.95 122.77 45.7 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.499 0 N-CA-C 105.094 -2.188 . . . . 0.0 105.094 166.147 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.5 m -78.98 -54.95 5.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.934 -1.104 . . . . 0.0 112.778 179.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.497 ' HA ' HG21 ' A' ' 113' ' ' VAL . 36.2 mtpt -147.79 162.92 38.24 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 124.27 1.986 . . . . 0.0 111.138 -164.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.88 104.71 17.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 1 N-CA-C 99.742 -4.17 . . . . 0.0 99.742 -170.449 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.283 1.3 mp -65.41 118.75 53.55 Favored Pre-proline 0 CA--C 1.566 1.572 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -176.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -61.19 134.16 50.84 Favored 'Trans proline' 0 C--N 1.364 1.346 0 C-N-CA 122.997 2.465 . . . . 0.0 112.993 173.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.67 -4.81 85.26 Favored Glycine 0 CA--C 1.544 1.874 0 N-CA-C 118.22 2.048 . . . . 0.0 118.22 -172.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.404 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -90.23 -173.07 44.83 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-O 123.499 1.61 . . . . 0.0 113.116 174.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.53 -34.52 72.38 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 116.363 1.986 . . . . 0.0 116.363 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -53.11 -42.43 65.98 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 120.126 1.33 . . . . 0.0 114.184 163.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.462 ' HA ' ' HB2' ' A' ' 110' ' ' ARG . . . -53.55 -40.73 65.77 Favored 'General case' 0 CA--C 1.562 1.426 0 N-CA-C 116.305 1.965 . . . . 0.0 116.305 174.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.32 -53.47 14.11 Favored 'General case' 0 CA--C 1.561 1.368 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 174.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -94.78 -28.68 15.15 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -167.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.33 86.63 0.09 OUTLIER Glycine 0 CA--C 1.532 1.129 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 176.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.462 ' HB2' ' HA ' ' A' ' 106' ' ' ALA . 29.1 ttm105 -89.73 69.57 7.69 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 122.057 0.932 . . . . 0.0 110.818 -175.282 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -162.35 -178.23 6.17 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 121.609 0.719 . . . . 0.0 110.294 -177.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 30.8 ptt180 50.81 26.83 2.77 Favored 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 118.891 2.922 . . . . 0.0 118.891 154.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.497 HG21 ' HA ' ' A' ' 98' ' ' LYS . 0.4 OUTLIER -47.98 -59.13 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-O 114.795 -2.526 . . . . 0.0 112.02 -179.803 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -43.58 71.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 117.88 2.548 . . . . 0.0 117.88 164.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -142.51 118.16 10.41 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 102.001 -3.333 . . . . 0.0 102.001 -171.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 12.8 m -73.82 86.85 1.73 Allowed 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 113.772 -1.558 . . . . 0.0 110.215 -170.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.3 tp -63.35 116.06 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 CA-C-O 122.11 0.957 . . . . 0.0 110.038 -176.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.513 HD23 ' HB2' ' A' ' 149' ' ' MET . 3.1 pp -96.64 -48.04 5.67 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 112.809 -1.996 . . . . 0.0 114.001 174.24 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -135.42 128.22 31.13 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 -175.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.512 HG23 HD23 ' A' ' 146' ' ' LEU . 5.5 p -121.72 122.26 66.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 172.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.618 HD22 ' HA ' ' A' ' 140' ' ' ALA 0.27 17.0 m120 79.37 -65.3 0.2 Allowed 'General case' 0 N--CA 1.503 2.198 0 CA-C-O 122.818 1.294 . . . . 0.0 111.558 -173.507 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 176.52 -25.28 0.0 OUTLIER 'General case' 0 CA--C 1.573 1.842 0 C-N-CA 128.408 2.683 . . . . 0.0 110.174 -162.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.467 HG12 HG13 ' A' ' 125' ' ' VAL . 2.1 t -70.04 135.83 27.39 Favored 'Isoleucine or valine' 0 C--N 1.361 1.085 0 C-N-CA 125.148 1.379 . . . . 0.0 109.409 179.047 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -88.21 100.0 12.64 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 113.209 -1.814 . . . . 0.0 109.841 176.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.605 HG11 ' HA ' ' A' ' 133' ' ' ALA 0.251 3.3 m -94.79 -119.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 CA-C-O 116.959 -1.496 . . . . 0.0 107.62 174.902 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.696 ' HD2' ' H ' ' A' ' 127' ' ' GLU 0.475 1.0 OUTLIER 56.14 -78.43 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -174.283 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.696 ' H ' ' HD2' ' A' ' 126' ' ' ARG . 25.3 tt0 -79.81 67.1 5.49 Favored 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 126.388 1.875 . . . . 0.0 111.288 168.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -153.77 167.92 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 -177.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 27.0 m -64.37 134.1 53.92 Favored 'General case' 0 CA--C 1.561 1.386 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.151 158.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.456 ' HA ' HD12 ' A' ' 94' ' ' ILE . 3.7 p80 -48.59 -31.51 6.72 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 118.64 2.83 . . . . 0.0 118.64 170.118 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.519 ' HA ' HG12 ' A' ' 134' ' ' VAL . 6.4 m -60.73 -38.6 85.67 Favored 'General case' 0 CA--C 1.563 1.465 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 171.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -67.53 -37.95 83.51 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 166.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.605 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -63.88 -52.44 59.97 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 170.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.57 ' HB ' HD11 ' A' ' 79' ' ' ILE . 3.4 p -54.9 -39.93 50.82 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.25 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 168.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -64.72 -40.46 95.37 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 117.058 -1.448 . . . . 0.0 114.181 173.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -67.98 -33.12 74.03 Favored 'General case' 0 CA--C 1.562 1.423 0 N-CA-C 116.539 2.052 . . . . 0.0 116.539 167.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.482 HD12 HG21 ' A' ' 120' ' ' VAL . 8.7 mp -54.24 -49.17 70.1 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 125.391 1.476 . . . . 0.0 113.763 160.441 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -66.31 -41.66 89.37 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 169.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -65.17 -17.69 64.69 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 116.461 2.023 . . . . 0.0 116.461 172.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.618 ' HA ' HD22 ' A' ' 121' ' ' ASN . . . -52.33 -41.84 63.33 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 117.622 2.453 . . . . 0.0 117.622 164.175 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 71.0 72.21 0.93 Allowed Glycine 0 C--N 1.339 0.714 0 CA-C-O 118.528 -1.151 . . . . 0.0 114.779 159.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . 0.267 4.5 m 68.5 -3.1 1.43 Allowed 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 117.906 2.558 . . . . 0.0 117.906 -173.078 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -148.38 103.19 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.251 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 171.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.441 ' HA ' ' HB1' ' A' ' 140' ' ' ALA . 36.0 m -84.99 122.38 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 124.034 0.934 . . . . 0.0 109.233 168.243 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 50.1 mtt180 -101.92 87.12 3.03 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 171.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.512 HD23 HG23 ' A' ' 120' ' ' VAL . 49.7 mt -92.01 136.53 33.1 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-O 122.47 1.129 . . . . 0.0 108.315 -172.155 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -132.48 118.12 18.89 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 104.359 -2.46 . . . . 0.0 104.359 178.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 33.6 m -126.71 133.0 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -167.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.513 ' HB2' HD23 ' A' ' 118' ' ' LEU . 26.7 ttt -92.17 148.45 22.15 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 123.621 1.677 . . . . 0.0 111.657 175.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.557 ' HA ' ' HE ' ' A' ' 150' ' ' ARG . 0.4 OUTLIER -93.88 123.87 37.51 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 112.698 -2.047 . . . . 0.0 108.455 163.42 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -53.15 -57.72 9.5 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 114.262 -1.335 . . . . 0.0 113.637 172.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 13.0 tptm -174.84 122.18 0.36 Allowed Pre-proline 0 CA--C 1.557 1.247 0 CA-C-O 116.936 -1.507 . . . . 0.0 108.974 -178.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -74.67 117.23 4.87 Favored 'Trans proline' 0 CA--C 1.568 2.204 0 C-N-CA 123.301 2.668 . . . . 0.0 111.749 173.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo . . . . . 0 C--N 1.366 1.458 0 C-N-CA 123.219 2.613 . . . . 0.0 112.261 177.658 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.559 1.292 0 CA-C-O 122.201 1.001 . . . . 0.0 111.695 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -139.33 138.89 37.05 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 123.341 1.543 . . . . 0.0 110.005 173.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -102.86 124.42 48.35 Favored 'General case' 0 CA--C 1.553 1.068 0 CA-C-N 113.452 -1.704 . . . . 0.0 108.294 172.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.43 HG21 HG11 ' A' ' 134' ' ' VAL . 20.1 m -92.68 129.2 38.68 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.243 172.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -103.29 101.55 11.48 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 -174.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.624 HG22 HD13 ' A' ' 75' ' ' LEU . 1.4 p . . . . . 0 C--O 1.252 1.208 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.338 -176.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 7' ' ' BAL . . . . . 0.448 ' O ' ' HB2' ' A' ' 98' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 N--CA 1.48 1.031 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -130.27 133.76 46.73 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 124.048 0.842 . . . . 0.0 109.304 -178.54 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -111.91 140.05 46.89 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.173 -178.037 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -115.48 117.13 29.52 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 114.518 -1.219 . . . . 0.0 108.054 -178.76 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.4 mp -134.41 124.89 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 -171.533 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.8 m -97.11 125.1 41.35 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 168.983 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 mp -123.67 137.85 54.64 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -177.848 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -112.56 131.78 55.44 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -172.56 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.634 ' HB2' ' HB2' ' A' ' 104' ' ' ALA . 6.7 tpm_? -157.48 -112.19 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.942 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.97 173.271 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 95.21 -154.08 20.99 Favored Glycine 0 C--N 1.341 0.842 0 C-N-CA 124.424 1.012 . . . . 0.0 111.753 -172.856 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . 0.278 25.9 t-20 73.08 -91.69 0.02 OUTLIER 'General case' 0 CA--C 1.562 1.405 0 CA-C-N 114.046 -1.077 . . . . 0.0 110.413 -179.648 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 64.9 m -105.1 -16.83 14.68 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 177.476 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -177.08 -149.49 7.78 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-O 124.875 2.375 . . . . 0.0 109.895 176.416 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.486 HD23 ' N ' ' A' ' 75' ' ' LEU . 0.3 OUTLIER -129.51 -4.31 4.79 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 111.438 -2.381 . . . . 0.0 112.247 -179.968 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.594 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 72.39 42.38 49.27 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 119.577 2.591 . . . . 0.0 119.577 163.054 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.449 ' CZ ' HD12 ' A' ' 75' ' ' LEU . 13.1 p90 -157.87 128.22 6.26 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 176.741 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.476 ' HB3' ' HD2' ' B' ' 3' ' ' LYS . 48.1 m -85.19 144.73 27.98 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.789 -1.55 . . . . 0.0 111.663 176.362 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.531 HG22 HD13 ' A' ' 96' ' ' ILE . 2.3 pp -119.2 127.92 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 113.013 -1.903 . . . . 0.0 109.546 -176.907 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.78 -166.74 0.94 Allowed 'General case' 0 CA--C 1.553 1.091 0 CA-C-O 123.417 1.579 . . . . 0.0 111.024 159.632 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.78 159.24 22.2 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-O 123.936 1.853 . . . . 0.0 115.195 -143.407 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.51 -161.18 23.23 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-N 111.162 -2.519 . . . . 0.0 113.057 179.191 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.405 HG22 ' HB2' ' A' ' 92' ' ' PRO . 71.4 p -53.99 -40.27 66.8 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 -177.638 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.451 ' HB2' HG23 ' A' ' 129' ' ' THR . 5.9 m-20 -92.88 7.9 41.91 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 116.099 1.889 . . . . 0.0 116.099 175.543 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -161.16 86.67 1.7 Allowed Pre-proline 0 CA--C 1.553 1.092 0 N-CA-C 101.154 -3.647 . . . . 0.0 101.154 178.945 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.404 ' HB2' ' HB3' ' A' ' 91' ' ' ASP . 61.0 Cg_endo -108.48 124.53 0.04 OUTLIER 'Trans proline' 0 CA--C 1.549 1.237 0 CA-C-N 124.437 2.62 . . . . 0.0 111.634 -173.023 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -109.03 -34.59 6.56 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 176.224 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -148.0 161.7 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 CA-C-O 123.268 1.508 . . . . 0.0 109.592 -151.802 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.45 -111.08 3.21 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-N 113.365 -1.743 . . . . 0.0 109.822 177.081 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -103.39 5.33 37.08 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 112.978 -1.611 . . . . 0.0 114.518 168.002 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.404 ' HB3' ' HB2' ' A' ' 86' ' ' PRO 0.428 75.9 m-20 100.93 -76.49 0.0 OUTLIER Pre-proline 0 CA--C 1.568 1.66 0 CA-C-O 116.262 -1.828 . . . . 0.0 108.711 -165.939 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.405 ' HB2' HG22 ' A' ' 83' ' ' THR . 81.2 Cg_endo -88.56 80.9 0.94 Allowed 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 123.409 2.74 . . . . 0.0 113.023 -176.338 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 52.9 m -156.65 109.63 2.59 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 105.512 -2.032 . . . . 0.0 105.512 -173.651 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.484 HD12 ' HA ' ' A' ' 130' ' ' HIS . 8.1 mm -68.95 117.9 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 178.559 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -129.26 140.24 51.52 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 113.459 -1.701 . . . . 0.0 107.514 -163.488 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.531 HD13 HG22 ' A' ' 79' ' ' ILE . 7.4 mm -85.84 107.46 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.346 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 175.365 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 77.0 m -91.11 -35.06 14.81 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 117.4 -1.286 . . . . 0.0 113.74 175.54 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.468 ' HA ' HG11 ' A' ' 113' ' ' VAL 0.321 0.0 OUTLIER -144.18 165.14 28.67 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 123.299 1.524 . . . . 0.0 111.72 175.54 . . . . . . . . 4 4 . 1 . 021 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -111.83 126.37 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 -176.451 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.304 1.4 mp -72.25 130.44 86.23 Favored Pre-proline 0 CA--C 1.567 1.606 0 CA-C-O 118.252 -0.88 . . . . 0.0 109.2 169.454 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -58.88 130.6 37.51 Favored 'Trans proline' 0 C--N 1.367 1.511 0 C-N-CA 123.54 2.826 . . . . 0.0 114.521 174.924 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 72.12 20.99 79.34 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 117.153 1.621 . . . . 0.0 117.153 -167.042 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.594 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -85.93 -176.81 50.09 Favored Glycine 0 C--N 1.337 0.636 0 N-CA-C 116.399 1.32 . . . . 0.0 116.399 177.203 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.634 ' HB2' ' HB2' ' A' ' 70' ' ' ARG . . . -63.81 -51.61 63.96 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 178.415 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.49 -38.91 89.04 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 174.167 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.92 -42.03 77.35 Favored 'General case' 0 CA--C 1.565 1.527 0 N-CA-C 115.821 1.786 . . . . 0.0 115.821 170.528 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.67 -51.1 20.83 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.604 1.162 . . . . 0.0 113.877 178.526 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -71.48 -49.85 37.25 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.38 1.072 . . . . 0.0 112.109 -176.134 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.45 -164.11 10.87 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 124.32 2.067 . . . . 0.0 112.498 179.082 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -139.6 56.49 1.65 Allowed 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 110.902 -2.649 . . . . 0.0 108.084 -177.606 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.613 HD23 ' H ' ' A' ' 111' ' ' LEU . 1.4 pt? -88.59 -160.99 0.7 Allowed 'General case' 0 CA--C 1.547 0.864 0 CA-C-O 125.18 2.419 . . . . 0.0 107.591 -174.107 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.94 149.77 42.13 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 102.718 -3.068 . . . . 0.0 102.718 162.667 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.51 HG23 ' H ' ' A' ' 114' ' ' ASN 0.266 14.4 m -45.99 -69.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 110.451 -3.068 . . . . 0.0 111.999 172.673 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.51 ' H ' HG23 ' A' ' 113' ' ' VAL . 25.0 m-80 -20.35 74.64 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 119.27 3.063 . . . . 0.0 119.27 172.949 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.461 ' HB3' HG11 ' A' ' 148' ' ' VAL . 47.2 m-20 -151.97 117.93 5.5 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 102.831 -3.026 . . . . 0.0 102.831 -176.367 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.0 m -80.62 93.57 6.15 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.03 -0.986 . . . . 0.0 108.571 -176.517 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.466 HG12 HD11 ' A' ' 137' ' ' LEU . 7.2 tp -59.7 112.94 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 C-N-CA 123.569 0.748 . . . . 0.0 111.306 178.949 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.629 ' HA ' ' HB3' ' A' ' 126' ' ' ARG 0.431 0.0 OUTLIER -105.67 -39.81 5.96 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 115.933 1.827 . . . . 0.0 115.933 -174.306 . . . . . . . . 4 4 . 1 . 021 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -136.19 135.27 38.99 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 105.019 -2.215 . . . . 0.0 105.019 171.72 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.457 HG11 HD12 ' A' ' 137' ' ' LEU . 9.9 p -123.55 121.95 63.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 170.43 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.576 HD22 ' HA ' ' A' ' 140' ' ' ALA 0.261 9.0 m120 77.17 -79.73 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 123.332 1.539 . . . . 0.0 108.93 -175.008 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.402 ' H ' ' H ' ' A' ' 123' ' ' VAL . 1.1 tt0 -165.25 -7.77 0.02 OUTLIER 'General case' 0 CA--C 1.576 1.978 0 C-N-CA 127.986 2.514 . . . . 0.0 110.78 -178.833 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.526 HG12 HG13 ' A' ' 125' ' ' VAL . 2.1 t -72.46 135.91 26.77 Favored 'Isoleucine or valine' 0 C--N 1.359 1.014 0 C-N-CA 125.443 1.497 . . . . 0.0 109.526 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -77.43 102.19 6.74 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 112.903 -1.953 . . . . 0.0 110.605 171.776 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.57 HG11 ' HA ' ' A' ' 133' ' ' ALA 0.261 2.2 m -109.78 -113.13 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-O 116.361 -1.781 . . . . 0.0 107.936 175.254 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.629 ' HB3' ' HA ' ' A' ' 118' ' ' LEU 0.328 0.0 OUTLIER 48.06 -82.72 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 117.753 2.501 . . . . 0.0 117.753 -176.12 . . . . . . . . 4 4 . 1 . 021 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.566 ' H ' ' HD3' ' A' ' 126' ' ' ARG . 2.9 tm-20 -88.35 70.4 9.09 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-O 123.696 1.712 . . . . 0.0 108.572 171.981 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.63 167.27 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 -178.689 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.451 HG23 ' HB2' ' A' ' 84' ' ' ASP . 11.6 m -58.45 132.42 53.66 Favored 'General case' 0 CA--C 1.555 1.146 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.206 159.358 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.484 ' HA ' HD12 ' A' ' 94' ' ' ILE . 2.7 p-80 -47.45 -34.16 6.97 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 117.37 2.359 . . . . 0.0 117.37 173.706 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.581 ' HA ' HG12 ' A' ' 134' ' ' VAL . 5.2 m -60.38 -40.5 91.06 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 174.925 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -67.24 -37.75 84.05 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 166.738 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.57 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -66.95 -55.86 12.7 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 173.663 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.606 HG23 HG22 ' B' ' 6' ' ' VAL . 8.6 p -47.09 -45.71 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 166.567 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.2 -54.15 49.27 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 115.765 -2.064 . . . . 0.0 111.72 174.862 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.97 -34.51 76.27 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 117.527 2.417 . . . . 0.0 117.527 174.074 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.466 HD11 HG12 ' A' ' 117' ' ' ILE . 6.0 mp -57.78 -55.34 36.09 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 125.636 1.575 . . . . 0.0 113.45 165.134 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -65.05 -33.77 76.84 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 115.898 1.814 . . . . 0.0 115.898 171.435 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -68.29 -23.64 64.77 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 117.135 2.272 . . . . 0.0 117.135 170.636 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.576 ' HA ' HD22 ' A' ' 121' ' ' ASN . . . -53.28 -28.46 28.03 Favored 'General case' 0 CA--C 1.56 1.362 0 N-CA-C 116.938 2.199 . . . . 0.0 116.938 156.046 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 91.09 -132.12 11.12 Favored Glycine 0 C--N 1.347 1.193 0 CA-C-O 122.53 1.072 . . . . 0.0 110.753 166.879 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 13.0 m -78.76 -2.06 37.68 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 169.152 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.05 103.8 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 -172.915 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.484 HG11 ' CD1' ' A' ' 75' ' ' LEU . 16.6 m -92.81 117.53 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 113.205 -1.816 . . . . 0.0 108.682 -178.985 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -89.57 94.22 9.78 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 169.837 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 82.1 mt -97.05 127.13 42.72 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 -173.521 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -126.12 120.01 29.05 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 102.963 -2.977 . . . . 0.0 102.963 177.178 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.461 HG11 ' HB3' ' A' ' 115' ' ' ASP . 16.8 m -124.65 132.89 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -173.346 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 57.5 ttm -100.27 112.38 24.7 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 119.759 1.163 . . . . 0.0 108.54 168.419 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -88.31 125.56 34.73 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 -178.541 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -56.59 -29.22 61.83 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 116.761 2.134 . . . . 0.0 116.761 169.581 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt 74.71 164.74 0.14 Allowed Pre-proline 0 CA--C 1.56 1.332 0 C-N-CA 124.326 1.05 . . . . 0.0 112.825 175.162 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -87.04 107.85 0.71 Allowed 'Trans proline' 0 CA--C 1.568 2.2 0 C-N-CA 123.161 2.574 . . . . 0.0 109.895 168.817 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo . . . . . 0 C--N 1.369 1.635 0 C-N-CA 123.233 2.622 . . . . 0.0 111.388 179.687 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.558 1.265 0 CA-C-O 122.585 1.184 . . . . 0.0 111.214 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -148.24 120.75 8.52 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 122.517 1.151 . . . . 0.0 108.874 173.402 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.476 ' HD2' ' HB3' ' A' ' 78' ' ' SER . 16.7 ttpp -92.1 124.78 36.45 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.42 174.784 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.569 HG21 HG21 ' A' ' 134' ' ' VAL . 3.1 m -87.25 143.04 27.46 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 122.174 0.988 . . . . 0.0 109.418 168.98 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.69 120.31 35.72 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 178.462 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.606 HG22 HG23 ' A' ' 134' ' ' VAL . 21.8 t . . . . . 0 N--CA 1.478 0.933 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 -160.84 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 121.802 0.811 . . . . 0.0 109.92 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -106.15 134.68 48.89 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.656 176.414 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -124.91 136.05 53.41 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -176.83 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.407 ' HB3' ' CE2' ' A' ' 147' ' ' TYR . 9.9 pt-20 -80.39 128.56 33.7 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 114.306 -1.316 . . . . 0.0 111.795 175.42 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 23.4 mt -129.57 118.12 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 -179.3 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.3 m -97.19 122.88 40.71 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 174.248 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.455 ' HB3' ' CG2' ' A' ' 144' ' ' VAL . 1.2 tt -119.85 161.45 20.79 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 113.098 -1.865 . . . . 0.0 106.7 174.902 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -83.09 142.16 31.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.425 -1.422 . . . . 0.0 108.912 173.622 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.449 ' HG2' ' HG ' ' A' ' 75' ' ' LEU . 4.2 tmt_? -79.86 82.27 5.98 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 120.001 -1.687 . . . . 0.0 109.153 168.098 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 31.07 -118.88 0.1 Allowed Glycine 0 N--CA 1.482 1.725 0 C-N-CA 125.911 1.72 . . . . 0.0 117.093 171.271 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.9 t30 -154.22 -67.47 0.14 Allowed 'General case' 0 CA--C 1.556 1.2 0 CA-C-N 112.976 -1.612 . . . . 0.0 107.294 170.307 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.3 m -83.64 -21.83 32.35 Favored 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 114.881 1.438 . . . . 0.0 114.881 168.938 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -138.8 -133.17 3.03 Favored Glycine 0 CA--C 1.535 1.307 0 N-CA-C 107.911 -2.076 . . . . 0.0 107.911 168.367 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.71 HD11 HG11 ' A' ' 144' ' ' VAL . 1.4 tt -121.46 -54.26 1.98 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.028 0.931 . . . . 0.0 109.643 179.702 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 118.02 22.83 3.76 Favored Glycine 0 N--CA 1.478 1.491 0 N-CA-C 118.017 1.967 . . . . 0.0 118.017 178.8 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -145.68 177.17 9.09 Favored 'General case' 0 CA--C 1.557 1.247 0 CA-C-O 123.749 1.738 . . . . 0.0 107.788 171.586 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.408 ' O ' HG23 ' A' ' 96' ' ' ILE . 1.8 m -134.91 145.13 47.92 Favored 'General case' 0 C--N 1.318 -0.804 0 O-C-N 119.909 -1.744 . . . . 0.0 107.559 -178.418 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.58 HG22 HG12 ' A' ' 96' ' ' ILE . 5.6 pt -112.22 137.0 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 114.695 -1.138 . . . . 0.0 112.006 -172.847 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.416 ' HB1' ' CB ' ' A' ' 87' ' ' HIS . . . -85.57 -174.3 5.1 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-O 123.976 1.846 . . . . 0.0 111.368 160.857 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.82 157.98 21.84 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 113.015 -1.902 . . . . 0.0 115.058 -145.78 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -104.69 -158.6 23.65 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 111.954 -2.123 . . . . 0.0 113.724 179.182 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.467 HG22 ' CB ' ' A' ' 92' ' ' PRO . 34.6 p -54.32 -38.24 65.76 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 116.872 2.175 . . . . 0.0 116.872 -178.0 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -83.25 -10.31 58.63 Favored 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 116.285 1.957 . . . . 0.0 116.285 174.406 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.15 92.29 2.35 Favored Pre-proline 0 CA--C 1.552 1.028 0 N-CA-C 101.095 -3.669 . . . . 0.0 101.095 -173.02 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -93.2 138.46 1.49 Allowed 'Trans proline' 0 CA--C 1.55 1.304 0 CA-C-N 124.879 2.778 . . . . 0.0 111.453 -176.405 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.416 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 28.3 t60 -100.72 -31.31 11.26 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 167.858 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.491 ' H ' HD12 ' A' ' 88' ' ' ILE . 0.2 OUTLIER -98.95 153.12 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 125.051 1.34 . . . . 0.0 109.974 -168.923 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -74.71 13.34 5.26 Favored Glycine 0 CA--C 1.549 2.167 0 N-CA-C 118.938 2.335 . . . . 0.0 118.938 176.572 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -92.7 -10.41 37.28 Favored 'General case' 0 CA--C 1.568 1.669 0 CA-C-O 117.178 -1.391 . . . . 0.0 114.403 162.321 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.466 ' HB3' ' HD3' ' A' ' 92' ' ' PRO 0.519 12.7 t70 88.28 -84.37 0.0 OUTLIER Pre-proline 0 CA--C 1.568 1.643 0 CA-C-O 115.85 -2.024 . . . . 0.0 109.616 -169.764 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.467 ' CB ' HG22 ' A' ' 83' ' ' THR . 84.6 Cg_endo -116.71 98.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.367 1.507 0 CA-C-N 125.458 2.985 . . . . 0.0 112.473 -164.827 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.4 m -158.19 125.22 4.95 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 -176.541 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.46 HG21 ' HB1' ' A' ' 133' ' ' ALA . 22.1 mm -78.4 123.24 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 178.517 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -116.67 154.67 30.15 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 112.684 -2.053 . . . . 0.0 107.969 177.717 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.58 HG12 HG22 ' A' ' 79' ' ' ILE 0.357 10.3 mt -95.39 123.79 47.7 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.076 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 161.001 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 49.6 m -74.3 -60.45 2.26 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.769 -1.207 . . . . 0.0 113.114 171.635 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.445 ' C ' HG11 ' A' ' 113' ' ' VAL . 14.0 ptmt -147.16 162.21 39.33 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 123.876 1.798 . . . . 0.0 111.48 -163.375 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.593 HG21 ' HA ' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -103.87 121.86 55.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 104.427 -2.434 . . . . 0.0 104.427 -175.157 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.259 1.6 mp -73.86 121.14 84.45 Favored Pre-proline 0 CA--C 1.567 1.623 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 173.353 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -61.02 138.1 76.25 Favored 'Trans proline' 0 C--N 1.365 1.425 0 C-N-CA 123.285 2.657 . . . . 0.0 113.701 172.581 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.32 0.58 83.79 Favored Glycine 0 CA--C 1.547 2.09 0 N-CA-C 118.153 2.021 . . . . 0.0 118.153 -170.936 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -89.96 -177.39 45.05 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-N 119.114 1.457 . . . . 0.0 112.978 174.444 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.37 -32.4 71.43 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 116.821 2.156 . . . . 0.0 116.821 176.631 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.8 -31.91 72.98 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 117.876 -1.059 . . . . 0.0 113.813 168.91 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.527 ' HA ' ' HB2' ' A' ' 110' ' ' ARG . . . -49.44 -43.47 44.79 Favored 'General case' 0 CA--C 1.559 1.319 0 N-CA-C 118.037 2.606 . . . . 0.0 118.037 164.68 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.8 -53.47 9.1 Favored 'General case' 0 CA--C 1.563 1.446 0 C-N-CA 124.466 1.106 . . . . 0.0 113.707 174.916 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -72.3 -52.13 17.64 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -174.16 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -166.94 92.51 0.1 Allowed Glycine 0 CA--C 1.529 0.907 0 N-CA-C 108.287 -1.925 . . . . 0.0 108.287 176.444 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.593 ' HA ' HG21 ' A' ' 99' ' ' ILE . 37.8 ttp180 -77.83 48.08 0.67 Allowed 'General case' 0 CA--C 1.573 1.851 0 N-CA-C 115.775 1.769 . . . . 0.0 115.775 179.548 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.96 -23.56 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 119.748 -1.845 . . . . 0.0 115.392 -159.62 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -96.8 3.88 52.04 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 117.956 2.576 . . . . 0.0 117.956 -167.221 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.506 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 2.5 m -38.01 -62.03 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.592 0 C-N-CA 127.048 2.139 . . . . 0.0 113.32 -169.371 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -54.52 79.5 0.0 OUTLIER 'General case' 0 CA--C 1.566 1.559 0 CA-C-O 124.464 2.078 . . . . 0.0 114.516 167.893 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -141.73 124.25 15.83 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 100.841 -3.763 . . . . 0.0 100.841 -177.376 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.1 m -75.18 85.2 2.39 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 114.198 -1.365 . . . . 0.0 109.54 -178.198 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.481 HG12 HD11 ' A' ' 137' ' ' LEU . 6.2 tp -65.63 115.64 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 CA-C-O 122.622 1.201 . . . . 0.0 109.602 179.755 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.487 ' HA ' ' HB3' ' A' ' 126' ' ' ARG . 3.1 pp -107.23 -45.12 4.18 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 112.233 -2.258 . . . . 0.0 115.206 179.769 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -130.9 134.78 47.08 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 -179.119 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.48 HG23 HD23 ' A' ' 146' ' ' LEU . 7.4 p -125.62 119.43 54.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 173.248 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . 0.279 9.6 m120 76.26 -88.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -174.312 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -148.05 -6.96 0.43 Allowed 'General case' 0 CA--C 1.576 1.953 0 C-N-CA 128.225 2.61 . . . . 0.0 110.71 177.027 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.3 t -69.81 136.5 26.02 Favored 'Isoleucine or valine' 0 C--N 1.359 1.011 0 C-N-CA 125.463 1.505 . . . . 0.0 109.728 178.502 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -89.61 102.21 14.89 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 113.355 -1.748 . . . . 0.0 108.544 175.03 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.524 HG11 ' HA ' ' A' ' 133' ' ' ALA 0.258 0.9 OUTLIER -99.71 -97.97 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-O 116.225 -1.845 . . . . 0.0 107.73 173.424 . . . . . . . . 4 4 . 1 . 022 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.487 ' HB3' ' HA ' ' A' ' 118' ' ' LEU 0.301 0.4 OUTLIER 46.7 -87.3 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 117.284 2.328 . . . . 0.0 117.284 179.984 . . . . . . . . 4 4 . 1 . 022 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -85.26 76.11 10.2 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-O 123.408 1.575 . . . . 0.0 108.763 170.232 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.0 p -146.09 168.87 6.57 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 CA-C-N 113.166 -1.834 . . . . 0.0 106.316 -179.784 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.487 HG22 ' H ' ' A' ' 131' ' ' SER . 33.1 m -62.1 137.28 58.23 Favored 'General case' 0 CA--C 1.562 1.407 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.326 158.051 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 10.2 p-80 -46.62 -33.21 4.0 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 117.552 2.427 . . . . 0.0 117.552 168.456 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.487 ' H ' HG22 ' A' ' 129' ' ' THR . 10.9 m -61.02 -41.23 96.16 Favored 'General case' 0 CA--C 1.555 1.159 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 175.109 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -69.0 -35.65 76.94 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 166.851 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.524 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -67.2 -53.88 26.2 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 172.634 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.538 ' HB ' HD11 ' A' ' 79' ' ' ILE . 2.5 p -49.26 -42.86 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 165.827 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -60.15 -55.61 31.69 Favored 'General case' 0 C--N 1.353 0.751 0 CA-C-O 115.799 -2.048 . . . . 0.0 113.24 173.682 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -65.63 -28.31 69.02 Favored 'General case' 0 CA--C 1.564 1.493 0 N-CA-C 117.09 2.255 . . . . 0.0 117.09 175.419 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.481 HD11 HG12 ' A' ' 117' ' ' ILE . 9.8 mp -62.96 -53.93 46.29 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 125.242 1.417 . . . . 0.0 113.876 167.326 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -66.79 -32.73 74.21 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 167.597 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -70.24 -11.5 60.95 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 117.481 2.4 . . . . 0.0 117.481 171.363 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.511 ' HB3' HG12 ' A' ' 144' ' ' VAL . . . -59.13 -1.24 0.17 Allowed 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 118.82 2.896 . . . . 0.0 118.82 163.663 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 93.45 -127.08 8.88 Favored Glycine 0 C--N 1.344 0.989 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 171.395 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.5 m -93.81 -0.5 55.8 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 169.011 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -150.6 111.03 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 -166.188 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.71 HG11 HD11 ' A' ' 75' ' ' LEU . 34.2 m -90.13 121.04 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 114.528 -1.214 . . . . 0.0 109.119 -179.408 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -103.98 88.24 2.97 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 178.653 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.48 HD23 HG23 ' A' ' 120' ' ' VAL . 77.4 mt -89.58 142.22 27.87 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.393 -172.279 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.407 ' CE2' ' HB3' ' A' ' 65' ' ' GLU . 38.4 m-85 -123.69 124.02 41.82 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 103.906 -2.627 . . . . 0.0 103.906 168.748 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 20.0 m -132.49 131.77 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -169.854 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.419 ' HB2' ' CD2' ' A' ' 118' ' ' LEU . 58.1 ttm -95.7 135.62 37.16 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 123.205 1.479 . . . . 0.0 110.791 177.069 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -102.01 138.61 38.74 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 113.37 -1.741 . . . . 0.0 108.742 161.088 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 62.68 70.04 0.57 Allowed 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.353 0.661 . . . . 0.0 110.903 175.647 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -76.26 115.92 51.43 Favored Pre-proline 0 CA--C 1.56 1.347 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -174.28 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -77.29 132.01 12.18 Favored 'Trans proline' 0 CA--C 1.563 1.955 0 C-N-CA 122.623 2.215 . . . . 0.0 111.881 -176.046 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo . . . . . 0 CA--C 1.553 1.437 0 C-N-CA 123.144 2.562 . . . . 0.0 113.588 169.959 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.558 1.271 0 CA-C-O 122.286 1.041 . . . . 0.0 110.19 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -140.84 124.34 16.83 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 122.986 1.374 . . . . 0.0 108.344 168.144 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.53 129.03 34.96 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 114.175 -1.375 . . . . 0.0 109.646 176.022 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 85.8 m -101.86 132.58 47.55 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.839 175.953 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -75.28 147.98 39.77 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 122.653 1.216 . . . . 0.0 110.666 174.021 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.41 ' O ' ' HB3' ' A' ' 75' ' ' LEU . 2.6 p . . . . . 0 C--O 1.247 0.927 0 N-CA-C 103.876 -2.638 . . . . 0.0 103.876 -178.895 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.7 p90 . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 121.566 0.698 . . . . 0.0 109.782 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -100.47 136.81 39.77 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.432 -177.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -102.41 116.78 33.33 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.3 mp -130.91 111.96 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 -175.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.3 m -94.25 131.04 40.25 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 168.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.561 HD11 ' HA ' ' A' ' 105' ' ' ALA . 8.9 tt -134.86 141.87 46.47 Favored 'General case' 0 CA--C 1.556 1.206 0 CA-C-N 113.91 -1.495 . . . . 0.0 108.488 -173.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 . . . . . 0 N--CA 1.488 1.444 0 C-N-CA 123.293 0.637 . . . . 0.0 109.894 177.834 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 CA--C 1.558 1.281 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 140.82 36.17 0.11 Allowed Glycine 0 CA--C 1.546 1.975 0 N-CA-C 116.848 1.499 . . . . 0.0 116.848 -166.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.439 ' CD2' ' HB2' ' A' ' 105' ' ' ALA . 0.3 OUTLIER -137.25 175.82 9.26 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 174.814 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 45.7 m -149.05 119.15 7.19 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 119.919 -1.738 . . . . 0.0 107.775 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.405 HD11 ' HB ' ' A' ' 134' ' ' VAL . 5.3 pt -97.22 132.23 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.461 -172.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -79.5 -177.49 5.82 Favored 'General case' 0 CA--C 1.556 1.193 0 CA-C-O 123.478 1.608 . . . . 0.0 111.673 156.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.75 163.03 25.67 Favored Glycine 0 CA--C 1.54 1.599 0 CA-C-N 113.751 -1.568 . . . . 0.0 116.576 -149.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.2 -156.74 20.48 Favored Glycine 0 N--CA 1.471 1.02 0 CA-C-N 112.553 -1.824 . . . . 0.0 114.135 177.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.72 -43.05 76.19 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 115.799 1.778 . . . . 0.0 115.799 177.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -62.33 -38.34 89.1 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 117.536 2.421 . . . . 0.0 117.536 172.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -142.17 89.35 8.7 Favored Pre-proline 0 CA--C 1.553 1.068 1 N-CA-C 99.424 -4.287 . . . . 0.0 99.424 -168.265 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -100.31 130.73 0.16 Allowed 'Trans proline' 0 CA--C 1.548 1.193 0 CA-C-N 124.361 2.593 . . . . 0.0 110.655 -175.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 72.0 t60 . . . . . 0 CA--C 1.582 2.177 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 154.274 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo . . . . . 0 CA--C 1.548 1.225 0 CA-C-O 122.534 0.973 . . . . 0.0 110.969 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 75.7 m -145.3 128.75 16.95 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 -174.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.443 ' H ' ' HA ' ' A' ' 126' ' ' ARG . 24.6 mm -74.41 115.81 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 -177.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -104.26 155.95 18.31 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 113.044 -1.889 . . . . 0.0 107.446 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . 0.31 97.6 mt -96.28 120.0 45.07 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.688 0 N-CA-C 104.686 -2.339 . . . . 0.0 104.686 160.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 43.4 m -92.42 -25.0 18.68 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 120.57 -1.331 . . . . 0.0 113.486 168.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -138.66 150.74 46.55 Favored 'General case' 0 CA--C 1.56 1.331 0 CA-C-N 120.72 1.6 . . . . 0.0 110.473 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -99.32 126.23 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 104.762 -2.31 . . . . 0.0 104.762 170.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.25 28.7 mm -73.96 120.77 83.0 Favored Pre-proline 0 CA--C 1.571 1.755 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 176.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.64 132.12 22.85 Favored 'Trans proline' 0 C--N 1.368 1.586 0 C-N-CA 123.834 3.022 . . . . 0.0 113.045 -175.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 74.94 0.08 59.32 Favored Glycine 0 CA--C 1.551 2.323 0 N-CA-C 118.59 2.196 . . . . 0.0 118.59 -168.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -88.1 -162.38 38.04 Favored Glycine 0 CA--C 1.544 1.904 0 CA-C-N 119.161 1.481 . . . . 0.0 113.525 177.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.24 -58.05 9.94 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.561 ' HA ' HD11 ' A' ' 68' ' ' LEU . . . -50.47 -45.68 56.36 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 117.843 2.534 . . . . 0.0 117.843 172.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.38 -40.53 73.92 Favored 'General case' 0 CA--C 1.56 1.341 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 177.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . 0.256 0.0 OUTLIER -72.14 -55.49 7.2 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 178.231 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.6 t70 . . . . . 0 CA--C 1.557 1.237 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -173.519 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 122.76 1.267 . . . . 0.0 114.39 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.7 m -85.67 104.87 15.79 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 112.568 -2.105 . . . . 0.0 107.455 -161.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . 0.336 11.0 tp -57.93 104.07 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.497 0 CA-C-O 122.339 1.066 . . . . 0.0 112.323 -170.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.439 ' HG ' ' HB2' ' A' ' 149' ' ' MET 0.317 0.1 OUTLIER -82.9 -63.62 1.33 Allowed 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 112.602 -2.09 . . . . 0.0 110.413 -176.142 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -132.49 135.54 46.08 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 173.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 5.7 p -119.13 112.47 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 105.709 -1.959 . . . . 0.0 105.709 171.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.717 HD21 ' HB2' ' A' ' 140' ' ' ALA 0.27 23.2 m-80 77.7 -78.89 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 122.821 1.296 . . . . 0.0 109.966 -174.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -159.5 -12.94 0.06 Allowed 'General case' 0 CA--C 1.573 1.838 0 C-N-CA 127.399 2.28 . . . . 0.0 110.951 -176.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.657 HG12 HG13 ' A' ' 125' ' ' VAL . 2.4 t -68.25 134.83 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.394 0 C-N-CA 125.376 1.47 . . . . 0.0 110.124 175.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -87.17 97.04 10.54 Favored 'General case' 0 CA--C 1.553 1.068 0 CA-C-N 113.434 -1.712 . . . . 0.0 108.638 177.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.657 HG13 HG12 ' A' ' 123' ' ' VAL 0.325 2.9 m -97.11 -142.49 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.599 179.616 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.443 ' HA ' ' H ' ' A' ' 94' ' ' ILE 0.323 0.9 OUTLIER 71.82 -83.66 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 124.664 1.185 . . . . 0.0 111.2 -173.299 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.56 69.87 10.17 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 123.752 1.739 . . . . 0.0 109.406 177.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.1 m -143.72 166.49 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 -175.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 46.7 m -56.71 129.74 42.46 Favored 'General case' 0 CA--C 1.568 1.666 0 CA-C-N 112.96 -1.927 . . . . 0.0 109.639 150.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -48.49 -32.22 7.55 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 168.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.543 ' HA ' HG12 ' A' ' 134' ' ' VAL . 16.1 m -57.62 -45.03 85.89 Favored 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 168.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.36 -38.52 84.1 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 169.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.474 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -73.23 -44.29 59.79 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 116.914 2.19 . . . . 0.0 116.914 172.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.543 HG12 ' HA ' ' A' ' 131' ' ' SER . 4.6 p -57.71 -44.93 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 168.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -60.0 -50.8 72.32 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-O 117.089 -1.434 . . . . 0.0 112.055 170.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.63 -31.91 69.94 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 117.939 2.57 . . . . 0.0 117.939 172.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 73.3 mt -59.26 -53.75 54.67 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 125.071 1.348 . . . . 0.0 113.619 164.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -68.6 -35.95 78.03 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 117.358 2.355 . . . . 0.0 117.358 172.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -64.09 -14.28 53.58 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 117.044 2.238 . . . . 0.0 117.044 169.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.717 ' HB2' HD21 ' A' ' 121' ' ' ASN . . . -54.99 -24.0 22.06 Favored 'General case' 0 CA--C 1.561 1.368 0 N-CA-C 118.756 2.873 . . . . 0.0 118.756 160.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 93.61 -125.99 8.45 Favored Glycine 0 N--CA 1.475 1.268 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 168.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.2 m -79.94 -3.36 47.86 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 168.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -149.93 106.8 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -166.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.513 HG23 ' HB3' ' A' ' 68' ' ' LEU . 2.4 m -81.74 117.55 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 124.192 0.997 . . . . 0.0 110.572 170.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 45.4 mtm180 -99.45 90.59 4.57 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 175.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 42.5 mt -94.25 128.52 40.76 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.322 -169.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -127.49 121.68 31.38 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 103.231 -2.877 . . . . 0.0 103.231 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 18.3 m -131.38 119.44 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 CA-C-N 119.815 1.189 . . . . 0.0 110.923 -163.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . 0.439 ' HB2' ' HG ' ' A' ' 118' ' ' LEU . 28.1 ttt . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 122.378 1.085 . . . . 0.0 111.256 -176.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.558 1.273 0 CA-C-O 122.55 1.167 . . . . 0.0 111.406 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -138.31 128.18 25.34 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 170.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 20.7 ttpp -78.97 114.5 17.97 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.551 170.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 85.8 m -88.66 126.54 35.35 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 122.412 1.101 . . . . 0.0 109.059 175.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -80.66 133.8 35.77 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 113.886 -1.506 . . . . 0.0 108.502 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.417 ' HB ' HG23 ' A' ' 134' ' ' VAL . 7.6 p . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 -170.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 26.8 p90 . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -113.67 141.54 47.1 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.196 -172.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.9 117.7 34.7 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.3 mp -123.76 131.08 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 -174.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.0 m -101.15 127.13 47.85 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 162.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.0 tp -133.79 130.75 38.43 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 113.979 -1.464 . . . . 0.0 107.574 -176.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 . . . . . 0 N--CA 1.485 1.307 0 O-C-N 121.352 -0.842 . . . . 0.0 109.848 178.494 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.558 HD11 HG21 ' A' ' 144' ' ' VAL . 1.3 tt . . . . . 0 N--CA 1.48 1.075 0 CA-C-O 118.119 -0.943 . . . . 0.0 110.101 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.445 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 103.75 44.36 1.67 Allowed Glycine 0 CA--C 1.533 1.179 0 N-CA-C 117.392 1.717 . . . . 0.0 117.392 173.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.46 ' CD1' HD13 ' A' ' 96' ' ' ILE . 0.1 OUTLIER -160.24 168.35 25.56 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.95 1.3 . . . . 0.0 108.487 176.252 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.468 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 3.0 m -131.81 119.7 21.62 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 120.622 -1.299 . . . . 0.0 111.068 -163.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.593 HG22 HG12 ' A' ' 96' ' ' ILE . 1.7 pt -95.51 129.22 45.93 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.279 -174.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.57 -173.92 4.35 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-O 123.299 1.523 . . . . 0.0 110.243 161.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.47 160.17 22.69 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 123.88 1.822 . . . . 0.0 116.046 -137.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -103.96 -162.0 24.77 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 111.26 -2.47 . . . . 0.0 115.449 -178.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 53.1 p -54.45 -40.16 68.12 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 116.395 1.998 . . . . 0.0 116.395 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.421 ' HB2' HG23 ' A' ' 129' ' ' THR . 9.6 m-20 -88.49 0.5 56.22 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 116.363 1.986 . . . . 0.0 116.363 175.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -163.27 87.84 1.27 Allowed Pre-proline 0 CA--C 1.557 1.242 0 N-CA-C 101.275 -3.602 . . . . 0.0 101.275 -176.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -97.5 143.19 0.67 Allowed 'Trans proline' 0 CA--C 1.549 1.265 0 CA-C-N 124.043 2.48 . . . . 0.0 111.073 -174.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 57.6 t60 . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 167.158 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo . . . . . 0 CA--C 1.545 1.039 0 CA-C-O 121.159 0.399 . . . . 0.0 112.371 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 67.9 m -154.93 109.52 2.99 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.497 HD12 ' HA ' ' A' ' 130' ' ' HIS . 17.6 mm -74.09 118.85 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 174.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.481 ' HB2' ' HA ' ' A' ' 116' ' ' SER . 2.2 p90 -143.65 134.05 24.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.148 -1.387 . . . . 0.0 108.255 -171.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.593 HG12 HG22 ' A' ' 79' ' ' ILE . 86.9 mt -83.31 121.75 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 177.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.8 m -96.9 -26.17 15.16 Favored 'General case' 0 CA--C 1.558 1.264 0 CA-C-N 112.659 -2.064 . . . . 0.0 113.501 173.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.468 ' HB2' ' HB2' ' A' ' 78' ' ' SER . 63.8 mttm -132.45 158.37 42.2 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 123.903 1.811 . . . . 0.0 112.121 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -121.92 118.01 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 N-CA-C 102.622 -3.103 . . . . 0.0 102.622 177.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.262 1.6 mp -72.33 131.46 84.91 Favored Pre-proline 0 CA--C 1.567 1.621 0 CA-C-O 118.291 -0.861 . . . . 0.0 108.82 174.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -62.19 134.74 50.57 Favored 'Trans proline' 0 CA--C 1.555 1.547 0 C-N-CA 123.332 2.688 . . . . 0.0 113.531 172.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.18 12.69 84.38 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 117.349 1.7 . . . . 0.0 117.349 -161.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.445 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -93.87 166.52 27.55 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-O 122.203 0.891 . . . . 0.0 113.589 177.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.463 ' HB3' HD23 ' A' ' 75' ' ' LEU . . . -69.82 -39.79 76.28 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 116.6 2.074 . . . . 0.0 116.6 -175.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.85 -26.32 65.09 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 172.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.03 -52.39 17.19 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 162.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -58.59 -60.9 3.09 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 125.922 1.689 . . . . 0.0 114.312 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.8 t70 . . . . . 0 CA--C 1.552 1.027 0 C-N-CA 124.089 0.955 . . . . 0.0 110.885 175.789 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . 0.315 11.9 t70 . . . . . 0 CA--C 1.535 0.385 0 CA-C-O 115.745 -2.074 . . . . 0.0 108.622 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.481 ' HA ' ' HB2' ' A' ' 95' ' ' PHE . 12.6 m -155.23 93.59 1.53 Allowed 'General case' 0 N--CA 1.48 1.037 0 O-C-N 125.47 1.731 . . . . 0.0 107.95 -173.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.4 tp -65.77 127.04 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-O 121.326 0.584 . . . . 0.0 109.967 175.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.58 ' HA ' ' HB3' ' A' ' 126' ' ' ARG 0.338 4.1 pp -96.31 -51.38 4.4 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 116.336 1.976 . . . . 0.0 116.336 171.631 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -135.93 138.56 42.49 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 103.637 -2.727 . . . . 0.0 103.637 -176.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 10.8 p -125.58 121.03 59.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 173.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.689 HD21 ' HB2' ' A' ' 140' ' ' ALA 0.31 38.6 m-80 80.88 -80.65 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 124.181 1.943 . . . . 0.0 109.474 -177.395 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -163.69 -17.37 0.03 OUTLIER 'General case' 0 CA--C 1.568 1.663 0 CA-C-N 110.322 -3.126 . . . . 0.0 109.893 -174.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.689 HG12 HG13 ' A' ' 125' ' ' VAL . 2.4 t -65.46 136.65 26.34 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.268 0 CA-C-O 123.568 1.651 . . . . 0.0 109.647 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -85.25 79.61 9.47 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 111.233 -2.712 . . . . 0.0 110.743 177.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.689 HG13 HG12 ' A' ' 123' ' ' VAL 0.264 1.2 m -87.03 -106.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 CA-C-O 116.672 -1.633 . . . . 0.0 107.883 -179.497 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.58 ' HB3' ' HA ' ' A' ' 118' ' ' LEU 0.254 25.0 ptt180 52.04 -88.87 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 116.604 2.075 . . . . 0.0 116.604 177.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.565 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 25.1 tt0 -86.53 72.77 10.21 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-O 123.259 1.504 . . . . 0.0 108.877 167.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.3 p -139.88 170.25 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 177.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.421 HG23 ' HB2' ' A' ' 84' ' ' ASP . 3.1 m -58.34 136.67 57.45 Favored 'General case' 0 CA--C 1.559 1.29 0 CA-C-N 114.062 -1.426 . . . . 0.0 111.739 159.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.497 ' HA ' HD12 ' A' ' 94' ' ' ILE 0.264 2.4 p-80 -46.79 -37.66 8.97 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 117.174 2.287 . . . . 0.0 117.174 171.339 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.438 ' HA ' HG12 ' A' ' 134' ' ' VAL . 53.6 p -56.33 -52.35 64.88 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 172.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.57 -36.48 78.61 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 173.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.624 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -71.12 -52.53 18.79 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 116.083 1.882 . . . . 0.0 116.083 172.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.438 HG12 ' HA ' ' A' ' 131' ' ' SER . 1.9 p -53.43 -44.16 54.53 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.183 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 171.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 139' ' ' GLU . 65.7 mm-40 -63.93 -48.77 75.26 Favored 'General case' 0 C--O 1.212 -0.878 0 CA-C-O 116.038 -1.934 . . . . 0.0 111.807 172.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.77 -28.67 70.14 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 117.384 2.365 . . . . 0.0 117.384 170.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -60.31 -53.98 51.13 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.008 1.323 . . . . 0.0 113.925 166.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -67.91 -39.15 83.63 Favored 'General case' 0 CA--C 1.569 1.691 0 N-CA-C 115.788 1.773 . . . . 0.0 115.788 171.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 135' ' ' GLU . 1.2 mm-40 -74.05 0.31 14.1 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 116.866 2.173 . . . . 0.0 116.866 171.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.689 ' HB2' HD21 ' A' ' 121' ' ' ASN . . . -57.71 -6.75 0.56 Allowed 'General case' 0 CA--C 1.555 1.172 0 N-CA-C 119.317 3.08 . . . . 0.0 119.317 157.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.62 -137.98 16.38 Favored Glycine 0 C--N 1.345 1.072 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 174.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.9 m -79.34 -8.56 59.17 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 169.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -147.76 112.72 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 CA-C-O 123.674 1.702 . . . . 0.0 107.244 -165.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.558 HG21 HD11 ' A' ' 75' ' ' LEU . 4.3 t -101.55 114.1 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 112.411 -2.177 . . . . 0.0 106.814 -169.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.403 ' HB2' ' HA ' ' A' ' 121' ' ' ASN . 70.1 mtm180 -96.08 91.79 6.12 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -177.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 45.4 mt -90.88 136.91 32.76 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.033 -173.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -128.49 121.49 29.0 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 104.867 -2.272 . . . . 0.0 104.867 173.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -129.53 122.43 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 -173.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . 0.409 ' HB2' ' CD2' ' A' ' 118' ' ' LEU . 56.4 ttm . . . . . 0 N--CA 1.477 0.916 0 O-C-N 124.442 1.088 . . . . 0.0 110.062 164.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.562 1.43 0 CA-C-O 122.948 1.356 . . . . 0.0 110.883 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -150.1 113.93 5.05 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 172.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -86.42 125.29 33.59 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.399 175.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 96.7 m -98.85 136.38 38.95 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-O 122.497 1.141 . . . . 0.0 110.008 176.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -84.95 129.19 34.84 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 113.508 -1.678 . . . . 0.0 108.198 173.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 p . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 177.499 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 33.3 p90 . . . . . 0 N--CA 1.48 1.057 0 CA-C-O 121.869 0.842 . . . . 0.0 109.975 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -109.99 131.87 54.67 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 114.389 -1.278 . . . . 0.0 108.223 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.89 126.19 37.86 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 114.362 -1.29 . . . . 0.0 109.294 176.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 40.9 mt -129.26 126.26 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 103.946 -2.613 . . . . 0.0 103.946 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.8 m -109.77 127.6 54.74 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 168.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.488 HD11 ' HA ' ' A' ' 105' ' ' ALA . 4.4 tp -127.44 162.11 27.14 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 113.347 -1.752 . . . . 0.0 107.396 175.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.402 ' O ' ' HB1' ' A' ' 104' ' ' ALA . 5.9 mt-10 . . . . . 0 N--CA 1.481 1.104 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.432 168.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.632 HD13 HG22 ' B' ' 6' ' ' VAL . 1.8 mp . . . . . 0 N--CA 1.48 1.054 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.615 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 129.97 50.4 0.12 Allowed Glycine 0 CA--C 1.54 1.61 0 C-N-CA 124.08 0.848 . . . . 0.0 114.526 -172.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.418 ' HA ' ' H ' ' A' ' 100' ' ' ILE . 36.8 p90 -151.88 158.36 43.11 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 165.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.454 ' HB2' ' HG2' ' A' ' 98' ' ' LYS . 67.1 m -96.05 154.0 17.47 Favored 'General case' 0 C--N 1.316 -0.888 0 O-C-N 119.569 -1.957 . . . . 0.0 110.533 171.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.478 HG22 HD13 ' A' ' 96' ' ' ILE . 2.5 pp -116.39 132.82 64.89 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-N 111.168 -2.742 . . . . 0.0 108.398 168.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.44 -171.3 3.29 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-O 123.613 1.673 . . . . 0.0 109.138 163.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.14 156.44 23.54 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 123.392 1.551 . . . . 0.0 115.251 -142.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.14 -158.58 23.19 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 111.955 -2.123 . . . . 0.0 113.643 -178.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.545 HG22 ' HB2' ' A' ' 92' ' ' PRO . 72.8 p -54.88 -41.55 70.99 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 117.736 2.495 . . . . 0.0 117.736 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -76.54 -13.59 60.07 Favored 'General case' 0 CA--C 1.568 1.663 0 N-CA-C 116.183 1.92 . . . . 0.0 116.183 172.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.31 82.0 6.51 Favored Pre-proline 0 CA--C 1.56 1.345 0 N-CA-C 102.557 -3.127 . . . . 0.0 102.557 -176.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -104.99 120.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.359 1.102 0 CA-C-N 124.976 2.813 . . . . 0.0 110.846 -169.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -179.447 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.545 ' HB2' HG22 ' A' ' 83' ' ' THR . 91.2 Cg_endo . . . . . 0 CA--C 1.547 1.169 0 CA-C-O 122.507 0.961 . . . . 0.0 112.455 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 66.8 m -155.7 127.65 7.51 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 103.83 -2.655 . . . . 0.0 103.83 -177.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.459 HG13 ' HB2' ' A' ' 133' ' ' ALA . 17.3 mm -76.28 122.3 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -110.02 151.06 27.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 113.057 -1.883 . . . . 0.0 107.936 178.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.478 HD13 HG22 ' A' ' 79' ' ' ILE . 20.6 mm -94.24 100.92 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.205 0 N-CA-C 102.979 -2.971 . . . . 0.0 102.979 165.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.2 t -80.82 -47.35 13.98 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 114.989 1.478 . . . . 0.0 114.989 -176.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.454 ' HG2' ' HB2' ' A' ' 78' ' ' SER 0.277 10.4 ptmt -143.75 152.47 41.3 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 121.782 0.801 . . . . 0.0 111.727 -173.593 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.12 123.21 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 N-CA-C 103.886 -2.635 . . . . 0.0 103.886 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.418 ' H ' ' HA ' ' A' ' 77' ' ' PHE 0.267 1.7 mp -72.96 125.88 90.83 Favored Pre-proline 0 CA--C 1.566 1.576 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 173.137 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -60.95 129.52 29.18 Favored 'Trans proline' 0 C--N 1.364 1.367 0 C-N-CA 123.329 2.686 . . . . 0.0 114.296 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.87 5.45 69.81 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 118.481 2.153 . . . . 0.0 118.481 -169.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.615 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -79.08 -175.63 47.21 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 124.31 0.957 . . . . 0.0 114.486 173.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.402 ' HB1' ' O ' ' A' ' 69' ' ' GLU . . . -64.88 -40.15 94.67 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 116.077 1.88 . . . . 0.0 116.077 -174.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.488 ' HA ' HD11 ' A' ' 68' ' ' LEU . . . -68.03 -36.84 80.58 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 173.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.32 -35.21 75.73 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 116.445 2.017 . . . . 0.0 116.445 167.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -70.64 -57.32 4.83 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 125.704 1.602 . . . . 0.0 112.395 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.0 t70 . . . . . 0 CA--C 1.557 1.225 0 C-N-CA 123.831 0.853 . . . . 0.0 112.443 -177.146 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 C--O 1.238 0.495 0 N-CA-C 103.717 -2.697 . . . . 0.0 103.717 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 45.0 m -89.98 90.52 8.19 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 113.085 -1.87 . . . . 0.0 108.169 -170.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.5 tp -61.77 121.83 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.009 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.536 ' HA ' ' HB3' ' A' ' 126' ' ' ARG . 1.5 pp -106.33 -50.67 3.1 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 113.16 -1.836 . . . . 0.0 115.91 175.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.42 ' H ' HD12 ' A' ' 118' ' ' LEU . 41.6 m-85 -123.33 132.75 54.1 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 177.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 5.8 p -122.22 116.39 48.99 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 N-CA-C 104.142 -2.54 . . . . 0.0 104.142 168.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.729 HD21 ' HB2' ' A' ' 140' ' ' ALA 0.282 18.5 m-80 79.83 -74.65 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 CA-C-O 123.348 1.547 . . . . 0.0 110.176 -174.203 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -167.54 -16.74 0.02 OUTLIER 'General case' 0 CA--C 1.578 2.027 0 CA-C-N 111.471 -2.604 . . . . 0.0 109.64 -175.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.405 HG12 HG13 ' A' ' 125' ' ' VAL . 2.0 t -67.66 134.78 29.65 Favored 'Isoleucine or valine' 0 C--N 1.361 1.099 0 CA-C-N 120.415 1.462 . . . . 0.0 110.351 176.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -86.27 99.45 11.58 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 113.419 -1.719 . . . . 0.0 109.046 176.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.504 HG11 ' HA ' ' A' ' 133' ' ' ALA . 1.3 m -95.93 -101.19 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 CA-C-O 116.401 -1.762 . . . . 0.0 107.381 175.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.536 ' HB3' ' HA ' ' A' ' 118' ' ' LEU 0.316 18.8 ptt180 50.97 -90.89 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.254 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 177.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.422 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 4.9 tt0 -88.23 65.57 8.12 Favored 'General case' 0 CA--C 1.557 1.225 0 CA-C-O 122.991 1.377 . . . . 0.0 109.54 171.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.7 p -130.36 169.86 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 176.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 33.2 m -61.02 134.87 57.53 Favored 'General case' 0 CA--C 1.56 1.342 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.43 158.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.424 ' HA ' HD12 ' A' ' 94' ' ' ILE . 9.1 p-80 -47.28 -33.41 5.57 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 117.922 2.564 . . . . 0.0 117.922 171.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.552 ' HA ' HG12 ' A' ' 134' ' ' VAL . 16.7 m -62.06 -38.88 90.46 Favored 'General case' 0 CA--C 1.562 1.439 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 173.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.62 -34.69 76.19 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 115.521 1.675 . . . . 0.0 115.521 166.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.504 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -72.44 -49.8 30.84 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 116.234 1.938 . . . . 0.0 116.234 174.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.633 HG23 ' HB ' ' B' ' 6' ' ' VAL . 4.0 p -49.88 -44.24 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.221 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 164.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -64.09 -49.21 73.14 Favored 'General case' 0 C--O 1.216 -0.658 0 CA-C-O 116.075 -1.917 . . . . 0.0 112.556 172.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.47 -32.75 73.68 Favored 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 117.184 2.29 . . . . 0.0 117.184 176.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -58.25 -46.47 85.9 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 162.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -72.36 -37.69 68.74 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 171.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -64.98 -19.95 66.24 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 116.272 1.953 . . . . 0.0 116.272 170.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.729 ' HB2' HD21 ' A' ' 121' ' ' ASN . . . -52.11 -10.66 0.13 Allowed 'General case' 0 CA--C 1.554 1.103 0 N-CA-C 119.246 3.054 . . . . 0.0 119.246 162.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 70.18 -154.51 52.66 Favored Glycine 0 C--N 1.348 1.243 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -175.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.5 m -59.83 -5.09 0.84 Allowed 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 118.506 2.78 . . . . 0.0 118.506 176.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.96 105.79 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 -170.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.468 HG11 HD21 ' A' ' 75' ' ' LEU . 15.8 m -85.88 123.1 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.07 174.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -108.13 90.22 3.23 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 56.7 mt -90.69 139.27 30.87 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.471 -171.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -135.64 117.88 15.58 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 104.52 -2.4 . . . . 0.0 104.52 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 35.3 m -129.64 118.53 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -164.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 53.2 ttm . . . . . 0 N--CA 1.489 1.518 0 CA-C-N 118.882 0.765 . . . . 0.0 109.746 173.498 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.557 1.212 0 CA-C-O 122.504 1.145 . . . . 0.0 111.285 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -136.24 128.05 29.2 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-O 123.507 1.622 . . . . 0.0 109.328 170.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 10.7 ttpp -97.42 111.27 23.6 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 113.754 -1.566 . . . . 0.0 107.796 172.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 88.5 m -93.76 144.66 25.21 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.418 -1.265 . . . . 0.0 109.108 173.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -87.19 145.02 26.57 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 113.864 -1.516 . . . . 0.0 108.672 178.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.633 ' HB ' HG23 ' A' ' 134' ' ' VAL . 7.6 p . . . . . 0 C--O 1.248 1.01 0 N-CA-C 104.5 -2.408 . . . . 0.0 104.5 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 27.0 p90 . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 121.609 0.719 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -101.46 133.15 46.54 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.812 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -97.84 128.52 44.51 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.72 170.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.533 HG13 ' HB2' ' A' ' 146' ' ' LEU . 23.5 pt -136.67 111.83 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 -174.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.0 m -91.96 120.24 32.44 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.42 ' HB3' ' CG2' ' A' ' 144' ' ' VAL . 6.7 tt -116.52 137.57 52.07 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 175.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 . . . . . 0 N--CA 1.483 1.222 0 O-C-N 120.956 -1.09 . . . . 0.0 111.564 177.17 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.568 HD21 HG22 ' B' ' 6' ' ' VAL . 0.1 OUTLIER . . . . . 0 CA--C 1.558 1.274 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.522 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 69.4 36.37 77.75 Favored Glycine 0 C--N 1.344 1.014 0 N-CA-C 118.761 2.264 . . . . 0.0 118.761 164.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -150.48 163.51 38.25 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 123.563 1.649 . . . . 0.0 108.489 174.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.5 m -127.25 127.82 45.01 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.582 -169.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.3 pp -101.18 124.03 54.6 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 113.504 -1.68 . . . . 0.0 108.643 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -85.68 -170.86 3.31 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 123.452 1.596 . . . . 0.0 110.051 158.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.1 159.34 24.34 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-O 123.859 1.811 . . . . 0.0 115.604 -136.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -104.24 -162.6 24.58 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 111.082 -2.559 . . . . 0.0 113.742 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.446 HG22 ' HB3' ' A' ' 92' ' ' PRO . 70.2 p -52.83 -41.75 64.5 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 116.67 2.1 . . . . 0.0 116.67 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -80.15 -17.32 52.8 Favored 'General case' 0 CA--C 1.565 1.55 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 175.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.29 96.07 4.27 Favored Pre-proline 0 CA--C 1.552 1.028 0 N-CA-C 101.822 -3.399 . . . . 0.0 101.822 -175.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -96.73 143.41 0.84 Allowed 'Trans proline' 0 CA--C 1.548 1.194 0 CA-C-N 123.688 2.353 . . . . 0.0 111.472 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 16.8 t60 . . . . . 0 CA--C 1.565 1.532 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 167.271 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.446 ' HB3' HG22 ' A' ' 83' ' ' THR . 1.4 Cg_endo . . . . . 0 CA--C 1.549 1.256 0 N-CA-C 110.636 -0.563 . . . . 0.0 110.636 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.5 m 78.3 106.87 0.07 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 168.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.487 HG13 ' HB2' ' A' ' 133' ' ' ALA . 11.3 mm -75.55 117.56 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 -173.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -128.4 135.44 49.54 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -171.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 89.5 mt -72.5 118.83 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.388 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 175.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.44 ' CG2' ' HG3' ' B' ' 3' ' ' LYS . 14.3 t -87.75 -29.69 20.85 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 169.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -144.25 163.08 34.7 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-O 125.568 2.604 . . . . 0.0 110.343 -174.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.479 HG22 ' HB3' ' A' ' 105' ' ' ALA . 1.2 pt -115.4 129.17 72.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 111.051 -2.795 . . . . 0.0 103.539 173.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.294 1.5 mp -72.19 123.78 89.95 Favored Pre-proline 0 CA--C 1.57 1.715 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 170.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.93 132.08 42.95 Favored 'Trans proline' 0 C--N 1.367 1.545 0 C-N-CA 123.558 2.838 . . . . 0.0 114.203 172.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 71.52 9.95 69.88 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 118.084 1.994 . . . . 0.0 118.084 -166.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.522 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -91.01 -179.29 43.06 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-O 123.033 1.351 . . . . 0.0 112.397 177.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.65 -33.79 66.82 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 117.523 2.416 . . . . 0.0 117.523 -174.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.479 ' HB3' HG22 ' A' ' 99' ' ' ILE . . . -60.94 -32.88 72.38 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 117.961 2.578 . . . . 0.0 117.961 165.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.35 -39.41 93.84 Favored 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 167.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.48 -56.02 6.75 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.387 1.075 . . . . 0.0 113.624 175.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.7 t70 . . . . . 0 CA--C 1.562 1.415 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -178.17 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 . . . . . 0 C--O 1.239 0.547 1 N-CA-C 100.091 -4.04 . . . . 0.0 100.091 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.8 m -75.02 86.93 2.34 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 112.992 -1.913 . . . . 0.0 109.097 -176.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.571 HD12 HD21 ' A' ' 137' ' ' LEU . 30.1 pt -64.91 121.22 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 125.065 1.346 . . . . 0.0 111.024 -174.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.869 HD11 ' H ' ' A' ' 149' ' ' MET . 0.0 OUTLIER -101.55 -50.17 3.81 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 112.736 -2.029 . . . . 0.0 112.778 -179.457 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -111.4 140.91 45.6 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 169.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.521 HG23 HD23 ' A' ' 146' ' ' LEU . 7.1 p -127.93 120.05 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 104.465 -2.42 . . . . 0.0 104.465 165.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.824 HD21 ' HB2' ' A' ' 140' ' ' ALA 0.27 24.5 m-80 79.67 -74.45 0.05 Allowed 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 123.592 1.663 . . . . 0.0 110.453 -176.162 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -164.49 -10.88 0.03 OUTLIER 'General case' 0 CA--C 1.578 2.038 0 CA-C-N 111.355 -2.657 . . . . 0.0 110.203 177.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.1 t -71.46 134.42 29.98 Favored 'Isoleucine or valine' 0 C--N 1.36 1.03 0 C-N-CA 125.682 1.593 . . . . 0.0 109.745 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -84.67 100.79 11.69 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 113.698 -1.592 . . . . 0.0 109.299 172.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.555 HG11 ' HA ' ' A' ' 133' ' ' ALA . 0.7 OUTLIER -96.97 -96.86 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 CA-C-O 116.08 -1.914 . . . . 0.0 106.894 171.517 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.552 ' HB3' ' HA ' ' A' ' 118' ' ' LEU 0.302 18.9 ptt180 46.79 -89.37 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 -178.374 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.421 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 6.6 mt-10 -85.9 65.95 9.37 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-O 123.672 1.701 . . . . 0.0 109.087 177.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.1 p -138.75 168.38 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 22.9 m -60.33 132.79 55.0 Favored 'General case' 0 CA--C 1.561 1.388 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.884 158.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.46 ' HA ' HD12 ' A' ' 94' ' ' ILE . 10.2 p-80 -46.53 -32.69 3.54 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 118.166 2.654 . . . . 0.0 118.166 170.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.505 ' HA ' HG12 ' A' ' 134' ' ' VAL . 16.5 m -62.4 -40.37 96.28 Favored 'General case' 0 CA--C 1.561 1.381 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 173.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.74 -37.69 87.07 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 167.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.555 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -66.94 -52.18 46.11 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 172.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.505 HG12 ' HA ' ' A' ' 131' ' ' SER . 4.9 p -53.65 -42.25 50.15 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.421 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 172.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -72.33 -39.82 67.88 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 116.267 -1.825 . . . . 0.0 112.93 174.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.436 ' HA ' ' HB3' ' A' ' 139' ' ' GLU . . . -60.59 -29.19 69.04 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 117.162 2.282 . . . . 0.0 117.162 165.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.593 HD11 HD21 ' A' ' 146' ' ' LEU . 2.8 mm? -62.78 -48.96 76.88 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.819 1.647 . . . . 0.0 114.93 165.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -68.21 -35.71 78.4 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 168.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.436 ' HB3' ' HA ' ' A' ' 136' ' ' ALA . 29.6 tt0 -64.65 -23.19 67.18 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 116.379 1.992 . . . . 0.0 116.379 171.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.824 ' HB2' HD21 ' A' ' 121' ' ' ASN . . . -54.2 -11.06 0.43 Allowed 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 118.794 2.887 . . . . 0.0 118.794 162.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 89.1 -136.98 13.92 Favored Glycine 0 C--N 1.345 1.066 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 172.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 26.8 m -77.75 -2.96 38.83 Favored 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 170.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.85 106.74 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 -170.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.491 HG11 ' CD1' ' A' ' 75' ' ' LEU . 10.7 m -88.39 116.21 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.324 1.45 . . . . 0.0 109.292 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 56.1 mtm180 -104.01 89.34 3.26 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -176.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.593 HD21 HD11 ' A' ' 137' ' ' LEU . 23.9 mt -88.33 138.34 31.52 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.736 0.779 . . . . 0.0 109.0 -170.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -120.97 127.53 51.89 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 5.7 p -133.55 112.45 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 CA-C-O 121.65 0.738 . . . . 0.0 109.85 175.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . 0.869 ' H ' HD11 ' A' ' 118' ' ' LEU . 27.3 ttt . . . . . 0 CA--C 1.544 0.739 0 C-N-CA 126.343 1.857 . . . . 0.0 110.793 161.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.56 1.356 0 CA-C-O 122.728 1.251 . . . . 0.0 110.899 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -142.0 127.04 18.39 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 123.082 1.42 . . . . 0.0 107.937 170.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.44 ' HG3' ' CG2' ' A' ' 97' ' ' THR . 1.6 tmmt? -89.91 122.13 32.66 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.024 169.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 62.8 m -92.35 135.87 33.67 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 122.715 1.245 . . . . 0.0 108.951 171.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -92.27 133.58 35.7 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 113.855 -1.52 . . . . 0.0 107.865 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.568 HG22 HD21 ' A' ' 75' ' ' LEU 0.254 11.7 p . . . . . 0 C--O 1.248 1.015 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 -169.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.457 ' HB3' HD21 ' A' ' 118' ' ' LEU . 40.9 p90 . . . . . 0 N--CA 1.478 0.955 0 CA-C-O 121.917 0.865 . . . . 0.0 110.686 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -107.43 135.92 48.09 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 114.55 -1.204 . . . . 0.0 108.077 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -95.43 127.59 41.59 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.841 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.495 HG22 HD13 ' A' ' 68' ' ' LEU . 4.2 mp -135.24 122.91 37.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 -177.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.7 m -105.22 122.79 46.66 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 173.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.495 HD13 HG22 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -120.7 132.57 55.15 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 114.305 -1.316 . . . . 0.0 108.581 -175.869 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 . . . . . 0 CA--C 1.547 0.842 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.812 -176.598 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.476 HD12 HG11 ' A' ' 144' ' ' VAL 0.405 0.2 OUTLIER . . . . . 0 N--CA 1.499 2.008 0 N-CA-C 118.016 2.599 . . . . 0.0 118.016 . . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.429 ' O ' HG13 ' A' ' 99' ' ' ILE . . . 99.29 20.44 17.86 Favored Glycine 0 C--O 1.218 -0.855 0 CA-C-O 115.437 -2.868 . . . . 0.0 117.18 168.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.42 ' O ' ' HB ' ' B' ' 6' ' ' VAL . 2.0 p90 -158.46 117.27 3.07 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 121.745 2.773 . . . . 0.0 109.678 -169.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.6 m -87.79 127.0 35.32 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.211 -1.359 . . . . 0.0 110.823 172.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.537 HG22 HG12 ' A' ' 96' ' ' ILE . 2.4 pp -105.74 127.22 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 113.62 -1.627 . . . . 0.0 108.947 -176.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -79.55 -173.05 3.56 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 124.015 1.864 . . . . 0.0 111.321 159.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' A' ' 85' ' ' ASN . . . -101.59 160.57 18.1 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-N 112.937 -1.938 . . . . 0.0 114.95 -142.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.456 ' H ' ' HB3' ' A' ' 130' ' ' HIS . . . -107.23 -162.22 21.75 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 110.939 -2.631 . . . . 0.0 111.711 -173.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.606 HG22 ' HB2' ' A' ' 92' ' ' PRO . 13.3 p -52.52 -43.1 64.91 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 117.661 2.467 . . . . 0.0 117.661 -173.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.514 ' HB3' HG23 ' A' ' 129' ' ' THR . 24.0 t70 -97.99 12.43 34.27 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 174.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.488 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 5.6 t30 -155.17 69.74 5.56 Favored Pre-proline 0 CA--C 1.555 1.151 0 N-CA-C 101.96 -3.348 . . . . 0.0 101.96 174.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -88.79 126.73 1.8 Allowed 'Trans proline' 0 C--N 1.365 1.444 0 CA-C-N 126.659 3.414 . . . . 0.0 112.208 -163.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 84.5 t60 . . . . . 0 N--CA 1.5 2.048 0 N-CA-C 115.213 1.561 . . . . 0.0 115.213 157.921 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.606 ' HB2' HG22 ' A' ' 83' ' ' THR . 14.6 Cg_endo . . . . . 0 CA--C 1.557 1.664 0 CA-C-O 122.732 1.055 . . . . 0.0 112.932 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.5 t -161.33 159.22 28.16 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 -172.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.526 HG13 ' HB2' ' A' ' 133' ' ' ALA . 12.2 mm -99.61 120.17 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 N-CA-C 105.256 -2.128 . . . . 0.0 105.256 -175.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -111.41 149.68 30.89 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 113.442 -1.708 . . . . 0.0 107.205 -174.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.537 HG12 HG22 ' A' ' 79' ' ' ILE . 23.0 mt -94.78 111.27 25.22 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.319 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 165.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 96.8 m -85.81 -30.85 22.66 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 117.264 -1.351 . . . . 0.0 113.431 169.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . 0.282 8.9 ptmm? -141.41 164.08 31.19 Favored 'General case' 0 CA--C 1.557 1.246 0 CA-C-N 120.673 1.579 . . . . 0.0 112.177 173.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 76' ' ' GLY . 1.7 tp -115.26 137.51 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 N-CA-C 104.57 -2.381 . . . . 0.0 104.57 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.273 1.6 mp -83.6 116.86 66.71 Favored Pre-proline 0 CA--C 1.57 1.743 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 168.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -63.0 146.01 94.57 Favored 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 123.736 2.957 . . . . 0.0 113.979 172.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.3 -13.65 26.2 Favored Glycine 0 CA--C 1.547 2.073 0 N-CA-C 117.586 1.794 . . . . 0.0 117.586 -169.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -83.19 -169.62 45.02 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 118.911 1.356 . . . . 0.0 113.162 173.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.89 -51.29 27.09 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -170.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.0 -32.86 72.44 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 116.915 2.191 . . . . 0.0 116.915 173.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.07 -51.3 48.2 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 170.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -65.06 -62.22 1.68 Allowed 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 125.313 1.445 . . . . 0.0 112.986 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 . . . . . 0 N--CA 1.486 1.348 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 -177.772 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.2 p30 . . . . . 0 CA--C 1.558 1.267 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.8 m -144.79 84.27 1.72 Allowed 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 175.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.563 HD12 HD11 ' A' ' 137' ' ' LEU . 28.1 pt -56.58 108.63 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 CA-C-O 123.558 1.646 . . . . 0.0 111.042 175.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.457 HD21 ' HB3' ' A' ' 63' ' ' TYR . 3.3 pp -101.19 -41.37 6.75 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 112.564 -2.107 . . . . 0.0 115.526 178.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -127.59 143.76 51.14 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.553 HG21 HD12 ' A' ' 137' ' ' LEU . 3.3 t -136.56 108.0 6.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 101.294 -3.595 . . . . 0.0 101.294 178.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.907 HD21 ' HB2' ' A' ' 140' ' ' ALA 0.283 25.0 m-80 82.51 -80.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 123.44 1.59 . . . . 0.0 109.504 178.593 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -152.82 -14.07 0.16 Allowed 'General case' 0 CA--C 1.568 1.635 0 CA-C-N 111.815 -2.448 . . . . 0.0 111.196 177.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.2 t -68.86 136.98 25.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 124.893 1.277 . . . . 0.0 109.733 174.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -96.08 101.08 12.7 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 112.574 -2.103 . . . . 0.0 109.018 176.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.548 HG11 ' HA ' ' A' ' 133' ' ' ALA 0.261 1.6 m -100.42 -103.84 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 CA-C-O 116.773 -1.584 . . . . 0.0 107.178 178.49 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.455 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.363 26.9 ptt85 44.21 -92.87 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 125.139 1.376 . . . . 0.0 114.572 -169.9 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.455 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 16.6 tt0 -72.84 74.84 1.15 Allowed 'General case' 0 CA--C 1.555 1.142 0 CA-C-O 124.297 1.998 . . . . 0.0 110.98 170.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.3 p -149.0 166.54 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 CA-C-N 111.993 -2.367 . . . . 0.0 105.232 -178.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.514 HG23 ' HB3' ' A' ' 84' ' ' ASP . 0.2 OUTLIER -54.6 122.49 10.71 Favored 'General case' 0 CA--C 1.557 1.224 0 CA-C-N 111.841 -2.436 . . . . 0.0 110.462 154.552 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.456 ' HB3' ' H ' ' A' ' 82' ' ' GLY . 1.6 p-80 -49.48 -31.24 9.59 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 117.436 2.384 . . . . 0.0 117.436 175.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.58 ' HA ' HG12 ' A' ' 134' ' ' VAL . 7.1 m -58.86 -38.05 77.89 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 115.373 1.619 . . . . 0.0 115.373 171.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.61 -37.06 79.47 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 165.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.548 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -63.19 -54.6 34.96 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 171.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.58 HG12 ' HA ' ' A' ' 131' ' ' SER . 9.8 p -52.45 -43.43 41.57 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 166.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -58.14 -50.39 73.65 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-O 115.888 -2.006 . . . . 0.0 111.817 171.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.55 -35.43 77.75 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 117.146 2.276 . . . . 0.0 117.146 173.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.563 HD11 HD12 ' A' ' 117' ' ' ILE . 9.3 mp -55.82 -52.6 63.43 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 125.04 1.336 . . . . 0.0 114.007 164.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -71.35 -31.82 67.8 Favored 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 174.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -67.16 -30.23 70.15 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 115.332 1.605 . . . . 0.0 115.332 171.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.907 ' HB2' HD21 ' A' ' 121' ' ' ASN . . . -50.27 -33.06 18.52 Favored 'General case' 0 CA--C 1.56 1.332 0 N-CA-C 117.202 2.297 . . . . 0.0 117.202 159.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 91.21 -125.18 7.9 Favored Glycine 0 C--N 1.348 1.229 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 166.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 11.6 m -73.38 -10.36 59.66 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 118.043 2.609 . . . . 0.0 118.043 169.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.2 104.44 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 -170.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.492 ' HA ' ' HB1' ' A' ' 140' ' ' ALA . 5.2 m -86.88 118.4 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 113.383 -1.735 . . . . 0.0 109.557 175.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 62.5 mtm180 -97.57 91.79 5.6 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 172.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.426 HD23 HG13 ' A' ' 120' ' ' VAL . 86.2 mt -93.24 138.69 31.39 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.906 0.86 . . . . 0.0 108.985 -173.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -130.67 120.99 24.73 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 177.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 21.2 m -130.77 129.64 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -166.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 23.9 ptt? . . . . . 0 N--CA 1.48 1.044 0 CA-C-O 122.46 1.124 . . . . 0.0 111.587 168.991 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 8.1 p90 . . . . . 0 CA--C 1.55 0.98 0 CA-C-O 122.194 0.997 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -115.06 149.19 37.88 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 123.738 1.733 . . . . 0.0 109.188 173.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 12.0 ttpp -103.97 109.28 20.98 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 113.189 -1.823 . . . . 0.0 107.305 176.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.59 131.31 38.84 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.625 175.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -85.58 121.92 28.95 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.42 ' HB ' ' O ' ' A' ' 77' ' ' PHE . 2.7 t . . . . . 0 C--O 1.248 0.977 0 N-CA-C 104.193 -2.521 . . . . 0.0 104.193 -170.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 34.0 p90 . . . . . 0 CA--C 1.551 1.008 0 CA-C-O 122.414 1.102 . . . . 0.0 112.575 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -101.53 129.16 47.56 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 113.354 -1.748 . . . . 0.0 108.254 166.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -116.29 129.27 56.19 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 114.224 -1.353 . . . . 0.0 109.163 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.454 HG13 ' HB2' ' A' ' 146' ' ' LEU . 6.2 pt -135.82 115.36 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 -174.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.3 m -86.43 118.18 25.7 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 171.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.495 HD21 ' HB1' ' A' ' 104' ' ' ALA . 8.2 tt -124.14 140.46 52.94 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 113.14 -1.845 . . . . 0.0 106.198 -171.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 . . . . . 0 N--CA 1.483 1.218 0 O-C-N 121.431 -0.793 . . . . 0.0 109.378 -176.455 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.416 HD13 HG12 ' B' ' 6' ' ' VAL . 6.9 mp . . . . . 0 CA--C 1.555 1.137 0 N-CA-C 106.349 -1.722 . . . . 0.0 106.349 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.537 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 127.57 50.39 0.15 Allowed Glycine 0 CA--C 1.543 1.815 0 C-N-CA 124.516 1.055 . . . . 0.0 114.916 -175.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.457 ' CD1' HD13 ' A' ' 96' ' ' ILE . 0.3 OUTLIER -159.33 149.58 19.15 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 122.998 1.38 . . . . 0.0 109.97 174.186 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.515 ' HB2' ' HB3' ' A' ' 98' ' ' LYS . 70.7 m -99.91 116.35 31.75 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.408 -0.807 . . . . 0.0 111.62 -175.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.616 HG22 HG12 ' A' ' 96' ' ' ILE . 1.1 pt -88.46 122.86 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.311 176.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.65 -172.09 3.87 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-O 123.263 1.506 . . . . 0.0 110.644 164.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' A' ' 85' ' ' ASN . . . -95.43 161.05 22.99 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-O 123.389 1.55 . . . . 0.0 116.341 -136.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.49 -162.58 23.43 Favored Glycine 0 N--CA 1.464 0.564 0 CA-C-N 111.919 -2.14 . . . . 0.0 116.298 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.449 HG22 ' HB3' ' A' ' 92' ' ' PRO . 59.6 p -52.08 -40.53 61.35 Favored 'General case' 0 CA--C 1.567 1.628 0 CA-C-N 112.516 -1.842 . . . . 0.0 115.595 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.42 ' HB2' HG22 ' A' ' 129' ' ' THR . 31.5 t70 -78.82 -30.54 45.39 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 172.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.401 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 0.1 OUTLIER -134.52 91.37 21.95 Favored Pre-proline 0 N--CA 1.478 0.972 0 N-CA-C 102.402 -3.185 . . . . 0.0 102.402 -173.824 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -100.01 147.81 0.44 Allowed 'Trans proline' 0 CA--C 1.549 1.251 0 CA-C-N 124.557 2.663 . . . . 0.0 111.221 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.488 ' HB2' ' CD2' ' B' ' 1' ' ' TYR . 43.3 t60 . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 166.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.449 ' HB3' HG22 ' A' ' 83' ' ' THR . 0.5 OUTLIER . . . . . 0 CA--C 1.553 1.448 0 N-CA-C 110.482 -0.622 . . . . 0.0 110.482 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 39.9 m 79.73 119.31 0.05 Allowed 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 167.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.549 HG13 ' CB ' ' A' ' 133' ' ' ALA . 10.0 mm -96.1 125.67 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 104.905 -2.258 . . . . 0.0 104.905 -172.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.435 ' HZ ' ' HB3' ' A' ' 87' ' ' HIS . 32.3 p90 -140.67 128.52 21.82 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 112.317 -2.22 . . . . 0.0 106.58 -159.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.616 HG12 HG22 ' A' ' 79' ' ' ILE . 73.6 mt -87.64 114.93 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.2 t -97.77 -13.85 21.14 Favored 'General case' 0 CA--C 1.559 1.301 0 CA-C-N 113.224 -1.807 . . . . 0.0 114.805 169.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 78' ' ' SER . 19.2 ttmm -141.11 158.11 44.36 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-O 124.832 2.253 . . . . 0.0 109.93 -173.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.29 131.87 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 111.531 -2.577 . . . . 0.0 105.894 -176.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.275 1.6 mp -78.69 131.62 67.2 Favored Pre-proline 0 CA--C 1.57 1.716 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 167.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.17 130.56 34.8 Favored 'Trans proline' 0 C--N 1.367 1.517 0 C-N-CA 123.416 2.744 . . . . 0.0 115.132 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 70.48 13.33 70.94 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 118.167 2.027 . . . . 0.0 118.167 -168.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.537 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -90.0 -162.11 38.04 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 124.371 0.986 . . . . 0.0 114.675 -175.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.495 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -68.27 -53.85 21.66 Favored 'General case' 0 CA--C 1.557 1.229 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -170.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.05 -24.49 64.18 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 117.286 2.328 . . . . 0.0 117.286 168.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.96 -34.98 71.98 Favored 'General case' 0 CA--C 1.565 1.551 0 N-CA-C 115.964 1.838 . . . . 0.0 115.964 168.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -55.29 6.01 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 124.929 1.292 . . . . 0.0 112.26 174.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.9 t70 . . . . . 0 N--CA 1.487 1.405 0 C-N-CA 123.26 0.624 . . . . 0.0 112.612 -174.964 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 95' ' ' PHE 0.308 6.9 m-20 . . . . . 0 N--CA 1.466 0.327 0 CA-C-O 116.728 -1.606 . . . . 0.0 108.248 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 69.4 m -160.37 102.42 1.39 Allowed 'General case' 0 N--CA 1.473 0.677 0 O-C-N 126.337 2.273 . . . . 0.0 107.352 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.445 HD13 ' H ' ' A' ' 117' ' ' ILE . 0.2 OUTLIER -99.0 150.27 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.416 0 CA-C-O 122.617 1.199 . . . . 0.0 108.911 179.465 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.908 HD11 ' H ' ' A' ' 149' ' ' MET . 0.0 OUTLIER -120.61 -37.36 3.02 Favored 'General case' 0 N--CA 1.502 2.154 0 C-N-CA 126.504 1.922 . . . . 0.0 111.784 -171.056 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -126.67 150.66 48.85 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-O 122.755 1.264 . . . . 0.0 108.237 173.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.49 ' HB ' HH22 ' A' ' 126' ' ' ARG . 14.6 p -129.65 121.22 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 169.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.739 HD21 ' HB2' ' A' ' 140' ' ' ALA 0.358 12.8 m-80 79.14 -88.67 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 123.595 1.664 . . . . 0.0 107.845 178.626 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -144.21 -16.45 0.58 Allowed 'General case' 0 CA--C 1.568 1.636 0 CA-C-N 110.478 -3.055 . . . . 0.0 110.37 174.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.7 t -66.45 134.54 29.82 Favored 'Isoleucine or valine' 0 C--N 1.36 1.054 0 CA-C-O 123.92 1.819 . . . . 0.0 109.949 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -89.47 57.8 4.12 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 110.254 -3.157 . . . . 0.0 112.923 173.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.8 m -70.86 -163.94 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.333 0 CA-C-O 123.632 1.682 . . . . 0.0 108.496 161.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.615 ' H ' HG22 ' A' ' 128' ' ' VAL 0.525 4.3 mmt85 86.51 -49.27 0.05 Allowed 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 115.019 1.489 . . . . 0.0 115.019 176.164 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -76.21 51.86 0.71 Allowed 'General case' 0 CA--C 1.571 1.756 0 CA-C-N 114.186 -1.37 . . . . 0.0 113.276 155.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.615 HG22 ' H ' ' A' ' 126' ' ' ARG . 30.4 m -148.58 170.15 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 -170.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.42 HG22 ' HB2' ' A' ' 84' ' ' ASP . 44.6 p -61.73 141.12 58.07 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 113.293 -1.776 . . . . 0.0 111.814 155.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.41 ' HA ' HD12 ' A' ' 94' ' ' ILE . 8.6 p-80 -44.39 -33.74 1.76 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 117.175 2.287 . . . . 0.0 117.175 171.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.602 ' HA ' HG12 ' A' ' 134' ' ' VAL . 16.1 m -62.78 -40.72 98.19 Favored 'General case' 0 CA--C 1.564 1.489 0 N-CA-C 115.702 1.742 . . . . 0.0 115.702 176.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.06 -37.94 81.87 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 169.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.549 ' CB ' HG13 ' A' ' 94' ' ' ILE . . . -67.8 -47.26 69.58 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 116.152 -1.88 . . . . 0.0 115.968 169.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.602 HG12 ' HA ' ' A' ' 131' ' ' SER . 13.0 p -53.39 -46.37 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-N 121.351 1.887 . . . . 0.0 113.221 166.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -53.18 -46.91 69.15 Favored 'General case' 0 CA--C 1.555 1.16 0 CA-C-O 117.527 -1.225 . . . . 0.0 113.02 168.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.63 -26.82 67.25 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 117.534 2.42 . . . . 0.0 117.534 170.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.476 ' CD2' HH21 ' A' ' 126' ' ' ARG . 3.5 mm? -68.76 -49.35 59.43 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 125.6 1.56 . . . . 0.0 113.845 171.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -66.22 -34.27 77.65 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 165.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -72.43 -21.65 61.22 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 116.932 2.197 . . . . 0.0 116.932 174.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.739 ' HB2' HD21 ' A' ' 121' ' ' ASN . . . -51.58 -20.8 2.13 Favored 'General case' 0 CA--C 1.563 1.451 0 N-CA-C 117.584 2.438 . . . . 0.0 117.584 155.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.78 -147.29 27.76 Favored Glycine 0 C--N 1.35 1.356 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 174.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 18.5 m -61.84 -6.5 2.76 Favored 'General case' 0 CA--C 1.571 1.783 0 N-CA-C 117.553 2.427 . . . . 0.0 117.553 173.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -146.58 101.68 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 -170.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.508 ' HA ' ' HB1' ' A' ' 140' ' ' ALA . 29.8 m -84.18 116.92 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.293 172.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.481 ' HB2' ' HA ' ' A' ' 121' ' ' ASN . 57.7 mtp85 -94.35 106.12 18.1 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 174.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.454 ' HB2' HG13 ' A' ' 66' ' ' ILE . 11.3 mt -107.02 124.05 49.08 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 -166.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -116.84 130.14 56.52 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 -174.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.02 127.77 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 176.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . 0.908 ' H ' HD11 ' A' ' 118' ' ' LEU . 67.3 mtt . . . . . 0 N--CA 1.475 0.799 0 C-N-CA 126.048 1.739 . . . . 0.0 108.671 171.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 1' ' ' TYR . . . . . 0.488 ' CD2' ' HB2' ' A' ' 87' ' ' HIS . 0.0 OUTLIER . . . . . 0 CA--C 1.557 1.226 0 CA-C-O 122.728 1.251 . . . . 0.0 110.565 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -157.12 151.11 24.72 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 123.351 1.548 . . . . 0.0 109.951 168.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.74 137.16 37.03 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 -176.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 27.6 m -85.34 133.78 34.13 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 166.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.95 99.98 12.52 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 -177.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.416 HG12 HD13 ' A' ' 75' ' ' LEU . 21.9 t . . . . . 0 C--O 1.25 1.091 0 N-CA-C 103.042 -2.947 . . . . 0.0 103.042 -165.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 17.8 p90 . . . . . 0 N--CA 1.475 0.792 0 CA-C-O 122.38 1.086 . . . . 0.0 108.101 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -114.03 136.2 53.18 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 113.697 -1.592 . . . . 0.0 107.71 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -99.63 121.42 41.19 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -172.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 18.2 mt -130.99 114.93 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 104.233 -2.506 . . . . 0.0 104.233 -172.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.0 m -96.6 124.91 40.74 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 169.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.468 ' HB3' ' CG2' ' A' ' 144' ' ' VAL . 5.2 tp -127.86 166.82 17.53 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 113.29 -1.777 . . . . 0.0 107.144 176.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 . . . . . 0 N--CA 1.48 1.074 0 O-C-N 121.352 -0.843 . . . . 0.0 109.392 164.456 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.567 HD11 HG11 ' A' ' 144' ' ' VAL . 1.0 OUTLIER . . . . . 0 N--CA 1.481 1.1 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.477 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 113.5 43.34 0.83 Allowed Glycine 0 CA--C 1.533 1.179 0 N-CA-C 117.155 1.622 . . . . 0.0 117.155 167.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.486 ' HE1' HD23 ' A' ' 137' ' ' LEU . 3.8 p90 -156.72 157.7 35.6 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.526 1.131 . . . . 0.0 109.11 172.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 51.1 m -96.66 137.76 35.25 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 120.621 -1.3 . . . . 0.0 110.155 171.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.42 HG22 HG12 ' A' ' 96' ' ' ILE . 1.2 pt -107.21 125.87 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.85 178.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -83.25 -178.46 7.09 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 124.254 1.978 . . . . 0.0 110.001 167.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 85' ' ' ASN . . . -91.51 159.08 25.79 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 112.923 -1.944 . . . . 0.0 115.228 -141.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -109.26 -170.97 20.63 Favored Glycine 0 C--O 1.224 -0.496 0 CA-C-N 110.472 -2.864 . . . . 0.0 113.034 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.563 HG22 ' HB2' ' A' ' 92' ' ' PRO . 29.6 p -43.5 -43.36 5.39 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 118.442 2.756 . . . . 0.0 118.442 -176.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -78.07 -28.64 48.88 Favored 'General case' 0 CA--C 1.561 1.403 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 175.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.419 ' O ' ' HA3' ' A' ' 81' ' ' GLY 0.258 2.0 t30 -143.81 71.96 17.03 Favored Pre-proline 0 CA--C 1.562 1.404 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -175.754 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -103.44 145.83 0.17 Allowed 'Trans proline' 0 C--N 1.375 1.937 0 CA-C-N 124.629 2.689 . . . . 0.0 111.652 -171.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 . . . . . 0 N--CA 1.495 1.812 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 162.71 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.563 ' HB2' HG22 ' A' ' 83' ' ' THR . 26.5 Cg_endo . . . . . 0 CA--C 1.555 1.556 0 CA-C-O 121.962 0.734 . . . . 0.0 112.1 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.2 t -161.23 128.35 4.08 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 -173.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.509 HG13 ' HB2' ' A' ' 133' ' ' ALA . 24.3 mm -76.31 121.1 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -133.01 131.66 40.96 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -175.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.42 HG12 HG22 ' A' ' 79' ' ' ILE 0.288 92.8 mt -65.56 127.82 27.31 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.908 0 CA-C-O 122.547 1.165 . . . . 0.0 109.374 179.421 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.34 -48.42 11.99 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.933 1.293 . . . . 0.0 113.63 174.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . 0.286 0.0 OUTLIER -143.42 163.67 32.44 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-O 123.021 1.391 . . . . 0.0 110.573 -176.432 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -108.24 116.56 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 103.607 -2.738 . . . . 0.0 103.607 173.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.422 ' H ' ' HA ' ' A' ' 77' ' ' PHE . 1.4 mp -68.0 129.17 93.24 Favored Pre-proline 0 CA--C 1.57 1.746 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 176.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.19 131.12 35.05 Favored 'Trans proline' 0 CA--C 1.555 1.529 0 C-N-CA 123.468 2.779 . . . . 0.0 114.112 172.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.4 1.27 88.36 Favored Glycine 0 CA--C 1.551 2.292 0 N-CA-C 117.72 1.848 . . . . 0.0 117.72 -164.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.477 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -78.33 157.53 44.61 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.281 0.943 . . . . 0.0 114.117 172.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.86 -25.39 67.88 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 117.51 2.411 . . . . 0.0 117.51 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.429 ' HA ' HD11 ' A' ' 68' ' ' LEU . . . -64.87 -44.46 89.63 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 173.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.74 -38.67 73.54 Favored 'General case' 0 CA--C 1.563 1.473 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 172.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -67.79 -62.7 1.29 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 125.16 1.384 . . . . 0.0 112.724 173.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.9 t70 . . . . . 0 N--CA 1.485 1.318 0 C-N-CA 124.242 1.017 . . . . 0.0 112.709 -171.526 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 . . . . . 0 C--O 1.241 0.626 0 N-CA-C 100.569 -3.863 . . . . 0.0 100.569 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 41.8 m -78.85 93.02 4.93 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 112.932 -1.94 . . . . 0.0 108.846 -168.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.4 tp -58.25 116.77 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.65 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.58 ' HA ' ' HB3' ' A' ' 126' ' ' ARG 0.266 1.9 pp -100.17 -50.42 3.97 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 113.216 -1.811 . . . . 0.0 114.638 175.706 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.408 ' H ' HD12 ' A' ' 118' ' ' LEU . 62.3 m-85 -126.41 133.09 51.36 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 104.605 -2.368 . . . . 0.0 104.605 177.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.426 HG23 HD23 ' A' ' 146' ' ' LEU . 7.6 p -123.84 117.45 51.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 170.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.687 HD21 ' HB2' ' A' ' 140' ' ' ALA 0.306 22.4 m-80 80.38 -69.85 0.09 Allowed 'General case' 0 N--CA 1.501 2.121 0 CA-C-O 123.334 1.54 . . . . 0.0 110.681 -174.401 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -172.05 -25.06 0.01 OUTLIER 'General case' 0 CA--C 1.575 1.914 0 C-N-CA 128.537 2.735 . . . . 0.0 109.178 -172.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.2 t -66.48 133.92 30.6 Favored 'Isoleucine or valine' 0 C--N 1.363 1.167 0 C-N-CA 125.298 1.439 . . . . 0.0 110.775 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -83.8 98.94 9.99 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 113.292 -1.776 . . . . 0.0 110.227 174.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.57 HG11 ' HA ' ' A' ' 133' ' ' ALA . 2.3 m -86.48 -98.34 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 CA-C-O 115.911 -1.995 . . . . 0.0 107.632 171.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.58 ' HB3' ' HA ' ' A' ' 118' ' ' LEU 0.274 5.7 ptt180 45.88 -99.58 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 CA-C-N 120.589 1.54 . . . . 0.0 113.638 178.44 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -80.05 81.22 6.35 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-O 123.407 1.575 . . . . 0.0 109.006 170.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.58 167.44 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 CA-C-N 112.76 -2.018 . . . . 0.0 106.179 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 25.0 m -60.58 132.49 54.05 Favored 'General case' 0 CA--C 1.561 1.372 0 CA-C-N 114.129 -1.396 . . . . 0.0 110.104 156.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.406 ' HA ' HD12 ' A' ' 94' ' ' ILE . 7.3 p-80 -46.54 -33.45 4.09 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 117.987 2.588 . . . . 0.0 117.987 171.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.493 ' HA ' HG12 ' A' ' 134' ' ' VAL . 12.0 m -62.97 -38.24 90.31 Favored 'General case' 0 CA--C 1.558 1.268 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 175.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.04 -34.34 77.85 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 165.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.57 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -70.46 -51.95 25.59 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 116.382 1.993 . . . . 0.0 116.382 173.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.493 HG12 ' HA ' ' A' ' 131' ' ' SER . 4.3 p -50.05 -43.64 20.96 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.374 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 165.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -64.74 -48.19 75.47 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 116.842 -1.551 . . . . 0.0 113.374 175.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.415 ' HA ' ' HB3' ' A' ' 139' ' ' GLU . . . -68.7 -31.95 71.41 Favored 'General case' 0 CA--C 1.563 1.471 0 N-CA-C 116.561 2.06 . . . . 0.0 116.561 176.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.486 HD23 ' HE1' ' A' ' 77' ' ' PHE . 8.8 mp -60.3 -52.1 66.7 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 125.32 1.448 . . . . 0.0 114.743 166.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -67.12 -33.95 76.55 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 167.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.415 ' HB3' ' HA ' ' A' ' 136' ' ' ALA . 9.1 tp10 -65.16 -24.18 67.32 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 173.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.687 ' HB2' HD21 ' A' ' 121' ' ' ASN . . . -50.97 -25.75 5.09 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 118.024 2.601 . . . . 0.0 118.024 163.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 66.96 83.91 0.1 Allowed Glycine 0 C--N 1.351 1.387 0 CA-C-O 118.695 -1.059 . . . . 0.0 113.11 157.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.8 m 75.04 -30.09 0.2 Allowed 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 117.237 2.31 . . . . 0.0 117.237 -175.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.0 108.84 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 -172.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.567 HG11 HD11 ' A' ' 75' ' ' LEU . 16.9 m -89.55 123.0 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 114.317 -1.31 . . . . 0.0 109.754 176.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -96.27 93.07 6.67 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 172.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.426 HD23 HG23 ' A' ' 120' ' ' VAL . 64.6 mt -98.5 133.5 42.77 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -171.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -131.55 115.38 16.05 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 178.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 35.7 m -126.32 129.13 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 -166.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.483 1.183 0 CA-C-O 121.574 0.702 . . . . 0.0 111.237 169.929 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 1.6 p90 . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 122.493 1.14 . . . . 0.0 112.31 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -139.33 138.11 36.37 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 113.852 -1.522 . . . . 0.0 107.501 172.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.55 122.26 34.8 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.153 -1.385 . . . . 0.0 108.627 177.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 96.8 m -86.8 133.47 33.64 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 173.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -74.81 142.74 44.19 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.117 173.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.426 ' HB ' HG23 ' A' ' 134' ' ' VAL . 7.4 p . . . . . 0 C--O 1.254 1.29 0 CA-C-N 113.976 -1.465 . . . . 0.0 108.661 169.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 32.9 p90 . . . . . 0 N--CA 1.477 0.921 0 CA-C-O 122.332 1.063 . . . . 0.0 111.646 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -110.18 130.25 55.57 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.45 126.79 41.89 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.158 174.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.2 mp -134.24 119.76 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 -176.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.2 m -95.42 122.73 38.44 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 168.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.561 ' HB3' HG23 ' A' ' 144' ' ' VAL . 9.9 tt -125.96 134.94 51.36 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 113.88 -1.509 . . . . 0.0 107.541 -173.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 . . . . . 0 N--CA 1.478 0.967 0 CA-C-O 122.209 1.005 . . . . 0.0 109.457 179.113 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.483 HD13 HG12 ' B' ' 6' ' ' VAL . 4.7 mp . . . . . 0 N--CA 1.477 0.913 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.642 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 138.47 39.12 0.11 Allowed Glycine 0 CA--C 1.535 1.284 0 N-CA-C 118.088 1.995 . . . . 0.0 118.088 -175.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.476 ' CD1' HD13 ' A' ' 96' ' ' ILE . 5.8 p90 -166.5 137.27 3.38 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 124.369 2.033 . . . . 0.0 109.119 -176.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.546 ' HB2' ' HB3' ' A' ' 98' ' ' LYS . 46.1 m -95.0 126.78 40.58 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 113.667 -1.606 . . . . 0.0 112.378 -173.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.712 HG22 HG12 ' A' ' 96' ' ' ILE . 4.1 pt -93.37 130.51 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 113.945 -1.479 . . . . 0.0 110.856 177.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.15 -171.79 3.66 Favored 'General case' 0 CA--C 1.556 1.176 0 CA-C-O 123.057 1.408 . . . . 0.0 110.522 163.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.76 161.47 28.32 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-O 122.888 1.271 . . . . 0.0 115.802 -146.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -108.73 -162.5 20.39 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 112.47 -1.865 . . . . 0.0 113.502 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.445 HG22 ' HB3' ' A' ' 92' ' ' PRO . 70.3 p -50.07 -40.86 46.77 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 116.699 2.111 . . . . 0.0 116.699 178.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -95.54 7.18 46.99 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.4 HD22 ' CE1' ' A' ' 130' ' ' HIS . 0.0 OUTLIER -162.79 90.53 1.27 Allowed Pre-proline 0 CA--C 1.561 1.398 0 N-CA-C 101.101 -3.666 . . . . 0.0 101.101 178.031 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -106.01 125.88 0.05 OUTLIER 'Trans proline' 0 CA--C 1.55 1.323 0 CA-C-N 124.577 2.67 . . . . 0.0 110.799 -177.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 . . . . . 0 N--CA 1.496 1.859 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 161.902 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.445 ' HB3' HG22 ' A' ' 83' ' ' THR . 15.6 Cg_endo . . . . . 0 CA--C 1.554 1.523 0 N-CA-C 111.043 -0.407 . . . . 0.0 111.043 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 55.3 m 79.58 119.53 0.05 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.308 1.443 . . . . 0.0 108.161 166.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.46 HG13 ' HB2' ' A' ' 133' ' ' ALA . 26.6 mm -80.89 140.34 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.482 ' HA ' ' O ' ' A' ' 115' ' ' ASP . 13.3 m-85 -123.23 150.86 42.9 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 114.328 -1.305 . . . . 0.0 111.097 175.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.712 HG12 HG22 ' A' ' 79' ' ' ILE . 53.7 mt -103.21 107.44 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 N-CA-C 103.951 -2.611 . . . . 0.0 103.951 150.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.2 m -95.92 -17.18 21.25 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 174.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.546 ' HB3' ' HB2' ' A' ' 78' ' ' SER 0.273 40.7 tttp -139.26 157.61 45.6 Favored 'General case' 0 CA--C 1.563 1.449 0 CA-C-O 123.818 1.77 . . . . 0.0 110.549 -175.453 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.75 129.9 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 105.299 -2.112 . . . . 0.0 105.299 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.268 1.5 mp -78.51 132.74 64.68 Favored Pre-proline 0 CA--C 1.569 1.705 0 CA-C-O 118.35 -0.833 . . . . 0.0 108.921 169.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -62.9 133.26 40.73 Favored 'Trans proline' 0 C--N 1.367 1.525 0 C-N-CA 123.411 2.741 . . . . 0.0 114.682 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 71.63 4.9 59.19 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 118.383 2.113 . . . . 0.0 118.383 -169.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.642 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -82.79 -172.32 48.23 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.084 0.85 . . . . 0.0 114.119 -179.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.27 -48.77 76.75 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -174.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.443 ' HA ' HD11 ' A' ' 68' ' ' LEU . . . -70.05 -30.19 67.39 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 118.026 2.602 . . . . 0.0 118.026 176.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.5 -40.55 93.17 Favored 'General case' 0 CA--C 1.567 1.602 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 163.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.46 -61.47 1.97 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.565 1.546 . . . . 0.0 112.728 177.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.7 t70 . . . . . 0 N--CA 1.482 1.162 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 -177.869 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.482 ' O ' ' HA ' ' A' ' 95' ' ' PHE 0.307 11.0 t70 . . . . . 0 C--O 1.213 -0.816 0 CA-C-O 117.226 -1.368 . . . . 0.0 107.608 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 75.7 m -96.8 69.59 2.45 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 120.38 1.446 . . . . 0.0 110.799 -170.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.5 tp -67.29 115.67 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-O 121.867 0.841 . . . . 0.0 108.785 174.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.418 HD21 ' HB2' ' A' ' 149' ' ' MET . 3.1 pp -102.24 -40.57 6.72 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.435 1.642 . . . . 0.0 115.435 177.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -138.97 145.59 39.92 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 -175.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.572 HG21 HD22 ' A' ' 137' ' ' LEU . 4.2 t -132.94 113.42 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 102.753 -3.054 . . . . 0.0 102.753 -176.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.71 HD21 ' HB2' ' A' ' 140' ' ' ALA 0.341 22.0 m-80 84.02 -85.1 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 123.342 1.544 . . . . 0.0 108.726 -179.665 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -156.11 -4.35 0.12 Allowed 'General case' 0 CA--C 1.565 1.522 0 CA-C-N 111.564 -2.562 . . . . 0.0 110.575 173.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.518 HG12 HG13 ' A' ' 125' ' ' VAL . 2.3 t -67.82 139.75 20.31 Favored 'Isoleucine or valine' 0 C--N 1.357 0.93 0 C-N-CA 125.29 1.436 . . . . 0.0 109.282 -178.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -81.74 71.32 8.76 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-N 111.288 -2.687 . . . . 0.0 112.939 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.539 HG11 ' HA ' ' A' ' 133' ' ' ALA 0.287 0.6 OUTLIER -82.79 -105.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-O 116.79 -1.576 . . . . 0.0 107.899 178.862 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.581 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.311 27.3 ptt85 49.3 -87.53 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 116.822 2.156 . . . . 0.0 116.822 179.636 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.581 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 27.6 tt0 -81.81 72.53 8.86 Favored 'General case' 0 CA--C 1.555 1.137 0 CA-C-O 123.418 1.58 . . . . 0.0 110.095 167.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.9 p -145.85 167.86 8.01 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 CA-C-N 113.403 -1.726 . . . . 0.0 106.71 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 7.0 m -59.42 132.75 54.93 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 114.044 -1.435 . . . . 0.0 110.2 157.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.4 ' CE1' HD22 ' A' ' 85' ' ' ASN . 2.9 p-80 -48.12 -31.91 6.2 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 117.607 2.447 . . . . 0.0 117.607 169.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.57 ' HA ' HG12 ' A' ' 134' ' ' VAL . 13.9 m -61.91 -38.53 88.71 Favored 'General case' 0 CA--C 1.564 1.486 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 173.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -69.28 -34.14 74.28 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 115.656 1.725 . . . . 0.0 115.656 164.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.539 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -65.18 -52.65 53.61 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 170.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.57 HG12 ' HA ' ' A' ' 131' ' ' SER . 12.7 p -50.41 -46.43 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 164.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -55.0 -50.42 69.06 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-O 116.68 -1.629 . . . . 0.0 112.606 172.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.88 -31.94 72.26 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 117.148 2.277 . . . . 0.0 117.148 170.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.572 HD22 HG21 ' A' ' 120' ' ' VAL . 3.1 mm? -59.55 -51.69 68.74 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 165.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -66.92 -42.4 85.47 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 171.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -69.59 -12.47 61.67 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 117.431 2.382 . . . . 0.0 117.431 173.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.71 ' HB2' HD21 ' A' ' 121' ' ' ASN . . . -53.49 -19.73 4.03 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 118.661 2.837 . . . . 0.0 118.661 157.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 83.26 -140.17 19.62 Favored Glycine 0 C--N 1.345 1.03 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 11.0 m -70.35 -5.84 31.05 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 116.605 2.076 . . . . 0.0 116.605 173.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -147.8 110.84 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -170.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.561 HG23 ' HB3' ' A' ' 68' ' ' LEU . 11.9 m -84.2 115.97 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 114.071 -1.422 . . . . 0.0 109.401 171.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.444 ' HB3' ' HA ' ' A' ' 121' ' ' ASN . 7.8 tpp180 -90.55 107.23 19.03 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 170.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 79.2 mt -108.27 135.64 49.25 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -172.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -125.54 118.2 25.24 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 177.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.43 121.84 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -177.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . 0.418 ' HB2' HD21 ' A' ' 118' ' ' LEU . 49.6 ttm . . . . . 0 N--CA 1.481 1.107 0 CA-C-O 122.16 0.981 . . . . 0.0 112.671 168.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.559 1.303 0 CA-C-O 122.68 1.229 . . . . 0.0 111.399 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -136.11 122.14 20.15 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 172.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 13.9 ttpp -95.88 112.78 24.42 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 113.923 -1.49 . . . . 0.0 107.583 173.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 4.6 m -76.28 131.02 39.0 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 172.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.94 105.46 17.78 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 178.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.483 HG12 HD13 ' A' ' 75' ' ' LEU . 11.7 t . . . . . 0 C--O 1.245 0.821 0 N-CA-C 102.363 -3.199 . . . . 0.0 102.363 -165.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.412 ' HB3' ' HB2' ' A' ' 149' ' ' MET . 26.3 p90 . . . . . 0 N--CA 1.481 1.091 0 CA-C-O 120.862 0.363 . . . . 0.0 110.254 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -122.04 133.73 54.79 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 122.617 1.198 . . . . 0.0 108.965 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -104.98 117.11 33.18 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 -176.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.606 HG13 ' HB2' ' A' ' 146' ' ' LEU . 3.1 pt -137.1 115.22 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 -168.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.9 m -94.77 130.26 41.39 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 171.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.6 HD11 ' HA ' ' A' ' 105' ' ' ALA . 0.5 OUTLIER -129.68 166.79 19.09 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 113.871 -1.513 . . . . 0.0 109.694 172.911 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 . . . . . 0 N--CA 1.478 0.958 0 CA-C-O 122.13 0.966 . . . . 0.0 110.686 175.178 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.527 HD23 HG11 ' A' ' 144' ' ' VAL . 1.5 mp . . . . . 0 N--CA 1.482 1.153 0 N-CA-C 110.547 -0.168 . . . . 0.0 110.547 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 136.59 25.91 0.43 Allowed Glycine 0 CA--C 1.542 1.77 0 CA-C-O 117.999 -1.445 . . . . 0.0 114.886 -175.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.497 ' HD1' HD11 ' A' ' 99' ' ' ILE . 0.0 OUTLIER -129.27 165.84 20.61 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 123.912 1.815 . . . . 0.0 107.72 172.744 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 35.2 m -111.94 143.98 42.02 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 154.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.723 HG22 HD13 ' A' ' 96' ' ' ILE . 2.4 pp -107.56 128.91 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 113.045 -1.889 . . . . 0.0 108.481 170.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -84.15 -166.26 1.38 Allowed 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 123.915 1.817 . . . . 0.0 108.633 162.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 85' ' ' ASN . . . -94.51 157.78 22.57 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 123.697 1.721 . . . . 0.0 113.835 -138.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -104.88 -163.85 24.08 Favored Glycine 0 CA--C 1.522 0.511 0 CA-C-N 111.349 -2.425 . . . . 0.0 113.0 178.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 61.0 p -51.16 -40.1 57.83 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 116.798 2.147 . . . . 0.0 116.798 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -88.03 -5.72 58.34 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 175.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.441 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 0.1 OUTLIER -149.49 82.88 6.65 Favored Pre-proline 0 CA--C 1.558 1.259 0 N-CA-C 101.747 -3.427 . . . . 0.0 101.747 177.308 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -106.75 128.52 0.05 OUTLIER 'Trans proline' 0 C--N 1.361 1.193 0 CA-C-N 125.298 2.928 . . . . 0.0 110.943 -173.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.4 ' HB2' ' CG ' ' B' ' 1' ' ' TYR . 10.6 t-160 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.56 0.695 . . . . 0.0 112.355 169.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo . . . . . 0 CA--C 1.555 1.556 0 N-CA-C 110.044 -0.791 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.9 m 76.15 110.21 0.07 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.058 1.343 . . . . 0.0 108.776 165.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.498 HG13 ' HB2' ' A' ' 133' ' ' ALA . 15.8 mm -73.28 129.53 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -119.2 153.54 34.77 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 112.993 -1.912 . . . . 0.0 108.981 -175.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.723 HD13 HG22 ' A' ' 79' ' ' ILE 0.258 10.9 mm -98.42 106.58 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.685 0 N-CA-C 100.24 -3.985 . . . . 0.0 100.24 170.39 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.543 HG21 ' HG2' ' B' ' 3' ' ' LYS . 10.0 t -93.45 -49.86 5.71 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 -173.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.94 136.18 44.05 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 169.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.497 HD11 ' HD1' ' A' ' 77' ' ' PHE . 0.9 OUTLIER -79.49 138.4 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 177.496 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.343 1.5 mp -72.88 115.57 41.44 Favored Pre-proline 0 CA--C 1.568 1.663 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 171.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -68.61 140.95 48.72 Favored 'Trans proline' 0 C--N 1.369 1.634 0 C-N-CA 123.328 2.685 . . . . 0.0 113.067 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.3 7.79 73.36 Favored Glycine 0 CA--C 1.552 2.399 0 N-CA-C 118.177 2.031 . . . . 0.0 118.177 -174.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -99.09 -165.76 30.09 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-N 119.217 1.509 . . . . 0.0 112.719 177.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 75' ' ' LEU . . . -62.03 -30.72 71.16 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 176.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.6 ' HA ' HD11 ' A' ' 68' ' ' LEU . . . -69.21 -40.85 77.77 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 116.873 2.175 . . . . 0.0 116.873 172.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.51 -41.63 96.29 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 170.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -72.96 -52.7 13.53 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 115.019 1.488 . . . . 0.0 115.019 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.0 t70 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 176.979 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.605 ' HB3' HG11 ' A' ' 148' ' ' VAL . 58.5 m-20 . . . . . 0 C--O 1.235 0.337 0 N-CA-C 103.288 -2.856 . . . . 0.0 103.288 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 21.5 m -84.64 82.52 8.38 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 114.414 -1.266 . . . . 0.0 109.508 -175.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.6 tp -64.21 123.09 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 CA-C-O 122.527 1.155 . . . . 0.0 111.441 -174.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.591 HD21 ' HB3' ' A' ' 149' ' ' MET . 0.0 OUTLIER -111.96 -53.28 2.72 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 112.334 -2.212 . . . . 0.0 112.053 174.896 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -122.63 133.66 54.52 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 -170.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.425 HG13 HD23 ' A' ' 146' ' ' LEU . 2.5 t -126.61 111.88 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 103.353 -2.832 . . . . 0.0 103.353 -178.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.651 HD21 ' HB2' ' A' ' 140' ' ' ALA 0.278 10.0 m-80 81.5 -78.4 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 123.371 1.558 . . . . 0.0 109.496 178.318 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -152.18 -22.47 0.18 Allowed 'General case' 0 CA--C 1.576 1.955 0 C-N-CA 128.219 2.607 . . . . 0.0 109.618 175.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.3 t -59.56 137.64 21.7 Favored 'Isoleucine or valine' 0 C--N 1.362 1.145 0 C-N-CA 125.469 1.508 . . . . 0.0 110.911 176.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -105.6 103.35 12.84 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 113.022 -1.899 . . . . 0.0 108.437 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.426 HG11 ' HA ' ' A' ' 133' ' ' ALA 0.262 0.5 OUTLIER -97.48 -90.24 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-O 117.012 -1.47 . . . . 0.0 108.166 176.806 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.464 ' HB3' ' HB3' ' A' ' 118' ' ' LEU 0.32 23.1 ptt180 51.16 -88.37 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 117.351 2.352 . . . . 0.0 117.351 178.601 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.431 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 2.8 mp0 -85.58 67.13 9.98 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 123.505 1.621 . . . . 0.0 109.472 173.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.3 p -137.13 169.17 20.08 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-O 124.263 1.982 . . . . 0.0 105.924 -178.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 5.3 m -59.25 134.94 57.46 Favored 'General case' 0 CA--C 1.56 1.334 0 CA-C-N 112.701 -2.045 . . . . 0.0 110.643 157.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.455 ' HA ' HD12 ' A' ' 94' ' ' ILE . 9.7 p-80 -45.78 -32.9 2.76 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 117.656 2.465 . . . . 0.0 117.656 169.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.475 ' HA ' HG12 ' A' ' 134' ' ' VAL . 9.4 m -63.41 -40.41 97.13 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 177.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -69.42 -36.74 76.98 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 168.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.498 ' HB2' HG13 ' A' ' 94' ' ' ILE . . . -67.23 -50.51 60.38 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 172.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.475 HG12 ' HA ' ' A' ' 131' ' ' SER . 2.7 p -52.96 -45.11 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 114.544 1.312 . . . . 0.0 114.544 166.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -60.42 -47.0 88.0 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-O 115.553 -2.165 . . . . 0.0 112.515 173.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.18 -35.97 82.52 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 117.044 2.239 . . . . 0.0 117.044 172.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.442 ' HB3' HG21 ' B' ' 6' ' ' VAL . 3.8 mm? -50.79 -54.26 25.04 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.299 1.04 . . . . 0.0 113.627 162.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -69.39 -38.45 78.01 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 174.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -63.4 -21.59 66.38 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 172.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.651 ' HB2' HD21 ' A' ' 121' ' ' ASN . . . -53.33 -22.81 7.87 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 118.674 2.842 . . . . 0.0 118.674 168.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 65.7 89.17 0.05 OUTLIER Glycine 0 C--N 1.351 1.384 0 CA-C-N 118.771 0.714 . . . . 0.0 114.5 155.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . 0.268 20.4 m 72.17 -30.3 0.21 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 118.02 2.6 . . . . 0.0 118.02 -172.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -146.82 110.72 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 -172.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.527 HG11 HD23 ' A' ' 75' ' ' LEU . 33.5 m -83.57 120.75 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.429 171.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -101.66 91.26 4.34 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 174.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.606 ' HB2' HG13 ' A' ' 66' ' ' ILE . 61.2 mt -95.31 137.9 33.74 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 122.536 1.16 . . . . 0.0 108.361 -172.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -127.67 124.64 38.42 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 175.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.605 HG11 ' HB3' ' A' ' 115' ' ' ASP . 28.6 m -134.13 115.91 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -163.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . 0.591 ' HB3' HD21 ' A' ' 118' ' ' LEU . 32.9 ttm . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 -175.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 1' ' ' TYR . . . . . 0.4 ' CG ' ' HB2' ' A' ' 87' ' ' HIS . 1.0 OUTLIER . . . . . 0 CA--C 1.56 1.338 0 CA-C-O 122.964 1.364 . . . . 0.0 111.673 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.88 157.92 39.98 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 123.225 1.488 . . . . 0.0 109.904 168.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.543 ' HG2' HG21 ' A' ' 97' ' ' THR . 0.2 OUTLIER -103.04 136.55 42.64 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 113.603 -1.635 . . . . 0.0 106.853 172.131 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 88.5 m -102.5 136.08 42.98 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 167.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -78.61 140.82 38.4 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-O 123.667 1.699 . . . . 0.0 108.812 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.442 HG21 ' HB3' ' A' ' 137' ' ' LEU . 7.5 p . . . . . 0 C--O 1.243 0.731 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.494 ' HB3' ' HB2' ' A' ' 149' ' ' MET . 20.9 p90 . . . . . 0 CA--C 1.552 1.028 0 CA-C-O 121.491 0.663 . . . . 0.0 110.967 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -110.84 126.75 54.98 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.76 124.99 34.68 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.189 174.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.477 HG13 ' HB2' ' A' ' 146' ' ' LEU . 3.1 pt -137.95 108.28 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 -175.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.8 m -91.39 118.26 30.38 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 172.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.449 ' HB3' ' CG2' ' A' ' 144' ' ' VAL . 3.9 tp -115.42 167.4 10.9 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 113.977 -1.465 . . . . 0.0 108.198 174.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 . . . . . 0 N--CA 1.482 1.125 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 170.125 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.713 HD11 HG11 ' A' ' 144' ' ' VAL . 1.3 tt . . . . . 0 CA--C 1.573 1.829 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 110.91 16.84 9.47 Favored Glycine 0 N--CA 1.478 1.489 0 N-CA-C 117.559 1.783 . . . . 0.0 117.559 169.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.432 ' CE2' HD22 ' A' ' 75' ' ' LEU . 27.7 p90 -143.0 173.0 11.94 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 124.306 2.003 . . . . 0.0 108.5 171.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.7 m -122.12 155.09 36.45 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 123.705 1.717 . . . . 0.0 106.481 176.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.569 HG22 HD13 ' A' ' 96' ' ' ILE . 1.1 pt -121.72 127.05 75.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 111.635 -2.53 . . . . 0.0 109.107 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.37 -168.26 1.29 Allowed 'General case' 0 CA--C 1.556 1.187 0 CA-C-O 123.339 1.542 . . . . 0.0 109.995 159.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.39 159.9 26.48 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 123.409 1.56 . . . . 0.0 115.16 -145.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.37 -160.84 23.31 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-N 111.906 -2.147 . . . . 0.0 113.542 178.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.501 HG22 ' HB3' ' A' ' 92' ' ' PRO . 30.3 p -52.83 -41.2 64.0 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 -178.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -83.04 -8.83 59.5 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 176.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.01 96.98 2.09 Favored Pre-proline 0 CA--C 1.556 1.197 0 N-CA-C 102.32 -3.215 . . . . 0.0 102.32 -173.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -99.15 134.84 0.26 Allowed 'Trans proline' 0 CA--C 1.551 1.338 0 CA-C-N 123.96 2.45 . . . . 0.0 111.543 174.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.448 ' HB2' ' CD2' ' B' ' 1' ' ' TYR . 9.1 t-80 . . . . . 0 N--CA 1.498 1.926 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 155.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.501 ' HB3' HG22 ' A' ' 83' ' ' THR . 3.2 Cg_endo . . . . . 0 CA--C 1.547 1.141 0 CA-C-O 121.339 0.475 . . . . 0.0 112.511 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.6 m 78.22 107.67 0.07 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.461 1.104 . . . . 0.0 108.534 166.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.514 HG13 ' HB2' ' A' ' 133' ' ' ALA . 13.0 mm -74.99 127.51 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 106.376 -1.712 . . . . 0.0 106.376 -177.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -115.18 149.42 37.69 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 113.432 -1.713 . . . . 0.0 108.458 -175.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.569 HD13 HG22 ' A' ' 79' ' ' ILE . 22.3 mm -97.35 104.23 15.64 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.278 0 N-CA-C 104.388 -2.449 . . . . 0.0 104.388 171.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.545 HG21 ' HG3' ' B' ' 3' ' ' LYS . 12.2 t -79.51 -46.64 17.01 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 -177.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.0 ptmt -150.31 146.03 26.51 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.772 0.796 . . . . 0.0 111.099 -170.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.54 135.1 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 178.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.7 mp -82.9 117.62 69.14 Favored Pre-proline 0 CA--C 1.565 1.52 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 172.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.69 135.16 51.01 Favored 'Trans proline' 0 C--N 1.367 1.537 0 C-N-CA 123.442 2.761 . . . . 0.0 113.09 169.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 87.33 -9.97 70.98 Favored Glycine 0 CA--C 1.548 2.156 0 N-CA-C 117.707 1.843 . . . . 0.0 117.707 -169.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -85.91 -179.58 50.01 Favored Glycine 0 CA--C 1.538 1.472 0 CA-C-N 119.44 1.62 . . . . 0.0 113.602 175.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.09 -33.7 72.2 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 117.1 2.259 . . . . 0.0 117.1 -177.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.62 -35.18 68.0 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 118.567 2.803 . . . . 0.0 118.567 169.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.85 -32.04 71.43 Favored 'General case' 0 CA--C 1.558 1.274 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 171.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.02 -53.59 8.14 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 119.706 1.139 . . . . 0.0 112.827 172.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.2 t70 . . . . . 0 N--CA 1.484 1.24 0 C-N-CA 123.773 0.829 . . . . 0.0 112.555 -170.927 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 . . . . . 0 CA--C 1.535 0.382 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 64.3 m -88.93 89.92 8.19 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -175.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.486 HG12 HD11 ' A' ' 137' ' ' LEU . 6.7 tp -63.21 128.01 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.073 178.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.746 HD21 ' HB3' ' A' ' 149' ' ' MET . 0.0 OUTLIER -114.93 -54.15 2.59 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 112.422 -2.172 . . . . 0.0 114.421 177.076 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -119.79 134.65 55.16 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 -174.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.431 HG23 HD23 ' A' ' 146' ' ' LEU . 9.1 p -123.94 118.34 53.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 169.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.587 HD21 ' CB ' ' A' ' 140' ' ' ALA 0.298 11.6 m-80 78.5 -81.25 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 122.953 1.359 . . . . 0.0 109.604 -177.213 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -152.91 -20.88 0.16 Allowed 'General case' 0 CA--C 1.568 1.659 0 C-N-CA 127.859 2.464 . . . . 0.0 110.177 -177.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.2 t -64.35 135.19 28.35 Favored 'Isoleucine or valine' 0 C--N 1.362 1.122 0 C-N-CA 125.318 1.447 . . . . 0.0 110.358 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -90.8 97.54 11.24 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 113.072 -1.877 . . . . 0.0 108.307 172.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.472 HG11 ' HA ' ' A' ' 133' ' ' ALA 0.282 0.2 OUTLIER -93.48 -93.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-O 116.447 -1.739 . . . . 0.0 107.159 170.263 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.554 ' HB3' ' HA ' ' A' ' 118' ' ' LEU 0.292 11.3 ptt180 48.39 -88.69 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 117.851 2.538 . . . . 0.0 117.851 178.615 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.521 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 1.7 tt0 -84.1 66.86 9.47 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-O 123.674 1.702 . . . . 0.0 108.804 172.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -139.7 169.96 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 CA-C-N 112.606 -2.088 . . . . 0.0 106.513 178.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 7.7 m -60.5 136.5 58.07 Favored 'General case' 0 CA--C 1.561 1.375 0 CA-C-N 113.439 -1.709 . . . . 0.0 110.843 159.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.408 ' HA ' HD12 ' A' ' 94' ' ' ILE . 8.8 p-80 -45.3 -35.23 3.34 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 118.263 2.69 . . . . 0.0 118.263 170.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.477 ' HA ' HG12 ' A' ' 134' ' ' VAL . 79.0 p -60.31 -42.24 95.15 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 116.786 2.143 . . . . 0.0 116.786 172.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -70.68 -37.78 73.66 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 169.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.514 ' HB2' HG13 ' A' ' 94' ' ' ILE . . . -59.79 -55.49 33.66 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 169.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.477 HG12 ' HA ' ' A' ' 131' ' ' SER . 2.2 p -53.13 -46.84 55.77 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 170.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -60.55 -45.99 91.84 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 115.838 -2.03 . . . . 0.0 112.844 176.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.7 -34.57 78.61 Favored 'General case' 0 CA--C 1.558 1.278 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 171.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.486 HD11 HG12 ' A' ' 117' ' ' ILE . 9.6 mp -58.65 -46.55 86.9 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 165.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -70.33 -33.06 71.04 Favored 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 170.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -73.26 -14.96 61.42 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 116.455 2.02 . . . . 0.0 116.455 172.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.587 ' CB ' HD21 ' A' ' 121' ' ' ASN . . . -56.91 1.06 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.172 0 N-CA-C 119.227 3.047 . . . . 0.0 119.227 162.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 77.25 -146.51 31.92 Favored Glycine 0 C--N 1.344 1.019 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 176.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.8 m -72.0 -6.95 45.87 Favored 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 173.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -147.49 107.71 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 -165.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.713 HG11 HD11 ' A' ' 75' ' ' LEU . 23.1 m -92.48 123.91 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 114.073 -1.422 . . . . 0.0 108.612 -174.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -103.15 87.12 2.82 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.477 ' HB2' HG13 ' A' ' 66' ' ' ILE . 73.7 mt -91.33 133.9 35.05 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 -170.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -124.42 121.83 35.97 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 33.3 m -129.56 117.53 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -167.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . 0.746 ' HB3' HD21 ' A' ' 118' ' ' LEU . 27.5 ttt . . . . . 0 N--CA 1.482 1.165 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -175.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 1' ' ' TYR . . . . . 0.448 ' CD2' ' HB2' ' A' ' 87' ' ' HIS . 0.3 OUTLIER . . . . . 0 CA--C 1.559 1.297 0 CA-C-O 122.887 1.327 . . . . 0.0 110.718 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 66.1 tttp -135.15 134.46 40.2 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-O 123.405 1.574 . . . . 0.0 108.205 165.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.545 ' HG3' HG21 ' A' ' 97' ' ' THR . 1.1 tmmt? -104.28 126.91 51.78 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 113.809 -1.541 . . . . 0.0 109.051 173.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.428 HG21 HG11 ' A' ' 134' ' ' VAL . 91.1 m -98.2 139.82 33.42 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 114.173 -1.376 . . . . 0.0 109.343 172.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -87.45 128.01 35.22 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 113.926 -1.488 . . . . 0.0 108.936 175.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.468 ' HB ' HG23 ' A' ' 134' ' ' VAL . 4.1 p . . . . . 0 C--O 1.248 1.025 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 175.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 8.8 p90 . . . . . 0 N--CA 1.481 1.078 0 CA-C-O 121.658 0.742 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -124.91 137.65 54.27 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 114.608 -1.178 . . . . 0.0 108.971 -177.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -103.27 132.3 49.64 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.66 175.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 21.0 pt -135.55 127.12 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -175.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.2 m -95.26 121.62 37.1 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 170.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 mp -119.75 126.9 52.18 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.373 -1.285 . . . . 0.0 107.632 -174.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.548 0.873 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.39 -172.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.606 HD23 HG12 ' B' ' 6' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.484 1.265 0 CA-C-O 118.558 -0.734 . . . . 0.0 111.363 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.553 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 104.06 37.71 2.86 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 117.427 1.731 . . . . 0.0 117.427 162.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.472 ' O ' ' HB ' ' B' ' 6' ' ' VAL . 0.0 OUTLIER -152.33 143.76 23.37 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 -172.42 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.464 ' CB ' ' HG2' ' A' ' 98' ' ' LYS . 50.1 m -106.91 122.25 46.04 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.572 -1.194 . . . . 0.0 108.538 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.555 HG22 HG12 ' A' ' 96' ' ' ILE . 5.1 pt -108.13 129.56 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 CA-C-O 121.674 0.749 . . . . 0.0 109.952 -171.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.434 ' HB1' ' CB ' ' A' ' 87' ' ' HIS . . . -86.57 -171.4 3.52 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-O 123.597 1.665 . . . . 0.0 111.281 158.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.44 159.65 21.15 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-O 123.713 1.73 . . . . 0.0 115.057 -137.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -102.77 -162.14 25.9 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 111.441 -2.38 . . . . 0.0 111.874 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 44.3 p -55.15 -40.38 70.53 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 116.922 2.193 . . . . 0.0 116.922 -174.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -75.51 -21.97 57.54 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 116.353 1.983 . . . . 0.0 116.353 174.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -145.28 95.94 4.98 Favored Pre-proline 0 CA--C 1.553 1.075 0 N-CA-C 101.498 -3.519 . . . . 0.0 101.498 -173.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -93.32 137.29 1.33 Allowed 'Trans proline' 0 CA--C 1.554 1.475 0 CA-C-N 124.079 2.493 . . . . 0.0 111.646 -177.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.434 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 23.2 t-80 . . . . . 0 N--CA 1.495 1.783 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 161.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo . . . . . 0 CA--C 1.545 1.056 0 CA-C-O 120.946 0.311 . . . . 0.0 112.113 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 66.8 m 73.17 138.6 0.05 Allowed 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 122.438 1.113 . . . . 0.0 109.323 176.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.428 HG13 ' HB2' ' A' ' 133' ' ' ALA . 15.0 mm -94.43 121.71 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 -169.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -124.57 138.17 54.34 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 -174.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.555 HG12 HG22 ' A' ' 79' ' ' ILE . 82.4 mt -82.35 122.98 37.83 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.627 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 169.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 89.3 m -93.57 -33.84 13.57 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 117.627 -1.177 . . . . 0.0 113.907 172.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.464 ' HG2' ' CB ' ' A' ' 78' ' ' SER 0.354 8.1 ptmm? -140.27 167.75 21.4 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-O 123.534 1.635 . . . . 0.0 110.885 173.351 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -109.14 129.22 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 103.835 -2.654 . . . . 0.0 103.835 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.427 ' HA ' ' HD2' ' A' ' 101' ' ' PRO 0.314 22.5 mt -83.74 121.76 76.26 Favored Pre-proline 0 CA--C 1.564 1.503 0 CA-C-O 117.915 -1.041 . . . . 0.0 108.789 175.142 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 100' ' ' ILE . 11.6 Cg_endo -55.96 141.18 86.48 Favored 'Trans proline' 0 C--N 1.371 1.746 0 C-N-CA 124.075 3.183 . . . . 0.0 115.581 178.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.95 15.04 79.83 Favored Glycine 0 CA--C 1.547 2.058 0 N-CA-C 117.27 1.668 . . . . 0.0 117.27 -164.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.553 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -89.23 176.83 43.9 Favored Glycine 0 C--N 1.34 0.772 0 C-N-CA 124.721 1.153 . . . . 0.0 115.578 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.37 -48.54 75.11 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 177.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.23 -34.0 74.16 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.69 -44.35 81.97 Favored 'General case' 0 CA--C 1.561 1.388 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 168.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.4 -65.4 0.82 Allowed 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 124.637 1.175 . . . . 0.0 111.791 176.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.2 t70 . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 115.478 1.659 . . . . 0.0 115.478 -174.142 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.3 p30 . . . . . 0 CA--C 1.542 0.651 0 N-CA-C 101.068 -3.678 . . . . 0.0 101.068 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.5 m -67.49 79.82 0.17 Allowed 'General case' 0 CA--C 1.554 1.108 0 CA-C-N 113.409 -1.723 . . . . 0.0 111.531 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.6 pt -70.14 100.61 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-O 123.406 1.574 . . . . 0.0 108.8 -176.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.8 pp -96.41 -38.7 9.93 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 112.909 -1.951 . . . . 0.0 114.94 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.445 ' HB2' ' HB2' ' A' ' 147' ' ' TYR . 20.9 m-85 -125.46 140.55 52.68 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 123.273 1.511 . . . . 0.0 107.067 177.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.462 HG21 HD22 ' A' ' 137' ' ' LEU . 3.5 t -134.0 113.04 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 102.259 -3.238 . . . . 0.0 102.259 -179.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.77 HD21 ' HB2' ' A' ' 140' ' ' ALA 0.32 22.3 m-80 83.97 -78.05 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 123.934 1.826 . . . . 0.0 110.134 179.572 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -156.38 -23.9 0.1 Allowed 'General case' 0 CA--C 1.572 1.791 0 CA-C-N 110.472 -3.058 . . . . 0.0 109.276 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.3 t -61.73 138.78 21.71 Favored 'Isoleucine or valine' 0 C--N 1.361 1.066 0 C-N-CA 125.604 1.561 . . . . 0.0 111.087 -177.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -94.88 87.91 5.13 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 111.348 -2.66 . . . . 0.0 110.81 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.47 HG11 ' HA ' ' A' ' 133' ' ' ALA 0.287 0.5 OUTLIER -92.37 -98.52 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 CA-C-O 117.104 -1.427 . . . . 0.0 108.154 -179.942 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.546 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.315 15.1 ptt180 48.37 -89.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 -179.514 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.546 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 21.9 tt0 -74.68 75.49 2.05 Favored 'General case' 0 CA--C 1.557 1.237 0 CA-C-O 123.738 1.732 . . . . 0.0 110.323 166.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -155.0 164.35 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 -175.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 34.0 m -60.06 132.11 52.92 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-N 113.586 -1.643 . . . . 0.0 109.671 156.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -46.82 -31.45 3.05 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 118.212 2.671 . . . . 0.0 118.212 171.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.544 ' HA ' HG12 ' A' ' 134' ' ' VAL . 14.6 m -60.09 -38.59 83.37 Favored 'General case' 0 CA--C 1.561 1.375 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 173.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -71.07 -35.93 72.08 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 166.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.47 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -59.88 -53.71 54.74 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 168.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.544 HG12 ' HA ' ' A' ' 131' ' ' SER . 9.7 p -55.99 -41.92 69.73 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.444 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 166.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -57.57 -43.56 84.61 Favored 'General case' 0 CA--C 1.556 1.191 0 CA-C-O 117.626 -1.178 . . . . 0.0 113.458 171.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.14 -33.43 75.45 Favored 'General case' 0 CA--C 1.558 1.263 0 N-CA-C 116.397 1.999 . . . . 0.0 116.397 167.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.462 HD22 HG21 ' A' ' 120' ' ' VAL . 4.3 mm? -59.65 -50.96 71.85 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 165.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -65.98 -38.33 88.27 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 173.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -65.96 -28.46 68.92 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 116.353 1.983 . . . . 0.0 116.353 171.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.77 ' HB2' HD21 ' A' ' 121' ' ' ASN . . . -52.43 -33.21 43.01 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 117.443 2.386 . . . . 0.0 117.443 161.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 93.62 -120.15 6.19 Favored Glycine 0 C--N 1.345 1.051 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 166.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.3 m -86.71 0.29 54.91 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 117.426 2.38 . . . . 0.0 117.426 168.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.95 101.99 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 -170.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.499 ' HA ' ' HB1' ' A' ' 140' ' ' ALA . 15.5 m -88.02 118.64 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 114.04 -1.436 . . . . 0.0 109.654 176.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 40.8 mtt180 -98.58 87.65 3.87 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 178.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 53.3 mt -90.45 136.52 33.0 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -170.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.445 ' HB2' ' HB2' ' A' ' 119' ' ' PHE . 41.6 m-85 -122.72 120.39 33.49 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 104.515 -2.402 . . . . 0.0 104.515 178.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -123.44 120.62 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 -176.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 28.3 ttt . . . . . 0 N--CA 1.476 0.835 0 O-C-N 124.519 1.137 . . . . 0.0 109.982 162.449 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 1.3 p90 . . . . . 0 CA--C 1.56 1.342 0 CA-C-O 122.569 1.176 . . . . 0.0 110.741 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -132.99 133.99 43.87 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-O 123.017 1.389 . . . . 0.0 108.473 170.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -95.69 124.96 39.95 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 113.782 -1.554 . . . . 0.0 108.736 169.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 4.7 m -83.69 140.41 32.16 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 123.309 1.528 . . . . 0.0 109.21 167.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -98.99 105.79 17.97 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 104.889 -2.263 . . . . 0.0 104.889 -177.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.606 HG12 HD23 ' A' ' 75' ' ' LEU . 12.3 t . . . . . 0 C--O 1.256 1.428 0 CA-C-O 123.03 1.395 . . . . 0.0 107.803 -165.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.59 ' HB3' ' HG2' ' A' ' 149' ' ' MET . 13.3 p90 . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 121.368 0.604 . . . . 0.0 110.353 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -107.77 132.99 52.8 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.562 172.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.22 121.4 43.59 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 113.824 -1.535 . . . . 0.0 108.593 -177.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 13.5 pt -135.32 118.7 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 -174.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.7 m -89.96 124.2 34.53 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 168.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.534 HD21 ' HA ' ' A' ' 105' ' ' ALA . 1.5 tp -116.05 125.0 51.84 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 114.22 -1.354 . . . . 0.0 109.293 -171.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 . . . . . 0 N--CA 1.471 0.594 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.423 -176.094 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.49 HD22 HG12 ' B' ' 6' ' ' VAL . 1.6 mp . . . . . 0 CA--C 1.56 1.341 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.558 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 145.71 67.41 0.01 OUTLIER Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 167.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.45 ' CZ ' HD23 ' A' ' 75' ' ' LEU . 2.7 p90 -163.62 141.01 7.32 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 124.292 1.996 . . . . 0.0 108.772 176.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.416 ' HB2' ' HB3' ' A' ' 98' ' ' LYS . 15.8 m -92.85 128.22 38.63 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 112.208 -2.269 . . . . 0.0 110.846 -178.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.467 HG12 HG23 ' A' ' 134' ' ' VAL . 1.9 pp -103.63 125.74 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.866 178.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.552 ' HB3' ' HB2' ' A' ' 95' ' ' PHE . . . -74.86 -175.53 2.55 Favored 'General case' 0 CA--C 1.555 1.138 0 CA-C-O 123.624 1.678 . . . . 0.0 111.076 164.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 85' ' ' ASN . . . -99.03 155.73 20.01 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-O 123.591 1.662 . . . . 0.0 115.469 -141.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.13 -160.29 21.51 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 111.37 -2.415 . . . . 0.0 113.891 177.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 38.9 p -58.67 -38.7 78.74 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 115.578 1.695 . . . . 0.0 115.578 -174.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.561 ' HB3' HG23 ' A' ' 129' ' ' THR . 11.2 t70 -96.53 12.91 29.85 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 175.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.405 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 0.8 OUTLIER -163.67 76.83 1.71 Allowed Pre-proline 0 N--CA 1.481 1.103 0 N-CA-C 100.868 -3.753 . . . . 0.0 100.868 -179.756 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -100.12 127.58 0.14 Allowed 'Trans proline' 0 C--N 1.364 1.382 0 CA-C-N 125.198 2.892 . . . . 0.0 111.07 -166.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 41.7 t60 . . . . . 0 CA--C 1.566 1.593 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 162.412 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo . . . . . 0 CA--C 1.54 0.783 0 N-CA-C 113.634 0.59 . . . . 0.0 113.634 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.7 m -158.64 122.67 4.0 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 -173.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.46 HG13 ' CB ' ' A' ' 133' ' ' ALA . 21.0 mm -79.42 126.06 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 -173.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.552 ' HB2' ' HB3' ' A' ' 80' ' ' ALA . 22.8 m-30 -117.72 161.54 19.52 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.646 -1.615 . . . . 0.0 107.32 -176.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 89.2 mt -105.8 112.73 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 103.738 -2.69 . . . . 0.0 103.738 149.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.6 m -95.61 -18.64 20.4 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 169.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.416 ' HB3' ' HB2' ' A' ' 78' ' ' SER . 53.2 tttp -136.99 153.62 50.63 Favored 'General case' 0 CA--C 1.556 1.2 0 CA-C-O 124.301 2.0 . . . . 0.0 109.954 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.433 HG22 ' HB3' ' A' ' 105' ' ' ALA . 0.6 OUTLIER -113.43 125.63 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-N 112.98 -1.918 . . . . 0.0 105.947 175.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.279 1.4 mp -71.55 127.61 90.86 Favored Pre-proline 0 CA--C 1.567 1.6 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 171.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.57 130.75 41.69 Favored 'Trans proline' 0 C--N 1.365 1.399 0 C-N-CA 123.558 2.838 . . . . 0.0 115.141 176.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 72.98 9.87 76.68 Favored Glycine 0 CA--C 1.551 2.324 0 N-CA-C 118.306 2.082 . . . . 0.0 118.306 -169.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.558 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -84.98 -168.71 45.03 Favored Glycine 0 C--N 1.336 0.577 0 N-CA-C 115.625 1.01 . . . . 0.0 115.625 -176.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.81 -52.61 55.86 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.534 ' HA ' HD21 ' A' ' 68' ' ' LEU . . . -67.7 -37.46 82.31 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 115.887 -2.006 . . . . 0.0 114.491 173.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.72 -51.18 66.11 Favored 'General case' 0 CA--C 1.562 1.438 0 CA-C-N 121.366 1.894 . . . . 0.0 114.936 173.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.8 -60.93 3.06 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 125.182 1.393 . . . . 0.0 113.25 176.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.2 t70 . . . . . 0 CA--C 1.557 1.248 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -173.815 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . 0.267 17.2 t70 . . . . . 0 N--CA 1.468 0.448 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.8 m -139.33 92.02 2.55 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 -177.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.505 HD11 ' HB ' ' A' ' 120' ' ' VAL . 0.0 OUTLIER -78.31 121.66 31.67 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.29 0 CA-C-O 122.445 1.116 . . . . 0.0 109.692 170.277 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.911 HD11 ' H ' ' A' ' 149' ' ' MET . 0.0 OUTLIER -106.05 -46.98 3.95 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.337 1.055 . . . . 0.0 113.144 179.504 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.465 ' HD1' HD23 ' A' ' 118' ' ' LEU . 68.1 m-85 -120.39 141.26 50.27 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 175.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.505 ' HB ' HD11 ' A' ' 117' ' ' ILE . 7.7 p -128.66 122.17 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 170.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.826 HD21 ' HB2' ' A' ' 140' ' ' ALA 0.314 34.1 m-80 79.19 -76.17 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 123.622 1.677 . . . . 0.0 110.767 -177.379 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -163.47 -20.85 0.04 OUTLIER 'General case' 0 CA--C 1.572 1.794 0 CA-C-N 111.291 -2.686 . . . . 0.0 109.778 -175.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.542 HG12 HG13 ' A' ' 125' ' ' VAL . 2.4 t -64.48 136.21 26.86 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.168 0 C-N-CA 125.334 1.453 . . . . 0.0 110.249 -177.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -88.69 80.92 7.14 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 112.237 -2.256 . . . . 0.0 110.392 175.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.546 HG11 ' HA ' ' A' ' 133' ' ' ALA . 0.2 OUTLIER -86.3 -89.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-O 117.074 -1.441 . . . . 0.0 107.892 179.735 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.595 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.305 11.6 ptt180 46.22 -92.96 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 124.993 1.317 . . . . 0.0 114.393 -177.661 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.595 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 16.3 mt-10 -84.2 66.79 9.49 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 123.866 1.793 . . . . 0.0 111.947 175.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.5 p -133.34 168.09 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 112.607 -2.088 . . . . 0.0 105.918 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.561 HG23 ' HB3' ' A' ' 84' ' ' ASP . 96.6 m -59.66 137.01 58.16 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-N 113.609 -1.632 . . . . 0.0 110.627 157.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.433 ' HA ' HD12 ' A' ' 94' ' ' ILE . 3.4 p-80 -46.91 -37.62 9.19 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 171.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.458 ' H ' HG22 ' A' ' 129' ' ' THR . 7.9 m -56.23 -45.42 79.96 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 177.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.34 -39.06 88.96 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 171.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.546 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -68.04 -51.1 50.69 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 116.278 1.955 . . . . 0.0 116.278 171.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.818 HG22 HG21 ' B' ' 6' ' ' VAL . 0.3 OUTLIER -59.94 -39.35 79.88 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 N-CA-C 115.888 1.81 . . . . 0.0 115.888 173.035 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.409 ' HA ' ' HG2' ' A' ' 138' ' ' LYS . 1.0 OUTLIER -63.79 -42.77 97.67 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-O 117.223 -1.37 . . . . 0.0 113.051 167.123 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.71 -31.36 72.55 Favored 'General case' 0 CA--C 1.565 1.527 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 169.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.501 ' O ' ' HB3' ' A' ' 140' ' ' ALA . 8.5 mp -61.49 -55.48 30.59 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 125.52 1.528 . . . . 0.0 112.322 166.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.409 ' HG2' ' HA ' ' A' ' 135' ' ' GLU . 17.7 ptpt -64.01 -31.88 73.23 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 116.729 2.122 . . . . 0.0 116.729 170.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -66.44 -27.66 68.0 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 169.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.826 ' HB2' HD21 ' A' ' 121' ' ' ASN . . . -51.81 -42.67 62.68 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 115.826 1.787 . . . . 0.0 115.826 159.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 90.07 -129.03 9.52 Favored Glycine 0 C--N 1.349 1.275 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 165.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.0 t -72.26 -2.04 17.49 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 117.353 2.353 . . . . 0.0 117.353 168.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.97 107.56 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 -173.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.593 ' HA ' ' HB1' ' A' ' 140' ' ' ALA . 4.2 t -113.94 105.85 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 -169.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.432 ' HB2' ' HA ' ' A' ' 121' ' ' ASN . 99.2 mtt180 -89.65 92.11 8.94 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -178.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 22.1 mt -93.96 131.22 39.64 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 -175.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.428 ' O ' HD22 ' A' ' 118' ' ' LEU . 79.5 m-85 -120.15 128.39 53.38 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 104.686 -2.339 . . . . 0.0 104.686 -178.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -136.64 128.37 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . 0.911 ' H ' HD11 ' A' ' 118' ' ' LEU . 63.9 mtm . . . . . 0 C--O 1.239 0.519 0 C-N-CA 127.016 2.126 . . . . 0.0 109.465 172.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.554 1.098 0 CA-C-O 123.33 1.538 . . . . 0.0 110.398 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 22.7 tptp -151.28 121.94 7.47 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 113.632 -1.622 . . . . 0.0 107.833 170.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 6.0 ptmm? -75.7 109.41 9.26 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 113.918 -1.492 . . . . 0.0 111.26 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 26.3 m -81.43 126.97 32.28 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 123.287 1.518 . . . . 0.0 108.884 -178.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.94 106.17 18.33 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 113.331 -1.759 . . . . 0.0 106.891 -174.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.818 HG21 HG22 ' A' ' 134' ' ' VAL . 42.8 t . . . . . 0 C--O 1.251 1.179 0 N-CA-C 105.218 -2.142 . . . . 0.0 105.218 -178.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 21.8 p90 . . . . . 0 N--CA 1.477 0.884 0 CA-C-O 121.857 0.837 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -98.42 126.39 43.93 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.47 125.37 35.15 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 113.368 -1.742 . . . . 0.0 108.199 173.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.474 ' HB ' ' HB2' ' A' ' 146' ' ' LEU . 19.0 mt -126.61 131.83 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 -176.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.3 m -106.6 120.69 42.63 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 171.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.4 tp -124.93 145.57 49.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 113.39 -1.732 . . . . 0.0 107.739 176.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.517 ' HG3' ' HB1' ' A' ' 104' ' ' ALA . 2.7 pt-20 . . . . . 0 CA--C 1.559 1.314 0 O-C-N 121.218 -0.926 . . . . 0.0 110.71 173.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.542 HD12 HG21 ' A' ' 144' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.51 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 76.1 50.48 7.61 Favored Glycine 0 C--N 1.338 0.663 0 N-CA-C 116.229 1.251 . . . . 0.0 116.229 175.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.489 ' HE1' HD23 ' A' ' 137' ' ' LEU . 17.8 p90 -155.2 149.29 25.8 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 123.172 1.463 . . . . 0.0 108.036 173.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.431 ' O ' HG23 ' A' ' 96' ' ' ILE . 3.6 m -97.31 136.07 38.32 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.164 177.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.409 HD11 ' HB ' ' A' ' 134' ' ' VAL . 1.2 pt -110.13 123.74 66.29 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-O 121.95 0.881 . . . . 0.0 109.576 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.417 ' HB2' ' OG1' ' A' ' 97' ' ' THR . . . -77.7 177.42 8.14 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-O 124.292 1.996 . . . . 0.0 110.247 157.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' A' ' 85' ' ' ASN . . . -96.75 164.71 22.99 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-O 124.24 2.022 . . . . 0.0 115.582 -140.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -102.78 -166.88 26.19 Favored Glycine 0 CA--C 1.521 0.465 0 CA-C-N 110.543 -2.828 . . . . 0.0 112.364 -175.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.443 HG22 ' HB3' ' A' ' 92' ' ' PRO . 63.1 p -44.57 -42.51 7.38 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 118.014 2.598 . . . . 0.0 118.014 -177.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -88.19 -7.6 56.61 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 115.993 1.849 . . . . 0.0 115.993 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.409 ' O ' ' HA3' ' A' ' 81' ' ' GLY 0.267 4.4 t30 -151.99 58.59 2.71 Favored Pre-proline 0 CA--C 1.571 1.755 0 CA-C-O 116.667 -1.635 . . . . 0.0 107.632 -178.508 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -97.57 135.04 0.37 Allowed 'Trans proline' 0 C--N 1.373 1.83 0 CA-C-N 126.282 3.279 . . . . 0.0 111.538 -170.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.554 ' HB2' ' CG ' ' B' ' 1' ' ' TYR . 7.9 t-80 . . . . . 0 N--CA 1.502 2.169 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 163.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.443 ' HB3' HG22 ' A' ' 83' ' ' THR . 23.6 Cg_endo . . . . . 0 CA--C 1.558 1.708 0 N-CA-C 110.403 -0.653 . . . . 0.0 110.403 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 53.1 m 75.71 134.72 0.05 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.991 1.316 . . . . 0.0 109.816 165.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.404 HG13 ' HB2' ' A' ' 133' ' ' ALA . 23.4 mm -96.14 124.44 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 105.812 -1.921 . . . . 0.0 105.812 -172.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -129.6 126.22 37.96 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -175.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.431 HG23 ' O ' ' A' ' 78' ' ' SER 0.349 60.2 mt -66.44 129.6 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.287 0 CA-C-O 122.895 1.331 . . . . 0.0 108.648 174.002 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.417 ' OG1' ' HB2' ' A' ' 80' ' ' ALA . 4.4 m -87.69 -41.4 13.38 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 124.846 1.258 . . . . 0.0 113.325 171.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -140.4 160.95 38.86 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 124.174 1.94 . . . . 0.0 110.465 -175.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -114.4 109.93 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 102.365 -3.198 . . . . 0.0 102.365 174.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.254 1.5 mp -66.71 121.28 76.74 Favored Pre-proline 0 CA--C 1.564 1.516 0 CA-C-O 117.774 -1.107 . . . . 0.0 109.395 -177.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -63.22 138.05 64.58 Favored 'Trans proline' 0 C--N 1.364 1.387 0 C-N-CA 123.373 2.715 . . . . 0.0 113.387 172.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.45 -6.83 56.49 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 117.977 1.951 . . . . 0.0 117.977 -168.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.51 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -90.01 176.81 42.64 Favored Glycine 0 CA--C 1.537 1.439 0 CA-C-O 122.435 1.019 . . . . 0.0 113.025 174.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.517 ' HB1' ' HG3' ' A' ' 69' ' ' GLU . . . -67.52 -36.82 81.77 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 117.332 2.345 . . . . 0.0 117.332 -175.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.402 ' HB2' ' HD2' ' A' ' 77' ' ' PHE . . . -68.06 -35.37 78.1 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 116.37 1.989 . . . . 0.0 116.37 168.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.8 -31.72 69.79 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 115.524 1.675 . . . . 0.0 115.524 166.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.34 -61.61 1.77 Allowed 'General case' 0 CA--C 1.566 1.584 0 C-N-CA 124.581 1.152 . . . . 0.0 111.739 171.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.8 t70 . . . . . 0 CA--C 1.556 1.209 0 C-N-CA 124.901 1.281 . . . . 0.0 112.369 -173.723 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 20.4 t70 . . . . . 0 C--O 1.24 0.581 0 N-CA-C 100.292 -3.966 . . . . 0.0 100.292 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.2 m -71.52 78.13 0.79 Allowed 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 113.026 -1.897 . . . . 0.0 109.982 -173.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 5.1 tp -73.86 109.97 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -174.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.733 HD21 ' HB3' ' A' ' 149' ' ' MET . 0.2 OUTLIER -110.0 -47.61 3.3 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 113.171 -1.831 . . . . 0.0 114.157 -175.224 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -116.87 136.5 52.9 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 172.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 14.0 p -124.86 123.73 66.33 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 170.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.533 HD21 ' HB2' ' A' ' 140' ' ' ALA 0.302 28.9 m-80 77.85 -84.46 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 123.757 1.741 . . . . 0.0 108.921 179.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -151.57 -22.14 0.2 Allowed 'General case' 0 CA--C 1.574 1.882 0 CA-C-N 110.82 -2.9 . . . . 0.0 109.131 -176.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.416 HG12 HG13 ' A' ' 125' ' ' VAL . 2.3 t -68.41 136.71 25.91 Favored 'Isoleucine or valine' 0 C--N 1.363 1.155 0 C-N-CA 125.781 1.632 . . . . 0.0 110.224 -178.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -89.5 98.98 12.08 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 111.999 -2.364 . . . . 0.0 108.457 170.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.543 HG11 ' HA ' ' A' ' 133' ' ' ALA 0.26 0.4 OUTLIER -95.01 -98.36 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 173.233 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.513 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.287 16.1 ptt85 51.7 -92.39 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 116.855 2.169 . . . . 0.0 116.855 176.965 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.513 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 8.5 tt0 -77.65 64.54 2.97 Favored 'General case' 0 CA--C 1.56 1.34 0 CA-C-O 123.648 1.689 . . . . 0.0 110.967 167.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -139.02 167.6 20.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 2.7 m -58.84 134.46 56.91 Favored 'General case' 0 CA--C 1.557 1.222 0 CA-C-N 112.697 -2.047 . . . . 0.0 110.7 157.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -45.41 -32.72 2.23 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 117.499 2.407 . . . . 0.0 117.499 168.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.9 m -60.55 -43.12 97.58 Favored 'General case' 0 CA--C 1.556 1.203 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 175.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -69.67 -37.36 76.64 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 167.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.543 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -60.25 -59.27 5.68 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 170.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.409 ' HB ' HD11 ' A' ' 79' ' ' ILE . 0.9 OUTLIER -50.81 -42.44 23.03 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 N-CA-C 116.43 2.011 . . . . 0.0 116.43 171.521 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.65 -48.18 75.75 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 116.317 -1.801 . . . . 0.0 112.607 174.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.51 -28.51 66.11 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 117.23 2.307 . . . . 0.0 117.23 174.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.489 HD23 ' HE1' ' A' ' 77' ' ' PHE . 5.0 mp -54.98 -53.5 54.86 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.159 1.383 . . . . 0.0 113.402 163.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -73.41 -38.58 65.52 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 172.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -65.93 0.11 2.01 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 116.549 2.055 . . . . 0.0 116.549 169.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.533 ' HB2' HD21 ' A' ' 121' ' ' ASN . . . -56.8 -9.96 0.93 Allowed 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 120.315 3.45 . . . . 0.0 120.315 162.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 102.69 -105.25 2.72 Favored Glycine 0 C--N 1.342 0.886 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 161.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.6 m -113.43 -7.83 13.43 Favored 'General case' 0 CA--C 1.576 1.943 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 163.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.19 111.98 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 -165.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.542 HG21 HD12 ' A' ' 75' ' ' LEU . 3.4 t -96.94 116.81 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 112.676 -2.056 . . . . 0.0 107.553 -174.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -99.83 91.07 4.66 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 177.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.474 ' HB2' ' HB ' ' A' ' 66' ' ' ILE . 22.9 mt -83.16 135.16 34.9 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -128.55 126.15 39.75 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.3 p -132.48 116.69 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 -173.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . 0.733 ' HB3' HD21 ' A' ' 118' ' ' LEU . 25.2 ttt . . . . . 0 N--CA 1.474 0.726 0 CA-C-O 123.201 1.477 . . . . 0.0 108.516 168.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 1' ' ' TYR . . . . . 0.554 ' CG ' ' HB2' ' A' ' 87' ' ' HIS . 0.4 OUTLIER . . . . . 0 CA--C 1.557 1.224 0 CA-C-O 122.227 1.013 . . . . 0.0 111.548 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -127.8 144.97 51.07 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 123.414 1.578 . . . . 0.0 107.707 165.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -101.26 126.69 48.03 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.03 176.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 98.4 m -97.38 130.94 44.47 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.031 172.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -76.66 138.98 40.38 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 113.964 -1.471 . . . . 0.0 109.564 170.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 6.0 p . . . . . 0 C--O 1.254 1.301 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.012 172.997 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 25.1 p90 . . . . . 0 N--CA 1.479 1.012 0 CA-C-O 121.995 0.902 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -109.5 145.53 36.11 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 113.99 -1.459 . . . . 0.0 108.848 176.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -107.52 121.57 44.9 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 112.658 -2.065 . . . . 0.0 106.095 -175.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.6 mp -130.64 128.26 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 -176.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.1 m -100.35 132.56 45.65 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 122.838 1.304 . . . . 0.0 107.547 163.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.444 HD11 ' HA ' ' A' ' 105' ' ' ALA . 9.6 tt -130.05 130.16 44.57 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 113.141 -1.845 . . . . 0.0 107.83 -169.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 . . . . . 0 N--CA 1.481 1.109 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 177.912 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.615 HD21 HG22 ' B' ' 6' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.56 1.355 0 CA-C-O 119.342 -0.361 . . . . 0.0 111.465 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.443 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 65.18 51.67 47.94 Favored Glycine 0 C--N 1.346 1.11 0 N-CA-C 117.279 1.671 . . . . 0.0 117.279 166.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.482 ' CD1' HD13 ' A' ' 96' ' ' ILE . 1.7 p90 -155.3 157.95 38.0 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 112.929 -1.635 . . . . 0.0 107.376 173.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.431 ' HB2' ' HB3' ' A' ' 98' ' ' LYS . 4.0 m -122.28 126.87 49.07 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 122.484 1.135 . . . . 0.0 109.341 -173.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.622 HG22 HG12 ' A' ' 96' ' ' ILE . 2.0 pt -91.33 127.77 43.5 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-N 113.444 -1.707 . . . . 0.0 109.309 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -83.87 -175.54 5.86 Favored 'General case' 0 CA--C 1.555 1.167 0 CA-C-O 123.641 1.686 . . . . 0.0 110.291 156.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.14 157.35 24.08 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 123.161 1.423 . . . . 0.0 116.58 -140.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -108.84 -169.36 20.84 Favored Glycine 0 N--CA 1.466 0.663 0 CA-C-N 111.914 -2.143 . . . . 0.0 114.289 178.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.585 HG22 ' HB2' ' A' ' 92' ' ' PRO . 18.2 p -43.69 -44.59 6.58 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 117.952 2.575 . . . . 0.0 117.952 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.412 ' HB3' HG23 ' A' ' 129' ' ' THR . 35.6 t70 -85.55 -15.24 43.32 Favored 'General case' 0 CA--C 1.564 1.506 0 N-CA-C 115.915 1.82 . . . . 0.0 115.915 177.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -150.64 73.92 8.8 Favored Pre-proline 0 CA--C 1.562 1.41 0 N-CA-C 103.893 -2.632 . . . . 0.0 103.893 -176.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -107.59 144.09 0.07 OUTLIER 'Trans proline' 0 C--N 1.374 1.915 0 CA-C-N 124.656 2.699 . . . . 0.0 112.446 -169.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 15.1 t60 . . . . . 0 N--CA 1.498 1.961 0 N-CA-C 114.695 1.369 . . . . 0.0 114.695 161.216 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.585 ' HB2' HG22 ' A' ' 83' ' ' THR . 19.1 Cg_endo . . . . . 0 CA--C 1.551 1.341 0 CA-C-O 121.593 0.58 . . . . 0.0 112.503 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 74.7 m -150.67 139.33 20.67 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 -179.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.49 HG13 ' HB2' ' A' ' 133' ' ' ALA . 31.5 mm -79.65 129.76 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 175.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.484 ' HA ' ' O ' ' A' ' 115' ' ' ASP 0.276 4.9 p90 -135.49 122.06 20.77 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 113.824 -1.534 . . . . 0.0 110.994 -177.067 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.622 HG12 HG22 ' A' ' 79' ' ' ILE . 71.0 mt -74.75 109.86 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 168.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 12.8 m -94.64 -14.62 24.73 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 114.978 -1.01 . . . . 0.0 113.714 172.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.431 ' HB3' ' HB2' ' A' ' 78' ' ' SER . 29.5 tttp -139.53 150.12 44.72 Favored 'General case' 0 CA--C 1.557 1.243 0 CA-C-O 124.356 2.027 . . . . 0.0 110.343 -175.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -117.2 125.02 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 N-CA-C 103.924 -2.621 . . . . 0.0 103.924 174.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.5 mp -74.14 133.55 78.24 Favored Pre-proline 0 CA--C 1.566 1.572 0 CA-C-O 118.518 -0.754 . . . . 0.0 109.324 171.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.5 132.87 40.0 Favored 'Trans proline' 0 CA--C 1.554 1.512 0 C-N-CA 123.301 2.668 . . . . 0.0 113.687 171.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.19 11.93 85.08 Favored Glycine 0 CA--C 1.546 2.028 0 N-CA-C 117.383 1.713 . . . . 0.0 117.383 -164.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.443 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -84.09 170.75 47.67 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-O 123.086 1.381 . . . . 0.0 114.244 177.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.21 -43.98 89.79 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 112.286 -1.957 . . . . 0.0 115.387 178.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.444 ' HA ' HD11 ' A' ' 68' ' ' LEU . . . -67.17 -32.93 74.35 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 118.496 2.776 . . . . 0.0 118.496 173.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.37 -39.01 91.75 Favored 'General case' 0 CA--C 1.567 1.598 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 165.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -67.32 -60.93 2.18 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.378 1.471 . . . . 0.0 113.042 173.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 N--CA 1.487 1.413 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -172.795 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.484 ' O ' ' HA ' ' A' ' 95' ' ' PHE 0.278 8.3 t70 . . . . . 0 N--CA 1.474 0.749 0 CA-C-O 117.729 -1.129 . . . . 0.0 109.127 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 48.5 m -72.61 74.67 1.08 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.411 1.084 . . . . 0.0 113.246 -169.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.0 tp -67.68 103.95 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 171.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.568 ' HA ' ' HB3' ' A' ' 126' ' ' ARG 0.293 1.0 OUTLIER -91.18 -54.96 3.72 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 113.104 -1.862 . . . . 0.0 113.145 177.632 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.427 ' H ' HD12 ' A' ' 118' ' ' LEU . 20.2 m-85 -118.28 138.92 52.04 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 105.358 -2.089 . . . . 0.0 105.358 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.8 p -127.28 114.9 38.66 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 170.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.822 HD21 ' HB2' ' A' ' 140' ' ' ALA 0.352 14.5 m-80 80.05 -83.03 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 123.489 1.614 . . . . 0.0 109.7 -177.704 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -148.3 -25.68 0.34 Allowed 'General case' 0 CA--C 1.566 1.579 0 CA-C-N 111.126 -2.761 . . . . 0.0 109.411 -178.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.426 ' CG1' HG13 ' A' ' 125' ' ' VAL . 2.3 t -61.75 135.72 26.02 Favored 'Isoleucine or valine' 0 C--N 1.362 1.119 0 C-N-CA 125.385 1.474 . . . . 0.0 110.286 174.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -97.92 72.29 2.22 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 112.117 -2.311 . . . . 0.0 109.852 175.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.586 HG11 ' HA ' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -63.21 -86.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 116.243 -1.837 . . . . 0.0 110.401 176.73 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.786 ' HD2' ' H ' ' A' ' 127' ' ' GLU 0.325 0.1 OUTLIER 49.22 -98.58 0.05 Allowed 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 120.269 1.395 . . . . 0.0 113.353 171.827 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.786 ' H ' ' HD2' ' A' ' 126' ' ' ARG . 10.2 mt-10 -80.64 69.13 7.08 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 126.695 1.998 . . . . 0.0 110.414 174.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.8 p -139.11 169.3 17.61 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 CA-C-N 112.87 -1.968 . . . . 0.0 106.093 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.422 HG22 ' H ' ' A' ' 131' ' ' SER . 46.8 m -60.15 135.21 57.65 Favored 'General case' 0 CA--C 1.558 1.288 0 CA-C-N 113.16 -1.836 . . . . 0.0 110.624 157.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.456 ' HA ' HD12 ' A' ' 94' ' ' ILE . 3.6 p-80 -46.15 -35.31 4.94 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 170.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.467 ' HA ' HG12 ' A' ' 134' ' ' VAL . 5.2 m -62.69 -43.04 99.81 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 125.311 1.444 . . . . 0.0 114.761 176.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.16 -37.33 87.07 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 169.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.586 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -69.66 -50.93 39.37 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 116.466 2.024 . . . . 0.0 116.466 172.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.467 HG12 ' HA ' ' A' ' 131' ' ' SER . 3.3 p -52.17 -42.67 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.475 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 170.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -72.82 -38.46 67.15 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 115.506 -2.188 . . . . 0.0 113.503 174.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.17 -34.05 77.16 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 116.937 2.199 . . . . 0.0 116.937 170.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.448 HD21 HD11 ' A' ' 96' ' ' ILE . 7.8 mp -55.59 -49.13 73.59 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.491 1.516 . . . . 0.0 114.939 162.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -68.05 -35.74 78.73 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 168.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.49 -20.76 66.12 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 173.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.822 ' HB2' HD21 ' A' ' 121' ' ' ASN . . . -52.86 -11.67 0.25 Allowed 'General case' 0 CA--C 1.561 1.377 0 N-CA-C 118.527 2.788 . . . . 0.0 118.527 161.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 79.97 -143.29 25.16 Favored Glycine 0 C--N 1.347 1.188 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 174.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 17.3 m -71.34 -4.52 26.56 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 116.691 2.108 . . . . 0.0 116.691 173.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.07 107.81 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 -170.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.556 ' HA ' ' HB1' ' A' ' 140' ' ' ALA . 3.5 t -93.66 114.84 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 113.797 -1.547 . . . . 0.0 108.24 -174.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.456 ' HB2' ' HA ' ' A' ' 121' ' ' ASN . 75.0 mtt-85 -96.39 94.82 7.65 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 -177.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 34.0 mt -99.58 138.82 36.14 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 122.069 0.938 . . . . 0.0 109.043 -170.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -128.78 115.82 18.54 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.24 129.15 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -173.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . 0.426 ' HB2' HD21 ' A' ' 118' ' ' LEU . 28.0 ttt . . . . . 0 CA--C 1.548 0.879 0 CA-C-O 123.307 1.527 . . . . 0.0 112.503 164.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 1.1 p90 . . . . . 0 N--CA 1.478 0.961 0 CA-C-O 122.977 1.37 . . . . 0.0 112.828 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . 0.554 ' HA ' ' HE3' ' B' ' 2' ' ' LYS . 0.3 OUTLIER -136.6 144.86 44.34 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 112.738 -2.028 . . . . 0.0 110.888 166.919 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.415 ' HB3' ' HE3' ' B' ' 3' ' ' LYS . 10.0 ttpp -92.24 109.97 21.35 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 113.534 -1.667 . . . . 0.0 108.481 178.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 98.7 m -88.38 131.93 34.65 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 122.401 1.096 . . . . 0.0 108.784 175.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.11 155.48 32.36 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 113.848 -1.524 . . . . 0.0 109.971 175.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.615 HG22 HD21 ' A' ' 75' ' ' LEU . 7.7 p . . . . . 0 C--O 1.247 0.957 0 N-CA-C 104.392 -2.447 . . . . 0.0 104.392 -171.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 14.5 p90 . . . . . 0 CA--C 1.558 1.258 0 CA-C-O 121.272 0.558 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -126.66 135.49 51.24 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 122.099 0.952 . . . . 0.0 108.846 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.27 120.62 42.85 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.059 -174.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.6 mp -135.1 125.32 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 -172.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.9 m -98.8 122.53 42.16 Favored 'General case' 0 CA--C 1.557 1.213 0 CA-C-O 122.338 1.066 . . . . 0.0 108.302 173.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 mp -118.26 127.21 53.51 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.576 1.55 . . . . 0.0 108.594 -174.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 . . . . . 0 N--CA 1.476 0.875 0 CA-C-O 121.223 0.535 . . . . 0.0 110.154 -178.837 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.607 ' HB2' HG13 ' B' ' 6' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 119.319 -0.372 . . . . 0.0 111.753 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.553 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 103.14 41.2 2.29 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 115.848 1.099 . . . . 0.0 115.848 164.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -158.32 127.2 5.56 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 123.425 1.583 . . . . 0.0 107.435 -175.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.3 m -87.56 137.45 32.32 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 121.246 -0.908 . . . . 0.0 111.126 174.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.451 HD11 ' HB ' ' A' ' 134' ' ' VAL . 2.5 pp -118.02 130.25 73.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 114.403 -1.271 . . . . 0.0 107.978 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -92.38 -169.68 2.29 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-O 123.288 1.518 . . . . 0.0 109.871 160.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.69 159.41 24.78 Favored Glycine 0 CA--C 1.537 1.459 0 CA-C-O 123.551 1.64 . . . . 0.0 115.783 -140.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.11 -162.26 21.87 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 111.606 -2.297 . . . . 0.0 112.316 -176.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 67.8 p -54.02 -41.11 67.65 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 117.373 2.361 . . . . 0.0 117.373 -177.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -75.51 -15.64 60.37 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 116.469 2.025 . . . . 0.0 116.469 173.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -152.77 86.05 4.29 Favored Pre-proline 0 CA--C 1.56 1.343 0 N-CA-C 101.585 -3.487 . . . . 0.0 101.585 -177.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -99.41 125.02 0.15 Allowed 'Trans proline' 0 CA--C 1.547 1.126 0 CA-C-N 124.241 2.55 . . . . 0.0 110.533 -170.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 60.7 t60 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 174.279 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo . . . . . 0 CA--C 1.551 1.36 0 N-CA-C 110.805 -0.498 . . . . 0.0 110.805 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 43.6 m 70.7 144.04 0.06 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 122.667 1.222 . . . . 0.0 109.204 175.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.545 HG13 ' HB2' ' A' ' 133' ' ' ALA . 10.1 mm -91.78 126.05 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 -174.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -124.83 142.1 51.66 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 -178.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.418 HG12 HG22 ' A' ' 79' ' ' ILE 0.254 46.9 mt -85.32 119.52 34.08 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.541 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 175.023 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 91.8 m -85.92 -33.21 21.25 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 117.806 -1.093 . . . . 0.0 113.476 169.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . 0.285 0.0 OUTLIER -141.01 163.66 32.38 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-O 124.779 2.228 . . . . 0.0 111.324 179.218 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.495 HG22 ' HB3' ' A' ' 105' ' ' ALA . 0.9 OUTLIER -104.18 119.87 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 166.323 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 24.0 mm -65.68 127.77 93.3 Favored Pre-proline 0 CA--C 1.566 1.58 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.164 178.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.74 129.06 32.62 Favored 'Trans proline' 0 C--N 1.365 1.406 0 C-N-CA 123.606 2.871 . . . . 0.0 115.286 -178.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.49 11.39 80.09 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 118.54 2.176 . . . . 0.0 118.54 -170.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.553 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -92.35 -175.92 41.9 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 124.546 1.069 . . . . 0.0 113.937 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.4 -51.96 63.62 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 117.146 2.276 . . . . 0.0 117.146 -171.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.495 ' HB3' HG22 ' A' ' 99' ' ' ILE . . . -56.04 -33.19 64.72 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 175.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -67.09 -44.74 79.23 Favored 'General case' 0 CA--C 1.563 1.457 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 169.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.33 -54.55 6.33 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 123.638 0.775 . . . . 0.0 112.306 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 . . . . . 0 N--CA 1.486 1.358 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -179.051 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 2.7 p30 . . . . . 0 CA--C 1.552 1.056 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.401 ' HB2' ' HB3' ' A' ' 149' ' ' MET . 40.0 m -127.81 79.61 1.91 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 176.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.42 HG23 ' HB ' ' A' ' 94' ' ' ILE . 7.5 tp -56.45 116.55 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-O 121.997 0.904 . . . . 0.0 110.666 -178.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.608 HD23 ' HB2' ' A' ' 149' ' ' MET . 3.0 pp -110.19 -47.85 3.25 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 116.785 2.143 . . . . 0.0 116.785 -174.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.453 ' HB2' ' HB2' ' A' ' 147' ' ' TYR . 47.9 m-85 -126.64 138.07 53.38 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 177.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.465 HG21 HD12 ' A' ' 137' ' ' LEU . 3.1 t -128.44 109.8 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 100.543 -3.873 . . . . 0.0 100.543 175.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.808 HD21 ' HB2' ' A' ' 140' ' ' ALA 0.378 8.9 m-80 83.3 -88.48 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 122.921 1.343 . . . . 0.0 109.389 179.86 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -145.26 -13.82 0.52 Allowed 'General case' 0 CA--C 1.567 1.627 0 CA-C-N 111.401 -2.636 . . . . 0.0 110.59 175.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.509 HG12 HG13 ' A' ' 125' ' ' VAL . 2.3 t -67.58 133.03 32.18 Favored 'Isoleucine or valine' 0 C--N 1.359 0.994 0 C-N-CA 125.431 1.492 . . . . 0.0 109.997 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -84.19 98.09 9.75 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 112.476 -2.147 . . . . 0.0 109.599 172.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.601 HG11 ' HA ' ' A' ' 133' ' ' ALA 0.258 2.0 m -97.51 -103.26 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-O 116.281 -1.818 . . . . 0.0 106.97 173.173 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.536 ' HB3' ' HA ' ' A' ' 118' ' ' LEU 0.289 13.2 ptt180 50.4 -93.33 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 120.217 1.371 . . . . 0.0 114.237 179.585 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.479 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 2.4 tt0 -79.25 68.68 5.3 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-O 123.425 1.583 . . . . 0.0 111.031 173.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.8 p -144.3 168.89 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.96 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 -173.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.419 HG22 ' H ' ' A' ' 131' ' ' SER . 27.4 m -61.76 130.86 47.81 Favored 'General case' 0 CA--C 1.559 1.3 0 CA-C-N 113.119 -1.855 . . . . 0.0 110.038 156.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.419 ' HA ' HD12 ' A' ' 94' ' ' ILE . 2.1 p-80 -47.7 -29.44 3.05 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 118.587 2.81 . . . . 0.0 118.587 169.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.519 ' HA ' HG12 ' A' ' 134' ' ' VAL . 8.1 m -63.09 -37.91 89.07 Favored 'General case' 0 CA--C 1.565 1.543 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 171.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -70.25 -36.13 74.27 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 165.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.601 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -61.19 -55.61 30.26 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 114.695 1.368 . . . . 0.0 114.695 169.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.519 HG12 ' HA ' ' A' ' 131' ' ' SER . 2.3 p -53.1 -40.55 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.162 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 169.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -58.17 -52.19 66.59 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 116.311 -1.804 . . . . 0.0 112.691 168.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.68 -35.62 74.83 Favored 'General case' 0 CA--C 1.561 1.391 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 173.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.513 HD23 HG11 ' B' ' 6' ' ' VAL . 9.6 mp -54.46 -53.92 47.86 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 125.296 1.438 . . . . 0.0 113.813 164.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.437 ' HA ' HD21 ' A' ' 75' ' ' LEU . 88.6 mttt -68.41 -33.54 74.4 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 116.507 2.04 . . . . 0.0 116.507 172.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -64.11 -32.19 73.66 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 115.17 1.544 . . . . 0.0 115.17 171.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.808 ' HB2' HD21 ' A' ' 121' ' ' ASN . . . -52.91 -36.57 59.69 Favored 'General case' 0 CA--C 1.557 1.214 0 N-CA-C 117.234 2.309 . . . . 0.0 117.234 163.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.12 -133.61 12.0 Favored Glycine 0 C--N 1.348 1.214 0 N-CA-C 111.644 -0.582 . . . . 0.0 111.644 167.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.3 t -66.4 -7.97 22.7 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 118.756 2.873 . . . . 0.0 118.756 170.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.32 107.84 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 -172.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.593 ' HA ' ' HB1' ' A' ' 140' ' ' ALA . 4.3 t -106.31 110.47 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 113.006 -1.907 . . . . 0.0 107.539 -173.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.522 ' HG3' ' HA ' ' A' ' 121' ' ' ASN . 9.8 ptt180 -101.77 91.46 4.41 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.422 HD23 HG13 ' A' ' 120' ' ' VAL . 78.0 mt -89.43 144.51 26.0 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 113.524 -1.671 . . . . 0.0 108.975 -175.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.453 ' HB2' ' HB2' ' A' ' 119' ' ' PHE . 88.9 m-85 -133.15 115.97 15.7 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 103.446 -2.798 . . . . 0.0 103.446 173.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 19.6 m -119.57 155.39 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -170.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . 0.608 ' HB2' HD23 ' A' ' 118' ' ' LEU . 60.7 ttp . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 122.494 1.14 . . . . 0.0 110.095 172.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 1.3 p90 . . . . . 0 CA--C 1.562 1.408 0 CA-C-O 122.313 1.054 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -133.72 125.21 28.1 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 123.141 1.448 . . . . 0.0 107.852 171.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 3.0 ttpt -96.76 133.56 41.18 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 113.872 -1.513 . . . . 0.0 108.131 175.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.3 150.14 27.02 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-O 123.121 1.439 . . . . 0.0 109.076 177.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -109.03 126.29 52.99 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 -176.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.607 HG13 ' HB2' ' A' ' 75' ' ' LEU 0.321 0.5 OUTLIER . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 173.7 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . 0.251 26.9 p90 . . . . . 0 CA--C 1.551 0.984 0 CA-C-O 121.652 0.739 . . . . 0.0 111.077 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -124.32 131.07 53.5 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -167.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -83.44 123.99 30.24 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 113.888 -1.505 . . . . 0.0 110.906 171.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.485 HG13 ' HB2' ' A' ' 146' ' ' LEU . 7.9 pt -140.33 118.12 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 -168.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.0 m -97.1 131.18 44.13 Favored 'General case' 0 CA--C 1.554 1.109 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 173.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.423 ' HG ' ' HB1' ' A' ' 104' ' ' ALA . 1.3 mp -125.35 131.53 52.98 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.176 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 . . . . . 0 N--CA 1.485 1.307 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -174.185 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.502 HD21 HG21 ' A' ' 144' ' ' VAL . 0.8 OUTLIER . . . . . 0 CA--C 1.559 1.32 0 CA-C-O 118.635 -0.697 . . . . 0.0 112.497 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.436 ' CA ' ' HA3' ' A' ' 103' ' ' GLY . . . 106.19 15.79 16.8 Favored Glycine 0 N--CA 1.479 1.532 0 N-CA-C 121.118 3.207 . . . . 0.0 121.118 172.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -150.05 143.62 25.25 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 124.483 2.087 . . . . 0.0 108.857 -177.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.0 m -111.91 128.38 56.13 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 112.357 -2.202 . . . . 0.0 108.422 178.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.5 pp -109.2 126.72 66.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.495 -1.23 . . . . 0.0 109.609 -173.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -83.36 -171.89 3.84 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-O 123.401 1.572 . . . . 0.0 110.715 162.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -98.9 163.82 20.5 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-O 123.999 1.888 . . . . 0.0 115.829 -143.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -111.45 -164.06 17.84 Favored Glycine 0 N--CA 1.464 0.553 0 CA-C-N 110.854 -2.673 . . . . 0.0 111.086 -172.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.495 HG22 ' HB2' ' A' ' 92' ' ' PRO . 11.3 p -51.64 -40.41 59.92 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 117.714 2.487 . . . . 0.0 117.714 -173.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -80.26 -17.54 51.9 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 171.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . 0.303 6.3 t30 -138.2 54.76 7.66 Favored Pre-proline 0 CA--C 1.567 1.633 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -174.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -100.44 124.79 0.12 Allowed 'Trans proline' 0 C--N 1.365 1.442 0 CA-C-N 124.804 2.751 . . . . 0.0 111.312 -157.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 . . . . . 0 N--CA 1.487 1.412 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 174.633 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.495 ' HB2' HG22 ' A' ' 83' ' ' THR . 85.9 Cg_endo . . . . . 0 CA--C 1.547 1.147 0 N-CA-C 114.161 0.793 . . . . 0.0 114.161 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 58.5 m -161.17 132.18 5.36 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.467 HG13 ' HB2' ' A' ' 133' ' ' ALA . 13.9 mm -82.29 124.88 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 -179.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -120.89 155.28 34.52 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 113.91 -1.495 . . . . 0.0 108.78 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 83.9 mt -92.62 117.39 35.88 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.629 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 158.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.407 ' CG2' ' HG3' ' B' ' 3' ' ' LYS . 10.1 t -86.04 -31.98 21.68 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 115.378 1.621 . . . . 0.0 115.378 169.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . 0.342 0.0 OUTLIER -143.54 164.4 30.47 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 124.618 2.151 . . . . 0.0 110.707 177.456 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -104.55 132.48 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 174.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.259 43.9 mt -87.75 117.21 68.21 Favored Pre-proline 0 CA--C 1.561 1.397 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 172.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.13 146.61 80.4 Favored 'Trans proline' 0 C--N 1.369 1.654 0 C-N-CA 123.673 2.915 . . . . 0.0 115.722 176.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.76 -8.84 47.45 Favored Glycine 0 CA--C 1.544 1.872 0 N-CA-C 117.649 1.82 . . . . 0.0 117.649 -170.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.436 ' HA3' ' CA ' ' A' ' 76' ' ' GLY . . . -96.54 -168.88 34.11 Favored Glycine 0 CA--C 1.539 1.564 0 CA-C-N 119.171 1.486 . . . . 0.0 115.098 -177.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.423 ' HB1' ' HG ' ' A' ' 68' ' ' LEU . . . -64.28 -47.5 79.29 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -175.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.59 -37.92 88.11 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 178.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.25 -44.85 90.52 Favored 'General case' 0 CA--C 1.564 1.489 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 168.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -66.62 -63.13 1.13 Allowed 'General case' 0 CA--C 1.564 1.498 0 C-N-CA 125.323 1.449 . . . . 0.0 113.136 178.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 CA--C 1.561 1.382 0 C-N-CA 124.651 1.18 . . . . 0.0 113.69 -179.201 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.5 ' HB3' HG11 ' A' ' 148' ' ' VAL . 41.2 m-20 . . . . . 0 CA--C 1.542 0.64 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.9 m -73.49 90.63 1.74 Allowed 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 113.912 -1.494 . . . . 0.0 108.784 -172.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.1 tp -66.76 118.18 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 CA-C-O 122.295 1.045 . . . . 0.0 110.312 -171.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.592 ' HA ' ' HB3' ' A' ' 126' ' ' ARG 0.328 3.1 pp -99.41 -51.31 3.82 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 112.424 -2.171 . . . . 0.0 115.046 178.29 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -133.76 140.84 47.21 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 -176.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.442 HG21 HD12 ' A' ' 137' ' ' LEU . 2.7 t -128.87 110.06 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 102.774 -3.047 . . . . 0.0 102.774 -178.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.846 HD21 ' HB2' ' A' ' 140' ' ' ALA 0.295 8.2 m-80 82.26 -79.04 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 123.3 1.524 . . . . 0.0 108.935 178.08 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -154.27 -9.03 0.14 Allowed 'General case' 0 CA--C 1.568 1.668 0 CA-C-N 111.712 -2.495 . . . . 0.0 111.782 171.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.54 HG12 HG13 ' A' ' 125' ' ' VAL . 2.4 t -68.17 137.03 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.189 0 CA-C-O 123.492 1.615 . . . . 0.0 109.871 -179.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -86.86 98.11 11.03 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 111.316 -2.675 . . . . 0.0 109.869 177.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.61 HG11 ' HA ' ' A' ' 133' ' ' ALA 0.28 2.7 m -108.77 -110.53 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 CA-C-O 116.356 -1.783 . . . . 0.0 107.464 179.691 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.592 ' HB3' ' HA ' ' A' ' 118' ' ' LEU 0.362 0.0 OUTLIER 53.57 -82.68 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -179.533 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.554 ' H ' ' HD3' ' A' ' 126' ' ' ARG . 19.6 mt-10 -86.28 68.86 10.38 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-O 123.356 1.551 . . . . 0.0 109.308 171.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.6 p -143.06 167.08 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 CA-C-O 123.849 1.785 . . . . 0.0 107.061 -178.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 11.6 m -56.38 129.1 39.09 Favored 'General case' 0 CA--C 1.558 1.257 0 CA-C-N 113.289 -1.778 . . . . 0.0 110.217 157.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -47.94 -31.95 5.84 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 117.701 2.482 . . . . 0.0 117.701 173.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.478 ' HA ' HG12 ' A' ' 134' ' ' VAL . 6.8 m -59.32 -41.51 89.26 Favored 'General case' 0 CA--C 1.559 1.305 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 172.033 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -70.51 -36.41 73.76 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 167.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.61 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -61.58 -56.08 23.77 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 170.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.478 HG12 ' HA ' ' A' ' 131' ' ' SER . 0.5 OUTLIER -55.4 -39.86 54.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 N-CA-C 115.891 1.812 . . . . 0.0 115.891 167.854 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.99 -54.84 33.43 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 115.383 -2.246 . . . . 0.0 111.272 168.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.76 -35.0 73.71 Favored 'General case' 0 CA--C 1.561 1.373 0 N-CA-C 117.565 2.431 . . . . 0.0 117.565 172.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.442 HD12 HG21 ' A' ' 120' ' ' VAL . 8.6 mp -57.74 -49.61 75.98 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 165.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -73.31 -34.94 65.99 Favored 'General case' 0 CA--C 1.564 1.511 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 175.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.19 -28.69 67.48 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 115.921 1.823 . . . . 0.0 115.921 171.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.846 ' HB2' HD21 ' A' ' 121' ' ' ASN . . . -51.62 -36.7 46.9 Favored 'General case' 0 CA--C 1.56 1.339 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 158.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 91.39 -131.68 10.9 Favored Glycine 0 C--N 1.349 1.286 0 CA-C-O 122.488 1.049 . . . . 0.0 110.518 167.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.5 m -76.63 -2.19 31.45 Favored 'General case' 0 CA--C 1.557 1.244 0 N-CA-C 117.148 2.277 . . . . 0.0 117.148 168.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.09 108.18 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 -171.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.54 ' HA ' ' HB1' ' A' ' 140' ' ' ALA . 6.7 t -116.04 116.33 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 113.834 -1.53 . . . . 0.0 107.348 -165.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.417 ' HB2' ' HA ' ' A' ' 121' ' ' ASN . 1.9 mpp_? -93.59 91.66 7.18 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 174.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.485 ' HB2' HG13 ' A' ' 66' ' ' ILE . 78.3 mt -91.45 141.38 28.81 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 176.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -132.86 113.82 13.33 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 103.562 -2.755 . . . . 0.0 103.562 176.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.5 HG11 ' HB3' ' A' ' 115' ' ' ASP . 32.2 m -127.68 139.51 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -165.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 26.1 ptm . . . . . 0 N--CA 1.479 0.993 0 CA-C-O 122.341 1.067 . . . . 0.0 110.427 170.681 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 2.8 p90 . . . . . 0 CA--C 1.557 1.234 0 CA-C-O 122.436 1.112 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -120.49 149.46 42.37 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-O 124.162 1.934 . . . . 0.0 108.267 167.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.407 ' HG3' ' CG2' ' A' ' 97' ' ' THR . 0.5 OUTLIER -103.5 130.04 50.79 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 113.434 -1.712 . . . . 0.0 109.001 168.616 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 1.3 m -86.94 147.2 25.86 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 122.456 1.122 . . . . 0.0 109.877 168.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -114.53 113.34 24.29 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -171.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.47 HG21 ' CG2' ' A' ' 134' ' ' VAL . 62.0 t . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 -169.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 37.7 p90 . . . . . 0 N--CA 1.477 0.912 0 CA-C-O 121.649 0.737 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -129.19 141.84 51.04 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 123.011 1.386 . . . . 0.0 109.37 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -97.73 121.9 40.18 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 112.905 -1.952 . . . . 0.0 108.559 173.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.485 HG13 ' HB2' ' A' ' 146' ' ' LEU . 8.8 pt -131.46 109.42 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 -172.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.7 m -93.49 124.29 37.39 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 122.337 1.065 . . . . 0.0 108.391 175.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.407 ' HB2' HG23 ' A' ' 144' ' ' VAL . 1.3 mp -110.33 131.05 55.4 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 113.471 -1.695 . . . . 0.0 107.49 177.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -170.71 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.472 HD21 ' HA ' ' A' ' 138' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 119.495 -0.288 . . . . 0.0 111.139 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.46 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 102.07 55.19 0.88 Allowed Glycine 0 N--CA 1.464 0.52 0 C-N-CA 124.176 0.893 . . . . 0.0 113.703 166.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.413 ' HB3' ' CG1' ' A' ' 99' ' ' ILE . 1.1 p90 -158.92 138.87 12.0 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-O 123.315 1.531 . . . . 0.0 111.152 178.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.473 ' HB2' ' HG2' ' A' ' 98' ' ' LYS . 5.0 m -100.0 120.16 39.39 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 122.854 1.311 . . . . 0.0 110.622 176.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.548 HD11 ' HB ' ' A' ' 134' ' ' VAL . 8.7 pt -95.45 136.09 27.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-N 113.087 -1.87 . . . . 0.0 109.876 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.04 -178.39 6.53 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-O 123.782 1.754 . . . . 0.0 109.698 157.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.433 ' HA3' ' O ' ' A' ' 85' ' ' ASN . . . -103.85 166.46 15.72 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-O 124.059 1.922 . . . . 0.0 116.319 -136.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -99.23 -162.07 29.45 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 111.242 -2.479 . . . . 0.0 112.499 -172.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.452 HG22 ' CB ' ' A' ' 92' ' ' PRO . 45.7 p -51.97 -43.09 63.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 116.517 2.043 . . . . 0.0 116.517 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -83.0 -13.73 55.37 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 116.277 1.954 . . . . 0.0 116.277 173.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.433 ' O ' ' HA3' ' A' ' 81' ' ' GLY 0.289 9.0 t30 -139.15 55.46 7.48 Favored Pre-proline 0 CA--C 1.565 1.529 0 CA-C-O 117.065 -1.445 . . . . 0.0 107.534 -172.905 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -83.63 132.3 5.7 Favored 'Trans proline' 0 C--N 1.365 1.412 0 CA-C-N 126.051 3.197 . . . . 0.0 112.648 -162.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 166.606 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.452 ' CB ' HG22 ' A' ' 83' ' ' THR . 88.7 Cg_endo . . . . . 0 CA--C 1.547 1.163 0 CA-C-O 120.886 0.286 . . . . 0.0 112.141 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.8 m -155.81 130.0 8.78 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 -177.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.442 HG13 ' HB2' ' A' ' 133' ' ' ALA . 15.6 mm -83.32 110.06 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 -177.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -130.18 130.83 45.2 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 -167.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.539 HG12 HG22 ' A' ' 79' ' ' ILE 0.298 82.5 mt -81.73 120.11 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.736 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 176.178 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.451 ' CG2' ' HD3' ' B' ' 3' ' ' LYS . 12.3 t -89.72 -28.88 19.11 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 168.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.473 ' HG2' ' HB2' ' A' ' 78' ' ' SER . 7.7 ptmm? -144.4 161.68 38.4 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-O 122.659 1.219 . . . . 0.0 109.777 172.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.413 ' CG1' ' HB3' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -123.02 139.27 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 177.791 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.403 ' HA ' ' HD2' ' A' ' 101' ' ' PRO 0.279 1.5 mp -79.14 124.93 84.37 Favored Pre-proline 0 CA--C 1.57 1.743 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.331 -179.03 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.596 ' HA ' ' HB2' ' A' ' 106' ' ' ALA . 60.1 Cg_endo -67.35 146.99 77.07 Favored 'Trans proline' 0 CA--C 1.56 1.79 0 C-N-CA 123.398 2.732 . . . . 0.0 113.107 166.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.76 -14.06 53.7 Favored Glycine 0 CA--C 1.548 2.122 0 N-CA-C 117.245 1.658 . . . . 0.0 117.245 -164.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.46 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -96.23 -166.3 33.99 Favored Glycine 0 CA--C 1.539 1.541 0 CA-C-N 118.914 1.357 . . . . 0.0 115.82 177.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.61 -51.19 70.95 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -177.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.407 ' HB1' HD13 ' A' ' 99' ' ' ILE . . . -59.48 -38.39 80.7 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 124.573 1.17 . . . . 0.0 114.075 169.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.596 ' HB2' ' HA ' ' A' ' 101' ' ' PRO . . . -46.19 -40.14 10.81 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 117.538 2.421 . . . . 0.0 117.538 166.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.38 -53.17 6.22 Favored 'General case' 0 CA--C 1.568 1.642 0 C-N-CA 123.734 0.813 . . . . 0.0 112.665 173.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.9 t70 . . . . . 0 N--CA 1.487 1.393 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -172.354 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 . . . . . 0 CA--C 1.542 0.645 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 65.9 p -67.51 89.32 0.23 Allowed 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 113.408 -1.724 . . . . 0.0 111.147 169.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.566 HD12 HD11 ' A' ' 137' ' ' LEU . 27.6 pt -74.27 101.19 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 123.683 1.706 . . . . 0.0 108.854 -176.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.484 ' HA ' ' HB3' ' A' ' 126' ' ' ARG . 1.4 pp -79.95 -39.1 30.9 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 112.58 -2.1 . . . . 0.0 115.578 177.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -132.89 150.46 52.16 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 175.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.512 HG23 HD23 ' A' ' 146' ' ' LEU . 9.4 p -131.2 124.11 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 172.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.762 HD21 ' HB2' ' A' ' 140' ' ' ALA 0.272 31.0 m-80 78.77 -70.2 0.11 Allowed 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 123.26 1.505 . . . . 0.0 111.554 -178.039 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.423 ' H ' ' H ' ' A' ' 123' ' ' VAL . 2.1 tt0 -177.93 -10.65 0.01 OUTLIER 'General case' 0 CA--C 1.583 2.213 0 C-N-CA 129.229 3.011 . . . . 0.0 109.391 -177.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.423 ' H ' ' H ' ' A' ' 122' ' ' GLU . 2.1 t -64.67 137.89 24.11 Favored 'Isoleucine or valine' 0 C--N 1.364 1.204 0 C-N-CA 125.801 1.641 . . . . 0.0 109.987 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -82.04 94.15 7.13 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 112.545 -2.116 . . . . 0.0 109.979 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.46 HG11 ' HA ' ' A' ' 133' ' ' ALA 0.339 0.8 OUTLIER -110.5 -112.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 CA-C-O 117.546 -1.216 . . . . 0.0 108.593 179.781 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.541 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.315 17.3 ptt180 55.15 -86.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 -174.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.541 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 32.9 mt-10 -82.06 69.47 8.78 Favored 'General case' 0 CA--C 1.555 1.156 0 CA-C-O 123.92 1.819 . . . . 0.0 109.986 172.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.7 m -137.0 166.34 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 112.627 -2.079 . . . . 0.0 105.677 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 25.8 p -55.83 135.69 51.76 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 113.12 -1.855 . . . . 0.0 111.301 149.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -50.04 -29.8 9.48 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 116.66 2.096 . . . . 0.0 116.66 167.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.465 ' HA ' HG12 ' A' ' 134' ' ' VAL . 5.1 m -57.09 -56.05 26.81 Favored 'General case' 0 CA--C 1.559 1.315 0 C-N-CA 124.432 1.093 . . . . 0.0 112.348 169.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -57.5 -38.7 75.04 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 173.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.46 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -62.15 -55.78 25.35 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 115.883 1.809 . . . . 0.0 115.883 166.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.548 ' HB ' HD11 ' A' ' 79' ' ' ILE . 3.7 p -57.74 -40.37 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 176.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -61.36 -44.38 97.26 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 116.657 -1.639 . . . . 0.0 112.999 168.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.59 -31.84 73.23 Favored 'General case' 0 CA--C 1.563 1.48 0 N-CA-C 117.628 2.455 . . . . 0.0 117.628 169.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.566 HD11 HD12 ' A' ' 117' ' ' ILE . 6.5 mp -60.07 -48.76 80.38 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 125.752 1.621 . . . . 0.0 113.29 166.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.472 ' HA ' HD21 ' A' ' 75' ' ' LEU . 53.2 mtmt -69.67 -32.83 71.69 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 168.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -67.71 -22.83 65.24 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 116.278 1.955 . . . . 0.0 116.278 171.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.762 ' HB2' HD21 ' A' ' 121' ' ' ASN . . . -51.9 -27.73 13.86 Favored 'General case' 0 CA--C 1.555 1.155 0 N-CA-C 118.072 2.619 . . . . 0.0 118.072 157.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 97.08 -116.15 5.43 Favored Glycine 0 C--N 1.344 1.025 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 166.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.6 m -92.5 1.27 57.34 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 116.413 2.005 . . . . 0.0 116.413 166.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.37 102.1 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 -171.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.455 ' HA ' ' HB1' ' A' ' 140' ' ' ALA . 1.4 m -85.09 116.33 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-N 113.72 -1.582 . . . . 0.0 109.821 173.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 31.8 mtp180 -100.79 87.79 3.41 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 122.443 1.116 . . . . 0.0 108.103 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.512 HD23 HG23 ' A' ' 120' ' ' VAL . 32.6 mt -87.5 133.94 33.69 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -170.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -118.9 119.57 34.74 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.4 p -127.05 121.65 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -176.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 52.3 ttm . . . . . 0 N--CA 1.477 0.888 0 CA-C-O 122.816 1.293 . . . . 0.0 110.286 163.342 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 1.1 p90 . . . . . 0 CA--C 1.555 1.17 0 CA-C-O 122.02 0.914 . . . . 0.0 111.352 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . 0.432 ' H ' HD21 ' A' ' 85' ' ' ASN . 4.6 mptp? -138.81 145.54 40.23 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 113.401 -1.727 . . . . 0.0 108.4 172.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.451 ' HD3' ' CG2' ' A' ' 97' ' ' THR . 7.4 ttpp -100.0 111.25 23.56 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 114.109 -1.405 . . . . 0.0 107.878 175.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 87.3 m -89.79 131.18 35.87 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 114.565 -1.198 . . . . 0.0 108.864 175.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.66 147.02 35.74 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 113.724 -1.58 . . . . 0.0 109.199 173.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.46 HG11 HD23 ' A' ' 137' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.256 1.402 0 CA-C-N 113.652 -1.613 . . . . 0.0 109.836 172.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.478 ' HB3' ' HB2' ' A' ' 149' ' ' MET . 32.4 p90 . . . . . 0 CA--C 1.551 0.999 0 CA-C-O 121.929 0.871 . . . . 0.0 110.65 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -115.61 129.81 56.64 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.055 175.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -88.47 127.15 35.51 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 113.679 -1.6 . . . . 0.0 110.944 175.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 20.8 mm -130.73 126.7 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 -177.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.6 m -88.9 132.79 34.53 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-O 123.561 1.648 . . . . 0.0 108.175 167.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.48 HD11 ' HA ' ' A' ' 105' ' ' ALA . 3.6 tp -136.01 150.17 49.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 112.263 -2.244 . . . . 0.0 107.931 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 122.065 0.936 . . . . 0.0 110.419 173.426 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.448 HD23 ' CZ ' ' A' ' 77' ' ' PHE . 6.6 mp . . . . . 0 N--CA 1.485 1.277 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.431 ' HA3' ' CA ' ' A' ' 103' ' ' GLY . . . 120.41 45.07 0.41 Allowed Glycine 0 CA--C 1.535 1.307 0 C-N-CA 124.476 1.036 . . . . 0.0 115.408 178.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.448 ' CZ ' HD23 ' A' ' 75' ' ' LEU . 0.8 OUTLIER -157.2 138.89 14.09 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 123.4 1.571 . . . . 0.0 109.472 -178.551 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.409 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 2.6 m -106.67 113.8 27.51 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.431 -1.259 . . . . 0.0 112.395 -166.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.56 HG22 HG12 ' A' ' 96' ' ' ILE . 1.1 pt -92.39 123.58 44.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.041 -175.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -83.34 -170.86 3.26 Favored 'General case' 0 CA--C 1.557 1.24 0 CA-C-O 123.5 1.619 . . . . 0.0 110.043 159.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 85' ' ' ASN . . . -94.72 160.65 23.48 Favored Glycine 0 CA--C 1.539 1.54 0 CA-C-O 123.715 1.73 . . . . 0.0 117.126 -138.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -109.62 -161.47 19.14 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-N 111.289 -2.456 . . . . 0.0 114.251 178.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 43.1 p -54.26 -41.87 69.31 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 117.222 2.304 . . . . 0.0 117.222 178.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -81.44 -19.28 42.77 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 116.371 1.989 . . . . 0.0 116.371 172.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.402 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 1.0 OUTLIER -141.27 84.04 13.09 Favored Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 102.587 -3.116 . . . . 0.0 102.587 -171.544 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -99.27 123.1 0.13 Allowed 'Trans proline' 0 CA--C 1.548 1.221 0 CA-C-N 124.385 2.602 . . . . 0.0 109.733 -175.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 39.1 t-80 . . . . . 0 N--CA 1.495 1.808 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 162.553 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo . . . . . 0 CA--C 1.542 0.913 0 CA-C-O 121.888 0.703 . . . . 0.0 112.791 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 63.0 m -160.5 124.79 3.65 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 -176.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.539 HG13 ' HB2' ' A' ' 133' ' ' ALA . 11.1 mm -69.86 131.94 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -170.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.483 ' HB2' ' O ' ' A' ' 115' ' ' ASP . 21.2 p90 -140.38 128.82 22.68 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.405 -1.271 . . . . 0.0 108.297 -168.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.56 HG12 HG22 ' A' ' 79' ' ' ILE . 70.2 mt -85.25 112.02 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 173.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 23.2 m -85.86 -28.56 24.34 Favored 'General case' 0 CA--C 1.556 1.199 0 CA-C-N 113.667 -1.606 . . . . 0.0 113.191 169.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.409 ' HB2' ' HB2' ' A' ' 78' ' ' SER . 27.4 mtpp -134.73 159.01 42.64 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 123.486 1.613 . . . . 0.0 111.203 -173.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -120.57 124.79 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 103.316 -2.846 . . . . 0.0 103.316 177.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.287 1.2 mp -66.51 130.72 94.14 Favored Pre-proline 0 CA--C 1.573 1.854 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.304 170.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.94 132.09 40.44 Favored 'Trans proline' 0 CA--C 1.554 1.493 0 C-N-CA 123.432 2.754 . . . . 0.0 114.156 173.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.46 14.17 82.77 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 117.249 1.66 . . . . 0.0 117.249 -163.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.431 ' CA ' ' HA3' ' A' ' 76' ' ' GLY . . . -89.92 171.07 37.03 Favored Glycine 0 C--N 1.337 0.638 0 CA-C-O 122.672 1.151 . . . . 0.0 114.388 -177.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.62 -38.0 70.84 Favored 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -172.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.48 ' HA ' HD11 ' A' ' 68' ' ' LEU . . . -66.28 -38.71 88.42 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 172.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.86 -42.71 76.71 Favored 'General case' 0 CA--C 1.562 1.421 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 170.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -72.54 -52.12 17.0 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.202 1.001 . . . . 0.0 113.685 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.1 t70 . . . . . 0 N--CA 1.48 1.054 0 C-N-CA 124.512 1.125 . . . . 0.0 112.351 -176.932 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.483 ' O ' ' HB2' ' A' ' 95' ' ' PHE 0.289 35.1 t70 . . . . . 0 C--O 1.222 -0.361 0 CA-C-O 117.069 -1.444 . . . . 0.0 111.258 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 45.4 m -155.78 77.57 0.97 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 -170.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.0 tp -66.65 124.39 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-O 121.667 0.746 . . . . 0.0 109.261 171.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.459 ' HA ' ' HB3' ' A' ' 126' ' ' ARG 0.259 0.8 OUTLIER -108.38 -43.97 4.21 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 174.699 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -129.85 133.68 47.07 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 104.786 -2.302 . . . . 0.0 104.786 177.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.7 p -123.76 123.49 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 174.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . 0.32 32.7 m-80 80.77 -72.2 0.06 Allowed 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 123.954 1.835 . . . . 0.0 110.37 -175.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -177.11 -17.57 0.01 OUTLIER 'General case' 0 CA--C 1.576 1.959 0 C-N-CA 129.006 2.923 . . . . 0.0 109.247 -173.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.412 HG12 HG13 ' A' ' 125' ' ' VAL . 2.2 t -64.9 135.56 28.02 Favored 'Isoleucine or valine' 0 C--N 1.363 1.173 0 C-N-CA 125.69 1.596 . . . . 0.0 110.131 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -78.84 86.41 4.75 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 111.131 -2.759 . . . . 0.0 111.226 173.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.414 HG11 ' HA ' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -94.99 -105.12 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 176.127 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.469 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.285 14.0 ptt85 47.42 -98.68 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.674 1.189 . . . . 0.0 113.85 -176.549 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.469 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 1.5 tt0 -71.46 72.95 0.72 Allowed 'General case' 0 CA--C 1.555 1.146 0 CA-C-O 124.227 1.965 . . . . 0.0 111.885 168.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.7 p -147.34 167.41 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 CA-C-N 112.141 -2.299 . . . . 0.0 105.153 -174.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 34.9 p -57.2 130.85 48.01 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 112.579 -2.1 . . . . 0.0 112.051 156.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.448 ' HA ' HD12 ' A' ' 94' ' ' ILE . 2.1 p-80 -48.16 -33.1 7.86 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 116.845 2.165 . . . . 0.0 116.845 168.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.562 ' HA ' HG12 ' A' ' 134' ' ' VAL . 13.2 m -63.61 -38.94 93.04 Favored 'General case' 0 CA--C 1.559 1.301 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 172.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.11 -32.93 73.58 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 167.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.539 ' HB2' HG13 ' A' ' 94' ' ' ILE . . . -73.18 -47.81 40.57 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 171.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.562 HG12 ' HA ' ' A' ' 131' ' ' SER . 11.3 p -52.07 -44.82 40.54 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.532 0 CA-C-N 120.47 1.486 . . . . 0.0 113.87 162.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -53.98 -52.02 62.05 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-O 115.989 -1.958 . . . . 0.0 112.23 170.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.24 -29.86 68.78 Favored 'General case' 0 CA--C 1.558 1.266 0 N-CA-C 118.108 2.633 . . . . 0.0 118.108 175.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 7.0 mp -55.49 -52.88 62.2 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.161 1.384 . . . . 0.0 112.821 162.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -69.33 -41.24 76.93 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 171.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -66.86 -4.65 9.83 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 116.524 2.046 . . . . 0.0 116.524 169.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.44 ' HB1' ' HA ' ' A' ' 144' ' ' VAL . . . -52.0 -36.08 48.68 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 117.018 2.229 . . . . 0.0 117.018 158.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 64.97 79.01 0.19 Allowed Glycine 0 C--N 1.348 1.233 0 O-C-N 123.849 0.718 . . . . 0.0 113.115 163.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . 0.267 15.7 m 73.81 -27.08 0.19 Allowed 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 117.561 2.43 . . . . 0.0 117.561 -172.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -145.88 107.98 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -171.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.44 ' HA ' ' HB1' ' A' ' 140' ' ' ALA . 1.6 t -91.14 115.16 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 125.846 1.658 . . . . 0.0 107.324 175.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 5.2 ttp180 -97.3 100.16 11.61 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 172.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 36.8 mt -90.75 142.41 27.79 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.532 -175.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -131.17 113.57 14.04 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 173.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.72 123.73 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -175.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . 0.478 ' HB2' ' HB3' ' A' ' 63' ' ' TYR . 25.7 ttt . . . . . 0 N--CA 1.479 0.98 0 O-C-N 124.366 1.041 . . . . 0.0 111.208 165.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.561 1.367 0 CA-C-O 123.699 1.714 . . . . 0.0 110.835 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -161.6 123.0 2.81 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 172.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -82.17 122.94 28.52 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 114.201 -1.363 . . . . 0.0 109.054 175.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 2.9 m -81.91 127.3 32.88 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 122.177 0.989 . . . . 0.0 108.389 170.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.0 103.53 16.24 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.422 ' HB ' ' O ' ' A' ' 77' ' ' PHE . 9.5 t . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -169.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.492 ' HB3' ' HB2' ' A' ' 149' ' ' MET . 43.0 p90 . . . . . 0 N--CA 1.478 0.955 0 CA-C-O 121.816 0.817 . . . . 0.0 111.04 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -102.26 138.46 39.17 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.14 176.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -107.07 125.41 51.01 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.541 HG12 ' HB2' ' A' ' 146' ' ' LEU . 0.1 OUTLIER -141.72 111.69 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 -174.501 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 86.3 m -84.67 129.81 34.79 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 122.224 1.012 . . . . 0.0 108.352 170.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.463 HD11 ' HA ' ' A' ' 105' ' ' ALA . 0.9 OUTLIER -137.62 128.14 26.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 113.317 -1.765 . . . . 0.0 107.085 -176.189 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 . . . . . 0 N--CA 1.481 1.122 0 O-C-N 121.943 -0.473 . . . . 0.0 110.303 179.528 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.446 HD21 HG21 ' A' ' 144' ' ' VAL . 2.7 tt . . . . . 0 CA--C 1.569 1.681 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.28 41.69 2.35 Favored Glycine 0 N--CA 1.475 1.259 0 O-C-N 120.434 -1.416 . . . . 0.0 116.376 168.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.473 ' HB2' HG13 ' B' ' 6' ' ' VAL . 72.4 m-85 -151.76 165.95 32.85 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 122.643 1.211 . . . . 0.0 110.883 179.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.32 121.75 20.52 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 168.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.72 HG22 HG12 ' A' ' 96' ' ' ILE . 6.4 pt -90.97 133.69 31.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 113.331 -1.758 . . . . 0.0 111.006 -177.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.36 -174.81 4.77 Favored 'General case' 0 CA--C 1.558 1.274 0 CA-C-O 123.258 1.504 . . . . 0.0 110.055 158.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -96.18 159.45 21.98 Favored Glycine 0 CA--C 1.539 1.568 0 CA-C-O 123.2 1.444 . . . . 0.0 116.059 -144.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -108.35 -164.19 20.99 Favored Glycine 0 N--CA 1.47 0.933 0 CA-C-N 112.276 -1.962 . . . . 0.0 112.226 -176.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.533 HG22 ' HB2' ' A' ' 92' ' ' PRO . 43.5 p -50.49 -39.11 47.5 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 118.355 2.724 . . . . 0.0 118.355 -177.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -73.8 -23.87 59.74 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 171.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -139.37 74.89 34.15 Favored Pre-proline 0 CA--C 1.567 1.622 0 N-CA-C 104.209 -2.515 . . . . 0.0 104.209 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -107.98 115.59 0.03 OUTLIER 'Trans proline' 0 C--N 1.364 1.386 0 CA-C-N 125.26 2.914 . . . . 0.0 111.092 -164.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 179.846 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.533 ' HB2' HG22 ' A' ' 83' ' ' THR . 46.2 Cg_endo . . . . . 0 CA--C 1.546 1.101 0 CA-C-O 122.779 1.075 . . . . 0.0 112.533 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 58.7 m -158.61 140.15 13.46 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 177.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.463 HD12 ' HA ' ' A' ' 130' ' ' HIS . 21.7 mm -81.46 130.07 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 -177.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.478 ' HA ' ' O ' ' A' ' 115' ' ' ASP . 40.4 m-85 -119.4 149.82 41.21 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 113.484 -1.689 . . . . 0.0 110.509 175.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.72 HG12 HG22 ' A' ' 79' ' ' ILE . 72.6 mt -106.06 114.55 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 104.381 -2.451 . . . . 0.0 104.381 148.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.9 t -98.74 -6.38 29.58 Favored 'General case' 0 CA--C 1.564 1.496 0 N-CA-C 115.386 1.625 . . . . 0.0 115.386 168.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -141.82 147.51 37.35 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-O 123.774 1.75 . . . . 0.0 108.963 -177.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.33 123.55 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 N-CA-C 103.224 -2.88 . . . . 0.0 103.224 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.368 1.2 mp -66.26 117.4 42.93 Favored Pre-proline 0 CA--C 1.566 1.567 0 CA-C-O 118.186 -0.912 . . . . 0.0 109.248 171.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -69.33 142.29 49.4 Favored 'Trans proline' 0 C--N 1.367 1.534 0 C-N-CA 123.224 2.616 . . . . 0.0 112.496 174.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.53 -6.05 19.1 Favored Glycine 0 CA--C 1.549 2.216 0 N-CA-C 117.772 1.869 . . . . 0.0 117.772 -168.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -83.67 -171.63 47.9 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-O 123.409 1.561 . . . . 0.0 112.157 175.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 75' ' ' LEU . . . -67.75 -41.87 82.7 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 -173.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.463 ' HA ' HD11 ' A' ' 68' ' ' LEU . . . -67.59 -26.41 66.26 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 119.719 3.229 . . . . 0.0 119.719 178.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -60.97 -46.03 92.39 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 166.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.56 -55.25 6.55 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 124.548 1.139 . . . . 0.0 113.082 174.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.9 t70 . . . . . 0 N--CA 1.484 1.234 0 C-N-CA 123.959 0.904 . . . . 0.0 112.015 -177.076 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 95' ' ' PHE 0.296 15.3 t70 . . . . . 0 C--O 1.213 -0.839 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 66.8 m -100.8 69.41 1.35 Allowed 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.061 1.301 . . . . 0.0 110.424 -173.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.487 HD11 HG22 ' A' ' 120' ' ' VAL . 18.0 tt -67.7 124.18 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 CA-C-O 122.1 0.952 . . . . 0.0 109.47 174.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.723 HD21 ' HB3' ' A' ' 149' ' ' MET . 0.0 OUTLIER -117.25 -47.23 2.67 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 113.525 -1.671 . . . . 0.0 114.824 -179.882 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -119.68 141.04 49.73 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.487 HG22 HD11 ' A' ' 117' ' ' ILE . 2.1 t -129.75 110.73 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 102.165 -3.272 . . . . 0.0 102.165 177.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.738 HD21 ' HB2' ' A' ' 140' ' ' ALA 0.32 20.7 m-80 83.21 -83.2 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 123.649 1.69 . . . . 0.0 108.712 178.681 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -153.08 -16.05 0.15 Allowed 'General case' 0 CA--C 1.571 1.781 0 CA-C-N 110.539 -3.028 . . . . 0.0 110.48 178.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.1 t -62.6 136.92 25.16 Favored 'Isoleucine or valine' 0 C--N 1.363 1.156 0 C-N-CA 125.118 1.367 . . . . 0.0 110.088 173.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -100.87 96.91 7.6 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 111.891 -2.413 . . . . 0.0 108.408 178.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . 0.257 0.2 OUTLIER -96.02 -100.35 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 CA-C-O 116.44 -1.743 . . . . 0.0 107.588 179.378 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.539 ' HD3' ' HB3' ' A' ' 118' ' ' LEU 0.34 29.0 ptt180 50.94 -84.34 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 116.666 2.099 . . . . 0.0 116.666 -177.802 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.441 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 1.9 mt-10 -79.13 69.5 5.33 Favored 'General case' 0 CA--C 1.557 1.226 0 CA-C-O 123.811 1.767 . . . . 0.0 110.486 168.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -147.76 168.57 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 -178.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.404 HG22 ' H ' ' A' ' 131' ' ' SER . 28.2 m -60.71 133.67 56.32 Favored 'General case' 0 CA--C 1.562 1.417 0 CA-C-N 114.262 -1.335 . . . . 0.0 110.529 158.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.463 ' HA ' HD12 ' A' ' 94' ' ' ILE . 7.7 p-80 -46.05 -33.86 3.71 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 118.024 2.602 . . . . 0.0 118.024 168.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.564 ' HA ' HG12 ' A' ' 134' ' ' VAL . 7.6 m -60.84 -38.26 84.87 Favored 'General case' 0 CA--C 1.559 1.316 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 173.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -70.78 -33.3 70.62 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 116.217 1.932 . . . . 0.0 116.217 167.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.457 ' HB2' HG13 ' A' ' 94' ' ' ILE . . . -74.48 -43.4 56.23 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 172.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.564 HG12 ' HA ' ' A' ' 131' ' ' SER . 2.3 p -55.69 -42.41 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 159.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -60.44 -46.36 90.33 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 116.097 -1.906 . . . . 0.0 113.27 170.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.05 -31.66 70.19 Favored 'General case' 0 CA--C 1.559 1.306 0 N-CA-C 116.951 2.204 . . . . 0.0 116.951 173.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.468 HD12 ' HA ' ' A' ' 134' ' ' VAL . 46.7 mt -58.94 -47.89 83.45 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 163.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -65.2 -44.76 87.3 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 168.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -64.03 -17.75 63.66 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 116.533 2.049 . . . . 0.0 116.533 174.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.738 ' HB2' HD21 ' A' ' 121' ' ' ASN . . . -53.5 -20.16 4.55 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 119.667 3.21 . . . . 0.0 119.667 160.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 91.45 -125.93 8.23 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 173.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 39.0 m -90.9 1.59 56.87 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 167.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -150.1 110.74 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -165.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.461 ' HA ' ' HB1' ' A' ' 140' ' ' ALA . 3.3 t -102.9 115.86 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 113.481 -1.69 . . . . 0.0 107.863 -172.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 78.4 mtt180 -96.91 101.28 12.83 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 175.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.541 ' HB2' HG12 ' A' ' 66' ' ' ILE . 14.0 mt -95.76 137.35 34.95 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -173.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -125.19 126.1 44.69 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -131.24 122.23 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 177.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . 0.723 ' HB3' HD21 ' A' ' 118' ' ' LEU . 28.3 ttt . . . . . 0 N--CA 1.472 0.667 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 171.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 2.7 p90 . . . . . 0 CA--C 1.55 0.974 0 CA-C-O 121.399 0.619 . . . . 0.0 110.352 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -130.02 146.89 51.72 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 123.538 1.637 . . . . 0.0 110.418 175.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 10.7 ttpp -107.82 113.7 27.13 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 113.222 -1.808 . . . . 0.0 108.1 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 43.6 m -84.81 137.35 33.23 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 122.029 0.918 . . . . 0.0 109.84 173.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.39 153.91 22.2 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-O 122.711 1.243 . . . . 0.0 110.146 176.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.473 HG13 ' HB2' ' A' ' 77' ' ' PHE . 4.2 p . . . . . 0 C--O 1.25 1.09 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 -171.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 20.9 p90 . . . . . 0 CA--C 1.552 1.026 0 CA-C-O 122.708 1.242 . . . . 0.0 109.674 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -104.0 134.71 46.82 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 113.52 -1.673 . . . . 0.0 106.883 -176.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -105.26 118.7 37.22 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 -174.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.485 HG13 ' HB2' ' A' ' 146' ' ' LEU . 2.5 pt -136.58 104.27 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 N-CA-C 106.39 -1.708 . . . . 0.0 106.39 -168.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.2 m -98.98 126.23 44.63 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 173.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.79 142.38 51.32 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.112 178.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 . . . . . 0 N--CA 1.484 1.268 0 O-C-N 121.446 -0.784 . . . . 0.0 110.795 -177.64 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.624 HD13 HG22 ' B' ' 6' ' ' VAL . 5.9 mp . . . . . 0 N--CA 1.469 0.489 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.404 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 102.48 37.58 3.24 Favored Glycine 0 CA--C 1.532 1.121 0 N-CA-C 116.455 1.342 . . . . 0.0 116.455 -172.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -148.17 159.41 43.98 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-O 124.192 1.949 . . . . 0.0 107.254 168.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.536 ' O ' HG23 ' A' ' 96' ' ' ILE . 8.7 m -100.81 155.3 18.0 Favored 'General case' 0 C--N 1.313 -1.013 0 O-C-N 120.459 -1.401 . . . . 0.0 110.717 177.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.57 HD11 ' HB ' ' A' ' 134' ' ' VAL . 4.4 pt -129.09 132.65 66.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.572 174.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -91.15 -170.43 2.65 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-O 124.249 1.976 . . . . 0.0 108.477 163.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 85' ' ' ASN . . . -95.33 160.18 22.8 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-N 113.12 -1.855 . . . . 0.0 114.915 -142.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -108.45 -158.55 19.47 Favored Glycine 0 CA--C 1.52 0.4 0 CA-C-N 111.542 -2.329 . . . . 0.0 111.852 -175.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.533 HG22 ' HB2' ' A' ' 92' ' ' PRO . 42.2 p -54.73 -39.76 68.57 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 117.627 2.454 . . . . 0.0 117.627 -176.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -73.85 -24.87 59.82 Favored 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 116.268 1.951 . . . . 0.0 116.268 170.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.443 HD22 ' CE1' ' A' ' 130' ' ' HIS . 0.2 OUTLIER -139.97 82.3 17.64 Favored Pre-proline 0 CA--C 1.556 1.177 0 N-CA-C 103.111 -2.922 . . . . 0.0 103.111 -176.119 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -107.5 118.24 0.03 OUTLIER 'Trans proline' 0 CA--C 1.548 1.224 0 CA-C-N 125.165 2.88 . . . . 0.0 111.288 -169.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -178.67 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.533 ' HB2' HG22 ' A' ' 83' ' ' THR . 30.5 Cg_endo . . . . . 0 CA--C 1.549 1.268 0 CA-C-O 122.609 1.004 . . . . 0.0 112.948 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 73.1 m -157.24 134.68 10.55 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 104.4 -2.444 . . . . 0.0 104.4 -177.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.456 HD12 ' HA ' ' A' ' 130' ' ' HIS . 14.0 mm -76.92 121.5 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 -176.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -113.61 151.18 32.05 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 113.714 -1.584 . . . . 0.0 107.492 176.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.55 HG12 HG22 ' A' ' 79' ' ' ILE 0.29 3.4 mt -93.95 122.77 45.7 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.499 0 N-CA-C 105.094 -2.188 . . . . 0.0 105.094 166.147 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.5 m -78.98 -54.95 5.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.934 -1.104 . . . . 0.0 112.778 179.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 36.2 mtpt -147.79 162.92 38.24 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 124.27 1.986 . . . . 0.0 111.138 -164.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.88 104.71 17.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 1 N-CA-C 99.742 -4.17 . . . . 0.0 99.742 -170.449 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.283 1.3 mp -65.41 118.75 53.55 Favored Pre-proline 0 CA--C 1.566 1.572 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -176.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -61.19 134.16 50.84 Favored 'Trans proline' 0 C--N 1.364 1.346 0 C-N-CA 122.997 2.465 . . . . 0.0 112.993 173.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.67 -4.81 85.26 Favored Glycine 0 CA--C 1.544 1.874 0 N-CA-C 118.22 2.048 . . . . 0.0 118.22 -172.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.404 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -90.23 -173.07 44.83 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-O 123.499 1.61 . . . . 0.0 113.116 174.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.53 -34.52 72.38 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 116.363 1.986 . . . . 0.0 116.363 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -53.11 -42.43 65.98 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 120.126 1.33 . . . . 0.0 114.184 163.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.55 -40.73 65.77 Favored 'General case' 0 CA--C 1.562 1.426 0 N-CA-C 116.305 1.965 . . . . 0.0 116.305 174.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.32 -53.47 14.11 Favored 'General case' 0 CA--C 1.561 1.368 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 174.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.8 t70 . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -167.913 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 . . . . . 0 C--O 1.24 0.584 0 N-CA-C 102.001 -3.333 . . . . 0.0 102.001 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 12.8 m -73.82 86.85 1.73 Allowed 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 113.772 -1.558 . . . . 0.0 110.215 -170.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.3 tp -63.35 116.06 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 CA-C-O 122.11 0.957 . . . . 0.0 110.038 -176.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.513 HD23 ' HB2' ' A' ' 149' ' ' MET . 3.1 pp -96.64 -48.04 5.67 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 112.809 -1.996 . . . . 0.0 114.001 174.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -135.42 128.22 31.13 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 -175.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.512 HG23 HD23 ' A' ' 146' ' ' LEU . 5.5 p -121.72 122.26 66.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 172.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.55 HD21 ' HB2' ' A' ' 140' ' ' ALA 0.27 45.6 m-80 79.37 -65.3 0.2 Allowed 'General case' 0 N--CA 1.503 2.198 0 CA-C-O 122.818 1.294 . . . . 0.0 111.558 -173.507 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 176.52 -25.28 0.0 OUTLIER 'General case' 0 CA--C 1.573 1.842 0 C-N-CA 128.408 2.683 . . . . 0.0 110.174 -162.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.467 HG12 HG13 ' A' ' 125' ' ' VAL . 2.1 t -70.04 135.83 27.39 Favored 'Isoleucine or valine' 0 C--N 1.361 1.085 0 C-N-CA 125.148 1.379 . . . . 0.0 109.409 179.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -88.21 100.0 12.64 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 113.209 -1.814 . . . . 0.0 109.841 176.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.605 HG11 ' HA ' ' A' ' 133' ' ' ALA 0.251 3.3 m -94.79 -119.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 CA-C-O 116.959 -1.496 . . . . 0.0 107.62 174.902 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.696 ' HD2' ' H ' ' A' ' 127' ' ' GLU 0.475 1.0 OUTLIER 56.14 -78.43 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -174.283 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.696 ' H ' ' HD2' ' A' ' 126' ' ' ARG . 25.3 tt0 -79.81 67.1 5.49 Favored 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 126.388 1.875 . . . . 0.0 111.288 168.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -153.77 167.92 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 -177.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 27.0 m -64.37 134.1 53.92 Favored 'General case' 0 CA--C 1.561 1.386 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.151 158.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.456 ' HA ' HD12 ' A' ' 94' ' ' ILE . 4.7 p-80 -48.59 -31.51 6.72 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 118.64 2.83 . . . . 0.0 118.64 170.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.519 ' HA ' HG12 ' A' ' 134' ' ' VAL . 6.4 m -60.73 -38.6 85.67 Favored 'General case' 0 CA--C 1.563 1.465 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 171.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -67.53 -37.95 83.51 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 166.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.605 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -63.88 -52.44 59.97 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 170.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.57 ' HB ' HD11 ' A' ' 79' ' ' ILE . 3.4 p -54.9 -39.93 50.82 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.25 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 168.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -64.72 -40.46 95.37 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 117.058 -1.448 . . . . 0.0 114.181 173.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -67.98 -33.12 74.03 Favored 'General case' 0 CA--C 1.562 1.423 0 N-CA-C 116.539 2.052 . . . . 0.0 116.539 167.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.482 HD12 HG21 ' A' ' 120' ' ' VAL . 8.7 mp -54.24 -49.17 70.1 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 125.391 1.476 . . . . 0.0 113.763 160.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -66.31 -41.66 89.37 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 169.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -65.17 -17.69 64.69 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 116.461 2.023 . . . . 0.0 116.461 172.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.55 ' HB2' HD21 ' A' ' 121' ' ' ASN . . . -52.33 -41.84 63.33 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 117.622 2.453 . . . . 0.0 117.622 164.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 71.0 72.21 0.93 Allowed Glycine 0 C--N 1.339 0.714 0 CA-C-O 118.528 -1.151 . . . . 0.0 114.779 159.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . 0.267 4.5 m 68.5 -3.1 1.43 Allowed 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 117.906 2.558 . . . . 0.0 117.906 -173.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -148.38 103.19 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.251 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 171.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.441 ' HA ' ' HB1' ' A' ' 140' ' ' ALA . 36.0 m -84.99 122.38 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 124.034 0.934 . . . . 0.0 109.233 168.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 50.1 mtt180 -101.92 87.12 3.03 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 171.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.512 HD23 HG23 ' A' ' 120' ' ' VAL . 49.7 mt -92.01 136.53 33.1 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-O 122.47 1.129 . . . . 0.0 108.315 -172.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -132.48 118.12 18.89 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 104.359 -2.46 . . . . 0.0 104.359 178.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 33.6 m -126.71 133.0 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -167.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . 0.513 ' HB2' HD23 ' A' ' 118' ' ' LEU . 26.7 ttt . . . . . 0 N--CA 1.483 1.18 0 CA-C-O 123.621 1.677 . . . . 0.0 111.657 175.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.559 1.292 0 CA-C-O 122.201 1.001 . . . . 0.0 111.695 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -139.33 138.89 37.05 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 123.341 1.543 . . . . 0.0 110.005 173.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -102.86 124.42 48.35 Favored 'General case' 0 CA--C 1.553 1.068 0 CA-C-N 113.452 -1.704 . . . . 0.0 108.294 172.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.43 HG21 HG11 ' A' ' 134' ' ' VAL . 20.1 m -92.68 129.2 38.68 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.243 172.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -103.29 101.55 11.48 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 -174.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.624 HG22 HD13 ' A' ' 75' ' ' LEU . 1.4 p . . . . . 0 C--O 1.252 1.208 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.338 -176.2 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 14.1 p90 . . . . . 0 N--CA 1.479 1.012 0 CA-C-O 121.783 0.802 . . . . 0.0 109.304 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -111.91 140.05 46.89 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.173 -178.037 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -115.48 117.13 29.52 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 114.518 -1.219 . . . . 0.0 108.054 -178.76 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.4 mp -134.41 124.89 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 -171.533 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.8 m -97.11 125.1 41.35 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 168.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 mp -123.67 137.85 54.64 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -177.848 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 . . . . . 0 N--CA 1.482 1.17 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -172.56 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.486 HD23 ' N ' ' A' ' 75' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.301 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.594 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 72.39 42.38 49.27 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 119.577 2.591 . . . . 0.0 119.577 163.054 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.449 ' CZ ' HD12 ' A' ' 75' ' ' LEU . 13.1 p90 -157.87 128.22 6.26 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 176.741 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.476 ' HB3' ' HD2' ' B' ' 3' ' ' LYS . 48.1 m -85.19 144.73 27.98 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.789 -1.55 . . . . 0.0 111.663 176.362 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.531 HG22 HD13 ' A' ' 96' ' ' ILE . 2.3 pp -119.2 127.92 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 113.013 -1.903 . . . . 0.0 109.546 -176.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.78 -166.74 0.94 Allowed 'General case' 0 CA--C 1.553 1.091 0 CA-C-O 123.417 1.579 . . . . 0.0 111.024 159.632 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.78 159.24 22.2 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-O 123.936 1.853 . . . . 0.0 115.195 -143.407 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.51 -161.18 23.23 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-N 111.162 -2.519 . . . . 0.0 113.057 179.191 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.405 HG22 ' HB2' ' A' ' 92' ' ' PRO . 71.4 p -53.99 -40.27 66.8 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 -177.638 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.451 ' HB2' HG23 ' A' ' 129' ' ' THR . 5.9 m-20 -92.88 7.9 41.91 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 116.099 1.889 . . . . 0.0 116.099 175.543 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -161.16 86.67 1.7 Allowed Pre-proline 0 CA--C 1.553 1.092 0 N-CA-C 101.154 -3.647 . . . . 0.0 101.154 178.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -108.48 124.53 0.04 OUTLIER 'Trans proline' 0 CA--C 1.549 1.237 0 CA-C-N 124.437 2.62 . . . . 0.0 111.634 -173.023 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 . . . . . 0 N--CA 1.492 1.666 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 176.224 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.405 ' HB2' HG22 ' A' ' 83' ' ' THR . 81.2 Cg_endo . . . . . 0 CA--C 1.552 1.421 0 CA-C-O 121.558 0.566 . . . . 0.0 113.023 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 52.9 m -156.65 109.63 2.59 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 105.512 -2.032 . . . . 0.0 105.512 -173.651 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.484 HD12 ' HA ' ' A' ' 130' ' ' HIS . 8.1 mm -68.95 117.9 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 178.559 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -129.26 140.24 51.52 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 113.459 -1.701 . . . . 0.0 107.514 -163.488 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.531 HD13 HG22 ' A' ' 79' ' ' ILE . 7.4 mm -85.84 107.46 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.346 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 175.365 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 77.0 m -91.11 -35.06 14.81 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 117.4 -1.286 . . . . 0.0 113.74 175.54 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . 0.321 0.0 OUTLIER -144.18 165.14 28.67 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 123.299 1.524 . . . . 0.0 111.72 175.54 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -111.83 126.37 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 -176.451 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.304 1.4 mp -72.25 130.44 86.23 Favored Pre-proline 0 CA--C 1.567 1.606 0 CA-C-O 118.252 -0.88 . . . . 0.0 109.2 169.454 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -58.88 130.6 37.51 Favored 'Trans proline' 0 C--N 1.367 1.511 0 C-N-CA 123.54 2.826 . . . . 0.0 114.521 174.924 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 72.12 20.99 79.34 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 117.153 1.621 . . . . 0.0 117.153 -167.042 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.594 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -85.93 -176.81 50.09 Favored Glycine 0 C--N 1.337 0.636 0 N-CA-C 116.399 1.32 . . . . 0.0 116.399 177.203 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.81 -51.61 63.96 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 178.415 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.49 -38.91 89.04 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 174.167 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.92 -42.03 77.35 Favored 'General case' 0 CA--C 1.565 1.527 0 N-CA-C 115.821 1.786 . . . . 0.0 115.821 170.528 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.67 -51.1 20.83 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.604 1.162 . . . . 0.0 113.877 178.526 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.2 t70 . . . . . 0 N--CA 1.482 1.151 0 C-N-CA 124.38 1.072 . . . . 0.0 112.109 -176.134 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.461 ' HB3' HG11 ' A' ' 148' ' ' VAL . 47.2 m-20 . . . . . 0 C--O 1.237 0.405 0 N-CA-C 102.831 -3.026 . . . . 0.0 102.831 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.0 m -80.62 93.57 6.15 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.03 -0.986 . . . . 0.0 108.571 -176.517 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.466 HG12 HD11 ' A' ' 137' ' ' LEU . 7.2 tp -59.7 112.94 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 C-N-CA 123.569 0.748 . . . . 0.0 111.306 178.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.629 ' HA ' ' HB3' ' A' ' 126' ' ' ARG 0.431 0.0 OUTLIER -105.67 -39.81 5.96 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 115.933 1.827 . . . . 0.0 115.933 -174.306 . . . . . . . . 4 4 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -136.19 135.27 38.99 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 105.019 -2.215 . . . . 0.0 105.019 171.72 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.457 HG11 HD12 ' A' ' 137' ' ' LEU . 9.9 p -123.55 121.95 63.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 170.43 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.696 HD21 ' HB2' ' A' ' 140' ' ' ALA 0.261 3.8 m-80 77.17 -79.73 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 123.332 1.539 . . . . 0.0 108.93 -175.008 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.402 ' H ' ' H ' ' A' ' 123' ' ' VAL . 1.1 tt0 -165.25 -7.77 0.02 OUTLIER 'General case' 0 CA--C 1.576 1.978 0 C-N-CA 127.986 2.514 . . . . 0.0 110.78 -178.833 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.526 HG12 HG13 ' A' ' 125' ' ' VAL . 2.1 t -72.46 135.91 26.77 Favored 'Isoleucine or valine' 0 C--N 1.359 1.014 0 C-N-CA 125.443 1.497 . . . . 0.0 109.526 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -77.43 102.19 6.74 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 112.903 -1.953 . . . . 0.0 110.605 171.776 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.57 HG11 ' HA ' ' A' ' 133' ' ' ALA 0.261 2.2 m -109.78 -113.13 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-O 116.361 -1.781 . . . . 0.0 107.936 175.254 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.629 ' HB3' ' HA ' ' A' ' 118' ' ' LEU 0.328 0.0 OUTLIER 48.06 -82.72 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 117.753 2.501 . . . . 0.0 117.753 -176.12 . . . . . . . . 4 4 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.566 ' H ' ' HD3' ' A' ' 126' ' ' ARG . 2.9 tm-20 -88.35 70.4 9.09 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-O 123.696 1.712 . . . . 0.0 108.572 171.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.63 167.27 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 -178.689 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.451 HG23 ' HB2' ' A' ' 84' ' ' ASP . 11.6 m -58.45 132.42 53.66 Favored 'General case' 0 CA--C 1.555 1.146 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.206 159.358 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.484 ' HA ' HD12 ' A' ' 94' ' ' ILE . 2.7 p-80 -47.45 -34.16 6.97 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 117.37 2.359 . . . . 0.0 117.37 173.706 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.581 ' HA ' HG12 ' A' ' 134' ' ' VAL . 5.2 m -60.38 -40.5 91.06 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 174.925 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -67.24 -37.75 84.05 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 166.738 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.57 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -66.95 -55.86 12.7 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 173.663 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.606 HG23 HG22 ' B' ' 6' ' ' VAL . 8.6 p -47.09 -45.71 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 166.567 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.2 -54.15 49.27 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 115.765 -2.064 . . . . 0.0 111.72 174.862 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.97 -34.51 76.27 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 117.527 2.417 . . . . 0.0 117.527 174.074 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.466 HD11 HG12 ' A' ' 117' ' ' ILE . 6.0 mp -57.78 -55.34 36.09 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 125.636 1.575 . . . . 0.0 113.45 165.134 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -65.05 -33.77 76.84 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 115.898 1.814 . . . . 0.0 115.898 171.435 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -68.29 -23.64 64.77 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 117.135 2.272 . . . . 0.0 117.135 170.636 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.696 ' HB2' HD21 ' A' ' 121' ' ' ASN . . . -53.28 -28.46 28.03 Favored 'General case' 0 CA--C 1.56 1.362 0 N-CA-C 116.938 2.199 . . . . 0.0 116.938 156.046 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 91.09 -132.12 11.12 Favored Glycine 0 C--N 1.347 1.193 0 CA-C-O 122.53 1.072 . . . . 0.0 110.753 166.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 13.0 m -78.76 -2.06 37.68 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 169.152 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.05 103.8 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 -172.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.484 HG11 ' CD1' ' A' ' 75' ' ' LEU . 16.6 m -92.81 117.53 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 113.205 -1.816 . . . . 0.0 108.682 -178.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -89.57 94.22 9.78 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 169.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 82.1 mt -97.05 127.13 42.72 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 -173.521 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -126.12 120.01 29.05 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 102.963 -2.977 . . . . 0.0 102.963 177.178 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.461 HG11 ' HB3' ' A' ' 115' ' ' ASP . 16.8 m -124.65 132.89 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -173.346 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 57.5 ttm . . . . . 0 N--CA 1.484 1.236 0 CA-C-N 119.759 1.163 . . . . 0.0 108.54 168.419 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.558 1.265 0 CA-C-O 122.585 1.184 . . . . 0.0 111.214 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -148.24 120.75 8.52 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 122.517 1.151 . . . . 0.0 108.874 173.402 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.476 ' HD2' ' HB3' ' A' ' 78' ' ' SER . 16.7 ttpp -92.1 124.78 36.45 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.42 174.784 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.569 HG21 HG21 ' A' ' 134' ' ' VAL . 3.1 m -87.25 143.04 27.46 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 122.174 0.988 . . . . 0.0 109.418 168.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.69 120.31 35.72 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 178.462 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.606 HG22 HG23 ' A' ' 134' ' ' VAL . 21.8 t . . . . . 0 N--CA 1.478 0.933 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 -160.84 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 41.3 p90 . . . . . 0 N--CA 1.475 0.778 0 CA-C-O 121.823 0.82 . . . . 0.0 111.656 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -124.91 136.05 53.41 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -176.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.407 ' HB3' ' CE2' ' A' ' 147' ' ' TYR . 9.9 pt-20 -80.39 128.56 33.7 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 114.306 -1.316 . . . . 0.0 111.795 175.42 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 23.4 mt -129.57 118.12 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 -179.3 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.3 m -97.19 122.88 40.71 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 174.248 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.455 ' HB3' ' CG2' ' A' ' 144' ' ' VAL . 1.2 tt -119.85 161.45 20.79 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 113.098 -1.865 . . . . 0.0 106.7 174.902 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 . . . . . 0 N--CA 1.489 1.483 0 O-C-N 120.425 -1.422 . . . . 0.0 108.912 173.622 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.71 HD11 HG11 ' A' ' 144' ' ' VAL . 1.4 tt . . . . . 0 N--CA 1.485 1.32 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 118.02 22.83 3.76 Favored Glycine 0 N--CA 1.478 1.491 0 N-CA-C 118.017 1.967 . . . . 0.0 118.017 178.8 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -145.68 177.17 9.09 Favored 'General case' 0 CA--C 1.557 1.247 0 CA-C-O 123.749 1.738 . . . . 0.0 107.788 171.586 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.408 ' O ' HG23 ' A' ' 96' ' ' ILE . 1.8 m -134.91 145.13 47.92 Favored 'General case' 0 C--N 1.318 -0.804 0 O-C-N 119.909 -1.744 . . . . 0.0 107.559 -178.418 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.58 HG22 HG12 ' A' ' 96' ' ' ILE . 5.6 pt -112.22 137.0 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 114.695 -1.138 . . . . 0.0 112.006 -172.847 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.416 ' HB1' ' CB ' ' A' ' 87' ' ' HIS . . . -85.57 -174.3 5.1 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-O 123.976 1.846 . . . . 0.0 111.368 160.857 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.82 157.98 21.84 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 113.015 -1.902 . . . . 0.0 115.058 -145.78 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -104.69 -158.6 23.65 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 111.954 -2.123 . . . . 0.0 113.724 179.182 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.467 HG22 ' CB ' ' A' ' 92' ' ' PRO . 34.6 p -54.32 -38.24 65.76 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 116.872 2.175 . . . . 0.0 116.872 -178.0 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -83.25 -10.31 58.63 Favored 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 116.285 1.957 . . . . 0.0 116.285 174.406 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.15 92.29 2.35 Favored Pre-proline 0 CA--C 1.552 1.028 0 N-CA-C 101.095 -3.669 . . . . 0.0 101.095 -173.02 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -93.2 138.46 1.49 Allowed 'Trans proline' 0 CA--C 1.55 1.304 0 CA-C-N 124.879 2.778 . . . . 0.0 111.453 -176.405 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.416 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 28.3 t60 . . . . . 0 N--CA 1.493 1.681 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 167.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.467 ' CB ' HG22 ' A' ' 83' ' ' THR . 84.6 Cg_endo . . . . . 0 CA--C 1.547 1.159 0 CA-C-O 121.576 0.573 . . . . 0.0 112.473 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.4 m -158.19 125.22 4.95 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 -176.541 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.46 HG21 ' HB1' ' A' ' 133' ' ' ALA . 22.1 mm -78.4 123.24 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 178.517 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -116.67 154.67 30.15 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 112.684 -2.053 . . . . 0.0 107.969 177.717 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.58 HG12 HG22 ' A' ' 79' ' ' ILE 0.357 10.3 mt -95.39 123.79 47.7 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.076 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 161.001 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 49.6 m -74.3 -60.45 2.26 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.769 -1.207 . . . . 0.0 113.114 171.635 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -147.16 162.21 39.33 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 123.876 1.798 . . . . 0.0 111.48 -163.375 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.87 121.86 55.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 104.427 -2.434 . . . . 0.0 104.427 -175.157 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.259 1.6 mp -73.86 121.14 84.45 Favored Pre-proline 0 CA--C 1.567 1.623 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 173.353 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -61.02 138.1 76.25 Favored 'Trans proline' 0 C--N 1.365 1.425 0 C-N-CA 123.285 2.657 . . . . 0.0 113.701 172.581 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.32 0.58 83.79 Favored Glycine 0 CA--C 1.547 2.09 0 N-CA-C 118.153 2.021 . . . . 0.0 118.153 -170.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -89.96 -177.39 45.05 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-N 119.114 1.457 . . . . 0.0 112.978 174.444 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.37 -32.4 71.43 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 116.821 2.156 . . . . 0.0 116.821 176.631 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.8 -31.91 72.98 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 117.876 -1.059 . . . . 0.0 113.813 168.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -49.44 -43.47 44.79 Favored 'General case' 0 CA--C 1.559 1.319 0 N-CA-C 118.037 2.606 . . . . 0.0 118.037 164.68 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.8 -53.47 9.1 Favored 'General case' 0 CA--C 1.563 1.446 0 C-N-CA 124.466 1.106 . . . . 0.0 113.707 174.916 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.8 t70 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -174.16 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.2 p30 . . . . . 0 C--O 1.243 0.718 0 N-CA-C 100.841 -3.763 . . . . 0.0 100.841 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.1 m -75.18 85.2 2.39 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 114.198 -1.365 . . . . 0.0 109.54 -178.198 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.481 HG12 HD11 ' A' ' 137' ' ' LEU . 6.2 tp -65.63 115.64 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 CA-C-O 122.622 1.201 . . . . 0.0 109.602 179.755 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.487 ' HA ' ' HB3' ' A' ' 126' ' ' ARG . 3.1 pp -107.23 -45.12 4.18 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 112.233 -2.258 . . . . 0.0 115.206 179.769 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -130.9 134.78 47.08 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 -179.119 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.48 HG23 HD23 ' A' ' 146' ' ' LEU . 7.4 p -125.62 119.43 54.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 173.248 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.543 HD21 ' HB2' ' A' ' 140' ' ' ALA 0.279 10.5 m-80 76.26 -88.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -174.312 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -148.05 -6.96 0.43 Allowed 'General case' 0 CA--C 1.576 1.953 0 C-N-CA 128.225 2.61 . . . . 0.0 110.71 177.027 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.3 t -69.81 136.5 26.02 Favored 'Isoleucine or valine' 0 C--N 1.359 1.011 0 C-N-CA 125.463 1.505 . . . . 0.0 109.728 178.502 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -89.61 102.21 14.89 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 113.355 -1.748 . . . . 0.0 108.544 175.03 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.524 HG11 ' HA ' ' A' ' 133' ' ' ALA 0.258 0.9 OUTLIER -99.71 -97.97 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-O 116.225 -1.845 . . . . 0.0 107.73 173.424 . . . . . . . . 4 4 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.487 ' HB3' ' HA ' ' A' ' 118' ' ' LEU 0.301 0.4 OUTLIER 46.7 -87.3 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 117.284 2.328 . . . . 0.0 117.284 179.984 . . . . . . . . 4 4 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -85.26 76.11 10.2 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-O 123.408 1.575 . . . . 0.0 108.763 170.232 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.0 p -146.09 168.87 6.57 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 CA-C-N 113.166 -1.834 . . . . 0.0 106.316 -179.784 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.487 HG22 ' H ' ' A' ' 131' ' ' SER . 33.1 m -62.1 137.28 58.23 Favored 'General case' 0 CA--C 1.562 1.407 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.326 158.051 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 10.2 p-80 -46.62 -33.21 4.0 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 117.552 2.427 . . . . 0.0 117.552 168.456 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.487 ' H ' HG22 ' A' ' 129' ' ' THR . 10.9 m -61.02 -41.23 96.16 Favored 'General case' 0 CA--C 1.555 1.159 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 175.109 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -69.0 -35.65 76.94 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 166.851 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.524 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -67.2 -53.88 26.2 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 172.634 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.538 ' HB ' HD11 ' A' ' 79' ' ' ILE . 2.5 p -49.26 -42.86 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 165.827 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -60.15 -55.61 31.69 Favored 'General case' 0 C--N 1.353 0.751 0 CA-C-O 115.799 -2.048 . . . . 0.0 113.24 173.682 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -65.63 -28.31 69.02 Favored 'General case' 0 CA--C 1.564 1.493 0 N-CA-C 117.09 2.255 . . . . 0.0 117.09 175.419 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.481 HD11 HG12 ' A' ' 117' ' ' ILE . 9.8 mp -62.96 -53.93 46.29 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 125.242 1.417 . . . . 0.0 113.876 167.326 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -66.79 -32.73 74.21 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 167.597 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -70.24 -11.5 60.95 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 117.481 2.4 . . . . 0.0 117.481 171.363 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.543 ' HB2' HD21 ' A' ' 121' ' ' ASN . . . -59.13 -1.24 0.17 Allowed 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 118.82 2.896 . . . . 0.0 118.82 163.663 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 93.45 -127.08 8.88 Favored Glycine 0 C--N 1.344 0.989 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 171.395 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.5 m -93.81 -0.5 55.8 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 169.011 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -150.6 111.03 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 -166.188 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.71 HG11 HD11 ' A' ' 75' ' ' LEU . 34.2 m -90.13 121.04 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 114.528 -1.214 . . . . 0.0 109.119 -179.408 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -103.98 88.24 2.97 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 178.653 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.48 HD23 HG23 ' A' ' 120' ' ' VAL . 77.4 mt -89.58 142.22 27.87 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.393 -172.279 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.407 ' CE2' ' HB3' ' A' ' 65' ' ' GLU . 38.4 m-85 -123.69 124.02 41.82 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 103.906 -2.627 . . . . 0.0 103.906 168.748 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 20.0 m -132.49 131.77 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -169.854 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . 0.419 ' HB2' ' CD2' ' A' ' 118' ' ' LEU . 58.1 ttm . . . . . 0 N--CA 1.477 0.904 0 CA-C-O 123.205 1.479 . . . . 0.0 110.791 177.069 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.558 1.271 0 CA-C-O 122.286 1.041 . . . . 0.0 110.19 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -140.84 124.34 16.83 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 122.986 1.374 . . . . 0.0 108.344 168.144 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.53 129.03 34.96 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 114.175 -1.375 . . . . 0.0 109.646 176.022 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 85.8 m -101.86 132.58 47.55 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.839 175.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -75.28 147.98 39.77 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 122.653 1.216 . . . . 0.0 110.666 174.021 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.41 ' O ' ' HB3' ' A' ' 75' ' ' LEU . 2.6 p . . . . . 0 C--O 1.247 0.927 0 N-CA-C 103.876 -2.638 . . . . 0.0 103.876 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 . . . . . 0 N--CA 1.484 1.26 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -126.36 130.48 50.87 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.566 0.698 . . . . 0.0 109.782 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -100.47 136.81 39.77 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.432 -177.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -102.41 116.78 33.33 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.3 mp -130.91 111.96 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 -175.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.3 m -94.25 131.04 40.25 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 168.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.561 HD11 ' HA ' ' A' ' 105' ' ' ALA . 8.9 tt -134.86 141.87 46.47 Favored 'General case' 0 CA--C 1.556 1.206 0 CA-C-N 113.91 -1.495 . . . . 0.0 108.488 -173.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -81.14 111.24 17.4 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.293 0.637 . . . . 0.0 109.894 177.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.425 ' HG3' ' HG ' ' A' ' 75' ' ' LEU . 59.9 ttt-85 -70.66 137.78 50.14 Favored 'General case' 0 CA--C 1.563 1.448 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.169 178.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -62.21 168.78 15.07 Favored Glycine 0 CA--C 1.55 2.277 0 N-CA-C 115.116 0.806 . . . . 0.0 115.116 166.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -61.41 -71.42 0.15 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.108 -1.231 . . . . 0.0 113.792 -167.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.3 m -102.75 -27.38 12.73 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 176.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -123.66 144.49 15.57 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 170.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.425 ' HG ' ' HG3' ' A' ' 70' ' ' ARG . 1.1 mp -76.5 -86.88 0.05 OUTLIER 'General case' 0 CA--C 1.558 1.281 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -177.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 140.82 36.17 0.11 Allowed Glycine 0 CA--C 1.546 1.975 0 N-CA-C 116.848 1.499 . . . . 0.0 116.848 -166.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.439 ' CD2' ' HB2' ' A' ' 105' ' ' ALA . 0.3 OUTLIER -137.25 175.82 9.26 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 174.814 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 45.7 m -149.05 119.15 7.19 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 119.919 -1.738 . . . . 0.0 107.775 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.405 HD11 ' HB ' ' A' ' 134' ' ' VAL . 5.3 pt -97.22 132.23 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.461 -172.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -79.5 -177.49 5.82 Favored 'General case' 0 CA--C 1.556 1.193 0 CA-C-O 123.478 1.608 . . . . 0.0 111.673 156.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.75 163.03 25.67 Favored Glycine 0 CA--C 1.54 1.599 0 CA-C-N 113.751 -1.568 . . . . 0.0 116.576 -149.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.2 -156.74 20.48 Favored Glycine 0 N--CA 1.471 1.02 0 CA-C-N 112.553 -1.824 . . . . 0.0 114.135 177.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.72 -43.05 76.19 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 115.799 1.778 . . . . 0.0 115.799 177.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -62.33 -38.34 89.1 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 117.536 2.421 . . . . 0.0 117.536 172.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -142.17 89.35 8.7 Favored Pre-proline 0 CA--C 1.553 1.068 1 N-CA-C 99.424 -4.287 . . . . 0.0 99.424 -168.265 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -100.31 130.73 0.16 Allowed 'Trans proline' 0 CA--C 1.548 1.193 0 CA-C-N 124.361 2.593 . . . . 0.0 110.655 -175.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -58.72 -22.5 57.72 Favored 'General case' 0 CA--C 1.582 2.177 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 154.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.418 HD11 ' HE2' ' A' ' 95' ' ' PHE . 0.4 OUTLIER -157.25 117.38 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.223 0 N-CA-C 104.033 -2.58 . . . . 0.0 104.033 -169.809 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -77.03 7.58 35.05 Favored Glycine 0 CA--C 1.559 2.799 0 N-CA-C 117.859 1.904 . . . . 0.0 117.859 165.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -97.82 -12.94 21.63 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -155.5 89.89 2.93 Favored Pre-proline 0 CA--C 1.559 1.32 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 176.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -70.49 93.98 0.59 Allowed 'Trans proline' 0 C--N 1.371 1.711 0 C-N-CA 122.821 2.347 . . . . 0.0 110.969 175.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 75.7 m -145.3 128.75 16.95 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 -174.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.443 ' H ' ' HA ' ' A' ' 126' ' ' ARG . 24.6 mm -74.41 115.81 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 -177.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.418 ' HE2' HD11 ' A' ' 88' ' ' ILE . 31.5 m-85 -104.26 155.95 18.31 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 113.044 -1.889 . . . . 0.0 107.446 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.427 ' HB ' ' O ' ' A' ' 113' ' ' VAL 0.31 97.6 mt -96.28 120.0 45.07 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.688 0 N-CA-C 104.686 -2.339 . . . . 0.0 104.686 160.03 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 43.4 m -92.42 -25.0 18.68 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 120.57 -1.331 . . . . 0.0 113.486 168.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -138.66 150.74 46.55 Favored 'General case' 0 CA--C 1.56 1.331 0 CA-C-N 120.72 1.6 . . . . 0.0 110.473 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -99.32 126.23 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 104.762 -2.31 . . . . 0.0 104.762 170.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.25 28.7 mm -73.96 120.77 83.0 Favored Pre-proline 0 CA--C 1.571 1.755 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 176.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.64 132.12 22.85 Favored 'Trans proline' 0 C--N 1.368 1.586 0 C-N-CA 123.834 3.022 . . . . 0.0 113.045 -175.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 74.94 0.08 59.32 Favored Glycine 0 CA--C 1.551 2.323 0 N-CA-C 118.59 2.196 . . . . 0.0 118.59 -168.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -88.1 -162.38 38.04 Favored Glycine 0 CA--C 1.544 1.904 0 CA-C-N 119.161 1.481 . . . . 0.0 113.525 177.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.24 -58.05 9.94 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.561 ' HA ' HD11 ' A' ' 68' ' ' LEU . . . -50.47 -45.68 56.36 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 117.843 2.534 . . . . 0.0 117.843 172.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.38 -40.53 73.92 Favored 'General case' 0 CA--C 1.56 1.341 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 177.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . 0.256 0.0 OUTLIER -72.14 -55.49 7.2 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 178.231 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -72.33 -38.3 68.69 Favored 'General case' 0 CA--C 1.557 1.237 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -173.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -141.6 -148.55 5.07 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-O 123.738 1.743 . . . . 0.0 111.164 171.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.88 59.94 0.13 Allowed 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 111.932 -2.134 . . . . 0.0 106.752 -169.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.634 ' H ' HD23 ' A' ' 111' ' ' LEU . 1.5 pt? -79.23 -164.06 0.58 Allowed 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 123.273 1.511 . . . . 0.0 109.128 -174.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.06 157.17 17.06 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 124.594 2.14 . . . . 0.0 106.437 155.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.427 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 33.4 m -58.88 -65.11 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 112.488 -2.142 . . . . 0.0 110.399 171.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -39.54 -18.34 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.256 1 N-CA-C 122.257 4.169 . . . . 0.0 122.257 -177.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -34.92 99.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 125.652 1.581 . . . . 0.0 114.39 163.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.7 m -85.67 104.87 15.79 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 112.568 -2.105 . . . . 0.0 107.455 -161.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . 0.336 11.0 tp -57.93 104.07 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.497 0 CA-C-O 122.339 1.066 . . . . 0.0 112.323 -170.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.439 ' HG ' ' HB2' ' A' ' 149' ' ' MET 0.317 0.1 OUTLIER -82.9 -63.62 1.33 Allowed 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 112.602 -2.09 . . . . 0.0 110.413 -176.142 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -132.49 135.54 46.08 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 173.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 5.7 p -119.13 112.47 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 105.709 -1.959 . . . . 0.0 105.709 171.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.717 HD21 ' HB2' ' A' ' 140' ' ' ALA 0.27 23.2 m-80 77.7 -78.89 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 122.821 1.296 . . . . 0.0 109.966 -174.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -159.5 -12.94 0.06 Allowed 'General case' 0 CA--C 1.573 1.838 0 C-N-CA 127.399 2.28 . . . . 0.0 110.951 -176.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.657 HG12 HG13 ' A' ' 125' ' ' VAL . 2.4 t -68.25 134.83 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.394 0 C-N-CA 125.376 1.47 . . . . 0.0 110.124 175.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -87.17 97.04 10.54 Favored 'General case' 0 CA--C 1.553 1.068 0 CA-C-N 113.434 -1.712 . . . . 0.0 108.638 177.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.657 HG13 HG12 ' A' ' 123' ' ' VAL 0.325 2.9 m -97.11 -142.49 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.599 179.616 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.443 ' HA ' ' H ' ' A' ' 94' ' ' ILE 0.323 0.9 OUTLIER 71.82 -83.66 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 124.664 1.185 . . . . 0.0 111.2 -173.299 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.56 69.87 10.17 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 123.752 1.739 . . . . 0.0 109.406 177.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.1 m -143.72 166.49 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 -175.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 46.7 m -56.71 129.74 42.46 Favored 'General case' 0 CA--C 1.568 1.666 0 CA-C-N 112.96 -1.927 . . . . 0.0 109.639 150.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -48.49 -32.22 7.55 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 168.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.543 ' HA ' HG12 ' A' ' 134' ' ' VAL . 16.1 m -57.62 -45.03 85.89 Favored 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 168.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.36 -38.52 84.1 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 169.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.474 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -73.23 -44.29 59.79 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 116.914 2.19 . . . . 0.0 116.914 172.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.543 HG12 ' HA ' ' A' ' 131' ' ' SER . 4.6 p -57.71 -44.93 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 168.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -60.0 -50.8 72.32 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-O 117.089 -1.434 . . . . 0.0 112.055 170.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.63 -31.91 69.94 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 117.939 2.57 . . . . 0.0 117.939 172.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 73.3 mt -59.26 -53.75 54.67 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 125.071 1.348 . . . . 0.0 113.619 164.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -68.6 -35.95 78.03 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 117.358 2.355 . . . . 0.0 117.358 172.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -64.09 -14.28 53.58 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 117.044 2.238 . . . . 0.0 117.044 169.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.717 ' HB2' HD21 ' A' ' 121' ' ' ASN . . . -54.99 -24.0 22.06 Favored 'General case' 0 CA--C 1.561 1.368 0 N-CA-C 118.756 2.873 . . . . 0.0 118.756 160.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 93.61 -125.99 8.45 Favored Glycine 0 N--CA 1.475 1.268 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 168.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.2 m -79.94 -3.36 47.86 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 168.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -149.93 106.8 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -166.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.513 HG23 ' HB3' ' A' ' 68' ' ' LEU . 2.4 m -81.74 117.55 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 124.192 0.997 . . . . 0.0 110.572 170.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 45.4 mtm180 -99.45 90.59 4.57 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 175.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 42.5 mt -94.25 128.52 40.76 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.322 -169.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -127.49 121.68 31.38 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 103.231 -2.877 . . . . 0.0 103.231 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 18.3 m -131.38 119.44 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 CA-C-N 119.815 1.189 . . . . 0.0 110.923 -163.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.439 ' HB2' ' HG ' ' A' ' 118' ' ' LEU . 28.1 ttt -91.64 148.07 22.54 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 122.378 1.085 . . . . 0.0 111.256 -176.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -95.12 109.29 21.38 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.632 173.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -118.08 -67.49 0.99 Allowed 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 113.962 -1.472 . . . . 0.0 108.712 178.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.429 ' HA ' ' HE2' ' A' ' 152' ' ' LYS . 6.7 mmpt? -125.93 84.74 60.57 Favored Pre-proline 0 CA--C 1.555 1.142 0 CA-C-O 118.12 -0.943 . . . . 0.0 109.331 178.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -81.64 115.52 2.81 Favored 'Trans proline' 0 CA--C 1.569 2.228 0 C-N-CA 123.728 2.952 . . . . 0.0 110.864 170.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo . . . . . 0 C--N 1.365 1.436 0 C-N-CA 123.339 2.692 . . . . 0.0 112.121 179.111 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.558 1.273 0 CA-C-O 122.55 1.167 . . . . 0.0 111.406 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -138.31 128.18 25.34 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 170.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 20.7 ttpp -78.97 114.5 17.97 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.551 170.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 85.8 m -88.66 126.54 35.35 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 122.412 1.101 . . . . 0.0 109.059 175.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -80.66 133.8 35.77 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 113.886 -1.506 . . . . 0.0 108.502 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.417 ' HB ' HG23 ' A' ' 134' ' ' VAL . 7.6 p . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 -170.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 . . . . . 0 N--CA 1.479 1.001 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -133.11 133.62 43.17 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 124.676 1.235 . . . . 0.0 109.078 176.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -113.67 141.54 47.1 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.196 -172.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.9 117.7 34.7 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.3 mp -123.76 131.08 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 -174.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.0 m -101.15 127.13 47.85 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 162.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.0 tp -133.79 130.75 38.43 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 113.979 -1.464 . . . . 0.0 107.574 -176.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -77.46 132.28 38.37 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.352 -0.842 . . . . 0.0 109.848 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.413 ' HG3' ' HG ' ' A' ' 75' ' ' LEU . 33.7 ttt180 -72.98 137.89 45.72 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 119.339 0.972 . . . . 0.0 109.758 174.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -46.86 -82.17 0.03 OUTLIER Glycine 0 CA--C 1.543 1.84 0 CA-C-N 114.734 -1.121 . . . . 0.0 115.866 176.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -166.39 -85.22 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.6 m -88.75 -25.42 22.3 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 125.027 1.331 . . . . 0.0 113.893 173.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -116.79 -174.03 17.05 Favored Glycine 0 CA--C 1.537 1.465 0 CA-C-O 124.801 2.334 . . . . 0.0 110.332 159.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.558 HD11 HG21 ' A' ' 144' ' ' VAL . 1.3 tt -111.25 -44.54 3.54 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 111.705 -2.248 . . . . 0.0 110.101 174.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.445 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 103.75 44.36 1.67 Allowed Glycine 0 CA--C 1.533 1.179 0 N-CA-C 117.392 1.717 . . . . 0.0 117.392 173.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.46 ' CD1' HD13 ' A' ' 96' ' ' ILE . 0.1 OUTLIER -160.24 168.35 25.56 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.95 1.3 . . . . 0.0 108.487 176.252 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.468 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 3.0 m -131.81 119.7 21.62 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 120.622 -1.299 . . . . 0.0 111.068 -163.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.593 HG22 HG12 ' A' ' 96' ' ' ILE . 1.7 pt -95.51 129.22 45.93 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.279 -174.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.57 -173.92 4.35 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-O 123.299 1.523 . . . . 0.0 110.243 161.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.47 160.17 22.69 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 123.88 1.822 . . . . 0.0 116.046 -137.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -103.96 -162.0 24.77 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 111.26 -2.47 . . . . 0.0 115.449 -178.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 53.1 p -54.45 -40.16 68.12 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 116.395 1.998 . . . . 0.0 116.395 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.421 ' HB2' HG23 ' A' ' 129' ' ' THR . 9.6 m-20 -88.49 0.5 56.22 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 116.363 1.986 . . . . 0.0 116.363 175.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -163.27 87.84 1.27 Allowed Pre-proline 0 CA--C 1.557 1.242 0 N-CA-C 101.275 -3.602 . . . . 0.0 101.275 -176.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -97.5 143.19 0.67 Allowed 'Trans proline' 0 CA--C 1.549 1.265 0 CA-C-N 124.043 2.48 . . . . 0.0 111.073 -174.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 57.6 t60 -105.69 -19.38 13.78 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 167.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.423 ' H ' HD12 ' A' ' 88' ' ' ILE . 2.4 mp -94.34 146.7 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 -165.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -64.29 -2.39 7.03 Favored Glycine 0 CA--C 1.559 2.802 0 N-CA-C 119.116 2.407 . . . . 0.0 119.116 167.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -91.65 -11.1 38.0 Favored 'General case' 0 CA--C 1.569 1.697 0 CA-C-O 116.908 -1.52 . . . . 0.0 114.767 163.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.471 ' HB3' ' HD3' ' A' ' 92' ' ' PRO 0.52 19.8 t70 92.59 -88.14 0.0 OUTLIER Pre-proline 0 CA--C 1.569 1.69 0 C-N-CA 126.582 1.953 . . . . 0.0 109.565 -168.685 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.471 ' HD3' ' HB3' ' A' ' 91' ' ' ASP . 70.9 Cg_endo -113.75 103.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.362 1.279 0 CA-C-N 124.455 2.627 . . . . 0.0 112.371 -154.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 67.9 m -154.93 109.52 2.99 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.497 HD12 ' HA ' ' A' ' 130' ' ' HIS . 17.6 mm -74.09 118.85 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 174.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.481 ' HB2' ' HA ' ' A' ' 116' ' ' SER . 2.2 p90 -143.65 134.05 24.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.148 -1.387 . . . . 0.0 108.255 -171.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.595 HD12 ' HB2' ' A' ' 114' ' ' ASN . 86.9 mt -83.31 121.75 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 177.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.8 m -96.9 -26.17 15.16 Favored 'General case' 0 CA--C 1.558 1.264 0 CA-C-N 112.659 -2.064 . . . . 0.0 113.501 173.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.468 ' HB2' ' HB2' ' A' ' 78' ' ' SER . 63.8 mttm -132.45 158.37 42.2 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 123.903 1.811 . . . . 0.0 112.121 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -121.92 118.01 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 N-CA-C 102.622 -3.103 . . . . 0.0 102.622 177.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.262 1.6 mp -72.33 131.46 84.91 Favored Pre-proline 0 CA--C 1.567 1.621 0 CA-C-O 118.291 -0.861 . . . . 0.0 108.82 174.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -62.19 134.74 50.57 Favored 'Trans proline' 0 CA--C 1.555 1.547 0 C-N-CA 123.332 2.688 . . . . 0.0 113.531 172.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.18 12.69 84.38 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 117.349 1.7 . . . . 0.0 117.349 -161.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.445 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -93.87 166.52 27.55 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-O 122.203 0.891 . . . . 0.0 113.589 177.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.463 ' HB3' HD23 ' A' ' 75' ' ' LEU . . . -69.82 -39.79 76.28 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 116.6 2.074 . . . . 0.0 116.6 -175.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.85 -26.32 65.09 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 172.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.03 -52.39 17.19 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 162.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -58.59 -60.9 3.09 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 125.922 1.689 . . . . 0.0 114.312 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -67.99 -48.27 66.24 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.089 0.955 . . . . 0.0 110.885 175.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.53 80.13 0.24 Allowed Glycine 0 C--N 1.353 1.498 0 CA-C-N 118.719 0.691 . . . . 0.0 112.426 166.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -121.08 -30.54 4.33 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 176.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -138.23 -163.49 1.46 Allowed 'General case' 0 CA--C 1.552 1.026 0 CA-C-O 124.21 1.957 . . . . 0.0 107.048 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -74.41 -146.94 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.465 0 CA-C-O 124.456 2.074 . . . . 0.0 111.271 165.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.516 ' HB ' HG22 ' A' ' 96' ' ' ILE 0.371 12.3 m -37.31 -76.48 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 C-N-CA 128.329 2.652 . . . . 0.0 112.847 160.077 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.595 ' HB2' HD12 ' A' ' 96' ' ' ILE . 11.7 t-20 -160.72 -16.16 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 112.819 -1.991 . . . . 0.0 109.715 154.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.41 ' H ' ' H ' ' A' ' 114' ' ' ASN 0.315 11.9 t70 74.27 -84.69 0.03 OUTLIER 'General case' 0 C--N 1.354 0.801 0 CA-C-O 115.745 -2.074 . . . . 0.0 108.622 -165.163 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.481 ' HA ' ' HB2' ' A' ' 95' ' ' PHE . 12.6 m -155.23 93.59 1.53 Allowed 'General case' 0 N--CA 1.48 1.037 0 O-C-N 125.47 1.731 . . . . 0.0 107.95 -173.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.4 tp -65.77 127.04 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-O 121.326 0.584 . . . . 0.0 109.967 175.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.58 ' HA ' ' HB3' ' A' ' 126' ' ' ARG 0.338 4.1 pp -96.31 -51.38 4.4 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 116.336 1.976 . . . . 0.0 116.336 171.631 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -135.93 138.56 42.49 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 103.637 -2.727 . . . . 0.0 103.637 -176.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 10.8 p -125.58 121.03 59.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 173.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.689 HD21 ' HB2' ' A' ' 140' ' ' ALA 0.31 38.6 m-80 80.88 -80.65 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 124.181 1.943 . . . . 0.0 109.474 -177.395 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -163.69 -17.37 0.03 OUTLIER 'General case' 0 CA--C 1.568 1.663 0 CA-C-N 110.322 -3.126 . . . . 0.0 109.893 -174.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.689 HG12 HG13 ' A' ' 125' ' ' VAL . 2.4 t -65.46 136.65 26.34 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.268 0 CA-C-O 123.568 1.651 . . . . 0.0 109.647 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -85.25 79.61 9.47 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 111.233 -2.712 . . . . 0.0 110.743 177.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.689 HG13 HG12 ' A' ' 123' ' ' VAL 0.264 1.2 m -87.03 -106.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 CA-C-O 116.672 -1.633 . . . . 0.0 107.883 -179.497 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.58 ' HB3' ' HA ' ' A' ' 118' ' ' LEU 0.254 25.0 ptt180 52.04 -88.87 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 116.604 2.075 . . . . 0.0 116.604 177.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.565 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 25.1 tt0 -86.53 72.77 10.21 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-O 123.259 1.504 . . . . 0.0 108.877 167.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.3 p -139.88 170.25 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 177.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.421 HG23 ' HB2' ' A' ' 84' ' ' ASP . 3.1 m -58.34 136.67 57.45 Favored 'General case' 0 CA--C 1.559 1.29 0 CA-C-N 114.062 -1.426 . . . . 0.0 111.739 159.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.497 ' HA ' HD12 ' A' ' 94' ' ' ILE 0.264 2.4 p-80 -46.79 -37.66 8.97 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 117.174 2.287 . . . . 0.0 117.174 171.339 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.438 ' HA ' HG12 ' A' ' 134' ' ' VAL . 53.6 p -56.33 -52.35 64.88 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 172.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.57 -36.48 78.61 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 173.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.624 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -71.12 -52.53 18.79 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 116.083 1.882 . . . . 0.0 116.083 172.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.438 HG12 ' HA ' ' A' ' 131' ' ' SER . 1.9 p -53.43 -44.16 54.53 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.183 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 171.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 139' ' ' GLU . 65.7 mm-40 -63.93 -48.77 75.26 Favored 'General case' 0 C--O 1.212 -0.878 0 CA-C-O 116.038 -1.934 . . . . 0.0 111.807 172.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.77 -28.67 70.14 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 117.384 2.365 . . . . 0.0 117.384 170.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -60.31 -53.98 51.13 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.008 1.323 . . . . 0.0 113.925 166.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -67.91 -39.15 83.63 Favored 'General case' 0 CA--C 1.569 1.691 0 N-CA-C 115.788 1.773 . . . . 0.0 115.788 171.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 135' ' ' GLU . 1.2 mm-40 -74.05 0.31 14.1 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 116.866 2.173 . . . . 0.0 116.866 171.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.689 ' HB2' HD21 ' A' ' 121' ' ' ASN . . . -57.71 -6.75 0.56 Allowed 'General case' 0 CA--C 1.555 1.172 0 N-CA-C 119.317 3.08 . . . . 0.0 119.317 157.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.62 -137.98 16.38 Favored Glycine 0 C--N 1.345 1.072 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 174.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.9 m -79.34 -8.56 59.17 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 169.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -147.76 112.72 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 CA-C-O 123.674 1.702 . . . . 0.0 107.244 -165.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.558 HG21 HD11 ' A' ' 75' ' ' LEU . 4.3 t -101.55 114.1 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 112.411 -2.177 . . . . 0.0 106.814 -169.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.403 ' HB2' ' HA ' ' A' ' 121' ' ' ASN . 70.1 mtm180 -96.08 91.79 6.12 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -177.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 45.4 mt -90.88 136.91 32.76 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.033 -173.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -128.49 121.49 29.0 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 104.867 -2.272 . . . . 0.0 104.867 173.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.424 HG21 ' O ' ' A' ' 114' ' ' ASN . 0.1 OUTLIER -129.53 122.43 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 -173.328 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.409 ' HB2' ' CD2' ' A' ' 118' ' ' LEU . 56.4 ttm -99.68 143.12 30.28 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 124.442 1.088 . . . . 0.0 110.062 164.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -83.37 139.93 32.72 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 122.375 1.083 . . . . 0.0 110.543 168.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.416 ' HG2' ' HD2' ' A' ' 153' ' ' PRO . 64.6 ttt180 -59.02 148.53 30.49 Favored 'General case' 0 CA--C 1.565 1.554 0 CA-C-N 114.073 -1.421 . . . . 0.0 112.352 177.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.97 -61.03 4.88 Favored Pre-proline 0 N--CA 1.492 1.646 0 CA-C-O 116.027 -1.94 . . . . 0.0 113.532 -178.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.45 ' HA ' ' HD3' ' A' ' 154' ' ' PRO . 59.0 Cg_endo -67.36 139.06 48.44 Favored 'Trans proline' 0 CA--C 1.566 2.106 0 C-N-CA 122.994 2.463 . . . . 0.0 113.494 173.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 153' ' ' PRO . 7.7 Cg_exo . . . . . 0 CA--C 1.554 1.486 0 C-N-CA 123.301 2.667 . . . . 0.0 111.576 173.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.562 1.43 0 CA-C-O 122.948 1.356 . . . . 0.0 110.883 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -150.1 113.93 5.05 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 172.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -86.42 125.29 33.59 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.399 175.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 96.7 m -98.85 136.38 38.95 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-O 122.497 1.141 . . . . 0.0 110.008 176.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -84.95 129.19 34.84 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 113.508 -1.678 . . . . 0.0 108.198 173.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 p . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 177.499 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 N--CA 1.481 1.099 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -108.51 132.73 53.53 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 124.08 0.863 . . . . 0.0 109.975 176.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -109.99 131.87 54.67 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 114.389 -1.278 . . . . 0.0 108.223 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.89 126.19 37.86 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 114.362 -1.29 . . . . 0.0 109.294 176.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 40.9 mt -129.26 126.26 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 103.946 -2.613 . . . . 0.0 103.946 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.8 m -109.77 127.6 54.74 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 168.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.488 HD11 ' HA ' ' A' ' 105' ' ' ALA . 4.4 tp -127.44 162.11 27.14 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 113.347 -1.752 . . . . 0.0 107.396 175.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.402 ' O ' ' HB1' ' A' ' 104' ' ' ALA . 5.9 mt-10 -87.52 145.56 26.18 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.432 168.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.486 ' HG3' ' HG ' ' A' ' 75' ' ' LEU . 16.4 ttp180 -102.0 124.88 48.37 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 170.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -58.51 149.04 37.02 Favored Glycine 0 CA--C 1.547 2.088 0 CA-C-N 115.42 -0.809 . . . . 0.0 113.773 167.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -54.05 -52.01 62.24 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 -174.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.4 m -83.22 -15.54 49.98 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 116.319 1.97 . . . . 0.0 116.319 175.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 168.67 165.85 26.75 Favored Glycine 0 CA--C 1.535 1.295 0 N-CA-C 107.208 -2.357 . . . . 0.0 107.208 -177.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.632 HD13 HG22 ' B' ' 6' ' ' VAL . 1.8 mp -79.12 -85.43 0.08 Allowed 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 -178.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.615 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 129.97 50.4 0.12 Allowed Glycine 0 CA--C 1.54 1.61 0 C-N-CA 124.08 0.848 . . . . 0.0 114.526 -172.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.418 ' HA ' ' H ' ' A' ' 100' ' ' ILE . 36.8 p90 -151.88 158.36 43.11 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 165.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.454 ' HB2' ' HG2' ' A' ' 98' ' ' LYS . 67.1 m -96.05 154.0 17.47 Favored 'General case' 0 C--N 1.316 -0.888 0 O-C-N 119.569 -1.957 . . . . 0.0 110.533 171.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.478 HG22 HD13 ' A' ' 96' ' ' ILE . 2.5 pp -116.39 132.82 64.89 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-N 111.168 -2.742 . . . . 0.0 108.398 168.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.44 -171.3 3.29 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-O 123.613 1.673 . . . . 0.0 109.138 163.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.14 156.44 23.54 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 123.392 1.551 . . . . 0.0 115.251 -142.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.14 -158.58 23.19 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 111.955 -2.123 . . . . 0.0 113.643 -178.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.545 HG22 ' HB2' ' A' ' 92' ' ' PRO . 72.8 p -54.88 -41.55 70.99 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 117.736 2.495 . . . . 0.0 117.736 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -76.54 -13.59 60.07 Favored 'General case' 0 CA--C 1.568 1.663 0 N-CA-C 116.183 1.92 . . . . 0.0 116.183 172.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.31 82.0 6.51 Favored Pre-proline 0 CA--C 1.56 1.345 0 N-CA-C 102.557 -3.127 . . . . 0.0 102.557 -176.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -104.99 120.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.359 1.102 0 CA-C-N 124.976 2.813 . . . . 0.0 110.846 -169.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -107.87 -36.01 6.49 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.13 143.98 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -148.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.91 -113.76 4.71 Favored Glycine 0 CA--C 1.536 1.359 0 CA-C-N 114.799 -1.091 . . . . 0.0 112.759 168.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -74.46 -7.81 54.23 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 168.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.467 ' HB2' ' HD3' ' A' ' 92' ' ' PRO 0.454 41.1 m-20 100.79 -81.88 0.0 OUTLIER Pre-proline 0 CA--C 1.566 1.579 0 CA-C-O 115.781 -2.057 . . . . 0.0 106.939 -173.578 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.545 ' HB2' HG22 ' A' ' 83' ' ' THR . 91.2 Cg_endo -86.13 86.92 0.88 Allowed 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 123.442 2.762 . . . . 0.0 112.455 -177.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 66.8 m -155.7 127.65 7.51 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 103.83 -2.655 . . . . 0.0 103.83 -177.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.459 HG13 ' HB2' ' A' ' 133' ' ' ALA . 17.3 mm -76.28 122.3 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -110.02 151.06 27.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 113.057 -1.883 . . . . 0.0 107.936 178.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.478 HD13 HG22 ' A' ' 79' ' ' ILE . 20.6 mm -94.24 100.92 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.205 0 N-CA-C 102.979 -2.971 . . . . 0.0 102.979 165.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.2 t -80.82 -47.35 13.98 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 114.989 1.478 . . . . 0.0 114.989 -176.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.598 ' HA ' HG21 ' A' ' 113' ' ' VAL 0.277 10.4 ptmt -143.75 152.47 41.3 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 121.782 0.801 . . . . 0.0 111.727 -173.593 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.12 123.21 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 N-CA-C 103.886 -2.635 . . . . 0.0 103.886 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.418 ' H ' ' HA ' ' A' ' 77' ' ' PHE 0.267 1.7 mp -72.96 125.88 90.83 Favored Pre-proline 0 CA--C 1.566 1.576 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 173.137 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -60.95 129.52 29.18 Favored 'Trans proline' 0 C--N 1.364 1.367 0 C-N-CA 123.329 2.686 . . . . 0.0 114.296 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.87 5.45 69.81 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 118.481 2.153 . . . . 0.0 118.481 -169.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.615 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -79.08 -175.63 47.21 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 124.31 0.957 . . . . 0.0 114.486 173.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.402 ' HB1' ' O ' ' A' ' 69' ' ' GLU . . . -64.88 -40.15 94.67 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 116.077 1.88 . . . . 0.0 116.077 -174.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.488 ' HA ' HD11 ' A' ' 68' ' ' LEU . . . -68.03 -36.84 80.58 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 173.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.32 -35.21 75.73 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 116.445 2.017 . . . . 0.0 116.445 167.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -70.64 -57.32 4.83 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 125.704 1.602 . . . . 0.0 112.395 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -74.86 -55.57 5.67 Favored 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 123.831 0.853 . . . . 0.0 112.443 -177.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -113.72 -151.75 10.72 Favored Glycine 0 N--CA 1.474 1.208 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 172.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 14.2 mtt-85 -173.82 73.67 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 176.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.525 HD23 ' H ' ' A' ' 111' ' ' LEU . 2.5 pt? -104.34 -166.7 1.27 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 124.114 1.912 . . . . 0.0 108.725 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -100.29 128.61 46.32 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 103.133 -2.914 . . . . 0.0 103.133 157.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.598 HG21 ' HA ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -37.34 -64.77 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 110.242 -3.163 . . . . 0.0 116.657 164.026 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -33.48 85.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 125.921 2.013 . . . . 0.0 116.154 -178.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -154.85 131.95 10.95 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 103.717 -2.697 . . . . 0.0 103.717 -177.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 45.0 m -89.98 90.52 8.19 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 113.085 -1.87 . . . . 0.0 108.169 -170.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.5 tp -61.77 121.83 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.009 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.536 ' HA ' ' HB3' ' A' ' 126' ' ' ARG . 1.5 pp -106.33 -50.67 3.1 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 113.16 -1.836 . . . . 0.0 115.91 175.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.42 ' H ' HD12 ' A' ' 118' ' ' LEU . 41.6 m-85 -123.33 132.75 54.1 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 177.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 5.8 p -122.22 116.39 48.99 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 N-CA-C 104.142 -2.54 . . . . 0.0 104.142 168.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.729 HD21 ' HB2' ' A' ' 140' ' ' ALA 0.282 18.5 m-80 79.83 -74.65 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 CA-C-O 123.348 1.547 . . . . 0.0 110.176 -174.203 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -167.54 -16.74 0.02 OUTLIER 'General case' 0 CA--C 1.578 2.027 0 CA-C-N 111.471 -2.604 . . . . 0.0 109.64 -175.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.405 HG12 HG13 ' A' ' 125' ' ' VAL . 2.0 t -67.66 134.78 29.65 Favored 'Isoleucine or valine' 0 C--N 1.361 1.099 0 CA-C-N 120.415 1.462 . . . . 0.0 110.351 176.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -86.27 99.45 11.58 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 113.419 -1.719 . . . . 0.0 109.046 176.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.504 HG11 ' HA ' ' A' ' 133' ' ' ALA . 1.3 m -95.93 -101.19 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 CA-C-O 116.401 -1.762 . . . . 0.0 107.381 175.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.536 ' HB3' ' HA ' ' A' ' 118' ' ' LEU 0.316 18.8 ptt180 50.97 -90.89 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.254 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 177.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.422 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 4.9 tt0 -88.23 65.57 8.12 Favored 'General case' 0 CA--C 1.557 1.225 0 CA-C-O 122.991 1.377 . . . . 0.0 109.54 171.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.7 p -130.36 169.86 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 176.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 33.2 m -61.02 134.87 57.53 Favored 'General case' 0 CA--C 1.56 1.342 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.43 158.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.424 ' HA ' HD12 ' A' ' 94' ' ' ILE . 9.1 p-80 -47.28 -33.41 5.57 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 117.922 2.564 . . . . 0.0 117.922 171.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.552 ' HA ' HG12 ' A' ' 134' ' ' VAL . 16.7 m -62.06 -38.88 90.46 Favored 'General case' 0 CA--C 1.562 1.439 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 173.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.62 -34.69 76.19 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 115.521 1.675 . . . . 0.0 115.521 166.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.504 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -72.44 -49.8 30.84 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 116.234 1.938 . . . . 0.0 116.234 174.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.633 HG23 ' HB ' ' B' ' 6' ' ' VAL . 4.0 p -49.88 -44.24 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.221 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 164.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -64.09 -49.21 73.14 Favored 'General case' 0 C--O 1.216 -0.658 0 CA-C-O 116.075 -1.917 . . . . 0.0 112.556 172.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.47 -32.75 73.68 Favored 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 117.184 2.29 . . . . 0.0 117.184 176.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -58.25 -46.47 85.9 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 162.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -72.36 -37.69 68.74 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 171.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -64.98 -19.95 66.24 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 116.272 1.953 . . . . 0.0 116.272 170.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.729 ' HB2' HD21 ' A' ' 121' ' ' ASN . . . -52.11 -10.66 0.13 Allowed 'General case' 0 CA--C 1.554 1.103 0 N-CA-C 119.246 3.054 . . . . 0.0 119.246 162.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 70.18 -154.51 52.66 Favored Glycine 0 C--N 1.348 1.243 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -175.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.5 m -59.83 -5.09 0.84 Allowed 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 118.506 2.78 . . . . 0.0 118.506 176.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.96 105.79 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 -170.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.468 HG11 HD21 ' A' ' 75' ' ' LEU . 15.8 m -85.88 123.1 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.07 174.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -108.13 90.22 3.23 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 56.7 mt -90.69 139.27 30.87 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.471 -171.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -135.64 117.88 15.58 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 104.52 -2.4 . . . . 0.0 104.52 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 35.3 m -129.64 118.53 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -164.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 53.2 ttm -118.21 134.15 55.27 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 118.882 0.765 . . . . 0.0 109.746 173.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -82.6 115.18 21.45 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 114.447 -1.251 . . . . 0.0 110.2 171.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 25.9 ttt180 -97.43 99.6 11.03 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 113.628 -1.624 . . . . 0.0 106.665 168.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -68.03 144.63 97.21 Favored Pre-proline 0 CA--C 1.568 1.648 0 CA-C-N 114.088 -1.415 . . . . 0.0 112.457 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -58.38 118.56 5.46 Favored 'Trans proline' 0 CA--C 1.567 2.162 0 C-N-CA 123.45 2.767 . . . . 0.0 114.398 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo . . . . . 0 C--N 1.367 1.516 0 C-N-CA 123.049 2.499 . . . . 0.0 111.703 179.652 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.557 1.212 0 CA-C-O 122.504 1.145 . . . . 0.0 111.285 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -136.24 128.05 29.2 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-O 123.507 1.622 . . . . 0.0 109.328 170.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 10.7 ttpp -97.42 111.27 23.6 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 113.754 -1.566 . . . . 0.0 107.796 172.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 88.5 m -93.76 144.66 25.21 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.418 -1.265 . . . . 0.0 109.108 173.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -87.19 145.02 26.57 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 113.864 -1.516 . . . . 0.0 108.672 178.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.633 ' HB ' HG23 ' A' ' 134' ' ' VAL . 7.6 p . . . . . 0 C--O 1.248 1.01 0 N-CA-C 104.5 -2.408 . . . . 0.0 104.5 -178.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' BAL . . . . . 0.408 ' HB3' HD11 ' A' ' 100' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 . . . . . 0 N--CA 1.481 1.079 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -125.17 134.68 52.31 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 124.833 1.333 . . . . 0.0 110.158 170.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -101.46 133.15 46.54 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.812 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -97.84 128.52 44.51 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.72 170.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.533 HG13 ' HB2' ' A' ' 146' ' ' LEU . 23.5 pt -136.67 111.83 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 -174.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.0 m -91.96 120.24 32.44 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.42 ' HB3' ' CG2' ' A' ' 144' ' ' VAL . 6.7 tt -116.52 137.57 52.07 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 175.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -79.58 122.36 26.4 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 120.956 -1.09 . . . . 0.0 111.564 177.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 -62.68 104.79 0.56 Allowed 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 118.855 0.752 . . . . 0.0 110.222 172.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -41.68 -61.49 2.19 Favored Glycine 0 N--CA 1.482 1.743 0 N-CA-C 116.338 1.295 . . . . 0.0 116.338 -173.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -154.43 -100.67 0.04 OUTLIER 'General case' 0 CA--C 1.559 1.316 0 O-C-N 123.994 0.467 . . . . 0.0 109.868 167.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.4 m -73.55 -24.78 60.16 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 168.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -118.15 175.02 15.53 Favored Glycine 0 CA--C 1.543 1.782 0 CA-C-O 125.849 2.916 . . . . 0.0 111.037 162.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.568 HD21 HG22 ' B' ' 6' ' ' VAL . 0.1 OUTLIER -119.73 5.29 11.0 Favored 'General case' 0 CA--C 1.558 1.274 0 CA-C-N 110.076 -3.062 . . . . 0.0 112.015 176.499 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.522 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 69.4 36.37 77.75 Favored Glycine 0 C--N 1.344 1.014 0 N-CA-C 118.761 2.264 . . . . 0.0 118.761 164.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -150.48 163.51 38.25 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 123.563 1.649 . . . . 0.0 108.489 174.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.5 m -127.25 127.82 45.01 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.582 -169.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.3 pp -101.18 124.03 54.6 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 113.504 -1.68 . . . . 0.0 108.643 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -85.68 -170.86 3.31 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 123.452 1.596 . . . . 0.0 110.051 158.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.1 159.34 24.34 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-O 123.859 1.811 . . . . 0.0 115.604 -136.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -104.24 -162.6 24.58 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 111.082 -2.559 . . . . 0.0 113.742 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.446 HG22 ' HB3' ' A' ' 92' ' ' PRO . 70.2 p -52.83 -41.75 64.5 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 116.67 2.1 . . . . 0.0 116.67 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -80.15 -17.32 52.8 Favored 'General case' 0 CA--C 1.565 1.55 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 175.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.29 96.07 4.27 Favored Pre-proline 0 CA--C 1.552 1.028 0 N-CA-C 101.822 -3.399 . . . . 0.0 101.822 -175.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -96.73 143.41 0.84 Allowed 'Trans proline' 0 CA--C 1.548 1.194 0 CA-C-N 123.688 2.353 . . . . 0.0 111.472 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 16.8 t60 -106.25 -27.85 10.78 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 167.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.532 ' H ' HD12 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -98.62 162.68 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 125.305 1.442 . . . . 0.0 111.506 179.64 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -83.64 12.57 51.66 Favored Glycine 0 CA--C 1.552 2.358 0 N-CA-C 118.651 2.221 . . . . 0.0 118.651 172.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -81.12 -11.58 59.44 Favored 'General case' 0 CA--C 1.57 1.718 0 CA-C-N 119.151 1.475 . . . . 0.0 114.554 163.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.431 ' HB3' ' HD3' ' A' ' 92' ' ' PRO 0.509 31.8 t70 91.57 -85.32 0.0 OUTLIER Pre-proline 0 CA--C 1.562 1.429 0 CA-C-O 116.089 -1.91 . . . . 0.0 109.017 -169.019 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.446 ' HB3' HG22 ' A' ' 83' ' ' THR . 1.4 Cg_endo -108.39 -139.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.28 0 CA-C-N 125.288 2.924 . . . . 0.0 110.636 -163.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.5 m 78.3 106.87 0.07 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 168.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.487 HG13 ' HB2' ' A' ' 133' ' ' ALA . 11.3 mm -75.55 117.56 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 -173.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.427 ' CE1' HG13 ' A' ' 88' ' ' ILE . 16.9 p90 -128.4 135.44 49.54 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -171.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.414 ' HB ' ' O ' ' A' ' 113' ' ' VAL . 89.5 mt -72.5 118.83 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.388 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 175.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.44 ' CG2' ' HG3' ' B' ' 3' ' ' LYS . 14.3 t -87.75 -29.69 20.85 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 169.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -144.25 163.08 34.7 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-O 125.568 2.604 . . . . 0.0 110.343 -174.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.674 HG21 ' HA ' ' A' ' 111' ' ' LEU . 1.2 pt -115.4 129.17 72.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 111.051 -2.795 . . . . 0.0 103.539 173.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.294 1.5 mp -72.19 123.78 89.95 Favored Pre-proline 0 CA--C 1.57 1.715 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 170.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.93 132.08 42.95 Favored 'Trans proline' 0 C--N 1.367 1.545 0 C-N-CA 123.558 2.838 . . . . 0.0 114.203 172.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 71.52 9.95 69.88 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 118.084 1.994 . . . . 0.0 118.084 -166.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.522 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -91.01 -179.29 43.06 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-O 123.033 1.351 . . . . 0.0 112.397 177.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.65 -33.79 66.82 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 117.523 2.416 . . . . 0.0 117.523 -174.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.479 ' HB3' HG22 ' A' ' 99' ' ' ILE . . . -60.94 -32.88 72.38 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 117.961 2.578 . . . . 0.0 117.961 165.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.35 -39.41 93.84 Favored 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 167.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.48 -56.02 6.75 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.387 1.075 . . . . 0.0 113.624 175.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -62.0 -39.38 92.06 Favored 'General case' 0 CA--C 1.562 1.415 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -178.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 108.86 38.26 1.9 Allowed Glycine 0 CA--C 1.541 1.67 0 C-N-CA 124.682 1.134 . . . . 0.0 113.649 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -113.61 39.94 2.53 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 122.625 1.202 . . . . 0.0 111.343 173.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.674 ' HA ' HG21 ' A' ' 99' ' ' ILE . 1.7 pt? -61.01 -23.57 65.51 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 118.114 2.635 . . . . 0.0 118.114 170.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 16.1 mtp-105 -77.91 95.36 4.75 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 125.588 2.613 . . . . 0.0 107.479 163.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.414 ' O ' ' HB ' ' A' ' 96' ' ' ILE 0.26 17.0 m -56.17 -67.99 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 1 CA-C-N 107.589 -4.369 . . . . 0.0 108.467 -175.834 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -55.3 68.95 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 126.174 2.171 . . . . 0.0 116.714 -175.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -123.91 102.38 7.75 Favored 'General case' 0 C--O 1.239 0.547 1 N-CA-C 100.091 -4.04 . . . . 0.0 100.091 173.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.8 m -75.02 86.93 2.34 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 112.992 -1.913 . . . . 0.0 109.097 -176.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.571 HD12 HD21 ' A' ' 137' ' ' LEU . 30.1 pt -64.91 121.22 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 125.065 1.346 . . . . 0.0 111.024 -174.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.869 HD11 ' H ' ' A' ' 149' ' ' MET . 0.0 OUTLIER -101.55 -50.17 3.81 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 112.736 -2.029 . . . . 0.0 112.778 -179.457 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -111.4 140.91 45.6 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 169.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.521 HG23 HD23 ' A' ' 146' ' ' LEU . 7.1 p -127.93 120.05 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 104.465 -2.42 . . . . 0.0 104.465 165.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.824 HD21 ' HB2' ' A' ' 140' ' ' ALA 0.27 24.5 m-80 79.67 -74.45 0.05 Allowed 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 123.592 1.663 . . . . 0.0 110.453 -176.162 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -164.49 -10.88 0.03 OUTLIER 'General case' 0 CA--C 1.578 2.038 0 CA-C-N 111.355 -2.657 . . . . 0.0 110.203 177.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.1 t -71.46 134.42 29.98 Favored 'Isoleucine or valine' 0 C--N 1.36 1.03 0 C-N-CA 125.682 1.593 . . . . 0.0 109.745 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -84.67 100.79 11.69 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 113.698 -1.592 . . . . 0.0 109.299 172.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.555 HG11 ' HA ' ' A' ' 133' ' ' ALA . 0.7 OUTLIER -96.97 -96.86 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 CA-C-O 116.08 -1.914 . . . . 0.0 106.894 171.517 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.552 ' HB3' ' HA ' ' A' ' 118' ' ' LEU 0.302 18.9 ptt180 46.79 -89.37 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 -178.374 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.421 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 6.6 mt-10 -85.9 65.95 9.37 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-O 123.672 1.701 . . . . 0.0 109.087 177.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.1 p -138.75 168.38 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 22.9 m -60.33 132.79 55.0 Favored 'General case' 0 CA--C 1.561 1.388 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.884 158.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.46 ' HA ' HD12 ' A' ' 94' ' ' ILE . 10.2 p-80 -46.53 -32.69 3.54 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 118.166 2.654 . . . . 0.0 118.166 170.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.505 ' HA ' HG12 ' A' ' 134' ' ' VAL . 16.5 m -62.4 -40.37 96.28 Favored 'General case' 0 CA--C 1.561 1.381 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 173.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.74 -37.69 87.07 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 167.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.555 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -66.94 -52.18 46.11 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 172.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.505 HG12 ' HA ' ' A' ' 131' ' ' SER . 4.9 p -53.65 -42.25 50.15 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.421 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 172.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -72.33 -39.82 67.88 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 116.267 -1.825 . . . . 0.0 112.93 174.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.436 ' HA ' ' HB3' ' A' ' 139' ' ' GLU . . . -60.59 -29.19 69.04 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 117.162 2.282 . . . . 0.0 117.162 165.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.593 HD11 HD21 ' A' ' 146' ' ' LEU . 2.8 mm? -62.78 -48.96 76.88 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.819 1.647 . . . . 0.0 114.93 165.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -68.21 -35.71 78.4 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 168.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.436 ' HB3' ' HA ' ' A' ' 136' ' ' ALA . 29.6 tt0 -64.65 -23.19 67.18 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 116.379 1.992 . . . . 0.0 116.379 171.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.824 ' HB2' HD21 ' A' ' 121' ' ' ASN . . . -54.2 -11.06 0.43 Allowed 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 118.794 2.887 . . . . 0.0 118.794 162.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 89.1 -136.98 13.92 Favored Glycine 0 C--N 1.345 1.066 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 172.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 26.8 m -77.75 -2.96 38.83 Favored 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 170.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.85 106.74 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 -170.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.491 HG11 ' CD1' ' A' ' 75' ' ' LEU . 10.7 m -88.39 116.21 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.324 1.45 . . . . 0.0 109.292 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 56.1 mtm180 -104.01 89.34 3.26 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -176.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.593 HD21 HD11 ' A' ' 137' ' ' LEU . 23.9 mt -88.33 138.34 31.52 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.736 0.779 . . . . 0.0 109.0 -170.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -120.97 127.53 51.89 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 5.7 p -133.55 112.45 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 CA-C-O 121.65 0.738 . . . . 0.0 109.85 175.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.869 ' H ' HD11 ' A' ' 118' ' ' LEU . 27.3 ttt -88.63 128.8 35.6 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.343 1.857 . . . . 0.0 110.793 161.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 90.7 mtt-85 -103.7 111.53 24.06 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 114.264 -1.334 . . . . 0.0 107.614 -174.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -96.29 -27.8 14.81 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 112.995 -1.911 . . . . 0.0 113.596 174.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 32.6 tttm -136.29 86.31 24.96 Favored Pre-proline 0 CA--C 1.561 1.403 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -52.18 -49.85 15.99 Favored 'Trans proline' 0 CA--C 1.572 2.405 0 C-N-CA 123.213 2.609 . . . . 0.0 116.977 163.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo . . . . . 0 C--N 1.376 1.997 0 CA-C-N 124.364 2.594 . . . . 0.0 113.045 179.339 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.56 1.356 0 CA-C-O 122.728 1.251 . . . . 0.0 110.899 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -142.0 127.04 18.39 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 123.082 1.42 . . . . 0.0 107.937 170.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.44 ' HG3' ' CG2' ' A' ' 97' ' ' THR . 1.6 tmmt? -89.91 122.13 32.66 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.024 169.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 62.8 m -92.35 135.87 33.67 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 122.715 1.245 . . . . 0.0 108.951 171.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -92.27 133.58 35.7 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 113.855 -1.52 . . . . 0.0 107.865 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.568 HG22 HD21 ' A' ' 75' ' ' LEU 0.254 11.7 p . . . . . 0 C--O 1.248 1.015 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 -169.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 . . . . . 0 N--CA 1.482 1.175 0 CA-C-O 120.91 0.386 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.457 ' HB3' HD21 ' A' ' 118' ' ' LEU . 40.9 p90 -123.95 136.98 54.67 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.686 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -107.43 135.92 48.09 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 114.55 -1.204 . . . . 0.0 108.077 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -95.43 127.59 41.59 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.841 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.495 HG22 HD13 ' A' ' 68' ' ' LEU . 4.2 mp -135.24 122.91 37.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 -177.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.7 m -105.22 122.79 46.66 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 173.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.495 HD13 HG22 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -120.7 132.57 55.15 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 114.305 -1.316 . . . . 0.0 108.581 -175.869 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -105.34 115.47 30.31 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.812 -176.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.573 ' HG2' ' HA ' ' A' ' 75' ' ' LEU . 1.6 tpm_? -116.22 -102.73 0.42 Allowed 'General case' 0 CA--C 1.568 1.65 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.513 166.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.1 54.16 0.81 Allowed Glycine 0 N--CA 1.472 1.083 0 C-N-CA 126.43 1.967 . . . . 0.0 113.729 -165.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -160.7 171.15 19.37 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-O 123.156 1.455 . . . . 0.0 108.937 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.4 m -70.05 -22.42 63.08 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 161.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -105.46 88.74 0.59 Allowed Glycine 0 CA--C 1.543 1.838 0 CA-C-N 119.541 1.064 . . . . 0.0 110.566 164.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.821 ' H ' HD23 ' A' ' 75' ' ' LEU 0.405 0.2 OUTLIER -70.12 -2.06 11.87 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 118.016 2.599 . . . . 0.0 118.016 168.769 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.429 ' O ' HG13 ' A' ' 99' ' ' ILE . . . 99.29 20.44 17.86 Favored Glycine 0 C--O 1.218 -0.855 0 CA-C-O 115.437 -2.868 . . . . 0.0 117.18 168.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.42 ' O ' ' HB ' ' B' ' 6' ' ' VAL . 2.0 p90 -158.46 117.27 3.07 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 121.745 2.773 . . . . 0.0 109.678 -169.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.6 m -87.79 127.0 35.32 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.211 -1.359 . . . . 0.0 110.823 172.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.537 HG22 HG12 ' A' ' 96' ' ' ILE . 2.4 pp -105.74 127.22 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 113.62 -1.627 . . . . 0.0 108.947 -176.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -79.55 -173.05 3.56 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 124.015 1.864 . . . . 0.0 111.321 159.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' A' ' 85' ' ' ASN . . . -101.59 160.57 18.1 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-N 112.937 -1.938 . . . . 0.0 114.95 -142.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.456 ' H ' ' HB3' ' A' ' 130' ' ' HIS . . . -107.23 -162.22 21.75 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 110.939 -2.631 . . . . 0.0 111.711 -173.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.606 HG22 ' HB2' ' A' ' 92' ' ' PRO . 13.3 p -52.52 -43.1 64.91 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 117.661 2.467 . . . . 0.0 117.661 -173.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.514 ' HB3' HG23 ' A' ' 129' ' ' THR . 24.0 t70 -97.99 12.43 34.27 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 174.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.488 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 5.6 t30 -155.17 69.74 5.56 Favored Pre-proline 0 CA--C 1.555 1.151 0 N-CA-C 101.96 -3.348 . . . . 0.0 101.96 174.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -88.79 126.73 1.8 Allowed 'Trans proline' 0 C--N 1.365 1.444 0 CA-C-N 126.659 3.414 . . . . 0.0 112.208 -163.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -56.99 -31.46 65.08 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 115.213 1.561 . . . . 0.0 115.213 157.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -148.83 124.33 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 N-CA-C 103.422 -2.807 . . . . 0.0 103.422 -171.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -77.9 7.75 40.97 Favored Glycine 0 CA--C 1.556 2.639 0 N-CA-C 117.795 1.878 . . . . 0.0 117.795 165.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -105.23 -8.99 17.97 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 125.296 1.438 . . . . 0.0 114.182 177.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -154.51 88.38 3.36 Favored Pre-proline 0 CA--C 1.555 1.163 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.606 ' HB2' HG22 ' A' ' 83' ' ' THR . 14.6 Cg_endo -62.61 96.1 0.16 Allowed 'Trans proline' 0 CA--C 1.557 1.664 0 C-N-CA 122.851 2.367 . . . . 0.0 112.932 170.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.5 t -161.33 159.22 28.16 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 -172.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.526 HG13 ' HB2' ' A' ' 133' ' ' ALA . 12.2 mm -99.61 120.17 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 N-CA-C 105.256 -2.128 . . . . 0.0 105.256 -175.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -111.41 149.68 30.89 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 113.442 -1.708 . . . . 0.0 107.205 -174.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.537 HG12 HG22 ' A' ' 79' ' ' ILE . 23.0 mt -94.78 111.27 25.22 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.319 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 165.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 96.8 m -85.81 -30.85 22.66 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 117.264 -1.351 . . . . 0.0 113.431 169.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.514 ' HA ' HG11 ' A' ' 113' ' ' VAL 0.282 8.9 ptmm? -141.41 164.08 31.19 Favored 'General case' 0 CA--C 1.557 1.246 0 CA-C-N 120.673 1.579 . . . . 0.0 112.177 173.522 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.594 ' HB ' HG12 ' A' ' 113' ' ' VAL . 1.7 tp -115.26 137.51 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 N-CA-C 104.57 -2.381 . . . . 0.0 104.57 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.273 1.6 mp -83.6 116.86 66.71 Favored Pre-proline 0 CA--C 1.57 1.743 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 168.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -63.0 146.01 94.57 Favored 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 123.736 2.957 . . . . 0.0 113.979 172.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.3 -13.65 26.2 Favored Glycine 0 CA--C 1.547 2.073 0 N-CA-C 117.586 1.794 . . . . 0.0 117.586 -169.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -83.19 -169.62 45.02 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 118.911 1.356 . . . . 0.0 113.162 173.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.531 ' HB2' ' HB2' ' A' ' 70' ' ' ARG . . . -70.89 -51.29 27.09 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -170.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.0 -32.86 72.44 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 116.915 2.191 . . . . 0.0 116.915 173.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.07 -51.3 48.2 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 170.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -65.06 -62.22 1.68 Allowed 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 125.313 1.445 . . . . 0.0 112.986 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -64.97 -37.61 88.23 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 -177.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.64 -66.45 0.27 Allowed Glycine 0 N--CA 1.474 1.172 0 CA-C-N 118.955 0.798 . . . . 0.0 113.19 -176.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 58.66 52.33 6.94 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 123.414 1.578 . . . . 0.0 112.239 -157.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.609 ' H ' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -84.28 0.89 47.27 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 112.967 -1.924 . . . . 0.0 115.671 -170.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 40.0 mtt180 65.01 129.3 0.02 OUTLIER 'General case' 0 C--N 1.349 0.544 0 CA-C-O 125.535 2.588 . . . . 0.0 111.608 -168.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.598 HG23 ' H ' ' A' ' 114' ' ' ASN 0.281 28.1 m -46.8 -71.09 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.131 1 CA-C-N 108.098 -4.137 . . . . 0.0 111.383 -167.035 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.598 ' H ' HG23 ' A' ' 113' ' ' VAL . 1.5 p-10 -31.11 75.98 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.972 0 O-C-N 127.371 2.92 . . . . 0.0 118.157 166.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -122.56 -164.26 1.16 Allowed 'General case' 0 CA--C 1.558 1.267 0 CA-C-N 110.519 -3.037 . . . . 0.0 104.774 162.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.8 m -144.79 84.27 1.72 Allowed 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 175.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.563 HD12 HD11 ' A' ' 137' ' ' LEU . 28.1 pt -56.58 108.63 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 CA-C-O 123.558 1.646 . . . . 0.0 111.042 175.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.457 HD21 ' HB3' ' A' ' 63' ' ' TYR . 3.3 pp -101.19 -41.37 6.75 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 112.564 -2.107 . . . . 0.0 115.526 178.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -127.59 143.76 51.14 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.553 HG21 HD12 ' A' ' 137' ' ' LEU . 3.3 t -136.56 108.0 6.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 101.294 -3.595 . . . . 0.0 101.294 178.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.907 HD21 ' HB2' ' A' ' 140' ' ' ALA 0.283 25.0 m-80 82.51 -80.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 123.44 1.59 . . . . 0.0 109.504 178.593 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -152.82 -14.07 0.16 Allowed 'General case' 0 CA--C 1.568 1.635 0 CA-C-N 111.815 -2.448 . . . . 0.0 111.196 177.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.2 t -68.86 136.98 25.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 124.893 1.277 . . . . 0.0 109.733 174.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -96.08 101.08 12.7 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 112.574 -2.103 . . . . 0.0 109.018 176.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.548 HG11 ' HA ' ' A' ' 133' ' ' ALA 0.261 1.6 m -100.42 -103.84 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 CA-C-O 116.773 -1.584 . . . . 0.0 107.178 178.49 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.455 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.363 26.9 ptt85 44.21 -92.87 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 125.139 1.376 . . . . 0.0 114.572 -169.9 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.455 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 16.6 tt0 -72.84 74.84 1.15 Allowed 'General case' 0 CA--C 1.555 1.142 0 CA-C-O 124.297 1.998 . . . . 0.0 110.98 170.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.3 p -149.0 166.54 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 CA-C-N 111.993 -2.367 . . . . 0.0 105.232 -178.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.514 HG23 ' HB3' ' A' ' 84' ' ' ASP . 0.2 OUTLIER -54.6 122.49 10.71 Favored 'General case' 0 CA--C 1.557 1.224 0 CA-C-N 111.841 -2.436 . . . . 0.0 110.462 154.552 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.456 ' HB3' ' H ' ' A' ' 82' ' ' GLY . 1.6 p-80 -49.48 -31.24 9.59 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 117.436 2.384 . . . . 0.0 117.436 175.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.58 ' HA ' HG12 ' A' ' 134' ' ' VAL . 7.1 m -58.86 -38.05 77.89 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 115.373 1.619 . . . . 0.0 115.373 171.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.61 -37.06 79.47 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 165.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.548 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -63.19 -54.6 34.96 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 171.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.58 HG12 ' HA ' ' A' ' 131' ' ' SER . 9.8 p -52.45 -43.43 41.57 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 166.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -58.14 -50.39 73.65 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-O 115.888 -2.006 . . . . 0.0 111.817 171.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.55 -35.43 77.75 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 117.146 2.276 . . . . 0.0 117.146 173.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.563 HD11 HD12 ' A' ' 117' ' ' ILE . 9.3 mp -55.82 -52.6 63.43 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 125.04 1.336 . . . . 0.0 114.007 164.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -71.35 -31.82 67.8 Favored 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 174.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -67.16 -30.23 70.15 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 115.332 1.605 . . . . 0.0 115.332 171.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.907 ' HB2' HD21 ' A' ' 121' ' ' ASN . . . -50.27 -33.06 18.52 Favored 'General case' 0 CA--C 1.56 1.332 0 N-CA-C 117.202 2.297 . . . . 0.0 117.202 159.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 91.21 -125.18 7.9 Favored Glycine 0 C--N 1.348 1.229 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 166.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 11.6 m -73.38 -10.36 59.66 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 118.043 2.609 . . . . 0.0 118.043 169.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.2 104.44 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 -170.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.492 ' HA ' ' HB1' ' A' ' 140' ' ' ALA . 5.2 m -86.88 118.4 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 113.383 -1.735 . . . . 0.0 109.557 175.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 62.5 mtm180 -97.57 91.79 5.6 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 172.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.426 HD23 HG13 ' A' ' 120' ' ' VAL . 86.2 mt -93.24 138.69 31.39 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.906 0.86 . . . . 0.0 108.985 -173.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -130.67 120.99 24.73 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 177.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 21.2 m -130.77 129.64 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -166.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 23.9 ptt? -90.87 152.48 20.73 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 122.46 1.124 . . . . 0.0 111.587 168.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 46.0 mtp180 -108.19 126.76 53.17 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 113.987 -1.46 . . . . 0.0 108.079 173.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -62.31 -26.16 68.27 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 165.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -99.88 107.84 48.54 Favored Pre-proline 0 CA--C 1.565 1.535 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 165.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -66.32 159.35 50.51 Favored 'Trans proline' 0 CA--C 1.569 2.234 0 C-N-CA 123.013 2.475 . . . . 0.0 114.021 170.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo . . . . . 0 CA--C 1.553 1.436 0 C-N-CA 123.387 2.725 . . . . 0.0 115.137 174.35 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 8.1 p90 . . . . . 0 CA--C 1.55 0.98 0 CA-C-O 122.194 0.997 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -115.06 149.19 37.88 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 123.738 1.733 . . . . 0.0 109.188 173.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 12.0 ttpp -103.97 109.28 20.98 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 113.189 -1.823 . . . . 0.0 107.305 176.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.59 131.31 38.84 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.625 175.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -85.58 121.92 28.95 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.42 ' HB ' ' O ' ' A' ' 77' ' ' PHE . 2.7 t . . . . . 0 C--O 1.248 0.977 0 N-CA-C 104.193 -2.521 . . . . 0.0 104.193 -170.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 . . . . . 0 N--CA 1.481 1.101 0 CA-C-O 120.988 0.423 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -90.94 133.72 35.04 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-O 122.414 1.102 . . . . 0.0 112.575 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -101.53 129.16 47.56 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 113.354 -1.748 . . . . 0.0 108.254 166.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -116.29 129.27 56.19 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 114.224 -1.353 . . . . 0.0 109.163 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.454 HG13 ' HB2' ' A' ' 146' ' ' LEU . 6.2 pt -135.82 115.36 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 -174.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.3 m -86.43 118.18 25.7 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 171.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.495 HD21 ' HB1' ' A' ' 104' ' ' ALA . 8.2 tt -124.14 140.46 52.94 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 113.14 -1.845 . . . . 0.0 106.198 -171.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -82.33 131.66 35.23 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 121.431 -0.793 . . . . 0.0 109.378 -176.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.528 ' HG3' ' HG ' ' A' ' 75' ' ' LEU . 42.4 ttt180 -67.61 92.06 0.31 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.69 -0.631 . . . . 0.0 109.714 175.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.431 ' H ' ' HB2' ' A' ' 104' ' ' ALA . . . 17.89 -94.12 0.01 OUTLIER Glycine 0 N--CA 1.48 1.574 0 N-CA-C 119.243 2.457 . . . . 0.0 119.243 177.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -158.36 -77.85 0.07 Allowed 'General case' 0 CA--C 1.559 1.327 0 CA-C-N 113.925 -1.138 . . . . 0.0 108.725 176.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 27.6 m -81.95 -25.5 34.8 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 175.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -140.54 -146.1 4.74 Favored Glycine 0 CA--C 1.536 1.352 0 N-CA-C 107.406 -2.278 . . . . 0.0 107.406 161.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.528 ' HG ' ' HG3' ' A' ' 70' ' ' ARG . 6.9 mp -87.95 -91.66 0.11 Allowed 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 106.349 -1.722 . . . . 0.0 106.349 173.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.537 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 127.57 50.39 0.15 Allowed Glycine 0 CA--C 1.543 1.815 0 C-N-CA 124.516 1.055 . . . . 0.0 114.916 -175.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.457 ' CD1' HD13 ' A' ' 96' ' ' ILE . 0.3 OUTLIER -159.33 149.58 19.15 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 122.998 1.38 . . . . 0.0 109.97 174.186 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.515 ' HB2' ' HB3' ' A' ' 98' ' ' LYS . 70.7 m -99.91 116.35 31.75 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.408 -0.807 . . . . 0.0 111.62 -175.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.616 HG22 HG12 ' A' ' 96' ' ' ILE . 1.1 pt -88.46 122.86 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.311 176.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.65 -172.09 3.87 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-O 123.263 1.506 . . . . 0.0 110.644 164.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' A' ' 85' ' ' ASN . . . -95.43 161.05 22.99 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-O 123.389 1.55 . . . . 0.0 116.341 -136.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.49 -162.58 23.43 Favored Glycine 0 N--CA 1.464 0.564 0 CA-C-N 111.919 -2.14 . . . . 0.0 116.298 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.449 HG22 ' HB3' ' A' ' 92' ' ' PRO . 59.6 p -52.08 -40.53 61.35 Favored 'General case' 0 CA--C 1.567 1.628 0 CA-C-N 112.516 -1.842 . . . . 0.0 115.595 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.42 ' HB2' HG22 ' A' ' 129' ' ' THR . 31.5 t70 -78.82 -30.54 45.39 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 172.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.401 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 0.1 OUTLIER -134.52 91.37 21.95 Favored Pre-proline 0 N--CA 1.478 0.972 0 N-CA-C 102.402 -3.185 . . . . 0.0 102.402 -173.824 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -100.01 147.81 0.44 Allowed 'Trans proline' 0 CA--C 1.549 1.251 0 CA-C-N 124.557 2.663 . . . . 0.0 111.221 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.488 ' HB2' ' CD2' ' B' ' 1' ' ' TYR . 43.3 t60 -110.01 -31.58 7.33 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 166.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.506 ' H ' HD12 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -94.05 153.93 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 CA-C-O 122.912 1.339 . . . . 0.0 110.711 -179.92 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -79.79 12.7 27.81 Favored Glycine 0 CA--C 1.549 2.197 0 N-CA-C 118.304 2.081 . . . . 0.0 118.304 172.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -75.84 -8.97 58.18 Favored 'General case' 0 CA--C 1.569 1.683 0 CA-C-N 119.26 1.53 . . . . 0.0 115.028 162.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.434 ' HB3' ' HD3' ' A' ' 92' ' ' PRO 0.506 31.6 t70 95.17 -78.93 0.0 OUTLIER Pre-proline 0 CA--C 1.565 1.521 0 CA-C-O 115.893 -2.003 . . . . 0.0 109.296 -172.718 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.485 ' O ' HD11 ' A' ' 88' ' ' ILE . 0.5 OUTLIER -116.86 -136.02 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.448 0 CA-C-N 124.661 2.7 . . . . 0.0 110.482 -166.638 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 39.9 m 79.73 119.31 0.05 Allowed 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 167.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.549 HG13 ' CB ' ' A' ' 133' ' ' ALA . 10.0 mm -96.1 125.67 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 104.905 -2.258 . . . . 0.0 104.905 -172.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.435 ' HZ ' ' HB3' ' A' ' 87' ' ' HIS . 32.3 p90 -140.67 128.52 21.82 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 112.317 -2.22 . . . . 0.0 106.58 -159.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.616 HG12 HG22 ' A' ' 79' ' ' ILE . 73.6 mt -87.64 114.93 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.2 t -97.77 -13.85 21.14 Favored 'General case' 0 CA--C 1.559 1.301 0 CA-C-N 113.224 -1.807 . . . . 0.0 114.805 169.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 78' ' ' SER . 19.2 ttmm -141.11 158.11 44.36 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-O 124.832 2.253 . . . . 0.0 109.93 -173.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.29 131.87 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 111.531 -2.577 . . . . 0.0 105.894 -176.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.275 1.6 mp -78.69 131.62 67.2 Favored Pre-proline 0 CA--C 1.57 1.716 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 167.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.17 130.56 34.8 Favored 'Trans proline' 0 C--N 1.367 1.517 0 C-N-CA 123.416 2.744 . . . . 0.0 115.132 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 70.48 13.33 70.94 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 118.167 2.027 . . . . 0.0 118.167 -168.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.537 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -90.0 -162.11 38.04 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 124.371 0.986 . . . . 0.0 114.675 -175.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.495 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -68.27 -53.85 21.66 Favored 'General case' 0 CA--C 1.557 1.229 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -170.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.05 -24.49 64.18 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 117.286 2.328 . . . . 0.0 117.286 168.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.96 -34.98 71.98 Favored 'General case' 0 CA--C 1.565 1.551 0 N-CA-C 115.964 1.838 . . . . 0.0 115.964 168.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -55.29 6.01 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 124.929 1.292 . . . . 0.0 112.26 174.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -77.03 -48.85 16.77 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.26 0.624 . . . . 0.0 112.612 -174.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -96.07 -140.99 11.46 Favored Glycine 0 CA--C 1.543 1.787 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 160.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 31.7 mtm-85 -156.01 -7.13 0.11 Allowed 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 177.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.8 pp -162.05 -46.69 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.181 -0.949 . . . . 0.0 110.883 -153.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 26.8 mtp180 -78.95 95.73 5.54 Favored 'General case' 0 C--N 1.36 1.024 0 CA-C-O 125.187 2.423 . . . . 0.0 105.297 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.442 ' HB ' HG22 ' A' ' 96' ' ' ILE 0.317 11.1 m -32.08 -62.74 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.659 1 CA-C-N 108.194 -4.094 . . . . 0.0 112.316 156.837 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.568 ' HB2' ' HB ' ' A' ' 96' ' ' ILE . 0.9 OUTLIER 158.64 -17.7 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 129.859 3.264 . . . . 0.0 110.392 168.16 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 95' ' ' PHE 0.308 6.9 m-20 84.59 -82.28 0.02 OUTLIER 'General case' 0 C--N 1.354 0.77 0 C-N-CA 126.55 1.94 . . . . 0.0 108.248 169.644 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 69.4 m -160.37 102.42 1.39 Allowed 'General case' 0 N--CA 1.473 0.677 0 O-C-N 126.337 2.273 . . . . 0.0 107.352 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.445 HD13 ' H ' ' A' ' 117' ' ' ILE . 0.2 OUTLIER -99.0 150.27 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.416 0 CA-C-O 122.617 1.199 . . . . 0.0 108.911 179.465 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.908 HD11 ' H ' ' A' ' 149' ' ' MET . 0.0 OUTLIER -120.61 -37.36 3.02 Favored 'General case' 0 N--CA 1.502 2.154 0 C-N-CA 126.504 1.922 . . . . 0.0 111.784 -171.056 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -126.67 150.66 48.85 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-O 122.755 1.264 . . . . 0.0 108.237 173.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.49 ' HB ' HH22 ' A' ' 126' ' ' ARG . 14.6 p -129.65 121.22 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 169.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.739 HD21 ' HB2' ' A' ' 140' ' ' ALA 0.358 12.8 m-80 79.14 -88.67 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 123.595 1.664 . . . . 0.0 107.845 178.626 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -144.21 -16.45 0.58 Allowed 'General case' 0 CA--C 1.568 1.636 0 CA-C-N 110.478 -3.055 . . . . 0.0 110.37 174.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.7 t -66.45 134.54 29.82 Favored 'Isoleucine or valine' 0 C--N 1.36 1.054 0 CA-C-O 123.92 1.819 . . . . 0.0 109.949 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -89.47 57.8 4.12 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 110.254 -3.157 . . . . 0.0 112.923 173.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.8 m -70.86 -163.94 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.333 0 CA-C-O 123.632 1.682 . . . . 0.0 108.496 161.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.615 ' H ' HG22 ' A' ' 128' ' ' VAL 0.525 4.3 mmt85 86.51 -49.27 0.05 Allowed 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 115.019 1.489 . . . . 0.0 115.019 176.164 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -76.21 51.86 0.71 Allowed 'General case' 0 CA--C 1.571 1.756 0 CA-C-N 114.186 -1.37 . . . . 0.0 113.276 155.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.615 HG22 ' H ' ' A' ' 126' ' ' ARG . 30.4 m -148.58 170.15 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 -170.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.42 HG22 ' HB2' ' A' ' 84' ' ' ASP . 44.6 p -61.73 141.12 58.07 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 113.293 -1.776 . . . . 0.0 111.814 155.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.41 ' HA ' HD12 ' A' ' 94' ' ' ILE . 8.6 p-80 -44.39 -33.74 1.76 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 117.175 2.287 . . . . 0.0 117.175 171.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.602 ' HA ' HG12 ' A' ' 134' ' ' VAL . 16.1 m -62.78 -40.72 98.19 Favored 'General case' 0 CA--C 1.564 1.489 0 N-CA-C 115.702 1.742 . . . . 0.0 115.702 176.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.06 -37.94 81.87 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 169.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.549 ' CB ' HG13 ' A' ' 94' ' ' ILE . . . -67.8 -47.26 69.58 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 116.152 -1.88 . . . . 0.0 115.968 169.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.602 HG12 ' HA ' ' A' ' 131' ' ' SER . 13.0 p -53.39 -46.37 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-N 121.351 1.887 . . . . 0.0 113.221 166.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -53.18 -46.91 69.15 Favored 'General case' 0 CA--C 1.555 1.16 0 CA-C-O 117.527 -1.225 . . . . 0.0 113.02 168.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.63 -26.82 67.25 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 117.534 2.42 . . . . 0.0 117.534 170.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.476 ' CD2' HH21 ' A' ' 126' ' ' ARG . 3.5 mm? -68.76 -49.35 59.43 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 125.6 1.56 . . . . 0.0 113.845 171.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -66.22 -34.27 77.65 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 165.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -72.43 -21.65 61.22 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 116.932 2.197 . . . . 0.0 116.932 174.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.739 ' HB2' HD21 ' A' ' 121' ' ' ASN . . . -51.58 -20.8 2.13 Favored 'General case' 0 CA--C 1.563 1.451 0 N-CA-C 117.584 2.438 . . . . 0.0 117.584 155.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.78 -147.29 27.76 Favored Glycine 0 C--N 1.35 1.356 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 174.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.487 ' HA ' ' HB3' ' A' ' 70' ' ' ARG . 18.5 m -61.84 -6.5 2.76 Favored 'General case' 0 CA--C 1.571 1.783 0 N-CA-C 117.553 2.427 . . . . 0.0 117.553 173.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -146.58 101.68 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 -170.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.508 ' HA ' ' HB1' ' A' ' 140' ' ' ALA . 29.8 m -84.18 116.92 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.293 172.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.481 ' HB2' ' HA ' ' A' ' 121' ' ' ASN . 57.7 mtp85 -94.35 106.12 18.1 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 174.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.555 HD13 HD21 ' A' ' 114' ' ' ASN . 11.3 mt -107.02 124.05 49.08 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 -166.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -116.84 130.14 56.52 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 -174.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.02 127.77 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 176.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.908 ' H ' HD11 ' A' ' 118' ' ' LEU . 67.3 mtt -93.9 113.25 25.23 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.048 1.739 . . . . 0.0 108.671 171.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -97.17 126.2 42.19 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 113.777 -1.556 . . . . 0.0 107.556 174.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -75.89 118.6 18.85 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 114.055 -1.43 . . . . 0.0 108.029 175.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.414 ' HB3' ' HD3' ' A' ' 153' ' ' PRO . 22.7 ttpp -164.79 -58.62 0.01 OUTLIER Pre-proline 0 CA--C 1.556 1.182 0 CA-C-O 115.59 -2.147 . . . . 0.0 107.642 176.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.414 ' HD3' ' HB3' ' A' ' 152' ' ' LYS . 3.0 Cg_exo -73.94 141.54 30.19 Favored 'Trans proline' 0 CA--C 1.566 2.088 0 CA-C-N 124.762 2.736 . . . . 0.0 111.603 177.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo . . . . . 0 CA--C 1.552 1.401 0 C-N-CA 123.104 2.536 . . . . 0.0 113.512 179.183 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' TYR . . . . . 0.488 ' CD2' ' HB2' ' A' ' 87' ' ' HIS . 0.0 OUTLIER . . . . . 0 CA--C 1.557 1.226 0 CA-C-O 122.728 1.251 . . . . 0.0 110.565 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -157.12 151.11 24.72 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 123.351 1.548 . . . . 0.0 109.951 168.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.74 137.16 37.03 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 -176.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 27.6 m -85.34 133.78 34.13 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 166.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.95 99.98 12.52 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 -177.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.416 HG12 HD13 ' A' ' 75' ' ' LEU . 21.9 t . . . . . 0 C--O 1.25 1.091 0 N-CA-C 103.042 -2.947 . . . . 0.0 103.042 -165.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -123.56 137.42 54.76 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.718 1.207 . . . . 0.0 108.101 -172.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -114.03 136.2 53.18 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 113.697 -1.592 . . . . 0.0 107.71 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -99.63 121.42 41.19 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -172.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 18.2 mt -130.99 114.93 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 104.233 -2.506 . . . . 0.0 104.233 -172.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.0 m -96.6 124.91 40.74 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 169.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.468 ' HB3' ' CG2' ' A' ' 144' ' ' VAL . 5.2 tp -127.86 166.82 17.53 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 113.29 -1.777 . . . . 0.0 107.144 176.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -79.85 144.44 33.46 Favored 'General case' 0 N--CA 1.48 1.074 0 O-C-N 121.352 -0.843 . . . . 0.0 109.392 164.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.447 ' HA ' ' HG ' ' A' ' 75' ' ' LEU . 7.3 ttp180 -75.91 79.32 2.81 Favored 'General case' 0 CA--C 1.558 1.256 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 162.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.17 -132.5 41.95 Favored Glycine 0 N--CA 1.479 1.559 0 CA-C-O 122.426 1.015 . . . . 0.0 114.509 170.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -137.73 -59.08 0.67 Allowed 'General case' 0 CA--C 1.555 1.166 0 CA-C-N 112.297 -1.951 . . . . 0.0 109.141 162.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.1 m -97.2 -19.02 18.9 Favored 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 166.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -128.59 -122.61 2.5 Favored Glycine 0 C--N 1.347 1.194 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 171.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.567 HD11 HG11 ' A' ' 144' ' ' VAL . 1.0 OUTLIER -137.71 -60.8 0.64 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.889 1.276 . . . . 0.0 109.309 -178.192 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.477 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 113.5 43.34 0.83 Allowed Glycine 0 CA--C 1.533 1.179 0 N-CA-C 117.155 1.622 . . . . 0.0 117.155 167.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.486 ' HE1' HD23 ' A' ' 137' ' ' LEU . 3.8 p90 -156.72 157.7 35.6 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.526 1.131 . . . . 0.0 109.11 172.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 51.1 m -96.66 137.76 35.25 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 120.621 -1.3 . . . . 0.0 110.155 171.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.42 HG22 HG12 ' A' ' 96' ' ' ILE . 1.2 pt -107.21 125.87 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.85 178.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -83.25 -178.46 7.09 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 124.254 1.978 . . . . 0.0 110.001 167.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 85' ' ' ASN . . . -91.51 159.08 25.79 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 112.923 -1.944 . . . . 0.0 115.228 -141.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -109.26 -170.97 20.63 Favored Glycine 0 C--O 1.224 -0.496 0 CA-C-N 110.472 -2.864 . . . . 0.0 113.034 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.563 HG22 ' HB2' ' A' ' 92' ' ' PRO . 29.6 p -43.5 -43.36 5.39 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 118.442 2.756 . . . . 0.0 118.442 -176.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -78.07 -28.64 48.88 Favored 'General case' 0 CA--C 1.561 1.403 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 175.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.419 ' O ' ' HA3' ' A' ' 81' ' ' GLY 0.258 2.0 t30 -143.81 71.96 17.03 Favored Pre-proline 0 CA--C 1.562 1.404 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -175.754 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -103.44 145.83 0.17 Allowed 'Trans proline' 0 C--N 1.375 1.937 0 CA-C-N 124.629 2.689 . . . . 0.0 111.652 -171.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -63.05 -26.68 68.95 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 162.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.65 124.08 70.84 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 -170.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -72.39 -11.29 76.06 Favored Glycine 0 CA--C 1.561 2.961 0 N-CA-C 117.686 1.835 . . . . 0.0 117.686 161.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -101.57 -10.73 19.83 Favored 'General case' 0 CA--C 1.565 1.554 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 176.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -142.43 86.1 10.13 Favored Pre-proline 0 CA--C 1.548 0.892 0 CA-C-N 120.438 1.472 . . . . 0.0 107.153 -174.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.563 ' HB2' HG22 ' A' ' 83' ' ' THR . 26.5 Cg_endo -65.88 97.4 0.34 Allowed 'Trans proline' 0 CA--C 1.555 1.556 0 C-N-CA 122.145 1.897 . . . . 0.0 112.1 161.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.2 t -161.23 128.35 4.08 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 -173.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.509 HG13 ' HB2' ' A' ' 133' ' ' ALA . 24.3 mm -76.31 121.1 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -133.01 131.66 40.96 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -175.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.428 ' HB ' ' O ' ' A' ' 113' ' ' VAL 0.288 92.8 mt -65.56 127.82 27.31 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.908 0 CA-C-O 122.547 1.165 . . . . 0.0 109.374 179.421 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.34 -48.42 11.99 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.933 1.293 . . . . 0.0 113.63 174.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.543 ' HA ' HG11 ' A' ' 113' ' ' VAL 0.286 0.0 OUTLIER -143.42 163.67 32.44 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-O 123.021 1.391 . . . . 0.0 110.573 -176.432 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -108.24 116.56 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 103.607 -2.738 . . . . 0.0 103.607 173.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.422 ' H ' ' HA ' ' A' ' 77' ' ' PHE . 1.4 mp -68.0 129.17 93.24 Favored Pre-proline 0 CA--C 1.57 1.746 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 176.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.19 131.12 35.05 Favored 'Trans proline' 0 CA--C 1.555 1.529 0 C-N-CA 123.468 2.779 . . . . 0.0 114.112 172.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.4 1.27 88.36 Favored Glycine 0 CA--C 1.551 2.292 0 N-CA-C 117.72 1.848 . . . . 0.0 117.72 -164.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.477 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -78.33 157.53 44.61 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.281 0.943 . . . . 0.0 114.117 172.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.86 -25.39 67.88 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 117.51 2.411 . . . . 0.0 117.51 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.429 ' HA ' HD11 ' A' ' 68' ' ' LEU . . . -64.87 -44.46 89.63 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 173.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -70.74 -38.67 73.54 Favored 'General case' 0 CA--C 1.563 1.473 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 172.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -67.79 -62.7 1.29 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 125.16 1.384 . . . . 0.0 112.724 173.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -69.91 -51.21 34.91 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.242 1.017 . . . . 0.0 112.709 -171.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -118.22 -161.5 11.93 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-O 123.184 1.436 . . . . 0.0 111.698 171.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 50.2 mtm-85 -156.22 71.15 0.71 Allowed 'General case' 0 N--CA 1.485 1.325 0 CA-C-N 112.881 -1.659 . . . . 0.0 107.166 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.641 HD23 ' H ' ' A' ' 111' ' ' LEU . 1.9 pt? -92.38 -169.11 2.13 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-O 124.586 2.136 . . . . 0.0 108.056 174.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -103.63 167.03 10.06 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 126.986 3.279 . . . . 0.0 106.077 156.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.543 HG11 ' HA ' ' A' ' 98' ' ' LYS 0.302 29.8 m -64.06 -69.96 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 108.813 -3.812 . . . . 0.0 108.113 178.123 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.418 ' H ' HG23 ' A' ' 113' ' ' VAL . 16.4 m120 -50.17 75.15 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 124.395 2.045 . . . . 0.0 116.52 174.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -134.08 110.64 9.76 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 100.569 -3.863 . . . . 0.0 100.569 174.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 41.8 m -78.85 93.02 4.93 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 112.932 -1.94 . . . . 0.0 108.846 -168.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.4 tp -58.25 116.77 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.65 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.58 ' HA ' ' HB3' ' A' ' 126' ' ' ARG 0.266 1.9 pp -100.17 -50.42 3.97 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 113.216 -1.811 . . . . 0.0 114.638 175.706 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.408 ' H ' HD12 ' A' ' 118' ' ' LEU . 62.3 m-85 -126.41 133.09 51.36 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 104.605 -2.368 . . . . 0.0 104.605 177.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.426 HG23 HD23 ' A' ' 146' ' ' LEU . 7.6 p -123.84 117.45 51.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 170.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.687 HD21 ' HB2' ' A' ' 140' ' ' ALA 0.306 22.4 m-80 80.38 -69.85 0.09 Allowed 'General case' 0 N--CA 1.501 2.121 0 CA-C-O 123.334 1.54 . . . . 0.0 110.681 -174.401 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -172.05 -25.06 0.01 OUTLIER 'General case' 0 CA--C 1.575 1.914 0 C-N-CA 128.537 2.735 . . . . 0.0 109.178 -172.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.2 t -66.48 133.92 30.6 Favored 'Isoleucine or valine' 0 C--N 1.363 1.167 0 C-N-CA 125.298 1.439 . . . . 0.0 110.775 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -83.8 98.94 9.99 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 113.292 -1.776 . . . . 0.0 110.227 174.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.57 HG11 ' HA ' ' A' ' 133' ' ' ALA . 2.3 m -86.48 -98.34 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 CA-C-O 115.911 -1.995 . . . . 0.0 107.632 171.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.58 ' HB3' ' HA ' ' A' ' 118' ' ' LEU 0.274 5.7 ptt180 45.88 -99.58 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 CA-C-N 120.589 1.54 . . . . 0.0 113.638 178.44 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -80.05 81.22 6.35 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-O 123.407 1.575 . . . . 0.0 109.006 170.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.58 167.44 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 CA-C-N 112.76 -2.018 . . . . 0.0 106.179 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 25.0 m -60.58 132.49 54.05 Favored 'General case' 0 CA--C 1.561 1.372 0 CA-C-N 114.129 -1.396 . . . . 0.0 110.104 156.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.406 ' HA ' HD12 ' A' ' 94' ' ' ILE . 7.3 p-80 -46.54 -33.45 4.09 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 117.987 2.588 . . . . 0.0 117.987 171.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.493 ' HA ' HG12 ' A' ' 134' ' ' VAL . 12.0 m -62.97 -38.24 90.31 Favored 'General case' 0 CA--C 1.558 1.268 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 175.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.04 -34.34 77.85 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 165.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.57 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -70.46 -51.95 25.59 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 116.382 1.993 . . . . 0.0 116.382 173.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.493 HG12 ' HA ' ' A' ' 131' ' ' SER . 4.3 p -50.05 -43.64 20.96 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.374 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 165.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -64.74 -48.19 75.47 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 116.842 -1.551 . . . . 0.0 113.374 175.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.415 ' HA ' ' HB3' ' A' ' 139' ' ' GLU . . . -68.7 -31.95 71.41 Favored 'General case' 0 CA--C 1.563 1.471 0 N-CA-C 116.561 2.06 . . . . 0.0 116.561 176.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.486 HD23 ' HE1' ' A' ' 77' ' ' PHE . 8.8 mp -60.3 -52.1 66.7 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 125.32 1.448 . . . . 0.0 114.743 166.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -67.12 -33.95 76.55 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 167.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.415 ' HB3' ' HA ' ' A' ' 136' ' ' ALA . 9.1 tp10 -65.16 -24.18 67.32 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 173.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.687 ' HB2' HD21 ' A' ' 121' ' ' ASN . . . -50.97 -25.75 5.09 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 118.024 2.601 . . . . 0.0 118.024 163.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 66.96 83.91 0.1 Allowed Glycine 0 C--N 1.351 1.387 0 CA-C-O 118.695 -1.059 . . . . 0.0 113.11 157.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.8 m 75.04 -30.09 0.2 Allowed 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 117.237 2.31 . . . . 0.0 117.237 -175.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.0 108.84 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 -172.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.567 HG11 HD11 ' A' ' 75' ' ' LEU . 16.9 m -89.55 123.0 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 114.317 -1.31 . . . . 0.0 109.754 176.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -96.27 93.07 6.67 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 172.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.426 HD23 HG23 ' A' ' 120' ' ' VAL . 64.6 mt -98.5 133.5 42.77 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -171.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -131.55 115.38 16.05 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 178.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 35.7 m -126.32 129.13 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 -166.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -94.93 141.02 29.14 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-O 121.574 0.702 . . . . 0.0 111.237 169.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 59.5 ttt180 -102.11 124.11 47.14 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 164.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -104.0 95.44 6.0 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.439 -1.255 . . . . 0.0 109.3 -176.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 41.8 tttm -94.34 -57.6 0.21 Allowed Pre-proline 0 CA--C 1.569 1.694 0 CA-C-O 114.806 -2.521 . . . . 0.0 110.227 160.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -71.62 116.49 4.72 Favored 'Trans proline' 0 C--N 1.376 2.016 0 CA-C-N 125.318 2.935 . . . . 0.0 111.59 -175.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo . . . . . 0 C--N 1.364 1.373 0 C-N-CA 122.887 2.391 . . . . 0.0 112.286 -179.825 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 1.6 p90 . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 122.493 1.14 . . . . 0.0 112.31 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -139.33 138.11 36.37 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 113.852 -1.522 . . . . 0.0 107.501 172.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.55 122.26 34.8 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.153 -1.385 . . . . 0.0 108.627 177.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 96.8 m -86.8 133.47 33.64 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 173.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -74.81 142.74 44.19 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.117 173.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.426 ' HB ' HG23 ' A' ' 134' ' ' VAL . 7.4 p . . . . . 0 C--O 1.254 1.29 0 CA-C-N 113.976 -1.465 . . . . 0.0 108.661 169.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 . . . . . 0 N--CA 1.48 1.033 0 CA-C-O 121.432 0.634 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -103.77 136.58 43.19 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 114.338 -1.301 . . . . 0.0 111.646 174.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -110.18 130.25 55.57 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.45 126.79 41.89 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.158 174.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.2 mp -134.24 119.76 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 -176.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.2 m -95.42 122.73 38.44 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 168.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.561 ' HB3' HG23 ' A' ' 144' ' ' VAL . 9.9 tt -125.96 134.94 51.36 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 113.88 -1.509 . . . . 0.0 107.541 -173.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -81.8 115.62 21.11 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 122.209 1.005 . . . . 0.0 109.457 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.467 ' CG ' ' HG ' ' A' ' 75' ' ' LEU . 0.8 OUTLIER -69.59 159.46 33.33 Favored 'General case' 0 CA--C 1.556 1.197 0 CA-C-N 113.071 -1.877 . . . . 0.0 111.814 178.646 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -67.79 -144.26 0.1 OUTLIER Glycine 0 CA--C 1.548 2.116 0 CA-C-N 115.041 -0.982 . . . . 0.0 114.834 174.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -123.65 -69.06 0.83 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -173.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 96.7 p -79.9 -25.45 40.58 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 116.384 1.994 . . . . 0.0 116.384 171.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -143.43 -152.38 5.65 Favored Glycine 0 CA--C 1.534 1.232 0 N-CA-C 107.893 -2.083 . . . . 0.0 107.893 168.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.483 HD13 HG12 ' B' ' 6' ' ' VAL . 4.7 mp -109.59 -84.7 0.55 Allowed 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 178.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.642 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 138.47 39.12 0.11 Allowed Glycine 0 CA--C 1.535 1.284 0 N-CA-C 118.088 1.995 . . . . 0.0 118.088 -175.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.476 ' CD1' HD13 ' A' ' 96' ' ' ILE . 5.8 p90 -166.5 137.27 3.38 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 124.369 2.033 . . . . 0.0 109.119 -176.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.546 ' HB2' ' HB3' ' A' ' 98' ' ' LYS . 46.1 m -95.0 126.78 40.58 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 113.667 -1.606 . . . . 0.0 112.378 -173.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.712 HG22 HG12 ' A' ' 96' ' ' ILE . 4.1 pt -93.37 130.51 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 113.945 -1.479 . . . . 0.0 110.856 177.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.15 -171.79 3.66 Favored 'General case' 0 CA--C 1.556 1.176 0 CA-C-O 123.057 1.408 . . . . 0.0 110.522 163.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.76 161.47 28.32 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-O 122.888 1.271 . . . . 0.0 115.802 -146.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -108.73 -162.5 20.39 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 112.47 -1.865 . . . . 0.0 113.502 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.445 HG22 ' HB3' ' A' ' 92' ' ' PRO . 70.3 p -50.07 -40.86 46.77 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 116.699 2.111 . . . . 0.0 116.699 178.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -95.54 7.18 46.99 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.4 HD22 ' CE1' ' A' ' 130' ' ' HIS . 0.0 OUTLIER -162.79 90.53 1.27 Allowed Pre-proline 0 CA--C 1.561 1.398 0 N-CA-C 101.101 -3.666 . . . . 0.0 101.101 178.031 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -106.01 125.88 0.05 OUTLIER 'Trans proline' 0 CA--C 1.55 1.323 0 CA-C-N 124.577 2.67 . . . . 0.0 110.799 -177.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -100.43 -21.91 15.22 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 161.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.404 HD13 ' CD1' ' A' ' 95' ' ' PHE . 0.0 OUTLIER -146.27 160.97 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 -162.457 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.4 170.61 43.7 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 124.166 1.981 . . . . 0.0 110.862 -170.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -78.64 -10.59 59.8 Favored 'General case' 0 CA--C 1.571 1.755 0 CA-C-N 112.026 -2.087 . . . . 0.0 114.942 165.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.463 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 19.9 t70 -167.13 -61.28 0.01 OUTLIER Pre-proline 0 CA--C 1.566 1.595 0 CA-C-O 115.516 -2.183 . . . . 0.0 105.516 175.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.463 ' HD3' ' HB3' ' A' ' 91' ' ' ASP . 15.6 Cg_endo -117.6 -127.86 0.0 OUTLIER 'Trans proline' 0 C--N 1.375 1.97 0 CA-C-N 124.993 2.819 . . . . 0.0 111.043 -168.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 55.3 m 79.58 119.53 0.05 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.308 1.443 . . . . 0.0 108.161 166.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.46 HG13 ' HB2' ' A' ' 133' ' ' ALA . 26.6 mm -80.89 140.34 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.482 ' HA ' ' O ' ' A' ' 115' ' ' ASP . 13.3 m-85 -123.23 150.86 42.9 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 114.328 -1.305 . . . . 0.0 111.097 175.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.712 HG12 HG22 ' A' ' 79' ' ' ILE . 53.7 mt -103.21 107.44 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 N-CA-C 103.951 -2.611 . . . . 0.0 103.951 150.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.2 m -95.92 -17.18 21.25 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 174.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.546 ' HB3' ' HB2' ' A' ' 78' ' ' SER 0.273 40.7 tttp -139.26 157.61 45.6 Favored 'General case' 0 CA--C 1.563 1.449 0 CA-C-O 123.818 1.77 . . . . 0.0 110.549 -175.453 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.75 129.9 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 105.299 -2.112 . . . . 0.0 105.299 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.268 1.5 mp -78.51 132.74 64.68 Favored Pre-proline 0 CA--C 1.569 1.705 0 CA-C-O 118.35 -0.833 . . . . 0.0 108.921 169.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -62.9 133.26 40.73 Favored 'Trans proline' 0 C--N 1.367 1.525 0 C-N-CA 123.411 2.741 . . . . 0.0 114.682 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 71.63 4.9 59.19 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 118.383 2.113 . . . . 0.0 118.383 -169.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.642 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -82.79 -172.32 48.23 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.084 0.85 . . . . 0.0 114.119 -179.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.27 -48.77 76.75 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -174.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.443 ' HA ' HD11 ' A' ' 68' ' ' LEU . . . -70.05 -30.19 67.39 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 118.026 2.602 . . . . 0.0 118.026 176.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.5 -40.55 93.17 Favored 'General case' 0 CA--C 1.567 1.602 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 163.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.46 -61.47 1.97 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.565 1.546 . . . . 0.0 112.728 177.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -58.66 -40.75 84.39 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 -177.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.07 -140.62 3.15 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 123.326 1.515 . . . . 0.0 111.312 168.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -141.51 50.65 1.58 Allowed 'General case' 0 CA--C 1.563 1.479 0 CA-C-N 111.863 -2.169 . . . . 0.0 108.103 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.55 ' H ' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -82.67 9.88 8.65 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 125.601 1.561 . . . . 0.0 114.638 175.716 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . 0.303 24.4 mtm180 76.43 166.53 0.26 Allowed 'General case' 0 C--N 1.35 0.61 0 CA-C-O 126.35 2.976 . . . . 0.0 111.047 -171.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . 0.328 35.8 m -28.08 -69.16 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.253 0 CA-C-N 109.495 -3.502 . . . . 0.0 113.237 161.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.493 ' HB2' HD12 ' A' ' 96' ' ' ILE . 2.5 t-20 157.95 -36.89 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 128.597 2.759 . . . . 0.0 107.665 174.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.482 ' O ' ' HA ' ' A' ' 95' ' ' PHE 0.307 11.0 t70 68.72 -102.02 0.05 Allowed 'General case' 0 C--O 1.213 -0.816 0 C-N-CA 126.42 1.888 . . . . 0.0 107.608 -175.316 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 75.7 m -96.8 69.59 2.45 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 120.38 1.446 . . . . 0.0 110.799 -170.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.5 tp -67.29 115.67 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-O 121.867 0.841 . . . . 0.0 108.785 174.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.418 HD21 ' HB2' ' A' ' 149' ' ' MET . 3.1 pp -102.24 -40.57 6.72 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.435 1.642 . . . . 0.0 115.435 177.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -138.97 145.59 39.92 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 -175.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.572 HG21 HD22 ' A' ' 137' ' ' LEU . 4.2 t -132.94 113.42 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 102.753 -3.054 . . . . 0.0 102.753 -176.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.71 HD21 ' HB2' ' A' ' 140' ' ' ALA 0.341 22.0 m-80 84.02 -85.1 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 123.342 1.544 . . . . 0.0 108.726 -179.665 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -156.11 -4.35 0.12 Allowed 'General case' 0 CA--C 1.565 1.522 0 CA-C-N 111.564 -2.562 . . . . 0.0 110.575 173.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.518 HG12 HG13 ' A' ' 125' ' ' VAL . 2.3 t -67.82 139.75 20.31 Favored 'Isoleucine or valine' 0 C--N 1.357 0.93 0 C-N-CA 125.29 1.436 . . . . 0.0 109.282 -178.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -81.74 71.32 8.76 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-N 111.288 -2.687 . . . . 0.0 112.939 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.539 HG11 ' HA ' ' A' ' 133' ' ' ALA 0.287 0.6 OUTLIER -82.79 -105.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-O 116.79 -1.576 . . . . 0.0 107.899 178.862 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.581 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.311 27.3 ptt85 49.3 -87.53 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 116.822 2.156 . . . . 0.0 116.822 179.636 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.581 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 27.6 tt0 -81.81 72.53 8.86 Favored 'General case' 0 CA--C 1.555 1.137 0 CA-C-O 123.418 1.58 . . . . 0.0 110.095 167.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.9 p -145.85 167.86 8.01 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 CA-C-N 113.403 -1.726 . . . . 0.0 106.71 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 7.0 m -59.42 132.75 54.93 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 114.044 -1.435 . . . . 0.0 110.2 157.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.4 ' CE1' HD22 ' A' ' 85' ' ' ASN . 2.9 p-80 -48.12 -31.91 6.2 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 117.607 2.447 . . . . 0.0 117.607 169.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.57 ' HA ' HG12 ' A' ' 134' ' ' VAL . 13.9 m -61.91 -38.53 88.71 Favored 'General case' 0 CA--C 1.564 1.486 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 173.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -69.28 -34.14 74.28 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 115.656 1.725 . . . . 0.0 115.656 164.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.539 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -65.18 -52.65 53.61 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 170.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.57 HG12 ' HA ' ' A' ' 131' ' ' SER . 12.7 p -50.41 -46.43 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 164.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -55.0 -50.42 69.06 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-O 116.68 -1.629 . . . . 0.0 112.606 172.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.88 -31.94 72.26 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 117.148 2.277 . . . . 0.0 117.148 170.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.572 HD22 HG21 ' A' ' 120' ' ' VAL . 3.1 mm? -59.55 -51.69 68.74 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 165.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -66.92 -42.4 85.47 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 171.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -69.59 -12.47 61.67 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 117.431 2.382 . . . . 0.0 117.431 173.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.71 ' HB2' HD21 ' A' ' 121' ' ' ASN . . . -53.49 -19.73 4.03 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 118.661 2.837 . . . . 0.0 118.661 157.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 83.26 -140.17 19.62 Favored Glycine 0 C--N 1.345 1.03 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 11.0 m -70.35 -5.84 31.05 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 116.605 2.076 . . . . 0.0 116.605 173.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -147.8 110.84 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -170.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.561 HG23 ' HB3' ' A' ' 68' ' ' LEU . 11.9 m -84.2 115.97 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 114.071 -1.422 . . . . 0.0 109.401 171.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.444 ' HB3' ' HA ' ' A' ' 121' ' ' ASN . 7.8 tpp180 -90.55 107.23 19.03 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 170.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 79.2 mt -108.27 135.64 49.25 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -172.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -125.54 118.2 25.24 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 177.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.43 121.84 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -177.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.418 ' HB2' HD21 ' A' ' 118' ' ' LEU . 49.6 ttm -102.64 134.85 45.33 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 122.16 0.981 . . . . 0.0 112.671 168.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -99.87 108.49 20.76 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 171.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 26.9 ttp180 -110.79 43.62 1.4 Allowed 'General case' 0 CA--C 1.567 1.607 0 CA-C-N 113.729 -1.578 . . . . 0.0 111.808 173.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.413 ' HB2' ' HD3' ' A' ' 153' ' ' PRO . 61.9 mttp -93.5 -53.95 0.25 Allowed Pre-proline 0 CA--C 1.555 1.162 0 CA-C-O 115.132 -2.366 . . . . 0.0 110.225 173.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.413 ' HD3' ' HB2' ' A' ' 152' ' ' LYS . 17.9 Cg_exo -48.83 -49.41 15.08 Favored 'Trans proline' 0 CA--C 1.571 2.326 0 CA-C-N 124.677 2.706 . . . . 0.0 116.314 167.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo . . . . . 0 C--N 1.375 1.966 0 C-N-CA 123.707 2.938 . . . . 0.0 111.749 173.506 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.559 1.303 0 CA-C-O 122.68 1.229 . . . . 0.0 111.399 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -136.11 122.14 20.15 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 172.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 13.9 ttpp -95.88 112.78 24.42 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 113.923 -1.49 . . . . 0.0 107.583 173.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 4.6 m -76.28 131.02 39.0 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 172.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.94 105.46 17.78 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 178.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.483 HG12 HD13 ' A' ' 75' ' ' LEU . 11.7 t . . . . . 0 C--O 1.245 0.821 0 N-CA-C 102.363 -3.199 . . . . 0.0 102.363 -165.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 . . . . . 0 N--CA 1.483 1.203 0 CA-C-O 120.499 0.19 . . . . 0.0 110.505 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.412 ' HB3' ' HB2' ' A' ' 149' ' ' MET . 26.3 p90 -121.77 140.78 51.92 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 124.41 1.069 . . . . 0.0 110.254 174.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -122.04 133.73 54.79 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 122.617 1.198 . . . . 0.0 108.965 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -104.98 117.11 33.18 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 -176.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.606 HG13 ' HB2' ' A' ' 146' ' ' LEU . 3.1 pt -137.1 115.22 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 -168.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.9 m -94.77 130.26 41.39 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 171.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.6 HD11 ' HA ' ' A' ' 105' ' ' ALA . 0.5 OUTLIER -129.68 166.79 19.09 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 113.871 -1.513 . . . . 0.0 109.694 172.911 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -85.36 121.37 27.99 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 122.13 0.966 . . . . 0.0 110.686 175.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.65 ' HD2' ' H ' ' A' ' 142' ' ' SER . 0.9 OUTLIER -78.33 107.92 11.29 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 169.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.415 ' H ' ' HA ' ' A' ' 75' ' ' LEU . . . -69.47 134.68 26.56 Favored Glycine 0 CA--C 1.543 1.837 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 165.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -50.13 -54.12 22.81 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 -170.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.4 m -84.5 -19.41 33.34 Favored 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 171.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -174.46 135.99 3.35 Favored Glycine 0 CA--C 1.536 1.363 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.527 HD23 HG11 ' A' ' 144' ' ' VAL . 1.5 mp -74.67 -61.91 1.71 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.248 1.019 . . . . 0.0 110.547 -177.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 136.59 25.91 0.43 Allowed Glycine 0 CA--C 1.542 1.77 0 CA-C-O 117.999 -1.445 . . . . 0.0 114.886 -175.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.497 ' HD1' HD11 ' A' ' 99' ' ' ILE . 0.0 OUTLIER -129.27 165.84 20.61 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 123.912 1.815 . . . . 0.0 107.72 172.744 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 35.2 m -111.94 143.98 42.02 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 154.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.723 HG22 HD13 ' A' ' 96' ' ' ILE . 2.4 pp -107.56 128.91 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 113.045 -1.889 . . . . 0.0 108.481 170.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -84.15 -166.26 1.38 Allowed 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 123.915 1.817 . . . . 0.0 108.633 162.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 85' ' ' ASN . . . -94.51 157.78 22.57 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 123.697 1.721 . . . . 0.0 113.835 -138.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -104.88 -163.85 24.08 Favored Glycine 0 CA--C 1.522 0.511 0 CA-C-N 111.349 -2.425 . . . . 0.0 113.0 178.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 61.0 p -51.16 -40.1 57.83 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 116.798 2.147 . . . . 0.0 116.798 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -88.03 -5.72 58.34 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 175.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.441 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 0.1 OUTLIER -149.49 82.88 6.65 Favored Pre-proline 0 CA--C 1.558 1.259 0 N-CA-C 101.747 -3.427 . . . . 0.0 101.747 177.308 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -106.75 128.52 0.05 OUTLIER 'Trans proline' 0 C--N 1.361 1.193 0 CA-C-N 125.298 2.928 . . . . 0.0 110.943 -173.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.4 ' HB2' ' CG ' ' B' ' 1' ' ' TYR . 10.6 t-160 -107.71 -55.41 2.36 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.56 0.695 . . . . 0.0 112.355 169.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.612 HD13 ' H ' ' A' ' 88' ' ' ILE . 0.2 OUTLIER -103.55 177.99 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.114 0 CA-C-O 123.663 1.696 . . . . 0.0 108.528 -172.494 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 94.4 -175.95 35.02 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 124.215 2.008 . . . . 0.0 110.431 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -79.45 -8.18 58.94 Favored 'General case' 0 CA--C 1.572 1.804 0 CA-C-N 112.092 -2.054 . . . . 0.0 115.065 162.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.421 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 19.2 t70 178.5 -61.92 0.0 OUTLIER Pre-proline 0 CA--C 1.568 1.653 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 175.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.421 ' HD3' ' HB3' ' A' ' 91' ' ' ASP . 15.6 Cg_endo -107.66 -120.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.372 1.804 0 CA-C-N 124.749 2.732 . . . . 0.0 110.044 -171.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.9 m 76.15 110.21 0.07 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.058 1.343 . . . . 0.0 108.776 165.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.498 HG13 ' HB2' ' A' ' 133' ' ' ALA . 15.8 mm -73.28 129.53 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -119.2 153.54 34.77 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 112.993 -1.912 . . . . 0.0 108.981 -175.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.792 HG22 ' CG2' ' A' ' 113' ' ' VAL 0.258 10.9 mm -98.42 106.58 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.685 0 N-CA-C 100.24 -3.985 . . . . 0.0 100.24 170.39 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.543 HG21 ' HG2' ' B' ' 3' ' ' LYS . 10.0 t -93.45 -49.86 5.71 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 -173.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.52 ' HA ' HG11 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -133.94 136.18 44.05 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 169.51 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.497 HD11 ' HD1' ' A' ' 77' ' ' PHE . 0.9 OUTLIER -79.49 138.4 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 177.496 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.343 1.5 mp -72.88 115.57 41.44 Favored Pre-proline 0 CA--C 1.568 1.663 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 171.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -68.61 140.95 48.72 Favored 'Trans proline' 0 C--N 1.369 1.634 0 C-N-CA 123.328 2.685 . . . . 0.0 113.067 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.3 7.79 73.36 Favored Glycine 0 CA--C 1.552 2.399 0 N-CA-C 118.177 2.031 . . . . 0.0 118.177 -174.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -99.09 -165.76 30.09 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-N 119.217 1.509 . . . . 0.0 112.719 177.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 75' ' ' LEU . . . -62.03 -30.72 71.16 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 176.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.6 ' HA ' HD11 ' A' ' 68' ' ' LEU . . . -69.21 -40.85 77.77 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 116.873 2.175 . . . . 0.0 116.873 172.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.51 -41.63 96.29 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 170.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -72.96 -52.7 13.53 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 115.019 1.488 . . . . 0.0 115.019 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -62.49 -37.99 88.11 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 176.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 114.75 47.01 0.58 Allowed Glycine 0 CA--C 1.536 1.406 0 C-N-CA 123.745 0.688 . . . . 0.0 113.935 168.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -121.45 24.12 10.04 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 169.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.627 ' H ' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -44.37 -30.68 0.88 Allowed 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 119.958 3.318 . . . . 0.0 119.958 170.285 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.446 ' H ' HD22 ' A' ' 111' ' ' LEU . 53.6 ttp180 -77.49 88.53 3.84 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 125.11 2.386 . . . . 0.0 107.764 163.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.792 ' CG2' HG22 ' A' ' 96' ' ' ILE 0.32 14.6 p -53.21 -65.5 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 109.515 -3.493 . . . . 0.0 113.692 -172.476 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.526 ' H ' HG13 ' A' ' 113' ' ' VAL . 30.9 m-80 -14.98 78.0 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 O-C-N 127.08 2.738 . . . . 0.0 117.959 166.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.605 ' HB3' HG11 ' A' ' 148' ' ' VAL . 58.5 m-20 -147.41 121.0 9.14 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 103.288 -2.856 . . . . 0.0 103.288 -177.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 21.5 m -84.64 82.52 8.38 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 114.414 -1.266 . . . . 0.0 109.508 -175.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.6 tp -64.21 123.09 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 CA-C-O 122.527 1.155 . . . . 0.0 111.441 -174.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.591 HD21 ' HB3' ' A' ' 149' ' ' MET . 0.0 OUTLIER -111.96 -53.28 2.72 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 112.334 -2.212 . . . . 0.0 112.053 174.896 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -122.63 133.66 54.52 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 -170.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.425 HG13 HD23 ' A' ' 146' ' ' LEU . 2.5 t -126.61 111.88 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 103.353 -2.832 . . . . 0.0 103.353 -178.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.651 HD21 ' HB2' ' A' ' 140' ' ' ALA 0.278 10.0 m-80 81.5 -78.4 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 123.371 1.558 . . . . 0.0 109.496 178.318 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -152.18 -22.47 0.18 Allowed 'General case' 0 CA--C 1.576 1.955 0 C-N-CA 128.219 2.607 . . . . 0.0 109.618 175.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.3 t -59.56 137.64 21.7 Favored 'Isoleucine or valine' 0 C--N 1.362 1.145 0 C-N-CA 125.469 1.508 . . . . 0.0 110.911 176.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -105.6 103.35 12.84 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 113.022 -1.899 . . . . 0.0 108.437 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.426 HG11 ' HA ' ' A' ' 133' ' ' ALA 0.262 0.5 OUTLIER -97.48 -90.24 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-O 117.012 -1.47 . . . . 0.0 108.166 176.806 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.464 ' HB3' ' HB3' ' A' ' 118' ' ' LEU 0.32 23.1 ptt180 51.16 -88.37 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 117.351 2.352 . . . . 0.0 117.351 178.601 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.431 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 2.8 mp0 -85.58 67.13 9.98 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 123.505 1.621 . . . . 0.0 109.472 173.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.3 p -137.13 169.17 20.08 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-O 124.263 1.982 . . . . 0.0 105.924 -178.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 5.3 m -59.25 134.94 57.46 Favored 'General case' 0 CA--C 1.56 1.334 0 CA-C-N 112.701 -2.045 . . . . 0.0 110.643 157.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.455 ' HA ' HD12 ' A' ' 94' ' ' ILE . 9.7 p-80 -45.78 -32.9 2.76 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 117.656 2.465 . . . . 0.0 117.656 169.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.475 ' HA ' HG12 ' A' ' 134' ' ' VAL . 9.4 m -63.41 -40.41 97.13 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 177.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -69.42 -36.74 76.98 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 168.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.498 ' HB2' HG13 ' A' ' 94' ' ' ILE . . . -67.23 -50.51 60.38 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 172.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.475 HG12 ' HA ' ' A' ' 131' ' ' SER . 2.7 p -52.96 -45.11 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 114.544 1.312 . . . . 0.0 114.544 166.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -60.42 -47.0 88.0 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-O 115.553 -2.165 . . . . 0.0 112.515 173.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.18 -35.97 82.52 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 117.044 2.239 . . . . 0.0 117.044 172.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.442 ' HB3' HG21 ' B' ' 6' ' ' VAL . 3.8 mm? -50.79 -54.26 25.04 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.299 1.04 . . . . 0.0 113.627 162.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -69.39 -38.45 78.01 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 174.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -63.4 -21.59 66.38 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 172.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.651 ' HB2' HD21 ' A' ' 121' ' ' ASN . . . -53.33 -22.81 7.87 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 118.674 2.842 . . . . 0.0 118.674 168.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 65.7 89.17 0.05 OUTLIER Glycine 0 C--N 1.351 1.384 0 CA-C-N 118.771 0.714 . . . . 0.0 114.5 155.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.65 ' H ' ' HD2' ' A' ' 70' ' ' ARG 0.268 20.4 m 72.17 -30.3 0.21 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 118.02 2.6 . . . . 0.0 118.02 -172.392 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -146.82 110.72 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 -172.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.527 HG11 HD23 ' A' ' 75' ' ' LEU . 33.5 m -83.57 120.75 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.429 171.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -101.66 91.26 4.34 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 174.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.606 ' HB2' HG13 ' A' ' 66' ' ' ILE . 61.2 mt -95.31 137.9 33.74 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 122.536 1.16 . . . . 0.0 108.361 -172.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -127.67 124.64 38.42 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 175.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.605 HG11 ' HB3' ' A' ' 115' ' ' ASP . 28.6 m -134.13 115.91 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -163.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.591 ' HB3' HD21 ' A' ' 118' ' ' LEU . 32.9 ttm -134.03 121.48 21.62 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 -175.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -97.12 158.05 15.63 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 113.163 -1.835 . . . . 0.0 109.895 166.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 60.96 74.91 0.43 Allowed 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.509 176.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . 0.256 0.0 OUTLIER -116.74 103.64 52.17 Favored Pre-proline 0 CA--C 1.554 1.1 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 -175.668 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -54.33 -49.11 18.06 Favored 'Trans proline' 0 CA--C 1.572 2.393 0 C-N-CA 123.27 2.647 . . . . 0.0 116.385 175.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo . . . . . 0 C--N 1.374 1.895 0 C-N-CA 123.563 2.842 . . . . 0.0 110.969 -177.147 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' TYR . . . . . 0.4 ' CG ' ' HB2' ' A' ' 87' ' ' HIS . 1.0 OUTLIER . . . . . 0 CA--C 1.56 1.338 0 CA-C-O 122.964 1.364 . . . . 0.0 111.673 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.88 157.92 39.98 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 123.225 1.488 . . . . 0.0 109.904 168.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.543 ' HG2' HG21 ' A' ' 97' ' ' THR . 0.2 OUTLIER -103.04 136.55 42.64 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 113.603 -1.635 . . . . 0.0 106.853 172.131 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 88.5 m -102.5 136.08 42.98 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 167.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -78.61 140.82 38.4 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-O 123.667 1.699 . . . . 0.0 108.812 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.442 HG21 ' HB3' ' A' ' 137' ' ' LEU . 7.5 p . . . . . 0 C--O 1.243 0.731 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 . . . . . 0 N--CA 1.482 1.134 0 CA-C-O 121.844 0.83 . . . . 0.0 111.313 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.494 ' HB3' ' HB2' ' A' ' 149' ' ' MET . 20.9 p90 -96.16 134.05 39.71 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.967 172.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -110.84 126.75 54.98 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.76 124.99 34.68 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.189 174.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.477 HG13 ' HB2' ' A' ' 146' ' ' LEU . 3.1 pt -137.95 108.28 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 -175.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.8 m -91.39 118.26 30.38 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 172.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.449 ' HB3' ' CG2' ' A' ' 144' ' ' VAL . 3.9 tp -115.42 167.4 10.9 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 113.977 -1.465 . . . . 0.0 108.198 174.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -93.51 138.42 31.81 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 170.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.565 ' HG3' ' HG ' ' A' ' 75' ' ' LEU . 56.7 ttp85 -84.84 111.67 19.85 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 168.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.33 140.19 48.08 Favored Glycine 0 CA--C 1.536 1.354 0 CA-C-N 114.295 -1.32 . . . . 0.0 112.003 169.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -59.26 -50.54 73.62 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -173.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.3 m -77.53 -19.8 55.2 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 171.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -177.19 131.67 1.86 Allowed Glycine 0 CA--C 1.533 1.174 0 N-CA-C 107.23 -2.348 . . . . 0.0 107.23 178.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.713 HD11 HG11 ' A' ' 144' ' ' VAL . 1.3 tt -48.4 -36.53 14.91 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 169.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 110.91 16.84 9.47 Favored Glycine 0 N--CA 1.478 1.489 0 N-CA-C 117.559 1.783 . . . . 0.0 117.559 169.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.432 ' CE2' HD22 ' A' ' 75' ' ' LEU . 27.7 p90 -143.0 173.0 11.94 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 124.306 2.003 . . . . 0.0 108.5 171.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.7 m -122.12 155.09 36.45 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 123.705 1.717 . . . . 0.0 106.481 176.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.569 HG22 HD13 ' A' ' 96' ' ' ILE . 1.1 pt -121.72 127.05 75.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 111.635 -2.53 . . . . 0.0 109.107 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.37 -168.26 1.29 Allowed 'General case' 0 CA--C 1.556 1.187 0 CA-C-O 123.339 1.542 . . . . 0.0 109.995 159.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.39 159.9 26.48 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 123.409 1.56 . . . . 0.0 115.16 -145.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.37 -160.84 23.31 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-N 111.906 -2.147 . . . . 0.0 113.542 178.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.501 HG22 ' HB3' ' A' ' 92' ' ' PRO . 30.3 p -52.83 -41.2 64.0 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 -178.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -83.04 -8.83 59.5 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 176.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.01 96.98 2.09 Favored Pre-proline 0 CA--C 1.556 1.197 0 N-CA-C 102.32 -3.215 . . . . 0.0 102.32 -173.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -99.15 134.84 0.26 Allowed 'Trans proline' 0 CA--C 1.551 1.338 0 CA-C-N 123.96 2.45 . . . . 0.0 111.543 174.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.448 ' HB2' ' CD2' ' B' ' 1' ' ' TYR . 9.1 t-80 -100.32 -21.02 15.59 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 155.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -151.72 135.27 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 N-CA-C 104.207 -2.516 . . . . 0.0 104.207 -164.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.43 161.48 37.47 Favored Glycine 0 CA--C 1.535 1.322 0 CA-C-O 123.633 1.685 . . . . 0.0 110.939 -165.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -79.63 -6.88 58.03 Favored 'General case' 0 CA--C 1.565 1.536 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 170.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.42 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 26.1 t70 -160.88 -61.4 0.02 OUTLIER Pre-proline 0 CA--C 1.562 1.415 0 CA-C-O 115.259 -2.305 . . . . 0.0 108.961 174.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.501 ' HB3' HG22 ' A' ' 83' ' ' THR . 3.2 Cg_endo -121.97 -146.86 0.0 OUTLIER 'Trans proline' 0 C--N 1.372 1.772 0 CA-C-N 125.183 2.887 . . . . 0.0 112.511 -159.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.6 m 78.22 107.67 0.07 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.461 1.104 . . . . 0.0 108.534 166.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.514 HG13 ' HB2' ' A' ' 133' ' ' ALA . 13.0 mm -74.99 127.51 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 106.376 -1.712 . . . . 0.0 106.376 -177.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -115.18 149.42 37.69 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 113.432 -1.713 . . . . 0.0 108.458 -175.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.569 HD13 HG22 ' A' ' 79' ' ' ILE . 22.3 mm -97.35 104.23 15.64 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.278 0 N-CA-C 104.388 -2.449 . . . . 0.0 104.388 171.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.545 HG21 ' HG3' ' B' ' 3' ' ' LYS . 12.2 t -79.51 -46.64 17.01 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 -177.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.637 ' HA ' HG21 ' A' ' 113' ' ' VAL . 12.0 ptmt -150.31 146.03 26.51 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.772 0.796 . . . . 0.0 111.099 -170.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.54 135.1 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 178.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.7 mp -82.9 117.62 69.14 Favored Pre-proline 0 CA--C 1.565 1.52 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 172.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.69 135.16 51.01 Favored 'Trans proline' 0 C--N 1.367 1.537 0 C-N-CA 123.442 2.761 . . . . 0.0 113.09 169.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 87.33 -9.97 70.98 Favored Glycine 0 CA--C 1.548 2.156 0 N-CA-C 117.707 1.843 . . . . 0.0 117.707 -169.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -85.91 -179.58 50.01 Favored Glycine 0 CA--C 1.538 1.472 0 CA-C-N 119.44 1.62 . . . . 0.0 113.602 175.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.09 -33.7 72.2 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 117.1 2.259 . . . . 0.0 117.1 -177.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.62 -35.18 68.0 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 118.567 2.803 . . . . 0.0 118.567 169.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.85 -32.04 71.43 Favored 'General case' 0 CA--C 1.558 1.274 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 171.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.02 -53.59 8.14 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 119.706 1.139 . . . . 0.0 112.827 172.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -78.54 -52.36 8.6 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.773 0.829 . . . . 0.0 112.555 -170.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -93.61 -45.5 3.42 Favored Glycine 0 CA--C 1.538 1.482 0 CA-C-O 118.161 -1.355 . . . . 0.0 114.616 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 27.3 ptt85 44.99 47.83 9.43 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -170.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -107.18 -165.56 1.08 Allowed 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 123.94 1.829 . . . . 0.0 108.0 -156.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 10.7 ptt180 -107.85 126.59 52.84 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 102.994 -2.965 . . . . 0.0 102.994 156.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.637 HG21 ' HA ' ' A' ' 98' ' ' LYS . 0.2 OUTLIER -42.26 -64.49 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-N 109.606 -3.452 . . . . 0.0 116.04 170.069 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -22.64 81.92 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.182 0 O-C-N 126.82 2.575 . . . . 0.0 116.891 175.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -157.21 128.69 6.93 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 -174.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 64.3 m -88.93 89.92 8.19 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -175.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.486 HG12 HD11 ' A' ' 137' ' ' LEU . 6.7 tp -63.21 128.01 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.073 178.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.746 HD21 ' HB3' ' A' ' 149' ' ' MET . 0.0 OUTLIER -114.93 -54.15 2.59 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 112.422 -2.172 . . . . 0.0 114.421 177.076 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -119.79 134.65 55.16 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 -174.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.431 HG23 HD23 ' A' ' 146' ' ' LEU . 9.1 p -123.94 118.34 53.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 169.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.587 HD21 ' CB ' ' A' ' 140' ' ' ALA 0.298 11.6 m-80 78.5 -81.25 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 122.953 1.359 . . . . 0.0 109.604 -177.213 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -152.91 -20.88 0.16 Allowed 'General case' 0 CA--C 1.568 1.659 0 C-N-CA 127.859 2.464 . . . . 0.0 110.177 -177.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.2 t -64.35 135.19 28.35 Favored 'Isoleucine or valine' 0 C--N 1.362 1.122 0 C-N-CA 125.318 1.447 . . . . 0.0 110.358 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -90.8 97.54 11.24 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 113.072 -1.877 . . . . 0.0 108.307 172.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.472 HG11 ' HA ' ' A' ' 133' ' ' ALA 0.282 0.2 OUTLIER -93.48 -93.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-O 116.447 -1.739 . . . . 0.0 107.159 170.263 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.554 ' HB3' ' HA ' ' A' ' 118' ' ' LEU 0.292 11.3 ptt180 48.39 -88.69 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 117.851 2.538 . . . . 0.0 117.851 178.615 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.521 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 1.7 tt0 -84.1 66.86 9.47 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-O 123.674 1.702 . . . . 0.0 108.804 172.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -139.7 169.96 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 CA-C-N 112.606 -2.088 . . . . 0.0 106.513 178.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 7.7 m -60.5 136.5 58.07 Favored 'General case' 0 CA--C 1.561 1.375 0 CA-C-N 113.439 -1.709 . . . . 0.0 110.843 159.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.408 ' HA ' HD12 ' A' ' 94' ' ' ILE . 8.8 p-80 -45.3 -35.23 3.34 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 118.263 2.69 . . . . 0.0 118.263 170.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.477 ' HA ' HG12 ' A' ' 134' ' ' VAL . 79.0 p -60.31 -42.24 95.15 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 116.786 2.143 . . . . 0.0 116.786 172.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -70.68 -37.78 73.66 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 169.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.514 ' HB2' HG13 ' A' ' 94' ' ' ILE . . . -59.79 -55.49 33.66 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 169.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.477 HG12 ' HA ' ' A' ' 131' ' ' SER . 2.2 p -53.13 -46.84 55.77 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 170.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -60.55 -45.99 91.84 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 115.838 -2.03 . . . . 0.0 112.844 176.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.7 -34.57 78.61 Favored 'General case' 0 CA--C 1.558 1.278 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 171.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.486 HD11 HG12 ' A' ' 117' ' ' ILE . 9.6 mp -58.65 -46.55 86.9 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 165.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -70.33 -33.06 71.04 Favored 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 170.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -73.26 -14.96 61.42 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 116.455 2.02 . . . . 0.0 116.455 172.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.587 ' CB ' HD21 ' A' ' 121' ' ' ASN . . . -56.91 1.06 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.172 0 N-CA-C 119.227 3.047 . . . . 0.0 119.227 162.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 77.25 -146.51 31.92 Favored Glycine 0 C--N 1.344 1.019 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 176.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.8 m -72.0 -6.95 45.87 Favored 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 173.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -147.49 107.71 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 -165.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.713 HG11 HD11 ' A' ' 75' ' ' LEU . 23.1 m -92.48 123.91 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 114.073 -1.422 . . . . 0.0 108.612 -174.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -103.15 87.12 2.82 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.477 ' HB2' HG13 ' A' ' 66' ' ' ILE . 73.7 mt -91.33 133.9 35.05 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 -170.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -124.42 121.83 35.97 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 33.3 m -129.56 117.53 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -167.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.746 ' HB3' HD21 ' A' ' 118' ' ' LEU . 27.5 ttt -125.96 142.5 51.49 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -175.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -82.55 108.85 16.26 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 113.38 -1.736 . . . . 0.0 109.914 177.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -70.61 -36.17 73.37 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 113.048 -1.887 . . . . 0.0 114.595 164.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -75.52 124.97 89.17 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-O 118.172 -0.918 . . . . 0.0 109.469 -177.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -62.42 163.44 20.71 Favored 'Trans proline' 0 CA--C 1.57 2.3 0 C-N-CA 122.411 2.074 . . . . 0.0 114.061 174.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo . . . . . 0 CA--C 1.555 1.527 0 C-N-CA 123.646 2.898 . . . . 0.0 116.076 174.88 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' TYR . . . . . 0.448 ' CD2' ' HB2' ' A' ' 87' ' ' HIS . 0.3 OUTLIER . . . . . 0 CA--C 1.559 1.297 0 CA-C-O 122.887 1.327 . . . . 0.0 110.718 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 66.1 tttp -135.15 134.46 40.2 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-O 123.405 1.574 . . . . 0.0 108.205 165.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.545 ' HG3' HG21 ' A' ' 97' ' ' THR . 1.1 tmmt? -104.28 126.91 51.78 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 113.809 -1.541 . . . . 0.0 109.051 173.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.428 HG21 HG11 ' A' ' 134' ' ' VAL . 91.1 m -98.2 139.82 33.42 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 114.173 -1.376 . . . . 0.0 109.343 172.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -87.45 128.01 35.22 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 113.926 -1.488 . . . . 0.0 108.936 175.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.468 ' HB ' HG23 ' A' ' 134' ' ' VAL . 4.1 p . . . . . 0 C--O 1.248 1.025 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 175.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -129.18 136.21 49.85 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 121.658 0.742 . . . . 0.0 109.599 175.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -124.91 137.65 54.27 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 114.608 -1.178 . . . . 0.0 108.971 -177.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -103.27 132.3 49.64 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.66 175.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 21.0 pt -135.55 127.12 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -175.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.2 m -95.26 121.62 37.1 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 170.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 mp -119.75 126.9 52.18 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.373 -1.285 . . . . 0.0 107.632 -174.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.82 125.45 40.39 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.39 -172.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.558 ' HB2' ' HB2' ' A' ' 104' ' ' ALA . 4.9 tpm_? -152.3 -101.54 0.05 Allowed 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.671 169.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.08 -168.45 54.7 Favored Glycine 0 C--N 1.347 1.151 0 C-N-CA 124.066 0.841 . . . . 0.0 113.306 -167.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 75.67 -87.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 113.827 -1.187 . . . . 0.0 110.634 166.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 56.0 m -81.79 -16.67 50.21 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 172.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 159.75 -139.88 6.44 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 107.291 -2.324 . . . . 0.0 107.291 178.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.606 HD23 HG12 ' B' ' 6' ' ' VAL . 0.3 OUTLIER -127.39 -30.92 2.57 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 125.615 1.566 . . . . 0.0 111.363 -179.684 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.553 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 104.06 37.71 2.86 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 117.427 1.731 . . . . 0.0 117.427 162.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.472 ' O ' ' HB ' ' B' ' 6' ' ' VAL . 0.0 OUTLIER -152.33 143.76 23.37 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 -172.42 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.464 ' CB ' ' HG2' ' A' ' 98' ' ' LYS . 50.1 m -106.91 122.25 46.04 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.572 -1.194 . . . . 0.0 108.538 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.555 HG22 HG12 ' A' ' 96' ' ' ILE . 5.1 pt -108.13 129.56 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 CA-C-O 121.674 0.749 . . . . 0.0 109.952 -171.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.434 ' HB1' ' CB ' ' A' ' 87' ' ' HIS . . . -86.57 -171.4 3.52 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-O 123.597 1.665 . . . . 0.0 111.281 158.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.44 159.65 21.15 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-O 123.713 1.73 . . . . 0.0 115.057 -137.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -102.77 -162.14 25.9 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 111.441 -2.38 . . . . 0.0 111.874 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 44.3 p -55.15 -40.38 70.53 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 116.922 2.193 . . . . 0.0 116.922 -174.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -75.51 -21.97 57.54 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 116.353 1.983 . . . . 0.0 116.353 174.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -145.28 95.94 4.98 Favored Pre-proline 0 CA--C 1.553 1.075 0 N-CA-C 101.498 -3.519 . . . . 0.0 101.498 -173.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -93.32 137.29 1.33 Allowed 'Trans proline' 0 CA--C 1.554 1.475 0 CA-C-N 124.079 2.493 . . . . 0.0 111.646 -177.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.434 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 23.2 t-80 -99.69 -24.62 14.66 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 161.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.462 HG22 ' H ' ' A' ' 90' ' ' ASP . 4.9 mp -90.86 142.46 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 -166.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.98 -9.78 22.99 Favored Glycine 0 CA--C 1.559 2.794 0 N-CA-C 119.117 2.407 . . . . 0.0 119.117 171.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.462 ' H ' HG22 ' A' ' 88' ' ' ILE . 37.5 t70 -85.42 -8.47 58.39 Favored 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 115.351 1.611 . . . . 0.0 115.351 164.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.442 ' HB3' ' HD3' ' A' ' 92' ' ' PRO 0.49 15.8 t70 95.86 -89.28 0.0 OUTLIER Pre-proline 0 CA--C 1.561 1.392 0 C-N-CA 126.161 1.784 . . . . 0.0 109.085 -172.712 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.442 ' HD3' ' HB3' ' A' ' 91' ' ' ASP . 14.0 Cg_endo -94.8 -151.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.223 0 CA-C-N 124.448 2.624 . . . . 0.0 112.113 -159.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 66.8 m 73.17 138.6 0.05 Allowed 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 122.438 1.113 . . . . 0.0 109.323 176.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.428 HG13 ' HB2' ' A' ' 133' ' ' ALA . 15.0 mm -94.43 121.71 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 -169.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -124.57 138.17 54.34 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 -174.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.555 HG12 HG22 ' A' ' 79' ' ' ILE . 82.4 mt -82.35 122.98 37.83 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.627 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 169.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 89.3 m -93.57 -33.84 13.57 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 117.627 -1.177 . . . . 0.0 113.907 172.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.512 ' HA ' HG11 ' A' ' 113' ' ' VAL 0.354 8.1 ptmm? -140.27 167.75 21.4 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-O 123.534 1.635 . . . . 0.0 110.885 173.351 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -109.14 129.22 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 103.835 -2.654 . . . . 0.0 103.835 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.427 ' HA ' ' HD2' ' A' ' 101' ' ' PRO 0.314 22.5 mt -83.74 121.76 76.26 Favored Pre-proline 0 CA--C 1.564 1.503 0 CA-C-O 117.915 -1.041 . . . . 0.0 108.789 175.142 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 100' ' ' ILE . 11.6 Cg_endo -55.96 141.18 86.48 Favored 'Trans proline' 0 C--N 1.371 1.746 0 C-N-CA 124.075 3.183 . . . . 0.0 115.581 178.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.95 15.04 79.83 Favored Glycine 0 CA--C 1.547 2.058 0 N-CA-C 117.27 1.668 . . . . 0.0 117.27 -164.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.553 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -89.23 176.83 43.9 Favored Glycine 0 C--N 1.34 0.772 0 C-N-CA 124.721 1.153 . . . . 0.0 115.578 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.558 ' HB2' ' HB2' ' A' ' 70' ' ' ARG . . . -64.37 -48.54 75.11 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 177.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.483 ' HB1' HD11 ' A' ' 111' ' ' LEU . . . -69.23 -34.0 74.16 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.69 -44.35 81.97 Favored 'General case' 0 CA--C 1.561 1.388 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 168.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.4 -65.4 0.82 Allowed 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 124.637 1.175 . . . . 0.0 111.791 176.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -65.63 -31.86 73.12 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 115.478 1.659 . . . . 0.0 115.478 -174.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.29 -167.61 11.13 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-O 123.839 1.799 . . . . 0.0 112.667 170.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -141.35 59.15 1.51 Allowed 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 112.182 -2.009 . . . . 0.0 107.509 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.483 HD11 ' HB1' ' A' ' 105' ' ' ALA . 1.7 pp -93.33 -164.31 1.16 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 124.455 2.074 . . . . 0.0 107.709 -165.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -116.03 141.81 47.63 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 104.007 -2.59 . . . . 0.0 104.007 163.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.512 HG11 ' HA ' ' A' ' 98' ' ' LYS 0.26 17.9 m -42.65 -65.42 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-N 109.064 -3.698 . . . . 0.0 112.734 172.163 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -52.5 78.9 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 126.457 1.903 . . . . 0.0 115.119 177.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -130.05 113.9 15.11 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 101.068 -3.678 . . . . 0.0 101.068 175.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.5 m -67.49 79.82 0.17 Allowed 'General case' 0 CA--C 1.554 1.108 0 CA-C-N 113.409 -1.723 . . . . 0.0 111.531 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.6 pt -70.14 100.61 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-O 123.406 1.574 . . . . 0.0 108.8 -176.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.8 pp -96.41 -38.7 9.93 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 112.909 -1.951 . . . . 0.0 114.94 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.445 ' HB2' ' HB2' ' A' ' 147' ' ' TYR . 20.9 m-85 -125.46 140.55 52.68 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 123.273 1.511 . . . . 0.0 107.067 177.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.462 HG21 HD22 ' A' ' 137' ' ' LEU . 3.5 t -134.0 113.04 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 102.259 -3.238 . . . . 0.0 102.259 -179.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.77 HD21 ' HB2' ' A' ' 140' ' ' ALA 0.32 22.3 m-80 83.97 -78.05 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 123.934 1.826 . . . . 0.0 110.134 179.572 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -156.38 -23.9 0.1 Allowed 'General case' 0 CA--C 1.572 1.791 0 CA-C-N 110.472 -3.058 . . . . 0.0 109.276 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.3 t -61.73 138.78 21.71 Favored 'Isoleucine or valine' 0 C--N 1.361 1.066 0 C-N-CA 125.604 1.561 . . . . 0.0 111.087 -177.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -94.88 87.91 5.13 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 111.348 -2.66 . . . . 0.0 110.81 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.47 HG11 ' HA ' ' A' ' 133' ' ' ALA 0.287 0.5 OUTLIER -92.37 -98.52 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 CA-C-O 117.104 -1.427 . . . . 0.0 108.154 -179.942 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.546 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.315 15.1 ptt180 48.37 -89.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 -179.514 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.546 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 21.9 tt0 -74.68 75.49 2.05 Favored 'General case' 0 CA--C 1.557 1.237 0 CA-C-O 123.738 1.732 . . . . 0.0 110.323 166.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -155.0 164.35 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 -175.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 34.0 m -60.06 132.11 52.92 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-N 113.586 -1.643 . . . . 0.0 109.671 156.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -46.82 -31.45 3.05 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 118.212 2.671 . . . . 0.0 118.212 171.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.544 ' HA ' HG12 ' A' ' 134' ' ' VAL . 14.6 m -60.09 -38.59 83.37 Favored 'General case' 0 CA--C 1.561 1.375 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 173.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -71.07 -35.93 72.08 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 166.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.47 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -59.88 -53.71 54.74 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 168.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.544 HG12 ' HA ' ' A' ' 131' ' ' SER . 9.7 p -55.99 -41.92 69.73 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.444 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 166.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -57.57 -43.56 84.61 Favored 'General case' 0 CA--C 1.556 1.191 0 CA-C-O 117.626 -1.178 . . . . 0.0 113.458 171.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.14 -33.43 75.45 Favored 'General case' 0 CA--C 1.558 1.263 0 N-CA-C 116.397 1.999 . . . . 0.0 116.397 167.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.462 HD22 HG21 ' A' ' 120' ' ' VAL . 4.3 mm? -59.65 -50.96 71.85 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 165.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -65.98 -38.33 88.27 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 173.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -65.96 -28.46 68.92 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 116.353 1.983 . . . . 0.0 116.353 171.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.77 ' HB2' HD21 ' A' ' 121' ' ' ASN . . . -52.43 -33.21 43.01 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 117.443 2.386 . . . . 0.0 117.443 161.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 93.62 -120.15 6.19 Favored Glycine 0 C--N 1.345 1.051 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 166.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.3 m -86.71 0.29 54.91 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 117.426 2.38 . . . . 0.0 117.426 168.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.95 101.99 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 -170.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.499 ' HA ' ' HB1' ' A' ' 140' ' ' ALA . 15.5 m -88.02 118.64 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 114.04 -1.436 . . . . 0.0 109.654 176.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 40.8 mtt180 -98.58 87.65 3.87 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 178.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 53.3 mt -90.45 136.52 33.0 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -170.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.445 ' HB2' ' HB2' ' A' ' 119' ' ' PHE . 41.6 m-85 -122.72 120.39 33.49 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 104.515 -2.402 . . . . 0.0 104.515 178.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -123.44 120.62 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 -176.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 28.3 ttt -96.65 116.37 29.01 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 124.519 1.137 . . . . 0.0 109.982 162.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -88.35 153.23 21.35 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-O 122.98 1.371 . . . . 0.0 111.082 173.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -117.75 153.92 32.59 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 113.011 -1.904 . . . . 0.0 109.14 167.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -115.72 96.92 47.81 Favored Pre-proline 0 CA--C 1.548 0.904 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 173.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -72.44 138.24 29.51 Favored 'Trans proline' 0 CA--C 1.564 2.011 0 C-N-CA 122.511 2.14 . . . . 0.0 111.624 172.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo . . . . . 0 CA--C 1.552 1.414 0 C-N-CA 123.082 2.522 . . . . 0.0 112.828 173.187 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 1.3 p90 . . . . . 0 CA--C 1.56 1.342 0 CA-C-O 122.569 1.176 . . . . 0.0 110.741 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -132.99 133.99 43.87 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-O 123.017 1.389 . . . . 0.0 108.473 170.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -95.69 124.96 39.95 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 113.782 -1.554 . . . . 0.0 108.736 169.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 4.7 m -83.69 140.41 32.16 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 123.309 1.528 . . . . 0.0 109.21 167.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -98.99 105.79 17.97 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 104.889 -2.263 . . . . 0.0 104.889 -177.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.606 HG12 HD23 ' A' ' 75' ' ' LEU . 12.3 t . . . . . 0 C--O 1.256 1.428 0 CA-C-O 123.03 1.395 . . . . 0.0 107.803 -165.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 149' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.482 1.154 0 CA-C-O 118.015 -0.993 . . . . 0.0 108.838 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.59 ' HB3' ' HG2' ' A' ' 149' ' ' MET . 13.3 p90 -127.06 139.82 52.73 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.594 0.758 . . . . 0.0 110.353 -176.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -107.77 132.99 52.8 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.562 172.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.22 121.4 43.59 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 113.824 -1.535 . . . . 0.0 108.593 -177.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 13.5 pt -135.32 118.7 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 -174.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.7 m -89.96 124.2 34.53 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 168.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.534 HD21 ' HA ' ' A' ' 105' ' ' ALA . 1.5 tp -116.05 125.0 51.84 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 114.22 -1.354 . . . . 0.0 109.293 -171.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -90.16 124.28 34.69 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.423 -176.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.401 ' CB ' ' HB2' ' A' ' 104' ' ' ALA . 9.8 tpt180 -165.37 -103.66 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 172.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 62.38 -141.97 47.52 Favored Glycine 0 C--N 1.354 1.568 0 C-N-CA 124.323 0.963 . . . . 0.0 113.421 -177.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . 0.273 24.2 t-20 71.49 -89.08 0.03 OUTLIER 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 123.811 0.844 . . . . 0.0 110.477 176.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.3 m -102.18 -14.7 16.93 Favored 'General case' 0 CA--C 1.564 1.508 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 174.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 158.37 161.74 11.26 Favored Glycine 0 CA--C 1.533 1.182 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -175.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.49 HD22 HG12 ' B' ' 6' ' ' VAL . 1.6 mp -86.46 -97.2 0.08 Allowed 'General case' 0 CA--C 1.56 1.341 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 -175.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.558 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 145.71 67.41 0.01 OUTLIER Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 167.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.45 ' CZ ' HD23 ' A' ' 75' ' ' LEU . 2.7 p90 -163.62 141.01 7.32 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 124.292 1.996 . . . . 0.0 108.772 176.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.416 ' HB2' ' HB3' ' A' ' 98' ' ' LYS . 15.8 m -92.85 128.22 38.63 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 112.208 -2.269 . . . . 0.0 110.846 -178.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.467 HG12 HG23 ' A' ' 134' ' ' VAL . 1.9 pp -103.63 125.74 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.866 178.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.552 ' HB3' ' HB2' ' A' ' 95' ' ' PHE . . . -74.86 -175.53 2.55 Favored 'General case' 0 CA--C 1.555 1.138 0 CA-C-O 123.624 1.678 . . . . 0.0 111.076 164.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 85' ' ' ASN . . . -99.03 155.73 20.01 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-O 123.591 1.662 . . . . 0.0 115.469 -141.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.13 -160.29 21.51 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 111.37 -2.415 . . . . 0.0 113.891 177.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 38.9 p -58.67 -38.7 78.74 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 115.578 1.695 . . . . 0.0 115.578 -174.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.561 ' HB3' HG23 ' A' ' 129' ' ' THR . 11.2 t70 -96.53 12.91 29.85 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 175.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.405 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 0.8 OUTLIER -163.67 76.83 1.71 Allowed Pre-proline 0 N--CA 1.481 1.103 0 N-CA-C 100.868 -3.753 . . . . 0.0 100.868 -179.756 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -100.12 127.58 0.14 Allowed 'Trans proline' 0 C--N 1.364 1.382 0 CA-C-N 125.198 2.892 . . . . 0.0 111.07 -166.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 41.7 t60 -80.72 -26.18 37.59 Favored 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 162.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.9 mp -106.1 138.01 33.56 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.041 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 -172.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -41.15 -81.25 0.03 OUTLIER Glycine 0 CA--C 1.544 1.853 0 N-CA-C 117.509 1.764 . . . . 0.0 117.509 176.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -113.7 10.45 17.93 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 114.827 1.417 . . . . 0.0 114.827 -178.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -126.53 76.07 74.03 Favored Pre-proline 0 N--CA 1.479 0.99 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -47.62 120.38 4.54 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 123.283 2.655 . . . . 0.0 113.634 162.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.7 m -158.64 122.67 4.0 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 -173.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.46 HG13 ' CB ' ' A' ' 133' ' ' ALA . 21.0 mm -79.42 126.06 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 -173.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.552 ' HB2' ' HB3' ' A' ' 80' ' ' ALA . 22.8 m-30 -117.72 161.54 19.52 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.646 -1.615 . . . . 0.0 107.32 -176.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.505 HD12 ' HB2' ' A' ' 114' ' ' ASN . 89.2 mt -105.8 112.73 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 103.738 -2.69 . . . . 0.0 103.738 149.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.6 m -95.61 -18.64 20.4 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 169.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.416 ' HB3' ' HB2' ' A' ' 78' ' ' SER . 53.2 tttp -136.99 153.62 50.63 Favored 'General case' 0 CA--C 1.556 1.2 0 CA-C-O 124.301 2.0 . . . . 0.0 109.954 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.433 HG22 ' HB3' ' A' ' 105' ' ' ALA . 0.6 OUTLIER -113.43 125.63 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-N 112.98 -1.918 . . . . 0.0 105.947 175.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.279 1.4 mp -71.55 127.61 90.86 Favored Pre-proline 0 CA--C 1.567 1.6 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 171.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.57 130.75 41.69 Favored 'Trans proline' 0 C--N 1.365 1.399 0 C-N-CA 123.558 2.838 . . . . 0.0 115.141 176.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 72.98 9.87 76.68 Favored Glycine 0 CA--C 1.551 2.324 0 N-CA-C 118.306 2.082 . . . . 0.0 118.306 -169.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.558 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -84.98 -168.71 45.03 Favored Glycine 0 C--N 1.336 0.577 0 N-CA-C 115.625 1.01 . . . . 0.0 115.625 -176.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.401 ' HB2' ' CB ' ' A' ' 70' ' ' ARG . . . -64.81 -52.61 55.86 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -177.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.534 ' HA ' HD21 ' A' ' 68' ' ' LEU . . . -67.7 -37.46 82.31 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 115.887 -2.006 . . . . 0.0 114.491 173.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.72 -51.18 66.11 Favored 'General case' 0 CA--C 1.562 1.438 0 CA-C-N 121.366 1.894 . . . . 0.0 114.936 173.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.8 -60.93 3.06 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 125.182 1.393 . . . . 0.0 113.25 176.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -69.64 -47.77 62.2 Favored 'General case' 0 CA--C 1.557 1.248 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -173.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -116.09 -71.48 0.47 Allowed Glycine 0 CA--C 1.534 1.227 0 C-N-CA 123.128 0.394 . . . . 0.0 112.755 -174.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 37.3 ttm105 58.65 46.41 14.57 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 123.191 1.472 . . . . 0.0 112.773 -159.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -91.32 -40.75 11.31 Favored 'General case' 0 CA--C 1.56 1.33 0 CA-C-N 113.508 -1.678 . . . . 0.0 112.693 -178.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -175.33 166.04 3.33 Favored 'General case' 0 CA--C 1.553 1.091 0 N-CA-C 101.431 -3.544 . . . . 0.0 101.431 175.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.422 ' HB ' HG22 ' A' ' 96' ' ' ILE 0.386 6.2 m -41.11 -69.08 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.561 1.366 0 CA-C-N 110.713 -2.949 . . . . 0.0 114.47 161.739 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.505 ' HB2' HD12 ' A' ' 96' ' ' ILE . 2.4 t30 174.28 -23.86 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 129.163 2.985 . . . . 0.0 107.298 165.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . 0.267 17.2 t70 79.93 -77.74 0.03 OUTLIER 'General case' 0 C--N 1.364 1.211 0 C-N-CA 126.805 2.042 . . . . 0.0 108.432 176.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.8 m -139.33 92.02 2.55 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 -177.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.505 HD11 ' HB ' ' A' ' 120' ' ' VAL . 0.0 OUTLIER -78.31 121.66 31.67 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.29 0 CA-C-O 122.445 1.116 . . . . 0.0 109.692 170.277 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.911 HD11 ' H ' ' A' ' 149' ' ' MET . 0.0 OUTLIER -106.05 -46.98 3.95 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.337 1.055 . . . . 0.0 113.144 179.504 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.465 ' HD1' HD23 ' A' ' 118' ' ' LEU . 68.1 m-85 -120.39 141.26 50.27 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 175.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.505 ' HB ' HD11 ' A' ' 117' ' ' ILE . 7.7 p -128.66 122.17 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 170.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.826 HD21 ' HB2' ' A' ' 140' ' ' ALA 0.314 34.1 m-80 79.19 -76.17 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 123.622 1.677 . . . . 0.0 110.767 -177.379 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -163.47 -20.85 0.04 OUTLIER 'General case' 0 CA--C 1.572 1.794 0 CA-C-N 111.291 -2.686 . . . . 0.0 109.778 -175.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.542 HG12 HG13 ' A' ' 125' ' ' VAL . 2.4 t -64.48 136.21 26.86 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.168 0 C-N-CA 125.334 1.453 . . . . 0.0 110.249 -177.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -88.69 80.92 7.14 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 112.237 -2.256 . . . . 0.0 110.392 175.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.546 HG11 ' HA ' ' A' ' 133' ' ' ALA . 0.2 OUTLIER -86.3 -89.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-O 117.074 -1.441 . . . . 0.0 107.892 179.735 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.595 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.305 11.6 ptt180 46.22 -92.96 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 124.993 1.317 . . . . 0.0 114.393 -177.661 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.595 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 16.3 mt-10 -84.2 66.79 9.49 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 123.866 1.793 . . . . 0.0 111.947 175.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.5 p -133.34 168.09 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 112.607 -2.088 . . . . 0.0 105.918 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.561 HG23 ' HB3' ' A' ' 84' ' ' ASP . 96.6 m -59.66 137.01 58.16 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-N 113.609 -1.632 . . . . 0.0 110.627 157.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.433 ' HA ' HD12 ' A' ' 94' ' ' ILE . 3.4 p-80 -46.91 -37.62 9.19 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 171.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.458 ' H ' HG22 ' A' ' 129' ' ' THR . 7.9 m -56.23 -45.42 79.96 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 177.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.34 -39.06 88.96 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 171.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.546 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -68.04 -51.1 50.69 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 116.278 1.955 . . . . 0.0 116.278 171.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.818 HG22 HG21 ' B' ' 6' ' ' VAL . 0.3 OUTLIER -59.94 -39.35 79.88 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 N-CA-C 115.888 1.81 . . . . 0.0 115.888 173.035 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.409 ' HA ' ' HG2' ' A' ' 138' ' ' LYS . 1.0 OUTLIER -63.79 -42.77 97.67 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-O 117.223 -1.37 . . . . 0.0 113.051 167.123 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.71 -31.36 72.55 Favored 'General case' 0 CA--C 1.565 1.527 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 169.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.501 ' O ' ' HB3' ' A' ' 140' ' ' ALA . 8.5 mp -61.49 -55.48 30.59 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 125.52 1.528 . . . . 0.0 112.322 166.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.409 ' HG2' ' HA ' ' A' ' 135' ' ' GLU . 17.7 ptpt -64.01 -31.88 73.23 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 116.729 2.122 . . . . 0.0 116.729 170.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -66.44 -27.66 68.0 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 169.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.826 ' HB2' HD21 ' A' ' 121' ' ' ASN . . . -51.81 -42.67 62.68 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 115.826 1.787 . . . . 0.0 115.826 159.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 90.07 -129.03 9.52 Favored Glycine 0 C--N 1.349 1.275 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 165.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.0 t -72.26 -2.04 17.49 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 117.353 2.353 . . . . 0.0 117.353 168.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.97 107.56 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 -173.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.593 ' HA ' ' HB1' ' A' ' 140' ' ' ALA . 4.2 t -113.94 105.85 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 -169.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.432 ' HB2' ' HA ' ' A' ' 121' ' ' ASN . 99.2 mtt180 -89.65 92.11 8.94 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -178.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 22.1 mt -93.96 131.22 39.64 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 -175.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.428 ' O ' HD22 ' A' ' 118' ' ' LEU . 79.5 m-85 -120.15 128.39 53.38 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 104.686 -2.339 . . . . 0.0 104.686 -178.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -136.64 128.37 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.911 ' H ' HD11 ' A' ' 118' ' ' LEU . 63.9 mtm -103.65 142.34 34.49 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 127.016 2.126 . . . . 0.0 109.465 172.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -108.4 114.91 29.14 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.188 -1.369 . . . . 0.0 107.492 -175.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -126.9 127.13 44.43 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 174.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 86.0 tttt 63.03 81.52 0.23 Allowed Pre-proline 0 CA--C 1.563 1.469 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.879 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -49.7 -45.6 30.95 Favored 'Trans proline' 0 CA--C 1.57 2.309 0 C-N-CA 123.087 2.524 . . . . 0.0 116.384 172.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo . . . . . 0 C--N 1.376 1.985 0 C-N-CA 123.484 2.789 . . . . 0.0 112.586 176.669 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.554 1.098 0 CA-C-O 123.33 1.538 . . . . 0.0 110.398 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 22.7 tptp -151.28 121.94 7.47 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 113.632 -1.622 . . . . 0.0 107.833 170.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 6.0 ptmm? -75.7 109.41 9.26 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 113.918 -1.492 . . . . 0.0 111.26 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 26.3 m -81.43 126.97 32.28 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 123.287 1.518 . . . . 0.0 108.884 -178.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.94 106.17 18.33 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 113.331 -1.759 . . . . 0.0 106.891 -174.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.818 HG21 HG22 ' A' ' 134' ' ' VAL . 42.8 t . . . . . 0 C--O 1.251 1.179 0 N-CA-C 105.218 -2.142 . . . . 0.0 105.218 -178.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -124.56 136.98 54.42 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.542 -178.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -98.42 126.39 43.93 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.47 125.37 35.15 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 113.368 -1.742 . . . . 0.0 108.199 173.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.474 ' HB ' ' HB2' ' A' ' 146' ' ' LEU . 19.0 mt -126.61 131.83 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 -176.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.3 m -106.6 120.69 42.63 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 171.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.4 tp -124.93 145.57 49.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 113.39 -1.732 . . . . 0.0 107.739 176.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.517 ' HG3' ' HB1' ' A' ' 104' ' ' ALA . 2.7 pt-20 -75.77 144.0 41.67 Favored 'General case' 0 CA--C 1.559 1.314 0 O-C-N 121.218 -0.926 . . . . 0.0 110.71 173.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -85.67 99.7 11.48 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 172.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -67.96 164.45 46.59 Favored Glycine 0 CA--C 1.543 1.814 0 CA-C-O 122.367 0.982 . . . . 0.0 113.373 177.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -65.06 -48.44 73.8 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 114.997 1.48 . . . . 0.0 114.997 -171.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 90.9 p -76.64 -15.41 59.83 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 166.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 150.11 179.42 25.9 Favored Glycine 0 CA--C 1.538 1.469 0 CA-C-O 125.67 2.816 . . . . 0.0 108.459 -172.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.763 ' H ' HD22 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -74.92 -14.07 60.61 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 111.462 -2.369 . . . . 0.0 114.798 174.869 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.51 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 76.1 50.48 7.61 Favored Glycine 0 C--N 1.338 0.663 0 N-CA-C 116.229 1.251 . . . . 0.0 116.229 175.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.489 ' HE1' HD23 ' A' ' 137' ' ' LEU . 17.8 p90 -155.2 149.29 25.8 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 123.172 1.463 . . . . 0.0 108.036 173.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.431 ' O ' HG23 ' A' ' 96' ' ' ILE . 3.6 m -97.31 136.07 38.32 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.164 177.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.409 HD11 ' HB ' ' A' ' 134' ' ' VAL . 1.2 pt -110.13 123.74 66.29 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-O 121.95 0.881 . . . . 0.0 109.576 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.417 ' HB2' ' OG1' ' A' ' 97' ' ' THR . . . -77.7 177.42 8.14 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-O 124.292 1.996 . . . . 0.0 110.247 157.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' A' ' 85' ' ' ASN . . . -96.75 164.71 22.99 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-O 124.24 2.022 . . . . 0.0 115.582 -140.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -102.78 -166.88 26.19 Favored Glycine 0 CA--C 1.521 0.465 0 CA-C-N 110.543 -2.828 . . . . 0.0 112.364 -175.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.443 HG22 ' HB3' ' A' ' 92' ' ' PRO . 63.1 p -44.57 -42.51 7.38 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 118.014 2.598 . . . . 0.0 118.014 -177.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -88.19 -7.6 56.61 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 115.993 1.849 . . . . 0.0 115.993 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.409 ' O ' ' HA3' ' A' ' 81' ' ' GLY 0.267 4.4 t30 -151.99 58.59 2.71 Favored Pre-proline 0 CA--C 1.571 1.755 0 CA-C-O 116.667 -1.635 . . . . 0.0 107.632 -178.508 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -97.57 135.04 0.37 Allowed 'Trans proline' 0 C--N 1.373 1.83 0 CA-C-N 126.282 3.279 . . . . 0.0 111.538 -170.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.554 ' HB2' ' CG ' ' B' ' 1' ' ' TYR . 7.9 t-80 -101.91 -21.63 14.5 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 163.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.427 ' H ' HD12 ' A' ' 88' ' ' ILE . 0.3 OUTLIER -138.91 165.19 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 C-N-CA 127.171 2.188 . . . . 0.0 105.261 -164.152 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.54 169.3 34.21 Favored Glycine 0 CA--C 1.525 0.666 0 CA-C-N 112.644 -2.071 . . . . 0.0 110.889 -169.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -77.21 -11.05 59.77 Favored 'General case' 0 CA--C 1.566 1.592 0 CA-C-N 111.834 -2.183 . . . . 0.0 115.592 166.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.488 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 18.5 t70 -170.06 -58.59 0.0 OUTLIER Pre-proline 0 CA--C 1.568 1.65 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 169.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.488 ' HD3' ' HB3' ' A' ' 91' ' ' ASP . 23.6 Cg_endo -114.78 -125.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 123.389 2.726 . . . . 0.0 110.403 -175.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 53.1 m 75.71 134.72 0.05 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.991 1.316 . . . . 0.0 109.816 165.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.404 HG13 ' HB2' ' A' ' 133' ' ' ALA . 23.4 mm -96.14 124.44 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 105.812 -1.921 . . . . 0.0 105.812 -172.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -129.6 126.22 37.96 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -175.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.584 ' HB ' ' O ' ' A' ' 113' ' ' VAL 0.349 60.2 mt -66.44 129.6 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.287 0 CA-C-O 122.895 1.331 . . . . 0.0 108.648 174.002 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.417 ' OG1' ' HB2' ' A' ' 80' ' ' ALA . 4.4 m -87.69 -41.4 13.38 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 124.846 1.258 . . . . 0.0 113.325 171.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.439 ' HA ' HG11 ' A' ' 113' ' ' VAL . 94.3 mttt -140.4 160.95 38.86 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 124.174 1.94 . . . . 0.0 110.465 -175.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -114.4 109.93 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 102.365 -3.198 . . . . 0.0 102.365 174.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.254 1.5 mp -66.71 121.28 76.74 Favored Pre-proline 0 CA--C 1.564 1.516 0 CA-C-O 117.774 -1.107 . . . . 0.0 109.395 -177.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -63.22 138.05 64.58 Favored 'Trans proline' 0 C--N 1.364 1.387 0 C-N-CA 123.373 2.715 . . . . 0.0 113.387 172.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.45 -6.83 56.49 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 117.977 1.951 . . . . 0.0 117.977 -168.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.51 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -90.01 176.81 42.64 Favored Glycine 0 CA--C 1.537 1.439 0 CA-C-O 122.435 1.019 . . . . 0.0 113.025 174.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.517 ' HB1' ' HG3' ' A' ' 69' ' ' GLU . . . -67.52 -36.82 81.77 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 117.332 2.345 . . . . 0.0 117.332 -175.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.402 ' HB2' ' HD2' ' A' ' 77' ' ' PHE . . . -68.06 -35.37 78.1 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 116.37 1.989 . . . . 0.0 116.37 168.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.8 -31.72 69.79 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 115.524 1.675 . . . . 0.0 115.524 166.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.34 -61.61 1.77 Allowed 'General case' 0 CA--C 1.566 1.584 0 C-N-CA 124.581 1.152 . . . . 0.0 111.739 171.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -80.96 -56.94 3.78 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 124.901 1.281 . . . . 0.0 112.369 -173.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -81.42 -70.62 1.33 Allowed Glycine 0 CA--C 1.536 1.376 0 N-CA-C 114.302 0.481 . . . . 0.0 114.302 -169.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 48.0 mtt-85 57.04 50.23 12.42 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 125.035 1.334 . . . . 0.0 112.869 -163.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.423 HD23 ' H ' ' A' ' 111' ' ' LEU . 2.2 pt? -100.63 -162.12 0.92 Allowed 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 123.533 1.635 . . . . 0.0 108.293 -160.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 4.8 ptt180 -84.63 134.35 34.38 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 125.504 2.573 . . . . 0.0 107.077 162.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.584 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 34.8 m -65.78 -51.57 60.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-N 111.261 -2.699 . . . . 0.0 110.23 168.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -62.3 61.58 0.01 OUTLIER 'General case' 0 CA--C 1.575 1.92 0 CA-C-O 123.846 1.784 . . . . 0.0 115.425 171.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -113.4 112.58 23.89 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 100.292 -3.966 . . . . 0.0 100.292 -178.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.2 m -71.52 78.13 0.79 Allowed 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 113.026 -1.897 . . . . 0.0 109.982 -173.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 5.1 tp -73.86 109.97 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -174.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.733 HD21 ' HB3' ' A' ' 149' ' ' MET . 0.2 OUTLIER -110.0 -47.61 3.3 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 113.171 -1.831 . . . . 0.0 114.157 -175.224 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -116.87 136.5 52.9 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 172.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 14.0 p -124.86 123.73 66.33 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 170.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.533 HD21 ' HB2' ' A' ' 140' ' ' ALA 0.302 28.9 m-80 77.85 -84.46 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 123.757 1.741 . . . . 0.0 108.921 179.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -151.57 -22.14 0.2 Allowed 'General case' 0 CA--C 1.574 1.882 0 CA-C-N 110.82 -2.9 . . . . 0.0 109.131 -176.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.416 HG12 HG13 ' A' ' 125' ' ' VAL . 2.3 t -68.41 136.71 25.91 Favored 'Isoleucine or valine' 0 C--N 1.363 1.155 0 C-N-CA 125.781 1.632 . . . . 0.0 110.224 -178.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -89.5 98.98 12.08 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 111.999 -2.364 . . . . 0.0 108.457 170.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.543 HG11 ' HA ' ' A' ' 133' ' ' ALA 0.26 0.4 OUTLIER -95.01 -98.36 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 173.233 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.513 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.287 16.1 ptt85 51.7 -92.39 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 116.855 2.169 . . . . 0.0 116.855 176.965 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.513 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 8.5 tt0 -77.65 64.54 2.97 Favored 'General case' 0 CA--C 1.56 1.34 0 CA-C-O 123.648 1.689 . . . . 0.0 110.967 167.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -139.02 167.6 20.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 2.7 m -58.84 134.46 56.91 Favored 'General case' 0 CA--C 1.557 1.222 0 CA-C-N 112.697 -2.047 . . . . 0.0 110.7 157.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -45.41 -32.72 2.23 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 117.499 2.407 . . . . 0.0 117.499 168.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.9 m -60.55 -43.12 97.58 Favored 'General case' 0 CA--C 1.556 1.203 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 175.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -69.67 -37.36 76.64 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 167.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.543 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -60.25 -59.27 5.68 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 170.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.409 ' HB ' HD11 ' A' ' 79' ' ' ILE . 0.9 OUTLIER -50.81 -42.44 23.03 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 N-CA-C 116.43 2.011 . . . . 0.0 116.43 171.521 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.65 -48.18 75.75 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 116.317 -1.801 . . . . 0.0 112.607 174.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.51 -28.51 66.11 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 117.23 2.307 . . . . 0.0 117.23 174.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.489 HD23 ' HE1' ' A' ' 77' ' ' PHE . 5.0 mp -54.98 -53.5 54.86 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.159 1.383 . . . . 0.0 113.402 163.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -73.41 -38.58 65.52 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 172.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -65.93 0.11 2.01 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 116.549 2.055 . . . . 0.0 116.549 169.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.533 ' HB2' HD21 ' A' ' 121' ' ' ASN . . . -56.8 -9.96 0.93 Allowed 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 120.315 3.45 . . . . 0.0 120.315 162.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 102.69 -105.25 2.72 Favored Glycine 0 C--N 1.342 0.886 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 161.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.6 m -113.43 -7.83 13.43 Favored 'General case' 0 CA--C 1.576 1.943 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 163.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.19 111.98 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 -165.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.542 HG21 HD12 ' A' ' 75' ' ' LEU . 3.4 t -96.94 116.81 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 112.676 -2.056 . . . . 0.0 107.553 -174.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -99.83 91.07 4.66 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 177.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.474 ' HB2' ' HB ' ' A' ' 66' ' ' ILE . 22.9 mt -83.16 135.16 34.9 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -128.55 126.15 39.75 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.3 p -132.48 116.69 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 -173.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.733 ' HB3' HD21 ' A' ' 118' ' ' LEU . 25.2 ttt -93.68 134.76 35.65 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 123.201 1.477 . . . . 0.0 108.516 168.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -82.41 155.88 24.44 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 112.493 -2.14 . . . . 0.0 110.774 173.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -72.95 151.17 41.97 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 112.219 -2.264 . . . . 0.0 109.727 177.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp 69.15 74.51 0.28 Allowed Pre-proline 0 N--CA 1.486 1.366 0 CA-C-O 118.062 -0.971 . . . . 0.0 109.084 -175.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -50.78 -48.15 22.01 Favored 'Trans proline' 0 CA--C 1.567 2.139 0 C-N-CA 122.975 2.45 . . . . 0.0 115.448 174.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo . . . . . 0 C--N 1.374 1.906 0 C-N-CA 123.452 2.768 . . . . 0.0 110.99 174.685 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' TYR . . . . . 0.554 ' CG ' ' HB2' ' A' ' 87' ' ' HIS . 0.4 OUTLIER . . . . . 0 CA--C 1.557 1.224 0 CA-C-O 122.227 1.013 . . . . 0.0 111.548 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -127.8 144.97 51.07 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 123.414 1.578 . . . . 0.0 107.707 165.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -101.26 126.69 48.03 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.03 176.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 98.4 m -97.38 130.94 44.47 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.031 172.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -76.66 138.98 40.38 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 113.964 -1.471 . . . . 0.0 109.564 170.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 6.0 p . . . . . 0 C--O 1.254 1.301 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.012 172.997 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.484 1.263 0 CA-C-O 121.261 0.553 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -119.86 138.7 53.24 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.21 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -109.5 145.53 36.11 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 113.99 -1.459 . . . . 0.0 108.848 176.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -107.52 121.57 44.9 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 112.658 -2.065 . . . . 0.0 106.095 -175.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.413 HG21 HD22 ' A' ' 111' ' ' LEU . 4.6 mp -130.64 128.26 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 -176.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.1 m -100.35 132.56 45.65 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 122.838 1.304 . . . . 0.0 107.547 163.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.444 HD11 ' HA ' ' A' ' 105' ' ' ALA . 9.6 tt -130.05 130.16 44.57 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 113.141 -1.845 . . . . 0.0 107.83 -169.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -83.78 124.04 30.5 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.613 ' HG3' ' HB3' ' A' ' 75' ' ' LEU . 29.6 ttt180 -74.39 -166.0 0.39 Allowed 'General case' 0 CA--C 1.573 1.858 0 CA-C-O 122.222 1.011 . . . . 0.0 112.327 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.559 ' H ' ' HG2' ' A' ' 70' ' ' ARG . . . -107.17 -107.64 3.21 Favored Glycine 0 CA--C 1.541 1.699 0 N-CA-C 109.964 -1.255 . . . . 0.0 109.964 168.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -121.9 -82.02 0.64 Allowed 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.53 0.732 . . . . 0.0 109.182 -174.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 89.0 p -100.31 -18.58 16.74 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 125.386 1.474 . . . . 0.0 114.776 173.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -113.68 162.3 12.42 Favored Glycine 0 CA--C 1.544 1.872 0 CA-C-O 125.566 2.759 . . . . 0.0 111.33 167.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.615 HD21 HG22 ' B' ' 6' ' ' VAL . 0.0 OUTLIER -117.86 -7.27 10.96 Favored 'General case' 0 CA--C 1.56 1.355 0 CA-C-N 109.41 -3.395 . . . . 0.0 111.465 172.155 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.443 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 65.18 51.67 47.94 Favored Glycine 0 C--N 1.346 1.11 0 N-CA-C 117.279 1.671 . . . . 0.0 117.279 166.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.482 ' CD1' HD13 ' A' ' 96' ' ' ILE . 1.7 p90 -155.3 157.95 38.0 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 112.929 -1.635 . . . . 0.0 107.376 173.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.431 ' HB2' ' HB3' ' A' ' 98' ' ' LYS . 4.0 m -122.28 126.87 49.07 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 122.484 1.135 . . . . 0.0 109.341 -173.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.622 HG22 HG12 ' A' ' 96' ' ' ILE . 2.0 pt -91.33 127.77 43.5 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-N 113.444 -1.707 . . . . 0.0 109.309 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -83.87 -175.54 5.86 Favored 'General case' 0 CA--C 1.555 1.167 0 CA-C-O 123.641 1.686 . . . . 0.0 110.291 156.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.14 157.35 24.08 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 123.161 1.423 . . . . 0.0 116.58 -140.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -108.84 -169.36 20.84 Favored Glycine 0 N--CA 1.466 0.663 0 CA-C-N 111.914 -2.143 . . . . 0.0 114.289 178.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.585 HG22 ' HB2' ' A' ' 92' ' ' PRO . 18.2 p -43.69 -44.59 6.58 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 117.952 2.575 . . . . 0.0 117.952 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.412 ' HB3' HG23 ' A' ' 129' ' ' THR . 35.6 t70 -85.55 -15.24 43.32 Favored 'General case' 0 CA--C 1.564 1.506 0 N-CA-C 115.915 1.82 . . . . 0.0 115.915 177.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -150.64 73.92 8.8 Favored Pre-proline 0 CA--C 1.562 1.41 0 N-CA-C 103.893 -2.632 . . . . 0.0 103.893 -176.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -107.59 144.09 0.07 OUTLIER 'Trans proline' 0 C--N 1.374 1.915 0 CA-C-N 124.656 2.699 . . . . 0.0 112.446 -169.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -65.38 -26.08 67.84 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 114.695 1.369 . . . . 0.0 114.695 161.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -142.74 121.13 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 N-CA-C 105.253 -2.128 . . . . 0.0 105.253 -168.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -80.55 2.64 77.46 Favored Glycine 0 CA--C 1.555 2.59 0 N-CA-C 117.53 1.772 . . . . 0.0 117.53 162.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -87.39 -12.99 44.64 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 175.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -159.61 96.79 1.6 Allowed Pre-proline 0 CA--C 1.553 1.089 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 173.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.585 ' HB2' HG22 ' A' ' 83' ' ' THR . 19.1 Cg_endo -61.34 101.43 0.2 Allowed 'Trans proline' 0 CA--C 1.551 1.341 0 C-N-CA 122.471 2.114 . . . . 0.0 112.503 165.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 74.7 m -150.67 139.33 20.67 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 -179.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.49 HG13 ' HB2' ' A' ' 133' ' ' ALA . 31.5 mm -79.65 129.76 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 175.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.484 ' HA ' ' O ' ' A' ' 115' ' ' ASP 0.276 4.9 p90 -135.49 122.06 20.77 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 113.824 -1.534 . . . . 0.0 110.994 -177.067 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.622 HG12 HG22 ' A' ' 79' ' ' ILE . 71.0 mt -74.75 109.86 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 168.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 12.8 m -94.64 -14.62 24.73 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 114.978 -1.01 . . . . 0.0 113.714 172.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.431 ' HB3' ' HB2' ' A' ' 78' ' ' SER . 29.5 tttp -139.53 150.12 44.72 Favored 'General case' 0 CA--C 1.557 1.243 0 CA-C-O 124.356 2.027 . . . . 0.0 110.343 -175.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -117.2 125.02 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 N-CA-C 103.924 -2.621 . . . . 0.0 103.924 174.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.408 HD11 ' HB3' ' B' ' 7' ' ' BAL . 1.5 mp -74.14 133.55 78.24 Favored Pre-proline 0 CA--C 1.566 1.572 0 CA-C-O 118.518 -0.754 . . . . 0.0 109.324 171.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.5 132.87 40.0 Favored 'Trans proline' 0 CA--C 1.554 1.512 0 C-N-CA 123.301 2.668 . . . . 0.0 113.687 171.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.19 11.93 85.08 Favored Glycine 0 CA--C 1.546 2.028 0 N-CA-C 117.383 1.713 . . . . 0.0 117.383 -164.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.443 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -84.09 170.75 47.67 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-O 123.086 1.381 . . . . 0.0 114.244 177.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.21 -43.98 89.79 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 112.286 -1.957 . . . . 0.0 115.387 178.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.444 ' HA ' HD11 ' A' ' 68' ' ' LEU . . . -67.17 -32.93 74.35 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 118.496 2.776 . . . . 0.0 118.496 173.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.37 -39.01 91.75 Favored 'General case' 0 CA--C 1.567 1.598 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 165.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -67.32 -60.93 2.18 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.378 1.471 . . . . 0.0 113.042 173.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -58.58 -45.07 89.81 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -172.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -174.65 -136.37 2.24 Favored Glycine 0 C--N 1.34 0.757 0 CA-C-O 122.889 1.271 . . . . 0.0 110.331 166.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -145.27 76.42 1.48 Allowed 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 104.756 -2.313 . . . . 0.0 104.756 -176.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.413 HD22 HG21 ' A' ' 66' ' ' ILE . 0.7 OUTLIER -90.87 5.83 46.94 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 164.689 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . 0.351 78.1 mtp180 89.26 168.92 0.04 OUTLIER 'General case' 0 C--N 1.354 0.804 0 CA-C-O 125.385 2.516 . . . . 0.0 110.496 -159.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.433 ' HB ' HG22 ' A' ' 96' ' ' ILE 0.344 15.5 m -22.6 -68.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 CA-C-N 111.137 -2.756 . . . . 0.0 114.221 146.813 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.483 ' HB2' HD12 ' A' ' 96' ' ' ILE . 2.7 t30 158.76 -28.15 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 129.047 2.939 . . . . 0.0 106.817 168.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.484 ' O ' ' HA ' ' A' ' 95' ' ' PHE 0.278 8.3 t70 46.48 -125.8 1.45 Allowed 'General case' 0 C--N 1.36 1.057 0 C-N-CA 126.111 1.764 . . . . 0.0 109.127 -169.033 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 48.5 m -72.61 74.67 1.08 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.411 1.084 . . . . 0.0 113.246 -169.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.0 tp -67.68 103.95 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 171.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.568 ' HA ' ' HB3' ' A' ' 126' ' ' ARG 0.293 1.0 OUTLIER -91.18 -54.96 3.72 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 113.104 -1.862 . . . . 0.0 113.145 177.632 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.427 ' H ' HD12 ' A' ' 118' ' ' LEU . 20.2 m-85 -118.28 138.92 52.04 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 105.358 -2.089 . . . . 0.0 105.358 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.8 p -127.28 114.9 38.66 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 170.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.822 HD21 ' HB2' ' A' ' 140' ' ' ALA 0.352 14.5 m-80 80.05 -83.03 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 123.489 1.614 . . . . 0.0 109.7 -177.704 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -148.3 -25.68 0.34 Allowed 'General case' 0 CA--C 1.566 1.579 0 CA-C-N 111.126 -2.761 . . . . 0.0 109.411 -178.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.426 ' CG1' HG13 ' A' ' 125' ' ' VAL . 2.3 t -61.75 135.72 26.02 Favored 'Isoleucine or valine' 0 C--N 1.362 1.119 0 C-N-CA 125.385 1.474 . . . . 0.0 110.286 174.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -97.92 72.29 2.22 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 112.117 -2.311 . . . . 0.0 109.852 175.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.586 HG11 ' HA ' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -63.21 -86.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 116.243 -1.837 . . . . 0.0 110.401 176.73 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.786 ' HD2' ' H ' ' A' ' 127' ' ' GLU 0.325 0.1 OUTLIER 49.22 -98.58 0.05 Allowed 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 120.269 1.395 . . . . 0.0 113.353 171.827 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.786 ' H ' ' HD2' ' A' ' 126' ' ' ARG . 10.2 mt-10 -80.64 69.13 7.08 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 126.695 1.998 . . . . 0.0 110.414 174.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.8 p -139.11 169.3 17.61 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 CA-C-N 112.87 -1.968 . . . . 0.0 106.093 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.422 HG22 ' H ' ' A' ' 131' ' ' SER . 46.8 m -60.15 135.21 57.65 Favored 'General case' 0 CA--C 1.558 1.288 0 CA-C-N 113.16 -1.836 . . . . 0.0 110.624 157.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.456 ' HA ' HD12 ' A' ' 94' ' ' ILE . 3.6 p-80 -46.15 -35.31 4.94 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 170.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.467 ' HA ' HG12 ' A' ' 134' ' ' VAL . 5.2 m -62.69 -43.04 99.81 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 125.311 1.444 . . . . 0.0 114.761 176.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.16 -37.33 87.07 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 169.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.586 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -69.66 -50.93 39.37 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 116.466 2.024 . . . . 0.0 116.466 172.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.467 HG12 ' HA ' ' A' ' 131' ' ' SER . 3.3 p -52.17 -42.67 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.475 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 170.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -72.82 -38.46 67.15 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 115.506 -2.188 . . . . 0.0 113.503 174.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.17 -34.05 77.16 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 116.937 2.199 . . . . 0.0 116.937 170.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.448 HD21 HD11 ' A' ' 96' ' ' ILE . 7.8 mp -55.59 -49.13 73.59 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.491 1.516 . . . . 0.0 114.939 162.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -68.05 -35.74 78.73 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 168.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.49 -20.76 66.12 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 173.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.822 ' HB2' HD21 ' A' ' 121' ' ' ASN . . . -52.86 -11.67 0.25 Allowed 'General case' 0 CA--C 1.561 1.377 0 N-CA-C 118.527 2.788 . . . . 0.0 118.527 161.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.504 ' O ' ' HD3' ' A' ' 70' ' ' ARG . . . 79.97 -143.29 25.16 Favored Glycine 0 C--N 1.347 1.188 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 174.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 17.3 m -71.34 -4.52 26.56 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 116.691 2.108 . . . . 0.0 116.691 173.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.07 107.81 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 -170.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.556 ' HA ' ' HB1' ' A' ' 140' ' ' ALA . 3.5 t -93.66 114.84 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 113.797 -1.547 . . . . 0.0 108.24 -174.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.456 ' HB2' ' HA ' ' A' ' 121' ' ' ASN . 75.0 mtt-85 -96.39 94.82 7.65 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 -177.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 34.0 mt -99.58 138.82 36.14 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 122.069 0.938 . . . . 0.0 109.043 -170.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -128.78 115.82 18.54 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.24 129.15 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -173.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.426 ' HB2' HD21 ' A' ' 118' ' ' LEU . 28.0 ttt -91.31 148.69 22.15 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-O 123.307 1.527 . . . . 0.0 112.503 164.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 -97.88 114.44 26.52 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 171.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -93.16 144.25 25.47 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 113.952 -1.476 . . . . 0.0 110.555 -175.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -93.85 106.41 21.63 Favored Pre-proline 0 CA--C 1.56 1.359 0 CA-C-N 113.522 -1.672 . . . . 0.0 107.734 169.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -49.96 -46.06 29.71 Favored 'Trans proline' 0 CA--C 1.57 2.316 0 C-N-CA 123.546 2.831 . . . . 0.0 116.689 171.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 C--N 1.374 1.907 0 C-N-CA 123.55 2.833 . . . . 0.0 111.114 175.295 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 1.1 p90 . . . . . 0 N--CA 1.478 0.961 0 CA-C-O 122.977 1.37 . . . . 0.0 112.828 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.554 ' HA ' ' HE3' ' B' ' 2' ' ' LYS . 0.3 OUTLIER -136.6 144.86 44.34 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 112.738 -2.028 . . . . 0.0 110.888 166.919 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.415 ' HB3' ' HE3' ' B' ' 3' ' ' LYS . 10.0 ttpp -92.24 109.97 21.35 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 113.534 -1.667 . . . . 0.0 108.481 178.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 98.7 m -88.38 131.93 34.65 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 122.401 1.096 . . . . 0.0 108.784 175.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.11 155.48 32.36 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 113.848 -1.524 . . . . 0.0 109.971 175.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.615 HG22 HD21 ' A' ' 75' ' ' LEU . 7.7 p . . . . . 0 C--O 1.247 0.957 0 N-CA-C 104.392 -2.447 . . . . 0.0 104.392 -171.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' BAL . . . . . 0.408 ' HB3' HD11 ' A' ' 100' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 . . . . . 0 N--CA 1.481 1.1 0 CA-C-O 121.808 0.813 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -130.05 141.1 50.76 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 124.126 0.97 . . . . 0.0 109.511 168.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -126.66 135.49 51.24 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 122.099 0.952 . . . . 0.0 108.846 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.27 120.62 42.85 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.059 -174.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.6 mp -135.1 125.32 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 -172.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.9 m -98.8 122.53 42.16 Favored 'General case' 0 CA--C 1.557 1.213 0 CA-C-O 122.338 1.066 . . . . 0.0 108.302 173.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 mp -118.26 127.21 53.51 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.576 1.55 . . . . 0.0 108.594 -174.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -100.66 129.09 46.53 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-O 121.223 0.535 . . . . 0.0 110.154 -178.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.751 ' HB2' ' HB2' ' A' ' 104' ' ' ALA . 9.3 tpt180 -157.28 -107.18 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 176.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.92 -162.82 54.05 Favored Glycine 0 C--N 1.352 1.42 0 C-N-CA 124.937 1.256 . . . . 0.0 111.614 -168.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 74.57 -89.27 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 113.375 -1.413 . . . . 0.0 111.18 170.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 80.4 p -86.42 -18.19 32.39 Favored 'General case' 0 CA--C 1.561 1.386 0 N-CA-C 116.476 2.028 . . . . 0.0 116.476 174.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 164.03 -146.01 11.03 Favored Glycine 0 CA--C 1.532 1.127 0 N-CA-C 107.475 -2.25 . . . . 0.0 107.475 179.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.607 ' HB2' HG13 ' B' ' 6' ' ' VAL . 0.0 OUTLIER -127.29 -34.63 2.27 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 113.556 -1.322 . . . . 0.0 111.753 -179.476 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.553 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 103.14 41.2 2.29 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 115.848 1.099 . . . . 0.0 115.848 164.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -158.32 127.2 5.56 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 123.425 1.583 . . . . 0.0 107.435 -175.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.3 m -87.56 137.45 32.32 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 121.246 -0.908 . . . . 0.0 111.126 174.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.451 HD11 ' HB ' ' A' ' 134' ' ' VAL . 2.5 pp -118.02 130.25 73.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 114.403 -1.271 . . . . 0.0 107.978 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -92.38 -169.68 2.29 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-O 123.288 1.518 . . . . 0.0 109.871 160.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.69 159.41 24.78 Favored Glycine 0 CA--C 1.537 1.459 0 CA-C-O 123.551 1.64 . . . . 0.0 115.783 -140.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.11 -162.26 21.87 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 111.606 -2.297 . . . . 0.0 112.316 -176.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 67.8 p -54.02 -41.11 67.65 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 117.373 2.361 . . . . 0.0 117.373 -177.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -75.51 -15.64 60.37 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 116.469 2.025 . . . . 0.0 116.469 173.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -152.77 86.05 4.29 Favored Pre-proline 0 CA--C 1.56 1.343 0 N-CA-C 101.585 -3.487 . . . . 0.0 101.585 -177.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -99.41 125.02 0.15 Allowed 'Trans proline' 0 CA--C 1.547 1.126 0 CA-C-N 124.241 2.55 . . . . 0.0 110.533 -170.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 60.7 t60 -103.82 -33.64 8.82 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 174.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.66 HD13 ' HB2' ' A' ' 95' ' ' PHE . 0.2 OUTLIER -156.7 157.9 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 CA-C-O 123.596 1.665 . . . . 0.0 108.338 -152.334 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 112.32 -129.59 9.11 Favored Glycine 0 C--N 1.337 0.595 0 CA-C-N 112.398 -2.183 . . . . 0.0 109.821 174.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -96.03 -6.43 38.79 Favored 'General case' 0 CA--C 1.572 1.8 0 CA-C-N 113.279 -1.461 . . . . 0.0 114.905 161.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.451 ' HB3' ' HD3' ' A' ' 92' ' ' PRO 0.318 32.7 t70 155.67 -72.63 0.0 OUTLIER Pre-proline 0 CA--C 1.559 1.301 0 N-CA-C 102.698 -3.075 . . . . 0.0 102.698 -179.171 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.451 ' HD3' ' HB3' ' A' ' 91' ' ' ASP . 92.2 Cg_endo -93.45 -141.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.369 1.63 0 C-N-CA 123.338 2.692 . . . . 0.0 110.805 -174.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 43.6 m 70.7 144.04 0.06 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 122.667 1.222 . . . . 0.0 109.204 175.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.545 HG13 ' HB2' ' A' ' 133' ' ' ALA . 10.1 mm -91.78 126.05 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 -174.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.66 ' HB2' HD13 ' A' ' 88' ' ' ILE . 29.5 m-85 -124.83 142.1 51.66 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 -178.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.429 HG22 ' HB ' ' A' ' 113' ' ' VAL 0.254 46.9 mt -85.32 119.52 34.08 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.541 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 175.023 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 91.8 m -85.92 -33.21 21.25 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 117.806 -1.093 . . . . 0.0 113.476 169.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . 0.285 0.0 OUTLIER -141.01 163.66 32.38 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-O 124.779 2.228 . . . . 0.0 111.324 179.218 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.495 HG22 ' HB3' ' A' ' 105' ' ' ALA . 0.9 OUTLIER -104.18 119.87 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 166.323 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 24.0 mm -65.68 127.77 93.3 Favored Pre-proline 0 CA--C 1.566 1.58 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.164 178.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.74 129.06 32.62 Favored 'Trans proline' 0 C--N 1.365 1.406 0 C-N-CA 123.606 2.871 . . . . 0.0 115.286 -178.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.49 11.39 80.09 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 118.54 2.176 . . . . 0.0 118.54 -170.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.553 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -92.35 -175.92 41.9 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 124.546 1.069 . . . . 0.0 113.937 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.751 ' HB2' ' HB2' ' A' ' 70' ' ' ARG . . . -63.4 -51.96 63.62 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 117.146 2.276 . . . . 0.0 117.146 -171.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.495 ' HB3' HG22 ' A' ' 99' ' ' ILE . . . -56.04 -33.19 64.72 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 175.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -67.09 -44.74 79.23 Favored 'General case' 0 CA--C 1.563 1.457 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 169.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.33 -54.55 6.33 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 123.638 0.775 . . . . 0.0 112.306 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -59.54 -42.16 91.7 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -179.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -161.7 -149.24 5.57 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-O 124.296 2.053 . . . . 0.0 113.536 171.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 38.1 mtm105 -146.71 60.7 1.21 Allowed 'General case' 0 CA--C 1.552 1.055 0 CA-C-N 110.446 -2.877 . . . . 0.0 105.797 -177.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.509 HD23 ' H ' ' A' ' 111' ' ' LEU . 1.3 pt? -60.92 -29.17 69.45 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 175.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 18.0 mtp-105 67.63 127.91 0.02 OUTLIER 'General case' 0 C--N 1.351 0.654 0 CA-C-O 124.732 2.206 . . . . 0.0 109.016 -162.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.429 ' HB ' HG22 ' A' ' 96' ' ' ILE 0.264 27.7 m -48.41 -65.86 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 109.178 -3.646 . . . . 0.0 110.56 -168.216 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -63.54 80.97 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.238 0 CA-C-O 124.688 2.185 . . . . 0.0 113.604 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -104.52 -170.07 1.71 Allowed 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 110.264 -3.153 . . . . 0.0 106.128 158.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.401 ' HB2' ' HB3' ' A' ' 149' ' ' MET . 40.0 m -127.81 79.61 1.91 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 176.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.42 HG23 ' HB ' ' A' ' 94' ' ' ILE . 7.5 tp -56.45 116.55 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-O 121.997 0.904 . . . . 0.0 110.666 -178.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.608 HD23 ' HB2' ' A' ' 149' ' ' MET . 3.0 pp -110.19 -47.85 3.25 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 116.785 2.143 . . . . 0.0 116.785 -174.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.453 ' HB2' ' HB2' ' A' ' 147' ' ' TYR . 47.9 m-85 -126.64 138.07 53.38 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 177.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.465 HG21 HD12 ' A' ' 137' ' ' LEU . 3.1 t -128.44 109.8 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 100.543 -3.873 . . . . 0.0 100.543 175.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.808 HD21 ' HB2' ' A' ' 140' ' ' ALA 0.378 8.9 m-80 83.3 -88.48 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 122.921 1.343 . . . . 0.0 109.389 179.86 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -145.26 -13.82 0.52 Allowed 'General case' 0 CA--C 1.567 1.627 0 CA-C-N 111.401 -2.636 . . . . 0.0 110.59 175.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.509 HG12 HG13 ' A' ' 125' ' ' VAL . 2.3 t -67.58 133.03 32.18 Favored 'Isoleucine or valine' 0 C--N 1.359 0.994 0 C-N-CA 125.431 1.492 . . . . 0.0 109.997 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -84.19 98.09 9.75 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 112.476 -2.147 . . . . 0.0 109.599 172.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.601 HG11 ' HA ' ' A' ' 133' ' ' ALA 0.258 2.0 m -97.51 -103.26 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-O 116.281 -1.818 . . . . 0.0 106.97 173.173 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.536 ' HB3' ' HA ' ' A' ' 118' ' ' LEU 0.289 13.2 ptt180 50.4 -93.33 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 120.217 1.371 . . . . 0.0 114.237 179.585 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.479 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 2.4 tt0 -79.25 68.68 5.3 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-O 123.425 1.583 . . . . 0.0 111.031 173.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.8 p -144.3 168.89 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.96 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 -173.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.419 HG22 ' H ' ' A' ' 131' ' ' SER . 27.4 m -61.76 130.86 47.81 Favored 'General case' 0 CA--C 1.559 1.3 0 CA-C-N 113.119 -1.855 . . . . 0.0 110.038 156.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.419 ' HA ' HD12 ' A' ' 94' ' ' ILE . 2.1 p-80 -47.7 -29.44 3.05 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 118.587 2.81 . . . . 0.0 118.587 169.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.519 ' HA ' HG12 ' A' ' 134' ' ' VAL . 8.1 m -63.09 -37.91 89.07 Favored 'General case' 0 CA--C 1.565 1.543 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 171.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -70.25 -36.13 74.27 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 165.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.601 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -61.19 -55.61 30.26 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 114.695 1.368 . . . . 0.0 114.695 169.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.519 HG12 ' HA ' ' A' ' 131' ' ' SER . 2.3 p -53.1 -40.55 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.162 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 169.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -58.17 -52.19 66.59 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 116.311 -1.804 . . . . 0.0 112.691 168.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.68 -35.62 74.83 Favored 'General case' 0 CA--C 1.561 1.391 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 173.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.513 HD23 HG11 ' B' ' 6' ' ' VAL . 9.6 mp -54.46 -53.92 47.86 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 125.296 1.438 . . . . 0.0 113.813 164.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.437 ' HA ' HD21 ' A' ' 75' ' ' LEU . 88.6 mttt -68.41 -33.54 74.4 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 116.507 2.04 . . . . 0.0 116.507 172.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -64.11 -32.19 73.66 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 115.17 1.544 . . . . 0.0 115.17 171.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.808 ' HB2' HD21 ' A' ' 121' ' ' ASN . . . -52.91 -36.57 59.69 Favored 'General case' 0 CA--C 1.557 1.214 0 N-CA-C 117.234 2.309 . . . . 0.0 117.234 163.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.12 -133.61 12.0 Favored Glycine 0 C--N 1.348 1.214 0 N-CA-C 111.644 -0.582 . . . . 0.0 111.644 167.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.3 t -66.4 -7.97 22.7 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 118.756 2.873 . . . . 0.0 118.756 170.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.32 107.84 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 -172.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.593 ' HA ' ' HB1' ' A' ' 140' ' ' ALA . 4.3 t -106.31 110.47 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 113.006 -1.907 . . . . 0.0 107.539 -173.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.522 ' HG3' ' HA ' ' A' ' 121' ' ' ASN . 9.8 ptt180 -101.77 91.46 4.41 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.422 HD23 HG13 ' A' ' 120' ' ' VAL . 78.0 mt -89.43 144.51 26.0 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 113.524 -1.671 . . . . 0.0 108.975 -175.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.453 ' HB2' ' HB2' ' A' ' 119' ' ' PHE . 88.9 m-85 -133.15 115.97 15.7 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 103.446 -2.798 . . . . 0.0 103.446 173.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 19.6 m -119.57 155.39 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -170.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.608 ' HB2' HD23 ' A' ' 118' ' ' LEU . 60.7 ttp -102.06 132.59 47.84 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 122.494 1.14 . . . . 0.0 110.095 172.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -101.65 114.32 28.26 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 113.521 -1.672 . . . . 0.0 107.106 164.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -80.06 130.92 35.63 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.247 -174.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt 75.96 124.96 0.03 OUTLIER Pre-proline 0 CA--C 1.555 1.152 0 CA-C-N 114.131 -1.395 . . . . 0.0 111.091 176.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -65.01 144.72 83.36 Favored 'Trans proline' 0 CA--C 1.568 2.199 0 C-N-CA 122.362 2.041 . . . . 0.0 113.491 173.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo . . . . . 0 CA--C 1.552 1.396 0 C-N-CA 123.26 2.64 . . . . 0.0 112.641 176.718 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 1.3 p90 . . . . . 0 CA--C 1.562 1.408 0 CA-C-O 122.313 1.054 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -133.72 125.21 28.1 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 123.141 1.448 . . . . 0.0 107.852 171.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 3.0 ttpt -96.76 133.56 41.18 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 113.872 -1.513 . . . . 0.0 108.131 175.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.3 150.14 27.02 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-O 123.121 1.439 . . . . 0.0 109.076 177.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -109.03 126.29 52.99 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 -176.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.607 HG13 ' HB2' ' A' ' 75' ' ' LEU 0.321 0.5 OUTLIER . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 173.7 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 . . . . . 0 N--CA 1.474 0.774 0 CA-C-O 121.689 0.757 . . . . 0.0 111.891 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . 0.251 26.9 p90 -90.05 128.17 36.23 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.077 173.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -124.32 131.07 53.5 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -167.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -83.44 123.99 30.24 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 113.888 -1.505 . . . . 0.0 110.906 171.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.485 HG13 ' HB2' ' A' ' 146' ' ' LEU . 7.9 pt -140.33 118.12 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 -168.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.0 m -97.1 131.18 44.13 Favored 'General case' 0 CA--C 1.554 1.109 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 173.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.423 ' HG ' ' HB1' ' A' ' 104' ' ' ALA . 1.3 mp -125.35 131.53 52.98 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.176 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -115.92 124.46 50.63 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -174.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.684 ' HB2' ' HB2' ' A' ' 104' ' ' ALA . 15.9 tpt180 -158.16 -109.27 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 176.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.89 -173.49 53.58 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-O 122.429 1.016 . . . . 0.0 113.771 -169.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . 0.267 56.3 t-20 71.6 -93.3 0.03 OUTLIER 'General case' 0 CA--C 1.56 1.365 0 CA-C-N 113.376 -1.412 . . . . 0.0 111.366 174.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.8 m -79.02 -18.75 53.04 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 115.91 1.818 . . . . 0.0 115.91 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 178.8 -151.1 10.04 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 108.454 -1.858 . . . . 0.0 108.454 172.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.502 HD21 HG21 ' A' ' 144' ' ' VAL . 0.8 OUTLIER -134.41 -30.94 1.11 Allowed 'General case' 0 CA--C 1.559 1.32 0 CA-C-N 113.468 -1.366 . . . . 0.0 112.497 169.927 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.436 ' CA ' ' HA3' ' A' ' 103' ' ' GLY . . . 106.19 15.79 16.8 Favored Glycine 0 N--CA 1.479 1.532 0 N-CA-C 121.118 3.207 . . . . 0.0 121.118 172.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -150.05 143.62 25.25 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 124.483 2.087 . . . . 0.0 108.857 -177.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.0 m -111.91 128.38 56.13 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 112.357 -2.202 . . . . 0.0 108.422 178.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.5 pp -109.2 126.72 66.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.495 -1.23 . . . . 0.0 109.609 -173.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -83.36 -171.89 3.84 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-O 123.401 1.572 . . . . 0.0 110.715 162.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -98.9 163.82 20.5 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-O 123.999 1.888 . . . . 0.0 115.829 -143.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -111.45 -164.06 17.84 Favored Glycine 0 N--CA 1.464 0.553 0 CA-C-N 110.854 -2.673 . . . . 0.0 111.086 -172.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.495 HG22 ' HB2' ' A' ' 92' ' ' PRO . 11.3 p -51.64 -40.41 59.92 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 117.714 2.487 . . . . 0.0 117.714 -173.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -80.26 -17.54 51.9 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 171.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . 0.303 6.3 t30 -138.2 54.76 7.66 Favored Pre-proline 0 CA--C 1.567 1.633 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -174.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -100.44 124.79 0.12 Allowed 'Trans proline' 0 C--N 1.365 1.442 0 CA-C-N 124.804 2.751 . . . . 0.0 111.312 -157.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -106.85 -35.07 7.05 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 174.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.2 mp -103.01 135.26 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -153.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.68 -116.36 5.66 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-N 114.311 -1.313 . . . . 0.0 112.29 165.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -89.37 8.08 32.53 Favored 'General case' 0 CA--C 1.563 1.479 0 N-CA-C 116.411 2.004 . . . . 0.0 116.411 172.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.43 ' HB2' ' HD3' ' A' ' 92' ' ' PRO 0.451 21.0 m-20 103.68 -81.19 0.0 OUTLIER Pre-proline 0 CA--C 1.57 1.737 0 C-N-CA 126.224 1.809 . . . . 0.0 109.999 -174.869 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.495 ' HB2' HG22 ' A' ' 83' ' ' THR . 85.9 Cg_endo -92.4 86.36 0.22 Allowed 'Trans proline' 0 C--N 1.366 1.481 0 C-N-CA 123.765 2.976 . . . . 0.0 114.161 -159.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 58.5 m -161.17 132.18 5.36 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.467 HG13 ' HB2' ' A' ' 133' ' ' ALA . 13.9 mm -82.29 124.88 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 -179.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -120.89 155.28 34.52 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 113.91 -1.495 . . . . 0.0 108.78 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.437 ' HB ' ' O ' ' A' ' 113' ' ' VAL . 83.9 mt -92.62 117.39 35.88 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.629 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 158.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.407 ' CG2' ' HG3' ' B' ' 3' ' ' LYS . 10.1 t -86.04 -31.98 21.68 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 115.378 1.621 . . . . 0.0 115.378 169.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.544 ' HA ' HG11 ' A' ' 113' ' ' VAL 0.342 0.0 OUTLIER -143.54 164.4 30.47 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 124.618 2.151 . . . . 0.0 110.707 177.456 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.6 HD13 ' HA ' ' A' ' 111' ' ' LEU . 0.8 OUTLIER -104.55 132.48 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 174.362 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.259 43.9 mt -87.75 117.21 68.21 Favored Pre-proline 0 CA--C 1.561 1.397 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 172.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.13 146.61 80.4 Favored 'Trans proline' 0 C--N 1.369 1.654 0 C-N-CA 123.673 2.915 . . . . 0.0 115.722 176.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.76 -8.84 47.45 Favored Glycine 0 CA--C 1.544 1.872 0 N-CA-C 117.649 1.82 . . . . 0.0 117.649 -170.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.436 ' HA3' ' CA ' ' A' ' 76' ' ' GLY . . . -96.54 -168.88 34.11 Favored Glycine 0 CA--C 1.539 1.564 0 CA-C-N 119.171 1.486 . . . . 0.0 115.098 -177.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.684 ' HB2' ' HB2' ' A' ' 70' ' ' ARG . . . -64.28 -47.5 79.29 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -175.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.59 -37.92 88.11 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 178.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.25 -44.85 90.52 Favored 'General case' 0 CA--C 1.564 1.489 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 168.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -66.62 -63.13 1.13 Allowed 'General case' 0 CA--C 1.564 1.498 0 C-N-CA 125.323 1.449 . . . . 0.0 113.136 178.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -65.53 -46.82 78.11 Favored 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 124.651 1.18 . . . . 0.0 113.69 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 123.5 57.6 0.19 Allowed Glycine 0 N--CA 1.479 1.537 0 C-N-CA 123.689 0.661 . . . . 0.0 113.206 174.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -116.51 40.61 2.86 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.703 1.201 . . . . 0.0 112.205 163.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.6 ' HA ' HD13 ' A' ' 99' ' ' ILE . 3.1 pp -58.54 -28.39 65.43 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 117.739 2.496 . . . . 0.0 117.739 167.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 59.0 ttt180 -80.78 89.91 5.82 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 124.391 2.043 . . . . 0.0 106.833 164.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.544 HG11 ' HA ' ' A' ' 98' ' ' LYS . 7.1 m -54.99 -60.05 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 110.097 -3.229 . . . . 0.0 111.307 -165.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 -54.27 43.73 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 119.819 3.266 . . . . 0.0 119.819 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.5 ' HB3' HG11 ' A' ' 148' ' ' VAL . 41.2 m-20 -76.91 105.78 8.19 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 165.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.9 m -73.49 90.63 1.74 Allowed 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 113.912 -1.494 . . . . 0.0 108.784 -172.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.1 tp -66.76 118.18 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 CA-C-O 122.295 1.045 . . . . 0.0 110.312 -171.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.592 ' HA ' ' HB3' ' A' ' 126' ' ' ARG 0.328 3.1 pp -99.41 -51.31 3.82 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 112.424 -2.171 . . . . 0.0 115.046 178.29 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -133.76 140.84 47.21 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 -176.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.442 HG21 HD12 ' A' ' 137' ' ' LEU . 2.7 t -128.87 110.06 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 102.774 -3.047 . . . . 0.0 102.774 -178.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.846 HD21 ' HB2' ' A' ' 140' ' ' ALA 0.295 8.2 m-80 82.26 -79.04 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 123.3 1.524 . . . . 0.0 108.935 178.08 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -154.27 -9.03 0.14 Allowed 'General case' 0 CA--C 1.568 1.668 0 CA-C-N 111.712 -2.495 . . . . 0.0 111.782 171.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.54 HG12 HG13 ' A' ' 125' ' ' VAL . 2.4 t -68.17 137.03 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.189 0 CA-C-O 123.492 1.615 . . . . 0.0 109.871 -179.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -86.86 98.11 11.03 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 111.316 -2.675 . . . . 0.0 109.869 177.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.61 HG11 ' HA ' ' A' ' 133' ' ' ALA 0.28 2.7 m -108.77 -110.53 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 CA-C-O 116.356 -1.783 . . . . 0.0 107.464 179.691 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.592 ' HB3' ' HA ' ' A' ' 118' ' ' LEU 0.362 0.0 OUTLIER 53.57 -82.68 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -179.533 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.554 ' H ' ' HD3' ' A' ' 126' ' ' ARG . 19.6 mt-10 -86.28 68.86 10.38 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-O 123.356 1.551 . . . . 0.0 109.308 171.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.6 p -143.06 167.08 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 CA-C-O 123.849 1.785 . . . . 0.0 107.061 -178.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 11.6 m -56.38 129.1 39.09 Favored 'General case' 0 CA--C 1.558 1.257 0 CA-C-N 113.289 -1.778 . . . . 0.0 110.217 157.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -47.94 -31.95 5.84 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 117.701 2.482 . . . . 0.0 117.701 173.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.478 ' HA ' HG12 ' A' ' 134' ' ' VAL . 6.8 m -59.32 -41.51 89.26 Favored 'General case' 0 CA--C 1.559 1.305 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 172.033 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -70.51 -36.41 73.76 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 167.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.61 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -61.58 -56.08 23.77 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 170.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.478 HG12 ' HA ' ' A' ' 131' ' ' SER . 0.5 OUTLIER -55.4 -39.86 54.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 N-CA-C 115.891 1.812 . . . . 0.0 115.891 167.854 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.99 -54.84 33.43 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 115.383 -2.246 . . . . 0.0 111.272 168.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.76 -35.0 73.71 Favored 'General case' 0 CA--C 1.561 1.373 0 N-CA-C 117.565 2.431 . . . . 0.0 117.565 172.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.442 HD12 HG21 ' A' ' 120' ' ' VAL . 8.6 mp -57.74 -49.61 75.98 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 165.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -73.31 -34.94 65.99 Favored 'General case' 0 CA--C 1.564 1.511 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 175.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.19 -28.69 67.48 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 115.921 1.823 . . . . 0.0 115.921 171.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.846 ' HB2' HD21 ' A' ' 121' ' ' ASN . . . -51.62 -36.7 46.9 Favored 'General case' 0 CA--C 1.56 1.339 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 158.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 91.39 -131.68 10.9 Favored Glycine 0 C--N 1.349 1.286 0 CA-C-O 122.488 1.049 . . . . 0.0 110.518 167.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.5 m -76.63 -2.19 31.45 Favored 'General case' 0 CA--C 1.557 1.244 0 N-CA-C 117.148 2.277 . . . . 0.0 117.148 168.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.09 108.18 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 -171.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.54 ' HA ' ' HB1' ' A' ' 140' ' ' ALA . 6.7 t -116.04 116.33 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 113.834 -1.53 . . . . 0.0 107.348 -165.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.417 ' HB2' ' HA ' ' A' ' 121' ' ' ASN . 1.9 mpp_? -93.59 91.66 7.18 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 174.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.485 ' HB2' HG13 ' A' ' 66' ' ' ILE . 78.3 mt -91.45 141.38 28.81 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 176.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -132.86 113.82 13.33 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 103.562 -2.755 . . . . 0.0 103.562 176.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.5 HG11 ' HB3' ' A' ' 115' ' ' ASP . 32.2 m -127.68 139.51 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -165.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 26.1 ptm -95.44 127.56 41.58 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 122.341 1.067 . . . . 0.0 110.427 170.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -101.33 125.42 47.96 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 174.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 30.2 mtp-105 -79.22 66.84 4.78 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.261 168.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -85.61 112.42 44.43 Favored Pre-proline 0 CA--C 1.555 1.167 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 -178.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -74.88 151.44 40.18 Favored 'Trans proline' 0 CA--C 1.566 2.123 0 C-N-CA 122.427 2.085 . . . . 0.0 112.896 176.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo . . . . . 0 CA--C 1.555 1.538 0 C-N-CA 123.858 3.039 . . . . 0.0 116.996 177.906 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 2.8 p90 . . . . . 0 CA--C 1.557 1.234 0 CA-C-O 122.436 1.112 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -120.49 149.46 42.37 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-O 124.162 1.934 . . . . 0.0 108.267 167.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.407 ' HG3' ' CG2' ' A' ' 97' ' ' THR . 0.5 OUTLIER -103.5 130.04 50.79 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 113.434 -1.712 . . . . 0.0 109.001 168.616 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 1.3 m -86.94 147.2 25.86 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 122.456 1.122 . . . . 0.0 109.877 168.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -114.53 113.34 24.29 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -171.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.47 HG21 ' CG2' ' A' ' 134' ' ' VAL . 62.0 t . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 -169.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 . . . . . 0 N--CA 1.479 0.983 0 CA-C-O 121.733 0.778 . . . . 0.0 111.255 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -118.75 138.36 52.72 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 114.117 -1.401 . . . . 0.0 110.865 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -129.19 141.84 51.04 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 123.011 1.386 . . . . 0.0 109.37 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -97.73 121.9 40.18 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 112.905 -1.952 . . . . 0.0 108.559 173.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.485 HG13 ' HB2' ' A' ' 146' ' ' LEU . 8.8 pt -131.46 109.42 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 -172.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.7 m -93.49 124.29 37.39 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 122.337 1.065 . . . . 0.0 108.391 175.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.407 ' HB2' HG23 ' A' ' 144' ' ' VAL . 1.3 mp -110.33 131.05 55.4 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 113.471 -1.695 . . . . 0.0 107.49 177.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -103.51 114.86 29.46 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -170.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.679 ' HB2' ' HB2' ' A' ' 104' ' ' ALA . 13.9 tpt180 -143.08 -106.64 0.13 Allowed 'General case' 0 CA--C 1.55 0.98 0 O-C-N 121.509 -0.744 . . . . 0.0 112.128 174.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.74 -152.41 23.09 Favored Glycine 0 C--N 1.342 0.904 0 C-N-CA 124.712 1.148 . . . . 0.0 111.954 -166.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . 0.256 16.6 m120 73.19 -92.02 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 114.356 -0.922 . . . . 0.0 110.853 177.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.2 m -103.87 -17.22 15.12 Favored 'General case' 0 CA--C 1.562 1.432 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 175.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 177.17 -139.32 4.32 Favored Glycine 0 CA--C 1.533 1.191 0 N-CA-C 108.293 -1.923 . . . . 0.0 108.293 178.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.472 HD21 ' HA ' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -130.87 -38.86 1.25 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 125.486 1.515 . . . . 0.0 111.139 -171.969 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.46 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 102.07 55.19 0.88 Allowed Glycine 0 N--CA 1.464 0.52 0 C-N-CA 124.176 0.893 . . . . 0.0 113.703 166.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.413 ' HB3' ' CG1' ' A' ' 99' ' ' ILE . 1.1 p90 -158.92 138.87 12.0 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-O 123.315 1.531 . . . . 0.0 111.152 178.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.473 ' HB2' ' HG2' ' A' ' 98' ' ' LYS . 5.0 m -100.0 120.16 39.39 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 122.854 1.311 . . . . 0.0 110.622 176.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.548 HD11 ' HB ' ' A' ' 134' ' ' VAL . 8.7 pt -95.45 136.09 27.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-N 113.087 -1.87 . . . . 0.0 109.876 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.04 -178.39 6.53 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-O 123.782 1.754 . . . . 0.0 109.698 157.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.433 ' HA3' ' O ' ' A' ' 85' ' ' ASN . . . -103.85 166.46 15.72 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-O 124.059 1.922 . . . . 0.0 116.319 -136.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -99.23 -162.07 29.45 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 111.242 -2.479 . . . . 0.0 112.499 -172.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.452 HG22 ' CB ' ' A' ' 92' ' ' PRO . 45.7 p -51.97 -43.09 63.41 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 116.517 2.043 . . . . 0.0 116.517 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -83.0 -13.73 55.37 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 116.277 1.954 . . . . 0.0 116.277 173.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.433 ' O ' ' HA3' ' A' ' 81' ' ' GLY 0.289 9.0 t30 -139.15 55.46 7.48 Favored Pre-proline 0 CA--C 1.565 1.529 0 CA-C-O 117.065 -1.445 . . . . 0.0 107.534 -172.905 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -83.63 132.3 5.7 Favored 'Trans proline' 0 C--N 1.365 1.412 0 CA-C-N 126.051 3.197 . . . . 0.0 112.648 -162.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -99.66 -23.68 14.96 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 166.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.487 HG22 ' H ' ' A' ' 90' ' ' ASP . 3.6 mp -92.32 142.98 12.31 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 -157.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -64.31 -1.66 6.03 Favored Glycine 0 CA--C 1.556 2.627 0 N-CA-C 119.435 2.534 . . . . 0.0 119.435 174.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.487 ' H ' HG22 ' A' ' 88' ' ' ILE . 7.4 m-20 -90.14 -8.57 50.94 Favored 'General case' 0 CA--C 1.568 1.648 0 CA-C-O 117.035 -1.46 . . . . 0.0 114.459 164.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.438 ' HB3' ' HD3' ' A' ' 92' ' ' PRO 0.467 0.3 OUTLIER 89.27 -85.46 0.0 OUTLIER Pre-proline 0 CA--C 1.563 1.48 0 C-N-CA 127.458 2.303 . . . . 0.0 109.815 -170.279 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.452 ' CB ' HG22 ' A' ' 83' ' ' THR . 88.7 Cg_endo -114.04 93.76 0.01 OUTLIER 'Trans proline' 0 C--N 1.367 1.527 0 CA-C-N 124.328 2.582 . . . . 0.0 112.141 -160.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.8 m -155.81 130.0 8.78 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 -177.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.442 HG13 ' HB2' ' A' ' 133' ' ' ALA . 15.6 mm -83.32 110.06 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 -177.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.444 ' HB3' HD11 ' A' ' 88' ' ' ILE . 72.7 t80 -130.18 130.83 45.2 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 -167.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.564 ' HB ' ' O ' ' A' ' 113' ' ' VAL 0.298 82.5 mt -81.73 120.11 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.736 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 176.178 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.451 ' CG2' ' HD3' ' B' ' 3' ' ' LYS . 12.3 t -89.72 -28.88 19.11 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 168.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.473 ' HG2' ' HB2' ' A' ' 78' ' ' SER . 7.7 ptmm? -144.4 161.68 38.4 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-O 122.659 1.219 . . . . 0.0 109.777 172.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.771 ' HB ' HG12 ' A' ' 113' ' ' VAL . 0.2 OUTLIER -123.02 139.27 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 177.791 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.403 ' HA ' ' HD2' ' A' ' 101' ' ' PRO 0.279 1.5 mp -79.14 124.93 84.37 Favored Pre-proline 0 CA--C 1.57 1.743 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.331 -179.03 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.596 ' HA ' ' HB2' ' A' ' 106' ' ' ALA . 60.1 Cg_endo -67.35 146.99 77.07 Favored 'Trans proline' 0 CA--C 1.56 1.79 0 C-N-CA 123.398 2.732 . . . . 0.0 113.107 166.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.76 -14.06 53.7 Favored Glycine 0 CA--C 1.548 2.122 0 N-CA-C 117.245 1.658 . . . . 0.0 117.245 -164.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.46 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -96.23 -166.3 33.99 Favored Glycine 0 CA--C 1.539 1.541 0 CA-C-N 118.914 1.357 . . . . 0.0 115.82 177.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.679 ' HB2' ' HB2' ' A' ' 70' ' ' ARG . . . -58.61 -51.19 70.95 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -177.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.407 ' HB1' HD13 ' A' ' 99' ' ' ILE . . . -59.48 -38.39 80.7 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 124.573 1.17 . . . . 0.0 114.075 169.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.596 ' HB2' ' HA ' ' A' ' 101' ' ' PRO . . . -46.19 -40.14 10.81 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 117.538 2.421 . . . . 0.0 117.538 166.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.38 -53.17 6.22 Favored 'General case' 0 CA--C 1.568 1.642 0 C-N-CA 123.734 0.813 . . . . 0.0 112.665 173.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -79.02 -52.95 7.53 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -172.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -161.9 97.2 0.15 Allowed Glycine 0 CA--C 1.532 1.132 0 N-CA-C 108.369 -1.892 . . . . 0.0 108.369 -178.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.585 ' HA ' HG21 ' A' ' 99' ' ' ILE . 15.7 ptt-85 -85.65 19.3 2.48 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 119.822 3.268 . . . . 0.0 119.822 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.419 HD22 ' N ' ' A' ' 112' ' ' ARG . 0.0 OUTLIER -140.51 -21.7 0.82 Allowed 'General case' 0 CA--C 1.564 1.496 0 C-N-CA 128.003 2.521 . . . . 0.0 111.335 -164.246 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.419 ' N ' HD22 ' A' ' 111' ' ' LEU . 3.8 ptp180 -78.38 18.73 0.52 Allowed 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 116.232 1.938 . . . . 0.0 116.232 179.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.771 HG12 ' HB ' ' A' ' 99' ' ' ILE 0.25 2.4 m -39.61 -59.36 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 127.665 2.386 . . . . 0.0 110.109 179.379 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 63.2 m-20 -51.79 37.85 0.0 OUTLIER 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 121.799 3.999 . . . . 0.0 121.799 166.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -102.35 110.67 22.68 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 165.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 65.9 p -67.51 89.32 0.23 Allowed 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 113.408 -1.724 . . . . 0.0 111.147 169.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.566 HD12 HD11 ' A' ' 137' ' ' LEU . 27.6 pt -74.27 101.19 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 123.683 1.706 . . . . 0.0 108.854 -176.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.484 ' HA ' ' HB3' ' A' ' 126' ' ' ARG . 1.4 pp -79.95 -39.1 30.9 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 112.58 -2.1 . . . . 0.0 115.578 177.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -132.89 150.46 52.16 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 175.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.512 HG23 HD23 ' A' ' 146' ' ' LEU . 9.4 p -131.2 124.11 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 172.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.762 HD21 ' HB2' ' A' ' 140' ' ' ALA 0.272 31.0 m-80 78.77 -70.2 0.11 Allowed 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 123.26 1.505 . . . . 0.0 111.554 -178.039 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.423 ' H ' ' H ' ' A' ' 123' ' ' VAL . 2.1 tt0 -177.93 -10.65 0.01 OUTLIER 'General case' 0 CA--C 1.583 2.213 0 C-N-CA 129.229 3.011 . . . . 0.0 109.391 -177.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.423 ' H ' ' H ' ' A' ' 122' ' ' GLU . 2.1 t -64.67 137.89 24.11 Favored 'Isoleucine or valine' 0 C--N 1.364 1.204 0 C-N-CA 125.801 1.641 . . . . 0.0 109.987 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -82.04 94.15 7.13 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 112.545 -2.116 . . . . 0.0 109.979 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.46 HG11 ' HA ' ' A' ' 133' ' ' ALA 0.339 0.8 OUTLIER -110.5 -112.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 CA-C-O 117.546 -1.216 . . . . 0.0 108.593 179.781 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.541 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.315 17.3 ptt180 55.15 -86.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 -174.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.541 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 32.9 mt-10 -82.06 69.47 8.78 Favored 'General case' 0 CA--C 1.555 1.156 0 CA-C-O 123.92 1.819 . . . . 0.0 109.986 172.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.7 m -137.0 166.34 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 112.627 -2.079 . . . . 0.0 105.677 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 25.8 p -55.83 135.69 51.76 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 113.12 -1.855 . . . . 0.0 111.301 149.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -50.04 -29.8 9.48 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 116.66 2.096 . . . . 0.0 116.66 167.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.465 ' HA ' HG12 ' A' ' 134' ' ' VAL . 5.1 m -57.09 -56.05 26.81 Favored 'General case' 0 CA--C 1.559 1.315 0 C-N-CA 124.432 1.093 . . . . 0.0 112.348 169.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -57.5 -38.7 75.04 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 173.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.46 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -62.15 -55.78 25.35 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 115.883 1.809 . . . . 0.0 115.883 166.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.548 ' HB ' HD11 ' A' ' 79' ' ' ILE . 3.7 p -57.74 -40.37 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 176.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -61.36 -44.38 97.26 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 116.657 -1.639 . . . . 0.0 112.999 168.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.59 -31.84 73.23 Favored 'General case' 0 CA--C 1.563 1.48 0 N-CA-C 117.628 2.455 . . . . 0.0 117.628 169.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.566 HD11 HD12 ' A' ' 117' ' ' ILE . 6.5 mp -60.07 -48.76 80.38 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 125.752 1.621 . . . . 0.0 113.29 166.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.472 ' HA ' HD21 ' A' ' 75' ' ' LEU . 53.2 mtmt -69.67 -32.83 71.69 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 168.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -67.71 -22.83 65.24 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 116.278 1.955 . . . . 0.0 116.278 171.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.762 ' HB2' HD21 ' A' ' 121' ' ' ASN . . . -51.9 -27.73 13.86 Favored 'General case' 0 CA--C 1.555 1.155 0 N-CA-C 118.072 2.619 . . . . 0.0 118.072 157.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 97.08 -116.15 5.43 Favored Glycine 0 C--N 1.344 1.025 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 166.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.6 m -92.5 1.27 57.34 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 116.413 2.005 . . . . 0.0 116.413 166.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.37 102.1 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 -171.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.455 ' HA ' ' HB1' ' A' ' 140' ' ' ALA . 1.4 m -85.09 116.33 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-N 113.72 -1.582 . . . . 0.0 109.821 173.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 31.8 mtp180 -100.79 87.79 3.41 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 122.443 1.116 . . . . 0.0 108.103 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.512 HD23 HG23 ' A' ' 120' ' ' VAL . 32.6 mt -87.5 133.94 33.69 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -170.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -118.9 119.57 34.74 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.4 p -127.05 121.65 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -176.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 52.3 ttm -100.47 136.25 40.65 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 122.816 1.293 . . . . 0.0 110.286 163.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 14.7 mmt180 -94.64 113.47 25.28 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 112.83 -1.987 . . . . 0.0 106.847 172.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 24.2 ttt180 -58.74 -55.3 36.88 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.478 157.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -97.89 123.78 50.25 Favored Pre-proline 0 CA--C 1.551 1.013 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -175.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.437 ' HA ' ' HD3' ' A' ' 154' ' ' PRO . 32.5 Cg_exo -58.13 136.33 74.18 Favored 'Trans proline' 0 CA--C 1.565 2.058 0 C-N-CA 122.909 2.406 . . . . 0.0 114.271 178.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 153' ' ' PRO . 20.3 Cg_exo . . . . . 0 CA--C 1.553 1.474 0 C-N-CA 123.042 2.495 . . . . 0.0 113.01 179.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 1.1 p90 . . . . . 0 CA--C 1.555 1.17 0 CA-C-O 122.02 0.914 . . . . 0.0 111.352 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.432 ' H ' HD21 ' A' ' 85' ' ' ASN . 4.6 mptp? -138.81 145.54 40.23 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 113.401 -1.727 . . . . 0.0 108.4 172.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.451 ' HD3' ' CG2' ' A' ' 97' ' ' THR . 7.4 ttpp -100.0 111.25 23.56 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 114.109 -1.405 . . . . 0.0 107.878 175.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 87.3 m -89.79 131.18 35.87 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 114.565 -1.198 . . . . 0.0 108.864 175.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.66 147.02 35.74 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 113.724 -1.58 . . . . 0.0 109.199 173.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.46 HG11 HD23 ' A' ' 137' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.256 1.402 0 CA-C-N 113.652 -1.613 . . . . 0.0 109.836 172.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 N--CA 1.483 1.209 0 CA-C-O 121.902 0.858 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.478 ' HB3' ' HB2' ' A' ' 149' ' ' MET . 32.4 p90 -107.08 138.1 43.89 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 114.22 -1.355 . . . . 0.0 110.65 176.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -115.61 129.81 56.64 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.055 175.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -88.47 127.15 35.51 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 113.679 -1.6 . . . . 0.0 110.944 175.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.434 HG21 HD12 ' A' ' 111' ' ' LEU . 20.8 mm -130.73 126.7 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 -177.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.6 m -88.9 132.79 34.53 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-O 123.561 1.648 . . . . 0.0 108.175 167.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.48 HD11 ' HA ' ' A' ' 105' ' ' ALA . 3.6 tp -136.01 150.17 49.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 112.263 -2.244 . . . . 0.0 107.931 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -80.11 140.42 36.43 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 122.065 0.936 . . . . 0.0 110.419 173.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.657 ' HD2' ' H ' ' A' ' 142' ' ' SER . 2.4 tmt_? -92.52 114.72 27.34 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 172.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.72 116.02 8.69 Favored Glycine 0 CA--C 1.541 1.706 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.318 164.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -61.5 -42.17 98.4 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 -168.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 57.1 m -83.55 -17.1 42.96 Favored 'General case' 0 CA--C 1.564 1.496 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 167.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -179.29 126.01 1.02 Allowed Glycine 0 C--N 1.343 0.936 0 N-CA-C 108.177 -1.969 . . . . 0.0 108.177 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.448 HD23 ' CZ ' ' A' ' 77' ' ' PHE . 6.6 mp -66.76 -74.73 0.11 Allowed 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.698 0.799 . . . . 0.0 108.944 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.431 ' HA3' ' CA ' ' A' ' 103' ' ' GLY . . . 120.41 45.07 0.41 Allowed Glycine 0 CA--C 1.535 1.307 0 C-N-CA 124.476 1.036 . . . . 0.0 115.408 178.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.448 ' CZ ' HD23 ' A' ' 75' ' ' LEU . 0.8 OUTLIER -157.2 138.89 14.09 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 123.4 1.571 . . . . 0.0 109.472 -178.551 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.409 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 2.6 m -106.67 113.8 27.51 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.431 -1.259 . . . . 0.0 112.395 -166.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.56 HG22 HG12 ' A' ' 96' ' ' ILE . 1.1 pt -92.39 123.58 44.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.041 -175.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -83.34 -170.86 3.26 Favored 'General case' 0 CA--C 1.557 1.24 0 CA-C-O 123.5 1.619 . . . . 0.0 110.043 159.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 85' ' ' ASN . . . -94.72 160.65 23.48 Favored Glycine 0 CA--C 1.539 1.54 0 CA-C-O 123.715 1.73 . . . . 0.0 117.126 -138.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -109.62 -161.47 19.14 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-N 111.289 -2.456 . . . . 0.0 114.251 178.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 43.1 p -54.26 -41.87 69.31 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 117.222 2.304 . . . . 0.0 117.222 178.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -81.44 -19.28 42.77 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 116.371 1.989 . . . . 0.0 116.371 172.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.402 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 1.0 OUTLIER -141.27 84.04 13.09 Favored Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 102.587 -3.116 . . . . 0.0 102.587 -171.544 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -99.27 123.1 0.13 Allowed 'Trans proline' 0 CA--C 1.548 1.221 0 CA-C-N 124.385 2.602 . . . . 0.0 109.733 -175.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 39.1 t-80 -74.89 -29.1 60.89 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 162.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.46 ' H ' HD12 ' A' ' 88' ' ' ILE . 0.3 OUTLIER -109.84 172.28 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 C-N-CA 126.248 1.819 . . . . 0.0 109.93 -178.213 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.15 -109.77 0.01 OUTLIER Glycine 0 CA--C 1.543 1.796 0 N-CA-C 115.98 1.152 . . . . 0.0 115.98 -176.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -99.65 24.21 8.57 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -173.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.47 75.03 8.79 Favored Pre-proline 0 CA--C 1.549 0.94 0 CA-C-N 119.312 0.96 . . . . 0.0 110.49 169.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -63.96 104.3 0.47 Allowed 'Trans proline' 0 C--N 1.369 1.632 0 C-N-CA 122.97 2.447 . . . . 0.0 112.791 171.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 63.0 m -160.5 124.79 3.65 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 -176.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.539 HG13 ' HB2' ' A' ' 133' ' ' ALA . 11.1 mm -69.86 131.94 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -170.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.483 ' HB2' ' O ' ' A' ' 115' ' ' ASP . 21.2 p90 -140.38 128.82 22.68 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.405 -1.271 . . . . 0.0 108.297 -168.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.573 HD12 ' HB2' ' A' ' 114' ' ' ASN . 70.2 mt -85.25 112.02 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 173.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 23.2 m -85.86 -28.56 24.34 Favored 'General case' 0 CA--C 1.556 1.199 0 CA-C-N 113.667 -1.606 . . . . 0.0 113.191 169.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.409 ' HB2' ' HB2' ' A' ' 78' ' ' SER . 27.4 mtpp -134.73 159.01 42.64 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 123.486 1.613 . . . . 0.0 111.203 -173.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -120.57 124.79 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 103.316 -2.846 . . . . 0.0 103.316 177.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.287 1.2 mp -66.51 130.72 94.14 Favored Pre-proline 0 CA--C 1.573 1.854 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.304 170.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.94 132.09 40.44 Favored 'Trans proline' 0 CA--C 1.554 1.493 0 C-N-CA 123.432 2.754 . . . . 0.0 114.156 173.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.46 14.17 82.77 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 117.249 1.66 . . . . 0.0 117.249 -163.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.431 ' CA ' ' HA3' ' A' ' 76' ' ' GLY . . . -89.92 171.07 37.03 Favored Glycine 0 C--N 1.337 0.638 0 CA-C-O 122.672 1.151 . . . . 0.0 114.388 -177.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.62 -38.0 70.84 Favored 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -172.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.48 ' HA ' HD11 ' A' ' 68' ' ' LEU . . . -66.28 -38.71 88.42 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 172.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.86 -42.71 76.71 Favored 'General case' 0 CA--C 1.562 1.421 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 170.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -72.54 -52.12 17.0 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.202 1.001 . . . . 0.0 113.685 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -69.0 -50.01 52.67 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.512 1.125 . . . . 0.0 112.351 -176.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.04 -146.48 5.14 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 124.657 2.254 . . . . 0.0 111.373 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.71 26.91 0.15 Allowed 'General case' 0 CA--C 1.567 1.622 0 CA-C-N 110.478 -2.861 . . . . 0.0 111.71 -172.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.868 ' H ' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -76.0 31.38 0.11 Allowed 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 126.127 1.771 . . . . 0.0 114.238 177.9 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . 0.308 67.0 mtp180 71.7 -178.63 0.21 Allowed 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 126.082 2.848 . . . . 0.0 111.108 -167.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.502 ' HB ' HG22 ' A' ' 96' ' ' ILE 0.374 17.2 m -25.03 -69.48 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.581 0 CA-C-N 110.534 -3.03 . . . . 0.0 114.406 146.822 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.573 ' HB2' HD12 ' A' ' 96' ' ' ILE . 8.6 t-20 172.38 -33.1 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 129.142 2.977 . . . . 0.0 106.685 168.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.483 ' O ' ' HB2' ' A' ' 95' ' ' PHE 0.289 35.1 t70 81.87 -70.38 0.07 Allowed 'General case' 0 C--N 1.354 0.792 0 C-N-CA 126.053 1.741 . . . . 0.0 111.258 -177.434 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 45.4 m -155.78 77.57 0.97 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 -170.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.0 tp -66.65 124.39 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-O 121.667 0.746 . . . . 0.0 109.261 171.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.459 ' HA ' ' HB3' ' A' ' 126' ' ' ARG 0.259 0.8 OUTLIER -108.38 -43.97 4.21 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 174.699 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -129.85 133.68 47.07 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 104.786 -2.302 . . . . 0.0 104.786 177.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.7 p -123.76 123.49 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 174.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . 0.32 32.7 m-80 80.77 -72.2 0.06 Allowed 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 123.954 1.835 . . . . 0.0 110.37 -175.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -177.11 -17.57 0.01 OUTLIER 'General case' 0 CA--C 1.576 1.959 0 C-N-CA 129.006 2.923 . . . . 0.0 109.247 -173.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.412 HG12 HG13 ' A' ' 125' ' ' VAL . 2.2 t -64.9 135.56 28.02 Favored 'Isoleucine or valine' 0 C--N 1.363 1.173 0 C-N-CA 125.69 1.596 . . . . 0.0 110.131 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -78.84 86.41 4.75 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 111.131 -2.759 . . . . 0.0 111.226 173.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.414 HG11 ' HA ' ' A' ' 133' ' ' ALA . 0.1 OUTLIER -94.99 -105.12 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 176.127 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.469 ' HG3' ' H ' ' A' ' 127' ' ' GLU 0.285 14.0 ptt85 47.42 -98.68 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.674 1.189 . . . . 0.0 113.85 -176.549 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.469 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 1.5 tt0 -71.46 72.95 0.72 Allowed 'General case' 0 CA--C 1.555 1.146 0 CA-C-O 124.227 1.965 . . . . 0.0 111.885 168.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.7 p -147.34 167.41 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 CA-C-N 112.141 -2.299 . . . . 0.0 105.153 -174.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 34.9 p -57.2 130.85 48.01 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 112.579 -2.1 . . . . 0.0 112.051 156.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.448 ' HA ' HD12 ' A' ' 94' ' ' ILE . 2.1 p-80 -48.16 -33.1 7.86 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 116.845 2.165 . . . . 0.0 116.845 168.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.562 ' HA ' HG12 ' A' ' 134' ' ' VAL . 13.2 m -63.61 -38.94 93.04 Favored 'General case' 0 CA--C 1.559 1.301 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 172.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.11 -32.93 73.58 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 167.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.539 ' HB2' HG13 ' A' ' 94' ' ' ILE . . . -73.18 -47.81 40.57 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 171.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.562 HG12 ' HA ' ' A' ' 131' ' ' SER . 11.3 p -52.07 -44.82 40.54 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.532 0 CA-C-N 120.47 1.486 . . . . 0.0 113.87 162.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -53.98 -52.02 62.05 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-O 115.989 -1.958 . . . . 0.0 112.23 170.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.24 -29.86 68.78 Favored 'General case' 0 CA--C 1.558 1.266 0 N-CA-C 118.108 2.633 . . . . 0.0 118.108 175.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 7.0 mp -55.49 -52.88 62.2 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.161 1.384 . . . . 0.0 112.821 162.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -69.33 -41.24 76.93 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 171.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -66.86 -4.65 9.83 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 116.524 2.046 . . . . 0.0 116.524 169.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.44 ' HB1' ' HA ' ' A' ' 144' ' ' VAL . . . -52.0 -36.08 48.68 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 117.018 2.229 . . . . 0.0 117.018 158.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 64.97 79.01 0.19 Allowed Glycine 0 C--N 1.348 1.233 0 O-C-N 123.849 0.718 . . . . 0.0 113.115 163.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.657 ' H ' ' HD2' ' A' ' 70' ' ' ARG 0.267 15.7 m 73.81 -27.08 0.19 Allowed 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 117.561 2.43 . . . . 0.0 117.561 -172.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -145.88 107.98 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -171.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.44 ' HA ' ' HB1' ' A' ' 140' ' ' ALA . 1.6 t -91.14 115.16 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 125.846 1.658 . . . . 0.0 107.324 175.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 5.2 ttp180 -97.3 100.16 11.61 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 172.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 36.8 mt -90.75 142.41 27.79 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.532 -175.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -131.17 113.57 14.04 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 173.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.72 123.73 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -175.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.478 ' HB2' ' HB3' ' A' ' 63' ' ' TYR . 25.7 ttt -111.12 134.2 52.9 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 124.366 1.041 . . . . 0.0 111.208 165.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.402 ' HE ' ' CG ' ' A' ' 115' ' ' ASP . 22.6 mtp180 -93.22 136.6 33.33 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.046 -1.433 . . . . 0.0 109.6 169.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -87.06 122.16 30.51 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 113.954 -1.475 . . . . 0.0 109.513 -179.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -63.99 -55.19 34.43 Favored Pre-proline 0 N--CA 1.486 1.33 0 CA-C-O 115.311 -2.281 . . . . 0.0 112.756 170.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.418 ' HA ' ' HD3' ' A' ' 154' ' ' PRO . 32.9 Cg_endo -63.45 123.92 12.9 Favored 'Trans proline' 0 CA--C 1.568 2.178 0 CA-C-N 124.16 2.521 . . . . 0.0 112.163 173.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 153' ' ' PRO . 19.3 Cg_exo . . . . . 0 C--N 1.366 1.462 0 C-N-CA 123.11 2.54 . . . . 0.0 112.874 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.561 1.367 0 CA-C-O 123.699 1.714 . . . . 0.0 110.835 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -161.6 123.0 2.81 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 172.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -82.17 122.94 28.52 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 114.201 -1.363 . . . . 0.0 109.054 175.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 2.9 m -81.91 127.3 32.88 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 122.177 0.989 . . . . 0.0 108.389 170.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.0 103.53 16.24 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.422 ' HB ' ' O ' ' A' ' 77' ' ' PHE . 9.5 t . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -169.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 . . . . . 0 N--CA 1.485 1.306 0 CA-C-O 121.66 0.743 . . . . 0.0 112.289 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.492 ' HB3' ' HB2' ' A' ' 149' ' ' MET . 43.0 p90 -111.65 136.1 51.34 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 114.3 -1.318 . . . . 0.0 111.04 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -102.26 138.46 39.17 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.14 176.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -107.07 125.41 51.01 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.541 HG12 ' HB2' ' A' ' 146' ' ' LEU . 0.1 OUTLIER -141.72 111.69 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 -174.501 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 86.3 m -84.67 129.81 34.79 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 122.224 1.012 . . . . 0.0 108.352 170.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.463 HD11 ' HA ' ' A' ' 105' ' ' ALA . 0.9 OUTLIER -137.62 128.14 26.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 113.317 -1.765 . . . . 0.0 107.085 -176.189 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -72.32 130.69 41.34 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 121.943 -0.473 . . . . 0.0 110.303 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 27.8 ttt-85 -75.21 123.81 25.95 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 173.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -64.96 155.52 48.53 Favored Glycine 0 CA--C 1.539 1.576 0 CA-C-N 113.968 -1.469 . . . . 0.0 112.78 171.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 57.7 m-80 -64.14 -51.94 61.47 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 113.512 -1.344 . . . . 0.0 113.233 -176.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 45.9 m -99.66 -16.56 18.15 Favored 'General case' 0 CA--C 1.561 1.403 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 175.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -154.38 119.85 0.97 Allowed Glycine 0 C--N 1.349 1.254 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.446 HD21 HG21 ' A' ' 144' ' ' VAL . 2.7 tt -63.02 -34.72 78.16 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 167.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.28 41.69 2.35 Favored Glycine 0 N--CA 1.475 1.259 0 O-C-N 120.434 -1.416 . . . . 0.0 116.376 168.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.473 ' HB2' HG13 ' B' ' 6' ' ' VAL . 72.4 m-85 -151.76 165.95 32.85 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 122.643 1.211 . . . . 0.0 110.883 179.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.32 121.75 20.52 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 168.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.72 HG22 HG12 ' A' ' 96' ' ' ILE . 6.4 pt -90.97 133.69 31.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 113.331 -1.758 . . . . 0.0 111.006 -177.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.56 ' HB1' HD11 ' A' ' 88' ' ' ILE . . . -88.36 -174.81 4.77 Favored 'General case' 0 CA--C 1.558 1.274 0 CA-C-O 123.258 1.504 . . . . 0.0 110.055 158.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -96.18 159.45 21.98 Favored Glycine 0 CA--C 1.539 1.568 0 CA-C-O 123.2 1.444 . . . . 0.0 116.059 -144.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -108.35 -164.19 20.99 Favored Glycine 0 N--CA 1.47 0.933 0 CA-C-N 112.276 -1.962 . . . . 0.0 112.226 -176.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.533 HG22 ' HB2' ' A' ' 92' ' ' PRO . 43.5 p -50.49 -39.11 47.5 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 118.355 2.724 . . . . 0.0 118.355 -177.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -73.8 -23.87 59.74 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 171.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -139.37 74.89 34.15 Favored Pre-proline 0 CA--C 1.567 1.622 0 N-CA-C 104.209 -2.515 . . . . 0.0 104.209 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -107.98 115.59 0.03 OUTLIER 'Trans proline' 0 C--N 1.364 1.386 0 CA-C-N 125.26 2.914 . . . . 0.0 111.092 -164.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -107.45 -43.97 4.41 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.56 HD11 ' HB1' ' A' ' 80' ' ' ALA . 0.8 OUTLIER -105.95 140.94 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -147.774 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.94 -111.58 3.49 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.766 170.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -80.46 -4.59 54.34 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 169.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.427 ' HB2' ' HD3' ' A' ' 92' ' ' PRO 0.457 33.4 m-20 103.32 -80.75 0.0 OUTLIER Pre-proline 0 CA--C 1.562 1.418 0 C-N-CA 126.561 1.944 . . . . 0.0 107.77 -172.122 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.533 ' HB2' HG22 ' A' ' 83' ' ' THR . 46.2 Cg_endo -94.15 89.01 0.13 Allowed 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 123.676 2.917 . . . . 0.0 112.533 -168.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 58.7 m -158.61 140.15 13.46 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 177.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.463 HD12 ' HA ' ' A' ' 130' ' ' HIS . 21.7 mm -81.46 130.07 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 -177.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.478 ' HA ' ' O ' ' A' ' 115' ' ' ASP . 40.4 m-85 -119.4 149.82 41.21 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 113.484 -1.689 . . . . 0.0 110.509 175.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.72 HG12 HG22 ' A' ' 79' ' ' ILE . 72.6 mt -106.06 114.55 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 104.381 -2.451 . . . . 0.0 104.381 148.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.9 t -98.74 -6.38 29.58 Favored 'General case' 0 CA--C 1.564 1.496 0 N-CA-C 115.386 1.625 . . . . 0.0 115.386 168.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -141.82 147.51 37.35 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-O 123.774 1.75 . . . . 0.0 108.963 -177.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.33 123.55 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 N-CA-C 103.224 -2.88 . . . . 0.0 103.224 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.368 1.2 mp -66.26 117.4 42.93 Favored Pre-proline 0 CA--C 1.566 1.567 0 CA-C-O 118.186 -0.912 . . . . 0.0 109.248 171.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -69.33 142.29 49.4 Favored 'Trans proline' 0 C--N 1.367 1.534 0 C-N-CA 123.224 2.616 . . . . 0.0 112.496 174.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.53 -6.05 19.1 Favored Glycine 0 CA--C 1.549 2.216 0 N-CA-C 117.772 1.869 . . . . 0.0 117.772 -168.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -83.67 -171.63 47.9 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-O 123.409 1.561 . . . . 0.0 112.157 175.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 75' ' ' LEU . . . -67.75 -41.87 82.7 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 -173.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.463 ' HA ' HD11 ' A' ' 68' ' ' LEU . . . -67.59 -26.41 66.26 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 119.719 3.229 . . . . 0.0 119.719 178.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -60.97 -46.03 92.39 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 166.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.56 -55.25 6.55 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 124.548 1.139 . . . . 0.0 113.082 174.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -60.09 -43.59 95.4 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.959 0.904 . . . . 0.0 112.015 -177.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 59.65 66.85 2.48 Favored Glycine 0 C--N 1.353 1.499 0 O-C-N 124.022 0.826 . . . . 0.0 112.979 164.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -106.61 -38.23 6.2 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 113.768 -1.216 . . . . 0.0 112.54 -174.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.471 HD13 HG13 ' A' ' 66' ' ' ILE . 2.0 pt? -143.34 -163.15 1.58 Allowed 'General case' 0 CA--C 1.553 1.077 0 CA-C-O 124.819 2.247 . . . . 0.0 107.058 -173.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . 0.266 6.0 mmt180 -75.1 -148.58 0.02 OUTLIER 'General case' 0 CA--C 1.559 1.301 0 CA-C-O 124.503 2.097 . . . . 0.0 111.968 164.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.439 ' HB ' HG22 ' A' ' 96' ' ' ILE 0.294 30.4 m -37.72 -67.91 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.737 0 CA-C-N 112.696 -2.047 . . . . 0.0 112.326 150.452 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.526 ' HB2' ' HB ' ' A' ' 96' ' ' ILE 0.311 0.6 OUTLIER 159.31 -39.32 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 128.077 2.551 . . . . 0.0 107.864 179.728 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 95' ' ' PHE 0.296 15.3 t70 67.72 -102.77 0.07 Allowed 'General case' 0 C--O 1.213 -0.839 0 C-N-CA 126.246 1.818 . . . . 0.0 106.737 178.65 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 66.8 m -100.8 69.41 1.35 Allowed 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.061 1.301 . . . . 0.0 110.424 -173.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.487 HD11 HG22 ' A' ' 120' ' ' VAL . 18.0 tt -67.7 124.18 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 CA-C-O 122.1 0.952 . . . . 0.0 109.47 174.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.723 HD21 ' HB3' ' A' ' 149' ' ' MET . 0.0 OUTLIER -117.25 -47.23 2.67 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 113.525 -1.671 . . . . 0.0 114.824 -179.882 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -119.68 141.04 49.73 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.487 HG22 HD11 ' A' ' 117' ' ' ILE . 2.1 t -129.75 110.73 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 102.165 -3.272 . . . . 0.0 102.165 177.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.738 HD21 ' HB2' ' A' ' 140' ' ' ALA 0.32 20.7 m-80 83.21 -83.2 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 123.649 1.69 . . . . 0.0 108.712 178.681 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -153.08 -16.05 0.15 Allowed 'General case' 0 CA--C 1.571 1.781 0 CA-C-N 110.539 -3.028 . . . . 0.0 110.48 178.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.1 t -62.6 136.92 25.16 Favored 'Isoleucine or valine' 0 C--N 1.363 1.156 0 C-N-CA 125.118 1.367 . . . . 0.0 110.088 173.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -100.87 96.91 7.6 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 111.891 -2.413 . . . . 0.0 108.408 178.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . 0.257 0.2 OUTLIER -96.02 -100.35 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 CA-C-O 116.44 -1.743 . . . . 0.0 107.588 179.378 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.539 ' HD3' ' HB3' ' A' ' 118' ' ' LEU 0.34 29.0 ptt180 50.94 -84.34 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 116.666 2.099 . . . . 0.0 116.666 -177.802 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.441 ' H ' ' HG3' ' A' ' 126' ' ' ARG . 1.9 mt-10 -79.13 69.5 5.33 Favored 'General case' 0 CA--C 1.557 1.226 0 CA-C-O 123.811 1.767 . . . . 0.0 110.486 168.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -147.76 168.57 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 -178.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.404 HG22 ' H ' ' A' ' 131' ' ' SER . 28.2 m -60.71 133.67 56.32 Favored 'General case' 0 CA--C 1.562 1.417 0 CA-C-N 114.262 -1.335 . . . . 0.0 110.529 158.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.463 ' HA ' HD12 ' A' ' 94' ' ' ILE . 7.7 p-80 -46.05 -33.86 3.71 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 118.024 2.602 . . . . 0.0 118.024 168.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.564 ' HA ' HG12 ' A' ' 134' ' ' VAL . 7.6 m -60.84 -38.26 84.87 Favored 'General case' 0 CA--C 1.559 1.316 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 173.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -70.78 -33.3 70.62 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 116.217 1.932 . . . . 0.0 116.217 167.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.457 ' HB2' HG13 ' A' ' 94' ' ' ILE . . . -74.48 -43.4 56.23 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 172.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.564 HG12 ' HA ' ' A' ' 131' ' ' SER . 2.3 p -55.69 -42.41 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 159.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -60.44 -46.36 90.33 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 116.097 -1.906 . . . . 0.0 113.27 170.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.05 -31.66 70.19 Favored 'General case' 0 CA--C 1.559 1.306 0 N-CA-C 116.951 2.204 . . . . 0.0 116.951 173.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.468 HD12 ' HA ' ' A' ' 134' ' ' VAL . 46.7 mt -58.94 -47.89 83.45 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 163.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -65.2 -44.76 87.3 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 168.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -64.03 -17.75 63.66 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 116.533 2.049 . . . . 0.0 116.533 174.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.738 ' HB2' HD21 ' A' ' 121' ' ' ASN . . . -53.5 -20.16 4.55 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 119.667 3.21 . . . . 0.0 119.667 160.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 91.45 -125.93 8.23 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 173.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 39.0 m -90.9 1.59 56.87 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 167.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -150.1 110.74 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -165.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.461 ' HA ' ' HB1' ' A' ' 140' ' ' ALA . 3.3 t -102.9 115.86 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 113.481 -1.69 . . . . 0.0 107.863 -172.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 78.4 mtt180 -96.91 101.28 12.83 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 175.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.541 ' HB2' HG12 ' A' ' 66' ' ' ILE . 14.0 mt -95.76 137.35 34.95 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -173.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -125.19 126.1 44.69 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -131.24 122.23 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 177.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.723 ' HB3' HD21 ' A' ' 118' ' ' LEU . 28.3 ttt -114.3 125.65 54.13 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 171.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -94.47 115.4 27.58 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 113.891 -1.504 . . . . 0.0 107.266 -177.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.93 153.46 8.65 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.952 166.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.22 123.66 89.36 Favored Pre-proline 0 CA--C 1.553 1.094 0 CA-C-O 117.489 -1.243 . . . . 0.0 109.253 -178.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.41 ' HA ' ' HD3' ' A' ' 154' ' ' PRO . 10.2 Cg_endo -53.57 120.56 8.03 Favored 'Trans proline' 0 CA--C 1.565 2.033 0 C-N-CA 123.462 2.775 . . . . 0.0 113.67 -176.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 153' ' ' PRO . 21.8 Cg_exo . . . . . 0 C--N 1.367 1.502 0 C-N-CA 123.027 2.485 . . . . 0.0 113.156 -176.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 2.7 p90 . . . . . 0 CA--C 1.55 0.974 0 CA-C-O 121.399 0.619 . . . . 0.0 110.352 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -130.02 146.89 51.72 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 123.538 1.637 . . . . 0.0 110.418 175.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 10.7 ttpp -107.82 113.7 27.13 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 113.222 -1.808 . . . . 0.0 108.1 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 43.6 m -84.81 137.35 33.23 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 122.029 0.918 . . . . 0.0 109.84 173.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.39 153.91 22.2 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-O 122.711 1.243 . . . . 0.0 110.146 176.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.473 HG13 ' HB2' ' A' ' 77' ' ' PHE . 4.2 p . . . . . 0 C--O 1.25 1.09 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 -171.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -128.72 139.41 52.23 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-O 122.708 1.242 . . . . 0.0 109.674 178.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -104.0 134.71 46.82 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 113.52 -1.673 . . . . 0.0 106.883 -176.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -105.26 118.7 37.22 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 -174.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.485 HG13 ' HB2' ' A' ' 146' ' ' LEU . 2.5 pt -136.58 104.27 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 N-CA-C 106.39 -1.708 . . . . 0.0 106.39 -168.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.2 m -98.98 126.23 44.63 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 173.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.679 HD22 ' HD2' ' A' ' 70' ' ' ARG . 0.8 OUTLIER -127.79 142.38 51.32 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.112 178.228 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -86.73 99.22 11.61 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 121.446 -0.784 . . . . 0.0 110.795 -177.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.679 ' HD2' HD22 ' A' ' 68' ' ' LEU . 0.7 OUTLIER -177.54 178.18 1.06 Allowed 'General case' 0 CA--C 1.558 1.288 0 CA-C-O 122.518 1.152 . . . . 0.0 111.874 -178.713 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 129.33 -159.12 22.32 Favored Glycine 0 N--CA 1.463 0.441 0 N-CA-C 107.958 -2.057 . . . . 0.0 107.958 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . 0.273 19.6 t-20 75.85 -90.64 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.165 0 CA-C-N 112.024 -2.088 . . . . 0.0 108.821 173.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 67.9 m -107.08 -17.85 14.06 Favored 'General case' 0 CA--C 1.56 1.358 0 CA-C-N 113.594 -1.639 . . . . 0.0 114.512 176.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -162.24 128.75 1.94 Allowed Glycine 0 C--N 1.348 1.217 0 CA-C-O 123.228 1.46 . . . . 0.0 110.429 -174.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.624 HD13 HG22 ' B' ' 6' ' ' VAL . 5.9 mp -106.76 -65.82 1.06 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 112.122 -2.039 . . . . 0.0 107.597 176.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.404 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 102.48 37.58 3.24 Favored Glycine 0 CA--C 1.532 1.121 0 N-CA-C 116.455 1.342 . . . . 0.0 116.455 -172.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -148.17 159.41 43.98 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-O 124.192 1.949 . . . . 0.0 107.254 168.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.536 ' O ' HG23 ' A' ' 96' ' ' ILE . 8.7 m -100.81 155.3 18.0 Favored 'General case' 0 C--N 1.313 -1.013 0 O-C-N 120.459 -1.401 . . . . 0.0 110.717 177.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.57 HD11 ' HB ' ' A' ' 134' ' ' VAL . 4.4 pt -129.09 132.65 66.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.572 174.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.435 ' CB ' HD11 ' A' ' 88' ' ' ILE . . . -91.15 -170.43 2.65 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-O 124.249 1.976 . . . . 0.0 108.477 163.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 85' ' ' ASN . . . -95.33 160.18 22.8 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-N 113.12 -1.855 . . . . 0.0 114.915 -142.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -108.45 -158.55 19.47 Favored Glycine 0 CA--C 1.52 0.4 0 CA-C-N 111.542 -2.329 . . . . 0.0 111.852 -175.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.533 HG22 ' HB2' ' A' ' 92' ' ' PRO . 42.2 p -54.73 -39.76 68.57 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 117.627 2.454 . . . . 0.0 117.627 -176.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -73.85 -24.87 59.82 Favored 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 116.268 1.951 . . . . 0.0 116.268 170.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.443 HD22 ' CE1' ' A' ' 130' ' ' HIS . 0.2 OUTLIER -139.97 82.3 17.64 Favored Pre-proline 0 CA--C 1.556 1.177 0 N-CA-C 103.111 -2.922 . . . . 0.0 103.111 -176.119 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.43 ' HB2' ' HB3' ' A' ' 91' ' ' ASP . 85.3 Cg_endo -107.5 118.24 0.03 OUTLIER 'Trans proline' 0 CA--C 1.548 1.224 0 CA-C-N 125.165 2.88 . . . . 0.0 111.288 -169.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -106.28 -38.71 6.15 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.435 HD11 ' CB ' ' A' ' 80' ' ' ALA . 0.6 OUTLIER -115.19 133.09 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 -147.795 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.75 -109.47 2.86 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-N 115.021 -0.991 . . . . 0.0 112.959 167.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -76.78 -9.25 58.55 Favored 'General case' 0 CA--C 1.562 1.406 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 171.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.455 ' HB2' ' HD3' ' A' ' 92' ' ' PRO 0.455 5.5 m-20 101.68 -84.53 0.0 OUTLIER Pre-proline 0 CA--C 1.566 1.575 0 C-N-CA 126.102 1.761 . . . . 0.0 107.617 -176.92 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.533 ' HB2' HG22 ' A' ' 83' ' ' THR . 30.5 Cg_endo -92.47 80.77 0.29 Allowed 'Trans proline' 0 C--N 1.367 1.522 0 C-N-CA 123.859 3.039 . . . . 0.0 112.948 -165.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 73.1 m -157.24 134.68 10.55 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 104.4 -2.444 . . . . 0.0 104.4 -177.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.456 HD12 ' HA ' ' A' ' 130' ' ' HIS . 14.0 mm -76.92 121.5 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 -176.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -113.61 151.18 32.05 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 113.714 -1.584 . . . . 0.0 107.492 176.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.55 HG12 HG22 ' A' ' 79' ' ' ILE 0.29 3.4 mt -93.95 122.77 45.7 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.499 0 N-CA-C 105.094 -2.188 . . . . 0.0 105.094 166.147 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.5 m -78.98 -54.95 5.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.934 -1.104 . . . . 0.0 112.778 179.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.497 ' HA ' HG21 ' A' ' 113' ' ' VAL . 36.2 mtpt -147.79 162.92 38.24 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 124.27 1.986 . . . . 0.0 111.138 -164.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.88 104.71 17.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 1 N-CA-C 99.742 -4.17 . . . . 0.0 99.742 -170.449 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.283 1.3 mp -65.41 118.75 53.55 Favored Pre-proline 0 CA--C 1.566 1.572 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -176.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -61.19 134.16 50.84 Favored 'Trans proline' 0 C--N 1.364 1.346 0 C-N-CA 122.997 2.465 . . . . 0.0 112.993 173.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.67 -4.81 85.26 Favored Glycine 0 CA--C 1.544 1.874 0 N-CA-C 118.22 2.048 . . . . 0.0 118.22 -172.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.404 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -90.23 -173.07 44.83 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-O 123.499 1.61 . . . . 0.0 113.116 174.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.53 -34.52 72.38 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 116.363 1.986 . . . . 0.0 116.363 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -53.11 -42.43 65.98 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 120.126 1.33 . . . . 0.0 114.184 163.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.462 ' HA ' ' HB2' ' A' ' 110' ' ' ARG . . . -53.55 -40.73 65.77 Favored 'General case' 0 CA--C 1.562 1.426 0 N-CA-C 116.305 1.965 . . . . 0.0 116.305 174.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.32 -53.47 14.11 Favored 'General case' 0 CA--C 1.561 1.368 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 174.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -94.78 -28.68 15.15 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -167.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.33 86.63 0.09 OUTLIER Glycine 0 CA--C 1.532 1.129 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 176.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.462 ' HB2' ' HA ' ' A' ' 106' ' ' ALA . 29.1 ttm105 -89.73 69.57 7.69 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 122.057 0.932 . . . . 0.0 110.818 -175.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -162.35 -178.23 6.17 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 121.609 0.719 . . . . 0.0 110.294 -177.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 30.8 ptt180 50.81 26.83 2.77 Favored 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 118.891 2.922 . . . . 0.0 118.891 154.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.497 HG21 ' HA ' ' A' ' 98' ' ' LYS . 0.4 OUTLIER -47.98 -59.13 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-O 114.795 -2.526 . . . . 0.0 112.02 -179.803 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -43.58 71.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 117.88 2.548 . . . . 0.0 117.88 164.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -142.51 118.16 10.41 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 102.001 -3.333 . . . . 0.0 102.001 -171.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 12.8 m -73.82 86.85 1.73 Allowed 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 113.772 -1.558 . . . . 0.0 110.215 -170.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.3 tp -63.35 116.06 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 CA-C-O 122.11 0.957 . . . . 0.0 110.038 -176.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.513 HD23 ' HB2' ' A' ' 149' ' ' MET . 3.1 pp -96.64 -48.04 5.67 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 112.809 -1.996 . . . . 0.0 114.001 174.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -135.42 128.22 31.13 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 -175.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.512 HG23 HD23 ' A' ' 146' ' ' LEU . 5.5 p -121.72 122.26 66.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 172.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.55 HD21 ' HB2' ' A' ' 140' ' ' ALA 0.27 45.6 m-80 79.37 -65.3 0.2 Allowed 'General case' 0 N--CA 1.503 2.198 0 CA-C-O 122.818 1.294 . . . . 0.0 111.558 -173.507 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 176.52 -25.28 0.0 OUTLIER 'General case' 0 CA--C 1.573 1.842 0 C-N-CA 128.408 2.683 . . . . 0.0 110.174 -162.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.467 HG12 HG13 ' A' ' 125' ' ' VAL . 2.1 t -70.04 135.83 27.39 Favored 'Isoleucine or valine' 0 C--N 1.361 1.085 0 C-N-CA 125.148 1.379 . . . . 0.0 109.409 179.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -88.21 100.0 12.64 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 113.209 -1.814 . . . . 0.0 109.841 176.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.605 HG11 ' HA ' ' A' ' 133' ' ' ALA 0.251 3.3 m -94.79 -119.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 CA-C-O 116.959 -1.496 . . . . 0.0 107.62 174.902 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.696 ' HD2' ' H ' ' A' ' 127' ' ' GLU 0.475 1.0 OUTLIER 56.14 -78.43 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -174.283 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.696 ' H ' ' HD2' ' A' ' 126' ' ' ARG . 25.3 tt0 -79.81 67.1 5.49 Favored 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 126.388 1.875 . . . . 0.0 111.288 168.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -153.77 167.92 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 -177.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 27.0 m -64.37 134.1 53.92 Favored 'General case' 0 CA--C 1.561 1.386 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.151 158.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.456 ' HA ' HD12 ' A' ' 94' ' ' ILE . 4.7 p-80 -48.59 -31.51 6.72 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 118.64 2.83 . . . . 0.0 118.64 170.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.519 ' HA ' HG12 ' A' ' 134' ' ' VAL . 6.4 m -60.73 -38.6 85.67 Favored 'General case' 0 CA--C 1.563 1.465 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 171.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -67.53 -37.95 83.51 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 166.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.605 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -63.88 -52.44 59.97 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 170.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.57 ' HB ' HD11 ' A' ' 79' ' ' ILE . 3.4 p -54.9 -39.93 50.82 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.25 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 168.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -64.72 -40.46 95.37 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 117.058 -1.448 . . . . 0.0 114.181 173.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -67.98 -33.12 74.03 Favored 'General case' 0 CA--C 1.562 1.423 0 N-CA-C 116.539 2.052 . . . . 0.0 116.539 167.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.482 HD12 HG21 ' A' ' 120' ' ' VAL . 8.7 mp -54.24 -49.17 70.1 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 125.391 1.476 . . . . 0.0 113.763 160.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -66.31 -41.66 89.37 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 169.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -65.17 -17.69 64.69 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 116.461 2.023 . . . . 0.0 116.461 172.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.55 ' HB2' HD21 ' A' ' 121' ' ' ASN . . . -52.33 -41.84 63.33 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 117.622 2.453 . . . . 0.0 117.622 164.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 71.0 72.21 0.93 Allowed Glycine 0 C--N 1.339 0.714 0 CA-C-O 118.528 -1.151 . . . . 0.0 114.779 159.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . 0.267 4.5 m 68.5 -3.1 1.43 Allowed 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 117.906 2.558 . . . . 0.0 117.906 -173.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -148.38 103.19 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.251 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 171.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.441 ' HA ' ' HB1' ' A' ' 140' ' ' ALA . 36.0 m -84.99 122.38 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 124.034 0.934 . . . . 0.0 109.233 168.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 50.1 mtt180 -101.92 87.12 3.03 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 171.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.512 HD23 HG23 ' A' ' 120' ' ' VAL . 49.7 mt -92.01 136.53 33.1 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-O 122.47 1.129 . . . . 0.0 108.315 -172.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -132.48 118.12 18.89 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 104.359 -2.46 . . . . 0.0 104.359 178.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 33.6 m -126.71 133.0 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -167.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.513 ' HB2' HD23 ' A' ' 118' ' ' LEU . 26.7 ttt -92.17 148.45 22.15 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 123.621 1.677 . . . . 0.0 111.657 175.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.557 ' HA ' ' HE ' ' A' ' 150' ' ' ARG . 0.4 OUTLIER -93.88 123.87 37.51 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 112.698 -2.047 . . . . 0.0 108.455 163.42 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -53.15 -57.72 9.5 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 114.262 -1.335 . . . . 0.0 113.637 172.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 13.0 tptm -174.84 122.18 0.36 Allowed Pre-proline 0 CA--C 1.557 1.247 0 CA-C-O 116.936 -1.507 . . . . 0.0 108.974 -178.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -74.67 117.23 4.87 Favored 'Trans proline' 0 CA--C 1.568 2.204 0 C-N-CA 123.301 2.668 . . . . 0.0 111.749 173.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo . . . . . 0 C--N 1.366 1.458 0 C-N-CA 123.219 2.613 . . . . 0.0 112.261 177.658 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.559 1.292 0 CA-C-O 122.201 1.001 . . . . 0.0 111.695 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -139.33 138.89 37.05 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 123.341 1.543 . . . . 0.0 110.005 173.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -102.86 124.42 48.35 Favored 'General case' 0 CA--C 1.553 1.068 0 CA-C-N 113.452 -1.704 . . . . 0.0 108.294 172.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.43 HG21 HG11 ' A' ' 134' ' ' VAL . 20.1 m -92.68 129.2 38.68 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.243 172.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -103.29 101.55 11.48 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 -174.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.624 HG22 HD13 ' A' ' 75' ' ' LEU . 1.4 p . . . . . 0 C--O 1.252 1.208 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.338 -176.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' BAL . . . . . 0.448 ' O ' ' HB2' ' A' ' 98' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 N--CA 1.48 1.031 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -130.27 133.76 46.73 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 124.048 0.842 . . . . 0.0 109.304 -178.54 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -111.91 140.05 46.89 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.173 -178.037 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -115.48 117.13 29.52 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 114.518 -1.219 . . . . 0.0 108.054 -178.76 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.4 mp -134.41 124.89 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 -171.533 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.8 m -97.11 125.1 41.35 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 168.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 mp -123.67 137.85 54.64 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -177.848 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -112.56 131.78 55.44 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -172.56 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.634 ' HB2' ' HB2' ' A' ' 104' ' ' ALA . 6.7 tpm_? -157.48 -112.19 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.942 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.97 173.271 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 95.21 -154.08 20.99 Favored Glycine 0 C--N 1.341 0.842 0 C-N-CA 124.424 1.012 . . . . 0.0 111.753 -172.856 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . 0.278 25.9 t-20 73.08 -91.69 0.02 OUTLIER 'General case' 0 CA--C 1.562 1.405 0 CA-C-N 114.046 -1.077 . . . . 0.0 110.413 -179.648 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 64.9 m -105.1 -16.83 14.68 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 177.476 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -177.08 -149.49 7.78 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-O 124.875 2.375 . . . . 0.0 109.895 176.416 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.486 HD23 ' N ' ' A' ' 75' ' ' LEU . 0.3 OUTLIER -129.51 -4.31 4.79 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 111.438 -2.381 . . . . 0.0 112.247 -179.968 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.594 ' HA3' ' HA3' ' A' ' 103' ' ' GLY . . . 72.39 42.38 49.27 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 119.577 2.591 . . . . 0.0 119.577 163.054 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.449 ' CZ ' HD12 ' A' ' 75' ' ' LEU . 13.1 p90 -157.87 128.22 6.26 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 176.741 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.476 ' HB3' ' HD2' ' B' ' 3' ' ' LYS . 48.1 m -85.19 144.73 27.98 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.789 -1.55 . . . . 0.0 111.663 176.362 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.531 HG22 HD13 ' A' ' 96' ' ' ILE . 2.3 pp -119.2 127.92 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 113.013 -1.903 . . . . 0.0 109.546 -176.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.78 -166.74 0.94 Allowed 'General case' 0 CA--C 1.553 1.091 0 CA-C-O 123.417 1.579 . . . . 0.0 111.024 159.632 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.78 159.24 22.2 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-O 123.936 1.853 . . . . 0.0 115.195 -143.407 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.51 -161.18 23.23 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-N 111.162 -2.519 . . . . 0.0 113.057 179.191 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.405 HG22 ' HB2' ' A' ' 92' ' ' PRO . 71.4 p -53.99 -40.27 66.8 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 -177.638 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.451 ' HB2' HG23 ' A' ' 129' ' ' THR . 5.9 m-20 -92.88 7.9 41.91 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 116.099 1.889 . . . . 0.0 116.099 175.543 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -161.16 86.67 1.7 Allowed Pre-proline 0 CA--C 1.553 1.092 0 N-CA-C 101.154 -3.647 . . . . 0.0 101.154 178.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.404 ' HB2' ' HB3' ' A' ' 91' ' ' ASP . 61.0 Cg_endo -108.48 124.53 0.04 OUTLIER 'Trans proline' 0 CA--C 1.549 1.237 0 CA-C-N 124.437 2.62 . . . . 0.0 111.634 -173.023 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -109.03 -34.59 6.56 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 176.224 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -148.0 161.7 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 CA-C-O 123.268 1.508 . . . . 0.0 109.592 -151.802 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.45 -111.08 3.21 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-N 113.365 -1.743 . . . . 0.0 109.822 177.081 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -103.39 5.33 37.08 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 112.978 -1.611 . . . . 0.0 114.518 168.002 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.404 ' HB3' ' HB2' ' A' ' 86' ' ' PRO 0.428 75.9 m-20 100.93 -76.49 0.0 OUTLIER Pre-proline 0 CA--C 1.568 1.66 0 CA-C-O 116.262 -1.828 . . . . 0.0 108.711 -165.939 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.405 ' HB2' HG22 ' A' ' 83' ' ' THR . 81.2 Cg_endo -88.56 80.9 0.94 Allowed 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 123.409 2.74 . . . . 0.0 113.023 -176.338 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 52.9 m -156.65 109.63 2.59 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 105.512 -2.032 . . . . 0.0 105.512 -173.651 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.484 HD12 ' HA ' ' A' ' 130' ' ' HIS . 8.1 mm -68.95 117.9 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 178.559 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -129.26 140.24 51.52 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 113.459 -1.701 . . . . 0.0 107.514 -163.488 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.531 HD13 HG22 ' A' ' 79' ' ' ILE . 7.4 mm -85.84 107.46 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.346 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 175.365 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 77.0 m -91.11 -35.06 14.81 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 117.4 -1.286 . . . . 0.0 113.74 175.54 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.468 ' HA ' HG11 ' A' ' 113' ' ' VAL 0.321 0.0 OUTLIER -144.18 165.14 28.67 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 123.299 1.524 . . . . 0.0 111.72 175.54 . . . . . . . . 4 4 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -111.83 126.37 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 -176.451 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.304 1.4 mp -72.25 130.44 86.23 Favored Pre-proline 0 CA--C 1.567 1.606 0 CA-C-O 118.252 -0.88 . . . . 0.0 109.2 169.454 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -58.88 130.6 37.51 Favored 'Trans proline' 0 C--N 1.367 1.511 0 C-N-CA 123.54 2.826 . . . . 0.0 114.521 174.924 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 72.12 20.99 79.34 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 117.153 1.621 . . . . 0.0 117.153 -167.042 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.594 ' HA3' ' HA3' ' A' ' 76' ' ' GLY . . . -85.93 -176.81 50.09 Favored Glycine 0 C--N 1.337 0.636 0 N-CA-C 116.399 1.32 . . . . 0.0 116.399 177.203 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.634 ' HB2' ' HB2' ' A' ' 70' ' ' ARG . . . -63.81 -51.61 63.96 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 178.415 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.49 -38.91 89.04 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 174.167 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.92 -42.03 77.35 Favored 'General case' 0 CA--C 1.565 1.527 0 N-CA-C 115.821 1.786 . . . . 0.0 115.821 170.528 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.67 -51.1 20.83 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.604 1.162 . . . . 0.0 113.877 178.526 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -71.48 -49.85 37.25 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.38 1.072 . . . . 0.0 112.109 -176.134 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.45 -164.11 10.87 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 124.32 2.067 . . . . 0.0 112.498 179.082 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -139.6 56.49 1.65 Allowed 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 110.902 -2.649 . . . . 0.0 108.084 -177.606 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.613 HD23 ' H ' ' A' ' 111' ' ' LEU . 1.4 pt? -88.59 -160.99 0.7 Allowed 'General case' 0 CA--C 1.547 0.864 0 CA-C-O 125.18 2.419 . . . . 0.0 107.591 -174.107 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.94 149.77 42.13 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 102.718 -3.068 . . . . 0.0 102.718 162.667 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.51 HG23 ' H ' ' A' ' 114' ' ' ASN 0.266 14.4 m -45.99 -69.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 110.451 -3.068 . . . . 0.0 111.999 172.673 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.51 ' H ' HG23 ' A' ' 113' ' ' VAL . 25.0 m-80 -20.35 74.64 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 119.27 3.063 . . . . 0.0 119.27 172.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.461 ' HB3' HG11 ' A' ' 148' ' ' VAL . 47.2 m-20 -151.97 117.93 5.5 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 102.831 -3.026 . . . . 0.0 102.831 -176.367 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.0 m -80.62 93.57 6.15 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.03 -0.986 . . . . 0.0 108.571 -176.517 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.466 HG12 HD11 ' A' ' 137' ' ' LEU . 7.2 tp -59.7 112.94 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 C-N-CA 123.569 0.748 . . . . 0.0 111.306 178.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.629 ' HA ' ' HB3' ' A' ' 126' ' ' ARG 0.431 0.0 OUTLIER -105.67 -39.81 5.96 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 115.933 1.827 . . . . 0.0 115.933 -174.306 . . . . . . . . 4 4 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -136.19 135.27 38.99 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 105.019 -2.215 . . . . 0.0 105.019 171.72 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.457 HG11 HD12 ' A' ' 137' ' ' LEU . 9.9 p -123.55 121.95 63.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 170.43 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.696 HD21 ' HB2' ' A' ' 140' ' ' ALA 0.261 3.8 m-80 77.17 -79.73 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 123.332 1.539 . . . . 0.0 108.93 -175.008 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.402 ' H ' ' H ' ' A' ' 123' ' ' VAL . 1.1 tt0 -165.25 -7.77 0.02 OUTLIER 'General case' 0 CA--C 1.576 1.978 0 C-N-CA 127.986 2.514 . . . . 0.0 110.78 -178.833 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.526 HG12 HG13 ' A' ' 125' ' ' VAL . 2.1 t -72.46 135.91 26.77 Favored 'Isoleucine or valine' 0 C--N 1.359 1.014 0 C-N-CA 125.443 1.497 . . . . 0.0 109.526 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -77.43 102.19 6.74 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 112.903 -1.953 . . . . 0.0 110.605 171.776 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.57 HG11 ' HA ' ' A' ' 133' ' ' ALA 0.261 2.2 m -109.78 -113.13 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-O 116.361 -1.781 . . . . 0.0 107.936 175.254 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.629 ' HB3' ' HA ' ' A' ' 118' ' ' LEU 0.328 0.0 OUTLIER 48.06 -82.72 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 117.753 2.501 . . . . 0.0 117.753 -176.12 . . . . . . . . 4 4 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.566 ' H ' ' HD3' ' A' ' 126' ' ' ARG . 2.9 tm-20 -88.35 70.4 9.09 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-O 123.696 1.712 . . . . 0.0 108.572 171.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.63 167.27 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 -178.689 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.451 HG23 ' HB2' ' A' ' 84' ' ' ASP . 11.6 m -58.45 132.42 53.66 Favored 'General case' 0 CA--C 1.555 1.146 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.206 159.358 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.484 ' HA ' HD12 ' A' ' 94' ' ' ILE . 2.7 p-80 -47.45 -34.16 6.97 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 117.37 2.359 . . . . 0.0 117.37 173.706 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.581 ' HA ' HG12 ' A' ' 134' ' ' VAL . 5.2 m -60.38 -40.5 91.06 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 174.925 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -67.24 -37.75 84.05 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 166.738 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.57 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -66.95 -55.86 12.7 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 173.663 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.606 HG23 HG22 ' B' ' 6' ' ' VAL . 8.6 p -47.09 -45.71 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 166.567 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.2 -54.15 49.27 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 115.765 -2.064 . . . . 0.0 111.72 174.862 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.97 -34.51 76.27 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 117.527 2.417 . . . . 0.0 117.527 174.074 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.466 HD11 HG12 ' A' ' 117' ' ' ILE . 6.0 mp -57.78 -55.34 36.09 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 125.636 1.575 . . . . 0.0 113.45 165.134 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -65.05 -33.77 76.84 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 115.898 1.814 . . . . 0.0 115.898 171.435 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -68.29 -23.64 64.77 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 117.135 2.272 . . . . 0.0 117.135 170.636 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.696 ' HB2' HD21 ' A' ' 121' ' ' ASN . . . -53.28 -28.46 28.03 Favored 'General case' 0 CA--C 1.56 1.362 0 N-CA-C 116.938 2.199 . . . . 0.0 116.938 156.046 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 91.09 -132.12 11.12 Favored Glycine 0 C--N 1.347 1.193 0 CA-C-O 122.53 1.072 . . . . 0.0 110.753 166.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 13.0 m -78.76 -2.06 37.68 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 169.152 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.05 103.8 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 -172.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.484 HG11 ' CD1' ' A' ' 75' ' ' LEU . 16.6 m -92.81 117.53 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 113.205 -1.816 . . . . 0.0 108.682 -178.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -89.57 94.22 9.78 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 169.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 82.1 mt -97.05 127.13 42.72 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 -173.521 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -126.12 120.01 29.05 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 102.963 -2.977 . . . . 0.0 102.963 177.178 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.461 HG11 ' HB3' ' A' ' 115' ' ' ASP . 16.8 m -124.65 132.89 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -173.346 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 57.5 ttm -100.27 112.38 24.7 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 119.759 1.163 . . . . 0.0 108.54 168.419 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -88.31 125.56 34.73 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 -178.541 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -56.59 -29.22 61.83 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 116.761 2.134 . . . . 0.0 116.761 169.581 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt 74.71 164.74 0.14 Allowed Pre-proline 0 CA--C 1.56 1.332 0 C-N-CA 124.326 1.05 . . . . 0.0 112.825 175.162 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -87.04 107.85 0.71 Allowed 'Trans proline' 0 CA--C 1.568 2.2 0 C-N-CA 123.161 2.574 . . . . 0.0 109.895 168.817 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo . . . . . 0 C--N 1.369 1.635 0 C-N-CA 123.233 2.622 . . . . 0.0 111.388 179.687 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.558 1.265 0 CA-C-O 122.585 1.184 . . . . 0.0 111.214 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -148.24 120.75 8.52 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 122.517 1.151 . . . . 0.0 108.874 173.402 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.476 ' HD2' ' HB3' ' A' ' 78' ' ' SER . 16.7 ttpp -92.1 124.78 36.45 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.42 174.784 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.569 HG21 HG21 ' A' ' 134' ' ' VAL . 3.1 m -87.25 143.04 27.46 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 122.174 0.988 . . . . 0.0 109.418 168.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.69 120.31 35.72 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 178.462 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.606 HG22 HG23 ' A' ' 134' ' ' VAL . 21.8 t . . . . . 0 N--CA 1.478 0.933 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 -160.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 121.802 0.811 . . . . 0.0 109.92 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -106.15 134.68 48.89 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.656 176.414 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -124.91 136.05 53.41 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -176.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.407 ' HB3' ' CE2' ' A' ' 147' ' ' TYR . 9.9 pt-20 -80.39 128.56 33.7 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 114.306 -1.316 . . . . 0.0 111.795 175.42 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 23.4 mt -129.57 118.12 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 -179.3 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.3 m -97.19 122.88 40.71 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 174.248 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.455 ' HB3' ' CG2' ' A' ' 144' ' ' VAL . 1.2 tt -119.85 161.45 20.79 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 113.098 -1.865 . . . . 0.0 106.7 174.902 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -83.09 142.16 31.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.425 -1.422 . . . . 0.0 108.912 173.622 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.449 ' HG2' ' HG ' ' A' ' 75' ' ' LEU . 4.2 tmt_? -79.86 82.27 5.98 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 120.001 -1.687 . . . . 0.0 109.153 168.098 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 31.07 -118.88 0.1 Allowed Glycine 0 N--CA 1.482 1.725 0 C-N-CA 125.911 1.72 . . . . 0.0 117.093 171.271 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.9 t30 -154.22 -67.47 0.14 Allowed 'General case' 0 CA--C 1.556 1.2 0 CA-C-N 112.976 -1.612 . . . . 0.0 107.294 170.307 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.3 m -83.64 -21.83 32.35 Favored 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 114.881 1.438 . . . . 0.0 114.881 168.938 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -138.8 -133.17 3.03 Favored Glycine 0 CA--C 1.535 1.307 0 N-CA-C 107.911 -2.076 . . . . 0.0 107.911 168.367 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.71 HD11 HG11 ' A' ' 144' ' ' VAL . 1.4 tt -121.46 -54.26 1.98 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.028 0.931 . . . . 0.0 109.643 179.702 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 118.02 22.83 3.76 Favored Glycine 0 N--CA 1.478 1.491 0 N-CA-C 118.017 1.967 . . . . 0.0 118.017 178.8 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -145.68 177.17 9.09 Favored 'General case' 0 CA--C 1.557 1.247 0 CA-C-O 123.749 1.738 . . . . 0.0 107.788 171.586 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.408 ' O ' HG23 ' A' ' 96' ' ' ILE . 1.8 m -134.91 145.13 47.92 Favored 'General case' 0 C--N 1.318 -0.804 0 O-C-N 119.909 -1.744 . . . . 0.0 107.559 -178.418 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.58 HG22 HG12 ' A' ' 96' ' ' ILE . 5.6 pt -112.22 137.0 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 114.695 -1.138 . . . . 0.0 112.006 -172.847 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.416 ' HB1' ' CB ' ' A' ' 87' ' ' HIS . . . -85.57 -174.3 5.1 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-O 123.976 1.846 . . . . 0.0 111.368 160.857 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.82 157.98 21.84 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 113.015 -1.902 . . . . 0.0 115.058 -145.78 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -104.69 -158.6 23.65 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 111.954 -2.123 . . . . 0.0 113.724 179.182 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.467 HG22 ' CB ' ' A' ' 92' ' ' PRO . 34.6 p -54.32 -38.24 65.76 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 116.872 2.175 . . . . 0.0 116.872 -178.0 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -83.25 -10.31 58.63 Favored 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 116.285 1.957 . . . . 0.0 116.285 174.406 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.15 92.29 2.35 Favored Pre-proline 0 CA--C 1.552 1.028 0 N-CA-C 101.095 -3.669 . . . . 0.0 101.095 -173.02 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -93.2 138.46 1.49 Allowed 'Trans proline' 0 CA--C 1.55 1.304 0 CA-C-N 124.879 2.778 . . . . 0.0 111.453 -176.405 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.416 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 28.3 t60 -100.72 -31.31 11.26 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 167.858 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.491 ' H ' HD12 ' A' ' 88' ' ' ILE . 0.2 OUTLIER -98.95 153.12 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 125.051 1.34 . . . . 0.0 109.974 -168.923 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -74.71 13.34 5.26 Favored Glycine 0 CA--C 1.549 2.167 0 N-CA-C 118.938 2.335 . . . . 0.0 118.938 176.572 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -92.7 -10.41 37.28 Favored 'General case' 0 CA--C 1.568 1.669 0 CA-C-O 117.178 -1.391 . . . . 0.0 114.403 162.321 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.466 ' HB3' ' HD3' ' A' ' 92' ' ' PRO 0.519 12.7 t70 88.28 -84.37 0.0 OUTLIER Pre-proline 0 CA--C 1.568 1.643 0 CA-C-O 115.85 -2.024 . . . . 0.0 109.616 -169.764 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.467 ' CB ' HG22 ' A' ' 83' ' ' THR . 84.6 Cg_endo -116.71 98.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.367 1.507 0 CA-C-N 125.458 2.985 . . . . 0.0 112.473 -164.827 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.4 m -158.19 125.22 4.95 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 -176.541 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.46 HG21 ' HB1' ' A' ' 133' ' ' ALA . 22.1 mm -78.4 123.24 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 178.517 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -116.67 154.67 30.15 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 112.684 -2.053 . . . . 0.0 107.969 177.717 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.58 HG12 HG22 ' A' ' 79' ' ' ILE 0.357 10.3 mt -95.39 123.79 47.7 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.076 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 161.001 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 49.6 m -74.3 -60.45 2.26 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.769 -1.207 . . . . 0.0 113.114 171.635 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.445 ' C ' HG11 ' A' ' 113' ' ' VAL . 14.0 ptmt -147.16 162.21 39.33 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 123.876 1.798 . . . . 0.0 111.48 -163.375 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.593 HG21 ' HA ' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -103.87 121.86 55.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 104.427 -2.434 . . . . 0.0 104.427 -175.157 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.259 1.6 mp -73.86 121.14 84.45 Favored Pre-proline 0 CA--C 1.567 1.623 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 173.353 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -61.02 138.1 76.25 Favored 'Trans proline' 0 C--N 1.365 1.425 0 C-N-CA 123.285 2.657 . . . . 0.0 113.701 172.581 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.32 0.58 83.79 Favored Glycine 0 CA--C 1.547 2.09 0 N-CA-C 118.153 2.021 . . . . 0.0 118.153 -170.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -89.96 -177.39 45.05 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-N 119.114 1.457 . . . . 0.0 112.978 174.444 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.37 -32.4 71.43 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 116.821 2.156 . . . . 0.0 116.821 176.631 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.8 -31.91 72.98 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 117.876 -1.059 . . . . 0.0 113.813 168.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.527 ' HA ' ' HB2' ' A' ' 110' ' ' ARG . . . -49.44 -43.47 44.79 Favored 'General case' 0 CA--C 1.559 1.319 0 N-CA-C 118.037 2.606 . . . . 0.0 118.037 164.68 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.8 -53.47 9.1 Favored 'General case' 0 CA--C 1.563 1.446 0 C-N-CA 124.466 1.106 . . . . 0.0 113.707 174.916 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -72.3 -52.13 17.64 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -174.16 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -166.94 92.51 0.1 Allowed Glycine 0 CA--C 1.529 0.907 0 N-CA-C 108.287 -1.925 . . . . 0.0 108.287 176.444 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.593 ' HA ' HG21 ' A' ' 99' ' ' ILE . 37.8 ttp180 -77.83 48.08 0.67 Allowed 'General case' 0 CA--C 1.573 1.851 0 N-CA-C 115.775 1.769 . . . . 0.0 115.775 179.548 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.96 -23.56 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 119.748 -1.845 . . . . 0.0 115.392 -159.62 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -96.8 3.88 52.04 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 117.956 2.576 . . . . 0.0 117.956 -167.221 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.506 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 2.5 m -38.01 -62.03 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.592 0 C-N-CA 127.048 2.139 . . . . 0.0 113.32 -169.371 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -54.52 79.5 0.0 OUTLIER 'General case' 0 CA--C 1.566 1.559 0 CA-C-O 124.464 2.078 . . . . 0.0 114.516 167.893 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -141.73 124.25 15.83 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 100.841 -3.763 . . . . 0.0 100.841 -177.376 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.1 m -75.18 85.2 2.39 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 114.198 -1.365 . . . . 0.0 109.54 -178.198 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.481 HG12 HD11 ' A' ' 137' ' ' LEU . 6.2 tp -65.63 115.64 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 CA-C-O 122.622 1.201 . . . . 0.0 109.602 179.755 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.487 ' HA ' ' HB3' ' A' ' 126' ' ' ARG . 3.1 pp -107.23 -45.12 4.18 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 112.233 -2.258 . . . . 0.0 115.206 179.769 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -130.9 134.78 47.08 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 -179.119 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.48 HG23 HD23 ' A' ' 146' ' ' LEU . 7.4 p -125.62 119.43 54.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 173.248 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.543 HD21 ' HB2' ' A' ' 140' ' ' ALA 0.279 10.5 m-80 76.26 -88.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -174.312 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -148.05 -6.96 0.43 Allowed 'General case' 0 CA--C 1.576 1.953 0 C-N-CA 128.225 2.61 . . . . 0.0 110.71 177.027 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.3 t -69.81 136.5 26.02 Favored 'Isoleucine or valine' 0 C--N 1.359 1.011 0 C-N-CA 125.463 1.505 . . . . 0.0 109.728 178.502 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -89.61 102.21 14.89 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 113.355 -1.748 . . . . 0.0 108.544 175.03 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.524 HG11 ' HA ' ' A' ' 133' ' ' ALA 0.258 0.9 OUTLIER -99.71 -97.97 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-O 116.225 -1.845 . . . . 0.0 107.73 173.424 . . . . . . . . 4 4 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.487 ' HB3' ' HA ' ' A' ' 118' ' ' LEU 0.301 0.4 OUTLIER 46.7 -87.3 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 117.284 2.328 . . . . 0.0 117.284 179.984 . . . . . . . . 4 4 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -85.26 76.11 10.2 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-O 123.408 1.575 . . . . 0.0 108.763 170.232 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.0 p -146.09 168.87 6.57 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 CA-C-N 113.166 -1.834 . . . . 0.0 106.316 -179.784 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.487 HG22 ' H ' ' A' ' 131' ' ' SER . 33.1 m -62.1 137.28 58.23 Favored 'General case' 0 CA--C 1.562 1.407 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.326 158.051 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 10.2 p-80 -46.62 -33.21 4.0 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 117.552 2.427 . . . . 0.0 117.552 168.456 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.487 ' H ' HG22 ' A' ' 129' ' ' THR . 10.9 m -61.02 -41.23 96.16 Favored 'General case' 0 CA--C 1.555 1.159 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 175.109 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -69.0 -35.65 76.94 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 166.851 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.524 ' HA ' HG11 ' A' ' 125' ' ' VAL . . . -67.2 -53.88 26.2 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 172.634 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.538 ' HB ' HD11 ' A' ' 79' ' ' ILE . 2.5 p -49.26 -42.86 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 165.827 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -60.15 -55.61 31.69 Favored 'General case' 0 C--N 1.353 0.751 0 CA-C-O 115.799 -2.048 . . . . 0.0 113.24 173.682 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -65.63 -28.31 69.02 Favored 'General case' 0 CA--C 1.564 1.493 0 N-CA-C 117.09 2.255 . . . . 0.0 117.09 175.419 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.481 HD11 HG12 ' A' ' 117' ' ' ILE . 9.8 mp -62.96 -53.93 46.29 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 125.242 1.417 . . . . 0.0 113.876 167.326 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -66.79 -32.73 74.21 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 167.597 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -70.24 -11.5 60.95 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 117.481 2.4 . . . . 0.0 117.481 171.363 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.543 ' HB2' HD21 ' A' ' 121' ' ' ASN . . . -59.13 -1.24 0.17 Allowed 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 118.82 2.896 . . . . 0.0 118.82 163.663 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 93.45 -127.08 8.88 Favored Glycine 0 C--N 1.344 0.989 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 171.395 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.5 m -93.81 -0.5 55.8 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 169.011 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -150.6 111.03 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 -166.188 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.71 HG11 HD11 ' A' ' 75' ' ' LEU . 34.2 m -90.13 121.04 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 114.528 -1.214 . . . . 0.0 109.119 -179.408 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -103.98 88.24 2.97 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 178.653 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.48 HD23 HG23 ' A' ' 120' ' ' VAL . 77.4 mt -89.58 142.22 27.87 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.393 -172.279 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.407 ' CE2' ' HB3' ' A' ' 65' ' ' GLU . 38.4 m-85 -123.69 124.02 41.82 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 103.906 -2.627 . . . . 0.0 103.906 168.748 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 20.0 m -132.49 131.77 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -169.854 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.419 ' HB2' ' CD2' ' A' ' 118' ' ' LEU . 58.1 ttm -95.7 135.62 37.16 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 123.205 1.479 . . . . 0.0 110.791 177.069 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -102.01 138.61 38.74 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 113.37 -1.741 . . . . 0.0 108.742 161.088 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 62.68 70.04 0.57 Allowed 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.353 0.661 . . . . 0.0 110.903 175.647 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -76.26 115.92 51.43 Favored Pre-proline 0 CA--C 1.56 1.347 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -174.28 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -77.29 132.01 12.18 Favored 'Trans proline' 0 CA--C 1.563 1.955 0 C-N-CA 122.623 2.215 . . . . 0.0 111.881 -176.046 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo . . . . . 0 CA--C 1.553 1.437 0 C-N-CA 123.144 2.562 . . . . 0.0 113.588 169.959 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.558 1.271 0 CA-C-O 122.286 1.041 . . . . 0.0 110.19 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -140.84 124.34 16.83 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 122.986 1.374 . . . . 0.0 108.344 168.144 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.53 129.03 34.96 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 114.175 -1.375 . . . . 0.0 109.646 176.022 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 85.8 m -101.86 132.58 47.55 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.839 175.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -75.28 147.98 39.77 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 122.653 1.216 . . . . 0.0 110.666 174.021 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.41 ' O ' ' HB3' ' A' ' 75' ' ' LEU . 2.6 p . . . . . 0 C--O 1.247 0.927 0 N-CA-C 103.876 -2.638 . . . . 0.0 103.876 -178.895 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 7' ' ' BAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_